,0,1
0,NAME.FIB,SIZE_FIB
1,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,c2.CGP_ chemical and genetic perturbations
2,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP,C7_ immunologic signatures
3,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP,C7_ immunologic signatures
4,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR,c2.CGP_ chemical and genetic perturbations
5,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP,C7_ immunologic signatures
6,WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,c2.CGP_ chemical and genetic perturbations
7,KONG_E2F3_TARGETS,c2.CGP_ chemical and genetic perturbations
8,LEE_EARLY_T_LYMPHOCYTE_UP,c2.CGP_ chemical and genetic perturbations
9,GNF2_CENPF,c4.CGN_ cancer gene neighborhoods
10,FISCHER_G2_M_CELL_CYCLE,c2.CGP_ chemical and genetic perturbations
11,GNF2_CDC20,c4.CGN_ cancer gene neighborhoods
12,GNF2_CDC2,c4.CGN_ cancer gene neighborhoods
13,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR,c2.CGP_ chemical and genetic perturbations
14,GNF2_CCNA2,c4.CGN_ cancer gene neighborhoods
15,ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER,c2.CGP_ chemical and genetic perturbations
16,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,c2.CGP_ chemical and genetic perturbations
17,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN,c2.CGP_ chemical and genetic perturbations
18,ZHANG_TLX_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
19,GNF2_CCNB2,c4.CGN_ cancer gene neighborhoods
20,GNF2_PCNA,c4.CGN_ cancer gene neighborhoods
21,GNF2_HMMR,c4.CGN_ cancer gene neighborhoods
22,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP,C7_ immunologic signatures
23,ZHAN_MULTIPLE_MYELOMA_PR_UP,c2.CGP_ chemical and genetic perturbations
24,ISHIDA_E2F_TARGETS,c2.CGP_ chemical and genetic perturbations
25,GNF2_CENPE,c4.CGN_ cancer gene neighborhoods
26,GO_MITOTIC_SISTER_CHROMATID_SEGREGATION,c5.BP_ GO biological process
27,GSE14415_NATURAL_TREG_VS_TCONV_DN,C7_ immunologic signatures
28,REICHERT_MITOSIS_LIN9_TARGETS,c2.CGP_ chemical and genetic perturbations
29,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP,C7_ immunologic signatures
30,ODONNELL_TFRC_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
31,CHANG_CYCLING_GENES,c2.CGP_ chemical and genetic perturbations
32,GO_NUCLEAR_CHROMOSOME_SEGREGATION,c5.BP_ GO biological process
33,NABA_ECM_GLYCOPROTEINS,c2.CP_ Canonical pathways
34,GNF2_ESPL1,c4.CGN_ cancer gene neighborhoods
35,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP,c2.CGP_ chemical and genetic perturbations
36,KANG_DOXORUBICIN_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
37,GO_SISTER_CHROMATID_SEGREGATION,c5.BP_ GO biological process
38,GO_CHROMOSOME_SEGREGATION,c5.BP_ GO biological process
39,WHITFIELD_CELL_CYCLE_LITERATURE,c2.CGP_ chemical and genetic perturbations
40,GNF2_RRM2,c4.CGN_ cancer gene neighborhoods
41,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP,C7_ immunologic signatures
42,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN,C7_ immunologic signatures
43,GNF2_MKI67,c4.CGN_ cancer gene neighborhoods
44,TANG_SENESCENCE_TP53_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
45,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP,C7_ immunologic signatures
46,NABA_CORE_MATRISOME,c2.CP_ Canonical pathways
47,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP,C7_ immunologic signatures
48,GNF2_RRM1,c4.CGN_ cancer gene neighborhoods
49,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP,C7_ immunologic signatures
50,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,c2.CGP_ chemical and genetic perturbations
51,BURTON_ADIPOGENESIS_3,c2.CGP_ chemical and genetic perturbations
52,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,c2.CGP_ chemical and genetic perturbations
53,PYEON_HPV_POSITIVE_TUMORS_UP,c2.CGP_ chemical and genetic perturbations
54,GO_EXTRACELLULAR_MATRIX,c5.CC_ GO cellular component
55,GNF2_BUB1,c4.CGN_ cancer gene neighborhoods
56,GO_CHROMOSOME_CENTROMERIC_REGION,c5.CC_ GO cellular component
57,GO_CONDENSED_CHROMOSOME_CENTROMERIC_REGION,c5.CC_ GO cellular component
58,AMUNDSON_GAMMA_RADIATION_RESPONSE,c2.CGP_ chemical and genetic perturbations
59,VERNELL_RETINOBLASTOMA_PATHWAY_UP,c2.CGP_ chemical and genetic perturbations
60,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
61,CROONQUIST_IL6_DEPRIVATION_DN,c2.CGP_ chemical and genetic perturbations
62,ZHANG_TLX_TARGETS_36HR_DN,c2.CGP_ chemical and genetic perturbations
63,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
64,GO_EXTRACELLULAR_MATRIX_COMPONENT,c5.CC_ GO cellular component
65,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP,c2.CGP_ chemical and genetic perturbations
66,WHITFIELD_CELL_CYCLE_G2,c2.CGP_ chemical and genetic perturbations
67,MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,c2.CGP_ chemical and genetic perturbations
68,GO_MITOTIC_NUCLEAR_DIVISION,c5.BP_ GO biological process
69,GO_CONDENSED_CHROMOSOME,c5.CC_ GO cellular component
70,GNF2_SMC4L1,c4.CGN_ cancer gene neighborhoods
71,GILDEA_METASTASIS,c2.CGP_ chemical and genetic perturbations
72,ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,c2.CGP_ chemical and genetic perturbations
73,GO_PROTEINACEOUS_EXTRACELLULAR_MATRIX,c5.CC_ GO cellular component
74,GO_KINETOCHORE,c5.CC_ GO cellular component
75,RICKMAN_HEAD_AND_NECK_CANCER_F,c2.CGP_ chemical and genetic perturbations
76,RB_P107_DN.V1_UP,C6_ oncogenic signatures
77,GNF2_TTK,c4.CGN_ cancer gene neighborhoods
78,MORI_IMMATURE_B_LYMPHOCYTE_DN,c2.CGP_ chemical and genetic perturbations
79,GO_SPINDLE_POLE,c5.CC_ GO cellular component
80,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP,C7_ immunologic signatures
81,GNF2_SMC2L1,c4.CGN_ cancer gene neighborhoods
82,GO_ORGANELLE_FISSION,c5.BP_ GO biological process
83,BURTON_ADIPOGENESIS_PEAK_AT_24HR,c2.CGP_ chemical and genetic perturbations
84,GNF2_H2AFX,c4.CGN_ cancer gene neighborhoods
85,GNF2_BUB1B,c4.CGN_ cancer gene neighborhoods
86,GREENBAUM_E2A_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
87,GO_CHROMOSOME_CONDENSATION,c5.BP_ GO biological process
88,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN,C7_ immunologic signatures
89,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP,C7_ immunologic signatures
90,GO_CENTROSOME_CYCLE,c5.BP_ GO biological process
91,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,c2.CGP_ chemical and genetic perturbations
92,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN,C7_ immunologic signatures
93,GO_STRAND_DISPLACEMENT,c5.BP_ GO biological process
94,WHITEFORD_PEDIATRIC_CANCER_MARKERS,c2.CGP_ chemical and genetic perturbations
95,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN,C7_ immunologic signatures
96,GO_SISTER_CHROMATID_COHESION,c5.BP_ GO biological process
97,KOBAYASHI_EGFR_SIGNALING_24HR_DN,c2.CGP_ chemical and genetic perturbations
98,CROONQUIST_NRAS_SIGNALING_DN,c2.CGP_ chemical and genetic perturbations
99,LINDVALL_IMMORTALIZED_BY_TERT_DN,c2.CGP_ chemical and genetic perturbations
100,BROWNE_HCMV_INFECTION_2HR_UP,c2.CGP_ chemical and genetic perturbations
101,GNF2_MCM4,c4.CGN_ cancer gene neighborhoods
102,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN,C7_ immunologic signatures
103,GO_POSITIVE_REGULATION_OF_CYTOKINESIS,c5.BP_ GO biological process
104,GO_CHROMOSOME_LOCALIZATION,c5.BP_ GO biological process
105,GO_REGULATION_OF_MICROTUBULE_BASED_PROCESS,c5.BP_ GO biological process
106,GSE45365_WT_VS_IFNAR_KO_BCELL_DN,C7_ immunologic signatures
107,MODULE_54,c4.CM_ cancer modules
108,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,c2.CGP_ chemical and genetic perturbations
109,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
110,GO_MITOTIC_SPINDLE_ORGANIZATION,c5.BP_ GO biological process
111,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP,C7_ immunologic signatures
112,FARMER_BREAST_CANCER_CLUSTER_2,c2.CGP_ chemical and genetic perturbations
113,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,c2.CGP_ chemical and genetic perturbations
114,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN,C7_ immunologic signatures
115,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,c2.CGP_ chemical and genetic perturbations
116,RUIZ_TNC_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
117,GO_POSITIVE_REGULATION_OF_CELL_DIVISION,c5.BP_ GO biological process
118,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,H_ hallmark gene sets
119,GO_CENTROMERE_COMPLEX_ASSEMBLY,c5.BP_ GO biological process
120,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN,C7_ immunologic signatures
121,GO_REGULATION_OF_CHROMOSOME_SEGREGATION,c5.BP_ GO biological process
122,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,c2.CGP_ chemical and genetic perturbations
123,GNF2_CKS2,c4.CGN_ cancer gene neighborhoods
124,GO_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR,c5.BP_ GO biological process
125,GO_POSITIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,c5.BP_ GO biological process
126,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN,C7_ immunologic signatures
127,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,c2.CGP_ chemical and genetic perturbations
128,KATSANOU_ELAVL1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
129,GO_CONDENSED_NUCLEAR_CHROMOSOME,c5.CC_ GO cellular component
130,REACTOME_MITOTIC_PROMETAPHASE,c2.CP_REACTOME_ Reactome gene sets
131,EGUCHI_CELL_CYCLE_RB1_TARGETS,c2.CGP_ chemical and genetic perturbations
132,HALLMARK_G2M_CHECKPOINT,H_ hallmark gene sets
133,GO_REGULATION_OF_CYTOKINESIS,c5.BP_ GO biological process
134,ZHANG_TLX_TARGETS_60HR_DN,c2.CGP_ chemical and genetic perturbations
135,GAVIN_FOXP3_TARGETS_CLUSTER_P6,c2.CGP_ chemical and genetic perturbations
136,VANTVEER_BREAST_CANCER_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
137,ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN,c2.CGP_ chemical and genetic perturbations
138,GO_MEIOTIC_CELL_CYCLE_PROCESS,c5.BP_ GO biological process
139,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN,C7_ immunologic signatures
140,REN_BOUND_BY_E2F,c2.CGP_ chemical and genetic perturbations
141,SCIBETTA_KDM5B_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
142,REACTOME_MUSCLE_CONTRACTION,c2.CP_REACTOME_ Reactome gene sets
143,GO_PROSTATE_GLAND_MORPHOGENESIS,c5.BP_ GO biological process
144,GO_SPINDLE,c5.CC_ GO cellular component
145,SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,c2.CGP_ chemical and genetic perturbations
146,HALLMARK_E2F_TARGETS,H_ hallmark gene sets
147,AFFAR_YY1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
148,GO_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE,c5.BP_ GO biological process
149,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,c2.CGP_ chemical and genetic perturbations
150,GO_POSITIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
151,PID_FANCONI_PATHWAY,c2.CP_ Canonical pathways
152,GO_BASEMENT_MEMBRANE,c5.CC_ GO cellular component
153,KAMMINGA_EZH2_TARGETS,c2.CGP_ chemical and genetic perturbations
154,FURUKAWA_DUSP6_TARGETS_PCI35_DN,c2.CGP_ chemical and genetic perturbations
155,GNF2_FEN1,c4.CGN_ cancer gene neighborhoods
156,MODULE_403,c4.CM_ cancer modules
157,GO_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT,c5.GO molecular function
158,GO_REGULATION_OF_CELL_DIVISION,c5.BP_ GO biological process
159,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN,c2.CGP_ chemical and genetic perturbations
160,GO_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,c5.BP_ GO biological process
161,GO_METAPHASE_PLATE_CONGRESSION,c5.BP_ GO biological process
162,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN,C7_ immunologic signatures
163,GSE14415_INDUCED_VS_NATURAL_TREG_DN,C7_ immunologic signatures
164,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_DN,C7_ immunologic signatures
165,TSAI_RESPONSE_TO_RADIATION_THERAPY,c2.CGP_ chemical and genetic perturbations
166,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN,C7_ immunologic signatures
167,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,c2.CGP_ chemical and genetic perturbations
168,REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION,c2.CP_REACTOME_ Reactome gene sets
169,GO_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,c5.BP_ GO biological process
170,GO_STRUCTURAL_CONSTITUENT_OF_MUSCLE,c5.GO molecular function
171,GO_MEIOTIC_CHROMOSOME_SEGREGATION,c5.BP_ GO biological process
172,GO_MEIOTIC_CELL_CYCLE,c5.BP_ GO biological process
173,GO_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY,c5.BP_ GO biological process
174,PUJANA_XPRSS_INT_NETWORK,c2.CGP_ chemical and genetic perturbations
175,GO_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
176,GO_OOCYTE_MATURATION,c5.BP_ GO biological process
177,FISCHER_G1_S_CELL_CYCLE,c2.CGP_ chemical and genetic perturbations
178,FINETTI_BREAST_CANCER_KINOME_RED,c2.CGP_ chemical and genetic perturbations
179,GO_BASAL_LAMINA,c5.CC_ GO cellular component
180,GO_OOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
181,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,c2.CGP_ chemical and genetic perturbations
182,REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2,c2.CP_REACTOME_ Reactome gene sets
183,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN,C7_ immunologic signatures
184,KAUFFMANN_MELANOMA_RELAPSE_UP,c2.CGP_ chemical and genetic perturbations
185,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,c2.CGP_ chemical and genetic perturbations
186,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN,c2.CGP_ chemical and genetic perturbations
187,GO_CHROMOSOMAL_REGION,c5.CC_ GO cellular component
188,LIU_PROSTATE_CANCER_DN,c2.CGP_ chemical and genetic perturbations
189,BASAKI_YBX1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
190,GO_HEPARIN_BINDING,c5.GO molecular function
191,GO_CELL_DIVISION,c5.BP_ GO biological process
192,REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION,c2.CP_REACTOME_ Reactome gene sets
193,GO_AMINOGLYCAN_CATABOLIC_PROCESS,c5.BP_ GO biological process
194,FARMER_BREAST_CANCER_CLUSTER_4,c2.CGP_ chemical and genetic perturbations
195,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,c2.CGP_ chemical and genetic perturbations
196,PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP,c2.CGP_ chemical and genetic perturbations
197,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,c2.CGP_ chemical and genetic perturbations
198,CORDENONSI_YAP_CONSERVED_SIGNATURE,C6_ oncogenic signatures
199,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,c2.CGP_ chemical and genetic perturbations
200,GO_REGULATION_OF_CENTROSOME_CYCLE,c5.BP_ GO biological process
201,GO_MEIOSIS_I,c5.BP_ GO biological process
202,WANG_SMARCE1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
203,LI_WILMS_TUMOR_ANAPLASTIC_UP,c2.CGP_ chemical and genetic perturbations
204,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,c2.CGP_ chemical and genetic perturbations
205,GO_NEGATIVE_REGULATION_OF_CELL_DIVISION,c5.BP_ GO biological process
206,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,c2.CGP_ chemical and genetic perturbations
207,GO_OOGENESIS,c5.BP_ GO biological process
208,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP,C7_ immunologic signatures
209,GO_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE,c5.BP_ GO biological process
210,MODULE_47,c4.CM_ cancer modules
211,PETROVA_PROX1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
212,GO_CELL_CYCLE_PHASE_TRANSITION,c5.BP_ GO biological process
213,GO_CARDIAC_CELL_DEVELOPMENT,c5.BP_ GO biological process
214,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN,C7_ immunologic signatures
215,GO_HOMOLOGOUS_CHROMOSOME_SEGREGATION,c5.BP_ GO biological process
216,GNF2_RFC3,c4.CGN_ cancer gene neighborhoods
217,PID_PLK1_PATHWAY,c2.CP_ Canonical pathways
218,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP,C7_ immunologic signatures
219,REACTOME_SMOOTH_MUSCLE_CONTRACTION,c2.CP_REACTOME_ Reactome gene sets
220,YANG_BCL3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
221,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN,C7_ immunologic signatures
222,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP,C7_ immunologic signatures
223,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,c2.CGP_ chemical and genetic perturbations
224,GSE14000_UNSTIM_VS_4H_LPS_DC_DN,C7_ immunologic signatures
225,GSE14415_INDUCED_TREG_VS_TCONV_UP,C7_ immunologic signatures
226,PID_E2F_PATHWAY,c2.CP_ Canonical pathways
227,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN,C7_ immunologic signatures
228,DELPUECH_FOXO3_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
229,SHEPARD_BMYB_TARGETS,c2.CGP_ chemical and genetic perturbations
230,RHODES_UNDIFFERENTIATED_CANCER,c2.CGP_ chemical and genetic perturbations
231,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
232,GSE42021_TREG_VS_TCONV_PLN_UP,C7_ immunologic signatures
233,GSE2706_UNSTIM_VS_8H_R848_DC_DN,C7_ immunologic signatures
234,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP,C7_ immunologic signatures
235,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,c2.CGP_ chemical and genetic perturbations
236,GSE2706_R848_VS_LPS_2H_STIM_DC_DN,C7_ immunologic signatures
237,GO_SPINDLE_MICROTUBULE,c5.CC_ GO cellular component
238,KEGG_OTHER_GLYCAN_DEGRADATION,c2.CP_BIOCARTA_ BioCarta gene sets
239,HU_GENOTOXIC_DAMAGE_4HR,c2.CGP_ chemical and genetic perturbations
240,REACTOME_G0_AND_EARLY_G1,c2.CP_REACTOME_ Reactome gene sets
241,WINNEPENNINCKX_MELANOMA_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
242,THUM_MIR21_TARGETS_HEART_DISEASE_UP,c2.CGP_ chemical and genetic perturbations
243,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,C7_ immunologic signatures
244,GO_GLYCOSAMINOGLYCAN_BINDING,c5.GO molecular function
245,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
246,GNF2_CKS1B,c4.CGN_ cancer gene neighborhoods
247,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,c2.CGP_ chemical and genetic perturbations
248,GO_MALE_MEIOSIS,c5.BP_ GO biological process
249,MODULE_122,c4.CM_ cancer modules
250,GO_REGULATION_OF_SISTER_CHROMATID_SEGREGATION,c5.BP_ GO biological process
251,MODULE_481,c4.CM_ cancer modules
252,CHICAS_RB1_TARGETS_GROWING,c2.CGP_ chemical and genetic perturbations
253,MARKEY_RB1_ACUTE_LOF_UP,c2.CGP_ chemical and genetic perturbations
254,GO_DETECTION_OF_MECHANICAL_STIMULUS,c5.BP_ GO biological process
255,GO_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,c5.BP_ GO biological process
256,FUJII_YBX1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
257,SHEPARD_CRUSH_AND_BURN_MUTANT_DN,c2.CGP_ chemical and genetic perturbations
258,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,c2.CGP_ chemical and genetic perturbations
259,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,c2.CGP_ chemical and genetic perturbations
260,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN,c2.CGP_ chemical and genetic perturbations
261,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,C7_ immunologic signatures
262,HALLMARK_MITOTIC_SPINDLE,H_ hallmark gene sets
263,HALLMARK_MYOGENESIS,H_ hallmark gene sets
264,GSE7852_LN_VS_THYMUS_TCONV_DN,C7_ immunologic signatures
265,MODULE_320,c4.CM_ cancer modules
266,GO_LYSOSOMAL_LUMEN,c5.CC_ GO cellular component
267,PRC2_EZH2_UP.V1_DN,C6_ oncogenic signatures
268,YU_MYC_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
269,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,c2.CGP_ chemical and genetic perturbations
270,WHITFIELD_CELL_CYCLE_S,c2.CGP_ chemical and genetic perturbations
271,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN,C7_ immunologic signatures
272,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15,c2.CGP_ chemical and genetic perturbations
273,VILLANUEVA_LIVER_CANCER_KRT19_UP,c2.CGP_ chemical and genetic perturbations
274,BIOCARTA_INTRINSIC_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
275,LE_EGR2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
276,REACTOME_SHC_MEDIATED_CASCADE,c2.CP_REACTOME_ Reactome gene sets
277,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,c2.CGP_ chemical and genetic perturbations
278,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,c2.CGP_ chemical and genetic perturbations
279,GO_CELL_CYCLE_CHECKPOINT,c5.BP_ GO biological process
280,KEGG_CELL_CYCLE,c2.CP_BIOCARTA_ BioCarta gene sets
281,WANG_LSD1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
282,GO_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,c5.BP_ GO biological process
283,MACAEVA_PBMC_RESPONSE_TO_IR,c2.CGP_ chemical and genetic perturbations
284,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN,C7_ immunologic signatures
285,CUI_TCF21_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
286,OLSSON_E2F3_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
287,GO_CELLULAR_RESPONSE_TO_VITAMIN,c5.BP_ GO biological process
288,MISSIAGLIA_REGULATED_BY_METHYLATION_DN,c2.CGP_ chemical and genetic perturbations
289,REACTOME_G1_S_SPECIFIC_TRANSCRIPTION,c2.CP_REACTOME_ Reactome gene sets
290,GO_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
291,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
292,GO_NEGATIVE_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY,c5.BP_ GO biological process
293,MODULE_125,c4.CM_ cancer modules
294,GO_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS,c5.BP_ GO biological process
295,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,C7_ immunologic signatures
296,GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,c5.BP_ GO biological process
297,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN,C7_ immunologic signatures
298,ONGUSAHA_TP53_TARGETS,c2.CGP_ chemical and genetic perturbations
299,GO_CELL_CYCLE_G1_S_PHASE_TRANSITION,c5.BP_ GO biological process
300,WHITFIELD_CELL_CYCLE_G2_M,c2.CGP_ chemical and genetic perturbations
301,GSE13411_NAIVE_VS_MEMORY_BCELL_UP,C7_ immunologic signatures
302,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,C7_ immunologic signatures
303,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,C7_ immunologic signatures
304,FOURNIER_ACINAR_DEVELOPMENT_LATE_DN,c2.CGP_ chemical and genetic perturbations
305,MODULE_544,c4.CM_ cancer modules
306,GO_MICROTUBULE_MOTOR_ACTIVITY,c5.GO molecular function
307,GO_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,c5.BP_ GO biological process
308,REACTOME_AMINE_LIGAND_BINDING_RECEPTORS,c2.CP_REACTOME_ Reactome gene sets
309,GO_MESODERMAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
310,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP,C7_ immunologic signatures
311,GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,c5.BP_ GO biological process
312,INGRAM_SHH_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
313,GO_MITOTIC_CELL_CYCLE_CHECKPOINT,c5.BP_ GO biological process
314,GO_REGULATION_OF_MUSCLE_SYSTEM_PROCESS,c5.BP_ GO biological process
315,GO_MICROTUBULE_ORGANIZING_CENTER_ORGANIZATION,c5.BP_ GO biological process
316,GO_DEVELOPMENTAL_CELL_GROWTH,c5.BP_ GO biological process
317,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,c2.CGP_ chemical and genetic perturbations
318,BIOCARTA_G2_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
319,GO_SMOOTH_MUSCLE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
320,BENPORATH_PROLIFERATION,c2.CGP_ chemical and genetic perturbations
321,GO_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY,c5.GO molecular function
322,ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN,c2.CGP_ chemical and genetic perturbations
323,REACTOME_HS_GAG_DEGRADATION,c2.CP_REACTOME_ Reactome gene sets
324,GO_RESPONSE_TO_TYPE_I_INTERFERON,c5.BP_ GO biological process
325,GNF2_RFC4,c4.CGN_ cancer gene neighborhoods
326,PTEN_DN.V1_UP,C6_ oncogenic signatures
327,KANG_GIST_WITH_PDGFRA_UP,c2.CGP_ chemical and genetic perturbations
328,GO_DOPAMINERGIC_NEURON_DIFFERENTIATION,c5.BP_ GO biological process
329,REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,c2.CP_REACTOME_ Reactome gene sets
330,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,c2.CGP_ chemical and genetic perturbations
331,GO_CENTROSOME_DUPLICATION,c5.BP_ GO biological process
332,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN,C7_ immunologic signatures
333,GO_PROTEOGLYCAN_BINDING,c5.GO molecular function
334,CHR14Q22,43
335,MODULE_158,c4.CM_ cancer modules
336,KRASNOSELSKAYA_ILF3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
337,VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,c2.CGP_ chemical and genetic perturbations
338,GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS,c5.BP_ GO biological process
339,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP,C7_ immunologic signatures
340,ZHANG_TLX_TARGETS_60HR_UP,c2.CGP_ chemical and genetic perturbations
341,REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE,c2.CP_REACTOME_ Reactome gene sets
342,CHANDRAN_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
343,KEGG_P53_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
344,GO_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,c5.BP_ GO biological process
345,GO_CELL_CYCLE_G2_M_PHASE_TRANSITION,c5.BP_ GO biological process
346,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN,C7_ immunologic signatures
347,ZHU_SKIL_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
348,GO_MICROTUBULE,c5.CC_ GO cellular component
349,BROWNE_INTERFERON_RESPONSIVE_GENES,c2.CGP_ chemical and genetic perturbations
350,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,C7_ immunologic signatures
351,GO_VASODILATION,c5.BP_ GO biological process
352,REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS,c2.CP_REACTOME_ Reactome gene sets
353,GO_NEUROMUSCULAR_JUNCTION,c5.CC_ GO cellular component
354,GO_ENDOCHONDRAL_BONE_MORPHOGENESIS,c5.BP_ GO biological process
355,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP,C7_ immunologic signatures
356,GO_REGULATION_OF_MUSCLE_HYPERTROPHY,c5.BP_ GO biological process
357,MORI_PRE_BI_LYMPHOCYTE_UP,c2.CGP_ chemical and genetic perturbations
358,GO_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
359,GO_KINESIN_COMPLEX,c5.CC_ GO cellular component
360,GO_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE,c5.BP_ GO biological process
361,GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,c5.BP_ GO biological process
362,GO_MICROTUBULE_CYTOSKELETON_ORGANIZATION,c5.BP_ GO biological process
363,SCHRAETS_MLL_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
364,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP,C7_ immunologic signatures
365,GO_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION,c5.BP_ GO biological process
366,GO_G2_DNA_DAMAGE_CHECKPOINT,c5.BP_ GO biological process
367,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN,C7_ immunologic signatures
368,BRACHAT_RESPONSE_TO_CISPLATIN,c2.CGP_ chemical and genetic perturbations
369,GO_DOUBLE_STRAND_BREAK_REPAIR,c5.BP_ GO biological process
370,GO_REGULATION_OF_NUCLEAR_DIVISION,c5.BP_ GO biological process
371,MODULE_315,c4.CM_ cancer modules
372,GO_REGULATION_OF_HEART_RATE,c5.BP_ GO biological process
373,REACTOME_FRS2_MEDIATED_CASCADE,c2.CP_REACTOME_ Reactome gene sets
374,BOQUEST_STEM_CELL_UP,c2.CGP_ chemical and genetic perturbations
375,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN,C7_ immunologic signatures
376,GO_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,c5.BP_ GO biological process
377,GO_POSITIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,c5.BP_ GO biological process
378,REACTOME_CELL_CYCLE_MITOTIC,c2.CP_REACTOME_ Reactome gene sets
379,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP,C7_ immunologic signatures
380,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_UP,C7_ immunologic signatures
381,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,c2.CGP_ chemical and genetic perturbations
382,MORF_BUB1,c4.CGN_ cancer gene neighborhoods
383,WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP,c2.CGP_ chemical and genetic perturbations
384,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN,c2.CGP_ chemical and genetic perturbations
385,GO_RESPONSE_TO_MUSCLE_STRETCH,c5.BP_ GO biological process
386,GO_SPINDLE_CHECKPOINT,c5.BP_ GO biological process
387,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN,C7_ immunologic signatures
388,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN,C7_ immunologic signatures
389,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP,C7_ immunologic signatures
390,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,C7_ immunologic signatures
391,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,c2.CGP_ chemical and genetic perturbations
392,GO_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,c5.BP_ GO biological process
393,GO_POSITIVE_REGULATION_OF_CELL_CYCLE,c5.BP_ GO biological process
394,PID_AURORA_B_PATHWAY,c2.CP_ Canonical pathways
395,GO_DNA_REPLICATION_INDEPENDENT_NUCLEOSOME_ORGANIZATION,c5.BP_ GO biological process
396,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,c2.CGP_ chemical and genetic perturbations
397,SANA_RESPONSE_TO_IFNG_UP,c2.CGP_ chemical and genetic perturbations
398,KEGG_TGF_BETA_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
399,MODULE_234,c4.CM_ cancer modules
400,MODULE_57,c4.CM_ cancer modules
401,GSE22045_TREG_VS_TCONV_UP,C7_ immunologic signatures
402,GO_MICROTUBULE_BINDING,c5.GO molecular function
403,MODULE_1,c4.CM_ cancer modules
404,SWEET_LUNG_CANCER_KRAS_DN,c2.CGP_ chemical and genetic perturbations
405,CHR11Q23,96
406,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,C7_ immunologic signatures
407,GO_NEGATIVE_REGULATION_OF_NUCLEAR_DIVISION,c5.BP_ GO biological process
408,MODULE_451,c4.CM_ cancer modules
409,GO_RECOMBINATIONAL_REPAIR,c5.BP_ GO biological process
410,GO_MITOTIC_DNA_INTEGRITY_CHECKPOINT,c5.BP_ GO biological process
411,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN,C7_ immunologic signatures
412,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN,C7_ immunologic signatures
413,GO_DNA_INTEGRITY_CHECKPOINT,c5.BP_ GO biological process
414,KRASNOSELSKAYA_ILF3_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
415,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN,C7_ immunologic signatures
416,SNF5_DN.V1_UP,C6_ oncogenic signatures
417,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
418,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN,C7_ immunologic signatures
419,ZHANG_TLX_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
420,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP,C7_ immunologic signatures
421,TACGGGT_MIR99A_MIR100_MIR99B,c3.MIR_ microRNA targets
422,GO_G_PROTEIN_ALPHA_SUBUNIT_BINDING,c5.GO molecular function
423,ZWANG_DOWN_BY_2ND_EGF_PULSE,c2.CGP_ chemical and genetic perturbations
424,GO_REGULATION_OF_SENSORY_PERCEPTION,c5.BP_ GO biological process
425,GO_NATURAL_KILLER_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,c5.BP_ GO biological process
426,GO_REGULATION_OF_MUSCLE_ADAPTATION,c5.BP_ GO biological process
427,PID_FOXM1_PATHWAY,c2.CP_ Canonical pathways
428,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN,C7_ immunologic signatures
429,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,C7_ immunologic signatures
430,WARTERS_IR_RESPONSE_5GY,c2.CGP_ chemical and genetic perturbations
431,YATTNATC_UNKNOWN,c3.TFT_ transcription factor targets
432,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN,C7_ immunologic signatures
433,GO_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS,c5.BP_ GO biological process
434,GO_NEGATIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,c5.BP_ GO biological process
435,GO_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,c5.BP_ GO biological process
436,GO_NEGATIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,c5.BP_ GO biological process
437,GO_AXIS_ELONGATION,c5.BP_ GO biological process
438,LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,c2.CGP_ chemical and genetic perturbations
439,GO_NEGATIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY,c5.BP_ GO biological process
440,LIM_MAMMARY_STEM_CELL_UP,c2.CGP_ chemical and genetic perturbations
441,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN,C7_ immunologic signatures
442,THILLAINADESAN_ZNF217_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
443,GO_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,c5.BP_ GO biological process
444,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,c2.CGP_ chemical and genetic perturbations
445,CERVERA_SDHB_TARGETS_2,c2.CGP_ chemical and genetic perturbations
446,HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR,c2.CGP_ chemical and genetic perturbations
447,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
448,GO_MOTOR_ACTIVITY,c5.GO molecular function
449,GO_MITOTIC_SPINDLE,c5.CC_ GO cellular component
450,MOSERLE_IFNA_RESPONSE,c2.CGP_ chemical and genetic perturbations
451,GO_PHOSPHOLIPID_TRANSLOCATING_ATPASE_ACTIVITY,c5.GO molecular function
452,GO_SPINDLE_ASSEMBLY,c5.BP_ GO biological process
453,GO_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
454,GO_PROTEIN_LOCALIZATION_TO_CYTOSKELETON,c5.BP_ GO biological process
455,WARTERS_RESPONSE_TO_IR_SKIN,c2.CGP_ chemical and genetic perturbations
456,MODULE_397,c4.CM_ cancer modules
457,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,c2.CGP_ chemical and genetic perturbations
458,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,c2.CGP_ chemical and genetic perturbations
459,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
460,GSE11386_NAIVE_VS_MEMORY_BCELL_UP,C7_ immunologic signatures
461,NEWMAN_ERCC6_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
462,FERRANDO_HOX11_NEIGHBORS,c2.CGP_ chemical and genetic perturbations
463,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN,C7_ immunologic signatures
464,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE,c2.CP_REACTOME_ Reactome gene sets
465,GOLDRATH_ANTIGEN_RESPONSE,c2.CGP_ chemical and genetic perturbations
466,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,c2.CGP_ chemical and genetic perturbations
467,GO_BLOOD_VESSEL_REMODELING,c5.BP_ GO biological process
468,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN,C7_ immunologic signatures
469,PUJANA_BRCA_CENTERED_NETWORK,c2.CGP_ chemical and genetic perturbations
470,BIOCARTA_ATM_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
471,GO_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.BP_ GO biological process
472,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,c2.CGP_ chemical and genetic perturbations
473,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,c2.CGP_ chemical and genetic perturbations
474,GO_GOLGI_LUMEN,c5.CC_ GO cellular component
475,GO_GROWTH_FACTOR_BINDING,c5.GO molecular function
476,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN,C7_ immunologic signatures
477,HALLMARK_INTERFERON_ALPHA_RESPONSE,H_ hallmark gene sets
478,CHR5Q11,30
479,LY_AGING_OLD_DN,c2.CGP_ chemical and genetic perturbations
480,BECKER_TAMOXIFEN_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
481,GO_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION,c5.BP_ GO biological process
482,GSE2706_R848_VS_LPS_8H_STIM_DC_DN,C7_ immunologic signatures
483,GO_MITOTIC_RECOMBINATION,c5.BP_ GO biological process
484,NABA_BASEMENT_MEMBRANES,c2.CP_ Canonical pathways
485,GO_MICROTUBULE_ORGANIZING_CENTER_PART,c5.CC_ GO cellular component
486,REACTOME_CELL_CYCLE,c2.CP_REACTOME_ Reactome gene sets
487,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,c2.CGP_ chemical and genetic perturbations
488,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP,C7_ immunologic signatures
489,REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
490,GO_T_TUBULE,c5.CC_ GO cellular component
491,BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX,c2.CGP_ chemical and genetic perturbations
492,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_DN,C7_ immunologic signatures
493,GO_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,c5.BP_ GO biological process
494,GO_MUSCLE_HYPERTROPHY,c5.BP_ GO biological process
495,BOWIE_RESPONSE_TO_TAMOXIFEN,c2.CGP_ chemical and genetic perturbations
496,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,C7_ immunologic signatures
497,GO_REGULATION_OF_HEART_GROWTH,c5.BP_ GO biological process
498,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN,C7_ immunologic signatures
499,GO_LUNG_ALVEOLUS_DEVELOPMENT,c5.BP_ GO biological process
500,GO_POSITIVE_REGULATION_OF_NUCLEAR_DIVISION,c5.BP_ GO biological process
501,REACTOME_ION_CHANNEL_TRANSPORT,c2.CP_REACTOME_ Reactome gene sets
502,SONG_TARGETS_OF_IE86_CMV_PROTEIN,c2.CGP_ chemical and genetic perturbations
503,GO_DNA_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
504,GO_MEMBRANE_DEPOLARIZATION,c5.BP_ GO biological process
505,GO_VACUOLAR_LUMEN,c5.CC_ GO cellular component
506,MODULE_330,c4.CM_ cancer modules
507,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN,C7_ immunologic signatures
508,GO_HISTONE_EXCHANGE,c5.BP_ GO biological process
509,GO_MUSCLE_STRUCTURE_DEVELOPMENT,c5.BP_ GO biological process
510,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,C7_ immunologic signatures
511,GO_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION,c5.BP_ GO biological process
512,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_UP,C7_ immunologic signatures
513,AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,c2.CGP_ chemical and genetic perturbations
514,LY_AGING_MIDDLE_DN,c2.CGP_ chemical and genetic perturbations
515,GO_LIPID_TRANSLOCATION,c5.BP_ GO biological process
516,SMIRNOV_RESPONSE_TO_IR_2HR_DN,c2.CGP_ chemical and genetic perturbations
517,GO_SPROUTING_ANGIOGENESIS,c5.BP_ GO biological process
518,GO_SPINDLE_MIDZONE,c5.CC_ GO cellular component
519,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN,C7_ immunologic signatures
520,ZHU_CMV_ALL_DN,c2.CGP_ chemical and genetic perturbations
521,GO_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,c5.BP_ GO biological process
522,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_UP,C7_ immunologic signatures
523,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN,C7_ immunologic signatures
524,LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,c2.CGP_ chemical and genetic perturbations
525,GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,c5.BP_ GO biological process
526,GO_CELLULAR_RESPONSE_TO_NUTRIENT,c5.BP_ GO biological process
527,SIMBULAN_PARP1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
528,MODULE_112,c4.CM_ cancer modules
529,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN,C7_ immunologic signatures
530,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,C7_ immunologic signatures
531,REACTOME_MITOTIC_G2_G2_M_PHASES,c2.CP_REACTOME_ Reactome gene sets
532,BLUM_RESPONSE_TO_SALIRASIB_DN,c2.CGP_ chemical and genetic perturbations
533,WILCOX_RESPONSE_TO_PROGESTERONE_DN,c2.CGP_ chemical and genetic perturbations
534,PID_BARD1_PATHWAY,c2.CP_ Canonical pathways
535,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,c2.CGP_ chemical and genetic perturbations
536,DANG_REGULATED_BY_MYC_DN,c2.CGP_ chemical and genetic perturbations
537,PEART_HDAC_PROLIFERATION_CLUSTER_UP,c2.CGP_ chemical and genetic perturbations
538,GO_NEUROMUSCULAR_JUNCTION_DEVELOPMENT,c5.BP_ GO biological process
539,GO_CENTRIOLE,c5.CC_ GO cellular component
540,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN,C7_ immunologic signatures
541,CHR19P12,15
542,GO_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,c5.BP_ GO biological process
543,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN,C7_ immunologic signatures
544,GO_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
545,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN,C7_ immunologic signatures
546,GO_SULFUR_COMPOUND_BINDING,c5.GO molecular function
547,GO_COLLAGEN_TRIMER,c5.CC_ GO cellular component
548,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
549,GO_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
550,OUYANG_PROSTATE_CANCER_MARKERS,c2.CGP_ chemical and genetic perturbations
551,CHR10P11,20
552,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN,C7_ immunologic signatures
553,GO_PROTEIN_LOCALIZATION_TO_CHROMOSOME,c5.BP_ GO biological process
554,GO_MUSCLE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
555,GO_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
556,GO_PROTEIN_BINDING_INVOLVED_IN_CELL_ADHESION,c5.GO molecular function
557,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN,C7_ immunologic signatures
558,RGTTAMWNATT_HNF1_01,c3.TFT_ transcription factor targets
559,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,c2.CGP_ chemical and genetic perturbations
560,FARMER_BREAST_CANCER_CLUSTER_1,c2.CGP_ chemical and genetic perturbations
561,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN,C7_ immunologic signatures
562,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP,C7_ immunologic signatures
563,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN,C7_ immunologic signatures
564,GO_POSITIVE_REGULATION_OF_HEART_CONTRACTION,c5.BP_ GO biological process
565,GENTILE_UV_LOW_DOSE_UP,c2.CGP_ chemical and genetic perturbations
566,BIOCARTA_ALK_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
567,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP,C7_ immunologic signatures
568,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP,c2.CGP_ chemical and genetic perturbations
569,HORIUCHI_WTAP_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
570,GO_REGULATION_OF_CENTROSOME_DUPLICATION,c5.BP_ GO biological process
571,PUJANA_BRCA2_PCC_NETWORK,c2.CGP_ chemical and genetic perturbations
572,GO_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,c5.BP_ GO biological process
573,LIU_SMARCA4_TARGETS,c2.CGP_ chemical and genetic perturbations
574,GO_NEURON_PROJECTION_GUIDANCE,c5.BP_ GO biological process
575,GO_SYNAPSE_ASSEMBLY,c5.BP_ GO biological process
576,GO_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,c5.BP_ GO biological process
577,MODULE_512,c4.CM_ cancer modules
578,GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN,C7_ immunologic signatures
579,NIKOLSKY_BREAST_CANCER_5P15_AMPLICON,c2.CGP_ chemical and genetic perturbations
580,GO_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,c5.BP_ GO biological process
581,MODULE_176,c4.CM_ cancer modules
582,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,c2.CGP_ chemical and genetic perturbations
583,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,C7_ immunologic signatures
584,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,c2.CGP_ chemical and genetic perturbations
585,GO_ATP_DEPENDENT_MICROTUBULE_MOTOR_ACTIVITY,c5.GO molecular function
586,MTOR_UP.V1_DN,C6_ oncogenic signatures
587,GO_POSITIVE_REGULATION_OF_HEART_GROWTH,c5.BP_ GO biological process
588,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,C7_ immunologic signatures
589,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
590,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN,C7_ immunologic signatures
591,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,c2.CGP_ chemical and genetic perturbations
592,REACTOME_G2_M_CHECKPOINTS,c2.CP_REACTOME_ Reactome gene sets
593,GO_TISSUE_REMODELING,c5.BP_ GO biological process
594,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP,C7_ immunologic signatures
595,CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,c2.CGP_ chemical and genetic perturbations
596,RB_DN.V1_UP,C6_ oncogenic signatures
597,SHEPARD_BMYB_MORPHOLINO_DN,c2.CGP_ chemical and genetic perturbations
598,GO_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,c5.BP_ GO biological process
599,BRACHAT_RESPONSE_TO_METHOTREXATE_UP,c2.CGP_ chemical and genetic perturbations
600,GO_CYCLIC_NUCLEOTIDE_BINDING,c5.GO molecular function
601,GO_CYTOSOLIC_CALCIUM_ION_TRANSPORT,c5.BP_ GO biological process
602,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP,C7_ immunologic signatures
603,GO_CARDIOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
604,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP,c2.CGP_ chemical and genetic perturbations
605,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,C7_ immunologic signatures
606,GO_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.BP_ GO biological process
607,GO_ORGAN_FORMATION,c5.BP_ GO biological process
608,GO_REGULATION_OF_MUSCLE_CONTRACTION,c5.BP_ GO biological process
609,REACTOME_DNA_REPLICATION,c2.CP_REACTOME_ Reactome gene sets
610,GO_REGULATION_OF_DNA_REPAIR,c5.BP_ GO biological process
611,GO_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,c5.BP_ GO biological process
612,GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION,c5.BP_ GO biological process
613,GO_POSITIVE_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION,c5.BP_ GO biological process
614,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
615,GO_MITOTIC_SPINDLE_ASSEMBLY,c5.BP_ GO biological process
616,LIM_MAMMARY_LUMINAL_MATURE_DN,c2.CGP_ chemical and genetic perturbations
617,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,C7_ immunologic signatures
618,GO_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,c5.BP_ GO biological process
619,GO_POSITIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
620,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,C7_ immunologic signatures
621,GO_AXONAL_FASCICULATION,c5.BP_ GO biological process
622,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP,C7_ immunologic signatures
623,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN,C7_ immunologic signatures
624,CHR2Q22,15
625,GO_SYNAPSIS,c5.BP_ GO biological process
626,GO_SYNAPSE_ORGANIZATION,c5.BP_ GO biological process
627,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN,C7_ immunologic signatures
628,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
629,KEGG_ECM_RECEPTOR_INTERACTION,c2.CP_BIOCARTA_ BioCarta gene sets
630,GO_BONE_MORPHOGENESIS,c5.BP_ GO biological process
631,GO_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
632,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,c2.CGP_ chemical and genetic perturbations
633,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN,c2.CGP_ chemical and genetic perturbations
634,GO_REGULATION_OF_CARTILAGE_DEVELOPMENT,c5.BP_ GO biological process
635,HORIUCHI_WTAP_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
636,MODULE_474,c4.CM_ cancer modules
637,TOMLINS_PROSTATE_CANCER_DN,c2.CGP_ chemical and genetic perturbations
638,GO_REGULATION_OF_CYTOSKELETON_ORGANIZATION,c5.BP_ GO biological process
639,GO_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,c5.BP_ GO biological process
640,GO_SEMAPHORIN_RECEPTOR_BINDING,c5.GO molecular function
641,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
642,GO_PROTEIN_LOCALIZATION_TO_CENTROSOME,c5.BP_ GO biological process
643,GO_DNA_PACKAGING_COMPLEX,c5.CC_ GO cellular component
644,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,C7_ immunologic signatures
645,PID_AURORA_A_PATHWAY,c2.CP_ Canonical pathways
646,GO_DNA_REPLICATION_INITIATION,c5.BP_ GO biological process
647,CAIRO_HEPATOBLASTOMA_CLASSES_DN,c2.CGP_ chemical and genetic perturbations
648,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,c2.CGP_ chemical and genetic perturbations
649,REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
650,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_DN,C7_ immunologic signatures
651,GO_WNT_ACTIVATED_RECEPTOR_ACTIVITY,c5.GO molecular function
652,CHR15Q24,63
653,GO_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,c5.BP_ GO biological process
654,CROONQUIST_STROMAL_STIMULATION_UP,c2.CGP_ chemical and genetic perturbations
655,PID_AVB3_INTEGRIN_PATHWAY,c2.CP_ Canonical pathways
656,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP,C7_ immunologic signatures
657,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
658,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_DN,C7_ immunologic signatures
659,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN,C7_ immunologic signatures
660,GO_MICROTUBULE_ASSOCIATED_COMPLEX,c5.CC_ GO cellular component
661,GO_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR,c5.BP_ GO biological process
662,GO_TISSUE_MIGRATION,c5.BP_ GO biological process
663,GO_SUPRAMOLECULAR_FIBER,c5.CC_ GO cellular component
664,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_UP,C7_ immunologic signatures
665,GO_MITOTIC_G2_M_TRANSITION_CHECKPOINT,c5.BP_ GO biological process
666,BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,c2.CGP_ chemical and genetic perturbations
667,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN,C7_ immunologic signatures
668,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,C7_ immunologic signatures
669,KANG_FLUOROURACIL_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
670,GO_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL,c5.BP_ GO biological process
671,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_DN,C7_ immunologic signatures
672,MACLACHLAN_BRCA1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
673,CHR9P13,45
674,CACTTTG_MIR520G_MIR520H,c3.MIR_ microRNA targets
675,GO_NEGATIVE_REGULATION_OF_CELL_CYCLE,c5.BP_ GO biological process
676,GO_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
677,DAUER_STAT3_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
678,REACTOME_FANCONI_ANEMIA_PATHWAY,c2.CP_REACTOME_ Reactome gene sets
679,PID_INTEGRIN1_PATHWAY,c2.CP_ Canonical pathways
680,GO_CHEMOREPELLENT_ACTIVITY,c5.GO molecular function
681,GO_MICROTUBULE_BASED_PROCESS,c5.BP_ GO biological process
682,GO_CELL_FATE_COMMITMENT_INVOLVED_IN_FORMATION_OF_PRIMARY_GERM_LAYER,c5.BP_ GO biological process
683,CHX10_01,c3.TFT_ transcription factor targets
684,E2F1_Q4_01,c3.TFT_ transcription factor targets
685,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP,C7_ immunologic signatures
686,RICKMAN_HEAD_AND_NECK_CANCER_B,c2.CGP_ chemical and genetic perturbations
687,GO_BRANCH_ELONGATION_OF_AN_EPITHELIUM,c5.BP_ GO biological process
688,GEORGES_CELL_CYCLE_MIR192_TARGETS,c2.CGP_ chemical and genetic perturbations
689,CORRE_MULTIPLE_MYELOMA_DN,c2.CGP_ chemical and genetic perturbations
690,E2F_Q6_01,c3.TFT_ transcription factor targets
691,SABATES_COLORECTAL_ADENOMA_DN,c2.CGP_ chemical and genetic perturbations
692,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,C7_ immunologic signatures
693,GO_ANKYRIN_BINDING,c5.GO molecular function
694,GO_NEGATIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,c5.BP_ GO biological process
695,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,c2.CGP_ chemical and genetic perturbations
696,GO_GLYCOPROTEIN_COMPLEX,c5.CC_ GO cellular component
697,GSE14415_NATURAL_TREG_VS_TCONV_UP,C7_ immunologic signatures
698,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
699,GO_POSITIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,c5.BP_ GO biological process
700,E2F_Q3_01,c3.TFT_ transcription factor targets
701,BURTON_ADIPOGENESIS_PEAK_AT_0HR,c2.CGP_ chemical and genetic perturbations
702,GO_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,c5.GO molecular function
703,GO_CAMP_BINDING,c5.GO molecular function
704,GSE2706_UNSTIM_VS_2H_LPS_DC_DN,C7_ immunologic signatures
705,GO_REGULATION_OF_BMP_SIGNALING_PATHWAY,c5.BP_ GO biological process
706,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP,C7_ immunologic signatures
707,REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
708,MODULE_382,c4.CM_ cancer modules
709,CHR3P21,192
710,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,C7_ immunologic signatures
711,GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN,C7_ immunologic signatures
712,GSE4142_PLASMA_CELL_VS_GC_BCELL_UP,C7_ immunologic signatures
713,WESTON_VEGFA_TARGETS_6HR,c2.CGP_ chemical and genetic perturbations
714,GO_NEGATIVE_REGULATION_OF_PROTEIN_MATURATION,c5.BP_ GO biological process
715,KUNINGER_IGF1_VS_PDGFB_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
716,VALK_AML_CLUSTER_13,c2.CGP_ chemical and genetic perturbations
717,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,C7_ immunologic signatures
718,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,c2.CGP_ chemical and genetic perturbations
719,GO_CHROMOSOME_SEPARATION,c5.BP_ GO biological process
720,REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,c2.CP_REACTOME_ Reactome gene sets
721,HNF3B_01,c3.TFT_ transcription factor targets
722,GO_POSITIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,c5.BP_ GO biological process
723,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN,C7_ immunologic signatures
724,GO_FEMALE_MEIOTIC_DIVISION,c5.BP_ GO biological process
725,GO_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,c5.BP_ GO biological process
726,GO_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION,c5.BP_ GO biological process
727,DOANE_RESPONSE_TO_ANDROGEN_DN,c2.CGP_ chemical and genetic perturbations
728,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,c2.CGP_ chemical and genetic perturbations
729,GO_CELLULAR_RESPONSE_TO_CALCIUM_ION,c5.BP_ GO biological process
730,GO_POSITIVE_REGULATION_OF_GLUCOSE_TRANSPORT,c5.BP_ GO biological process
731,CHR13Q34,30
732,E2F_Q3,c3.TFT_ transcription factor targets
733,GO_REGULATION_OF_HEART_CONTRACTION,c5.BP_ GO biological process
734,GO_REGULATION_OF_BLOOD_CIRCULATION,c5.BP_ GO biological process
735,NAKAMURA_ADIPOGENESIS_EARLY_DN,c2.CGP_ chemical and genetic perturbations
736,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,C7_ immunologic signatures
737,GO_RESPONSE_TO_MECHANICAL_STIMULUS,c5.BP_ GO biological process
738,GO_REGULATION_OF_GLUCOSE_IMPORT,c5.BP_ GO biological process
739,GO_RESPONSE_TO_UV_B,c5.BP_ GO biological process
740,GO_REGULATION_OF_CATENIN_IMPORT_INTO_NUCLEUS,c5.BP_ GO biological process
741,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
742,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP,C7_ immunologic signatures
743,KARAKAS_TGFB1_SIGNALING,c2.CGP_ chemical and genetic perturbations
744,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP,C7_ immunologic signatures
745,GO_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,c5.BP_ GO biological process
746,GO_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,c5.BP_ GO biological process
747,GO_RESPONSE_TO_ALKALOID,c5.BP_ GO biological process
748,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,C7_ immunologic signatures
749,GEORGANTAS_HSC_MARKERS,c2.CGP_ chemical and genetic perturbations
750,GO_CELLULAR_RESPONSE_TO_IONIZING_RADIATION,c5.BP_ GO biological process
751,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN,C7_ immunologic signatures
752,CHR8P12,28
753,GO_DNA_DEPENDENT_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY,c5.BP_ GO biological process
754,STTTCRNTTT_IRF_Q6,c3.TFT_ transcription factor targets
755,PID_SYNDECAN_1_PATHWAY,c2.CP_ Canonical pathways
756,GO_MUSCLE_ORGAN_DEVELOPMENT,c5.BP_ GO biological process
757,GO_DNA_SECONDARY_STRUCTURE_BINDING,c5.GO molecular function
758,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,C7_ immunologic signatures
759,GO_REGULATION_OF_CELL_CYCLE_PROCESS,c5.BP_ GO biological process
760,KANG_DOXORUBICIN_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
761,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP,C7_ immunologic signatures
762,GO_REGULATION_OF_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS,c5.BP_ GO biological process
763,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,C7_ immunologic signatures
764,GO_MATING,c5.BP_ GO biological process
765,PIT1_Q6,c3.TFT_ transcription factor targets
766,REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,c2.CP_REACTOME_ Reactome gene sets
767,E2F_Q6,c3.TFT_ transcription factor targets
768,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,C7_ immunologic signatures
769,KAUFFMANN_DNA_REPAIR_GENES,c2.CGP_ chemical and genetic perturbations
770,EINAV_INTERFERON_SIGNATURE_IN_CANCER,c2.CGP_ chemical and genetic perturbations
771,GO_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_REGULATOR_ACTIVITY,c5.GO molecular function
772,GO_POSITIVE_REGULATION_OF_BLOOD_PRESSURE,c5.BP_ GO biological process
773,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,c2.CGP_ chemical and genetic perturbations
774,GO_SYNAPTONEMAL_COMPLEX_ORGANIZATION,c5.BP_ GO biological process
775,GO_CELL_MORPHOGENESIS_INVOLVED_IN_NEURON_DIFFERENTIATION,c5.BP_ GO biological process
776,GO_TUBULIN_BINDING,c5.GO molecular function
777,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,c2.CGP_ chemical and genetic perturbations
778,GSE3982_DC_VS_MAC_DN,C7_ immunologic signatures
779,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN,C7_ immunologic signatures
780,GO_EPITHELIAL_CELL_PROLIFERATION,c5.BP_ GO biological process
781,GABRIELY_MIR21_TARGETS,c2.CGP_ chemical and genetic perturbations
782,GO_FEMALE_GAMETE_GENERATION,c5.BP_ GO biological process
783,E2F1DP1RB_01,c3.TFT_ transcription factor targets
784,GO_REGULATION_OF_REPRODUCTIVE_PROCESS,c5.BP_ GO biological process
785,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,c2.CGP_ chemical and genetic perturbations
786,MODULE_259,c4.CM_ cancer modules
787,WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC,c2.CGP_ chemical and genetic perturbations
788,GO_REPLACEMENT_OSSIFICATION,c5.BP_ GO biological process
789,HAN_JNK_SINGALING_UP,c2.CGP_ chemical and genetic perturbations
790,DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN,c2.CGP_ chemical and genetic perturbations
791,E2F_Q4,c3.TFT_ transcription factor targets
792,GO_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,c5.BP_ GO biological process
793,HECKER_IFNB1_TARGETS,c2.CGP_ chemical and genetic perturbations
794,E2F1_Q3,c3.TFT_ transcription factor targets
795,GO_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,c5.BP_ GO biological process
796,GO_SPINDLE_LOCALIZATION,c5.BP_ GO biological process
797,SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,c2.CGP_ chemical and genetic perturbations
798,IRF7_01,c3.TFT_ transcription factor targets
799,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,c2.CGP_ chemical and genetic perturbations
800,GO_AXON_EXTENSION,c5.BP_ GO biological process
801,GO_CENTRAL_NERVOUS_SYSTEM_PROJECTION_NEURON_AXONOGENESIS,c5.BP_ GO biological process
802,GO_REGULATION_OF_MEMBRANE_LIPID_DISTRIBUTION,c5.BP_ GO biological process
803,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,C7_ immunologic signatures
804,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,c2.CGP_ chemical and genetic perturbations
805,KANG_IMMORTALIZED_BY_TERT_UP,c2.CGP_ chemical and genetic perturbations
806,VALK_AML_WITH_EVI1,c2.CGP_ chemical and genetic perturbations
807,COWLING_MYCN_TARGETS,c2.CGP_ chemical and genetic perturbations
808,GO_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
809,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,C7_ immunologic signatures
810,CHR3Q22,34
811,RIZ_ERYTHROID_DIFFERENTIATION_HEMGN,c2.CGP_ chemical and genetic perturbations
812,GO_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,c5.BP_ GO biological process
813,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN,C7_ immunologic signatures
814,E2F1_Q6,c3.TFT_ transcription factor targets
815,MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER,c2.CGP_ chemical and genetic perturbations
816,PLASARI_TGFB1_TARGETS_10HR_DN,c2.CGP_ chemical and genetic perturbations
817,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN,C7_ immunologic signatures
818,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
819,CHICAS_RB1_TARGETS_CONFLUENT,c2.CGP_ chemical and genetic perturbations
820,GO_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
821,GO_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY,c5.BP_ GO biological process
822,KRAS.PROSTATE_UP.V1_UP,C6_ oncogenic signatures
823,GO_NEURON_PROJECTION_MORPHOGENESIS,c5.BP_ GO biological process
824,NIELSEN_LEIOMYOSARCOMA_DN,c2.CGP_ chemical and genetic perturbations
825,GO_CARBOHYDRATE_DERIVATIVE_CATABOLIC_PROCESS,c5.BP_ GO biological process
826,HALMOS_CEBPA_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
827,GO_REGULATION_OF_HEART_RATE_BY_CARDIAC_CONDUCTION,c5.BP_ GO biological process
828,GO_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
829,GO_RESPONSE_TO_COCAINE,c5.BP_ GO biological process
830,CHR11Q24,58
831,GO_REGULATION_OF_CALCIUM_ION_TRANSPORT,c5.BP_ GO biological process
832,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,C7_ immunologic signatures
833,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,c2.CGP_ chemical and genetic perturbations
834,E2F_Q4_01,c3.TFT_ transcription factor targets
835,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,C7_ immunologic signatures
836,MODULE_12,c4.CM_ cancer modules
837,GAVIN_FOXP3_TARGETS_CLUSTER_P4,c2.CGP_ chemical and genetic perturbations
838,REACTOME_MITOTIC_M_M_G1_PHASES,c2.CP_REACTOME_ Reactome gene sets
839,HFH8_01,c3.TFT_ transcription factor targets
840,GO_EPITHELIAL_TUBE_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS,c5.BP_ GO biological process
841,REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,c2.CP_REACTOME_ Reactome gene sets
842,ASTON_MAJOR_DEPRESSIVE_DISORDER_UP,c2.CGP_ chemical and genetic perturbations
843,GO_NEGATIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
844,GO_POSITIVE_REGULATION_OF_MUSCLE_CONTRACTION,c5.BP_ GO biological process
845,GO_DEVELOPMENTAL_GROWTH,c5.BP_ GO biological process
846,GO_ACTIN_MEDIATED_CELL_CONTRACTION,c5.BP_ GO biological process
847,GO_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,c5.BP_ GO biological process
848,GO_MICROTUBULE_POLYMERIZATION,c5.BP_ GO biological process
849,GO_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
850,ONDER_CDH1_TARGETS_2_UP,c2.CGP_ chemical and genetic perturbations
851,GO_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION,c5.BP_ GO biological process
852,LINDGREN_BLADDER_CANCER_CLUSTER_2B,c2.CGP_ chemical and genetic perturbations
853,GO_REGULATION_OF_WOUND_HEALING,c5.BP_ GO biological process
854,GO_MUSCLE_SYSTEM_PROCESS,c5.BP_ GO biological process
855,GO_NEGATIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,c5.BP_ GO biological process
856,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,c2.CGP_ chemical and genetic perturbations
857,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,c2.CGP_ chemical and genetic perturbations
858,GO_CENTROSOME,c5.CC_ GO cellular component
859,GO_SUBSTRATE_DEPENDENT_CELL_MIGRATION,c5.BP_ GO biological process
860,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,c2.CGP_ chemical and genetic perturbations
861,MODULE_200,c4.CM_ cancer modules
862,MODULE_201,c4.CM_ cancer modules
863,GO_REGULATION_OF_SPINDLE_ORGANIZATION,c5.BP_ GO biological process
864,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN,C7_ immunologic signatures
865,ZHU_CMV_24_HR_DN,c2.CGP_ chemical and genetic perturbations
866,GO_DNA_PACKAGING,c5.BP_ GO biological process
867,GO_MICROTUBULE_END,c5.CC_ GO cellular component
868,GO_GERM_CELL_NUCLEUS,c5.CC_ GO cellular component
869,REACTOME_SIGNALING_BY_FGFR_MUTANTS,c2.CP_REACTOME_ Reactome gene sets
870,WALLACE_PROSTATE_CANCER_RACE_UP,c2.CGP_ chemical and genetic perturbations
871,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN,C7_ immunologic signatures
872,GO_REGULATION_OF_MITOTIC_CELL_CYCLE,c5.BP_ GO biological process
873,GO_CONTRACTILE_FIBER,c5.CC_ GO cellular component
874,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,C7_ immunologic signatures
875,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,c2.CGP_ chemical and genetic perturbations
876,GO_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,c5.BP_ GO biological process
877,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,C7_ immunologic signatures
878,REACTOME_KINESINS,c2.CP_REACTOME_ Reactome gene sets
879,GO_ANGIOGENESIS,c5.BP_ GO biological process
880,GO_ACTOMYOSIN_STRUCTURE_ORGANIZATION,c5.BP_ GO biological process
881,GO_GROWTH,c5.BP_ GO biological process
882,GO_EPIDERMIS_MORPHOGENESIS,c5.BP_ GO biological process
883,GO_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,c5.BP_ GO biological process
884,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_DN,C7_ immunologic signatures
885,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,C7_ immunologic signatures
886,GO_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION,c5.BP_ GO biological process
887,REACTOME_PI_3K_CASCADE,c2.CP_REACTOME_ Reactome gene sets
888,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_DN,C7_ immunologic signatures
889,GO_G1_DNA_DAMAGE_CHECKPOINT,c5.BP_ GO biological process
890,GO_TELOMERE_MAINTENANCE_VIA_RECOMBINATION,c5.BP_ GO biological process
891,E2F_03,c3.TFT_ transcription factor targets
892,GO_HISTONE_KINASE_ACTIVITY,c5.GO molecular function
893,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
894,GO_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
895,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN,C7_ immunologic signatures
896,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP,C7_ immunologic signatures
897,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP,C7_ immunologic signatures
898,GO_NEGATIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
899,GO_MUSCLE_CELL_DEVELOPMENT,c5.BP_ GO biological process
900,GO_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX,c5.CC_ GO cellular component
901,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,c2.CGP_ chemical and genetic perturbations
902,GU_PDEF_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
903,GO_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,c5.BP_ GO biological process
904,GO_PROSTATE_GLAND_DEVELOPMENT,c5.BP_ GO biological process
905,GO_MUSCLE_FIBER_DEVELOPMENT,c5.BP_ GO biological process
906,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP,C7_ immunologic signatures
907,TRAYNOR_RETT_SYNDROM_UP,c2.CGP_ chemical and genetic perturbations
908,HASLINGER_B_CLL_WITH_13Q14_DELETION,c2.CGP_ chemical and genetic perturbations
909,BIOCARTA_PAR1_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
910,GO_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY,c5.GO molecular function
911,GO_COMPLEX_OF_COLLAGEN_TRIMERS,c5.CC_ GO cellular component
912,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP,c2.CGP_ chemical and genetic perturbations
913,GO_CALCIUM_ION_IMPORT,c5.BP_ GO biological process
914,GSE30083_SP1_VS_SP2_THYMOCYTE_DN,C7_ immunologic signatures
915,AAAYWAACM_HFH4_01,c3.TFT_ transcription factor targets
916,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,c2.CGP_ chemical and genetic perturbations
917,GO_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,c5.BP_ GO biological process
918,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,c2.CGP_ chemical and genetic perturbations
919,GCM_SIRT2,c4.CGN_ cancer gene neighborhoods
920,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
921,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP,C7_ immunologic signatures
922,GSE27786_CD8_TCELL_VS_MONO_MAC_DN,C7_ immunologic signatures
923,GO_MYOFILAMENT,c5.CC_ GO cellular component
924,GO_VASOCONSTRICTION,c5.BP_ GO biological process
925,GO_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS,c5.BP_ GO biological process
926,GSE13306_RA_VS_UNTREATED_TREG_DN,C7_ immunologic signatures
927,GNF2_IGFBP1,c4.CGN_ cancer gene neighborhoods
928,GO_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,c5.BP_ GO biological process
929,GO_NEURON_PROJECTION_DEVELOPMENT,c5.BP_ GO biological process
930,GEISS_RESPONSE_TO_DSRNA_UP,c2.CGP_ chemical and genetic perturbations
931,GO_CARDIAC_CHAMBER_DEVELOPMENT,c5.BP_ GO biological process
932,ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN,c2.CGP_ chemical and genetic perturbations
933,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,c2.CP_REACTOME_ Reactome gene sets
934,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP,C7_ immunologic signatures
935,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN,C7_ immunologic signatures
936,GO_ACTION_POTENTIAL,c5.BP_ GO biological process
937,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP,C7_ immunologic signatures
938,GO_CELL_GROWTH,c5.BP_ GO biological process
939,GO_NEGATIVE_REGULATION_OF_CHEMOTAXIS,c5.BP_ GO biological process
940,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN,C7_ immunologic signatures
941,ATF2_S_UP.V1_DN,C6_ oncogenic signatures
942,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,c2.CGP_ chemical and genetic perturbations
943,NABA_ECM_AFFILIATED,c2.CP_ Canonical pathways
944,GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,c5.BP_ GO biological process
945,DAZARD_UV_RESPONSE_CLUSTER_G6,c2.CGP_ chemical and genetic perturbations
946,ACAACTT_MIR382,c3.MIR_ microRNA targets
947,GO_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
948,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,C7_ immunologic signatures
949,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN,C7_ immunologic signatures
950,GO_NEGATIVE_REGULATION_OF_PROTEOLYSIS,c5.BP_ GO biological process
951,GO_HISTONE_PHOSPHORYLATION,c5.BP_ GO biological process
952,GO_CARDIAC_CHAMBER_MORPHOGENESIS,c5.BP_ GO biological process
953,GO_STRIATUM_DEVELOPMENT,c5.BP_ GO biological process
954,GO_POSITIVE_REGULATION_OF_OSSIFICATION,c5.BP_ GO biological process
955,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,c2.CGP_ chemical and genetic perturbations
956,GO_ACTIN_CYTOSKELETON,c5.CC_ GO cellular component
957,FRIDMAN_SENESCENCE_UP,c2.CGP_ chemical and genetic perturbations
958,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN,C7_ immunologic signatures
959,PLASARI_NFIC_TARGETS_BASAL_UP,c2.CGP_ chemical and genetic perturbations
960,GO_REGULATION_OF_LIPID_KINASE_ACTIVITY,c5.BP_ GO biological process
961,TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,c2.CGP_ chemical and genetic perturbations
962,GO_AXIS_SPECIFICATION,c5.BP_ GO biological process
963,CHR4P16,78
964,GO_NEURON_PROJECTION_EXTENSION,c5.BP_ GO biological process
965,HFH3_01,c3.TFT_ transcription factor targets
966,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,C7_ immunologic signatures
967,EN1_01,c3.TFT_ transcription factor targets
968,GSE27786_NKTCELL_VS_ERYTHROBLAST_DN,C7_ immunologic signatures
969,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN,C7_ immunologic signatures
970,PID_PRL_SIGNALING_EVENTS_PATHWAY,c2.CP_ Canonical pathways
971,GO_REGULATION_OF_JNK_CASCADE,c5.BP_ GO biological process
972,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN,C7_ immunologic signatures
973,YU_BAP1_TARGETS,c2.CGP_ chemical and genetic perturbations
974,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP,c2.CGP_ chemical and genetic perturbations
975,BOQUEST_STEM_CELL_DN,c2.CGP_ chemical and genetic perturbations
976,CHYLA_CBFA2T3_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
977,MITSIADES_RESPONSE_TO_APLIDIN_DN,c2.CGP_ chemical and genetic perturbations
978,MATZUK_MEIOTIC_AND_DNA_REPAIR,c2.CGP_ chemical and genetic perturbations
979,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_UP,C7_ immunologic signatures
980,REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,c2.CP_REACTOME_ Reactome gene sets
981,GO_LYMPH_VESSEL_DEVELOPMENT,c5.BP_ GO biological process
982,RIGGI_EWING_SARCOMA_PROGENITOR_UP,c2.CGP_ chemical and genetic perturbations
983,LEE_NEURAL_CREST_STEM_CELL_DN,c2.CGP_ chemical and genetic perturbations
984,FOX_Q2,c3.TFT_ transcription factor targets
985,DAZARD_RESPONSE_TO_UV_NHEK_DN,c2.CGP_ chemical and genetic perturbations
986,GO_REGULATION_OF_CALCIUM_ION_IMPORT,c5.BP_ GO biological process
987,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,C7_ immunologic signatures
988,GO_REGULATION_OF_CELL_CYCLE_CHECKPOINT,c5.BP_ GO biological process
989,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,c2.CGP_ chemical and genetic perturbations
990,LEE_AGING_MUSCLE_UP,c2.CGP_ chemical and genetic perturbations
991,GNF2_KISS1,c4.CGN_ cancer gene neighborhoods
992,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN,C7_ immunologic signatures
993,GO_CELL_PROLIFERATION_IN_FOREBRAIN,c5.BP_ GO biological process
994,GO_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,c5.BP_ GO biological process
995,NIELSEN_LEIOMYOSARCOMA_CNN1_UP,c2.CGP_ chemical and genetic perturbations
996,TAVAZOIE_METASTASIS,c2.CGP_ chemical and genetic perturbations
997,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN,C7_ immunologic signatures
998,GO_LUNG_MORPHOGENESIS,c5.BP_ GO biological process
999,NAKAMURA_ADIPOGENESIS_LATE_DN,c2.CGP_ chemical and genetic perturbations
1000,IRF1_01,c3.TFT_ transcription factor targets
1001,MORF_THRA,c4.CGN_ cancer gene neighborhoods
1002,SRF_C,c3.TFT_ transcription factor targets
1003,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,c2.CGP_ chemical and genetic perturbations
1004,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_UP,C7_ immunologic signatures
1005,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN,C7_ immunologic signatures
1006,MODULE_199,c4.CM_ cancer modules
1007,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP,C7_ immunologic signatures
1008,REACTOME_SIGNALING_BY_FGFR,c2.CP_REACTOME_ Reactome gene sets
1009,BIOCARTA_MYOSIN_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
1010,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,c2.CGP_ chemical and genetic perturbations
1011,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,c2.CGP_ chemical and genetic perturbations
1012,TTCCGTT_MIR191,c3.MIR_ microRNA targets
1013,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,c2.CGP_ chemical and genetic perturbations
1014,GO_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,c5.GO molecular function
1015,GO_DNA_RECOMBINATION,c5.BP_ GO biological process
1016,CHR11P14,20
1017,GSE2706_2H_VS_8H_R848_STIM_DC_DN,C7_ immunologic signatures
1018,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_UP,C7_ immunologic signatures
1019,GO_PHOSPHATIDYLINOSITOL_BINDING,c5.GO molecular function
1020,WGGAATGY_TEF1_Q6,c3.TFT_ transcription factor targets
1021,GO_COLLAGEN_FIBRIL_ORGANIZATION,c5.BP_ GO biological process
1022,DER_IFN_ALPHA_RESPONSE_UP,c2.CGP_ chemical and genetic perturbations
1023,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,C7_ immunologic signatures
1024,GO_NEGATIVE_REGULATION_OF_GROWTH,c5.BP_ GO biological process
1025,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN,c2.CGP_ chemical and genetic perturbations
1026,GO_PROTEIN_DEPOLYMERIZATION,c5.BP_ GO biological process
1027,GO_ESC_E_Z_COMPLEX,c5.CC_ GO cellular component
1028,GO_PLATELET_ALPHA_GRANULE,c5.CC_ GO cellular component
1029,HOELZEL_NF1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1030,GO_RECIPROCAL_DNA_RECOMBINATION,c5.BP_ GO biological process
1031,GO_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,c5.BP_ GO biological process
1032,GO_MULTICELLULAR_ORGANISM_AGING,c5.BP_ GO biological process
1033,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_DN,C7_ immunologic signatures
1034,GSE369_IFNG_KO_VS_WT_LIVER_UP,C7_ immunologic signatures
1035,GO_ACTIN_FILAMENT_BASED_MOVEMENT,c5.BP_ GO biological process
1036,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,c2.CGP_ chemical and genetic perturbations
1037,GO_RESPONSE_TO_MONOAMINE,c5.BP_ GO biological process
1038,ESC_V6.5_UP_EARLY.V1_DN,C6_ oncogenic signatures
1039,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN,C7_ immunologic signatures
1040,GO_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION,c5.BP_ GO biological process
1041,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
1042,GSE21379_WT_VS_SAP_KO_CD4_TCELL_DN,C7_ immunologic signatures
1043,GO_MYOSIN_FILAMENT,c5.CC_ GO cellular component
1044,SMID_BREAST_CANCER_NORMAL_LIKE_UP,c2.CGP_ chemical and genetic perturbations
1045,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,c2.CGP_ chemical and genetic perturbations
1046,GO_NEURON_FATE_COMMITMENT,c5.BP_ GO biological process
1047,GO_REPLICATION_FORK,c5.CC_ GO cellular component
1048,GO_NEGATIVE_REGULATION_OF_LOCOMOTION,c5.BP_ GO biological process
1049,GO_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,c5.BP_ GO biological process
1050,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN,C7_ immunologic signatures
1051,YNGTTNNNATT_UNKNOWN,c3.TFT_ transcription factor targets
1052,BIOCARTA_P53_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
1053,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN,C7_ immunologic signatures
1054,GO_INTEGRIN_BINDING,c5.GO molecular function
1055,CATTTCA_MIR203,c3.MIR_ microRNA targets
1056,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,c2.CGP_ chemical and genetic perturbations
1057,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP,C7_ immunologic signatures
1058,GO_GLUTAMATE_SECRETION,c5.BP_ GO biological process
1059,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_UP,C7_ immunologic signatures
1060,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,c2.CGP_ chemical and genetic perturbations
1061,GO_BLOOD_VESSEL_MORPHOGENESIS,c5.BP_ GO biological process
1062,RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN,c2.CGP_ chemical and genetic perturbations
1063,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,c2.CGP_ chemical and genetic perturbations
1064,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP,C7_ immunologic signatures
1065,GO_CENTRAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT,c5.BP_ GO biological process
1066,FRIDMAN_IMMORTALIZATION_DN,c2.CGP_ chemical and genetic perturbations
1067,BIOCARTA_CTLA4_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
1068,KEGG_OOCYTE_MEIOSIS,c2.CP_BIOCARTA_ BioCarta gene sets
1069,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP,C7_ immunologic signatures
1070,HALLMARK_UV_RESPONSE_DN,H_ hallmark gene sets
1071,REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE,c2.CP_REACTOME_ Reactome gene sets
1072,GO_SARCOPLASMIC_RETICULUM_MEMBRANE,c5.CC_ GO cellular component
1073,GO_RESPONSE_TO_NICOTINE,c5.BP_ GO biological process
1074,GSE22886_IL2_VS_IL15_STIM_NKCELL_UP,C7_ immunologic signatures
1075,SWEET_KRAS_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
1076,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN,C7_ immunologic signatures
1077,STREICHER_LSM1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1078,GSE17186_MEMORY_VS_NAIVE_BCELL_DN,C7_ immunologic signatures
1079,HALLMARK_INTERFERON_GAMMA_RESPONSE,H_ hallmark gene sets
1080,WONG_ENDMETRIUM_CANCER_DN,c2.CGP_ chemical and genetic perturbations
1081,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN,C7_ immunologic signatures
1082,CIZ_01,c3.TFT_ transcription factor targets
1083,REACTOME_SIGNALING_BY_BMP,c2.CP_REACTOME_ Reactome gene sets
1084,GO_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,c5.BP_ GO biological process
1085,GO_INTERSTRAND_CROSS_LINK_REPAIR,c5.BP_ GO biological process
1086,BILBAN_B_CLL_LPL_DN,c2.CGP_ chemical and genetic perturbations
1087,GO_NEUROMUSCULAR_PROCESS,c5.BP_ GO biological process
1088,GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN,C7_ immunologic signatures
1089,GSE34006_WT_VS_A2AR_KO_TREG_DN,C7_ immunologic signatures
1090,GO_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,c5.BP_ GO biological process
1091,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN,c2.CGP_ chemical and genetic perturbations
1092,GO_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,c5.BP_ GO biological process
1093,SANSOM_WNT_PATHWAY_REQUIRE_MYC,c2.CGP_ chemical and genetic perturbations
1094,GSE360_DC_VS_MAC_T_GONDII_UP,C7_ immunologic signatures
1095,GO_STRIATED_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
1096,GO_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,c5.BP_ GO biological process
1097,GO_ORGAN_INDUCTION,c5.BP_ GO biological process
1098,GO_MUSCLE_CONTRACTION,c5.BP_ GO biological process
1099,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,c2.CGP_ chemical and genetic perturbations
1100,GO_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
1101,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,C7_ immunologic signatures
1102,GAL_LEUKEMIC_STEM_CELL_DN,c2.CGP_ chemical and genetic perturbations
1103,FREAC2_01,c3.TFT_ transcription factor targets
1104,GO_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING,c5.BP_ GO biological process
1105,MODULE_109,c4.CM_ cancer modules
1106,REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,c2.CGP_ chemical and genetic perturbations
1107,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP,C7_ immunologic signatures
1108,GO_BONE_REMODELING,c5.BP_ GO biological process
1109,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,c2.CGP_ chemical and genetic perturbations
1110,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,C7_ immunologic signatures
1111,MODULE_118,c4.CM_ cancer modules
1112,GO_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
1113,GO_GLAND_MORPHOGENESIS,c5.BP_ GO biological process
1114,GSE24210_RESTING_TREG_VS_TCONV_UP,C7_ immunologic signatures
1115,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP,C7_ immunologic signatures
1116,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,C7_ immunologic signatures
1117,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,c2.CGP_ chemical and genetic perturbations
1118,GO_REGULATION_OF_AXON_GUIDANCE,c5.BP_ GO biological process
1119,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN,c2.CGP_ chemical and genetic perturbations
1120,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP,C7_ immunologic signatures
1121,GO_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,c5.BP_ GO biological process
1122,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN,c2.CGP_ chemical and genetic perturbations
1123,SEKI_INFLAMMATORY_RESPONSE_LPS_DN,c2.CGP_ chemical and genetic perturbations
1124,GSE6259_DEC205_POS_DC_VS_BCELL_UP,C7_ immunologic signatures
1125,ROZANOV_MMP14_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1126,MMEF2_Q6,c3.TFT_ transcription factor targets
1127,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,C7_ immunologic signatures
1128,GO_ACTIN_MYOSIN_FILAMENT_SLIDING,c5.BP_ GO biological process
1129,GO_MULTI_ORGANISM_BEHAVIOR,c5.BP_ GO biological process
1130,YTAATTAA_LHX3_01,c3.TFT_ transcription factor targets
1131,GO_POSITIVE_REGULATION_OF_EXOCYTOSIS,c5.BP_ GO biological process
1132,RIGGI_EWING_SARCOMA_PROGENITOR_DN,c2.CGP_ chemical and genetic perturbations
1133,REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
1134,GO_PHAGOCYTOSIS_ENGULFMENT,c5.BP_ GO biological process
1135,GO_CELL_CYCLE_ARREST,c5.BP_ GO biological process
1136,GO_I_BAND,c5.CC_ GO cellular component
1137,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
1138,CHR3P24,30
1139,GO_CELLULAR_RESPONSE_TO_CAMP,c5.BP_ GO biological process
1140,PEREZ_TP53_AND_TP63_TARGETS,c2.CGP_ chemical and genetic perturbations
1141,MODULE_127,c4.CM_ cancer modules
1142,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP,C7_ immunologic signatures
1143,GSE3982_BCELL_VS_NKCELL_DN,C7_ immunologic signatures
1144,GO_POSITIVE_REGULATION_OF_COAGULATION,c5.BP_ GO biological process
1145,KEGG_HOMOLOGOUS_RECOMBINATION,c2.CP_BIOCARTA_ BioCarta gene sets
1146,MODULE_387,c4.CM_ cancer modules
1147,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,C7_ immunologic signatures
1148,GO_DNA_REPLICATION,c5.BP_ GO biological process
1149,GSE6259_BCELL_VS_CD8_TCELL_DN,C7_ immunologic signatures
1150,GO_FORMATION_OF_PRIMARY_GERM_LAYER,c5.BP_ GO biological process
1151,IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM,c2.CGP_ chemical and genetic perturbations
1152,NADERI_BREAST_CANCER_PROGNOSIS_UP,c2.CGP_ chemical and genetic perturbations
1153,GO_POSITIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
1154,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN,C7_ immunologic signatures
1155,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP,C7_ immunologic signatures
1156,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_UP,C7_ immunologic signatures
1157,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
1158,SMID_BREAST_CANCER_LUMINAL_A_UP,c2.CGP_ chemical and genetic perturbations
1159,REACTOME_MEIOTIC_RECOMBINATION,c2.CP_REACTOME_ Reactome gene sets
1160,REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES,c2.CP_REACTOME_ Reactome gene sets
1161,CHIBA_RESPONSE_TO_TSA,c2.CGP_ chemical and genetic perturbations
1162,GO_POSITIVE_REGULATION_OF_CELL_CYCLE_ARREST,c5.BP_ GO biological process
1163,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,C7_ immunologic signatures
1164,GO_BONE_DEVELOPMENT,c5.BP_ GO biological process
1165,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_DN,C7_ immunologic signatures
1166,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,c2.CGP_ chemical and genetic perturbations
1167,REACTOME_COLLAGEN_FORMATION,c2.CP_REACTOME_ Reactome gene sets
1168,CHR5Q35,82
1169,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,C7_ immunologic signatures
1170,CHR1Q32,116
1171,E2F1_Q4,c3.TFT_ transcription factor targets
1172,GO_REGULATION_OF_SYSTEM_PROCESS,c5.BP_ GO biological process
1173,CHIBA_RESPONSE_TO_TSA_UP,c2.CGP_ chemical and genetic perturbations
1174,ATM_DN.V1_UP,C6_ oncogenic signatures
1175,AACATTC_MIR4093P,c3.MIR_ microRNA targets
1176,GO_POSITIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,c5.BP_ GO biological process
1177,GO_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,c5.BP_ GO biological process
1178,MODULE_2,c4.CM_ cancer modules
1179,LAU_APOPTOSIS_CDKN2A_UP,c2.CGP_ chemical and genetic perturbations
1180,REACTOME_STRIATED_MUSCLE_CONTRACTION,c2.CP_REACTOME_ Reactome gene sets
1181,VANASSE_BCL2_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1182,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,c2.CGP_ chemical and genetic perturbations
1183,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN,C7_ immunologic signatures
1184,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN,C7_ immunologic signatures
1185,GO_SMOOTH_MUSCLE_CONTRACTION,c5.BP_ GO biological process
1186,GO_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,c5.BP_ GO biological process
1187,GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,c5.BP_ GO biological process
1188,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN,C7_ immunologic signatures
1189,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,C7_ immunologic signatures
1190,E2F4DP1_01,c3.TFT_ transcription factor targets
1191,PEDRIOLI_MIR31_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1192,CCAWWNAAGG_SRF_Q4,c3.TFT_ transcription factor targets
1193,FOXD3_01,c3.TFT_ transcription factor targets
1194,HNF1_Q6,c3.TFT_ transcription factor targets
1195,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,C7_ immunologic signatures
1196,GO_CARDIAC_CONDUCTION,c5.BP_ GO biological process
1197,GO_3_5_CYCLIC_AMP_PHOSPHODIESTERASE_ACTIVITY,c5.GO molecular function
1198,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,c2.CGP_ chemical and genetic perturbations
1199,GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP,C7_ immunologic signatures
1200,GNF2_TIMP2,c4.CGN_ cancer gene neighborhoods
1201,GO_WALKING_BEHAVIOR,c5.BP_ GO biological process
1202,KEGG_REGULATION_OF_AUTOPHAGY,c2.CP_BIOCARTA_ BioCarta gene sets
1203,GO_CYTOSKELETON_DEPENDENT_CYTOKINESIS,c5.BP_ GO biological process
1204,REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING,c2.CP_REACTOME_ Reactome gene sets
1205,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,C7_ immunologic signatures
1206,GO_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,c5.BP_ GO biological process
1207,GSE22886_CTRL_VS_LPS_24H_DC_DN,C7_ immunologic signatures
1208,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,C7_ immunologic signatures
1209,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN,C7_ immunologic signatures
1210,GO_MATING_BEHAVIOR,c5.BP_ GO biological process
1211,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_UP,C7_ immunologic signatures
1212,SASAKI_ADULT_T_CELL_LEUKEMIA,c2.CGP_ chemical and genetic perturbations
1213,GO_AGING,c5.BP_ GO biological process
1214,REACTOME_CGMP_EFFECTS,c2.CP_REACTOME_ Reactome gene sets
1215,MODULE_329,c4.CM_ cancer modules
1216,P53_DN.V1_DN,C6_ oncogenic signatures
1217,YAATNANRNNNCAG_UNKNOWN,c3.TFT_ transcription factor targets
1218,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR,c2.CP_REACTOME_ Reactome gene sets
1219,RRAGTTGT_UNKNOWN,c3.TFT_ transcription factor targets
1220,HFH1_01,c3.TFT_ transcription factor targets
1221,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,c2.CGP_ chemical and genetic perturbations
1222,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,C7_ immunologic signatures
1223,TAGCTTT_MIR9,c3.MIR_ microRNA targets
1224,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,c2.CGP_ chemical and genetic perturbations
1225,GO_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,c5.BP_ GO biological process
1226,WHITFIELD_CELL_CYCLE_G1_S,c2.CGP_ chemical and genetic perturbations
1227,WEINMANN_ADAPTATION_TO_HYPOXIA_UP,c2.CGP_ chemical and genetic perturbations
1228,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN,C7_ immunologic signatures
1229,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,c2.CGP_ chemical and genetic perturbations
1230,ZHANG_TLX_TARGETS_36HR_UP,c2.CGP_ chemical and genetic perturbations
1231,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,C7_ immunologic signatures
1232,GO_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,c5.BP_ GO biological process
1233,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,C7_ immunologic signatures
1234,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,C7_ immunologic signatures
1235,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP,C7_ immunologic signatures
1236,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_UP,C7_ immunologic signatures
1237,BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN,c2.CGP_ chemical and genetic perturbations
1238,GO_NEGATIVE_REGULATION_OF_AXON_GUIDANCE,c5.BP_ GO biological process
1239,GO_AUDITORY_RECEPTOR_CELL_DIFFERENTIATION,c5.BP_ GO biological process
1240,GSE2706_UNSTIM_VS_2H_R848_DC_DN,C7_ immunologic signatures
1241,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
1242,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP,C7_ immunologic signatures
1243,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN,C7_ immunologic signatures
1244,GO_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS,c5.BP_ GO biological process
1245,GO_CELL_JUNCTION_ORGANIZATION,c5.BP_ GO biological process
1246,ZHU_CMV_8_HR_UP,c2.CGP_ chemical and genetic perturbations
1247,CHR9P22,30
1248,CARD_MIR302A_TARGETS,c2.CGP_ chemical and genetic perturbations
1249,GO_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
1250,THEODOROU_MAMMARY_TUMORIGENESIS,c2.CGP_ chemical and genetic perturbations
1251,GO_ODONTOGENESIS,c5.BP_ GO biological process
1252,GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,c2.CGP_ chemical and genetic perturbations
1253,ZHU_CMV_8_HR_DN,c2.CGP_ chemical and genetic perturbations
1254,GO_NEUROPILIN_BINDING,c5.GO molecular function
1255,GO_RESPIRATORY_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
1256,GO_ALPHA_ACTININ_BINDING,c5.GO molecular function
1257,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,c2.CGP_ chemical and genetic perturbations
1258,GO_ADULT_BEHAVIOR,c5.BP_ GO biological process
1259,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,c2.CGP_ chemical and genetic perturbations
1260,GO_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,c5.BP_ GO biological process
1261,GSE17721_LPS_VS_POLYIC_16H_BMDC_DN,C7_ immunologic signatures
1262,SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,c2.CGP_ chemical and genetic perturbations
1263,HOWLIN_CITED1_TARGETS_1_UP,c2.CGP_ chemical and genetic perturbations
1264,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP,C7_ immunologic signatures
1265,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
1266,CHR9Q31,40
1267,FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,c2.CGP_ chemical and genetic perturbations
1268,GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_CONTRACTION,c5.BP_ GO biological process
1269,REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS,c2.CP_REACTOME_ Reactome gene sets
1270,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP,C7_ immunologic signatures
1271,GO_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
1272,CHR6P22,54
1273,GO_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,c5.BP_ GO biological process
1274,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP,C7_ immunologic signatures
1275,PRC2_SUZ12_UP.V1_DN,C6_ oncogenic signatures
1276,GO_CELL_CORTEX,c5.CC_ GO cellular component
1277,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN,C7_ immunologic signatures
1278,CORRE_MULTIPLE_MYELOMA_UP,c2.CGP_ chemical and genetic perturbations
1279,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP,c2.CGP_ chemical and genetic perturbations
1280,GSE18893_TCONV_VS_TREG_24H_CULTURE_DN,C7_ immunologic signatures
1281,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,c2.CGP_ chemical and genetic perturbations
1282,GO_MESODERM_MORPHOGENESIS,c5.BP_ GO biological process
1283,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
1284,GO_REGULATION_OF_CELL_SUBSTRATE_ADHESION,c5.BP_ GO biological process
1285,GO_POSITIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
1286,CTGRYYYNATT_UNKNOWN,c3.TFT_ transcription factor targets
1287,TGCACTT_MIR519C_MIR519B_MIR519A,c3.MIR_ microRNA targets
1288,CHR5P15,48
1289,P53_DN.V1_UP,C6_ oncogenic signatures
1290,GO_CARDIAC_ATRIUM_DEVELOPMENT,c5.BP_ GO biological process
1291,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP,C7_ immunologic signatures
1292,SMID_BREAST_CANCER_LUMINAL_A_DN,c2.CGP_ chemical and genetic perturbations
1293,GNF2_MMP11,c4.CGN_ cancer gene neighborhoods
1294,GNF2_CDKN1C,c4.CGN_ cancer gene neighborhoods
1295,HNF3ALPHA_Q6,c3.TFT_ transcription factor targets
1296,GO_SCHWANN_CELL_DEVELOPMENT,c5.BP_ GO biological process
1297,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP,C7_ immunologic signatures
1298,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN,C7_ immunologic signatures
1299,REACTOME_CHROMOSOME_MAINTENANCE,c2.CP_REACTOME_ Reactome gene sets
1300,CHR15Q22,70
1301,GO_CELL_SUBSTRATE_ADHESION,c5.BP_ GO biological process
1302,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN,C7_ immunologic signatures
1303,GO_GLYCOLIPID_BINDING,c5.GO molecular function
1304,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,c2.CGP_ chemical and genetic perturbations
1305,GO_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
1306,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN,C7_ immunologic signatures
1307,KANNAN_TP53_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
1308,GNF2_EGFR,c4.CGN_ cancer gene neighborhoods
1309,SMAD3_Q6,c3.TFT_ transcription factor targets
1310,PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,c2.CGP_ chemical and genetic perturbations
1311,GO_INTERCALATED_DISC,c5.CC_ GO cellular component
1312,CTIP_DN.V1_UP,C6_ oncogenic signatures
1313,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,C7_ immunologic signatures
1314,GO_REGULATION_OF_OSSIFICATION,c5.BP_ GO biological process
1315,VECCHI_GASTRIC_CANCER_EARLY_UP,c2.CGP_ chemical and genetic perturbations
1316,BENPORATH_PRC2_TARGETS,c2.CGP_ chemical and genetic perturbations
1317,VECCHI_GASTRIC_CANCER_EARLY_DN,c2.CGP_ chemical and genetic perturbations
1318,BROWNE_HCMV_INFECTION_8HR_UP,c2.CGP_ chemical and genetic perturbations
1319,GO_NEGATIVE_REGULATION_OF_ORGANELLE_ORGANIZATION,c5.BP_ GO biological process
1320,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP,C7_ immunologic signatures
1321,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,c2.CGP_ chemical and genetic perturbations
1322,HUANG_DASATINIB_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
1323,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,C7_ immunologic signatures
1324,WINTER_HYPOXIA_DN,c2.CGP_ chemical and genetic perturbations
1325,GO_DNA_REPAIR,c5.BP_ GO biological process
1326,CHR3P14,30
1327,GO_MESONEPHROS_DEVELOPMENT,c5.BP_ GO biological process
1328,BIOCARTA_CELLCYCLE_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
1329,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
1330,RNCTGNYNRNCTGNY_UNKNOWN,c3.TFT_ transcription factor targets
1331,E2F1_UP.V1_UP,C6_ oncogenic signatures
1332,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,C7_ immunologic signatures
1333,GO_ARTERY_DEVELOPMENT,c5.BP_ GO biological process
1334,GO_POSITIVE_REGULATION_OF_WOUND_HEALING,c5.BP_ GO biological process
1335,NABA_COLLAGENS,c2.CP_ Canonical pathways
1336,GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
1337,GCNP_SHH_UP_LATE.V1_UP,C6_ oncogenic signatures
1338,NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN,c2.CGP_ chemical and genetic perturbations
1339,LIANG_SILENCED_BY_METHYLATION_2,c2.CGP_ chemical and genetic perturbations
1340,GO_AXO_DENDRITIC_TRANSPORT,c5.BP_ GO biological process
1341,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP,C7_ immunologic signatures
1342,IGLESIAS_E2F_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
1343,MODULE_60,c4.CM_ cancer modules
1344,GO_DEFENSE_RESPONSE_TO_VIRUS,c5.BP_ GO biological process
1345,GO_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,c5.BP_ GO biological process
1346,GO_LYSOPHOSPHOLIPASE_ACTIVITY,c5.GO molecular function
1347,MODULE_99,c4.CM_ cancer modules
1348,GO_CELL_MATRIX_ADHESION,c5.BP_ GO biological process
1349,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_UP,C7_ immunologic signatures
1350,ZHAN_MULTIPLE_MYELOMA_MS_UP,c2.CGP_ chemical and genetic perturbations
1351,LHX3_01,c3.TFT_ transcription factor targets
1352,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN,c2.CGP_ chemical and genetic perturbations
1353,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
1354,GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,c5.BP_ GO biological process
1355,ESC_J1_UP_LATE.V1_UP,C6_ oncogenic signatures
1356,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
1357,GO_AXONAL_GROWTH_CONE,c5.CC_ GO cellular component
1358,GO_SECRETORY_GRANULE_LUMEN,c5.CC_ GO cellular component
1359,GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP,C7_ immunologic signatures
1360,KIM_GERMINAL_CENTER_T_HELPER_DN,c2.CGP_ chemical and genetic perturbations
1361,MACLACHLAN_BRCA1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
1362,GO_AUTOPHAGOSOME_ORGANIZATION,c5.BP_ GO biological process
1363,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN,C7_ immunologic signatures
1364,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP,C7_ immunologic signatures
1365,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN,C7_ immunologic signatures
1366,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_UP,C7_ immunologic signatures
1367,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,c2.CGP_ chemical and genetic perturbations
1368,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
1369,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,c2.CGP_ chemical and genetic perturbations
1370,GO_FOREBRAIN_REGIONALIZATION,c5.BP_ GO biological process
1371,GO_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,c5.BP_ GO biological process
1372,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP,C7_ immunologic signatures
1373,CAR_IGFBP1,c4.CGN_ cancer gene neighborhoods
1374,WOO_LIVER_CANCER_RECURRENCE_UP,c2.CGP_ chemical and genetic perturbations
1375,GO_VASCULATURE_DEVELOPMENT,c5.BP_ GO biological process
1376,DOUGLAS_BMI1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1377,RIZ_ERYTHROID_DIFFERENTIATION_12HR,c2.CGP_ chemical and genetic perturbations
1378,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,c2.CGP_ chemical and genetic perturbations
1379,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP,C7_ immunologic signatures
1380,GO_REGULATION_OF_CELL_GROWTH,c5.BP_ GO biological process
1381,GO_PEPTIDE_HORMONE_BINDING,c5.GO molecular function
1382,BCAT.100_UP.V1_DN,C6_ oncogenic signatures
1383,GO_REPRODUCTIVE_BEHAVIOR,c5.BP_ GO biological process
1384,GO_CELL_CELL_CONTACT_ZONE,c5.CC_ GO cellular component
1385,REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,c2.CP_REACTOME_ Reactome gene sets
1386,GO_MULTICELLULAR_ORGANISM_METABOLIC_PROCESS,c5.BP_ GO biological process
1387,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,C7_ immunologic signatures
1388,GSE369_SOCS3_KO_VS_WT_LIVER_DN,C7_ immunologic signatures
1389,GO_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,c5.BP_ GO biological process
1390,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN,C7_ immunologic signatures
1391,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN,C7_ immunologic signatures
1392,GO_ACTIN_BINDING,c5.GO molecular function
1393,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN,C7_ immunologic signatures
1394,MORF_BUB1B,c4.CGN_ cancer gene neighborhoods
1395,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP,C7_ immunologic signatures
1396,GO_DNA_DEPENDENT_DNA_REPLICATION,c5.BP_ GO biological process
1397,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,c2.CGP_ chemical and genetic perturbations
1398,GO_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,c5.BP_ GO biological process
1399,GO_RESPONSE_TO_IONIZING_RADIATION,c5.BP_ GO biological process
1400,GO_NEURON_RECOGNITION,c5.BP_ GO biological process
1401,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,C7_ immunologic signatures
1402,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_DN,C7_ immunologic signatures
1403,GSE3982_DC_VS_TH2_DN,C7_ immunologic signatures
1404,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP,C7_ immunologic signatures
1405,GO_PERICENTRIOLAR_MATERIAL,c5.CC_ GO cellular component
1406,GSE2706_2H_VS_8H_LPS_STIM_DC_DN,C7_ immunologic signatures
1407,GO_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,c5.BP_ GO biological process
1408,GO_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION,c5.BP_ GO biological process
1409,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN,C7_ immunologic signatures
1410,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,C7_ immunologic signatures
1411,GO_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY,c5.BP_ GO biological process
1412,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
1413,SENESE_HDAC2_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1414,GO_CYTOKINESIS,c5.BP_ GO biological process
1415,WINZEN_DEGRADED_VIA_KHSRP,c2.CGP_ chemical and genetic perturbations
1416,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_DN,C7_ immunologic signatures
1417,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,c2.CGP_ chemical and genetic perturbations
1418,GSE30083_SP2_VS_SP3_THYMOCYTE_UP,C7_ immunologic signatures
1419,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,C7_ immunologic signatures
1420,AFFAR_YY1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1421,GO_ACTOMYOSIN,c5.CC_ GO cellular component
1422,PID_ATF2_PATHWAY,c2.CP_ Canonical pathways
1423,GO_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,c5.BP_ GO biological process
1424,NOJIMA_SFRP2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
1425,LU_EZH2_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1426,CHR14Q11,102
1427,TATTATA_MIR374,c3.MIR_ microRNA targets
1428,REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
1429,BIOCARTA_ECM_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
1430,GO_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY,c5.BP_ GO biological process
1431,GO_ESTABLISHMENT_OF_MITOTIC_SPINDLE_LOCALIZATION,c5.BP_ GO biological process
1432,GO_SYNAPTONEMAL_COMPLEX,c5.CC_ GO cellular component
1433,FREAC4_01,c3.TFT_ transcription factor targets
1434,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
1435,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_UP,C7_ immunologic signatures
1436,KORKOLA_YOLK_SAC_TUMOR,c2.CGP_ chemical and genetic perturbations
1437,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1438,FURUKAWA_DUSP6_TARGETS_PCI35_UP,c2.CGP_ chemical and genetic perturbations
1439,GO_RESPONSE_TO_CALCIUM_ION,c5.BP_ GO biological process
1440,ONDER_CDH1_TARGETS_1_UP,c2.CGP_ chemical and genetic perturbations
1441,GO_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
1442,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN,c2.CGP_ chemical and genetic perturbations
1443,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,c2.CGP_ chemical and genetic perturbations
1444,E2F1DP2_01,c3.TFT_ transcription factor targets
1445,BROWNE_HCMV_INFECTION_24HR_DN,c2.CGP_ chemical and genetic perturbations
1446,GO_RESPONSE_TO_PROSTAGLANDIN,c5.BP_ GO biological process
1447,GO_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
1448,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,c2.CGP_ chemical and genetic perturbations
1449,GO_POSITIVE_REGULATION_OF_LIPASE_ACTIVITY,c5.BP_ GO biological process
1450,WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN,c2.CGP_ chemical and genetic perturbations
1451,EVI1_05,c3.TFT_ transcription factor targets
1452,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP,c2.CGP_ chemical and genetic perturbations
1453,GO_REGULATION_OF_MAST_CELL_ACTIVATION,c5.BP_ GO biological process
1454,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP,C7_ immunologic signatures
1455,E2F1DP1_01,c3.TFT_ transcription factor targets
1456,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
1457,GO_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,c5.BP_ GO biological process
1458,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP,C7_ immunologic signatures
1459,GO_CELL_FATE_COMMITMENT,c5.BP_ GO biological process
1460,GO_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS,c5.GO molecular function
1461,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,c2.CGP_ chemical and genetic perturbations
1462,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,C7_ immunologic signatures
1463,GO_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,c5.BP_ GO biological process
1464,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP,C7_ immunologic signatures
1465,E2F_02,c3.TFT_ transcription factor targets
1466,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,C7_ immunologic signatures
1467,MODULE_24,c4.CM_ cancer modules
1468,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_UP,C7_ immunologic signatures
1469,GO_POSITIVE_REGULATION_OF_MUSCLE_HYPERTROPHY,c5.BP_ GO biological process
1470,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN,C7_ immunologic signatures
1471,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,C7_ immunologic signatures
1472,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,c2.CGP_ chemical and genetic perturbations
1473,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_DN,C7_ immunologic signatures
1474,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,c2.CGP_ chemical and genetic perturbations
1475,GO_GASTRULATION,c5.BP_ GO biological process
1476,GO_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT,c5.BP_ GO biological process
1477,GO_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,c5.BP_ GO biological process
1478,GO_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_MEDIATED_BY_A_CHEMICAL_SIGNAL,c5.BP_ GO biological process
1479,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN,C7_ immunologic signatures
1480,GO_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE,c5.BP_ GO biological process
1481,GTGCCAA_MIR96,c3.MIR_ microRNA targets
1482,GO_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,c5.BP_ GO biological process
1483,GSE17721_0.5H_VS_12H_CPG_BMDC_DN,C7_ immunologic signatures
1484,GO_GLYCEROLIPID_CATABOLIC_PROCESS,c5.BP_ GO biological process
1485,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,c2.CGP_ chemical and genetic perturbations
1486,KRAS.DF.V1_DN,C6_ oncogenic signatures
1487,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
1488,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_DN,C7_ immunologic signatures
1489,GO_OLFACTORY_LOBE_DEVELOPMENT,c5.BP_ GO biological process
1490,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B,c2.CGP_ chemical and genetic perturbations
1491,HADDAD_B_LYMPHOCYTE_PROGENITOR,c2.CGP_ chemical and genetic perturbations
1492,PID_BMP_PATHWAY,c2.CP_ Canonical pathways
1493,GO_CELLULAR_RESPONSE_TO_RADIATION,c5.BP_ GO biological process
1494,MODULE_493,c4.CM_ cancer modules
1495,MORF_STK17A,c4.CGN_ cancer gene neighborhoods
1496,GO_POSITIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION,c5.BP_ GO biological process
1497,VANHARANTA_UTERINE_FIBROID_DN,c2.CGP_ chemical and genetic perturbations
1498,GO_POSITIVE_REGULATION_OF_MAPK_CASCADE,c5.BP_ GO biological process
1499,GSE34515_CD16_POS_MONOCYTE_VS_DC_DN,C7_ immunologic signatures
1500,GO_POSITIVE_REGULATION_OF_BLOOD_CIRCULATION,c5.BP_ GO biological process
1501,REACTOME_INTERFERON_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
1502,GSE557_CIITA_KO_VS_I_AB_KO_DC_UP,C7_ immunologic signatures
1503,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,C7_ immunologic signatures
1504,GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP,C7_ immunologic signatures
1505,CATTGTYY_SOX9_B1,c3.TFT_ transcription factor targets
1506,GO_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,c5.BP_ GO biological process
1507,REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS,c2.CP_REACTOME_ Reactome gene sets
1508,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP,C7_ immunologic signatures
1509,ZHANG_INTERFERON_RESPONSE,c2.CGP_ chemical and genetic perturbations
1510,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_UP,C7_ immunologic signatures
1511,GO_MIDBODY,c5.CC_ GO cellular component
1512,GO_OSSIFICATION,c5.BP_ GO biological process
1513,LI_CISPLATIN_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
1514,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,C7_ immunologic signatures
1515,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP,C7_ immunologic signatures
1516,GO_NOTOCHORD_DEVELOPMENT,c5.BP_ GO biological process
1517,SANA_TNF_SIGNALING_DN,c2.CGP_ chemical and genetic perturbations
1518,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,C7_ immunologic signatures
1519,GO_DNA_DOUBLE_STRAND_BREAK_PROCESSING,c5.BP_ GO biological process
1520,GSE30083_SP1_VS_SP3_THYMOCYTE_DN,C7_ immunologic signatures
1521,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP,C7_ immunologic signatures
1522,GSE36009_WT_VS_NLRP10_KO_DC_UP,C7_ immunologic signatures
1523,WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP,c2.CGP_ chemical and genetic perturbations
1524,GO_ESTABLISHMENT_OF_CELL_POLARITY,c5.BP_ GO biological process
1525,E2F4DP2_01,c3.TFT_ transcription factor targets
1526,GO_REGULATION_OF_METAL_ION_TRANSPORT,c5.BP_ GO biological process
1527,REACTOME_PHOSPHORYLATION_OF_THE_APC_C,c2.CP_REACTOME_ Reactome gene sets
1528,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_UP,C7_ immunologic signatures
1529,MEL18_DN.V1_DN,C6_ oncogenic signatures
1530,GO_RESPONSE_TO_CAMP,c5.BP_ GO biological process
1531,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,C7_ immunologic signatures
1532,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_DN,C7_ immunologic signatures
1533,TRAYNOR_RETT_SYNDROM_DN,c2.CGP_ chemical and genetic perturbations
1534,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN,C7_ immunologic signatures
1535,CHR14Q24,80
1536,GO_CALCIUM_ION_IMPORT_INTO_CYTOSOL,c5.BP_ GO biological process
1537,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,C7_ immunologic signatures
1538,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
1539,MODULE_202,c4.CM_ cancer modules
1540,GO_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS,c5.BP_ GO biological process
1541,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN,C7_ immunologic signatures
1542,GSE37532_WT_VS_PPARG_KO_LN_TREG_DN,C7_ immunologic signatures
1543,CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,c2.CGP_ chemical and genetic perturbations
1544,GO_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_3_PHOSPHOMONOESTERS,c5.GO molecular function
1545,KRAS.LUNG.BREAST_UP.V1_DN,C6_ oncogenic signatures
1546,GO_ENDODERMAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
1547,XU_GH1_EXOGENOUS_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1548,GO_CENTRAL_NERVOUS_SYSTEM_NEURON_AXONOGENESIS,c5.BP_ GO biological process
1549,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,c2.CGP_ chemical and genetic perturbations
1550,KEGG_CALCIUM_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
1551,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
1552,GO_CELLULAR_RESPONSE_TO_ALCOHOL,c5.BP_ GO biological process
1553,GO_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION,c5.BP_ GO biological process
1554,GO_MITOTIC_CYTOKINESIS,c5.BP_ GO biological process
1555,CHR8P21,67
1556,GO_EAR_DEVELOPMENT,c5.BP_ GO biological process
1557,TAVOR_CEBPA_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
1558,BIDUS_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
1559,GO_KIDNEY_EPITHELIUM_DEVELOPMENT,c5.BP_ GO biological process
1560,REACTOME_NCAM1_INTERACTIONS,c2.CP_REACTOME_ Reactome gene sets
1561,GO_MICROTUBULE_PLUS_END,c5.CC_ GO cellular component
1562,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,c2.CGP_ chemical and genetic perturbations
1563,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP,C7_ immunologic signatures
1564,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP,C7_ immunologic signatures
1565,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP,C7_ immunologic signatures
1566,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION,c2.CP_REACTOME_ Reactome gene sets
1567,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN,C7_ immunologic signatures
1568,GO_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION,c5.BP_ GO biological process
1569,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,c2.CGP_ chemical and genetic perturbations
1570,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,c2.CGP_ chemical and genetic perturbations
1571,GO_REGULATION_OF_MEMBRANE_REPOLARIZATION,c5.BP_ GO biological process
1572,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP,C7_ immunologic signatures
1573,ZHAN_LATE_DIFFERENTIATION_GENES_DN,c2.CGP_ chemical and genetic perturbations
1574,CHR7Q36,50
1575,GO_SARCOLEMMA,c5.CC_ GO cellular component
1576,GO_PERICARDIUM_DEVELOPMENT,c5.BP_ GO biological process
1577,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN,C7_ immunologic signatures
1578,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,C7_ immunologic signatures
1579,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,c2.CGP_ chemical and genetic perturbations
1580,VALK_AML_CLUSTER_10,c2.CGP_ chemical and genetic perturbations
1581,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN,C7_ immunologic signatures
1582,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,C7_ immunologic signatures
1583,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,c2.CGP_ chemical and genetic perturbations
1584,GO_POSITIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,c5.BP_ GO biological process
1585,MODULE_419,c4.CM_ cancer modules
1586,CERVERA_SDHB_TARGETS_1_UP,c2.CGP_ chemical and genetic perturbations
1587,GO_SEGMENTATION,c5.BP_ GO biological process
1588,GO_REGULATION_OF_MEIOTIC_CELL_CYCLE,c5.BP_ GO biological process
1589,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN,C7_ immunologic signatures
1590,MODULE_129,c4.CM_ cancer modules
1591,JAEGER_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
1592,GSE360_CTRL_VS_T_GONDII_DC_DN,C7_ immunologic signatures
1593,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,c2.CGP_ chemical and genetic perturbations
1594,GO_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,c5.BP_ GO biological process
1595,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP,C7_ immunologic signatures
1596,KONDO_EZH2_TARGETS,c2.CGP_ chemical and genetic perturbations
1597,SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,c2.CGP_ chemical and genetic perturbations
1598,GO_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,c5.BP_ GO biological process
1599,GO_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS,c5.BP_ GO biological process
1600,GO_CELL_MATURATION,c5.BP_ GO biological process
1601,HMEF2_Q6,c3.TFT_ transcription factor targets
1602,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,c2.CGP_ chemical and genetic perturbations
1603,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,c2.CGP_ chemical and genetic perturbations
1604,REACTOME_MEIOSIS,c2.CP_REACTOME_ Reactome gene sets
1605,MODULE_573,c4.CM_ cancer modules
1606,BROWNE_HCMV_INFECTION_4HR_UP,c2.CGP_ chemical and genetic perturbations
1607,RICKMAN_HEAD_AND_NECK_CANCER_A,c2.CGP_ chemical and genetic perturbations
1608,RASHI_RESPONSE_TO_IONIZING_RADIATION_4,c2.CGP_ chemical and genetic perturbations
1609,GO_ACTIN_FILAMENT_BUNDLE,c5.CC_ GO cellular component
1610,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,C7_ immunologic signatures
1611,GO_ARTERY_MORPHOGENESIS,c5.BP_ GO biological process
1612,GO_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION,c5.BP_ GO biological process
1613,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
1614,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN,C7_ immunologic signatures
1615,KENNY_CTNNB1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
1616,LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,c2.CGP_ chemical and genetic perturbations
1617,GO_REGULATION_OF_INTERLEUKIN_2_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
1618,GO_REGULATION_OF_MACROPHAGE_ACTIVATION,c5.BP_ GO biological process
1619,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,C7_ immunologic signatures
1620,GO_MUSCLE_ADAPTATION,c5.BP_ GO biological process
1621,GO_REGULATION_OF_NFAT_PROTEIN_IMPORT_INTO_NUCLEUS,c5.BP_ GO biological process
1622,AFP1_Q6,c3.TFT_ transcription factor targets
1623,GGCCAGT_MIR193A_MIR193B,c3.MIR_ microRNA targets
1624,NAKAMURA_CANCER_MICROENVIRONMENT_DN,c2.CGP_ chemical and genetic perturbations
1625,EVI1_04,c3.TFT_ transcription factor targets
1626,BENPORATH_NOS_TARGETS,c2.CGP_ chemical and genetic perturbations
1627,GO_LUNG_EPITHELIUM_DEVELOPMENT,c5.BP_ GO biological process
1628,GO_LEUKOCYTE_MEDIATED_CYTOTOXICITY,c5.BP_ GO biological process
1629,REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,c2.CP_REACTOME_ Reactome gene sets
1630,GSE3982_BASOPHIL_VS_TH1_UP,C7_ immunologic signatures
1631,GO_ADAPTATION_OF_SIGNALING_PATHWAY,c5.BP_ GO biological process
1632,RODRIGUES_DCC_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1633,MODULE_252,c4.CM_ cancer modules
1634,MORF_FLT1,c4.CGN_ cancer gene neighborhoods
1635,GO_CELL_DIVISION_SITE,c5.CC_ GO cellular component
1636,GO_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,c5.BP_ GO biological process
1637,ROY_WOUND_BLOOD_VESSEL_UP,c2.CGP_ chemical and genetic perturbations
1638,PITX2_Q2,c3.TFT_ transcription factor targets
1639,KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,c2.CP_BIOCARTA_ BioCarta gene sets
1640,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_DN,C7_ immunologic signatures
1641,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,C7_ immunologic signatures
1642,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN,C7_ immunologic signatures
1643,MODULE_100,c4.CM_ cancer modules
1644,SENESE_HDAC1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1645,BAELDE_DIABETIC_NEPHROPATHY_DN,c2.CGP_ chemical and genetic perturbations
1646,MODULE_342,c4.CM_ cancer modules
1647,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
1648,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP,C7_ immunologic signatures
1649,PEREZ_TP63_TARGETS,c2.CGP_ chemical and genetic perturbations
1650,BENPORATH_ES_CORE_NINE_CORRELATED,c2.CGP_ chemical and genetic perturbations
1651,PID_WNT_SIGNALING_PATHWAY,c2.CP_ Canonical pathways
1652,GO_LUNG_CELL_DIFFERENTIATION,c5.BP_ GO biological process
1653,BROWNE_HCMV_INFECTION_12HR_DN,c2.CGP_ chemical and genetic perturbations
1654,GO_PLATELET_ALPHA_GRANULE_LUMEN,c5.CC_ GO cellular component
1655,CHR4Q35,24
1656,GO_NEGATIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,c5.BP_ GO biological process
1657,AREB6_04,c3.TFT_ transcription factor targets
1658,GO_DEVELOPMENTAL_MATURATION,c5.BP_ GO biological process
1659,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,c2.CGP_ chemical and genetic perturbations
1660,GO_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,c5.BP_ GO biological process
1661,LABBE_WNT3A_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
1662,GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP,C7_ immunologic signatures
1663,GO_REGULATION_OF_ERBB_SIGNALING_PATHWAY,c5.BP_ GO biological process
1664,GO_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM,c5.BP_ GO biological process
1665,LUI_THYROID_CANCER_CLUSTER_1,c2.CGP_ chemical and genetic perturbations
1666,GO_RESPONSE_TO_RADIATION,c5.BP_ GO biological process
1667,GO_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,c5.BP_ GO biological process
1668,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,C7_ immunologic signatures
1669,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_DN,C7_ immunologic signatures
1670,MODULE_137,c4.CM_ cancer modules
1671,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,C7_ immunologic signatures
1672,CHR2P24,44
1673,CHR15Q21,76
1674,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
1675,GO_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
1676,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,C7_ immunologic signatures
1677,GO_REGULATION_OF_PROTEIN_MATURATION,c5.BP_ GO biological process
1678,ONDER_CDH1_SIGNALING_VIA_CTNNB1,c2.CGP_ chemical and genetic perturbations
1679,GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP,C7_ immunologic signatures
1680,GO_LOCOMOTORY_BEHAVIOR,c5.BP_ GO biological process
1681,MODULE_52,c4.CM_ cancer modules
1682,MODULE_524,c4.CM_ cancer modules
1683,HNF3_Q6,c3.TFT_ transcription factor targets
1684,GSE7460_CD8_TCELL_VS_TREG_ACT_DN,C7_ immunologic signatures
1685,HOEGERKORP_CD44_TARGETS_TEMPORAL_DN,c2.CGP_ chemical and genetic perturbations
1686,TTTGCAC_MIR19A_MIR19B,c3.MIR_ microRNA targets
1687,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,c2.CGP_ chemical and genetic perturbations
1688,CHR9Q22,61
1689,GO_PHOSPHOLIPID_BINDING,c5.GO molecular function
1690,GO_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,c5.BP_ GO biological process
1691,TTANWNANTGGM_UNKNOWN,c3.TFT_ transcription factor targets
1692,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,C7_ immunologic signatures
1693,GO_POSITIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY,c5.BP_ GO biological process
1694,GO_RESPONSE_TO_DIETARY_EXCESS,c5.BP_ GO biological process
1695,GO_NEURON_MATURATION,c5.BP_ GO biological process
1696,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,c2.CGP_ chemical and genetic perturbations
1697,GO_HEAD_MORPHOGENESIS,c5.BP_ GO biological process
1698,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP,C7_ immunologic signatures
1699,GO_RESPONSE_TO_EPINEPHRINE,c5.BP_ GO biological process
1700,GO_NEGATIVE_REGULATION_OF_AXON_EXTENSION,c5.BP_ GO biological process
1701,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP,c2.CGP_ chemical and genetic perturbations
1702,MODULE_85,c4.CM_ cancer modules
1703,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN,C7_ immunologic signatures
1704,GO_ENDOTHELIAL_CELL_PROLIFERATION,c5.BP_ GO biological process
1705,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,c2.CGP_ chemical and genetic perturbations
1706,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN,C7_ immunologic signatures
1707,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,c2.CGP_ chemical and genetic perturbations
1708,GO_MONOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
1709,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,C7_ immunologic signatures
1710,BIOCARTA_NO1_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
1711,DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY,c2.CGP_ chemical and genetic perturbations
1712,REACTOME_DOUBLE_STRAND_BREAK_REPAIR,c2.CP_REACTOME_ Reactome gene sets
1713,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,c2.CGP_ chemical and genetic perturbations
1714,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN,C7_ immunologic signatures
1715,GO_PROTEIN_POLYMERIZATION,c5.BP_ GO biological process
1716,GSE3039_B2_VS_B1_BCELL_UP,C7_ immunologic signatures
1717,GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN,C7_ immunologic signatures
1718,GO_KERATINOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
1719,TTAYRTAA_E4BP4_01,c3.TFT_ transcription factor targets
1720,CHR13Q13,20
1721,JAK2_DN.V1_UP,C6_ oncogenic signatures
1722,REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,c2.CP_REACTOME_ Reactome gene sets
1723,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5,c2.CGP_ chemical and genetic perturbations
1724,GO_NEGATIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
1725,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP,C7_ immunologic signatures
1726,GO_NEGATIVE_REGULATION_OF_CELL_GROWTH,c5.BP_ GO biological process
1727,MODULE_66,c4.CM_ cancer modules
1728,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_UP,C7_ immunologic signatures
1729,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,C7_ immunologic signatures
1730,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN,C7_ immunologic signatures
1731,GO_POSITIVE_REGULATION_OF_HEART_RATE,c5.BP_ GO biological process
1732,GO_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,c5.BP_ GO biological process
1733,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,C7_ immunologic signatures
1734,FOXO1_01,c3.TFT_ transcription factor targets
1735,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN,C7_ immunologic signatures
1736,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN,C7_ immunologic signatures
1737,PID_LYMPH_ANGIOGENESIS_PATHWAY,c2.CP_ Canonical pathways
1738,KEGG_DILATED_CARDIOMYOPATHY,c2.CP_BIOCARTA_ BioCarta gene sets
1739,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP,C7_ immunologic signatures
1740,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN,C7_ immunologic signatures
1741,GO_CIRCULATORY_SYSTEM_PROCESS,c5.BP_ GO biological process
1742,GO_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
1743,POOLA_INVASIVE_BREAST_CANCER_DN,c2.CGP_ chemical and genetic perturbations
1744,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN,C7_ immunologic signatures
1745,CASTELLANO_NRAS_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
1746,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
1747,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,C7_ immunologic signatures
1748,MODULE_198,c4.CM_ cancer modules
1749,GO_NEGATIVE_REGULATION_OF_ANION_TRANSPORT,c5.BP_ GO biological process
1750,GO_ESTABLISHMENT_OF_SPINDLE_ORIENTATION,c5.BP_ GO biological process
1751,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,C7_ immunologic signatures
1752,CHR7P14,32
1753,GO_SULFUR_COMPOUND_CATABOLIC_PROCESS,c5.BP_ GO biological process
1754,GO_STRIATED_MUSCLE_ADAPTATION,c5.BP_ GO biological process
1755,GO_RESPONSE_TO_ALCOHOL,c5.BP_ GO biological process
1756,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
1757,GO_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY,c5.BP_ GO biological process
1758,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
1759,GSE37532_WT_VS_PPARG_KO_LN_TCONV_DN,C7_ immunologic signatures
1760,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_UP,C7_ immunologic signatures
1761,REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK,c2.CP_REACTOME_ Reactome gene sets
1762,ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF,c2.CGP_ chemical and genetic perturbations
1763,GO_CALCIUM_DEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,c5.BP_ GO biological process
1764,GSE2706_UNSTIM_VS_8H_LPS_DC_DN,C7_ immunologic signatures
1765,PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,c2.CP_ Canonical pathways
1766,KAMIKUBO_MYELOID_MN1_NETWORK,c2.CGP_ chemical and genetic perturbations
1767,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,c2.CGP_ chemical and genetic perturbations
1768,GO_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
1769,REACTOME_RAP1_SIGNALLING,c2.CP_REACTOME_ Reactome gene sets
1770,UROSEVIC_RESPONSE_TO_IMIQUIMOD,c2.CGP_ chemical and genetic perturbations
1771,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_DN,C7_ immunologic signatures
1772,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,C7_ immunologic signatures
1773,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN,C7_ immunologic signatures
1774,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN,c2.CGP_ chemical and genetic perturbations
1775,GO_REGULATION_OF_COAGULATION,c5.BP_ GO biological process
1776,POU1F1_Q6,c3.TFT_ transcription factor targets
1777,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,C7_ immunologic signatures
1778,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
1779,BURTON_ADIPOGENESIS_PEAK_AT_2HR,c2.CGP_ chemical and genetic perturbations
1780,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP,C7_ immunologic signatures
1781,OCT1_07,c3.TFT_ transcription factor targets
1782,GO_ACTIVATION_OF_ADENYLATE_CYCLASE_ACTIVITY,c5.BP_ GO biological process
1783,IL21_UP.V1_DN,C6_ oncogenic signatures
1784,GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY,c5.GO molecular function
1785,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,C7_ immunologic signatures
1786,GO_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION,c5.BP_ GO biological process
1787,GO_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,c5.BP_ GO biological process
1788,GO_DESMOSOME,c5.CC_ GO cellular component
1789,E2F3_UP.V1_UP,C6_ oncogenic signatures
1790,XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,c2.CGP_ chemical and genetic perturbations
1791,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP,C7_ immunologic signatures
1792,KIM_MYC_AMPLIFICATION_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1793,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
1794,GO_CYTOPLASMIC_REGION,c5.CC_ GO cellular component
1795,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,c2.CGP_ chemical and genetic perturbations
1796,KEEN_RESPONSE_TO_ROSIGLITAZONE_DN,c2.CGP_ chemical and genetic perturbations
1797,GO_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,c5.BP_ GO biological process
1798,GAL_LEUKEMIC_STEM_CELL_UP,c2.CGP_ chemical and genetic perturbations
1799,GO_CELLULAR_RESPONSE_TO_ALKALOID,c5.BP_ GO biological process
1800,AP2REP_01,c3.TFT_ transcription factor targets
1801,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN,C7_ immunologic signatures
1802,KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,c2.CP_BIOCARTA_ BioCarta gene sets
1803,WANG_RESPONSE_TO_BEXAROTENE_DN,c2.CGP_ chemical and genetic perturbations
1804,CROMER_TUMORIGENESIS_UP,c2.CGP_ chemical and genetic perturbations
1805,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP,C7_ immunologic signatures
1806,BMI1_DN_MEL18_DN.V1_DN,C6_ oncogenic signatures
1807,JI_METASTASIS_REPRESSED_BY_STK11,c2.CGP_ chemical and genetic perturbations
1808,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,c2.CGP_ chemical and genetic perturbations
1809,FINAK_BREAST_CANCER_SDPP_SIGNATURE,c2.CGP_ chemical and genetic perturbations
1810,NABA_ECM_REGULATORS,c2.CP_ Canonical pathways
1811,GO_CYTOPLASMIC_MICROTUBULE,c5.CC_ GO cellular component
1812,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_UP,C7_ immunologic signatures
1813,CAHOY_ASTROGLIAL,C6_ oncogenic signatures
1814,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN,c2.CGP_ chemical and genetic perturbations
1815,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
1816,MODULE_58,c4.CM_ cancer modules
1817,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,C7_ immunologic signatures
1818,MEF2_02,c3.TFT_ transcription factor targets
1819,BROWNE_HCMV_INFECTION_30MIN_UP,c2.CGP_ chemical and genetic perturbations
1820,GO_SKELETAL_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
1821,GSE17721_0.5H_VS_8H_CPG_BMDC_DN,C7_ immunologic signatures
1822,GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY,c5.GO molecular function
1823,GO_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
1824,GSE7460_TREG_VS_TCONV_ACT_UP,C7_ immunologic signatures
1825,GO_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
1826,CAGTATT_MIR200B_MIR200C_MIR429,c3.MIR_ microRNA targets
1827,CHUNG_BLISTER_CYTOTOXICITY_DN,c2.CGP_ chemical and genetic perturbations
1828,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,c2.CGP_ chemical and genetic perturbations
1829,KIM_WT1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1830,GO_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,c5.BP_ GO biological process
1831,GO_APICAL_JUNCTION_COMPLEX,c5.CC_ GO cellular component
1832,BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,c2.CGP_ chemical and genetic perturbations
1833,GO_NEGATIVE_REGULATION_OF_CELL_ACTIVATION,c5.BP_ GO biological process
1834,FRASOR_RESPONSE_TO_ESTRADIOL_DN,c2.CGP_ chemical and genetic perturbations
1835,MODULE_222,c4.CM_ cancer modules
1836,GO_ADRENERGIC_RECEPTOR_BINDING,c5.GO molecular function
1837,NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP,c2.CGP_ chemical and genetic perturbations
1838,GO_NEURAL_PRECURSOR_CELL_PROLIFERATION,c5.BP_ GO biological process
1839,MAHADEVAN_RESPONSE_TO_MP470_DN,c2.CGP_ chemical and genetic perturbations
1840,BIOCARTA_SPPA_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
1841,PID_P73PATHWAY,c2.CP_ Canonical pathways
1842,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN,C7_ immunologic signatures
1843,GO_SENSORY_ORGAN_MORPHOGENESIS,c5.BP_ GO biological process
1844,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP,c2.CGP_ chemical and genetic perturbations
1845,CCCAGAG_MIR326,c3.MIR_ microRNA targets
1846,GSE7460_TCONV_VS_TREG_LN_DN,C7_ immunologic signatures
1847,GO_DEVELOPMENTAL_INDUCTION,c5.BP_ GO biological process
1848,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN,C7_ immunologic signatures
1849,MODULE_213,c4.CM_ cancer modules
1850,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_UP,C7_ immunologic signatures
1851,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
1852,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,c2.CGP_ chemical and genetic perturbations
1853,PILON_KLF1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
1854,GO_NEURON_PROJECTION_REGENERATION,c5.BP_ GO biological process
1855,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,c2.CGP_ chemical and genetic perturbations
1856,PRC2_EZH2_UP.V1_UP,C6_ oncogenic signatures
1857,GO_PRIMARY_LYSOSOME,c5.CC_ GO cellular component
1858,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
1859,GO_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,c5.BP_ GO biological process
1860,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,C7_ immunologic signatures
1861,CSR_EARLY_UP.V1_DN,C6_ oncogenic signatures
1862,GO_REGULATION_OF_DNA_METABOLIC_PROCESS,c5.BP_ GO biological process
1863,POOLA_INVASIVE_BREAST_CANCER_UP,c2.CGP_ chemical and genetic perturbations
1864,GO_CELL_AGGREGATION,c5.BP_ GO biological process
1865,XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,c2.CGP_ chemical and genetic perturbations
1866,GO_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS,c5.BP_ GO biological process
1867,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP,C7_ immunologic signatures
1868,GO_NEGATIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,c5.BP_ GO biological process
1869,GO_NEGATIVE_REGULATION_OF_CELL_ADHESION,c5.BP_ GO biological process
1870,SAGIV_CD24_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
1871,GO_GLUTAMATE_RECEPTOR_ACTIVITY,c5.GO molecular function
1872,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN,C7_ immunologic signatures
1873,GO_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,c5.BP_ GO biological process
1874,MIZUSHIMA_AUTOPHAGOSOME_FORMATION,c2.CGP_ chemical and genetic perturbations
1875,GO_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
1876,GO_EMBRYONIC_PATTERN_SPECIFICATION,c5.BP_ GO biological process
1877,KRIGE_AMINO_ACID_DEPRIVATION,c2.CGP_ chemical and genetic perturbations
1878,GO_ADHERENS_JUNCTION_ORGANIZATION,c5.BP_ GO biological process
1879,GO_PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY,c5.GO molecular function
1880,GO_RESPONSE_TO_ISOQUINOLINE_ALKALOID,c5.BP_ GO biological process
1881,MODULE_11,c4.CM_ cancer modules
1882,TGFB_UP.V1_DN,C6_ oncogenic signatures
1883,RIGGINS_TAMOXIFEN_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
1884,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,C7_ immunologic signatures
1885,GO_ATP_DEPENDENT_CHROMATIN_REMODELING,c5.BP_ GO biological process
1886,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,c2.CGP_ chemical and genetic perturbations
1887,GROSS_HYPOXIA_VIA_ELK3_UP,c2.CGP_ chemical and genetic perturbations
1888,GO_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE,c5.BP_ GO biological process
1889,HOXA4_Q2,c3.TFT_ transcription factor targets
1890,GO_REGULATION_OF_ERK1_AND_ERK2_CASCADE,c5.BP_ GO biological process
1891,THUM_SYSTOLIC_HEART_FAILURE_UP,c2.CGP_ chemical and genetic perturbations
1892,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,c2.CGP_ chemical and genetic perturbations
1893,GO_FOREBRAIN_NEURON_DEVELOPMENT,c5.BP_ GO biological process
1894,GO_ENDODERM_FORMATION,c5.BP_ GO biological process
1895,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP,C7_ immunologic signatures
1896,GO_NEGATIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,c5.BP_ GO biological process
1897,GO_SUBPALLIUM_DEVELOPMENT,c5.BP_ GO biological process
1898,GO_DIENCEPHALON_DEVELOPMENT,c5.BP_ GO biological process
1899,GO_POSITIVE_REGULATION_OF_JUN_KINASE_ACTIVITY,c5.BP_ GO biological process
1900,GSE40273_EOS_KO_VS_WT_TREG_DN,C7_ immunologic signatures
1901,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
1902,CHR17Q22,20
1903,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,C7_ immunologic signatures
1904,GO_ADULT_LOCOMOTORY_BEHAVIOR,c5.BP_ GO biological process
1905,XU_AKT1_TARGETS_6HR,c2.CGP_ chemical and genetic perturbations
1906,VANHARANTA_UTERINE_FIBROID_UP,c2.CGP_ chemical and genetic perturbations
1907,HELLER_HDAC_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
1908,GO_REGULATION_OF_ACTION_POTENTIAL,c5.BP_ GO biological process
1909,GO_L_ALPHA_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
1910,GCAAGAC_MIR431,c3.MIR_ microRNA targets
1911,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN,C7_ immunologic signatures
1912,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP,C7_ immunologic signatures
1913,FREAC7_01,c3.TFT_ transcription factor targets
1914,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_DN,C7_ immunologic signatures
1915,GO_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,c5.BP_ GO biological process
1916,SERVITJA_LIVER_HNF1A_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
1917,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,C7_ immunologic signatures
1918,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,C7_ immunologic signatures
1919,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN,C7_ immunologic signatures
1920,GO_KINASE_INHIBITOR_ACTIVITY,c5.GO molecular function
1921,GO_NEGATIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,c5.BP_ GO biological process
1922,GSE27786_LSK_VS_ERYTHROBLAST_DN,C7_ immunologic signatures
1923,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,C7_ immunologic signatures
1924,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN,C7_ immunologic signatures
1925,GO_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,c5.BP_ GO biological process
1926,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP,C7_ immunologic signatures
1927,GO_REGULATION_OF_AMINE_TRANSPORT,c5.BP_ GO biological process
1928,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN,C7_ immunologic signatures
1929,GO_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,c5.BP_ GO biological process
1930,GO_NEGATIVE_REGULATION_OF_B_CELL_ACTIVATION,c5.BP_ GO biological process
1931,GO_RESPONSE_TO_PROSTAGLANDIN_E,c5.BP_ GO biological process
1932,GO_RESPONSE_TO_LEPTIN,c5.BP_ GO biological process
1933,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_DN,C7_ immunologic signatures
1934,GO_FEEDING_BEHAVIOR,c5.BP_ GO biological process
1935,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP,C7_ immunologic signatures
1936,GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,c5.BP_ GO biological process
1937,ST_WNT_BETA_CATENIN_PATHWAY,c2.CP_ Canonical pathways
1938,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,C7_ immunologic signatures
1939,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_UP,C7_ immunologic signatures
1940,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP,C7_ immunologic signatures
1941,SUBTIL_PROGESTIN_TARGETS,c2.CGP_ chemical and genetic perturbations
1942,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,c2.CGP_ chemical and genetic perturbations
1943,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN,C7_ immunologic signatures
1944,VALK_AML_WITH_FLT3_ITD,c2.CGP_ chemical and genetic perturbations
1945,GO_DNA_CONFORMATION_CHANGE,c5.BP_ GO biological process
1946,VALK_AML_CLUSTER_9,c2.CGP_ chemical and genetic perturbations
1947,REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS,c2.CP_REACTOME_ Reactome gene sets
1948,TGGNNNNNNKCCAR_UNKNOWN,c3.TFT_ transcription factor targets
1949,AP4_Q5,c3.TFT_ transcription factor targets
1950,CACCAGC_MIR138,c3.MIR_ microRNA targets
1951,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,C7_ immunologic signatures
1952,GO_NEGATIVE_CHEMOTAXIS,c5.BP_ GO biological process
1953,MASSARWEH_TAMOXIFEN_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
1954,GO_RESPONSE_TO_KETONE,c5.BP_ GO biological process
1955,CHR11Q21,26
1956,PID_INTEGRIN3_PATHWAY,c2.CP_ Canonical pathways
1957,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,C7_ immunologic signatures
1958,GO_NEGATIVE_REGULATION_OF_PHOSPHORYLATION,c5.BP_ GO biological process
1959,GO_SCAVENGER_RECEPTOR_ACTIVITY,c5.GO molecular function
1960,REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA,c2.CP_REACTOME_ Reactome gene sets
1961,GO_HEART_DEVELOPMENT,c5.BP_ GO biological process
1962,REACTOME_DNA_STRAND_ELONGATION,c2.CP_REACTOME_ Reactome gene sets
1963,GO_AMEBOIDAL_TYPE_CELL_MIGRATION,c5.BP_ GO biological process
1964,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,c2.CGP_ chemical and genetic perturbations
1965,GO_POSITIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,c5.BP_ GO biological process
1966,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP,C7_ immunologic signatures
1967,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN,C7_ immunologic signatures
1968,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN,C7_ immunologic signatures
1969,MIKKELSEN_ES_HCP_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
1970,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP,C7_ immunologic signatures
1971,YRCCAKNNGNCGC_UNKNOWN,c3.TFT_ transcription factor targets
1972,GSE39556_CD8A_DC_VS_NK_CELL_UP,C7_ immunologic signatures
1973,MODULE_196,c4.CM_ cancer modules
1974,GO_PROTEIN_K11_LINKED_UBIQUITINATION,c5.BP_ GO biological process
1975,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN,C7_ immunologic signatures
1976,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP,C7_ immunologic signatures
1977,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
1978,TACAATC_MIR508,c3.MIR_ microRNA targets
1979,MANALO_HYPOXIA_UP,c2.CGP_ chemical and genetic perturbations
1980,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN,C7_ immunologic signatures
1981,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,c2.CP_REACTOME_ Reactome gene sets
1982,GSE45365_NK_CELL_VS_CD8_TCELL_UP,C7_ immunologic signatures
1983,HUANG_DASATINIB_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
1984,GO_EPIDERMAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
1985,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_DN,C7_ immunologic signatures
1986,GO_SOMITOGENESIS,c5.BP_ GO biological process
1987,GSE12366_GC_VS_MEMORY_BCELL_DN,C7_ immunologic signatures
1988,GO_POSITIVE_REGULATION_OF_DEPHOSPHORYLATION,c5.BP_ GO biological process
1989,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_DN,C7_ immunologic signatures
1990,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_DN,C7_ immunologic signatures
1991,NIELSEN_SYNOVIAL_SARCOMA_UP,c2.CGP_ chemical and genetic perturbations
1992,GO_REGULATION_OF_MEMBRANE_POTENTIAL,c5.BP_ GO biological process
1993,ATAAGCT_MIR21,c3.MIR_ microRNA targets
1994,GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP,C7_ immunologic signatures
1995,GO_SEGMENT_SPECIFICATION,c5.BP_ GO biological process
1996,DCA_UP.V1_UP,C6_ oncogenic signatures
1997,BIOCARTA_ACH_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
1998,WILCOX_RESPONSE_TO_PROGESTERONE_UP,c2.CGP_ chemical and genetic perturbations
1999,BILD_E2F3_ONCOGENIC_SIGNATURE,c2.CGP_ chemical and genetic perturbations
2000,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,C7_ immunologic signatures
2001,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_UP,C7_ immunologic signatures
2002,REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,c2.CP_REACTOME_ Reactome gene sets
2003,GO_SKELETAL_SYSTEM_MORPHOGENESIS,c5.BP_ GO biological process
2004,GO_MESENCHYME_DEVELOPMENT,c5.BP_ GO biological process
2005,GO_FIBRIL_ORGANIZATION,c5.BP_ GO biological process
2006,MODULE_19,c4.CM_ cancer modules
2007,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN,C7_ immunologic signatures
2008,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,C7_ immunologic signatures
2009,CHR5Q12,31
2010,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN,c2.CGP_ chemical and genetic perturbations
2011,PID_ENDOTHELIN_PATHWAY,c2.CP_ Canonical pathways
2012,CAATGCA_MIR33,c3.MIR_ microRNA targets
2013,SRF_Q4,c3.TFT_ transcription factor targets
2014,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_UP,C7_ immunologic signatures
2015,CHR3P25,59
2016,CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,c2.CGP_ chemical and genetic perturbations
2017,GO_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,c5.BP_ GO biological process
2018,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP,C7_ immunologic signatures
2019,GO_EPITHELIAL_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
2020,SRF_Q5_01,c3.TFT_ transcription factor targets
2021,GO_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,c5.BP_ GO biological process
2022,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,C7_ immunologic signatures
2023,CHR2Q36,33
2024,AGGAAGC_MIR5163P,c3.MIR_ microRNA targets
2025,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
2026,WANG_LSD1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
2027,GO_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,c5.BP_ GO biological process
2028,MEIS1BHOXA9_01,c3.TFT_ transcription factor targets
2029,SASSON_RESPONSE_TO_FORSKOLIN_DN,c2.CGP_ chemical and genetic perturbations
2030,GSE3982_BCELL_VS_TH1_DN,C7_ immunologic signatures
2031,GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP,C7_ immunologic signatures
2032,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,c2.CGP_ chemical and genetic perturbations
2033,REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE,c2.CP_REACTOME_ Reactome gene sets
2034,PETRETTO_CARDIAC_HYPERTROPHY,c2.CGP_ chemical and genetic perturbations
2035,ELVIDGE_HYPOXIA_UP,c2.CGP_ chemical and genetic perturbations
2036,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,c2.CGP_ chemical and genetic perturbations
2037,MORF_TNFRSF25,c4.CGN_ cancer gene neighborhoods
2038,GO_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
2039,GO_POSITIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,c5.BP_ GO biological process
2040,GSE12366_GC_VS_NAIVE_BCELL_UP,C7_ immunologic signatures
2041,RORA2_01,c3.TFT_ transcription factor targets
2042,HALLMARK_SPERMATOGENESIS,H_ hallmark gene sets
2043,ROZANOV_MMP14_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
2044,GO_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE,c5.BP_ GO biological process
2045,GO_POSITIVE_REGULATION_OF_NUCLEOSIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
2046,GSE7831_1H_VS_4H_CPG_STIM_PDC_DN,C7_ immunologic signatures
2047,GO_REGULATION_OF_DEVELOPMENTAL_GROWTH,c5.BP_ GO biological process
2048,GO_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,c5.BP_ GO biological process
2049,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,c2.CGP_ chemical and genetic perturbations
2050,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,c2.CGP_ chemical and genetic perturbations
2051,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,C7_ immunologic signatures
2052,GO_MICROTUBULE_NUCLEATION,c5.BP_ GO biological process
2053,GO_CALCIUM_CHANNEL_COMPLEX,c5.CC_ GO cellular component
2054,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,c2.CGP_ chemical and genetic perturbations
2055,KEGG_GAP_JUNCTION,c2.CP_BIOCARTA_ BioCarta gene sets
2056,GO_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,c5.BP_ GO biological process
2057,REACTOME_MITOTIC_G1_G1_S_PHASES,c2.CP_REACTOME_ Reactome gene sets
2058,GO_CAMP_MEDIATED_SIGNALING,c5.BP_ GO biological process
2059,LANDIS_ERBB2_BREAST_TUMORS_65_DN,c2.CGP_ chemical and genetic perturbations
2060,SU_TESTIS,c2.CGP_ chemical and genetic perturbations
2061,GO_PML_BODY,c5.CC_ GO cellular component
2062,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,c2.CGP_ chemical and genetic perturbations
2063,GO_SYNAPTIC_SIGNALING,c5.BP_ GO biological process
2064,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,C7_ immunologic signatures
2065,GO_NEGATIVE_REGULATION_OF_ION_TRANSPORT,c5.BP_ GO biological process
2066,GO_PDZ_DOMAIN_BINDING,c5.GO molecular function
2067,GSE37301_PRO_BCELL_VS_CD4_TCELL_DN,C7_ immunologic signatures
2068,GSE4142_NAIVE_VS_MEMORY_BCELL_UP,C7_ immunologic signatures
2069,GSE13547_WT_VS_ZFX_KO_BCELL_DN,C7_ immunologic signatures
2070,LTE2_UP.V1_DN,C6_ oncogenic signatures
2071,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN,C7_ immunologic signatures
2072,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,c2.CGP_ chemical and genetic perturbations
2073,LE_NEURONAL_DIFFERENTIATION_UP,c2.CGP_ chemical and genetic perturbations
2074,MAHADEVAN_IMATINIB_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
2075,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN,C7_ immunologic signatures
2076,NKX25_02,c3.TFT_ transcription factor targets
2077,REACTOME_LAGGING_STRAND_SYNTHESIS,c2.CP_REACTOME_ Reactome gene sets
2078,SOX9_B1,c3.TFT_ transcription factor targets
2079,ATGCAGT_MIR217,c3.MIR_ microRNA targets
2080,GO_REGULATION_OF_EXTENT_OF_CELL_GROWTH,c5.BP_ GO biological process
2081,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN,C7_ immunologic signatures
2082,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
2083,GO_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY,c5.GO molecular function
2084,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
2085,GO_REGULATION_OF_CALCINEURIN_NFAT_SIGNALING_CASCADE,c5.BP_ GO biological process
2086,LEE_LIVER_CANCER_CIPROFIBRATE_UP,c2.CGP_ chemical and genetic perturbations
2087,GSE28408_LY6G_POS_VS_NEG_DC_DN,C7_ immunologic signatures
2088,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,C7_ immunologic signatures
2089,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
2090,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN,C7_ immunologic signatures
2091,GO_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,c5.BP_ GO biological process
2092,GO_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
2093,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,C7_ immunologic signatures
2094,CHR4Q26,15
2095,MASSARWEH_RESPONSE_TO_ESTRADIOL,c2.CGP_ chemical and genetic perturbations
2096,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
2097,MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,c2.CGP_ chemical and genetic perturbations
2098,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP,C7_ immunologic signatures
2099,GO_FOREBRAIN_DEVELOPMENT,c5.BP_ GO biological process
2100,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,C7_ immunologic signatures
2101,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP,C7_ immunologic signatures
2102,GO_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,c5.BP_ GO biological process
2103,GO_CARTILAGE_DEVELOPMENT,c5.BP_ GO biological process
2104,GO_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY,c5.BP_ GO biological process
2105,PKCA_DN.V1_UP,C6_ oncogenic signatures
2106,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN,C7_ immunologic signatures
2107,GO_REGULATION_OF_AXONOGENESIS,c5.BP_ GO biological process
2108,IVANOVSKA_MIR106B_TARGETS,c2.CGP_ chemical and genetic perturbations
2109,GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,c5.BP_ GO biological process
2110,GO_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,c5.BP_ GO biological process
2111,GO_POSITIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,c5.BP_ GO biological process
2112,GO_PLATELET_DEGRANULATION,c5.BP_ GO biological process
2113,REACTOME_REGULATION_OF_INSULIN_SECRETION,c2.CP_REACTOME_ Reactome gene sets
2114,GO_HEART_GROWTH,c5.BP_ GO biological process
2115,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN,C7_ immunologic signatures
2116,GO_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM,c5.BP_ GO biological process
2117,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,c2.CP_BIOCARTA_ BioCarta gene sets
2118,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,C7_ immunologic signatures
2119,MODULE_130,c4.CM_ cancer modules
2120,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
2121,BROWNE_HCMV_INFECTION_8HR_DN,c2.CGP_ chemical and genetic perturbations
2122,GO_SOMITE_DEVELOPMENT,c5.BP_ GO biological process
2123,GO_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.BP_ GO biological process
2124,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,C7_ immunologic signatures
2125,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_DN,C7_ immunologic signatures
2126,MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,c2.CGP_ chemical and genetic perturbations
2127,IRF2_01,c3.TFT_ transcription factor targets
2128,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN,C7_ immunologic signatures
2129,GSE40273_XBP1_KO_VS_WT_TREG_DN,C7_ immunologic signatures
2130,GO_REGULATION_OF_CHEMOTAXIS,c5.BP_ GO biological process
2131,GO_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA,c5.BP_ GO biological process
2132,FOXO4_01,c3.TFT_ transcription factor targets
2133,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
2134,KRAS.600.LUNG.BREAST_UP.V1_DN,C6_ oncogenic signatures
2135,GO_POSITIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,c5.BP_ GO biological process
2136,GO_SENSORY_ORGAN_DEVELOPMENT,c5.BP_ GO biological process
2137,ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,c2.CGP_ chemical and genetic perturbations
2138,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP,C7_ immunologic signatures
2139,GO_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
2140,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP,C7_ immunologic signatures
2141,MODULE_38,c4.CM_ cancer modules
2142,GO_CARDIAC_SEPTUM_DEVELOPMENT,c5.BP_ GO biological process
2143,GO_REGULATION_OF_CATECHOLAMINE_SECRETION,c5.BP_ GO biological process
2144,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,c2.CGP_ chemical and genetic perturbations
2145,GSE14350_IL2RB_KO_VS_WT_TEFF_UP,C7_ immunologic signatures
2146,GSE30083_SP1_VS_SP4_THYMOCYTE_DN,C7_ immunologic signatures
2147,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_UP,C7_ immunologic signatures
2148,GSE3982_CTRL_VS_LPS_4H_MAC_DN,C7_ immunologic signatures
2149,GO_NEGATIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
2150,GO_PEPTIDASE_INHIBITOR_ACTIVITY,c5.GO molecular function
2151,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
2152,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN,C7_ immunologic signatures
2153,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,c2.CGP_ chemical and genetic perturbations
2154,HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN,c2.CGP_ chemical and genetic perturbations
2155,GO_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH,c5.BP_ GO biological process
2156,GO_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY,c5.BP_ GO biological process
2157,MODULE_84,c4.CM_ cancer modules
2158,GO_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE,c5.BP_ GO biological process
2159,GO_CELLULAR_RESPONSE_TO_FATTY_ACID,c5.BP_ GO biological process
2160,GO_REGULATION_OF_MAP_KINASE_ACTIVITY,c5.BP_ GO biological process
2161,PID_ATR_PATHWAY,c2.CP_ Canonical pathways
2162,MODULE_80,c4.CM_ cancer modules
2163,GO_NEGATIVE_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION,c5.BP_ GO biological process
2164,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP,C7_ immunologic signatures
2165,GO_BONE_RESORPTION,c5.BP_ GO biological process
2166,FIGUEROA_AML_METHYLATION_CLUSTER_6_DN,c2.CGP_ chemical and genetic perturbations
2167,GO_NEGATIVE_REGULATION_OF_AMINE_TRANSPORT,c5.BP_ GO biological process
2168,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,C7_ immunologic signatures
2169,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP,C7_ immunologic signatures
2170,TGFB_UP.V1_UP,C6_ oncogenic signatures
2171,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_UP,C7_ immunologic signatures
2172,KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,c2.CP_BIOCARTA_ BioCarta gene sets
2173,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,C7_ immunologic signatures
2174,GO_SECRETION_BY_CELL,c5.BP_ GO biological process
2175,GO_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,c5.BP_ GO biological process
2176,GO_CYCLIC_NUCLEOTIDE_CATABOLIC_PROCESS,c5.BP_ GO biological process
2177,CTCTATG_MIR368,c3.MIR_ microRNA targets
2178,BIOCARTA_ATRBRCA_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
2179,GSE21063_WT_VS_NFATC1_KO_BCELL_DN,C7_ immunologic signatures
2180,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,c2.CGP_ chemical and genetic perturbations
2181,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN,C7_ immunologic signatures
2182,GO_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,c5.BP_ GO biological process
2183,GO_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,c5.BP_ GO biological process
2184,PTF1BETA_Q6,c3.TFT_ transcription factor targets
2185,BROWNE_HCMV_INFECTION_18HR_UP,c2.CGP_ chemical and genetic perturbations
2186,LEF1_UP.V1_DN,C6_ oncogenic signatures
2187,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
2188,GO_BONE_MINERALIZATION,c5.BP_ GO biological process
2189,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,C7_ immunologic signatures
2190,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN,C7_ immunologic signatures
2191,PID_ALPHA_SYNUCLEIN_PATHWAY,c2.CP_ Canonical pathways
2192,ONO_FOXP3_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
2193,GHANDHI_DIRECT_IRRADIATION_UP,c2.CGP_ chemical and genetic perturbations
2194,GO_DENDRITIC_CELL_DIFFERENTIATION,c5.BP_ GO biological process
2195,ALK_DN.V1_DN,C6_ oncogenic signatures
2196,ZHAN_MULTIPLE_MYELOMA_CD1_UP,c2.CGP_ chemical and genetic perturbations
2197,GO_SIGNAL_TRANSDUCTION_IN_RESPONSE_TO_DNA_DAMAGE,c5.BP_ GO biological process
2198,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_UP,C7_ immunologic signatures
2199,GO_CELL_JUNCTION_ASSEMBLY,c5.BP_ GO biological process
2200,MARCHINI_TRABECTEDIN_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
2201,GSE14000_UNSTIM_VS_16H_LPS_DC_DN,C7_ immunologic signatures
2202,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN,C7_ immunologic signatures
2203,MATZUK_SPERMATOCYTE,c2.CGP_ chemical and genetic perturbations
2204,CHR10P12,28
2205,MODULE_135,c4.CM_ cancer modules
2206,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,c2.CGP_ chemical and genetic perturbations
2207,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
2208,GO_MESODERM_DEVELOPMENT,c5.BP_ GO biological process
2209,GSE7852_TREG_VS_TCONV_THYMUS_UP,C7_ immunologic signatures
2210,MCCLUNG_COCAINE_REWARD_5D,c2.CGP_ chemical and genetic perturbations
2211,HELLER_SILENCED_BY_METHYLATION_UP,c2.CGP_ chemical and genetic perturbations
2212,GO_REGULATION_OF_GLUCOSE_TRANSPORT,c5.BP_ GO biological process
2213,GO_EYE_MORPHOGENESIS,c5.BP_ GO biological process
2214,GSE14415_INDUCED_VS_NATURAL_TREG_UP,C7_ immunologic signatures
2215,GO_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS,c5.BP_ GO biological process
2216,GO_UBIQUITIN_LIKE_PROTEIN_TRANSFERASE_ACTIVITY,c5.GO molecular function
2217,GO_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,c5.BP_ GO biological process
2218,GSE17721_0.5H_VS_24H_CPG_BMDC_DN,C7_ immunologic signatures
2219,GO_NEURAL_CREST_CELL_DIFFERENTIATION,c5.BP_ GO biological process
2220,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
2221,GO_POSITIVE_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS,c5.BP_ GO biological process
2222,GOUYER_TATI_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
2223,GO_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,c5.BP_ GO biological process
2224,SPIRA_SMOKERS_LUNG_CANCER_DN,c2.CGP_ chemical and genetic perturbations
2225,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN,C7_ immunologic signatures
2226,MULLIGHAN_NPM1_SIGNATURE_3_UP,c2.CGP_ chemical and genetic perturbations
2227,TEF1_Q6,c3.TFT_ transcription factor targets
2228,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP,C7_ immunologic signatures
2229,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
2230,AGCATTA_MIR155,c3.MIR_ microRNA targets
2231,GO_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,c5.BP_ GO biological process
2232,GO_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY,c5.GO molecular function
2233,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN,C7_ immunologic signatures
2234,WANG_MLL_TARGETS,c2.CGP_ chemical and genetic perturbations
2235,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_UP,C7_ immunologic signatures
2236,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,C7_ immunologic signatures
2237,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,c2.CGP_ chemical and genetic perturbations
2238,GO_DOPAMINE_METABOLIC_PROCESS,c5.BP_ GO biological process
2239,GO_CYCLIC_NUCLEOTIDE_MEDIATED_SIGNALING,c5.BP_ GO biological process
2240,RAO_BOUND_BY_SALL4_ISOFORM_A,c2.CGP_ chemical and genetic perturbations
2241,GO_SITE_OF_DOUBLE_STRAND_BREAK,c5.CC_ GO cellular component
2242,GO_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
2243,GO_POSITIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,c5.BP_ GO biological process
2244,GO_REGULATION_OF_VASCULATURE_DEVELOPMENT,c5.BP_ GO biological process
2245,GO_RESPONSE_TO_RETINOIC_ACID,c5.BP_ GO biological process
2246,MODULE_197,c4.CM_ cancer modules
2247,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_DN,C7_ immunologic signatures
2248,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,C7_ immunologic signatures
2249,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_UP,C7_ immunologic signatures
2250,GO_REGULATION_OF_CAMP_METABOLIC_PROCESS,c5.BP_ GO biological process
2251,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,C7_ immunologic signatures
2252,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,c2.CGP_ chemical and genetic perturbations
2253,GO_SEX_CHROMOSOME,c5.CC_ GO cellular component
2254,MODULE_421,c4.CM_ cancer modules
2255,ZHANG_RESPONSE_TO_CANTHARIDIN_UP,c2.CGP_ chemical and genetic perturbations
2256,GO_REGULATION_OF_EXOCYTOSIS,c5.BP_ GO biological process
2257,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
2258,OLSSON_E2F3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
2259,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,C7_ immunologic signatures
2260,GO_COLLAGEN_BINDING,c5.GO molecular function
2261,GO_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION,c5.BP_ GO biological process
2262,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN,C7_ immunologic signatures
2263,GO_REGULATION_OF_CELL_MATRIX_ADHESION,c5.BP_ GO biological process
2264,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP,C7_ immunologic signatures
2265,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP,C7_ immunologic signatures
2266,GSE42724_MEMORY_VS_B1_BCELL_DN,C7_ immunologic signatures
2267,CHR8P22,29
2268,CDX2_Q5,c3.TFT_ transcription factor targets
2269,BAKKER_FOXO3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
2270,REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS,c2.CP_REACTOME_ Reactome gene sets
2271,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,C7_ immunologic signatures
2272,GSE3982_MAC_VS_TH2_UP,C7_ immunologic signatures
2273,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN,C7_ immunologic signatures
2274,HAND1E47_01,c3.TFT_ transcription factor targets
2275,GO_RESPONSE_TO_GONADOTROPIN,c5.BP_ GO biological process
2276,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP,C7_ immunologic signatures
2277,AMIT_EGF_RESPONSE_480_MCF10A,c2.CGP_ chemical and genetic perturbations
2278,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,c2.CGP_ chemical and genetic perturbations
2279,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
2280,NKX22_01,c3.TFT_ transcription factor targets
2281,REACTOME_PLATELET_CALCIUM_HOMEOSTASIS,c2.CP_REACTOME_ Reactome gene sets
2282,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,c2.CGP_ chemical and genetic perturbations
2283,GO_REGULATION_OF_CELL_SIZE,c5.BP_ GO biological process
2284,MODULE_241,c4.CM_ cancer modules
2285,GO_NEGATIVE_REGULATION_OF_KINASE_ACTIVITY,c5.BP_ GO biological process
2286,GO_OUTFLOW_TRACT_MORPHOGENESIS,c5.BP_ GO biological process
2287,CHR5Q13,51
2288,HOWLIN_CITED1_TARGETS_1_DN,c2.CGP_ chemical and genetic perturbations
2289,ZHENG_BOUND_BY_FOXP3,c2.CGP_ chemical and genetic perturbations
2290,MODULE_291,c4.CM_ cancer modules
2291,YKACATTT_UNKNOWN,c3.TFT_ transcription factor targets
2292,CHR1P36,254
2293,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,C7_ immunologic signatures
2294,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
2295,GO_HORMONE_BINDING,c5.GO molecular function
2296,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP,C7_ immunologic signatures
2297,GO_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE,c5.BP_ GO biological process
2298,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP,C7_ immunologic signatures
2299,MODULE_174,c4.CM_ cancer modules
2300,GO_NOTCH_RECEPTOR_PROCESSING,c5.BP_ GO biological process
2301,MAHAJAN_RESPONSE_TO_IL1A_UP,c2.CGP_ chemical and genetic perturbations
2302,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP,C7_ immunologic signatures
2303,CHR15Q23,25
2304,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
2305,REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,c2.CP_REACTOME_ Reactome gene sets
2306,GO_POSITIVE_REGULATION_OF_LOCOMOTION,c5.BP_ GO biological process
2307,CHR17P12,21
2308,REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION,c2.CP_REACTOME_ Reactome gene sets
2309,PASINI_SUZ12_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
2310,ATF2_UP.V1_DN,C6_ oncogenic signatures
2311,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN,C7_ immunologic signatures
2312,GO_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,c5.BP_ GO biological process
2313,GO_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
2314,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP,C7_ immunologic signatures
2315,GO_NEGATIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,c5.BP_ GO biological process
2316,GO_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON,c5.GO molecular function
2317,GO_REGULATION_OF_DNA_RECOMBINATION,c5.BP_ GO biological process
2318,GO_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE,c5.CC_ GO cellular component
2319,MODULE_51,c4.CM_ cancer modules
2320,GO_HEART_MORPHOGENESIS,c5.BP_ GO biological process
2321,GO_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
2322,PAX5_02,c3.TFT_ transcription factor targets
2323,GO_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING,c5.GO molecular function
2324,GO_MULTICELLULAR_ORGANISMAL_MACROMOLECULE_METABOLIC_PROCESS,c5.BP_ GO biological process
2325,GO_MYOBLAST_DIFFERENTIATION,c5.BP_ GO biological process
2326,GO_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,c5.BP_ GO biological process
2327,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN,C7_ immunologic signatures
2328,GO_GLYCOPROTEIN_BINDING,c5.GO molecular function
2329,DURAND_STROMA_S_UP,c2.CGP_ chemical and genetic perturbations
2330,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN,C7_ immunologic signatures
2331,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN,C7_ immunologic signatures
2332,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,c2.CP_REACTOME_ Reactome gene sets
2333,GO_REGULATION_OF_STEM_CELL_PROLIFERATION,c5.BP_ GO biological process
2334,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,c2.CGP_ chemical and genetic perturbations
2335,OUYANG_PROSTATE_CANCER_PROGRESSION_UP,c2.CGP_ chemical and genetic perturbations
2336,ALX4_01,c3.TFT_ transcription factor targets
2337,GO_RESPONSE_TO_TESTOSTERONE,c5.BP_ GO biological process
2338,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN,C7_ immunologic signatures
2339,GO_POSITIVE_REGULATION_OF_DNA_REPAIR,c5.BP_ GO biological process
2340,RIZ_ERYTHROID_DIFFERENTIATION_HBZ,c2.CGP_ chemical and genetic perturbations
2341,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP,C7_ immunologic signatures
2342,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,C7_ immunologic signatures
2343,GO_TISSUE_MORPHOGENESIS,c5.BP_ GO biological process
2344,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,C7_ immunologic signatures
2345,TCTCTCC_MIR185,c3.MIR_ microRNA targets
2346,GO_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM,c5.BP_ GO biological process
2347,CART1_01,c3.TFT_ transcription factor targets
2348,GO_REGULATION_OF_ORGAN_GROWTH,c5.BP_ GO biological process
2349,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_DN,C7_ immunologic signatures
2350,BIOCARTA_G1_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
2351,GO_POSITIVE_REGULATION_OF_AXON_EXTENSION,c5.BP_ GO biological process
2352,WEST_ADRENOCORTICAL_TUMOR_UP,c2.CGP_ chemical and genetic perturbations
2353,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN,C7_ immunologic signatures
2354,REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,c2.CP_REACTOME_ Reactome gene sets
2355,GO_DAMAGED_DNA_BINDING,c5.GO molecular function
2356,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_DN,C7_ immunologic signatures
2357,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP,C7_ immunologic signatures
2358,GSE27786_BCELL_VS_ERYTHROBLAST_DN,C7_ immunologic signatures
2359,CTTGTAT_MIR381,c3.MIR_ microRNA targets
2360,GO_SYNAPTIC_TRANSMISSION_CHOLINERGIC,c5.BP_ GO biological process
2361,AMIT_SERUM_RESPONSE_120_MCF10A,c2.CGP_ chemical and genetic perturbations
2362,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,C7_ immunologic signatures
2363,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
2364,GO_ACTIN_FILAMENT,c5.CC_ GO cellular component
2365,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN,C7_ immunologic signatures
2366,VERHAAK_AML_WITH_NPM1_MUTATED_DN,c2.CGP_ chemical and genetic perturbations
2367,GO_RESPONSE_TO_IMMOBILIZATION_STRESS,c5.BP_ GO biological process
2368,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN,c2.CGP_ chemical and genetic perturbations
2369,GO_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY,c5.GO molecular function
2370,GO_ACTIN_NUCLEATION,c5.BP_ GO biological process
2371,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,C7_ immunologic signatures
2372,GO_POSITIVE_REGULATION_OF_ORGAN_GROWTH,c5.BP_ GO biological process
2373,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP,C7_ immunologic signatures
2374,GO_TELENCEPHALON_DEVELOPMENT,c5.BP_ GO biological process
2375,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN,C7_ immunologic signatures
2376,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN,C7_ immunologic signatures
2377,KEGG_BLADDER_CANCER,c2.CP_BIOCARTA_ BioCarta gene sets
2378,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,c2.CGP_ chemical and genetic perturbations
2379,GO_POSITIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,c5.BP_ GO biological process
2380,GO_POSITIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,c5.BP_ GO biological process
2381,HOQUE_METHYLATED_IN_CANCER,c2.CGP_ chemical and genetic perturbations
2382,GO_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT,c5.BP_ GO biological process
2383,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,c2.CGP_ chemical and genetic perturbations
2384,FOXJ2_01,c3.TFT_ transcription factor targets
2385,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
2386,CHR1P31,64
2387,CHR5Q23,45
2388,GSE3039_CD4_TCELL_VS_B2_BCELL_UP,C7_ immunologic signatures
2389,GO_SECRETORY_GRANULE,c5.CC_ GO cellular component
2390,GO_BODY_MORPHOGENESIS,c5.BP_ GO biological process
2391,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN,c2.CGP_ chemical and genetic perturbations
2392,GO_CELLULAR_RESPONSE_TO_VIRUS,c5.BP_ GO biological process
2393,ZHANG_BREAST_CANCER_PROGENITORS_UP,c2.CGP_ chemical and genetic perturbations
2394,GO_PRONUCLEUS,c5.CC_ GO cellular component
2395,GO_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,c5.BP_ GO biological process
2396,GO_REGULATION_OF_SODIUM_ION_TRANSPORT,c5.BP_ GO biological process
2397,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP,C7_ immunologic signatures
2398,GO_DETECTION_OF_ABIOTIC_STIMULUS,c5.BP_ GO biological process
2399,GO_REGULATION_OF_ENERGY_HOMEOSTASIS,c5.BP_ GO biological process
2400,REACTOME_BASIGIN_INTERACTIONS,c2.CP_REACTOME_ Reactome gene sets
2401,PID_GLYPICAN_1PATHWAY,c2.CP_ Canonical pathways
2402,SABATES_COLORECTAL_ADENOMA_UP,c2.CGP_ chemical and genetic perturbations
2403,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_DN,C7_ immunologic signatures
2404,GO_REGULATION_OF_ION_HOMEOSTASIS,c5.BP_ GO biological process
2405,GO_REGULATION_OF_MONOOXYGENASE_ACTIVITY,c5.BP_ GO biological process
2406,GO_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
2407,GO_REGULATION_OF_KERATINOCYTE_PROLIFERATION,c5.BP_ GO biological process
2408,MODULE_214,c4.CM_ cancer modules
2409,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
2410,PID_ATM_PATHWAY,c2.CP_ Canonical pathways
2411,PHONG_TNF_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
2412,GSE39022_LN_VS_SPLEEN_DC_UP,C7_ immunologic signatures
2413,BERENJENO_TRANSFORMED_BY_RHOA_UP,c2.CGP_ chemical and genetic perturbations
2414,GO_DEFENSE_RESPONSE_TO_OTHER_ORGANISM,c5.BP_ GO biological process
2415,GO_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,c5.BP_ GO biological process
2416,GO_ANATOMICAL_STRUCTURE_HOMEOSTASIS,c5.BP_ GO biological process
2417,JAK2_DN.V1_DN,C6_ oncogenic signatures
2418,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
2419,STK33_UP,C6_ oncogenic signatures
2420,KERLEY_RESPONSE_TO_CISPLATIN_UP,c2.CGP_ chemical and genetic perturbations
2421,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_UP,C7_ immunologic signatures
2422,GO_MULTICELLULAR_ORGANISM_GROWTH,c5.BP_ GO biological process
2423,GO_POSITIVE_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,c5.BP_ GO biological process
2424,GSE14000_4H_VS_16H_LPS_DC_DN,C7_ immunologic signatures
2425,SRF_Q6,c3.TFT_ transcription factor targets
2426,LINDSTEDT_DENDRITIC_CELL_MATURATION_B,c2.CGP_ chemical and genetic perturbations
2427,BROWNE_HCMV_INFECTION_48HR_UP,c2.CGP_ chemical and genetic perturbations
2428,MZF1_01,c3.TFT_ transcription factor targets
2429,GO_REGULATION_OF_CELL_CYCLE_ARREST,c5.BP_ GO biological process
2430,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP,C7_ immunologic signatures
2431,GACAATC_MIR219,c3.MIR_ microRNA targets
2432,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,C7_ immunologic signatures
2433,GO_ORGANELLE_LOCALIZATION,c5.BP_ GO biological process
2434,GO_MORPHOGENESIS_OF_AN_EPITHELIUM,c5.BP_ GO biological process
2435,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP,C7_ immunologic signatures
2436,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP,C7_ immunologic signatures
2437,GO_RESPONSE_TO_LITHIUM_ION,c5.BP_ GO biological process
2438,FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,c2.CGP_ chemical and genetic perturbations
2439,CEBP_01,c3.TFT_ transcription factor targets
2440,MODULE_53,c4.CM_ cancer modules
2441,MORF_CCNF,c4.CGN_ cancer gene neighborhoods
2442,GO_ADHERENS_JUNCTION_ASSEMBLY,c5.BP_ GO biological process
2443,GO_CEREBELLAR_CORTEX_DEVELOPMENT,c5.BP_ GO biological process
2444,GSE7852_TREG_VS_TCONV_LN_UP,C7_ immunologic signatures
2445,WIERENGA_STAT5A_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
2446,REACTOME_HEMOSTASIS,c2.CP_REACTOME_ Reactome gene sets
2447,MODULE_256,c4.CM_ cancer modules
2448,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_UP,C7_ immunologic signatures
2449,CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB,c2.CGP_ chemical and genetic perturbations
2450,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN,C7_ immunologic signatures
2451,GO_NEGATIVE_REGULATION_OF_DEPHOSPHORYLATION,c5.BP_ GO biological process
2452,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP,C7_ immunologic signatures
2453,GSE21063_WT_VS_NFATC1_KO_BCELL_UP,C7_ immunologic signatures
2454,TGATTTRY_GFI1_01,c3.TFT_ transcription factor targets
2455,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP,C7_ immunologic signatures
2456,REACTOME_SIGNALING_BY_RHO_GTPASES,c2.CP_REACTOME_ Reactome gene sets
2457,GO_CARDIAC_VENTRICLE_DEVELOPMENT,c5.BP_ GO biological process
2458,RYTAAWNNNTGAY_UNKNOWN,c3.TFT_ transcription factor targets
2459,ERB2_UP.V1_DN,C6_ oncogenic signatures
2460,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,C7_ immunologic signatures
2461,GO_REGENERATION,c5.BP_ GO biological process
2462,SIMBULAN_PARP1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
2463,BASSO_HAIRY_CELL_LEUKEMIA_UP,c2.CGP_ chemical and genetic perturbations
2464,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP,c2.CGP_ chemical and genetic perturbations
2465,OCT_C,c3.TFT_ transcription factor targets
2466,GO_POSTREPLICATION_REPAIR,c5.BP_ GO biological process
2467,WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2,c2.CGP_ chemical and genetic perturbations
2468,GO_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE,c5.BP_ GO biological process
2469,CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,c2.CGP_ chemical and genetic perturbations
2470,SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP,c2.CGP_ chemical and genetic perturbations
2471,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,c2.CGP_ chemical and genetic perturbations
2472,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN,C7_ immunologic signatures
2473,ELVIDGE_HYPOXIA_BY_DMOG_UP,c2.CGP_ chemical and genetic perturbations
2474,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP,C7_ immunologic signatures
2475,GO_EPHRIN_RECEPTOR_BINDING,c5.GO molecular function
2476,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_DN,C7_ immunologic signatures
2477,MODULE_438,c4.CM_ cancer modules
2478,PID_CIRCADIAN_PATHWAY,c2.CP_ Canonical pathways
2479,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,C7_ immunologic signatures
2480,WAKASUGI_HAVE_ZNF143_BINDING_SITES,c2.CGP_ chemical and genetic perturbations
2481,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,C7_ immunologic signatures
2482,PID_TAP63_PATHWAY,c2.CP_ Canonical pathways
2483,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_DN,C7_ immunologic signatures
2484,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
2485,GO_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,c5.BP_ GO biological process
2486,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_DN,C7_ immunologic signatures
2487,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
2488,GO_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
2489,AGCACTT_MIR93_MIR302A_MIR302B_MIR302C_MIR302D_MIR372_MIR373_MIR520E_MIR520A_MIR526B_MIR520B_MIR520C_MIR520D,c3.MIR_ microRNA targets
2490,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
2491,GO_ACTIVATION_OF_PROTEIN_KINASE_B_ACTIVITY,c5.BP_ GO biological process
2492,LU_AGING_BRAIN_UP,c2.CGP_ chemical and genetic perturbations
2493,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
2494,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP,C7_ immunologic signatures
2495,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP,C7_ immunologic signatures
2496,MODULE_303,c4.CM_ cancer modules
2497,GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,c5.BP_ GO biological process
2498,GO_ACTIN_FILAMENT_BASED_PROCESS,c5.BP_ GO biological process
2499,CHR14Q32,98
2500,GO_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY,c5.BP_ GO biological process
2501,MODULE_189,c4.CM_ cancer modules
2502,GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY,c5.GO molecular function
2503,GO_REGULATION_OF_FIBROBLAST_PROLIFERATION,c5.BP_ GO biological process
2504,CHR17Q23,58
2505,GO_REFLEX,c5.BP_ GO biological process
2506,GO_REGULATION_OF_PHOSPHATASE_ACTIVITY,c5.BP_ GO biological process
2507,MODULE_205,c4.CM_ cancer modules
2508,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,C7_ immunologic signatures
2509,GO_AORTA_MORPHOGENESIS,c5.BP_ GO biological process
2510,BILD_CTNNB1_ONCOGENIC_SIGNATURE,c2.CGP_ chemical and genetic perturbations
2511,GO_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT,c5.BP_ GO biological process
2512,GO_TISSUE_REGENERATION,c5.BP_ GO biological process
2513,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_DN,C7_ immunologic signatures
2514,JEON_SMAD6_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
2515,GO_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS,c5.BP_ GO biological process
2516,MEF2_Q6_01,c3.TFT_ transcription factor targets
2517,GO_PROTEOGLYCAN_METABOLIC_PROCESS,c5.BP_ GO biological process
2518,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP,C7_ immunologic signatures
2519,GO_NEGATIVE_REGULATION_OF_CELL_MATRIX_ADHESION,c5.BP_ GO biological process
2520,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP,C7_ immunologic signatures
2521,GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,c5.BP_ GO biological process
2522,REACTOME_HS_GAG_BIOSYNTHESIS,c2.CP_REACTOME_ Reactome gene sets
2523,GO_CELL_FATE_DETERMINATION,c5.BP_ GO biological process
2524,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP,C7_ immunologic signatures
2525,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,c2.CGP_ chemical and genetic perturbations
2526,GO_VACUOLE_ORGANIZATION,c5.BP_ GO biological process
2527,GSE17721_POLYIC_VS_CPG_16H_BMDC_UP,C7_ immunologic signatures
2528,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_DN,C7_ immunologic signatures
2529,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN,C7_ immunologic signatures
2530,GO_STEROID_HYDROXYLASE_ACTIVITY,c5.GO molecular function
2531,GO_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS,c5.GO molecular function
2532,GO_ANTIPORTER_ACTIVITY,c5.GO molecular function
2533,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,C7_ immunologic signatures
2534,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN,C7_ immunologic signatures
2535,JEON_SMAD6_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
2536,GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,c5.BP_ GO biological process
2537,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,c2.CGP_ chemical and genetic perturbations
2538,ESC_J1_UP_EARLY.V1_DN,C6_ oncogenic signatures
2539,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN,C7_ immunologic signatures
2540,GO_HORMONE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
2541,GO_NEGATIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,c5.BP_ GO biological process
2542,GSE3982_MAC_VS_BCELL_UP,C7_ immunologic signatures
2543,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,C7_ immunologic signatures
2544,HALLMARK_P53_PATHWAY,H_ hallmark gene sets
2545,TAAYNRNNTCC_UNKNOWN,c3.TFT_ transcription factor targets
2546,LINDSTEDT_DENDRITIC_CELL_MATURATION_C,c2.CGP_ chemical and genetic perturbations
2547,CHR8P23,38
2548,GSE12839_CTRL_VS_IL12_TREATED_PBMC_UP,C7_ immunologic signatures
2549,LANDIS_BREAST_CANCER_PROGRESSION_DN,c2.CGP_ chemical and genetic perturbations
2550,GO_TRANSLESION_SYNTHESIS,c5.BP_ GO biological process
2551,KIM_GLIS2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
2552,GO_EPIDERMIS_DEVELOPMENT,c5.BP_ GO biological process
2553,SENESE_HDAC3_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
2554,PEDRIOLI_MIR31_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
2555,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,C7_ immunologic signatures
2556,GO_AMMONIUM_ION_BINDING,c5.GO molecular function
2557,GO_NEGATIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,c5.BP_ GO biological process
2558,CEBP_C,c3.TFT_ transcription factor targets
2559,GO_MYOSIN_COMPLEX,c5.CC_ GO cellular component
2560,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP,C7_ immunologic signatures
2561,MODULE_6,c4.CM_ cancer modules
2562,SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,c2.CGP_ chemical and genetic perturbations
2563,GO_REGULATION_OF_TELOMERASE_ACTIVITY,c5.BP_ GO biological process
2564,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,c2.CGP_ chemical and genetic perturbations
2565,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,C7_ immunologic signatures
2566,GO_RESPONSE_TO_ACETYLCHOLINE,c5.BP_ GO biological process
2567,GO_NOTCH_BINDING,c5.GO molecular function
2568,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
2569,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP,C7_ immunologic signatures
2570,GO_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION,c5.BP_ GO biological process
2571,NELSON_RESPONSE_TO_ANDROGEN_DN,c2.CGP_ chemical and genetic perturbations
2572,GO_TAXIS,c5.BP_ GO biological process
2573,GO_MECHANORECEPTOR_DIFFERENTIATION,c5.BP_ GO biological process
2574,GO_NEGATIVE_REGULATION_OF_TOR_SIGNALING,c5.BP_ GO biological process
2575,GO_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,c5.BP_ GO biological process
2576,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP,C7_ immunologic signatures
2577,P53_02,c3.TFT_ transcription factor targets
2578,GO_CEREBRAL_CORTEX_DEVELOPMENT,c5.BP_ GO biological process
2579,HALLMARK_TGF_BETA_SIGNALING,H_ hallmark gene sets
2580,GO_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,c5.BP_ GO biological process
2581,GO_METALLOENDOPEPTIDASE_ACTIVITY,c5.GO molecular function
2582,GO_ORGAN_GROWTH,c5.BP_ GO biological process
2583,CHR4Q32,27
2584,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,C7_ immunologic signatures
2585,BEIER_GLIOMA_STEM_CELL_UP,c2.CGP_ chemical and genetic perturbations
2586,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
2587,GO_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,c5.BP_ GO biological process
2588,WESTON_VEGFA_TARGETS,c2.CGP_ chemical and genetic perturbations
2589,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP,C7_ immunologic signatures
2590,CDPCR3HD_01,c3.TFT_ transcription factor targets
2591,MORF_PAX7,c4.CGN_ cancer gene neighborhoods
2592,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN,C7_ immunologic signatures
2593,HALLMARK_KRAS_SIGNALING_DN,H_ hallmark gene sets
2594,GO_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,c5.BP_ GO biological process
2595,GO_EPHRIN_RECEPTOR_ACTIVITY,c5.GO molecular function
2596,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
2597,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN,C7_ immunologic signatures
2598,GO_REGULATION_OF_ACTIN_FILAMENT_BASED_MOVEMENT,c5.BP_ GO biological process
2599,GO_DNA_DEPENDENT_ATPASE_ACTIVITY,c5.GO molecular function
2600,GAGACTG_MIR452,c3.MIR_ microRNA targets
2601,GO_REGULATION_OF_LIPASE_ACTIVITY,c5.BP_ GO biological process
2602,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,c2.CGP_ chemical and genetic perturbations
2603,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,C7_ immunologic signatures
2604,CUI_TCF21_TARGETS_2_UP,c2.CGP_ chemical and genetic perturbations
2605,CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP,c2.CGP_ chemical and genetic perturbations
2606,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,C7_ immunologic signatures
2607,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,C7_ immunologic signatures
2608,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_DN,C7_ immunologic signatures
2609,GO_POSITIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,c5.BP_ GO biological process
2610,GSE22886_TH1_VS_TH2_48H_ACT_UP,C7_ immunologic signatures
2611,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP,C7_ immunologic signatures
2612,HOOI_ST7_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
2613,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,c2.CGP_ chemical and genetic perturbations
2614,GO_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,c5.BP_ GO biological process
2615,GO_SODIUM_CHANNEL_REGULATOR_ACTIVITY,c5.GO molecular function
2616,GO_MYELOID_DENDRITIC_CELL_DIFFERENTIATION,c5.BP_ GO biological process
2617,GO_SALIVARY_GLAND_DEVELOPMENT,c5.BP_ GO biological process
2618,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_DN,C7_ immunologic signatures
2619,GGGCATT_MIR365,c3.MIR_ microRNA targets
2620,MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
2621,XU_GH1_AUTOCRINE_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
2622,WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN,c2.CGP_ chemical and genetic perturbations
2623,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP,c2.CGP_ chemical and genetic perturbations
2624,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN,C7_ immunologic signatures
2625,AAANWWTGC_UNKNOWN,c3.TFT_ transcription factor targets
2626,MIKKELSEN_IPS_WITH_HCP_H3K27ME3,c2.CGP_ chemical and genetic perturbations
2627,BMI1_DN.V1_UP,C6_ oncogenic signatures
2628,GRANDVAUX_IRF3_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
2629,GO_REGULATION_OF_P38MAPK_CASCADE,c5.BP_ GO biological process
2630,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_UP,C7_ immunologic signatures
2631,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP,C7_ immunologic signatures
2632,GO_EXOCYTOSIS,c5.BP_ GO biological process
2633,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,c2.CGP_ chemical and genetic perturbations
2634,GO_POSITIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,c5.BP_ GO biological process
2635,GO_REGULATION_OF_INTERFERON_BETA_PRODUCTION,c5.BP_ GO biological process
2636,GO_CARDIAC_SEPTUM_MORPHOGENESIS,c5.BP_ GO biological process
2637,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,C7_ immunologic signatures
2638,GO_COCHLEA_MORPHOGENESIS,c5.BP_ GO biological process
2639,MODULE_92,c4.CM_ cancer modules
2640,ALPHACP1_01,c3.TFT_ transcription factor targets
2641,CTGAGCC_MIR24,c3.MIR_ microRNA targets
2642,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN,C7_ immunologic signatures
2643,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
2644,GO_NEGATIVE_REGULATION_OF_MAPK_CASCADE,c5.BP_ GO biological process
2645,GO_PROTEIN_HETERODIMERIZATION_ACTIVITY,c5.GO molecular function
2646,GSE7852_LN_VS_THYMUS_TREG_DN,C7_ immunologic signatures
2647,MORF_MYC,c4.CGN_ cancer gene neighborhoods
2648,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
2649,GO_CELLULAR_RESPONSE_TO_KETONE,c5.BP_ GO biological process
2650,WEBER_METHYLATED_IN_COLON_CANCER,c2.CGP_ chemical and genetic perturbations
2651,GSE3982_NKCELL_VS_TH2_UP,C7_ immunologic signatures
2652,GO_CATECHOLAMINE_METABOLIC_PROCESS,c5.BP_ GO biological process
2653,GO_LYMPHOCYTE_MEDIATED_IMMUNITY,c5.BP_ GO biological process
2654,GO_NEGATIVE_REGULATION_OF_VIRAL_PROCESS,c5.BP_ GO biological process
2655,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP,C7_ immunologic signatures
2656,GO_RIBONUCLEOTIDE_CATABOLIC_PROCESS,c5.BP_ GO biological process
2657,KEGG_AXON_GUIDANCE,c2.CP_BIOCARTA_ BioCarta gene sets
2658,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,C7_ immunologic signatures
2659,GO_REGULATION_OF_URINE_VOLUME,c5.BP_ GO biological process
2660,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,C7_ immunologic signatures
2661,SESTO_RESPONSE_TO_UV_C2,c2.CGP_ chemical and genetic perturbations
2662,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_DN,C7_ immunologic signatures
2663,GO_ENDOCRINE_PROCESS,c5.BP_ GO biological process
2664,GATA1_04,c3.TFT_ transcription factor targets
2665,GO_EXTRACELLULAR_MATRIX_DISASSEMBLY,c5.BP_ GO biological process
2666,ACATTCC_MIR1_MIR206,c3.MIR_ microRNA targets
2667,GSE27786_CD4_VS_CD8_TCELL_UP,C7_ immunologic signatures
2668,OHM_METHYLATED_IN_ADULT_CANCERS,c2.CGP_ chemical and genetic perturbations
2669,GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP,C7_ immunologic signatures
2670,GO_PHOSPHOLIPASE_C_ACTIVITY,c5.GO molecular function
2671,CTAWWWATA_RSRFC4_Q2,c3.TFT_ transcription factor targets
2672,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_UP,C7_ immunologic signatures
2673,GO_WNT_PROTEIN_BINDING,c5.GO molecular function
2674,GO_PROTEIN_KINASE_C_ACTIVITY,c5.GO molecular function
2675,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
2676,GO_HORMONE_ACTIVITY,c5.GO molecular function
2677,GO_ACTIVATION_OF_JUN_KINASE_ACTIVITY,c5.BP_ GO biological process
2678,GO_MUSCLE_ORGAN_MORPHOGENESIS,c5.BP_ GO biological process
2679,GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
2680,GO_RESPONSE_TO_OXYGEN_LEVELS,c5.BP_ GO biological process
2681,CHR6P12,35
2682,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_UP,C7_ immunologic signatures
2683,LIEN_BREAST_CARCINOMA_METAPLASTIC,c2.CGP_ chemical and genetic perturbations
2684,GSE45365_BCELL_VS_CD8_TCELL_UP,C7_ immunologic signatures
2685,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN,C7_ immunologic signatures
2686,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,C7_ immunologic signatures
2687,GO_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,c5.BP_ GO biological process
2688,LEIN_CEREBELLUM_MARKERS,c2.CGP_ chemical and genetic perturbations
2689,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP,C7_ immunologic signatures
2690,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN,C7_ immunologic signatures
2691,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,C7_ immunologic signatures
2692,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN,C7_ immunologic signatures
2693,SRF_01,c3.TFT_ transcription factor targets
2694,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,c2.CGP_ chemical and genetic perturbations
2695,MODULE_5,c4.CM_ cancer modules
2696,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN,C7_ immunologic signatures
2697,NIELSEN_LIPOSARCOMA_DN,c2.CGP_ chemical and genetic perturbations
2698,GO_MULTICELLULAR_ORGANISMAL_SIGNALING,c5.BP_ GO biological process
2699,MCCLUNG_COCAIN_REWARD_4WK,c2.CGP_ chemical and genetic perturbations
2700,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN,C7_ immunologic signatures
2701,GO_MESONEPHRIC_TUBULE_MORPHOGENESIS,c5.BP_ GO biological process
2702,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN,C7_ immunologic signatures
2703,MODULE_253,c4.CM_ cancer modules
2704,GSE3982_MAST_CELL_VS_TH1_DN,C7_ immunologic signatures
2705,GO_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,c5.BP_ GO biological process
2706,GSE3982_BCELL_VS_TH2_DN,C7_ immunologic signatures
2707,GO_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_BINDING,c5.GO molecular function
2708,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,C7_ immunologic signatures
2709,GO_CELL_FATE_SPECIFICATION,c5.BP_ GO biological process
2710,GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP,C7_ immunologic signatures
2711,GSE14350_IL2RB_KO_VS_WT_TREG_DN,C7_ immunologic signatures
2712,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,c2.CGP_ chemical and genetic perturbations
2713,DER_IFN_GAMMA_RESPONSE_UP,c2.CGP_ chemical and genetic perturbations
2714,SMIRNOV_RESPONSE_TO_IR_6HR_DN,c2.CGP_ chemical and genetic perturbations
2715,MODULE_458,c4.CM_ cancer modules
2716,GO_DIGESTIVE_TRACT_MORPHOGENESIS,c5.BP_ GO biological process
2717,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN,C7_ immunologic signatures
2718,GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,c2.CGP_ chemical and genetic perturbations
2719,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,c2.CGP_ chemical and genetic perturbations
2720,REACTOME_PLATELET_HOMEOSTASIS,c2.CP_REACTOME_ Reactome gene sets
2721,POU6F1_01,c3.TFT_ transcription factor targets
2722,GO_TRIGLYCERIDE_CATABOLIC_PROCESS,c5.BP_ GO biological process
2723,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,c2.CGP_ chemical and genetic perturbations
2724,STEGER_ADIPOGENESIS_DN,c2.CGP_ chemical and genetic perturbations
2725,GO_RESPONSE_TO_UV,c5.BP_ GO biological process
2726,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_DN,C7_ immunologic signatures
2727,GO_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSPORT,c5.BP_ GO biological process
2728,GO_PROTEIN_KINASE_C_BINDING,c5.GO molecular function
2729,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP,C7_ immunologic signatures
2730,CACCCBINDINGFACTOR_Q6,c3.TFT_ transcription factor targets
2731,AMIT_EGF_RESPONSE_240_MCF10A,c2.CGP_ chemical and genetic perturbations
2732,GO_POSITIVE_REGULATION_OF_HISTONE_METHYLATION,c5.BP_ GO biological process
2733,GO_ARACHIDONIC_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
2734,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,C7_ immunologic signatures
2735,CTATGCA_MIR153,c3.MIR_ microRNA targets
2736,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
2737,GO_RESPONSE_TO_VITAMIN_D,c5.BP_ GO biological process
2738,GO_TRANSMITTER_GATED_CHANNEL_ACTIVITY,c5.GO molecular function
2739,LIU_VMYB_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
2740,GO_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,c5.BP_ GO biological process
2741,GO_AXON_REGENERATION,c5.BP_ GO biological process
2742,DORSEY_GAB2_TARGETS,c2.CGP_ chemical and genetic perturbations
2743,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP,C7_ immunologic signatures
2744,NABA_PROTEOGLYCANS,c2.CP_ Canonical pathways
2745,GO_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
2746,GO_CALCIUM_ION_TRANSPORT,c5.BP_ GO biological process
2747,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP,C7_ immunologic signatures
2748,STK33_NOMO_UP,C6_ oncogenic signatures
2749,GO_ENZYME_ACTIVATOR_ACTIVITY,c5.GO molecular function
2750,MARKEY_RB1_ACUTE_LOF_DN,c2.CGP_ chemical and genetic perturbations
2751,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,C7_ immunologic signatures
2752,GSE27786_NKCELL_VS_ERYTHROBLAST_DN,C7_ immunologic signatures
2753,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_UP,C7_ immunologic signatures
2754,GSE11924_TH2_VS_TH17_CD4_TCELL_UP,C7_ immunologic signatures
2755,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_DN,C7_ immunologic signatures
2756,GSE12366_GC_VS_MEMORY_BCELL_UP,C7_ immunologic signatures
2757,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
2758,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP,C7_ immunologic signatures
2759,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,C7_ immunologic signatures
2760,GO_POSTSYNAPTIC_MEMBRANE_ORGANIZATION,c5.BP_ GO biological process
2761,WEST_ADRENOCORTICAL_TUMOR_DN,c2.CGP_ chemical and genetic perturbations
2762,GO_MESENCHYMAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
2763,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
2764,YNTTTNNNANGCARM_UNKNOWN,c3.TFT_ transcription factor targets
2765,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_UP,C7_ immunologic signatures
2766,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,C7_ immunologic signatures
2767,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN,C7_ immunologic signatures
2768,GO_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,c5.BP_ GO biological process
2769,KRCTCNNNNMANAGC_UNKNOWN,c3.TFT_ transcription factor targets
2770,GO_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,c5.BP_ GO biological process
2771,GO_ATRIAL_SEPTUM_DEVELOPMENT,c5.BP_ GO biological process
2772,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN,C7_ immunologic signatures
2773,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN,C7_ immunologic signatures
2774,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,c2.CGP_ chemical and genetic perturbations
2775,GO_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION,c5.BP_ GO biological process
2776,GR_Q6,c3.TFT_ transcription factor targets
2777,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,C7_ immunologic signatures
2778,NFY_01,c3.TFT_ transcription factor targets
2779,GO_REGULATION_OF_GENE_EXPRESSION_BY_GENETIC_IMPRINTING,c5.BP_ GO biological process
2780,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,c2.CGP_ chemical and genetic perturbations
2781,BRN2_01,c3.TFT_ transcription factor targets
2782,GO_EATING_BEHAVIOR,c5.BP_ GO biological process
2783,GO_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY,c5.GO molecular function
2784,GO_AORTA_DEVELOPMENT,c5.BP_ GO biological process
2785,GCM_Q2,c3.TFT_ transcription factor targets
2786,AR_Q6,c3.TFT_ transcription factor targets
2787,GO_REGULATION_OF_NEURON_PROJECTION_REGENERATION,c5.BP_ GO biological process
2788,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP,C7_ immunologic signatures
2789,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,c2.CGP_ chemical and genetic perturbations
2790,KIM_MYCN_AMPLIFICATION_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
2791,BIOCARTA_AGR_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
2792,HUANG_FOXA2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
2793,GO_DNA_STRAND_ELONGATION,c5.BP_ GO biological process
2794,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
2795,ACCAAAG_MIR9,c3.MIR_ microRNA targets
2796,GO_NEGATIVE_REGULATION_OF_WOUND_HEALING,c5.BP_ GO biological process
2797,HAN_SATB1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
2798,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN,C7_ immunologic signatures
2799,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,C7_ immunologic signatures
2800,RB_P130_DN.V1_UP,C6_ oncogenic signatures
2801,GO_CARDIAC_MUSCLE_CELL_CONTRACTION,c5.BP_ GO biological process
2802,REACTOME_INTERFERON_GAMMA_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
2803,NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,c2.CGP_ chemical and genetic perturbations
2804,ONDER_CDH1_TARGETS_2_DN,c2.CGP_ chemical and genetic perturbations
2805,GSE3982_MAST_CELL_VS_BASOPHIL_DN,C7_ immunologic signatures
2806,GO_NEGATIVE_REGULATION_OF_OSSIFICATION,c5.BP_ GO biological process
2807,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,C7_ immunologic signatures
2808,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,c2.CGP_ chemical and genetic perturbations
2809,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN,C7_ immunologic signatures
2810,GSE17721_12H_VS_24H_CPG_BMDC_UP,C7_ immunologic signatures
2811,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,C7_ immunologic signatures
2812,RAO_BOUND_BY_SALL4_ISOFORM_B,c2.CGP_ chemical and genetic perturbations
2813,REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS,c2.CP_REACTOME_ Reactome gene sets
2814,GSE30083_SP3_VS_SP4_THYMOCYTE_UP,C7_ immunologic signatures
2815,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,C7_ immunologic signatures
2816,GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN,C7_ immunologic signatures
2817,GO_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN,c5.BP_ GO biological process
2818,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
2819,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP,C7_ immunologic signatures
2820,GO_MULTI_MULTICELLULAR_ORGANISM_PROCESS,c5.BP_ GO biological process
2821,GO_BETA_AMYLOID_BINDING,c5.GO molecular function
2822,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,C7_ immunologic signatures
2823,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,C7_ immunologic signatures
2824,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_UP,C7_ immunologic signatures
2825,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,c2.CGP_ chemical and genetic perturbations
2826,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP,C7_ immunologic signatures
2827,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
2828,GO_INSULIN_LIKE_GROWTH_FACTOR_BINDING,c5.GO molecular function
2829,GO_CELL_KILLING,c5.BP_ GO biological process
2830,GTGACTT_MIR224,c3.MIR_ microRNA targets
2831,GO_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
2832,GO_ENZYME_INHIBITOR_ACTIVITY,c5.GO molecular function
2833,GO_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,c5.BP_ GO biological process
2834,GO_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,c5.BP_ GO biological process
2835,GO_CHONDROCYTE_DIFFERENTIATION,c5.BP_ GO biological process
2836,GO_CENTRIOLAR_SATELLITE,c5.CC_ GO cellular component
2837,GSE27786_BCELL_VS_NKTCELL_UP,C7_ immunologic signatures
2838,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,c2.CGP_ chemical and genetic perturbations
2839,ZIRN_TRETINOIN_RESPONSE_UP,c2.CGP_ chemical and genetic perturbations
2840,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,c2.CGP_ chemical and genetic perturbations
2841,GO_BLOOD_COAGULATION_INTRINSIC_PATHWAY,c5.BP_ GO biological process
2842,GSE25677_MPL_VS_R848_STIM_BCELL_DN,C7_ immunologic signatures
2843,GO_STARTLE_RESPONSE,c5.BP_ GO biological process
2844,GO_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
2845,WGTTNNNNNAAA_UNKNOWN,c3.TFT_ transcription factor targets
2846,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,C7_ immunologic signatures
2847,STAT3_01,c3.TFT_ transcription factor targets
2848,GO_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY,c5.BP_ GO biological process
2849,GO_INNER_EAR_MORPHOGENESIS,c5.BP_ GO biological process
2850,CHEN_HOXA5_TARGETS_9HR_UP,c2.CGP_ chemical and genetic perturbations
2851,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN,C7_ immunologic signatures
2852,GO_ASYMMETRIC_PROTEIN_LOCALIZATION,c5.BP_ GO biological process
2853,GO_GROWTH_FACTOR_ACTIVITY,c5.GO molecular function
2854,GSE27786_BCELL_VS_CD4_TCELL_UP,C7_ immunologic signatures
2855,REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
2856,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP,C7_ immunologic signatures
2857,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP,C7_ immunologic signatures
2858,GO_COCHLEA_DEVELOPMENT,c5.BP_ GO biological process
2859,OCT1_03,c3.TFT_ transcription factor targets
2860,TAATAAT_MIR126,c3.MIR_ microRNA targets
2861,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN,C7_ immunologic signatures
2862,DURAND_STROMA_NS_UP,c2.CGP_ chemical and genetic perturbations
2863,GSE22886_NEUTROPHIL_VS_MONOCYTE_UP,C7_ immunologic signatures
2864,GO_REGULATION_OF_CELL_ACTIVATION,c5.BP_ GO biological process
2865,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,C7_ immunologic signatures
2866,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_UP,C7_ immunologic signatures
2867,GO_LIPOPROTEIN_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
2868,MODULE_64,c4.CM_ cancer modules
2869,GO_PERIPHERAL_NERVOUS_SYSTEM_AXON_ENSHEATHMENT,c5.BP_ GO biological process
2870,GO_ANCHORED_COMPONENT_OF_MEMBRANE,c5.CC_ GO cellular component
2871,GO_REGULATED_EXOCYTOSIS,c5.BP_ GO biological process
2872,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_DN,C7_ immunologic signatures
2873,GO_MICROFILAMENT_MOTOR_ACTIVITY,c5.GO molecular function
2874,TFIIA_Q6,c3.TFT_ transcription factor targets
2875,GO_IONOTROPIC_GLUTAMATE_RECEPTOR_COMPLEX,c5.CC_ GO cellular component
2876,GO_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,c5.BP_ GO biological process
2877,GCM_IL6ST,c4.CGN_ cancer gene neighborhoods
2878,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,C7_ immunologic signatures
2879,GO_NEURAL_CREST_CELL_MIGRATION,c5.BP_ GO biological process
2880,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,c2.CGP_ chemical and genetic perturbations
2881,GSE14026_TH1_VS_TH17_DN,C7_ immunologic signatures
2882,NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON,c2.CGP_ chemical and genetic perturbations
2883,GO_NEGATIVE_REGULATION_OF_AXONOGENESIS,c5.BP_ GO biological process
2884,GO_POLYSACCHARIDE_BINDING,c5.GO molecular function
2885,GO_MICROTUBULE_ANCHORING,c5.BP_ GO biological process
2886,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,c2.CGP_ chemical and genetic perturbations
2887,STK33_SKM_UP,C6_ oncogenic signatures
2888,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,c2.CGP_ chemical and genetic perturbations
2889,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN,C7_ immunologic signatures
2890,VANTVEER_BREAST_CANCER_BRCA1_DN,c2.CGP_ chemical and genetic perturbations
2891,RP58_01,c3.TFT_ transcription factor targets
2892,RAAGNYNNCTTY_UNKNOWN,c3.TFT_ transcription factor targets
2893,DAZARD_UV_RESPONSE_CLUSTER_G2,c2.CGP_ chemical and genetic perturbations
2894,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP,C7_ immunologic signatures
2895,GO_VESICLE_LUMEN,c5.CC_ GO cellular component
2896,KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS,c2.CP_BIOCARTA_ BioCarta gene sets
2897,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,c2.CGP_ chemical and genetic perturbations
2898,ACCTGTTG_UNKNOWN,c3.TFT_ transcription factor targets
2899,AAGCACA_MIR218,c3.MIR_ microRNA targets
2900,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,C7_ immunologic signatures
2901,MODULE_436,c4.CM_ cancer modules
2902,YAMAZAKI_TCEB3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
2903,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,C7_ immunologic signatures
2904,GO_RESPONSE_TO_DRUG,c5.BP_ GO biological process
2905,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,C7_ immunologic signatures
2906,GO_REGULATION_OF_POTASSIUM_ION_TRANSPORT,c5.BP_ GO biological process
2907,CHANG_CORE_SERUM_RESPONSE_DN,c2.CGP_ chemical and genetic perturbations
2908,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP,C7_ immunologic signatures
2909,GO_NEUROTROPHIN_SIGNALING_PATHWAY,c5.BP_ GO biological process
2910,GO_REGULATION_OF_TRANSPORTER_ACTIVITY,c5.BP_ GO biological process
2911,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,C7_ immunologic signatures
2912,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,c2.CGP_ chemical and genetic perturbations
2913,GO_CAMP_METABOLIC_PROCESS,c5.BP_ GO biological process
2914,GO_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,c5.BP_ GO biological process
2915,GO_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,c5.BP_ GO biological process
2916,JNK_DN.V1_UP,C6_ oncogenic signatures
2917,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
2918,GO_EAR_MORPHOGENESIS,c5.BP_ GO biological process
2919,SGCGSSAAA_E2F1DP2_01,c3.TFT_ transcription factor targets
2920,PID_RB_1PATHWAY,c2.CP_ Canonical pathways
2921,CADWELL_ATG16L1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
2922,GO_REGULATION_OF_JUN_KINASE_ACTIVITY,c5.BP_ GO biological process
2923,REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS,c2.CP_REACTOME_ Reactome gene sets
2924,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN,C7_ immunologic signatures
2925,GO_DIVALENT_INORGANIC_CATION_TRANSPORT,c5.BP_ GO biological process
2926,NEMETH_INFLAMMATORY_RESPONSE_LPS_DN,c2.CGP_ chemical and genetic perturbations
2927,GO_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS,c5.BP_ GO biological process
2928,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,C7_ immunologic signatures
2929,MARZEC_IL2_SIGNALING_DN,c2.CGP_ chemical and genetic perturbations
2930,GO_NEGATIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,c5.BP_ GO biological process
2931,GO_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,c5.GO molecular function
2932,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,C7_ immunologic signatures
2933,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP,C7_ immunologic signatures
2934,GSE17721_CTRL_VS_LPS_0.5H_BMDC_UP,C7_ immunologic signatures
2935,GO_OSTEOBLAST_DEVELOPMENT,c5.BP_ GO biological process
2936,GAZIN_EPIGENETIC_SILENCING_BY_KRAS,c2.CGP_ chemical and genetic perturbations
2937,GO_REGULATION_OF_ORGAN_FORMATION,c5.BP_ GO biological process
2938,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_UP,C7_ immunologic signatures
2939,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,C7_ immunologic signatures
2940,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
2941,MODULE_79,c4.CM_ cancer modules
2942,GO_REGULATION_OF_PLATELET_AGGREGATION,c5.BP_ GO biological process
2943,STAT5A_01,c3.TFT_ transcription factor targets
2944,GO_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION,c5.BP_ GO biological process
2945,GO_ERK1_AND_ERK2_CASCADE,c5.BP_ GO biological process
2946,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
2947,MORF_LTK,c4.CGN_ cancer gene neighborhoods
2948,GO_CONNECTIVE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
2949,GGCACTT_MIR519E,c3.MIR_ microRNA targets
2950,HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2,c2.CGP_ chemical and genetic perturbations
2951,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN,C7_ immunologic signatures
2952,TGGTGCT_MIR29A_MIR29B_MIR29C,c3.MIR_ microRNA targets
2953,GO_REGULATION_OF_DEPHOSPHORYLATION,c5.BP_ GO biological process
2954,CAGTGTT_MIR141_MIR200A,c3.MIR_ microRNA targets
2955,GO_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY,c5.BP_ GO biological process
2956,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_UP,C7_ immunologic signatures
2957,BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,c2.CGP_ chemical and genetic perturbations
2958,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN,C7_ immunologic signatures
2959,GO_ACTIVATION_OF_MAPKK_ACTIVITY,c5.BP_ GO biological process
2960,MODULE_33,c4.CM_ cancer modules
2961,GO_POSITIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,c5.BP_ GO biological process
2962,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP,C7_ immunologic signatures
2963,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,c2.CGP_ chemical and genetic perturbations
2964,GO_PROTEIN_KINASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
2965,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_UP,C7_ immunologic signatures
2966,GSE3982_DC_VS_NKCELL_DN,C7_ immunologic signatures
2967,GSE3982_MAC_VS_TH1_UP,C7_ immunologic signatures
2968,HALLMARK_TNFA_SIGNALING_VIA_NFKB,H_ hallmark gene sets
2969,PLASARI_TGFB1_TARGETS_10HR_UP,c2.CGP_ chemical and genetic perturbations
2970,GO_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
2971,PATTERSON_DOCETAXEL_RESISTANCE,c2.CGP_ chemical and genetic perturbations
2972,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN,C7_ immunologic signatures
2973,KEGG_GNRH_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
2974,MODULE_124,c4.CM_ cancer modules
2975,FOXO4_02,c3.TFT_ transcription factor targets
2976,GO_SITE_OF_POLARIZED_GROWTH,c5.CC_ GO cellular component
2977,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,C7_ immunologic signatures
2978,GO_CELLULAR_RESPONSE_TO_ACID_CHEMICAL,c5.BP_ GO biological process
2979,GO_POSITIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS,c5.BP_ GO biological process
2980,GO_REGULATION_OF_VIRAL_GENOME_REPLICATION,c5.BP_ GO biological process
2981,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,c2.CGP_ chemical and genetic perturbations
2982,NFAT_Q6,c3.TFT_ transcription factor targets
2983,ICSBP_Q6,c3.TFT_ transcription factor targets
2984,REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE,c2.CP_REACTOME_ Reactome gene sets
2985,GO_CELL_AGING,c5.BP_ GO biological process
2986,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_UP,C7_ immunologic signatures
2987,GO_DEATH_RECEPTOR_BINDING,c5.GO molecular function
2988,ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN,c2.CGP_ chemical and genetic perturbations
2989,GO_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,c5.BP_ GO biological process
2990,GO_RESPONSE_TO_AXON_INJURY,c5.BP_ GO biological process
2991,GO_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,c5.BP_ GO biological process
2992,GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
2993,RIZ_ERYTHROID_DIFFERENTIATION,c2.CGP_ chemical and genetic perturbations
2994,CHR6Q14,25
2995,GO_POSITIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,c5.BP_ GO biological process
2996,REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,c2.CP_REACTOME_ Reactome gene sets
2997,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,c2.CGP_ chemical and genetic perturbations
2998,RGAANNTTC_HSF1_01,c3.TFT_ transcription factor targets
2999,GO_ESTABLISHMENT_OF_MITOTIC_SPINDLE_ORIENTATION,c5.BP_ GO biological process
3000,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP,C7_ immunologic signatures
3001,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,C7_ immunologic signatures
3002,LIANG_SILENCED_BY_METHYLATION_UP,c2.CGP_ chemical and genetic perturbations
3003,CHICAS_RB1_TARGETS_SENESCENT,c2.CGP_ chemical and genetic perturbations
3004,GO_DEFENSE_RESPONSE_TO_BACTERIUM,c5.BP_ GO biological process
3005,GO_NEGATIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,c5.BP_ GO biological process
3006,GSE15767_MED_VS_SCS_MAC_LN_UP,C7_ immunologic signatures
3007,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_UP,C7_ immunologic signatures
3008,MEF2_03,c3.TFT_ transcription factor targets
3009,MATZUK_EMBRYONIC_GERM_CELL,c2.CGP_ chemical and genetic perturbations
3010,GO_HINDBRAIN_MORPHOGENESIS,c5.BP_ GO biological process
3011,VANTVEER_BREAST_CANCER_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
3012,CRX_DN.V1_DN,C6_ oncogenic signatures
3013,GO_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,c5.BP_ GO biological process
3014,TCTAGAG_MIR517,c3.MIR_ microRNA targets
3015,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN,C7_ immunologic signatures
3016,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP,C7_ immunologic signatures
3017,GO_POSITIVE_REGULATION_OF_LIPID_KINASE_ACTIVITY,c5.BP_ GO biological process
3018,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_DN,C7_ immunologic signatures
3019,KEGG_MAPK_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
3020,BENPORATH_OCT4_TARGETS,c2.CGP_ chemical and genetic perturbations
3021,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,c2.CGP_ chemical and genetic perturbations
3022,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,c2.CGP_ chemical and genetic perturbations
3023,GSE17721_0.5H_VS_8H_POLYIC_BMDC_DN,C7_ immunologic signatures
3024,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP,C7_ immunologic signatures
3025,GSE7460_TCONV_VS_TREG_THYMUS_DN,C7_ immunologic signatures
3026,GO_CELL_ADHESION_MOLECULE_BINDING,c5.GO molecular function
3027,REACTOME_PI3K_CASCADE,c2.CP_REACTOME_ Reactome gene sets
3028,YATGNWAAT_OCT_C,c3.TFT_ transcription factor targets
3029,GO_EMBRYONIC_DIGESTIVE_TRACT_DEVELOPMENT,c5.BP_ GO biological process
3030,GO_REGULATION_OF_OSTEOBLAST_PROLIFERATION,c5.BP_ GO biological process
3031,KEGG_FOCAL_ADHESION,c2.CP_BIOCARTA_ BioCarta gene sets
3032,GO_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM,c5.BP_ GO biological process
3033,BMI1_DN_MEL18_DN.V1_UP,C6_ oncogenic signatures
3034,CTIP_DN.V1_DN,C6_ oncogenic signatures
3035,MCLACHLAN_DENTAL_CARIES_DN,c2.CGP_ chemical and genetic perturbations
3036,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP,C7_ immunologic signatures
3037,BRUINS_UVC_RESPONSE_EARLY_LATE,c2.CGP_ chemical and genetic perturbations
3038,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
3039,GSE17721_12H_VS_24H_LPS_BMDC_UP,C7_ immunologic signatures
3040,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,c2.CGP_ chemical and genetic perturbations
3041,GO_CARTILAGE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,c5.BP_ GO biological process
3042,GO_NEGATIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION,c5.BP_ GO biological process
3043,GO_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS,c5.BP_ GO biological process
3044,GO_RENAL_TUBULE_DEVELOPMENT,c5.BP_ GO biological process
3045,GO_FIBROBLAST_GROWTH_FACTOR_BINDING,c5.GO molecular function
3046,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN,C7_ immunologic signatures
3047,GO_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,c5.BP_ GO biological process
3048,KEGG_NOTCH_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
3049,CTTTGCA_MIR527,c3.MIR_ microRNA targets
3050,GO_RESPONSE_TO_WOUNDING,c5.BP_ GO biological process
3051,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
3052,ODONNELL_TFRC_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
3053,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP,C7_ immunologic signatures
3054,KEGG_LONG_TERM_DEPRESSION,c2.CP_BIOCARTA_ BioCarta gene sets
3055,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,C7_ immunologic signatures
3056,ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE,c2.CGP_ chemical and genetic perturbations
3057,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,c2.CGP_ chemical and genetic perturbations
3058,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP,c2.CGP_ chemical and genetic perturbations
3059,MODULE_168,c4.CM_ cancer modules
3060,GO_CELL_SEPARATION_AFTER_CYTOKINESIS,c5.BP_ GO biological process
3061,GO_CORE_PROMOTER_BINDING,c5.GO molecular function
3062,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
3063,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP,C7_ immunologic signatures
3064,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP,C7_ immunologic signatures
3065,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
3066,ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,c2.CGP_ chemical and genetic perturbations
3067,GSE12366_GC_VS_NAIVE_BCELL_DN,C7_ immunologic signatures
3068,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_DN,C7_ immunologic signatures
3069,GO_ACTININ_BINDING,c5.GO molecular function
3070,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP,c2.CGP_ chemical and genetic perturbations
3071,REACTOME_SIGNALING_BY_PDGF,c2.CP_REACTOME_ Reactome gene sets
3072,PAX4_04,c3.TFT_ transcription factor targets
3073,GO_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
3074,PID_FGF_PATHWAY,c2.CP_ Canonical pathways
3075,GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,c5.GO molecular function
3076,RPS14_DN.V1_DN,C6_ oncogenic signatures
3077,DELYS_THYROID_CANCER_DN,c2.CGP_ chemical and genetic perturbations
3078,GSE3982_DC_VS_MAC_LPS_STIM_DN,C7_ immunologic signatures
3079,PID_RAS_PATHWAY,c2.CP_ Canonical pathways
3080,GO_SECOND_MESSENGER_MEDIATED_SIGNALING,c5.BP_ GO biological process
3081,GO_RELAXATION_OF_MUSCLE,c5.BP_ GO biological process
3082,KORKOLA_CORRELATED_WITH_POU5F1,c2.CGP_ chemical and genetic perturbations
3083,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP,C7_ immunologic signatures
3084,GO_BLASTOCYST_GROWTH,c5.BP_ GO biological process
3085,REACTOME_G1_S_TRANSITION,c2.CP_REACTOME_ Reactome gene sets
3086,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP,C7_ immunologic signatures
3087,GO_NEGATIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,c5.BP_ GO biological process
3088,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_DN,C7_ immunologic signatures
3089,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,C7_ immunologic signatures
3090,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_DN,C7_ immunologic signatures
3091,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN,C7_ immunologic signatures
3092,GO_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
3093,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_UP,C7_ immunologic signatures
3094,GAVIN_FOXP3_TARGETS_CLUSTER_P7,c2.CGP_ chemical and genetic perturbations
3095,GSE12366_NAIVE_VS_MEMORY_BCELL_DN,C7_ immunologic signatures
3096,GO_SMAD_BINDING,c5.GO molecular function
3097,SMIRNOV_RESPONSE_TO_IR_6HR_UP,c2.CGP_ chemical and genetic perturbations
3098,GO_REGULATION_OF_CELLULAR_COMPONENT_SIZE,c5.BP_ GO biological process
3099,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,C7_ immunologic signatures
3100,GO_CELL_CELL_JUNCTION,c5.CC_ GO cellular component
3101,GO_REGULATION_OF_MYOBLAST_DIFFERENTIATION,c5.BP_ GO biological process
3102,GO_ENDOSOME_ORGANIZATION,c5.BP_ GO biological process
3103,GO_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,c5.BP_ GO biological process
3104,GSE18893_TCONV_VS_TREG_2H_CULTURE_DN,C7_ immunologic signatures
3105,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
3106,KRAS.KIDNEY_UP.V1_UP,C6_ oncogenic signatures
3107,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,C7_ immunologic signatures
3108,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
3109,GO_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
3110,GO_EXCITATORY_SYNAPSE,c5.CC_ GO cellular component
3111,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,C7_ immunologic signatures
3112,DASU_IL6_SIGNALING_SCAR_UP,c2.CGP_ chemical and genetic perturbations
3113,GSE24210_IL35_TREATED_VS_RESTING_TREG_DN,C7_ immunologic signatures
3114,GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS,c5.BP_ GO biological process
3115,GSE17721_CTRL_VS_LPS_1H_BMDC_DN,C7_ immunologic signatures
3116,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN,C7_ immunologic signatures
3117,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP,C7_ immunologic signatures
3118,GO_CALMODULIN_BINDING,c5.GO molecular function
3119,GO_PEPTIDYL_SERINE_MODIFICATION,c5.BP_ GO biological process
3120,GO_RESPONSE_TO_X_RAY,c5.BP_ GO biological process
3121,BAELDE_DIABETIC_NEPHROPATHY_UP,c2.CGP_ chemical and genetic perturbations
3122,GO_EMBRYONIC_MORPHOGENESIS,c5.BP_ GO biological process
3123,RADMACHER_AML_PROGNOSIS,c2.CGP_ chemical and genetic perturbations
3124,MCCABE_HOXC6_TARGETS_CANCER_UP,c2.CGP_ chemical and genetic perturbations
3125,GRADE_COLON_VS_RECTAL_CANCER_UP,c2.CGP_ chemical and genetic perturbations
3126,GO_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION,c5.BP_ GO biological process
3127,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP,C7_ immunologic signatures
3128,GSE36009_UNSTIM_VS_LPS_STIM_DC_UP,C7_ immunologic signatures
3129,GO_COMPLEMENT_ACTIVATION,c5.BP_ GO biological process
3130,ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP,c2.CGP_ chemical and genetic perturbations
3131,KIM_PTEN_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
3132,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,c2.CGP_ chemical and genetic perturbations
3133,FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,c2.CGP_ chemical and genetic perturbations
3134,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,C7_ immunologic signatures
3135,GO_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,c5.GO molecular function
3136,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP,C7_ immunologic signatures
3137,GO_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION,c5.BP_ GO biological process
3138,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN,C7_ immunologic signatures
3139,MODULE_27,c4.CM_ cancer modules
3140,GSE17721_LPS_VS_CPG_12H_BMDC_UP,C7_ immunologic signatures
3141,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,C7_ immunologic signatures
3142,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN,C7_ immunologic signatures
3143,MODULE_128,c4.CM_ cancer modules
3144,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,c2.CGP_ chemical and genetic perturbations
3145,GO_FAT_CELL_DIFFERENTIATION,c5.BP_ GO biological process
3146,GO_CALCIUM_ION_REGULATED_EXOCYTOSIS,c5.BP_ GO biological process
3147,GATA3_01,c3.TFT_ transcription factor targets
3148,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP,C7_ immunologic signatures
3149,GSE3982_BASOPHIL_VS_TH2_UP,C7_ immunologic signatures
3150,GENTILE_UV_RESPONSE_CLUSTER_D4,c2.CGP_ chemical and genetic perturbations
3151,GO_NEGATIVE_REGULATION_OF_DNA_REPLICATION,c5.BP_ GO biological process
3152,GO_SIGNAL_RELEASE,c5.BP_ GO biological process
3153,MARKEY_RB1_CHRONIC_LOF_UP,c2.CGP_ chemical and genetic perturbations
3154,GO_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,c5.BP_ GO biological process
3155,GSE17721_0.5H_VS_4H_CPG_BMDC_DN,C7_ immunologic signatures
3156,REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR,c2.CP_REACTOME_ Reactome gene sets
3157,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,C7_ immunologic signatures
3158,REACTOME_G1_PHASE,c2.CP_REACTOME_ Reactome gene sets
3159,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,C7_ immunologic signatures
3160,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN,C7_ immunologic signatures
3161,BALDWIN_PRKCI_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
3162,MATZUK_SPERMATID_DIFFERENTIATION,c2.CGP_ chemical and genetic perturbations
3163,OKAWA_NEUROBLASTOMA_1P36_31_DELETION,c2.CGP_ chemical and genetic perturbations
3164,AZARE_STAT3_TARGETS,c2.CGP_ chemical and genetic perturbations
3165,CHUNG_BLISTER_CYTOTOXICITY_UP,c2.CGP_ chemical and genetic perturbations
3166,SERVITJA_ISLET_HNF1A_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
3167,REACTOME_PACKAGING_OF_TELOMERE_ENDS,c2.CP_REACTOME_ Reactome gene sets
3168,REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS,c2.CP_REACTOME_ Reactome gene sets
3169,LIAO_METASTASIS,c2.CGP_ chemical and genetic perturbations
3170,KEGG_MELANOGENESIS,c2.CP_BIOCARTA_ BioCarta gene sets
3171,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP,C7_ immunologic signatures
3172,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
3173,GO_RESPONSE_TO_CORTICOSTEROID,c5.BP_ GO biological process
3174,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,c2.CGP_ chemical and genetic perturbations
3175,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP,C7_ immunologic signatures
3176,TSUNODA_CISPLATIN_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
3177,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP,C7_ immunologic signatures
3178,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP,C7_ immunologic signatures
3179,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN,c2.CGP_ chemical and genetic perturbations
3180,SREBP_Q3,c3.TFT_ transcription factor targets
3181,LOPES_METHYLATED_IN_COLON_CANCER_UP,c2.CGP_ chemical and genetic perturbations
3182,NFY_Q6,c3.TFT_ transcription factor targets
3183,MODULE_173,c4.CM_ cancer modules
3184,GO_PITUITARY_GLAND_DEVELOPMENT,c5.BP_ GO biological process
3185,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP,C7_ immunologic signatures
3186,GO_CELL_SUBSTRATE_ADHERENS_JUNCTION_ASSEMBLY,c5.BP_ GO biological process
3187,RODWELL_AGING_KIDNEY_UP,c2.CGP_ chemical and genetic perturbations
3188,ROVERSI_GLIOMA_LOH_REGIONS,c2.CGP_ chemical and genetic perturbations
3189,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN,C7_ immunologic signatures
3190,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP,C7_ immunologic signatures
3191,MODULE_389,c4.CM_ cancer modules
3192,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP,c2.CGP_ chemical and genetic perturbations
3193,GO_MYELOID_DENDRITIC_CELL_ACTIVATION,c5.BP_ GO biological process
3194,GO_ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY,c5.BP_ GO biological process
3195,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP,C7_ immunologic signatures
3196,HOEBEKE_LYMPHOID_STEM_CELL_DN,c2.CGP_ chemical and genetic perturbations
3197,GO_RESPONSE_TO_ORGANOPHOSPHORUS,c5.BP_ GO biological process
3198,GO_MAMMARY_GLAND_MORPHOGENESIS,c5.BP_ GO biological process
3199,MODULE_244,c4.CM_ cancer modules
3200,MEF2_01,c3.TFT_ transcription factor targets
3201,GO_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,c5.GO molecular function
3202,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP,C7_ immunologic signatures
3203,GO_CELLULAR_RESPONSE_TO_RETINOIC_ACID,c5.BP_ GO biological process
3204,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
3205,GSE20715_WT_VS_TLR4_KO_LUNG_UP,C7_ immunologic signatures
3206,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP,C7_ immunologic signatures
3207,MODULE_44,c4.CM_ cancer modules
3208,GO_NEURON_NEURON_SYNAPTIC_TRANSMISSION,c5.BP_ GO biological process
3209,MCDOWELL_ACUTE_LUNG_INJURY_UP,c2.CGP_ chemical and genetic perturbations
3210,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
3211,GO_POSITIVE_REGULATION_OF_KINASE_ACTIVITY,c5.BP_ GO biological process
3212,GSE16266_CTRL_VS_LPS_STIM_MEF_DN,C7_ immunologic signatures
3213,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN,C7_ immunologic signatures
3214,RAF_UP.V1_DN,C6_ oncogenic signatures
3215,GSE17721_LPS_VS_CPG_0.5H_BMDC_DN,C7_ immunologic signatures
3216,WTTGKCTG_UNKNOWN,c3.TFT_ transcription factor targets
3217,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN,C7_ immunologic signatures
3218,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,C7_ immunologic signatures
3219,AKT_UP.V1_DN,C6_ oncogenic signatures
3220,CHR17P11,55
3221,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,C7_ immunologic signatures
3222,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,c2.CGP_ chemical and genetic perturbations
3223,KRAS.BREAST_UP.V1_DN,C6_ oncogenic signatures
3224,GO_EYE_DEVELOPMENT,c5.BP_ GO biological process
3225,ESC_J1_UP_EARLY.V1_UP,C6_ oncogenic signatures
3226,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,C7_ immunologic signatures
3227,BERNARD_PPAPDC1B_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
3228,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN,C7_ immunologic signatures
3229,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_UP,C7_ immunologic signatures
3230,GO_NITRIC_OXIDE_SYNTHASE_BINDING,c5.GO molecular function
3231,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP,C7_ immunologic signatures
3232,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_UP,C7_ immunologic signatures
3233,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
3234,GO_MYOFIBRIL_ASSEMBLY,c5.BP_ GO biological process
3235,GO_ORGANIC_CATION_TRANSPORT,c5.BP_ GO biological process
3236,WILLIAMS_ESR1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
3237,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,C7_ immunologic signatures
3238,GO_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,c5.BP_ GO biological process
3239,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,c2.CGP_ chemical and genetic perturbations
3240,GO_RESPONSE_TO_VITAMIN,c5.BP_ GO biological process
3241,GO_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,c5.BP_ GO biological process
3242,BILBAN_B_CLL_LPL_UP,c2.CGP_ chemical and genetic perturbations
3243,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
3244,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN,C7_ immunologic signatures
3245,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,C7_ immunologic signatures
3246,PID_BETA_CATENIN_DEG_PATHWAY,c2.CP_ Canonical pathways
3247,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,C7_ immunologic signatures
3248,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_UP,C7_ immunologic signatures
3249,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
3250,PID_A6B1_A6B4_INTEGRIN_PATHWAY,c2.CP_ Canonical pathways
3251,KIM_LIVER_CANCER_POOR_SURVIVAL_DN,c2.CGP_ chemical and genetic perturbations
3252,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP,C7_ immunologic signatures
3253,MODULE_70,c4.CM_ cancer modules
3254,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN,C7_ immunologic signatures
3255,GO_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX,c5.CC_ GO cellular component
3256,GO_RESPONSE_TO_METAL_ION,c5.BP_ GO biological process
3257,GO_METHYLATED_HISTONE_BINDING,c5.GO molecular function
3258,GO_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,c5.BP_ GO biological process
3259,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_UP,C7_ immunologic signatures
3260,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,c2.CGP_ chemical and genetic perturbations
3261,GSE7460_TCONV_VS_TREG_LN_UP,C7_ immunologic signatures
3262,GSE360_DC_VS_MAC_L_MAJOR_UP,C7_ immunologic signatures
3263,CHR1P22,60
3264,GO_POSITIVE_REGULATION_OF_CELL_DEVELOPMENT,c5.BP_ GO biological process
3265,GO_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING,c5.BP_ GO biological process
3266,GSE12366_GC_BCELL_VS_PLASMA_CELL_UP,C7_ immunologic signatures
3267,GO_REGULATION_OF_RUFFLE_ASSEMBLY,c5.BP_ GO biological process
3268,GO_POSITIVE_REGULATION_OF_ION_TRANSPORT,c5.BP_ GO biological process
3269,HLF_01,c3.TFT_ transcription factor targets
3270,GO_NEGATIVE_REGULATION_OF_EXOCYTOSIS,c5.BP_ GO biological process
3271,CSR_LATE_UP.V1_UP,C6_ oncogenic signatures
3272,HNF1_01,c3.TFT_ transcription factor targets
3273,GSE3982_MAC_VS_TH1_DN,C7_ immunologic signatures
3274,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
3275,GO_REGULATION_OF_BLOOD_PRESSURE,c5.BP_ GO biological process
3276,E4BP4_01,c3.TFT_ transcription factor targets
3277,GO_POSITIVE_REGULATION_OF_TELOMERASE_ACTIVITY,c5.BP_ GO biological process
3278,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,c2.CGP_ chemical and genetic perturbations
3279,GSE7852_THYMUS_VS_FAT_TREG_DN,C7_ immunologic signatures
3280,PAX2_02,c3.TFT_ transcription factor targets
3281,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,c2.CGP_ chemical and genetic perturbations
3282,MOHANKUMAR_HOXA1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
3283,GO_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,c5.BP_ GO biological process
3284,DCA_UP.V1_DN,C6_ oncogenic signatures
3285,GNF2_CDH11,c4.CGN_ cancer gene neighborhoods
3286,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
3287,GO_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,c5.BP_ GO biological process
3288,BURTON_ADIPOGENESIS_7,c2.CGP_ chemical and genetic perturbations
3289,CHR4Q28,25
3290,NFAT_Q4_01,c3.TFT_ transcription factor targets
3291,GO_RESPONSE_TO_GROWTH_FACTOR,c5.BP_ GO biological process
3292,GO_APICAL_JUNCTION_ASSEMBLY,c5.BP_ GO biological process
3293,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,c2.CGP_ chemical and genetic perturbations
3294,GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP,C7_ immunologic signatures
3295,GO_CEREBELLAR_CORTEX_MORPHOGENESIS,c5.BP_ GO biological process
3296,GO_RESPONSE_TO_BMP,c5.BP_ GO biological process
3297,GO_NEGATIVE_REGULATION_OF_GTPASE_ACTIVITY,c5.BP_ GO biological process
3298,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN,C7_ immunologic signatures
3299,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_DN,C7_ immunologic signatures
3300,GO_SECRETORY_VESICLE,c5.CC_ GO cellular component
3301,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DN,C7_ immunologic signatures
3302,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,C7_ immunologic signatures
3303,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,c2.CGP_ chemical and genetic perturbations
3304,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,C7_ immunologic signatures
3305,GO_BHLH_TRANSCRIPTION_FACTOR_BINDING,c5.GO molecular function
3306,AAACCAC_MIR140,c3.MIR_ microRNA targets
3307,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN,c2.CGP_ chemical and genetic perturbations
3308,GSE16385_MONOCYTE_VS_MACROPHAGE_DN,C7_ immunologic signatures
3309,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP,C7_ immunologic signatures
3310,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_UP,C7_ immunologic signatures
3311,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN,C7_ immunologic signatures
3312,KRAS.KIDNEY_UP.V1_DN,C6_ oncogenic signatures
3313,WENG_POR_TARGETS_GLOBAL_DN,c2.CGP_ chemical and genetic perturbations
3314,SENESE_HDAC3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
3315,GO_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
3316,GO_STEM_CELL_DIFFERENTIATION,c5.BP_ GO biological process
3317,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,C7_ immunologic signatures
3318,BAE_BRCA1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
3319,HOLLERN_EMT_BREAST_TUMOR_DN,c2.CGP_ chemical and genetic perturbations
3320,GO_REGULATION_OF_NEURON_MIGRATION,c5.BP_ GO biological process
3321,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,C7_ immunologic signatures
3322,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
3323,MOREIRA_RESPONSE_TO_TSA_DN,c2.CGP_ chemical and genetic perturbations
3324,GO_GENETIC_IMPRINTING,c5.BP_ GO biological process
3325,GO_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
3326,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN,C7_ immunologic signatures
3327,GO_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,c5.BP_ GO biological process
3328,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,c2.CP_BIOCARTA_ BioCarta gene sets
3329,GO_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,c5.BP_ GO biological process
3330,AMIT_EGF_RESPONSE_60_MCF10A,c2.CGP_ chemical and genetic perturbations
3331,GSE27786_CD4_TCELL_VS_MONO_MAC_DN,C7_ immunologic signatures
3332,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP,C7_ immunologic signatures
3333,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN,C7_ immunologic signatures
3334,MODULE_345,c4.CM_ cancer modules
3335,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,c2.CGP_ chemical and genetic perturbations
3336,KEGG_PATHWAYS_IN_CANCER,c2.CP_BIOCARTA_ BioCarta gene sets
3337,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,c2.CGP_ chemical and genetic perturbations
3338,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN,C7_ immunologic signatures
3339,CHEBOTAEV_GR_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
3340,MARKEY_RB1_CHRONIC_LOF_DN,c2.CGP_ chemical and genetic perturbations
3341,GO_INTESTINAL_EPITHELIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
3342,GO_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,c5.BP_ GO biological process
3343,GO_CARDIAC_VENTRICLE_MORPHOGENESIS,c5.BP_ GO biological process
3344,GO_ATPASE_ACTIVITY,c5.GO molecular function
3345,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP,C7_ immunologic signatures
3346,ZHAN_MULTIPLE_MYELOMA_LB_DN,c2.CGP_ chemical and genetic perturbations
3347,GO_STRUCTURE_SPECIFIC_DNA_BINDING,c5.GO molecular function
3348,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,C7_ immunologic signatures
3349,GO_RESPONSE_TO_ACID_CHEMICAL,c5.BP_ GO biological process
3350,HFH4_01,c3.TFT_ transcription factor targets
3351,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN,C7_ immunologic signatures
3352,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,C7_ immunologic signatures
3353,GO_REGULATION_OF_GASTRULATION,c5.BP_ GO biological process
3354,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,C7_ immunologic signatures
3355,NCX_01,c3.TFT_ transcription factor targets
3356,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,C7_ immunologic signatures
3357,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_UP,C7_ immunologic signatures
3358,GO_CELLULAR_RESPONSE_TO_UV,c5.BP_ GO biological process
3359,JNK_DN.V1_DN,C6_ oncogenic signatures
3360,GSE17721_4_VS_24H_CPG_BMDC_UP,C7_ immunologic signatures
3361,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN,C7_ immunologic signatures
3362,GO_RESPONSE_TO_MINERALOCORTICOID,c5.BP_ GO biological process
3363,GO_CELL_CELL_JUNCTION_ASSEMBLY,c5.BP_ GO biological process
3364,GO_APICAL_PART_OF_CELL,c5.CC_ GO cellular component
3365,GO_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,c5.BP_ GO biological process
3366,GO_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
3367,URS_ADIPOCYTE_DIFFERENTIATION_UP,c2.CGP_ chemical and genetic perturbations
3368,HALLMARK_COAGULATION,H_ hallmark gene sets
3369,GNF2_INPP5D,c4.CGN_ cancer gene neighborhoods
3370,GO_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,c5.BP_ GO biological process
3371,ATGTACA_MIR493,c3.MIR_ microRNA targets
3372,HUPER_BREAST_BASAL_VS_LUMINAL_UP,c2.CGP_ chemical and genetic perturbations
3373,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_DN,C7_ immunologic signatures
3374,CEBPGAMMA_Q6,c3.TFT_ transcription factor targets
3375,CCAWYNNGAAR_UNKNOWN,c3.TFT_ transcription factor targets
3376,GO_SECRETION,c5.BP_ GO biological process
3377,GSE13306_RA_VS_UNTREATED_TCONV_DN,C7_ immunologic signatures
3378,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
3379,CHR13Q14,57
3380,AREB6_03,c3.TFT_ transcription factor targets
3381,GO_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,c5.BP_ GO biological process
3382,CAMPS_COLON_CANCER_COPY_NUMBER_DN,c2.CGP_ chemical and genetic perturbations
3383,HOOI_ST7_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
3384,GO_LIPOPROTEIN_METABOLIC_PROCESS,c5.BP_ GO biological process
3385,KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION,c2.CP_BIOCARTA_ BioCarta gene sets
3386,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN,C7_ immunologic signatures
3387,GO_POSITIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,c5.BP_ GO biological process
3388,GO_VESICLE_DOCKING,c5.BP_ GO biological process
3389,BAUS_TFF2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
3390,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN,C7_ immunologic signatures
3391,GO_NEURAL_TUBE_FORMATION,c5.BP_ GO biological process
3392,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_DN,C7_ immunologic signatures
3393,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_DN,C7_ immunologic signatures
3394,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN,C7_ immunologic signatures
3395,BERENJENO_TRANSFORMED_BY_RHOA_DN,c2.CGP_ chemical and genetic perturbations
3396,GSE7852_LN_VS_FAT_TREG_DN,C7_ immunologic signatures
3397,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
3398,MODULE_220,c4.CM_ cancer modules
3399,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN,C7_ immunologic signatures
3400,GO_GAMMA_TUBULIN_COMPLEX,c5.CC_ GO cellular component
3401,GSE40443_INDUCED_VS_TOTAL_TREG_DN,C7_ immunologic signatures
3402,BCAT.100_UP.V1_UP,C6_ oncogenic signatures
3403,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,C7_ immunologic signatures
3404,WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION,c2.CGP_ chemical and genetic perturbations
3405,GSE17721_0.5H_VS_12H_LPS_BMDC_DN,C7_ immunologic signatures
3406,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_UP,C7_ immunologic signatures
3407,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,c2.CGP_ chemical and genetic perturbations
3408,PID_INTEGRIN_A4B1_PATHWAY,c2.CP_ Canonical pathways
3409,TGTGTGA_MIR377,c3.MIR_ microRNA targets
3410,GO_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,c5.BP_ GO biological process
3411,GO_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY,c5.GO molecular function
3412,LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,c2.CGP_ chemical and genetic perturbations
3413,CHR1Q31,36
3414,AMIT_EGF_RESPONSE_60_HELA,c2.CGP_ chemical and genetic perturbations
3415,CHR5Q34,21
3416,REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE,c2.CP_REACTOME_ Reactome gene sets
3417,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN,c2.CGP_ chemical and genetic perturbations
3418,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
3419,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,C7_ immunologic signatures
3420,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN,C7_ immunologic signatures
3421,GSE24726_WT_VS_E2_2_KO_PDC_UP,C7_ immunologic signatures
3422,ESC_V6.5_UP_LATE.V1_UP,C6_ oncogenic signatures
3423,BROWNE_HCMV_INFECTION_16HR_DN,c2.CGP_ chemical and genetic perturbations
3424,GO_ACID_SECRETION,c5.BP_ GO biological process
3425,GO_CAMERA_TYPE_EYE_MORPHOGENESIS,c5.BP_ GO biological process
3426,GO_MESENCHYME_MORPHOGENESIS,c5.BP_ GO biological process
3427,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,C7_ immunologic signatures
3428,GATA4_Q3,c3.TFT_ transcription factor targets
3429,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,C7_ immunologic signatures
3430,GO_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
3431,GSE14350_TREG_VS_TEFF_UP,C7_ immunologic signatures
3432,TEF_Q6,c3.TFT_ transcription factor targets
3433,AMIT_SERUM_RESPONSE_40_MCF10A,c2.CGP_ chemical and genetic perturbations
3434,TCF1P_Q6,c3.TFT_ transcription factor targets
3435,GO_DNA_HELICASE_ACTIVITY,c5.GO molecular function
3436,OUILLETTE_CLL_13Q14_DELETION_DN,c2.CGP_ chemical and genetic perturbations
3437,GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN,C7_ immunologic signatures
3438,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_DN,C7_ immunologic signatures
3439,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN,C7_ immunologic signatures
3440,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN,C7_ immunologic signatures
3441,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP,C7_ immunologic signatures
3442,GO_PROTEIN_TYROSINE_KINASE_ACTIVITY,c5.GO molecular function
3443,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN,C7_ immunologic signatures
3444,GO_POST_EMBRYONIC_DEVELOPMENT,c5.BP_ GO biological process
3445,GO_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
3446,MODULE_456,c4.CM_ cancer modules
3447,SHIPP_DLBCL_CURED_VS_FATAL_UP,c2.CGP_ chemical and genetic perturbations
3448,GO_SECRETORY_GRANULE_ORGANIZATION,c5.BP_ GO biological process
3449,GO_PHOSPHOLIPID_TRANSPORTER_ACTIVITY,c5.GO molecular function
3450,BIOCARTA_SPRY_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
3451,GO_WOUND_HEALING,c5.BP_ GO biological process
3452,GO_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION,c5.BP_ GO biological process
3453,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP,C7_ immunologic signatures
3454,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN,C7_ immunologic signatures
3455,OHGUCHI_LIVER_HNF4A_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
3456,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,c2.CGP_ chemical and genetic perturbations
3457,ACTTTAT_MIR1425P,c3.MIR_ microRNA targets
3458,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP,C7_ immunologic signatures
3459,GCACCTT_MIR18A_MIR18B,c3.MIR_ microRNA targets
3460,GO_URONIC_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
3461,GO_NEGATIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,c5.BP_ GO biological process
3462,MODULE_146,c4.CM_ cancer modules
3463,VARELA_ZMPSTE24_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
3464,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,C7_ immunologic signatures
3465,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN,C7_ immunologic signatures
3466,SHIN_B_CELL_LYMPHOMA_CLUSTER_8,c2.CGP_ chemical and genetic perturbations
3467,GO_MAINTENANCE_OF_CELL_NUMBER,c5.BP_ GO biological process
3468,GO_REGULATION_OF_POSITIVE_CHEMOTAXIS,c5.BP_ GO biological process
3469,DAWSON_METHYLATED_IN_LYMPHOMA_TCL1,c2.CGP_ chemical and genetic perturbations
3470,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP,C7_ immunologic signatures
3471,MODULE_23,c4.CM_ cancer modules
3472,GO_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
3473,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP,C7_ immunologic signatures
3474,GO_ASSOCIATIVE_LEARNING,c5.BP_ GO biological process
3475,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,C7_ immunologic signatures
3476,GENTILE_UV_LOW_DOSE_DN,c2.CGP_ chemical and genetic perturbations
3477,GO_TERPENOID_METABOLIC_PROCESS,c5.BP_ GO biological process
3478,KEGG_MELANOMA,c2.CP_BIOCARTA_ BioCarta gene sets
3479,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP,C7_ immunologic signatures
3480,ISRE_01,c3.TFT_ transcription factor targets
3481,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP,c2.CGP_ chemical and genetic perturbations
3482,REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A,c2.CP_REACTOME_ Reactome gene sets
3483,GO_BEHAVIOR,c5.BP_ GO biological process
3484,GAGCCTG_MIR484,c3.MIR_ microRNA targets
3485,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP,C7_ immunologic signatures
3486,MODULE_316,c4.CM_ cancer modules
3487,GO_RESPONSE_TO_STEROID_HORMONE,c5.BP_ GO biological process
3488,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP,C7_ immunologic signatures
3489,GO_DEFINITIVE_HEMOPOIESIS,c5.BP_ GO biological process
3490,GO_ACTIN_FILAMENT_ORGANIZATION,c5.BP_ GO biological process
3491,YRTCANNRCGC_UNKNOWN,c3.TFT_ transcription factor targets
3492,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN,C7_ immunologic signatures
3493,GO_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM,c5.BP_ GO biological process
3494,GO_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS,c5.BP_ GO biological process
3495,MORF_BCL2,c4.CGN_ cancer gene neighborhoods
3496,CHR6P23,16
3497,GSE10325_BCELL_VS_LUPUS_BCELL_DN,C7_ immunologic signatures
3498,GO_REGULATION_OF_ODONTOGENESIS,c5.BP_ GO biological process
3499,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,c2.CGP_ chemical and genetic perturbations
3500,GO_NEGATIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,c5.BP_ GO biological process
3501,REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION,c2.CP_REACTOME_ Reactome gene sets
3502,GO_NEUTRAL_LIPID_CATABOLIC_PROCESS,c5.BP_ GO biological process
3503,GO_THYROID_GLAND_DEVELOPMENT,c5.BP_ GO biological process
3504,GO_POSITIVE_REGULATION_OF_CYTOKINE_SECRETION,c5.BP_ GO biological process
3505,GO_REGULATION_OF_ORGAN_MORPHOGENESIS,c5.BP_ GO biological process
3506,GO_MISMATCH_REPAIR,c5.BP_ GO biological process
3507,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP,C7_ immunologic signatures
3508,GO_REGULATION_OF_T_CELL_PROLIFERATION,c5.BP_ GO biological process
3509,AAAYRNCTG_UNKNOWN,c3.TFT_ transcription factor targets
3510,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_UP,C7_ immunologic signatures
3511,GO_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS,c5.BP_ GO biological process
3512,CREBP1_01,c3.TFT_ transcription factor targets
3513,KARLSSON_TGFB1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
3514,WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,c2.CGP_ chemical and genetic perturbations
3515,MODULE_170,c4.CM_ cancer modules
3516,GSE17721_LPS_VS_CPG_4H_BMDC_UP,C7_ immunologic signatures
3517,MORF_ATRX,c4.CGN_ cancer gene neighborhoods
3518,DUAN_PRDM5_TARGETS,c2.CGP_ chemical and genetic perturbations
3519,GO_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_BINDING,c5.GO molecular function
3520,BIOCARTA_PGC1A_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
3521,LE_NEURONAL_DIFFERENTIATION_DN,c2.CGP_ chemical and genetic perturbations
3522,GO_DRUG_METABOLIC_PROCESS,c5.BP_ GO biological process
3523,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_DN,C7_ immunologic signatures
3524,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN,C7_ immunologic signatures
3525,HOFMANN_CELL_LYMPHOMA_DN,c2.CGP_ chemical and genetic perturbations
3526,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
3527,ACTGAAA_MIR30A3P_MIR30E3P,c3.MIR_ microRNA targets
3528,GSE20715_0H_VS_48H_OZONE_LUNG_DN,C7_ immunologic signatures
3529,GO_AMINOGLYCAN_METABOLIC_PROCESS,c5.BP_ GO biological process
3530,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
3531,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,C7_ immunologic signatures
3532,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
3533,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_UP,C7_ immunologic signatures
3534,MORF_ETV3,c4.CGN_ cancer gene neighborhoods
3535,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN,C7_ immunologic signatures
3536,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP,C7_ immunologic signatures
3537,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_UP,C7_ immunologic signatures
3538,MODULE_98,c4.CM_ cancer modules
3539,GO_ATPASE_ACTIVITY_COUPLED_TO_MOVEMENT_OF_SUBSTANCES,c5.GO molecular function
3540,SANA_TNF_SIGNALING_UP,c2.CGP_ chemical and genetic perturbations
3541,GSE2826_XID_VS_BTK_KO_BCELL_DN,C7_ immunologic signatures
3542,PIGF_UP.V1_DN,C6_ oncogenic signatures
3543,GO_SCHWANN_CELL_DIFFERENTIATION,c5.BP_ GO biological process
3544,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN,C7_ immunologic signatures
3545,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,C7_ immunologic signatures
3546,BCAT_BILD_ET_AL_UP,C6_ oncogenic signatures
3547,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
3548,GO_RESPONSE_TO_LIGHT_STIMULUS,c5.BP_ GO biological process
3549,REACTOME_GENERIC_TRANSCRIPTION_PATHWAY,c2.CP_REACTOME_ Reactome gene sets
3550,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP,C7_ immunologic signatures
3551,GO_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,c5.BP_ GO biological process
3552,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP,C7_ immunologic signatures
3553,GO_POSITIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
3554,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN,C7_ immunologic signatures
3555,E2F1_Q6_01,c3.TFT_ transcription factor targets
3556,GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
3557,GO_PROTEIN_TRIMERIZATION,c5.BP_ GO biological process
3558,GSE22886_NAIVE_TCELL_VS_NKCELL_DN,C7_ immunologic signatures
3559,ZHAN_MULTIPLE_MYELOMA_SPIKED,c2.CGP_ chemical and genetic perturbations
3560,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
3561,CHR20P12,27
3562,KEGG_ONE_CARBON_POOL_BY_FOLATE,c2.CP_BIOCARTA_ BioCarta gene sets
3563,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_DN,C7_ immunologic signatures
3564,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP,C7_ immunologic signatures
3565,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP,C7_ immunologic signatures
3566,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,c2.CP_REACTOME_ Reactome gene sets
3567,GSE3982_MAST_CELL_VS_NKCELL_DN,C7_ immunologic signatures
3568,LENAOUR_DENDRITIC_CELL_MATURATION_UP,c2.CGP_ chemical and genetic perturbations
3569,GO_SKIN_EPIDERMIS_DEVELOPMENT,c5.BP_ GO biological process
3570,GO_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
3571,REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION,c2.CP_REACTOME_ Reactome gene sets
3572,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN,C7_ immunologic signatures
3573,RPS14_DN.V1_UP,C6_ oncogenic signatures
3574,OCT1_04,c3.TFT_ transcription factor targets
3575,MEIS1AHOXA9_01,c3.TFT_ transcription factor targets
3576,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP,C7_ immunologic signatures
3577,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN,C7_ immunologic signatures
3578,WIERENGA_STAT5A_TARGETS_GROUP2,c2.CGP_ chemical and genetic perturbations
3579,CHR3Q13,57
3580,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP,C7_ immunologic signatures
3581,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN,C7_ immunologic signatures
3582,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,C7_ immunologic signatures
3583,GO_AXON_PART,c5.CC_ GO cellular component
3584,GO_NEGATIVE_REGULATION_OF_GLIOGENESIS,c5.BP_ GO biological process
3585,GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,c5.BP_ GO biological process
3586,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,C7_ immunologic signatures
3587,GO_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,c5.BP_ GO biological process
3588,GSE6259_33D1_POS_DC_VS_BCELL_DN,C7_ immunologic signatures
3589,GO_NEGATIVE_REGULATION_OF_TRANSFERASE_ACTIVITY,c5.BP_ GO biological process
3590,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN,C7_ immunologic signatures
3591,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN,C7_ immunologic signatures
3592,RAPA_EARLY_UP.V1_UP,C6_ oncogenic signatures
3593,GO_NEGATIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
3594,GSE3982_DC_VS_NEUTROPHIL_DN,C7_ immunologic signatures
3595,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN,C7_ immunologic signatures
3596,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_DN,C7_ immunologic signatures
3597,HNF1_C,c3.TFT_ transcription factor targets
3598,ZHU_CMV_ALL_UP,c2.CGP_ chemical and genetic perturbations
3599,STAT5B_01,c3.TFT_ transcription factor targets
3600,AP3_Q6,c3.TFT_ transcription factor targets
3601,AGCTCCT_MIR28,c3.MIR_ microRNA targets
3602,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,C7_ immunologic signatures
3603,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP,C7_ immunologic signatures
3604,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP,c2.CGP_ chemical and genetic perturbations
3605,GO_GLOMERULAR_EPITHELIUM_DEVELOPMENT,c5.BP_ GO biological process
3606,GTACAGG_MIR486,c3.MIR_ microRNA targets
3607,GO_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,c5.BP_ GO biological process
3608,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,c2.CGP_ chemical and genetic perturbations
3609,S8_01,c3.TFT_ transcription factor targets
3610,FERRARI_RESPONSE_TO_FENRETINIDE_UP,c2.CGP_ chemical and genetic perturbations
3611,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,C7_ immunologic signatures
3612,KEGG_LONG_TERM_POTENTIATION,c2.CP_BIOCARTA_ BioCarta gene sets
3613,DAIRKEE_TERT_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
3614,RSRFC4_01,c3.TFT_ transcription factor targets
3615,LEE_LIVER_CANCER_MYC_E2F1_UP,c2.CGP_ chemical and genetic perturbations
3616,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,c2.CGP_ chemical and genetic perturbations
3617,MODULE_95,c4.CM_ cancer modules
3618,KEGG_CELL_ADHESION_MOLECULES_CAMS,c2.CP_BIOCARTA_ BioCarta gene sets
3619,GO_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE,c5.BP_ GO biological process
3620,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP,C7_ immunologic signatures
3621,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,c2.CGP_ chemical and genetic perturbations
3622,AREB6_02,c3.TFT_ transcription factor targets
3623,GO_DIGESTIVE_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
3624,STAT4_01,c3.TFT_ transcription factor targets
3625,GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP,C7_ immunologic signatures
3626,FUJII_YBX1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
3627,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN,C7_ immunologic signatures
3628,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,c2.CGP_ chemical and genetic perturbations
3629,GO_POSITIVE_REGULATION_OF_CAMP_METABOLIC_PROCESS,c5.BP_ GO biological process
3630,EGFR_UP.V1_UP,C6_ oncogenic signatures
3631,CTCCAAG_MIR432,c3.MIR_ microRNA targets
3632,GO_PEPTIDE_CROSS_LINKING,c5.BP_ GO biological process
3633,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,C7_ immunologic signatures
3634,SOX5_01,c3.TFT_ transcription factor targets
3635,RADAEVA_RESPONSE_TO_IFNA1_UP,c2.CGP_ chemical and genetic perturbations
3636,SMID_BREAST_CANCER_LUMINAL_B_DN,c2.CGP_ chemical and genetic perturbations
3637,GO_MICROTUBULE_BASED_MOVEMENT,c5.BP_ GO biological process
3638,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,c2.CGP_ chemical and genetic perturbations
3639,CHR11Q22,37
3640,GO_NEGATIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,c5.BP_ GO biological process
3641,GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP,C7_ immunologic signatures
3642,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,c2.CP_REACTOME_ Reactome gene sets
3643,E2A_Q2,c3.TFT_ transcription factor targets
3644,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
3645,GO_ENDODERM_DEVELOPMENT,c5.BP_ GO biological process
3646,GO_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
3647,GO_AMPA_GLUTAMATE_RECEPTOR_COMPLEX,c5.CC_ GO cellular component
3648,GO_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
3649,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
3650,LEE_LIVER_CANCER_E2F1_UP,c2.CGP_ chemical and genetic perturbations
3651,MORF_LMO1,c4.CGN_ cancer gene neighborhoods
3652,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP,C7_ immunologic signatures
3653,YOSHIMURA_MAPK8_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
3654,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN,c2.CGP_ chemical and genetic perturbations
3655,BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING,c2.CGP_ chemical and genetic perturbations
3656,VALK_AML_CLUSTER_6,c2.CGP_ chemical and genetic perturbations
3657,KRAS.600_UP.V1_DN,C6_ oncogenic signatures
3658,GNF2_MLF1,c4.CGN_ cancer gene neighborhoods
3659,GO_TRANSCRIPTION_COFACTOR_BINDING,c5.GO molecular function
3660,GO_ENDODEOXYRIBONUCLEASE_ACTIVITY,c5.GO molecular function
3661,GSE36095_WT_VS_HDAC9_KO_TREG_UP,C7_ immunologic signatures
3662,VALK_AML_CLUSTER_3,c2.CGP_ chemical and genetic perturbations
3663,TTGCACT_MIR130A_MIR301_MIR130B,c3.MIR_ microRNA targets
3664,GSE7764_NKCELL_VS_SPLENOCYTE_UP,C7_ immunologic signatures
3665,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP,C7_ immunologic signatures
3666,GO_CHONDROITIN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,c5.BP_ GO biological process
3667,LXR_DR4_Q3,c3.TFT_ transcription factor targets
3668,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_UP,C7_ immunologic signatures
3669,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_DN,C7_ immunologic signatures
3670,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,c2.CP_REACTOME_ Reactome gene sets
3671,GO_REGULATION_OF_SPROUTING_ANGIOGENESIS,c5.BP_ GO biological process
3672,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,c2.CGP_ chemical and genetic perturbations
3673,MEK_UP.V1_UP,C6_ oncogenic signatures
3674,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP,C7_ immunologic signatures
3675,GO_REGULATION_OF_GLIOGENESIS,c5.BP_ GO biological process
3676,HALLMARK_APOPTOSIS,H_ hallmark gene sets
3677,GO_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
3678,GO_REGULATION_OF_HISTONE_H3_K9_METHYLATION,c5.BP_ GO biological process
3679,GO_CENTRIOLE_ASSEMBLY,c5.BP_ GO biological process
3680,PID_CD8_TCR_PATHWAY,c2.CP_ Canonical pathways
3681,NAKAMURA_ADIPOGENESIS_EARLY_UP,c2.CGP_ chemical and genetic perturbations
3682,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN,C7_ immunologic signatures
3683,GO_SYNAPTIC_VESICLE_RECYCLING,c5.BP_ GO biological process
3684,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN,C7_ immunologic signatures
3685,GSE3982_NKCELL_VS_TH2_DN,C7_ immunologic signatures
3686,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,C7_ immunologic signatures
3687,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,C7_ immunologic signatures
3688,GO_RESPONSE_TO_DSRNA,c5.BP_ GO biological process
3689,GO_ACTIN_BASED_CELL_PROJECTION,c5.CC_ GO cellular component
3690,GO_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR,c5.BP_ GO biological process
3691,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,c2.CGP_ chemical and genetic perturbations
3692,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_DN,C7_ immunologic signatures
3693,CHR17Q25,140
3694,GO_REGIONALIZATION,c5.BP_ GO biological process
3695,OCT1_05,c3.TFT_ transcription factor targets
3696,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP,c2.CGP_ chemical and genetic perturbations
3697,CDP_02,c3.TFT_ transcription factor targets
3698,GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP,C7_ immunologic signatures
3699,DER_IFN_BETA_RESPONSE_UP,c2.CGP_ chemical and genetic perturbations
3700,GO_REGULATION_OF_DNA_REPLICATION,c5.BP_ GO biological process
3701,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_DN,C7_ immunologic signatures
3702,CHR8P11,33
3703,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP,C7_ immunologic signatures
3704,GSE10325_BCELL_VS_LUPUS_BCELL_UP,C7_ immunologic signatures
3705,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_UP,C7_ immunologic signatures
3706,OCT1_06,c3.TFT_ transcription factor targets
3707,MODULE_163,c4.CM_ cancer modules
3708,JI_RESPONSE_TO_FSH_DN,c2.CGP_ chemical and genetic perturbations
3709,GO_SODIUM_ION_HOMEOSTASIS,c5.BP_ GO biological process
3710,GO_REGULATION_OF_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
3711,GACAGGG_MIR339,c3.MIR_ microRNA targets
3712,SCHOEN_NFKB_SIGNALING,c2.CGP_ chemical and genetic perturbations
3713,GSE12505_WT_VS_E2_2_HET_PDC_UP,C7_ immunologic signatures
3714,GO_NUCLEAR_CHROMOSOME,c5.CC_ GO cellular component
3715,OUILLETTE_CLL_13Q14_DELETION_UP,c2.CGP_ chemical and genetic perturbations
3716,GO_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,c5.BP_ GO biological process
3717,GO_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS,c5.BP_ GO biological process
3718,CHR1Q23,61
3719,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN,C7_ immunologic signatures
3720,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_DN,C7_ immunologic signatures
3721,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,C7_ immunologic signatures
3722,MODULE_63,c4.CM_ cancer modules
3723,GO_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,c5.BP_ GO biological process
3724,GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP,C7_ immunologic signatures
3725,WESTON_VEGFA_TARGETS_12HR,c2.CGP_ chemical and genetic perturbations
3726,PAX3_B,c3.TFT_ transcription factor targets
3727,WNT_UP.V1_UP,C6_ oncogenic signatures
3728,GO_NON_RECOMBINATIONAL_REPAIR,c5.BP_ GO biological process
3729,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,C7_ immunologic signatures
3730,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_DN,C7_ immunologic signatures
3731,GO_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.BP_ GO biological process
3732,GSE17721_0.5H_VS_24H_LPS_BMDC_DN,C7_ immunologic signatures
3733,CHR9P21,23
3734,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_UP,C7_ immunologic signatures
3735,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,c2.CGP_ chemical and genetic perturbations
3736,E2F1_Q3_01,c3.TFT_ transcription factor targets
3737,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,c2.CGP_ chemical and genetic perturbations
3738,DELASERNA_MYOD_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
3739,GCM_ERBB2IP,c4.CGN_ cancer gene neighborhoods
3740,BIOCARTA_TGFB_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
3741,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_UP,C7_ immunologic signatures
3742,GO_NEGATIVE_REGULATION_OF_ORGAN_GROWTH,c5.BP_ GO biological process
3743,GO_PROTEIN_AUTOPHOSPHORYLATION,c5.BP_ GO biological process
3744,GO_NAD_ADP_RIBOSYLTRANSFERASE_ACTIVITY,c5.GO molecular function
3745,GO_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR,c5.BP_ GO biological process
3746,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,c2.CGP_ chemical and genetic perturbations
3747,GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,c5.BP_ GO biological process
3748,AMEF2_Q6,c3.TFT_ transcription factor targets
3749,WIELAND_UP_BY_HBV_INFECTION,c2.CGP_ chemical and genetic perturbations
3750,GO_APICAL_PLASMA_MEMBRANE,c5.CC_ GO cellular component
3751,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP,C7_ immunologic signatures
3752,GSE15659_TREG_VS_TCONV_UP,C7_ immunologic signatures
3753,AP4_Q6,c3.TFT_ transcription factor targets
3754,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,C7_ immunologic signatures
3755,YANG_BREAST_CANCER_ESR1_BULK_DN,c2.CGP_ chemical and genetic perturbations
3756,CHR14Q13,27
3757,CAIRO_HEPATOBLASTOMA_DN,c2.CGP_ chemical and genetic perturbations
3758,GFI1_01,c3.TFT_ transcription factor targets
3759,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN,C7_ immunologic signatures
3760,SMIRNOV_RESPONSE_TO_IR_2HR_UP,c2.CGP_ chemical and genetic perturbations
3761,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,C7_ immunologic signatures
3762,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN,C7_ immunologic signatures
3763,ATM_DN.V1_DN,C6_ oncogenic signatures
3764,OCT1_02,c3.TFT_ transcription factor targets
3765,GSE2585_CTEC_VS_THYMIC_DC_DN,C7_ immunologic signatures
3766,GO_IMMUNOGLOBULIN_PRODUCTION,c5.BP_ GO biological process
3767,KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
3768,GO_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
3769,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP,C7_ immunologic signatures
3770,PRC2_EED_UP.V1_DN,C6_ oncogenic signatures
3771,MENSE_HYPOXIA_UP,c2.CGP_ chemical and genetic perturbations
3772,BORCZUK_MALIGNANT_MESOTHELIOMA_DN,c2.CGP_ chemical and genetic perturbations
3773,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN,C7_ immunologic signatures
3774,CDPCR1_01,c3.TFT_ transcription factor targets
3775,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
3776,GO_REGULATION_OF_CGMP_METABOLIC_PROCESS,c5.BP_ GO biological process
3777,MODULE_292,c4.CM_ cancer modules
3778,GCNP_SHH_UP_LATE.V1_DN,C6_ oncogenic signatures
3779,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN,C7_ immunologic signatures
3780,GO_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION,c5.BP_ GO biological process
3781,GO_RESPONSE_TO_PURINE_CONTAINING_COMPOUND,c5.BP_ GO biological process
3782,GO_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
3783,GO_BIOMINERAL_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
3784,CHENG_IMPRINTED_BY_ESTRADIOL,c2.CGP_ chemical and genetic perturbations
3785,GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,c2.CGP_ chemical and genetic perturbations
3786,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP,C7_ immunologic signatures
3787,GO_NEURON_DEATH,c5.BP_ GO biological process
3788,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
3789,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_DN,C7_ immunologic signatures
3790,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN,C7_ immunologic signatures
3791,GO_NUCLEAR_HETEROCHROMATIN,c5.CC_ GO cellular component
3792,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP,C7_ immunologic signatures
3793,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,c2.CGP_ chemical and genetic perturbations
3794,GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,c5.BP_ GO biological process
3795,GSE7852_LN_VS_THYMUS_TREG_UP,C7_ immunologic signatures
3796,CHR9Q32,23
3797,GO_HAIR_CELL_DIFFERENTIATION,c5.BP_ GO biological process
3798,PR_Q2,c3.TFT_ transcription factor targets
3799,GSE17721_CTRL_VS_CPG_4H_BMDC_DN,C7_ immunologic signatures
3800,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,c2.CGP_ chemical and genetic perturbations
3801,GO_CELLULAR_RESPONSE_TO_GAMMA_RADIATION,c5.BP_ GO biological process
3802,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP,C7_ immunologic signatures
3803,BHAT_ESR1_TARGETS_VIA_AKT1_DN,c2.CGP_ chemical and genetic perturbations
3804,CHR8Q23,21
3805,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP,C7_ immunologic signatures
3806,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,C7_ immunologic signatures
3807,GO_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,c5.BP_ GO biological process
3808,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,C7_ immunologic signatures
3809,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,C7_ immunologic signatures
3810,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP,C7_ immunologic signatures
3811,AATGGAG_MIR136,c3.MIR_ microRNA targets
3812,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,C7_ immunologic signatures
3813,PENG_GLUTAMINE_DEPRIVATION_UP,c2.CGP_ chemical and genetic perturbations
3814,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,C7_ immunologic signatures
3815,GO_OSTEOBLAST_DIFFERENTIATION,c5.BP_ GO biological process
3816,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP,C7_ immunologic signatures
3817,ARP1_01,c3.TFT_ transcription factor targets
3818,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,C7_ immunologic signatures
3819,HUANG_FOXA2_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
3820,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,c2.CGP_ chemical and genetic perturbations
3821,YEGNASUBRAMANIAN_PROSTATE_CANCER,c2.CGP_ chemical and genetic perturbations
3822,MODULE_537,c4.CM_ cancer modules
3823,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_FLAVIN_OR_FLAVOPROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,c5.GO molecular function
3824,GO_SCF_UBIQUITIN_LIGASE_COMPLEX,c5.CC_ GO cellular component
3825,GO_GERM_CELL_DEVELOPMENT,c5.BP_ GO biological process
3826,DIRMEIER_LMP1_RESPONSE_LATE_UP,c2.CGP_ chemical and genetic perturbations
3827,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,c2.CGP_ chemical and genetic perturbations
3828,GO_RESPONSE_TO_ESTROGEN,c5.BP_ GO biological process
3829,GSE3982_DC_VS_BCELL_UP,C7_ immunologic signatures
3830,PID_LYSOPHOSPHOLIPID_PATHWAY,c2.CP_ Canonical pathways
3831,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP,C7_ immunologic signatures
3832,GO_INTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY,c5.GO molecular function
3833,GO_FACE_DEVELOPMENT,c5.BP_ GO biological process
3834,GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,c5.BP_ GO biological process
3835,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,c2.CGP_ chemical and genetic perturbations
3836,REACTOME_SPHINGOLIPID_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
3837,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
3838,GO_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX,c5.CC_ GO cellular component
3839,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
3840,GO_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,c5.BP_ GO biological process
3841,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
3842,GO_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,c5.BP_ GO biological process
3843,PAX8_B,c3.TFT_ transcription factor targets
3844,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
3845,GO_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_E_STIMULUS,c5.BP_ GO biological process
3846,GSE27786_LIN_NEG_VS_BCELL_DN,C7_ immunologic signatures
3847,GO_RESPONSE_TO_INTERFERON_GAMMA,c5.BP_ GO biological process
3848,GO_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
3849,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,C7_ immunologic signatures
3850,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN,C7_ immunologic signatures
3851,GO_NEGATIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,c5.BP_ GO biological process
3852,KAMMINGA_SENESCENCE,c2.CGP_ chemical and genetic perturbations
3853,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_UP,C7_ immunologic signatures
3854,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,c2.CGP_ chemical and genetic perturbations
3855,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP,C7_ immunologic signatures
3856,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN,C7_ immunologic signatures
3857,GSE11924_TFH_VS_TH1_CD4_TCELL_UP,C7_ immunologic signatures
3858,GO_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,c5.BP_ GO biological process
3859,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP,C7_ immunologic signatures
3860,TAL1BETAE47_01,c3.TFT_ transcription factor targets
3861,ROSS_AML_WITH_AML1_ETO_FUSION,c2.CGP_ chemical and genetic perturbations
3862,KUMAR_TARGETS_OF_MLL_AF9_FUSION,c2.CGP_ chemical and genetic perturbations
3863,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_UP,C7_ immunologic signatures
3864,BORLAK_LIVER_CANCER_EGF_UP,c2.CGP_ chemical and genetic perturbations
3865,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP,C7_ immunologic signatures
3866,GSE360_L_MAJOR_VS_T_GONDII_DC_DN,C7_ immunologic signatures
3867,GCTCTTG_MIR335,c3.MIR_ microRNA targets
3868,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN,C7_ immunologic signatures
3869,GO_REGULATION_OF_LIPID_CATABOLIC_PROCESS,c5.BP_ GO biological process
3870,GO_KIDNEY_MESENCHYME_DEVELOPMENT,c5.BP_ GO biological process
3871,IVANOVA_HEMATOPOIESIS_MATURE_CELL,c2.CGP_ chemical and genetic perturbations
3872,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN,C7_ immunologic signatures
3873,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,c2.CGP_ chemical and genetic perturbations
3874,CHOP_01,c3.TFT_ transcription factor targets
3875,YAGI_AML_WITH_T_8_21_TRANSLOCATION,c2.CGP_ chemical and genetic perturbations
3876,GSE22886_DC_VS_MONOCYTE_DN,C7_ immunologic signatures
3877,BIOCARTA_TOB1_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
3878,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN,C7_ immunologic signatures
3879,CHR11Q25,16
3880,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,C7_ immunologic signatures
3881,GO_REGULATION_OF_EMBRYONIC_DEVELOPMENT,c5.BP_ GO biological process
3882,GO_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,c5.BP_ GO biological process
3883,GO_REGULATION_OF_CATION_CHANNEL_ACTIVITY,c5.BP_ GO biological process
3884,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
3885,RODRIGUES_THYROID_CARCINOMA_DN,c2.CGP_ chemical and genetic perturbations
3886,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_DN,C7_ immunologic signatures
3887,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_DN,C7_ immunologic signatures
3888,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN,C7_ immunologic signatures
3889,REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,c2.CP_REACTOME_ Reactome gene sets
3890,MILI_PSEUDOPODIA,c2.CGP_ chemical and genetic perturbations
3891,CHR16Q24,65
3892,BIOCARTA_CXCR4_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
3893,GO_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,c5.BP_ GO biological process
3894,HP1SITEFACTOR_Q6,c3.TFT_ transcription factor targets
3895,GO_NEGATIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,c5.BP_ GO biological process
3896,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,C7_ immunologic signatures
3897,GSE27786_LSK_VS_CD8_TCELL_UP,C7_ immunologic signatures
3898,AAAGACA_MIR511,c3.MIR_ microRNA targets
3899,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN,C7_ immunologic signatures
3900,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN,C7_ immunologic signatures
3901,ACCATTT_MIR522,c3.MIR_ microRNA targets
3902,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,C7_ immunologic signatures
3903,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN,C7_ immunologic signatures
3904,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,c2.CGP_ chemical and genetic perturbations
3905,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,C7_ immunologic signatures
3906,VDR_Q3,c3.TFT_ transcription factor targets
3907,GO_TUBE_MORPHOGENESIS,c5.BP_ GO biological process
3908,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
3909,GNF2_IGF1,c4.CGN_ cancer gene neighborhoods
3910,GSE11818_WT_VS_DICER_KO_TREG_UP,C7_ immunologic signatures
3911,TAL1BETAITF2_01,c3.TFT_ transcription factor targets
3912,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,c2.CGP_ chemical and genetic perturbations
3913,GO_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS,c5.BP_ GO biological process
3914,GO_PEPTIDE_HORMONE_PROCESSING,c5.BP_ GO biological process
3915,REACTOME_CTLA4_INHIBITORY_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
3916,GO_UBIQUITIN_LIGASE_COMPLEX,c5.CC_ GO cellular component
3917,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN,C7_ immunologic signatures
3918,GO_AXON_CYTOPLASM,c5.CC_ GO cellular component
3919,GO_PHOSPHATIDYLINOSITOL_3_4_BISPHOSPHATE_BINDING,c5.GO molecular function
3920,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN,C7_ immunologic signatures
3921,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,C7_ immunologic signatures
3922,SESTO_RESPONSE_TO_UV_C5,c2.CGP_ chemical and genetic perturbations
3923,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,c2.CGP_ chemical and genetic perturbations
3924,GO_PATTERN_SPECIFICATION_PROCESS,c5.BP_ GO biological process
3925,GO_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT,c5.BP_ GO biological process
3926,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
3927,SIRNA_EIF4GI_DN,C6_ oncogenic signatures
3928,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,C7_ immunologic signatures
3929,GO_RESPONSE_TO_HYDROGEN_PEROXIDE,c5.BP_ GO biological process
3930,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP,C7_ immunologic signatures
3931,GSE6269_FLU_VS_E_COLI_INF_PBMC_UP,C7_ immunologic signatures
3932,GO_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,c5.BP_ GO biological process
3933,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP,C7_ immunologic signatures
3934,GO_RESPONSE_TO_FATTY_ACID,c5.BP_ GO biological process
3935,GO_POSITIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,c5.BP_ GO biological process
3936,GO_RESPONSE_TO_IRON_ION,c5.BP_ GO biological process
3937,GO_CELL_CELL_ADHERENS_JUNCTION,c5.CC_ GO cellular component
3938,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP,C7_ immunologic signatures
3939,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP,C7_ immunologic signatures
3940,GO_NEGATIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS,c5.BP_ GO biological process
3941,KAUFFMANN_DNA_REPLICATION_GENES,c2.CGP_ chemical and genetic perturbations
3942,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,C7_ immunologic signatures
3943,GSE14308_TH17_VS_INDUCED_TREG_UP,C7_ immunologic signatures
3944,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP,C7_ immunologic signatures
3945,EVI1_06,c3.TFT_ transcription factor targets
3946,MODULE_207,c4.CM_ cancer modules
3947,NKX3A_01,c3.TFT_ transcription factor targets
3948,AP2_Q6,c3.TFT_ transcription factor targets
3949,GO_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
3950,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_DN,C7_ immunologic signatures
3951,GSE13229_IMM_VS_MATURE_NKCELL_DN,C7_ immunologic signatures
3952,REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS,c2.CP_REACTOME_ Reactome gene sets
3953,COLDREN_GEFITINIB_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
3954,GATA1_02,c3.TFT_ transcription factor targets
3955,GO_PRESYNAPTIC_PROCESS_INVOLVED_IN_SYNAPTIC_TRANSMISSION,c5.BP_ GO biological process
3956,NKX62_Q2,c3.TFT_ transcription factor targets
3957,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN,C7_ immunologic signatures
3958,GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS,c5.BP_ GO biological process
3959,BIOCARTA_INTEGRIN_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
3960,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_DN,C7_ immunologic signatures
3961,RNTCANNRNNYNATTW_UNKNOWN,c3.TFT_ transcription factor targets
3962,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,C7_ immunologic signatures
3963,GO_POSITIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,c5.BP_ GO biological process
3964,GSE43955_1H_VS_10H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
3965,GO_CELL_BODY,c5.CC_ GO cellular component
3966,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,c2.CGP_ chemical and genetic perturbations
3967,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_UP,C7_ immunologic signatures
3968,GO_ENDOCARDIAL_CUSHION_DEVELOPMENT,c5.BP_ GO biological process
3969,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,c2.CGP_ chemical and genetic perturbations
3970,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP,C7_ immunologic signatures
3971,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN,C7_ immunologic signatures
3972,GO_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
3973,REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,c2.CP_REACTOME_ Reactome gene sets
3974,GO_UROGENITAL_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
3975,ISSAEVA_MLL2_TARGETS,c2.CGP_ chemical and genetic perturbations
3976,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,C7_ immunologic signatures
3977,GO_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BINDING,c5.GO molecular function
3978,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN,C7_ immunologic signatures
3979,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
3980,GO_POSITIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,c5.BP_ GO biological process
3981,GO_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY,c5.GO molecular function
3982,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,C7_ immunologic signatures
3983,GSE7852_LN_VS_FAT_TCONV_DN,C7_ immunologic signatures
3984,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,C7_ immunologic signatures
3985,KRAS.AMP.LUNG_UP.V1_DN,C6_ oncogenic signatures
3986,GCNP_SHH_UP_EARLY.V1_UP,C6_ oncogenic signatures
3987,FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,c2.CGP_ chemical and genetic perturbations
3988,GO_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,c5.BP_ GO biological process
3989,GSE13229_MATURE_VS_INTMATURE_NKCELL_UP,C7_ immunologic signatures
3990,CHR12P13,120
3991,ST_GA12_PATHWAY,c2.CP_ Canonical pathways
3992,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,C7_ immunologic signatures
3993,REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,c2.CP_REACTOME_ Reactome gene sets
3994,ZHAN_MULTIPLE_MYELOMA_LB_UP,c2.CGP_ chemical and genetic perturbations
3995,GO_REGULATION_OF_RENAL_SYSTEM_PROCESS,c5.BP_ GO biological process
3996,GSE14308_TH1_VS_INDUCED_TREG_UP,C7_ immunologic signatures
3997,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,c2.CGP_ chemical and genetic perturbations
3998,GO_PROTEIN_DNA_COMPLEX,c5.CC_ GO cellular component
3999,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
4000,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_DN,C7_ immunologic signatures
4001,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,C7_ immunologic signatures
4002,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN,C7_ immunologic signatures
4003,GO_METANEPHRIC_NEPHRON_DEVELOPMENT,c5.BP_ GO biological process
4004,GO_ENDONUCLEASE_ACTIVITY,c5.GO molecular function
4005,SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER,c2.CGP_ chemical and genetic perturbations
4006,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,c2.CGP_ chemical and genetic perturbations
4007,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_UP,C7_ immunologic signatures
4008,GSE17721_CTRL_VS_CPG_0.5H_BMDC_UP,C7_ immunologic signatures
4009,GO_VESICLE_DOCKING_INVOLVED_IN_EXOCYTOSIS,c5.BP_ GO biological process
4010,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,C7_ immunologic signatures
4011,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,c2.CGP_ chemical and genetic perturbations
4012,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,c2.CGP_ chemical and genetic perturbations
4013,GSE27786_NKTCELL_VS_MONO_MAC_DN,C7_ immunologic signatures
4014,ATATGCA_MIR448,c3.MIR_ microRNA targets
4015,HOXA9_DN.V1_UP,C6_ oncogenic signatures
4016,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,C7_ immunologic signatures
4017,REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS,c2.CP_REACTOME_ Reactome gene sets
4018,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP,C7_ immunologic signatures
4019,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
4020,GO_MYELOID_CELL_DIFFERENTIATION,c5.BP_ GO biological process
4021,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,c2.CGP_ chemical and genetic perturbations
4022,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,C7_ immunologic signatures
4023,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP,C7_ immunologic signatures
4024,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP,C7_ immunologic signatures
4025,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN,C7_ immunologic signatures
4026,LIAO_HAVE_SOX4_BINDING_SITES,c2.CGP_ chemical and genetic perturbations
4027,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,c2.CGP_ chemical and genetic perturbations
4028,BIOCARTA_CDMAC_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
4029,ODONNELL_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
4030,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN,C7_ immunologic signatures
4031,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,c2.CGP_ chemical and genetic perturbations
4032,GO_MALE_SEX_DIFFERENTIATION,c5.BP_ GO biological process
4033,GO_REGULATION_OF_VASOCONSTRICTION,c5.BP_ GO biological process
4034,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN,C7_ immunologic signatures
4035,GSE13306_TREG_VS_TCONV_UP,C7_ immunologic signatures
4036,GTGGGTGK_UNKNOWN,c3.TFT_ transcription factor targets
4037,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,c2.CGP_ chemical and genetic perturbations
4038,LEE_RECENT_THYMIC_EMIGRANT,c2.CGP_ chemical and genetic perturbations
4039,MYC_UP.V1_DN,C6_ oncogenic signatures
4040,GO_FIBRONECTIN_BINDING,c5.GO molecular function
4041,GO_DNA_REPAIR_COMPLEX,c5.CC_ GO cellular component
4042,GTGCAAA_MIR507,c3.MIR_ microRNA targets
4043,GO_IONOTROPIC_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
4044,GO_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
4045,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,C7_ immunologic signatures
4046,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP,C7_ immunologic signatures
4047,GO_TISSUE_HOMEOSTASIS,c5.BP_ GO biological process
4048,NAKAYAMA_FGF2_TARGETS,c2.CGP_ chemical and genetic perturbations
4049,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_DN,C7_ immunologic signatures
4050,KEGG_TYPE_II_DIABETES_MELLITUS,c2.CP_BIOCARTA_ BioCarta gene sets
4051,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,C7_ immunologic signatures
4052,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN,C7_ immunologic signatures
4053,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_DN,C7_ immunologic signatures
4054,REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,c2.CP_REACTOME_ Reactome gene sets
4055,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN,C7_ immunologic signatures
4056,RAMASWAMY_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
4057,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,c2.CGP_ chemical and genetic perturbations
4058,GGATTA_PITX2_Q2,c3.TFT_ transcription factor targets
4059,MODULE_358,c4.CM_ cancer modules
4060,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_DN,C7_ immunologic signatures
4061,FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,c2.CGP_ chemical and genetic perturbations
4062,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN,C7_ immunologic signatures
4063,PBX1_02,c3.TFT_ transcription factor targets
4064,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,C7_ immunologic signatures
4065,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_DN,C7_ immunologic signatures
4066,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP,C7_ immunologic signatures
4067,GO_CHONDROCYTE_DEVELOPMENT,c5.BP_ GO biological process
4068,GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN,C7_ immunologic signatures
4069,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,c2.CGP_ chemical and genetic perturbations
4070,BIOCARTA_UCALPAIN_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
4071,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,c2.CP_BIOCARTA_ BioCarta gene sets
4072,SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,c2.CGP_ chemical and genetic perturbations
4073,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,C7_ immunologic signatures
4074,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN,C7_ immunologic signatures
4075,PBX1_01,c3.TFT_ transcription factor targets
4076,WILLIAMS_ESR2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4077,MCGOWAN_RSP6_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4078,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN,C7_ immunologic signatures
4079,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN,C7_ immunologic signatures
4080,NKX61_01,c3.TFT_ transcription factor targets
4081,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN,C7_ immunologic signatures
4082,GO_POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,c5.BP_ GO biological process
4083,JISON_SICKLE_CELL_DISEASE_UP,c2.CGP_ chemical and genetic perturbations
4084,GO_POTASSIUM_ION_IMPORT,c5.BP_ GO biological process
4085,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,C7_ immunologic signatures
4086,GO_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS,c5.BP_ GO biological process
4087,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_DN,C7_ immunologic signatures
4088,GSE10325_CD4_TCELL_VS_BCELL_UP,C7_ immunologic signatures
4089,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP,C7_ immunologic signatures
4090,GO_PALATE_DEVELOPMENT,c5.BP_ GO biological process
4091,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,C7_ immunologic signatures
4092,GO_VENTRICULAR_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
4093,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN,C7_ immunologic signatures
4094,GO_PALLIUM_DEVELOPMENT,c5.BP_ GO biological process
4095,GSE25087_FETAL_VS_ADULT_TCONV_DN,C7_ immunologic signatures
4096,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN,C7_ immunologic signatures
4097,GSE27786_NKTCELL_VS_NEUTROPHIL_DN,C7_ immunologic signatures
4098,GO_POSITIVE_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION,c5.BP_ GO biological process
4099,KATSANOU_ELAVL1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4100,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN,C7_ immunologic signatures
4101,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,C7_ immunologic signatures
4102,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_UP,C7_ immunologic signatures
4103,GO_CELLULAR_RESPONSE_TO_LITHIUM_ION,c5.BP_ GO biological process
4104,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP,C7_ immunologic signatures
4105,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_UP,C7_ immunologic signatures
4106,GO_NEUROEPITHELIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
4107,MORF_ERCC4,c4.CGN_ cancer gene neighborhoods
4108,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
4109,YIH_RESPONSE_TO_ARSENITE_C2,c2.CGP_ chemical and genetic perturbations
4110,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP,C7_ immunologic signatures
4111,GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP,C7_ immunologic signatures
4112,GO_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION,c5.BP_ GO biological process
4113,GSE40273_XBP1_KO_VS_WT_TREG_UP,C7_ immunologic signatures
4114,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_DN,C7_ immunologic signatures
4115,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN,C7_ immunologic signatures
4116,FIRESTEIN_PROLIFERATION,c2.CGP_ chemical and genetic perturbations
4117,WANG_METHYLATED_IN_BREAST_CANCER,c2.CGP_ chemical and genetic perturbations
4118,EVI1_02,c3.TFT_ transcription factor targets
4119,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,C7_ immunologic signatures
4120,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,C7_ immunologic signatures
4121,GSE13229_IMM_VS_INTMATURE_NKCELL_UP,C7_ immunologic signatures
4122,GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN,C7_ immunologic signatures
4123,GO_LYMPHOCYTE_COSTIMULATION,c5.BP_ GO biological process
4124,ENGELMANN_CANCER_PROGENITORS_DN,c2.CGP_ chemical and genetic perturbations
4125,GO_PLATELET_AGGREGATION,c5.BP_ GO biological process
4126,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_DN,C7_ immunologic signatures
4127,RYAAAKNNNNNNTTGW_UNKNOWN,c3.TFT_ transcription factor targets
4128,LA_MEN1_TARGETS,c2.CGP_ chemical and genetic perturbations
4129,SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,c2.CP_ Canonical pathways
4130,LI_CISPLATIN_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
4131,GO_HISTONE_ACETYLTRANSFERASE_BINDING,c5.GO molecular function
4132,ST_G_ALPHA_I_PATHWAY,c2.CP_ Canonical pathways
4133,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,C7_ immunologic signatures
4134,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN,C7_ immunologic signatures
4135,MORF_ITGA2,c4.CGN_ cancer gene neighborhoods
4136,CDPCR3_01,c3.TFT_ transcription factor targets
4137,GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,c5.BP_ GO biological process
4138,GO_SKIN_DEVELOPMENT,c5.BP_ GO biological process
4139,CHR4Q25,26
4140,GO_HINDBRAIN_DEVELOPMENT,c5.BP_ GO biological process
4141,GO_REGULATION_OF_PLATELET_ACTIVATION,c5.BP_ GO biological process
4142,REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B,c2.CP_REACTOME_ Reactome gene sets
4143,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP,C7_ immunologic signatures
4144,REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,c2.CP_REACTOME_ Reactome gene sets
4145,LEIN_CHOROID_PLEXUS_MARKERS,c2.CGP_ chemical and genetic perturbations
4146,GO_NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,c5.BP_ GO biological process
4147,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP,C7_ immunologic signatures
4148,GO_CYTOKINE_BINDING,c5.GO molecular function
4149,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN,C7_ immunologic signatures
4150,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP,C7_ immunologic signatures
4151,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
4152,SRC_UP.V1_UP,C6_ oncogenic signatures
4153,GO_NEGATIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,c5.BP_ GO biological process
4154,STK33_SKM_DN,C6_ oncogenic signatures
4155,PID_FOXO_PATHWAY,c2.CP_ Canonical pathways
4156,GO_EXTRACELLULAR_GLUTAMATE_GATED_ION_CHANNEL_ACTIVITY,c5.GO molecular function
4157,GO_RESPONSE_TO_TEMPERATURE_STIMULUS,c5.BP_ GO biological process
4158,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
4159,PID_P53_DOWNSTREAM_PATHWAY,c2.CP_ Canonical pathways
4160,IRF_Q6,c3.TFT_ transcription factor targets
4161,GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN,C7_ immunologic signatures
4162,PID_SMAD2_3NUCLEAR_PATHWAY,c2.CP_ Canonical pathways
4163,WANG_CLIM2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4164,SMITH_LIVER_CANCER,c2.CGP_ chemical and genetic perturbations
4165,GO_SENSORY_PERCEPTION_OF_PAIN,c5.BP_ GO biological process
4166,GSE25087_TREG_VS_TCONV_ADULT_UP,C7_ immunologic signatures
4167,GO_DNA_LIGATION,c5.BP_ GO biological process
4168,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
4169,GO_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE,c5.BP_ GO biological process
4170,CHR1P32,58
4171,GO_HEART_PROCESS,c5.BP_ GO biological process
4172,GO_MEMBRANE_INVAGINATION,c5.BP_ GO biological process
4173,GSE3982_EOSINOPHIL_VS_MAST_CELL_UP,C7_ immunologic signatures
4174,LIU_CDX2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4175,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP,C7_ immunologic signatures
4176,GO_HYPEROSMOTIC_RESPONSE,c5.BP_ GO biological process
4177,PRC1_BMI_UP.V1_UP,C6_ oncogenic signatures
4178,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,c2.CGP_ chemical and genetic perturbations
4179,ALK_DN.V1_UP,C6_ oncogenic signatures
4180,GO_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,c5.BP_ GO biological process
4181,GO_SULFUR_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
4182,FOXJ2_02,c3.TFT_ transcription factor targets
4183,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,C7_ immunologic signatures
4184,GO_NEURAL_TUBE_DEVELOPMENT,c5.BP_ GO biological process
4185,AGCYRWTTC_UNKNOWN,c3.TFT_ transcription factor targets
4186,VALK_AML_CLUSTER_4,c2.CGP_ chemical and genetic perturbations
4187,MORF_NF1,c4.CGN_ cancer gene neighborhoods
4188,CAGTCAC_MIR134,c3.MIR_ microRNA targets
4189,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN,C7_ immunologic signatures
4190,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
4191,CCATCCA_MIR432,c3.MIR_ microRNA targets
4192,GO_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION,c5.BP_ GO biological process
4193,GSE14308_TH1_VS_TH17_UP,C7_ immunologic signatures
4194,BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN,c2.CGP_ chemical and genetic perturbations
4195,TCCAGAT_MIR5165P,c3.MIR_ microRNA targets
4196,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,C7_ immunologic signatures
4197,REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,c2.CP_REACTOME_ Reactome gene sets
4198,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,c2.CGP_ chemical and genetic perturbations
4199,LIU_TARGETS_OF_VMYB_VS_CMYB_DN,c2.CGP_ chemical and genetic perturbations
4200,GSE3982_NKCELL_VS_TH1_UP,C7_ immunologic signatures
4201,GO_CGMP_METABOLIC_PROCESS,c5.BP_ GO biological process
4202,PID_EPHB_FWD_PATHWAY,c2.CP_ Canonical pathways
4203,GSE17721_POLYIC_VS_CPG_2H_BMDC_DN,C7_ immunologic signatures
4204,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,c2.CGP_ chemical and genetic perturbations
4205,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP,C7_ immunologic signatures
4206,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_DN,C7_ immunologic signatures
4207,GO_EMBRYONIC_HEART_TUBE_MORPHOGENESIS,c5.BP_ GO biological process
4208,GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP,C7_ immunologic signatures
4209,GO_EMBRYONIC_ORGAN_MORPHOGENESIS,c5.BP_ GO biological process
4210,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP,C7_ immunologic signatures
4211,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN,C7_ immunologic signatures
4212,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN,C7_ immunologic signatures
4213,GO_TELOMERE_ORGANIZATION,c5.BP_ GO biological process
4214,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,C7_ immunologic signatures
4215,GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING,c5.GO molecular function
4216,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP,C7_ immunologic signatures
4217,GO_SERINE_TYPE_EXOPEPTIDASE_ACTIVITY,c5.GO molecular function
4218,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,C7_ immunologic signatures
4219,GSE12366_GC_BCELL_VS_PLASMA_CELL_DN,C7_ immunologic signatures
4220,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP,C7_ immunologic signatures
4221,GO_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
4222,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN,C7_ immunologic signatures
4223,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,c2.CGP_ chemical and genetic perturbations
4224,GO_INOSITOL_LIPID_MEDIATED_SIGNALING,c5.BP_ GO biological process
4225,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
4226,GO_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,c5.BP_ GO biological process
4227,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_UP,C7_ immunologic signatures
4228,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN,c2.CGP_ chemical and genetic perturbations
4229,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,c2.CGP_ chemical and genetic perturbations
4230,GO_RENAL_SYSTEM_PROCESS,c5.BP_ GO biological process
4231,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP,C7_ immunologic signatures
4232,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,c2.CGP_ chemical and genetic perturbations
4233,GO_APPENDAGE_DEVELOPMENT,c5.BP_ GO biological process
4234,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP,C7_ immunologic signatures
4235,GO_REGULATION_OF_HEART_MORPHOGENESIS,c5.BP_ GO biological process
4236,GO_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
4237,GO_PROTEIN_AUTOUBIQUITINATION,c5.BP_ GO biological process
4238,GSE45837_WT_VS_GFI1_KO_PDC_UP,C7_ immunologic signatures
4239,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP,C7_ immunologic signatures
4240,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,C7_ immunologic signatures
4241,ZF5_B,c3.TFT_ transcription factor targets
4242,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,C7_ immunologic signatures
4243,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP,C7_ immunologic signatures
4244,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_DN,C7_ immunologic signatures
4245,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_DN,C7_ immunologic signatures
4246,SEMENZA_HIF1_TARGETS,c2.CGP_ chemical and genetic perturbations
4247,BILANGES_SERUM_SENSITIVE_VIA_TSC2,c2.CGP_ chemical and genetic perturbations
4248,GO_REGULATION_OF_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,c5.BP_ GO biological process
4249,GO_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
4250,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,C7_ immunologic signatures
4251,GSE13522_WT_VS_IFNG_KO_SKIN_DN,C7_ immunologic signatures
4252,GSE13306_TREG_RA_VS_TCONV_RA_UP,C7_ immunologic signatures
4253,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
4254,LEE_LIVER_CANCER_MYC_UP,c2.CGP_ chemical and genetic perturbations
4255,GRE_C,c3.TFT_ transcription factor targets
4256,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN,C7_ immunologic signatures
4257,GO_REGULATION_OF_BEHAVIOR,c5.BP_ GO biological process
4258,AAAGGAT_MIR501,c3.MIR_ microRNA targets
4259,GSE45365_WT_VS_IFNAR_KO_BCELL_UP,C7_ immunologic signatures
4260,GO_PEPTIDASE_REGULATOR_ACTIVITY,c5.GO molecular function
4261,BURTON_ADIPOGENESIS_9,c2.CGP_ chemical and genetic perturbations
4262,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP,C7_ immunologic signatures
4263,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,C7_ immunologic signatures
4264,GO_POSITIVE_REGULATION_OF_ATPASE_ACTIVITY,c5.BP_ GO biological process
4265,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN,C7_ immunologic signatures
4266,BOSCO_TH1_CYTOTOXIC_MODULE,c2.CGP_ chemical and genetic perturbations
4267,GO_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_BINDING,c5.GO molecular function
4268,GO_POSITIVE_REGULATION_OF_PROTEIN_MATURATION,c5.BP_ GO biological process
4269,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,C7_ immunologic signatures
4270,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,C7_ immunologic signatures
4271,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP,C7_ immunologic signatures
4272,GSE3982_CTRL_VS_LPS_48H_DC_DN,C7_ immunologic signatures
4273,CHR2Q33,77
4274,PLASARI_TGFB1_TARGETS_1HR_UP,c2.CGP_ chemical and genetic perturbations
4275,MODULE_530,c4.CM_ cancer modules
4276,GSE17721_LPS_VS_CPG_2H_BMDC_DN,C7_ immunologic signatures
4277,KIM_MYCN_AMPLIFICATION_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4278,CHO_NR4A1_TARGETS,c2.CGP_ chemical and genetic perturbations
4279,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN,C7_ immunologic signatures
4280,MORF_RFC5,c4.CGN_ cancer gene neighborhoods
4281,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP,C7_ immunologic signatures
4282,ARGGGTTAA_UNKNOWN,c3.TFT_ transcription factor targets
4283,MODULE_171,c4.CM_ cancer modules
4284,GSE27786_CD8_TCELL_VS_NKCELL_DN,C7_ immunologic signatures
4285,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,C7_ immunologic signatures
4286,VANTVEER_BREAST_CANCER_ESR1_UP,c2.CGP_ chemical and genetic perturbations
4287,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN,C7_ immunologic signatures
4288,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,C7_ immunologic signatures
4289,GO_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,c5.BP_ GO biological process
4290,GCAAAAA_MIR129,c3.MIR_ microRNA targets
4291,GO_OVARIAN_FOLLICLE_DEVELOPMENT,c5.BP_ GO biological process
4292,GO_NEGATIVE_REGULATION_OF_STAT_CASCADE,c5.BP_ GO biological process
4293,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP,C7_ immunologic signatures
4294,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP,C7_ immunologic signatures
4295,SHIN_B_CELL_LYMPHOMA_CLUSTER_7,c2.CGP_ chemical and genetic perturbations
4296,ATACCTC_MIR202,c3.MIR_ microRNA targets
4297,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP,C7_ immunologic signatures
4298,GO_FOREBRAIN_GENERATION_OF_NEURONS,c5.BP_ GO biological process
4299,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP,C7_ immunologic signatures
4300,GO_ACTIN_MONOMER_BINDING,c5.GO molecular function
4301,GATAAGR_GATA_C,c3.TFT_ transcription factor targets
4302,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
4303,GO_PHOSPHATASE_BINDING,c5.GO molecular function
4304,RTTTNNNYTGGM_UNKNOWN,c3.TFT_ transcription factor targets
4305,POU3F2_02,c3.TFT_ transcription factor targets
4306,GO_REGULATION_OF_STEM_CELL_DIFFERENTIATION,c5.BP_ GO biological process
4307,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
4308,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN,C7_ immunologic signatures
4309,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_DN,C7_ immunologic signatures
4310,VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN,c2.CGP_ chemical and genetic perturbations
4311,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,c2.CGP_ chemical and genetic perturbations
4312,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,c2.CGP_ chemical and genetic perturbations
4313,MODULE_97,c4.CM_ cancer modules
4314,GSE7852_THYMUS_VS_FAT_TCONV_UP,C7_ immunologic signatures
4315,HALMOS_CEBPA_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4316,GSE17721_LPS_VS_CPG_16H_BMDC_DN,C7_ immunologic signatures
4317,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN,C7_ immunologic signatures
4318,GO_K63_LINKED_POLYUBIQUITIN_BINDING,c5.GO molecular function
4319,MEISSNER_NPC_HCP_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
4320,MYB_Q6,c3.TFT_ transcription factor targets
4321,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_DN,C7_ immunologic signatures
4322,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
4323,GSE36826_WT_VS_IL1R_KO_SKIN_UP,C7_ immunologic signatures
4324,MORF_MDM2,c4.CGN_ cancer gene neighborhoods
4325,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,C7_ immunologic signatures
4326,GO_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
4327,GO_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE,c5.CC_ GO cellular component
4328,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP,C7_ immunologic signatures
4329,AKT_UP.V1_UP,C6_ oncogenic signatures
4330,NF1_Q6_01,c3.TFT_ transcription factor targets
4331,NAGASHIMA_NRG1_SIGNALING_UP,c2.CGP_ chemical and genetic perturbations
4332,GO_CELLULAR_RESPONSE_TO_ANTIBIOTIC,c5.BP_ GO biological process
4333,GO_EXCITATORY_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY,c5.GO molecular function
4334,GO_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,c5.BP_ GO biological process
4335,MORF_IL13,c4.CGN_ cancer gene neighborhoods
4336,GTATTAT_MIR3693P,c3.MIR_ microRNA targets
4337,MODULE_67,c4.CM_ cancer modules
4338,GO_HOMOTYPIC_CELL_CELL_ADHESION,c5.BP_ GO biological process
4339,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN,C7_ immunologic signatures
4340,GO_PROTEIN_ACTIVATION_CASCADE,c5.BP_ GO biological process
4341,GO_POSITIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,c5.BP_ GO biological process
4342,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_DN,C7_ immunologic signatures
4343,REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS,c2.CP_REACTOME_ Reactome gene sets
4344,NADERI_BREAST_CANCER_PROGNOSIS_DN,c2.CGP_ chemical and genetic perturbations
4345,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN,C7_ immunologic signatures
4346,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,c2.CGP_ chemical and genetic perturbations
4347,GSE1460_DP_VS_CD4_THYMOCYTE_UP,C7_ immunologic signatures
4348,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN,C7_ immunologic signatures
4349,GO_TRABECULA_MORPHOGENESIS,c5.BP_ GO biological process
4350,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
4351,GO_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,c5.BP_ GO biological process
4352,PID_P38_MKK3_6PATHWAY,c2.CP_ Canonical pathways
4353,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP,C7_ immunologic signatures
4354,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN,C7_ immunologic signatures
4355,GO_MYOSIN_BINDING,c5.GO molecular function
4356,GO_IMMUNE_EFFECTOR_PROCESS,c5.BP_ GO biological process
4357,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN,C7_ immunologic signatures
4358,GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN,C7_ immunologic signatures
4359,HSF1_01,c3.TFT_ transcription factor targets
4360,CHR14Q21,36
4361,MORF_RUNX1,c4.CGN_ cancer gene neighborhoods
4362,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP,C7_ immunologic signatures
4363,GO_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
4364,GO_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,c5.BP_ GO biological process
4365,RREB1_01,c3.TFT_ transcription factor targets
4366,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP,C7_ immunologic signatures
4367,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN,C7_ immunologic signatures
4368,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN,C7_ immunologic signatures
4369,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,C7_ immunologic signatures
4370,GO_CYCLASE_ACTIVITY,c5.GO molecular function
4371,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN,C7_ immunologic signatures
4372,GO_ENDOTHELIAL_CELL_MIGRATION,c5.BP_ GO biological process
4373,GSE3982_DC_VS_MAC_UP,C7_ immunologic signatures
4374,GSE43955_1H_VS_60H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
4375,GO_MULTICELLULAR_ORGANISMAL_HOMEOSTASIS,c5.BP_ GO biological process
4376,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN,C7_ immunologic signatures
4377,GO_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND,c5.BP_ GO biological process
4378,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,C7_ immunologic signatures
4379,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,c2.CGP_ chemical and genetic perturbations
4380,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_DN,C7_ immunologic signatures
4381,GO_SINGLE_ORGANISM_BEHAVIOR,c5.BP_ GO biological process
4382,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,c2.CGP_ chemical and genetic perturbations
4383,GSE2706_UNSTIM_VS_2H_R848_DC_UP,C7_ immunologic signatures
4384,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,c2.CGP_ chemical and genetic perturbations
4385,TGCAAAC_MIR452,c3.MIR_ microRNA targets
4386,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_DN,C7_ immunologic signatures
4387,HNF4ALPHA_Q6,c3.TFT_ transcription factor targets
4388,GRUETZMANN_PANCREATIC_CANCER_UP,c2.CGP_ chemical and genetic perturbations
4389,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,C7_ immunologic signatures
4390,ATGCTGG_MIR338,c3.MIR_ microRNA targets
4391,GO_CELL_CORTEX_PART,c5.CC_ GO cellular component
4392,GO_POSITIVE_REGULATION_OF_AXONOGENESIS,c5.BP_ GO biological process
4393,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP,C7_ immunologic signatures
4394,AAGCCAT_MIR135A_MIR135B,c3.MIR_ microRNA targets
4395,GO_OVULATION_CYCLE,c5.BP_ GO biological process
4396,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_DN,C7_ immunologic signatures
4397,REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS,c2.CP_REACTOME_ Reactome gene sets
4398,COMP1_01,c3.TFT_ transcription factor targets
4399,GO_REGULATION_OF_INTERLEUKIN_1_SECRETION,c5.BP_ GO biological process
4400,YAP1_DN,C6_ oncogenic signatures
4401,GSE6259_CD4_TCELL_VS_CD8_TCELL_DN,C7_ immunologic signatures
4402,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN,C7_ immunologic signatures
4403,NOTCH_DN.V1_UP,C6_ oncogenic signatures
4404,GO_HISTONE_BINDING,c5.GO molecular function
4405,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_UP,C7_ immunologic signatures
4406,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
4407,GSE17721_LPS_VS_CPG_2H_BMDC_UP,C7_ immunologic signatures
4408,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_UP,C7_ immunologic signatures
4409,GO_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,c5.BP_ GO biological process
4410,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP,C7_ immunologic signatures
4411,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_UP,C7_ immunologic signatures
4412,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_UP,C7_ immunologic signatures
4413,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN,C7_ immunologic signatures
4414,GO_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,c5.BP_ GO biological process
4415,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,C7_ immunologic signatures
4416,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_UP,C7_ immunologic signatures
4417,GO_MEMBRANE_MICRODOMAIN,c5.CC_ GO cellular component
4418,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_DN,C7_ immunologic signatures
4419,GO_DENDRITIC_SHAFT,c5.CC_ GO cellular component
4420,GO_DEOXYRIBONUCLEASE_ACTIVITY,c5.GO molecular function
4421,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP,C7_ immunologic signatures
4422,KOBAYASHI_EGFR_SIGNALING_24HR_UP,c2.CGP_ chemical and genetic perturbations
4423,HOEGERKORP_CD44_TARGETS_DIRECT_UP,c2.CGP_ chemical and genetic perturbations
4424,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_DN,C7_ immunologic signatures
4425,GO_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
4426,GO_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION,c5.BP_ GO biological process
4427,GSE17721_CTRL_VS_CPG_8H_BMDC_DN,C7_ immunologic signatures
4428,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP,C7_ immunologic signatures
4429,TGAGATT_MIR216,c3.MIR_ microRNA targets
4430,IKEDA_MIR1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4431,MODULE_26,c4.CM_ cancer modules
4432,GSE7852_TREG_VS_TCONV_FAT_DN,C7_ immunologic signatures
4433,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,C7_ immunologic signatures
4434,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP,C7_ immunologic signatures
4435,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,C7_ immunologic signatures
4436,GO_RECYCLING_ENDOSOME,c5.CC_ GO cellular component
4437,MORF_IL4,c4.CGN_ cancer gene neighborhoods
4438,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP,C7_ immunologic signatures
4439,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,c2.CGP_ chemical and genetic perturbations
4440,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,c2.CGP_ chemical and genetic perturbations
4441,GSE339_CD8POS_VS_CD4CD8DN_DC_DN,C7_ immunologic signatures
4442,GO_POSITIVE_REGULATION_OF_SECRETION,c5.BP_ GO biological process
4443,GO_RAS_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,c5.GO molecular function
4444,GO_NUCLEAR_REPLICATION_FORK,c5.CC_ GO cellular component
4445,GSE17721_CTRL_VS_POLYIC_24H_BMDC_DN,C7_ immunologic signatures
4446,GO_REGULATION_OF_PROTEIN_IMPORT,c5.BP_ GO biological process
4447,BURTON_ADIPOGENESIS_8,c2.CGP_ chemical and genetic perturbations
4448,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN,C7_ immunologic signatures
4449,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_UP,C7_ immunologic signatures
4450,GO_LRR_DOMAIN_BINDING,c5.GO molecular function
4451,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
4452,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_,c2.CP_REACTOME_ Reactome gene sets
4453,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,c2.CGP_ chemical and genetic perturbations
4454,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_UP,C7_ immunologic signatures
4455,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN,C7_ immunologic signatures
4456,GO_REGULATION_OF_ION_TRANSPORT,c5.BP_ GO biological process
4457,GO_SYNAPTIC_VESICLE_LOCALIZATION,c5.BP_ GO biological process
4458,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP,C7_ immunologic signatures
4459,GO_METENCEPHALON_DEVELOPMENT,c5.BP_ GO biological process
4460,STAT5A_02,c3.TFT_ transcription factor targets
4461,GO_TRABECULA_FORMATION,c5.BP_ GO biological process
4462,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_DN,C7_ immunologic signatures
4463,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4464,GO_REGULATION_OF_AMINO_ACID_TRANSPORT,c5.BP_ GO biological process
4465,GO_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,c5.BP_ GO biological process
4466,GO_QUATERNARY_AMMONIUM_GROUP_BINDING,c5.GO molecular function
4467,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP,C7_ immunologic signatures
4468,AKT_UP_MTOR_DN.V1_UP,C6_ oncogenic signatures
4469,REACTOME_TIE2_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
4470,GO_NUCLEASE_ACTIVITY,c5.GO molecular function
4471,ATGTTTC_MIR494,c3.MIR_ microRNA targets
4472,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP,C7_ immunologic signatures
4473,CHR7Q31,61
4474,GO_RESPONSE_TO_AMMONIUM_ION,c5.BP_ GO biological process
4475,MODULE_433,c4.CM_ cancer modules
4476,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_UP,C7_ immunologic signatures
4477,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP,C7_ immunologic signatures
4478,GO_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
4479,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,c2.CGP_ chemical and genetic perturbations
4480,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP,C7_ immunologic signatures
4481,GSE1566_WT_VS_EZH2_KO_LN_TCELL_UP,C7_ immunologic signatures
4482,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,c2.CGP_ chemical and genetic perturbations
4483,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP,C7_ immunologic signatures
4484,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP,C7_ immunologic signatures
4485,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,C7_ immunologic signatures
4486,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,c2.CGP_ chemical and genetic perturbations
4487,GSE6259_CD4_TCELL_VS_CD8_TCELL_UP,C7_ immunologic signatures
4488,GSE21033_3H_VS_12H_POLYIC_STIM_DC_UP,C7_ immunologic signatures
4489,BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN,c2.CGP_ chemical and genetic perturbations
4490,GO_ACTIVATION_OF_PHOSPHOLIPASE_C_ACTIVITY,c5.BP_ GO biological process
4491,GO_VISUAL_BEHAVIOR,c5.BP_ GO biological process
4492,CP2_02,c3.TFT_ transcription factor targets
4493,GO_CELL_SUBSTRATE_JUNCTION_ASSEMBLY,c5.BP_ GO biological process
4494,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN,C7_ immunologic signatures
4495,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
4496,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP,C7_ immunologic signatures
4497,GO_POSITIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,c5.BP_ GO biological process
4498,GO_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_HORMONE,c5.BP_ GO biological process
4499,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN,C7_ immunologic signatures
4500,HATADA_METHYLATED_IN_LUNG_CANCER_UP,c2.CGP_ chemical and genetic perturbations
4501,GO_KINASE_REGULATOR_ACTIVITY,c5.GO molecular function
4502,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,C7_ immunologic signatures
4503,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_UP,C7_ immunologic signatures
4504,GO_LATERAL_PLASMA_MEMBRANE,c5.CC_ GO cellular component
4505,GO_SYNAPTIC_VESICLE_CYCLE,c5.BP_ GO biological process
4506,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP,C7_ immunologic signatures
4507,NF1_Q6,c3.TFT_ transcription factor targets
4508,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP,C7_ immunologic signatures
4509,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
4510,GO_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,c5.BP_ GO biological process
4511,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,C7_ immunologic signatures
4512,NFE2L2.V2,C6_ oncogenic signatures
4513,CHR4P15,34
4514,CHR6Q25,45
4515,GO_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_COUPLED_TO_CYCLIC_NUCLEOTIDE_SECOND_MESSENGER,c5.BP_ GO biological process
4516,NABA_SECRETED_FACTORS,c2.CP_ Canonical pathways
4517,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_UP,C7_ immunologic signatures
4518,CHR14Q31,20
4519,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_UP,C7_ immunologic signatures
4520,TGTATGA_MIR4853P,c3.MIR_ microRNA targets
4521,GO_EMBRYONIC_EYE_MORPHOGENESIS,c5.BP_ GO biological process
4522,GO_RESPONSE_TO_ESTRADIOL,c5.BP_ GO biological process
4523,WANG_LMO4_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4524,LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES,c2.CGP_ chemical and genetic perturbations
4525,GO_NEGATIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
4526,GO_NOTCH_SIGNALING_PATHWAY,c5.BP_ GO biological process
4527,GO_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY,c5.BP_ GO biological process
4528,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN,C7_ immunologic signatures
4529,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,C7_ immunologic signatures
4530,CHR9Q33,48
4531,GNF2_CASP8,c4.CGN_ cancer gene neighborhoods
4532,AIGNER_ZEB1_TARGETS,c2.CGP_ chemical and genetic perturbations
4533,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP,C7_ immunologic signatures
4534,CAGGGTC_MIR504,c3.MIR_ microRNA targets
4535,NFY_C,c3.TFT_ transcription factor targets
4536,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,C7_ immunologic signatures
4537,HOLLERN_MICROACINAR_BREAST_TUMOR_UP,c2.CGP_ chemical and genetic perturbations
4538,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,c2.CGP_ chemical and genetic perturbations
4539,LEE_CALORIE_RESTRICTION_NEOCORTEX_UP,c2.CGP_ chemical and genetic perturbations
4540,GESERICK_TERT_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4541,TCGA_GLIOBLASTOMA_COPY_NUMBER_DN,c2.CGP_ chemical and genetic perturbations
4542,GO_DIVALENT_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
4543,WANG_SMARCE1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4544,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,C7_ immunologic signatures
4545,GO_ACTIN_FILAMENT_BINDING,c5.GO molecular function
4546,GO_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN,c5.BP_ GO biological process
4547,HAHTOLA_SEZARY_SYNDROM_DN,c2.CGP_ chemical and genetic perturbations
4548,CHR7P15,53
4549,E12_Q6,c3.TFT_ transcription factor targets
4550,MODULE_138,c4.CM_ cancer modules
4551,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,C7_ immunologic signatures
4552,MODULE_72,c4.CM_ cancer modules
4553,REACTOME_GPCR_LIGAND_BINDING,c2.CP_REACTOME_ Reactome gene sets
4554,GSE2706_UNSTIM_VS_2H_LPS_DC_UP,C7_ immunologic signatures
4555,GO_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,c5.BP_ GO biological process
4556,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP,C7_ immunologic signatures
4557,KRAS.300_UP.V1_DN,C6_ oncogenic signatures
4558,GO_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,c5.BP_ GO biological process
4559,GO_REGULATION_OF_CARBOHYDRATE_CATABOLIC_PROCESS,c5.BP_ GO biological process
4560,GO_MONOSACCHARIDE_TRANSPORT,c5.BP_ GO biological process
4561,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_UP,C7_ immunologic signatures
4562,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP,C7_ immunologic signatures
4563,GOLDRATH_IMMUNE_MEMORY,c2.CGP_ chemical and genetic perturbations
4564,GUILLAUMOND_KLF10_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4565,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,C7_ immunologic signatures
4566,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,C7_ immunologic signatures
4567,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN,C7_ immunologic signatures
4568,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
4569,GO_CELL_ACTIVATION,c5.BP_ GO biological process
4570,GO_TUBE_FORMATION,c5.BP_ GO biological process
4571,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,c2.CGP_ chemical and genetic perturbations
4572,PAX2_01,c3.TFT_ transcription factor targets
4573,MORF_NOS2A,c4.CGN_ cancer gene neighborhoods
4574,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,C7_ immunologic signatures
4575,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,C7_ immunologic signatures
4576,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,C7_ immunologic signatures
4577,HSF2_01,c3.TFT_ transcription factor targets
4578,CHR14Q23,38
4579,GO_REGULATION_OF_NEUROTRANSMITTER_LEVELS,c5.BP_ GO biological process
4580,GO_CELLULAR_RESPONSE_TO_DRUG,c5.BP_ GO biological process
4581,GO_REGULATION_OF_LIPID_METABOLIC_PROCESS,c5.BP_ GO biological process
4582,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
4583,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN,C7_ immunologic signatures
4584,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,c2.CGP_ chemical and genetic perturbations
4585,GO_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
4586,GO_PROTEIN_PHOSPHATASE_2A_BINDING,c5.GO molecular function
4587,GGARNTKYCCA_UNKNOWN,c3.TFT_ transcription factor targets
4588,HENDRICKS_SMARCA4_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4589,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,c2.CGP_ chemical and genetic perturbations
4590,KANG_IMMORTALIZED_BY_TERT_DN,c2.CGP_ chemical and genetic perturbations
4591,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP,C7_ immunologic signatures
4592,LTE2_UP.V1_UP,C6_ oncogenic signatures
4593,MODULE_486,c4.CM_ cancer modules
4594,SREBP1_Q6,c3.TFT_ transcription factor targets
4595,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP,C7_ immunologic signatures
4596,GO_GLAND_DEVELOPMENT,c5.BP_ GO biological process
4597,SCHURINGA_STAT5A_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4598,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_DN,C7_ immunologic signatures
4599,TAAWWATAG_RSRFC4_Q2,c3.TFT_ transcription factor targets
4600,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN,C7_ immunologic signatures
4601,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP,C7_ immunologic signatures
4602,ZHAN_MULTIPLE_MYELOMA_MS_DN,c2.CGP_ chemical and genetic perturbations
4603,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,c2.CGP_ chemical and genetic perturbations
4604,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN,C7_ immunologic signatures
4605,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_DN,C7_ immunologic signatures
4606,MODULE_426,c4.CM_ cancer modules
4607,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_DN,C7_ immunologic signatures
4608,GO_POSTSYNAPSE,c5.CC_ GO cellular component
4609,GSE3982_EOSINOPHIL_VS_TH2_UP,C7_ immunologic signatures
4610,MODULE_500,c4.CM_ cancer modules
4611,GSE17721_CTRL_VS_CPG_1H_BMDC_DN,C7_ immunologic signatures
4612,GO_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,c5.BP_ GO biological process
4613,GSE3982_DC_VS_BCELL_DN,C7_ immunologic signatures
4614,CHR2P11,40
4615,GO_EMBRYONIC_ORGAN_DEVELOPMENT,c5.BP_ GO biological process
4616,ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,c2.CGP_ chemical and genetic perturbations
4617,VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,c2.CGP_ chemical and genetic perturbations
4618,CAR_HPX,c4.CGN_ cancer gene neighborhoods
4619,GSE7852_THYMUS_VS_FAT_TCONV_DN,C7_ immunologic signatures
4620,GO_REGULATION_OF_B_CELL_DIFFERENTIATION,c5.BP_ GO biological process
4621,GO_MEMBRANE_DOCKING,c5.BP_ GO biological process
4622,GO_SINGLE_ORGANISM_CELL_ADHESION,c5.BP_ GO biological process
4623,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN,C7_ immunologic signatures
4624,GO_POSITIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,c5.BP_ GO biological process
4625,CHR16Q21,16
4626,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,C7_ immunologic signatures
4627,MODULE_75,c4.CM_ cancer modules
4628,DITTMER_PTHLH_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4629,GO_POSITIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
4630,GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN,C7_ immunologic signatures
4631,GSE7852_TREG_VS_TCONV_UP,C7_ immunologic signatures
4632,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN,C7_ immunologic signatures
4633,GO_RAS_PROTEIN_SIGNAL_TRANSDUCTION,c5.BP_ GO biological process
4634,GO_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND,c5.BP_ GO biological process
4635,KOYAMA_SEMA3B_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4636,GO_DENDRITE_MORPHOGENESIS,c5.BP_ GO biological process
4637,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP,C7_ immunologic signatures
4638,GO_MODULATION_OF_SYNAPTIC_TRANSMISSION,c5.BP_ GO biological process
4639,MULLIGHAN_MLL_SIGNATURE_2_DN,c2.CGP_ chemical and genetic perturbations
4640,P53_DN.V2_DN,C6_ oncogenic signatures
4641,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,c2.CGP_ chemical and genetic perturbations
4642,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,C7_ immunologic signatures
4643,REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,c2.CP_REACTOME_ Reactome gene sets
4644,GSE3982_DC_VS_TH2_UP,C7_ immunologic signatures
4645,GO_POSITIVE_REGULATION_OF_AMINE_TRANSPORT,c5.BP_ GO biological process
4646,FOSTER_KDM1A_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4647,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,c2.CGP_ chemical and genetic perturbations
4648,PID_TCR_PATHWAY,c2.CP_ Canonical pathways
4649,CHEN_ETV5_TARGETS_TESTIS,c2.CGP_ chemical and genetic perturbations
4650,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
4651,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN,C7_ immunologic signatures
4652,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
4653,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN,C7_ immunologic signatures
4654,GO_RESPONSE_TO_BACTERIUM,c5.BP_ GO biological process
4655,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP,C7_ immunologic signatures
4656,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN,c2.CGP_ chemical and genetic perturbations
4657,RATTENBACHER_BOUND_BY_CELF1,c2.CGP_ chemical and genetic perturbations
4658,GO_DENDRITE_MEMBRANE,c5.CC_ GO cellular component
4659,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
4660,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP,C7_ immunologic signatures
4661,YAATNRNNNYNATT_UNKNOWN,c3.TFT_ transcription factor targets
4662,GO_REGULATION_OF_RECEPTOR_ACTIVITY,c5.BP_ GO biological process
4663,GO_CELLULAR_RESPONSE_TO_INTERFERON_GAMMA,c5.BP_ GO biological process
4664,GO_RHO_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,c5.GO molecular function
4665,REACTOME_DNA_REPAIR,c2.CP_REACTOME_ Reactome gene sets
4666,REACTOME_OPIOID_SIGNALLING,c2.CP_REACTOME_ Reactome gene sets
4667,GO_REGULATION_OF_ORGANELLE_ASSEMBLY,c5.BP_ GO biological process
4668,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,c2.CGP_ chemical and genetic perturbations
4669,IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM,c2.CGP_ chemical and genetic perturbations
4670,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN,C7_ immunologic signatures
4671,FXR_Q3,c3.TFT_ transcription factor targets
4672,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN,C7_ immunologic signatures
4673,GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN,C7_ immunologic signatures
4674,PRC2_SUZ12_UP.V1_UP,C6_ oncogenic signatures
4675,BROWNE_HCMV_INFECTION_6HR_UP,c2.CGP_ chemical and genetic perturbations
4676,GO_RHYTHMIC_PROCESS,c5.BP_ GO biological process
4677,ST_JNK_MAPK_PATHWAY,c2.CP_ Canonical pathways
4678,GO_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,c5.GO molecular function
4679,MODULE_182,c4.CM_ cancer modules
4680,GO_POSITIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,c5.BP_ GO biological process
4681,GO_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
4682,KEGG_LYSOSOME,c2.CP_BIOCARTA_ BioCarta gene sets
4683,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,C7_ immunologic signatures
4684,GO_REGULATION_OF_CHROMOSOME_ORGANIZATION,c5.BP_ GO biological process
4685,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_UP,C7_ immunologic signatures
4686,MARTINEZ_RB1_AND_TP53_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4687,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,C7_ immunologic signatures
4688,GO_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,c5.BP_ GO biological process
4689,KRAS.PROSTATE_UP.V1_DN,C6_ oncogenic signatures
4690,GO_PROTEIN_SUMOYLATION,c5.BP_ GO biological process
4691,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,C7_ immunologic signatures
4692,GSE360_L_MAJOR_VS_T_GONDII_DC_UP,C7_ immunologic signatures
4693,MODULE_385,c4.CM_ cancer modules
4694,GO_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,c5.BP_ GO biological process
4695,VEGF_A_UP.V1_UP,C6_ oncogenic signatures
4696,BROWNE_HCMV_INFECTION_20HR_DN,c2.CGP_ chemical and genetic perturbations
4697,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN,C7_ immunologic signatures
4698,WONG_IFNA2_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
4699,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP,C7_ immunologic signatures
4700,BIOCARTA_MPR_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
4701,IL21_UP.V1_UP,C6_ oncogenic signatures
4702,KORKOLA_TERATOMA,c2.CGP_ chemical and genetic perturbations
4703,CEBP_Q3,c3.TFT_ transcription factor targets
4704,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,C7_ immunologic signatures
4705,SMID_BREAST_CANCER_LUMINAL_B_UP,c2.CGP_ chemical and genetic perturbations
4706,GO_L_AMINO_ACID_TRANSPORT,c5.BP_ GO biological process
4707,GSE17721_CTRL_VS_CPG_12H_BMDC_DN,C7_ immunologic signatures
4708,REACTOME_TIGHT_JUNCTION_INTERACTIONS,c2.CP_REACTOME_ Reactome gene sets
4709,GO_REGULATION_OF_TELOMERE_CAPPING,c5.BP_ GO biological process
4710,ATF2_UP.V1_UP,C6_ oncogenic signatures
4711,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,C7_ immunologic signatures
4712,AACWWCAANK_UNKNOWN,c3.TFT_ transcription factor targets
4713,GO_EMBRYONIC_DIGESTIVE_TRACT_MORPHOGENESIS,c5.BP_ GO biological process
4714,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
4715,GO_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE,c5.CC_ GO cellular component
4716,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
4717,GO_T_CELL_SELECTION,c5.BP_ GO biological process
4718,ATGTTAA_MIR302C,c3.MIR_ microRNA targets
4719,GO_MYOBLAST_FUSION,c5.BP_ GO biological process
4720,GO_SYNAPTIC_VESICLE_ENDOCYTOSIS,c5.BP_ GO biological process
4721,GO_AUTOPHAGY,c5.BP_ GO biological process
4722,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
4723,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN,C7_ immunologic signatures
4724,GO_NEGATIVE_REGULATION_OF_PLATELET_ACTIVATION,c5.BP_ GO biological process
4725,OSADA_ASCL1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4726,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_UP,C7_ immunologic signatures
4727,YANAGIHARA_ESX1_TARGETS,c2.CGP_ chemical and genetic perturbations
4728,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_DN,C7_ immunologic signatures
4729,GO_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,c5.BP_ GO biological process
4730,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,c2.CGP_ chemical and genetic perturbations
4731,KYNG_WERNER_SYNDROM_UP,c2.CGP_ chemical and genetic perturbations
4732,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN,C7_ immunologic signatures
4733,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,c2.CGP_ chemical and genetic perturbations
4734,GO_ANION_ANION_ANTIPORTER_ACTIVITY,c5.GO molecular function
4735,NGUYEN_NOTCH1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4736,GSE13547_WT_VS_ZFX_KO_BCELL_UP,C7_ immunologic signatures
4737,GO_EXTRACELLULAR_MATRIX_ASSEMBLY,c5.BP_ GO biological process
4738,GO_AUTOPHAGOSOME_MEMBRANE,c5.CC_ GO cellular component
4739,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN,C7_ immunologic signatures
4740,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,c2.CGP_ chemical and genetic perturbations
4741,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP,C7_ immunologic signatures
4742,BIOCARTA_INSULIN_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
4743,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
4744,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,C7_ immunologic signatures
4745,GO_AUDITORY_RECEPTOR_CELL_DEVELOPMENT,c5.BP_ GO biological process
4746,MORF_MAGEA9,c4.CGN_ cancer gene neighborhoods
4747,GO_POSITIVE_REGULATION_OF_GROWTH,c5.BP_ GO biological process
4748,GO_SIDE_OF_MEMBRANE,c5.CC_ GO cellular component
4749,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,C7_ immunologic signatures
4750,BURTON_ADIPOGENESIS_11,c2.CGP_ chemical and genetic perturbations
4751,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_DN,C7_ immunologic signatures
4752,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN,C7_ immunologic signatures
4753,GO_CATION_TRANSPORTING_ATPASE_ACTIVITY,c5.GO molecular function
4754,GO_MACROPHAGE_DIFFERENTIATION,c5.BP_ GO biological process
4755,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,C7_ immunologic signatures
4756,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
4757,APPEL_IMATINIB_RESPONSE,c2.CGP_ chemical and genetic perturbations
4758,KEGG_BASAL_CELL_CARCINOMA,c2.CP_BIOCARTA_ BioCarta gene sets
4759,GO_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,c5.BP_ GO biological process
4760,REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING,c2.CP_REACTOME_ Reactome gene sets
4761,LANDIS_ERBB2_BREAST_TUMORS_324_DN,c2.CGP_ chemical and genetic perturbations
4762,GO_HYALURONAN_METABOLIC_PROCESS,c5.BP_ GO biological process
4763,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP,C7_ immunologic signatures
4764,NUMATA_CSF3_SIGNALING_VIA_STAT3,c2.CGP_ chemical and genetic perturbations
4765,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_UP,C7_ immunologic signatures
4766,GCM_MAP4K4,c4.CGN_ cancer gene neighborhoods
4767,GO_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,c5.GO molecular function
4768,MORF_RAGE,c4.CGN_ cancer gene neighborhoods
4769,MYAATNNNNNNNGGC_UNKNOWN,c3.TFT_ transcription factor targets
4770,CHR1Q42,72
4771,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,C7_ immunologic signatures
4772,FOSTER_TOLERANT_MACROPHAGE_UP,c2.CGP_ chemical and genetic perturbations
4773,PAX8_01,c3.TFT_ transcription factor targets
4774,GO_CHEMOATTRACTANT_ACTIVITY,c5.GO molecular function
4775,FOXM1_01,c3.TFT_ transcription factor targets
4776,NFY_Q6_01,c3.TFT_ transcription factor targets
4777,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP,C7_ immunologic signatures
4778,YAMAZAKI_TCEB3_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4779,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN,C7_ immunologic signatures
4780,FALVELLA_SMOKERS_WITH_LUNG_CANCER,c2.CGP_ chemical and genetic perturbations
4781,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP,C7_ immunologic signatures
4782,GO_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,c5.BP_ GO biological process
4783,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,c2.CGP_ chemical and genetic perturbations
4784,NEWMAN_ERCC6_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4785,GSE3982_DC_VS_TH1_DN,C7_ immunologic signatures
4786,GO_NEGATIVE_REGULATION_OF_PROTEIN_BINDING,c5.BP_ GO biological process
4787,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_UP,C7_ immunologic signatures
4788,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN,C7_ immunologic signatures
4789,REACTOME_G_ALPHA1213_SIGNALLING_EVENTS,c2.CP_REACTOME_ Reactome gene sets
4790,LEE_LIVER_CANCER_DENA_UP,c2.CGP_ chemical and genetic perturbations
4791,KEGG_NITROGEN_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
4792,GO_PROTEIN_DEPHOSPHORYLATION,c5.BP_ GO biological process
4793,GO_CENTROSOME_LOCALIZATION,c5.BP_ GO biological process
4794,KEGG_DORSO_VENTRAL_AXIS_FORMATION,c2.CP_BIOCARTA_ BioCarta gene sets
4795,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,C7_ immunologic signatures
4796,PDGF_ERK_DN.V1_DN,C6_ oncogenic signatures
4797,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_UP,C7_ immunologic signatures
4798,ZHENG_FOXP3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4799,GO_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
4800,GO_POSITIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,c5.BP_ GO biological process
4801,GO_AMIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
4802,ELVIDGE_HIF1A_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4803,MORF_CAMK4,c4.CGN_ cancer gene neighborhoods
4804,BIOCARTA_BCELLSURVIVAL_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
4805,REACTOME_PLC_BETA_MEDIATED_EVENTS,c2.CP_REACTOME_ Reactome gene sets
4806,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_UP,C7_ immunologic signatures
4807,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP,C7_ immunologic signatures
4808,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_DN,C7_ immunologic signatures
4809,GSE45365_NK_CELL_VS_CD11B_DC_UP,C7_ immunologic signatures
4810,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,C7_ immunologic signatures
4811,REACTOME_NEPHRIN_INTERACTIONS,c2.CP_REACTOME_ Reactome gene sets
4812,GSE14415_INDUCED_TREG_VS_TCONV_DN,C7_ immunologic signatures
4813,GO_SYNAPTIC_MEMBRANE,c5.CC_ GO cellular component
4814,MODULE_166,c4.CM_ cancer modules
4815,BROWNE_HCMV_INFECTION_12HR_UP,c2.CGP_ chemical and genetic perturbations
4816,GO_LEUKOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
4817,GO_NEPHRON_EPITHELIUM_DEVELOPMENT,c5.BP_ GO biological process
4818,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP,C7_ immunologic signatures
4819,GO_ACTIVE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
4820,DING_LUNG_CANCER_BY_MUTATION_RATE,c2.CGP_ chemical and genetic perturbations
4821,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
4822,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN,C7_ immunologic signatures
4823,GO_REGULATION_OF_STAT_CASCADE,c5.BP_ GO biological process
4824,KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,c2.CGP_ chemical and genetic perturbations
4825,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP,C7_ immunologic signatures
4826,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
4827,LEIN_OLIGODENDROCYTE_MARKERS,c2.CGP_ chemical and genetic perturbations
4828,GO_RESPONSE_TO_VIRUS,c5.BP_ GO biological process
4829,GO_LOW_DENSITY_LIPOPROTEIN_PARTICLE_BINDING,c5.GO molecular function
4830,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,C7_ immunologic signatures
4831,HUI_MAPK14_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
4832,RGAGGAARY_PU1_Q6,c3.TFT_ transcription factor targets
4833,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,C7_ immunologic signatures
4834,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP,c2.CGP_ chemical and genetic perturbations
4835,GSE6875_TCONV_VS_FOXP3_KO_TREG_UP,C7_ immunologic signatures
4836,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,C7_ immunologic signatures
4837,MODULE_324,c4.CM_ cancer modules
4838,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN,C7_ immunologic signatures
4839,RAF_UP.V1_UP,C6_ oncogenic signatures
4840,P53_DECAMER_Q2,c3.TFT_ transcription factor targets
4841,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
4842,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
4843,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,C7_ immunologic signatures
4844,REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS,c2.CP_REACTOME_ Reactome gene sets
4845,TCF11_01,c3.TFT_ transcription factor targets
4846,GO_GLIOGENESIS,c5.BP_ GO biological process
4847,GO_PEPTIDE_TRANSPORT,c5.BP_ GO biological process
4848,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN,C7_ immunologic signatures
4849,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,C7_ immunologic signatures
4850,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,C7_ immunologic signatures
4851,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,C7_ immunologic signatures
4852,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,C7_ immunologic signatures
4853,GO_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL,c5.BP_ GO biological process
4854,HALLMARK_WNT_BETA_CATENIN_SIGNALING,H_ hallmark gene sets
4855,PID_ARF6_TRAFFICKING_PATHWAY,c2.CP_ Canonical pathways
4856,RAPA_EARLY_UP.V1_DN,C6_ oncogenic signatures
4857,GO_ACIDIC_AMINO_ACID_TRANSPORT,c5.BP_ GO biological process
4858,HOLLERN_SQUAMOUS_BREAST_TUMOR,c2.CGP_ chemical and genetic perturbations
4859,MORF_FOSL1,c4.CGN_ cancer gene neighborhoods
4860,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,C7_ immunologic signatures
4861,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN,C7_ immunologic signatures
4862,GO_EXOCRINE_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
4863,MODULE_521,c4.CM_ cancer modules
4864,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,C7_ immunologic signatures
4865,GO_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,c5.BP_ GO biological process
4866,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN,C7_ immunologic signatures
4867,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP,C7_ immunologic signatures
4868,GSE2585_THYMIC_DC_VS_MTEC_DN,C7_ immunologic signatures
4869,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
4870,GSE2585_CTEC_VS_THYMIC_DC_UP,C7_ immunologic signatures
4871,XU_RESPONSE_TO_TRETINOIN_UP,c2.CGP_ chemical and genetic perturbations
4872,GSE15330_WT_VS_IKAROS_KO_HSC_UP,C7_ immunologic signatures
4873,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN,C7_ immunologic signatures
4874,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN,C7_ immunologic signatures
4875,TAATGTG_MIR323,c3.MIR_ microRNA targets
4876,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,C7_ immunologic signatures
4877,REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT,c2.CP_REACTOME_ Reactome gene sets
4878,GO_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,c5.BP_ GO biological process
4879,GO_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT5_PROTEIN,c5.BP_ GO biological process
4880,GSE2585_CD80_HIGH_VS_LOW_MTEC_UP,C7_ immunologic signatures
4881,GSE2585_CTEC_VS_MTEC_THYMUS_DN,C7_ immunologic signatures
4882,GSE23568_ID3_KO_VS_WT_CD8_TCELL_UP,C7_ immunologic signatures
4883,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,C7_ immunologic signatures
4884,GO_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM,c5.BP_ GO biological process
4885,SESTO_RESPONSE_TO_UV_C8,c2.CGP_ chemical and genetic perturbations
4886,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,c2.CGP_ chemical and genetic perturbations
4887,GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,c5.BP_ GO biological process
4888,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,C7_ immunologic signatures
4889,GO_NEGATIVE_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,c5.BP_ GO biological process
4890,GO_REGULATION_OF_PEPTIDASE_ACTIVITY,c5.BP_ GO biological process
4891,GO_PROTEIN_PALMITOYLATION,c5.BP_ GO biological process
4892,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
4893,CHR11P11,50
4894,GSE40655_FOXO1_KO_VS_WT_NTREG_DN,C7_ immunologic signatures
4895,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
4896,HARRIS_HYPOXIA,c2.CGP_ chemical and genetic perturbations
4897,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,C7_ immunologic signatures
4898,REACTOME_MEIOTIC_SYNAPSIS,c2.CP_REACTOME_ Reactome gene sets
4899,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,C7_ immunologic signatures
4900,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
4901,GSE13306_TREG_VS_TCONV_SPLEEN_UP,C7_ immunologic signatures
4902,GO_PLATELET_ACTIVATION,c5.BP_ GO biological process
4903,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP,C7_ immunologic signatures
4904,PID_NOTCH_PATHWAY,c2.CP_ Canonical pathways
4905,GO_SOMATIC_RECOMBINATION_OF_IMMUNOGLOBULIN_GENE_SEGMENTS,c5.BP_ GO biological process
4906,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
4907,BROWNE_HCMV_INFECTION_6HR_DN,c2.CGP_ chemical and genetic perturbations
4908,ROY_WOUND_BLOOD_VESSEL_DN,c2.CGP_ chemical and genetic perturbations
4909,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_DN,C7_ immunologic signatures
4910,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_UP,C7_ immunologic signatures
4911,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_DN,C7_ immunologic signatures
4912,GO_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
4913,GO_INOSITOL_PHOSPHATE_METABOLIC_PROCESS,c5.BP_ GO biological process
4914,GATA_C,c3.TFT_ transcription factor targets
4915,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,C7_ immunologic signatures
4916,REACTOME_DAG_AND_IP3_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
4917,BIOCARTA_NFAT_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
4918,PID_INTEGRIN_A9B1_PATHWAY,c2.CP_ Canonical pathways
4919,NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON,c2.CGP_ chemical and genetic perturbations
4920,PRC2_EED_UP.V1_UP,C6_ oncogenic signatures
4921,GO_METALLOPEPTIDASE_ACTIVITY,c5.GO molecular function
4922,MSX1_01,c3.TFT_ transcription factor targets
4923,HENDRICKS_SMARCA4_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4924,GO_ANCHORING_JUNCTION,c5.CC_ GO cellular component
4925,MIKKELSEN_ES_LCP_WITH_H3K4ME3,c2.CGP_ chemical and genetic perturbations
4926,GSE22886_TH1_VS_TH2_48H_ACT_DN,C7_ immunologic signatures
4927,TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D,c3.MIR_ microRNA targets
4928,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,C7_ immunologic signatures
4929,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_DN,C7_ immunologic signatures
4930,GO_ACTIVATION_OF_GTPASE_ACTIVITY,c5.BP_ GO biological process
4931,GO_CORTICAL_ACTIN_CYTOSKELETON,c5.CC_ GO cellular component
4932,GO_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,c5.BP_ GO biological process
4933,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
4934,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5,c2.CGP_ chemical and genetic perturbations
4935,MODULE_254,c4.CM_ cancer modules
4936,GO_REGULATION_OF_CARDIAC_CONDUCTION,c5.BP_ GO biological process
4937,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,C7_ immunologic signatures
4938,ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,c2.CGP_ chemical and genetic perturbations
4939,GSE27786_BCELL_VS_CD8_TCELL_UP,C7_ immunologic signatures
4940,GSE6259_BCELL_VS_CD8_TCELL_UP,C7_ immunologic signatures
4941,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN,C7_ immunologic signatures
4942,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,c2.CGP_ chemical and genetic perturbations
4943,GO_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,c5.BP_ GO biological process
4944,NUTT_GBM_VS_AO_GLIOMA_UP,c2.CGP_ chemical and genetic perturbations
4945,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
4946,NAKAMURA_ADIPOGENESIS_LATE_UP,c2.CGP_ chemical and genetic perturbations
4947,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN,C7_ immunologic signatures
4948,CHR12Q15,21
4949,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,c2.CGP_ chemical and genetic perturbations
4950,GO_STEM_CELL_PROLIFERATION,c5.BP_ GO biological process
4951,GO_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,c5.BP_ GO biological process
4952,GSE27786_LIN_NEG_VS_CD8_TCELL_DN,C7_ immunologic signatures
4953,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP,C7_ immunologic signatures
4954,GO_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS,c5.BP_ GO biological process
4955,HU_ANGIOGENESIS_UP,c2.CGP_ chemical and genetic perturbations
4956,GSE3982_MAC_VS_NEUTROPHIL_DN,C7_ immunologic signatures
4957,ZHAN_MULTIPLE_MYELOMA_CD1_DN,c2.CGP_ chemical and genetic perturbations
4958,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
4959,GO_LAMELLAR_BODY,c5.CC_ GO cellular component
4960,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN,C7_ immunologic signatures
4961,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,C7_ immunologic signatures
4962,GO_CORONARY_VASCULATURE_DEVELOPMENT,c5.BP_ GO biological process
4963,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP,C7_ immunologic signatures
4964,DAZARD_UV_RESPONSE_CLUSTER_G4,c2.CGP_ chemical and genetic perturbations
4965,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
4966,GO_HYPOTHALAMUS_DEVELOPMENT,c5.BP_ GO biological process
4967,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP,C7_ immunologic signatures
4968,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP,C7_ immunologic signatures
4969,GO_REGULATION_OF_CHEMOKINE_PRODUCTION,c5.BP_ GO biological process
4970,KOYAMA_SEMA3B_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4971,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP,C7_ immunologic signatures
4972,RUAN_RESPONSE_TO_TROGLITAZONE_UP,c2.CGP_ chemical and genetic perturbations
4973,GO_POSITIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
4974,GSE15659_TREG_VS_TCONV_DN,C7_ immunologic signatures
4975,GO_OVULATION_CYCLE_PROCESS,c5.BP_ GO biological process
4976,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,c2.CGP_ chemical and genetic perturbations
4977,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,C7_ immunologic signatures
4978,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_DN,C7_ immunologic signatures
4979,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,C7_ immunologic signatures
4980,GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN,C7_ immunologic signatures
4981,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP,C7_ immunologic signatures
4982,PID_RHOA_PATHWAY,c2.CP_ Canonical pathways
4983,MTF1_Q4,c3.TFT_ transcription factor targets
4984,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,C7_ immunologic signatures
4985,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1,c2.CGP_ chemical and genetic perturbations
4986,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,c2.CGP_ chemical and genetic perturbations
4987,GO_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,c5.BP_ GO biological process
4988,CEBPB_02,c3.TFT_ transcription factor targets
4989,REACTOME_CD28_CO_STIMULATION,c2.CP_REACTOME_ Reactome gene sets
4990,PID_SHP2_PATHWAY,c2.CP_ Canonical pathways
4991,GSE27786_BCELL_VS_MONO_MAC_DN,C7_ immunologic signatures
4992,UDAYAKUMAR_MED1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
4993,GO_ORGANOPHOSPHATE_ESTER_TRANSPORT,c5.BP_ GO biological process
4994,GO_BETA_CATENIN_BINDING,c5.GO molecular function
4995,REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL,c2.CP_REACTOME_ Reactome gene sets
4996,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN,C7_ immunologic signatures
4997,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_DN,C7_ immunologic signatures
4998,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,C7_ immunologic signatures
4999,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,c2.CGP_ chemical and genetic perturbations
5000,GNF2_RTN1,c4.CGN_ cancer gene neighborhoods
5001,IL2_UP.V1_DN,C6_ oncogenic signatures
5002,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA,c2.CP_REACTOME_ Reactome gene sets
5003,GO_TEMPERATURE_HOMEOSTASIS,c5.BP_ GO biological process
5004,DR3_Q4,c3.TFT_ transcription factor targets
5005,MORF_MSH3,c4.CGN_ cancer gene neighborhoods
5006,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
5007,GO_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,c5.BP_ GO biological process
5008,GO_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,c5.BP_ GO biological process
5009,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,C7_ immunologic signatures
5010,GO_PLASMA_MEMBRANE_ORGANIZATION,c5.BP_ GO biological process
5011,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP,C7_ immunologic signatures
5012,GO_NEGATIVE_REGULATION_OF_COAGULATION,c5.BP_ GO biological process
5013,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP,C7_ immunologic signatures
5014,LMO2COM_02,c3.TFT_ transcription factor targets
5015,GO_REGULATION_OF_MULTI_ORGANISM_PROCESS,c5.BP_ GO biological process
5016,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,C7_ immunologic signatures
5017,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,c2.CGP_ chemical and genetic perturbations
5018,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_UP,C7_ immunologic signatures
5019,GO_SPECIFICATION_OF_SYMMETRY,c5.BP_ GO biological process
5020,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_DN,C7_ immunologic signatures
5021,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,C7_ immunologic signatures
5022,GO_EXTRACELLULAR_MATRIX_BINDING,c5.GO molecular function
5023,REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,c2.CP_REACTOME_ Reactome gene sets
5024,GO_INNATE_IMMUNE_RESPONSE,c5.BP_ GO biological process
5025,GO_LIPID_PHOSPHORYLATION,c5.BP_ GO biological process
5026,GSE17721_CTRL_VS_CPG_6H_BMDC_DN,C7_ immunologic signatures
5027,MODULE_362,c4.CM_ cancer modules
5028,ZIC2_01,c3.TFT_ transcription factor targets
5029,GO_SINGLE_STRANDED_DNA_BINDING,c5.GO molecular function
5030,GTACTGT_MIR101,c3.MIR_ microRNA targets
5031,KEGG_SMALL_CELL_LUNG_CANCER,c2.CP_BIOCARTA_ BioCarta gene sets
5032,GO_REGULATION_OF_CELL_CELL_ADHESION,c5.BP_ GO biological process
5033,ATAGGAA_MIR202,c3.MIR_ microRNA targets
5034,GO_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_BINDING,c5.GO molecular function
5035,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,c2.CGP_ chemical and genetic perturbations
5036,REACTOME_DIABETES_PATHWAYS,c2.CP_REACTOME_ Reactome gene sets
5037,GO_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT,c5.BP_ GO biological process
5038,GO_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,c5.BP_ GO biological process
5039,NFKB_C,c3.TFT_ transcription factor targets
5040,MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED,c2.CGP_ chemical and genetic perturbations
5041,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,C7_ immunologic signatures
5042,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_UP,C7_ immunologic signatures
5043,GO_PHOSPHATIDYLINOSITOL_3_KINASE_BINDING,c5.GO molecular function
5044,GSE15659_RESTING_VS_ACTIVATED_TREG_UP,C7_ immunologic signatures
5045,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP,C7_ immunologic signatures
5046,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP,C7_ immunologic signatures
5047,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,c2.CGP_ chemical and genetic perturbations
5048,ATACTGT_MIR144,c3.MIR_ microRNA targets
5049,PID_TELOMERASE_PATHWAY,c2.CP_ Canonical pathways
5050,KOHOUTEK_CCNT1_TARGETS,c2.CGP_ chemical and genetic perturbations
5051,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,C7_ immunologic signatures
5052,CHRXQ26,28
5053,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP,C7_ immunologic signatures
5054,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,C7_ immunologic signatures
5055,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,C7_ immunologic signatures
5056,GO_REGULATION_OF_ACTIN_FILAMENT_LENGTH,c5.BP_ GO biological process
5057,RSRFC4_Q2,c3.TFT_ transcription factor targets
5058,MODULE_18,c4.CM_ cancer modules
5059,NAKAYAMA_FRA2_TARGETS,c2.CGP_ chemical and genetic perturbations
5060,CACBINDINGPROTEIN_Q6,c3.TFT_ transcription factor targets
5061,GHANDHI_BYSTANDER_IRRADIATION_UP,c2.CGP_ chemical and genetic perturbations
5062,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN,C7_ immunologic signatures
5063,YAP1_UP,C6_ oncogenic signatures
5064,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,C7_ immunologic signatures
5065,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,c2.CGP_ chemical and genetic perturbations
5066,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN,C7_ immunologic signatures
5067,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN,C7_ immunologic signatures
5068,GO_REGULATION_OF_NEUROTRANSMITTER_SECRETION,c5.BP_ GO biological process
5069,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_UP,C7_ immunologic signatures
5070,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,c2.CGP_ chemical and genetic perturbations
5071,TANG_SENESCENCE_TP53_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5072,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,c2.CGP_ chemical and genetic perturbations
5073,GO_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING,c5.BP_ GO biological process
5074,THUM_SYSTOLIC_HEART_FAILURE_DN,c2.CGP_ chemical and genetic perturbations
5075,ULE_SPLICING_VIA_NOVA2,c2.CGP_ chemical and genetic perturbations
5076,GO_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,c5.BP_ GO biological process
5077,GO_RESPONSE_TO_MUSCLE_ACTIVITY,c5.BP_ GO biological process
5078,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,C7_ immunologic signatures
5079,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP,C7_ immunologic signatures
5080,FOXO3_01,c3.TFT_ transcription factor targets
5081,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP,C7_ immunologic signatures
5082,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,C7_ immunologic signatures
5083,FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,c2.CGP_ chemical and genetic perturbations
5084,GO_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,c5.BP_ GO biological process
5085,GO_XENOPHAGY,c5.BP_ GO biological process
5086,MORF_FSHR,c4.CGN_ cancer gene neighborhoods
5087,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,c2.CGP_ chemical and genetic perturbations
5088,NRSF_01,c3.TFT_ transcription factor targets
5089,GACTGTT_MIR212_MIR132,c3.MIR_ microRNA targets
5090,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP,C7_ immunologic signatures
5091,GO_GLUTAMATE_RECEPTOR_BINDING,c5.GO molecular function
5092,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,C7_ immunologic signatures
5093,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP,C7_ immunologic signatures
5094,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,C7_ immunologic signatures
5095,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_UP,C7_ immunologic signatures
5096,GSE339_CD4POS_VS_CD4CD8DN_DC_UP,C7_ immunologic signatures
5097,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,c2.CGP_ chemical and genetic perturbations
5098,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN,C7_ immunologic signatures
5099,GO_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,c5.BP_ GO biological process
5100,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP,c2.CGP_ chemical and genetic perturbations
5101,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,c2.CGP_ chemical and genetic perturbations
5102,GO_ANTEROGRADE_AXONAL_TRANSPORT,c5.BP_ GO biological process
5103,MODULE_354,c4.CM_ cancer modules
5104,GCATTTG_MIR105,c3.MIR_ microRNA targets
5105,PID_HDAC_CLASSIII_PATHWAY,c2.CP_ Canonical pathways
5106,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP,C7_ immunologic signatures
5107,GO_CALCIUM_CHANNEL_REGULATOR_ACTIVITY,c5.GO molecular function
5108,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP,C7_ immunologic signatures
5109,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN,C7_ immunologic signatures
5110,ZHAN_MULTIPLE_MYELOMA_PR_DN,c2.CGP_ chemical and genetic perturbations
5111,GO_ORGANONITROGEN_COMPOUND_CATABOLIC_PROCESS,c5.BP_ GO biological process
5112,GO_REGULATION_OF_CYTOKINE_PRODUCTION,c5.BP_ GO biological process
5113,GO_RESPONSE_TO_ETHANOL,c5.BP_ GO biological process
5114,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP,C7_ immunologic signatures
5115,GO_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE,c5.BP_ GO biological process
5116,GO_PHOSPHOLIPID_TRANSPORT,c5.BP_ GO biological process
5117,E2F_01,c3.TFT_ transcription factor targets
5118,TTGCCAA_MIR182,c3.MIR_ microRNA targets
5119,GO_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,c5.BP_ GO biological process
5120,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,C7_ immunologic signatures
5121,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP,C7_ immunologic signatures
5122,DURCHDEWALD_SKIN_CARCINOGENESIS_UP,c2.CGP_ chemical and genetic perturbations
5123,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,C7_ immunologic signatures
5124,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
5125,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
5126,JOHNSTONE_PARVB_TARGETS_2_DN,c2.CGP_ chemical and genetic perturbations
5127,MORF_LCAT,c4.CGN_ cancer gene neighborhoods
5128,GO_CYCLIN_BINDING,c5.GO molecular function
5129,KEGG_DNA_REPLICATION,c2.CP_BIOCARTA_ BioCarta gene sets
5130,CROONQUIST_IL6_DEPRIVATION_UP,c2.CGP_ chemical and genetic perturbations
5131,GATA1_05,c3.TFT_ transcription factor targets
5132,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_DN,C7_ immunologic signatures
5133,GAVIN_FOXP3_TARGETS_CLUSTER_P2,c2.CGP_ chemical and genetic perturbations
5134,IWANAGA_CARCINOGENESIS_BY_KRAS_DN,c2.CGP_ chemical and genetic perturbations
5135,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN,C7_ immunologic signatures
5136,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN,C7_ immunologic signatures
5137,TGIF_01,c3.TFT_ transcription factor targets
5138,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP,C7_ immunologic signatures
5139,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,C7_ immunologic signatures
5140,GO_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,c5.BP_ GO biological process
5141,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,C7_ immunologic signatures
5142,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_DN,C7_ immunologic signatures
5143,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,c2.CGP_ chemical and genetic perturbations
5144,REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
5145,GO_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,c5.BP_ GO biological process
5146,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP,C7_ immunologic signatures
5147,GO_RESPONSE_TO_INTERFERON_ALPHA,c5.BP_ GO biological process
5148,WELCSH_BRCA1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5149,CHR4Q13,19
5150,GO_DETECTION_OF_VISIBLE_LIGHT,c5.BP_ GO biological process
5151,CHANG_IMMORTALIZED_BY_HPV31_UP,c2.CGP_ chemical and genetic perturbations
5152,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN,C7_ immunologic signatures
5153,TATA_C,c3.TFT_ transcription factor targets
5154,GSE20366_TREG_VS_TCONV_DN,C7_ immunologic signatures
5155,MEISSNER_NPC_HCP_WITH_H3K4ME2,c2.CGP_ chemical and genetic perturbations
5156,FAC1_01,c3.TFT_ transcription factor targets
5157,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,C7_ immunologic signatures
5158,GHO_ATF5_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
5159,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
5160,KANG_AR_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
5161,GOZGIT_ESR1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5162,GO_CORTICAL_CYTOSKELETON,c5.CC_ GO cellular component
5163,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP,C7_ immunologic signatures
5164,PASINI_SUZ12_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5165,GO_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE,c5.BP_ GO biological process
5166,GO_INTRACELLULAR_LIPID_TRANSPORT,c5.BP_ GO biological process
5167,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,c2.CGP_ chemical and genetic perturbations
5168,GO_POSITIVE_REGULATION_OF_RECEPTOR_ACTIVITY,c5.BP_ GO biological process
5169,GO_NEGATIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,c5.BP_ GO biological process
5170,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP,C7_ immunologic signatures
5171,ATF2_S_UP.V1_UP,C6_ oncogenic signatures
5172,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_DN,C7_ immunologic signatures
5173,GO_ION_ANTIPORTER_ACTIVITY,c5.GO molecular function
5174,MILI_PSEUDOPODIA_CHEMOTAXIS_UP,c2.CGP_ chemical and genetic perturbations
5175,GO_MAMMARY_GLAND_DEVELOPMENT,c5.BP_ GO biological process
5176,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
5177,CAGGTCC_MIR492,c3.MIR_ microRNA targets
5178,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP,C7_ immunologic signatures
5179,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_DN,C7_ immunologic signatures
5180,TSAI_RESPONSE_TO_IONIZING_RADIATION,c2.CGP_ chemical and genetic perturbations
5181,AMIT_SERUM_RESPONSE_60_MCF10A,c2.CGP_ chemical and genetic perturbations
5182,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,C7_ immunologic signatures
5183,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN,C7_ immunologic signatures
5184,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP,C7_ immunologic signatures
5185,GSE3039_CD4_TCELL_VS_NKT_CELL_UP,C7_ immunologic signatures
5186,GO_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,c5.BP_ GO biological process
5187,LEE_LIVER_CANCER_ACOX1_UP,c2.CGP_ chemical and genetic perturbations
5188,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP,C7_ immunologic signatures
5189,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,c2.CGP_ chemical and genetic perturbations
5190,REACTOME_CELL_JUNCTION_ORGANIZATION,c2.CP_REACTOME_ Reactome gene sets
5191,GO_RESPONSE_TO_INORGANIC_SUBSTANCE,c5.BP_ GO biological process
5192,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_DN,C7_ immunologic signatures
5193,GSE7852_TREG_VS_TCONV_LN_DN,C7_ immunologic signatures
5194,VERHAAK_GLIOBLASTOMA_PRONEURAL,c2.CGP_ chemical and genetic perturbations
5195,GSE8835_CD4_VS_CD8_TCELL_DN,C7_ immunologic signatures
5196,MODY_HIPPOCAMPUS_NEONATAL,c2.CGP_ chemical and genetic perturbations
5197,FRASOR_RESPONSE_TO_ESTRADIOL_UP,c2.CGP_ chemical and genetic perturbations
5198,GO_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,c5.BP_ GO biological process
5199,MCAATNNNNNGCG_UNKNOWN,c3.TFT_ transcription factor targets
5200,GO_POSITIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,c5.BP_ GO biological process
5201,MARTINEZ_TP53_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
5202,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN,C7_ immunologic signatures
5203,GO_POSITIVE_REGULATION_OF_STAT_CASCADE,c5.BP_ GO biological process
5204,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP,C7_ immunologic signatures
5205,TTGGAGA_MIR5155P_MIR519E,c3.MIR_ microRNA targets
5206,PHONG_TNF_RESPONSE_NOT_VIA_P38,c2.CGP_ chemical and genetic perturbations
5207,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN,C7_ immunologic signatures
5208,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP,C7_ immunologic signatures
5209,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,c2.CGP_ chemical and genetic perturbations
5210,SNACANNNYSYAGA_UNKNOWN,c3.TFT_ transcription factor targets
5211,MYB_Q3,c3.TFT_ transcription factor targets
5212,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN,C7_ immunologic signatures
5213,GO_NEGATIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,c5.BP_ GO biological process
5214,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,C7_ immunologic signatures
5215,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP,C7_ immunologic signatures
5216,GO_POSITIVE_REGULATION_OF_CHROMATIN_MODIFICATION,c5.BP_ GO biological process
5217,MORF_WNT1,c4.CGN_ cancer gene neighborhoods
5218,GO_METANEPHROS_DEVELOPMENT,c5.BP_ GO biological process
5219,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP,C7_ immunologic signatures
5220,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP,c2.CGP_ chemical and genetic perturbations
5221,GO_EMBRYONIC_SKELETAL_SYSTEM_MORPHOGENESIS,c5.BP_ GO biological process
5222,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP,C7_ immunologic signatures
5223,GNF2_SNRK,c4.CGN_ cancer gene neighborhoods
5224,GO_B_CELL_MEDIATED_IMMUNITY,c5.BP_ GO biological process
5225,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN,C7_ immunologic signatures
5226,MODULE_126,c4.CM_ cancer modules
5227,GO_REGULATION_OF_CYTOPLASMIC_TRANSPORT,c5.BP_ GO biological process
5228,GO_POSITIVE_CHEMOTAXIS,c5.BP_ GO biological process
5229,CHR7Q32,36
5230,GO_ORGANELLE_ASSEMBLY,c5.BP_ GO biological process
5231,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN,C7_ immunologic signatures
5232,TAL1ALPHAE47_01,c3.TFT_ transcription factor targets
5233,GSE3039_CD4_TCELL_VS_NKT_CELL_DN,C7_ immunologic signatures
5234,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN,C7_ immunologic signatures
5235,SANSOM_APC_TARGETS,c2.CGP_ chemical and genetic perturbations
5236,AACTGAC_MIR223,c3.MIR_ microRNA targets
5237,GO_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY,c5.GO molecular function
5238,GO_POSITIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
5239,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
5240,MODULE_123,c4.CM_ cancer modules
5241,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,C7_ immunologic signatures
5242,GSE14308_TH2_VS_TH17_UP,C7_ immunologic signatures
5243,MYOGENIN_Q6,c3.TFT_ transcription factor targets
5244,GO_PERIKARYON,c5.CC_ GO cellular component
5245,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
5246,HALLMARK_INFLAMMATORY_RESPONSE,H_ hallmark gene sets
5247,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,C7_ immunologic signatures
5248,GO_REGULATION_OF_RESPONSE_TO_WOUNDING,c5.BP_ GO biological process
5249,MODULE_164,c4.CM_ cancer modules
5250,BIOCARTA_AMI_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
5251,GO_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE,c5.BP_ GO biological process
5252,ATGAAGG_MIR205,c3.MIR_ microRNA targets
5253,GSE3982_MAC_VS_NKCELL_UP,C7_ immunologic signatures
5254,MODULE_312,c4.CM_ cancer modules
5255,GSE17721_CTRL_VS_LPS_4H_BMDC_DN,C7_ immunologic signatures
5256,WANG_NFKB_TARGETS,c2.CGP_ chemical and genetic perturbations
5257,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_UP,C7_ immunologic signatures
5258,CHR5Q21,20
5259,GO_CELLULAR_RESPONSE_TO_STARVATION,c5.BP_ GO biological process
5260,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_DN,C7_ immunologic signatures
5261,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,C7_ immunologic signatures
5262,BERNARD_PPAPDC1B_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5263,GO_A_BAND,c5.CC_ GO cellular component
5264,GO_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,c5.BP_ GO biological process
5265,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,c2.CGP_ chemical and genetic perturbations
5266,GSE3982_MAST_CELL_VS_TH2_DN,C7_ immunologic signatures
5267,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN,C7_ immunologic signatures
5268,AGTCAGC_MIR345,c3.MIR_ microRNA targets
5269,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP,C7_ immunologic signatures
5270,GO_MEGAKARYOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
5271,ACAACCT_MIR453,c3.MIR_ microRNA targets
5272,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP,C7_ immunologic signatures
5273,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,C7_ immunologic signatures
5274,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP,C7_ immunologic signatures
5275,JAEGER_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
5276,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_DN,C7_ immunologic signatures
5277,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN,C7_ immunologic signatures
5278,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,C7_ immunologic signatures
5279,GO_ENDOPEPTIDASE_ACTIVITY,c5.GO molecular function
5280,GSE7852_TREG_VS_TCONV_FAT_UP,C7_ immunologic signatures
5281,GO_UBIQUITIN_LIKE_PROTEIN_BINDING,c5.GO molecular function
5282,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
5283,CCCNNGGGAR_OLF1_01,c3.TFT_ transcription factor targets
5284,STAT3_02,c3.TFT_ transcription factor targets
5285,CHR4Q23,15
5286,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,C7_ immunologic signatures
5287,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN,C7_ immunologic signatures
5288,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP,C7_ immunologic signatures
5289,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,C7_ immunologic signatures
5290,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_UP,C7_ immunologic signatures
5291,GO_ATP_DEPENDENT_DNA_HELICASE_ACTIVITY,c5.GO molecular function
5292,GO_ENDOMEMBRANE_SYSTEM_ORGANIZATION,c5.BP_ GO biological process
5293,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
5294,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN,C7_ immunologic signatures
5295,MODULE_111,c4.CM_ cancer modules
5296,KRAS.LUNG_UP.V1_DN,C6_ oncogenic signatures
5297,GO_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION,c5.BP_ GO biological process
5298,AML1_Q6,c3.TFT_ transcription factor targets
5299,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP,C7_ immunologic signatures
5300,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_UP,C7_ immunologic signatures
5301,KEGG_PROSTATE_CANCER,c2.CP_BIOCARTA_ BioCarta gene sets
5302,MODULE_274,c4.CM_ cancer modules
5303,RASHI_RESPONSE_TO_IONIZING_RADIATION_1,c2.CGP_ chemical and genetic perturbations
5304,SIMBULAN_UV_RESPONSE_NORMAL_DN,c2.CGP_ chemical and genetic perturbations
5305,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,c2.CGP_ chemical and genetic perturbations
5306,GO_PLASMA_MEMBRANE_RECEPTOR_COMPLEX,c5.CC_ GO cellular component
5307,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP,C7_ immunologic signatures
5308,MCCABE_BOUND_BY_HOXC6,c2.CGP_ chemical and genetic perturbations
5309,WCAANNNYCAG_UNKNOWN,c3.TFT_ transcription factor targets
5310,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,c2.CGP_ chemical and genetic perturbations
5311,MODULE_277,c4.CM_ cancer modules
5312,GO_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY,c5.BP_ GO biological process
5313,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
5314,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP,C7_ immunologic signatures
5315,LI_INDUCED_T_TO_NATURAL_KILLER_DN,c2.CGP_ chemical and genetic perturbations
5316,YGACNNYACAR_UNKNOWN,c3.TFT_ transcription factor targets
5317,GSE3982_MAC_VS_NKCELL_DN,C7_ immunologic signatures
5318,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,C7_ immunologic signatures
5319,GO_MYELOID_CELL_DEVELOPMENT,c5.BP_ GO biological process
5320,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP,C7_ immunologic signatures
5321,MEDINA_SMARCA4_TARGETS,c2.CGP_ chemical and genetic perturbations
5322,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,C7_ immunologic signatures
5323,GO_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,c5.BP_ GO biological process
5324,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,c2.CGP_ chemical and genetic perturbations
5325,GO_KIDNEY_MORPHOGENESIS,c5.BP_ GO biological process
5326,IL15_UP.V1_DN,C6_ oncogenic signatures
5327,GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP,C7_ immunologic signatures
5328,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,C7_ immunologic signatures
5329,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP,C7_ immunologic signatures
5330,GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING,c5.GO molecular function
5331,HE_PTEN_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5332,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,C7_ immunologic signatures
5333,GO_KERATINIZATION,c5.BP_ GO biological process
5334,TIEN_INTESTINE_PROBIOTICS_6HR_DN,c2.CGP_ chemical and genetic perturbations
5335,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN,C7_ immunologic signatures
5336,GO_CELLULAR_RESPONSE_TO_LIPID,c5.BP_ GO biological process
5337,HARRIS_BRAIN_CANCER_PROGENITORS,c2.CGP_ chemical and genetic perturbations
5338,GO_REGULATION_OF_TOR_SIGNALING,c5.BP_ GO biological process
5339,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN,C7_ immunologic signatures
5340,BMI1_DN.V1_DN,C6_ oncogenic signatures
5341,GO_RESPONSE_TO_NUTRIENT,c5.BP_ GO biological process
5342,GAANYNYGACNY_UNKNOWN,c3.TFT_ transcription factor targets
5343,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_DN,C7_ immunologic signatures
5344,MODULE_346,c4.CM_ cancer modules
5345,CHR4Q12,22
5346,LABBE_WNT3A_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
5347,GSE17721_CTRL_VS_LPS_2H_BMDC_DN,C7_ immunologic signatures
5348,KEGG_COMPLEMENT_AND_COAGULATION_CASCADES,c2.CP_BIOCARTA_ BioCarta gene sets
5349,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN,C7_ immunologic signatures
5350,GSE27786_CD4_TCELL_VS_NKCELL_DN,C7_ immunologic signatures
5351,MTOR_UP.N4.V1_DN,C6_ oncogenic signatures
5352,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP,C7_ immunologic signatures
5353,GO_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE,c5.BP_ GO biological process
5354,PAX6_01,c3.TFT_ transcription factor targets
5355,KRAS.LUNG.BREAST_UP.V1_UP,C6_ oncogenic signatures
5356,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_UP,C7_ immunologic signatures
5357,CHR18P11,48
5358,TBK1.DF_DN,C6_ oncogenic signatures
5359,MODULE_48,c4.CM_ cancer modules
5360,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_DN,C7_ immunologic signatures
5361,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,C7_ immunologic signatures
5362,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_UP,C7_ immunologic signatures
5363,GO_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS,c5.BP_ GO biological process
5364,MULLIGHAN_MLL_SIGNATURE_1_DN,c2.CGP_ chemical and genetic perturbations
5365,MORF_TNFRSF6,c4.CGN_ cancer gene neighborhoods
5366,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN,c2.CGP_ chemical and genetic perturbations
5367,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP,C7_ immunologic signatures
5368,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN,C7_ immunologic signatures
5369,GO_POSITIVE_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
5370,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,C7_ immunologic signatures
5371,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,C7_ immunologic signatures
5372,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN,C7_ immunologic signatures
5373,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP,C7_ immunologic signatures
5374,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,C7_ immunologic signatures
5375,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_UP,C7_ immunologic signatures
5376,BIOCARTA_TNFR2_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
5377,BIOCARTA_IGF1R_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
5378,GSE3982_MAST_CELL_VS_NEUTROPHIL_DN,C7_ immunologic signatures
5379,GNCF_01,c3.TFT_ transcription factor targets
5380,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN,C7_ immunologic signatures
5381,AP4_Q6_01,c3.TFT_ transcription factor targets
5382,MORF_MT4,c4.CGN_ cancer gene neighborhoods
5383,GO_PHOSPHATIDYLSERINE_BINDING,c5.GO molecular function
5384,GSE45365_BCELL_VS_CD8_TCELL_DN,C7_ immunologic signatures
5385,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,c2.CGP_ chemical and genetic perturbations
5386,GO_CLATHRIN_MEDIATED_ENDOCYTOSIS,c5.BP_ GO biological process
5387,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,C7_ immunologic signatures
5388,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN,C7_ immunologic signatures
5389,GO_FILAMENTOUS_ACTIN,c5.CC_ GO cellular component
5390,GO_CELLULAR_SENESCENCE,c5.BP_ GO biological process
5391,TTTTGAG_MIR373,c3.MIR_ microRNA targets
5392,GO_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
5393,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_DN,C7_ immunologic signatures
5394,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP,C7_ immunologic signatures
5395,GO_POSITIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,c5.BP_ GO biological process
5396,GO_POSITIVE_REGULATION_OF_INTERLEUKIN_1_SECRETION,c5.BP_ GO biological process
5397,GO_REGULATION_OF_INCLUSION_BODY_ASSEMBLY,c5.BP_ GO biological process
5398,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN,C7_ immunologic signatures
5399,MORF_BRCA1,c4.CGN_ cancer gene neighborhoods
5400,FIRESTEIN_CTNNB1_PATHWAY,c2.CGP_ chemical and genetic perturbations
5401,GO_REGULATION_OF_LEUKOCYTE_PROLIFERATION,c5.BP_ GO biological process
5402,GO_T_CELL_MEDIATED_IMMUNITY,c5.BP_ GO biological process
5403,REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE,c2.CP_REACTOME_ Reactome gene sets
5404,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,c2.CGP_ chemical and genetic perturbations
5405,GO_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION,c5.BP_ GO biological process
5406,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP,C7_ immunologic signatures
5407,GSE3982_MAST_CELL_VS_TH2_UP,C7_ immunologic signatures
5408,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN,C7_ immunologic signatures
5409,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
5410,GO_SEX_DIFFERENTIATION,c5.BP_ GO biological process
5411,GO_AMMONIUM_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
5412,DELASERNA_MYOD_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
5413,GO_MYOSIN_II_COMPLEX,c5.CC_ GO cellular component
5414,HAN_SATB1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
5415,GO_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY,c5.GO molecular function
5416,GO_REGULATION_OF_FATTY_ACID_OXIDATION,c5.BP_ GO biological process
5417,GO_ANDROGEN_RECEPTOR_BINDING,c5.GO molecular function
5418,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6,c2.CGP_ chemical and genetic perturbations
5419,PID_P53_REGULATION_PATHWAY,c2.CP_ Canonical pathways
5420,GSE25087_TREG_VS_TCONV_FETUS_UP,C7_ immunologic signatures
5421,AML1_01,c3.TFT_ transcription factor targets
5422,KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
5423,GO_SYNTAXIN_BINDING,c5.GO molecular function
5424,GO_GAMETE_GENERATION,c5.BP_ GO biological process
5425,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,C7_ immunologic signatures
5426,GSE13522_WT_VS_IFNAR_KO_SKIN_UP,C7_ immunologic signatures
5427,STAT5A_03,c3.TFT_ transcription factor targets
5428,CHR1Q25,55
5429,GO_RHO_GTPASE_BINDING,c5.GO molecular function
5430,GO_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,c5.BP_ GO biological process
5431,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN,c2.CGP_ chemical and genetic perturbations
5432,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP,C7_ immunologic signatures
5433,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
5434,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP,C7_ immunologic signatures
5435,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5436,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,c2.CGP_ chemical and genetic perturbations
5437,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
5438,TSENG_IRS1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5439,PID_AMB2_NEUTROPHILS_PATHWAY,c2.CP_ Canonical pathways
5440,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,c2.CGP_ chemical and genetic perturbations
5441,CHR15Q26,54
5442,GSE2826_WT_VS_XID_BCELL_UP,C7_ immunologic signatures
5443,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,C7_ immunologic signatures
5444,KEGG_WNT_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
5445,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN,C7_ immunologic signatures
5446,CEBP_Q2,c3.TFT_ transcription factor targets
5447,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,c2.CGP_ chemical and genetic perturbations
5448,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN,c2.CGP_ chemical and genetic perturbations
5449,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN,C7_ immunologic signatures
5450,GO_MACROMITOPHAGY,c5.BP_ GO biological process
5451,IKEDA_MIR30_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5452,FOSTER_TOLERANT_MACROPHAGE_DN,c2.CGP_ chemical and genetic perturbations
5453,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,c2.CGP_ chemical and genetic perturbations
5454,GSE17721_0.5H_VS_12H_POLYIC_BMDC_DN,C7_ immunologic signatures
5455,GO_SNARE_BINDING,c5.GO molecular function
5456,GO_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,c5.BP_ GO biological process
5457,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN,C7_ immunologic signatures
5458,GO_RESPONSE_TO_INCREASED_OXYGEN_LEVELS,c5.BP_ GO biological process
5459,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP,C7_ immunologic signatures
5460,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_UP,C7_ immunologic signatures
5461,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP,C7_ immunologic signatures
5462,RIZ_ERYTHROID_DIFFERENTIATION_6HR,c2.CGP_ chemical and genetic perturbations
5463,RUIZ_TNC_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5464,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR,c2.CGP_ chemical and genetic perturbations
5465,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP,C7_ immunologic signatures
5466,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN,C7_ immunologic signatures
5467,CHR7Q33,16
5468,GO_CHANNEL_REGULATOR_ACTIVITY,c5.GO molecular function
5469,GO_EPITHELIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
5470,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP,C7_ immunologic signatures
5471,TATA_01,c3.TFT_ transcription factor targets
5472,GSE2706_UNSTIM_VS_8H_R848_DC_UP,C7_ immunologic signatures
5473,GSE17721_CTRL_VS_LPS_1H_BMDC_UP,C7_ immunologic signatures
5474,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN,C7_ immunologic signatures
5475,ZHU_CMV_24_HR_UP,c2.CGP_ chemical and genetic perturbations
5476,GO_CELL_SUBSTRATE_JUNCTION,c5.CC_ GO cellular component
5477,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN,c2.CGP_ chemical and genetic perturbations
5478,EGFR_UP.V1_DN,C6_ oncogenic signatures
5479,GO_REGULATION_OF_NEUROBLAST_PROLIFERATION,c5.BP_ GO biological process
5480,GO_MIDBRAIN_DEVELOPMENT,c5.BP_ GO biological process
5481,GO_REGULATION_OF_DNA_METHYLATION,c5.BP_ GO biological process
5482,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN,C7_ immunologic signatures
5483,GNF2_CCNA1,c4.CGN_ cancer gene neighborhoods
5484,PKCA_DN.V1_DN,C6_ oncogenic signatures
5485,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,C7_ immunologic signatures
5486,BIOCARTA_BIOPEPTIDES_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
5487,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP,C7_ immunologic signatures
5488,BIOCARTA_CSK_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
5489,MODULE_169,c4.CM_ cancer modules
5490,GO_CARBOHYDRATE_TRANSPORT,c5.BP_ GO biological process
5491,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN,C7_ immunologic signatures
5492,REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,c2.CP_REACTOME_ Reactome gene sets
5493,STAT6_02,c3.TFT_ transcription factor targets
5494,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN,C7_ immunologic signatures
5495,GO_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX,c5.CC_ GO cellular component
5496,GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING,c5.GO molecular function
5497,KYNG_RESPONSE_TO_H2O2,c2.CGP_ chemical and genetic perturbations
5498,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,c2.CGP_ chemical and genetic perturbations
5499,GO_ENDOPLASMIC_RETICULUM_LUMEN,c5.CC_ GO cellular component
5500,GSE24210_TCONV_VS_TREG_DN,C7_ immunologic signatures
5501,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,C7_ immunologic signatures
5502,GO_LEUKOCYTE_MEDIATED_IMMUNITY,c5.BP_ GO biological process
5503,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN,C7_ immunologic signatures
5504,GO_TRACHEA_DEVELOPMENT,c5.BP_ GO biological process
5505,GO_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,c5.BP_ GO biological process
5506,GO_REGULATION_OF_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
5507,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP,C7_ immunologic signatures
5508,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN,C7_ immunologic signatures
5509,YAGI_AML_WITH_T_9_11_TRANSLOCATION,c2.CGP_ chemical and genetic perturbations
5510,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,C7_ immunologic signatures
5511,GO_CHONDROITIN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
5512,GO_RESPONSE_TO_LIPOPROTEIN_PARTICLE,c5.BP_ GO biological process
5513,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
5514,GO_MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
5515,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP,C7_ immunologic signatures
5516,PID_IL2_1PATHWAY,c2.CP_ Canonical pathways
5517,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_UP,C7_ immunologic signatures
5518,GO_POSITIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
5519,GO_HIGH_DENSITY_LIPOPROTEIN_PARTICLE,c5.CC_ GO cellular component
5520,GO_MACROAUTOPHAGY,c5.BP_ GO biological process
5521,GO_TYPE_I_INTERFERON_RECEPTOR_BINDING,c5.GO molecular function
5522,GSE30083_SP2_VS_SP4_THYMOCYTE_UP,C7_ immunologic signatures
5523,MODULE_308,c4.CM_ cancer modules
5524,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_UP,C7_ immunologic signatures
5525,GO_ACTIN_FILAMENT_POLYMERIZATION,c5.BP_ GO biological process
5526,TST1_01,c3.TFT_ transcription factor targets
5527,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_UP,C7_ immunologic signatures
5528,GO_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,c5.BP_ GO biological process
5529,CHR2Q13,20
5530,KEGG_PANCREATIC_CANCER,c2.CP_BIOCARTA_ BioCarta gene sets
5531,SRY_02,c3.TFT_ transcription factor targets
5532,BIOCARTA_IL6_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
5533,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP,C7_ immunologic signatures
5534,GSE339_CD4POS_VS_CD8POS_DC_UP,C7_ immunologic signatures
5535,GO_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,c5.GO molecular function
5536,KASLER_HDAC7_TARGETS_2_DN,c2.CGP_ chemical and genetic perturbations
5537,GO_RECEPTOR_CLUSTERING,c5.BP_ GO biological process
5538,GO_CARBOHYDRATE_HOMEOSTASIS,c5.BP_ GO biological process
5539,GSE360_CTRL_VS_L_MAJOR_MAC_DN,C7_ immunologic signatures
5540,ZHANG_PROLIFERATING_VS_QUIESCENT,c2.CGP_ chemical and genetic perturbations
5541,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP,C7_ immunologic signatures
5542,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN,C7_ immunologic signatures
5543,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,c2.CGP_ chemical and genetic perturbations
5544,GO_EARLY_ENDOSOME_MEMBRANE,c5.CC_ GO cellular component
5545,PID_SMAD2_3PATHWAY,c2.CP_ Canonical pathways
5546,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
5547,ATTCTTT_MIR186,c3.MIR_ microRNA targets
5548,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP,C7_ immunologic signatures
5549,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP,C7_ immunologic signatures
5550,GO_NEPHRON_DEVELOPMENT,c5.BP_ GO biological process
5551,GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_BINDING,c5.GO molecular function
5552,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,C7_ immunologic signatures
5553,MORF_KDR,c4.CGN_ cancer gene neighborhoods
5554,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP,C7_ immunologic signatures
5555,CHR4P12,18
5556,CAHOY_NEURONAL,C6_ oncogenic signatures
5557,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,C7_ immunologic signatures
5558,GSE25677_MPL_VS_R848_STIM_BCELL_UP,C7_ immunologic signatures
5559,KEGG_COLORECTAL_CANCER,c2.CP_BIOCARTA_ BioCarta gene sets
5560,GO_POSTSYNAPTIC_MEMBRANE,c5.CC_ GO cellular component
5561,CHR3Q21,80
5562,GGCAGTG_MIR3243P,c3.MIR_ microRNA targets
5563,GO_14_3_3_PROTEIN_BINDING,c5.GO molecular function
5564,HMGIY_Q6,c3.TFT_ transcription factor targets
5565,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP,C7_ immunologic signatures
5566,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_DN,C7_ immunologic signatures
5567,GO_PLASMA_MEMBRANE_PROTEIN_COMPLEX,c5.CC_ GO cellular component
5568,GO_RESPONSE_TO_PEPTIDE,c5.BP_ GO biological process
5569,DELACROIX_RAR_BOUND_ES,c2.CGP_ chemical and genetic perturbations
5570,GSE21033_3H_VS_12H_POLYIC_STIM_DC_DN,C7_ immunologic signatures
5571,MITSIADES_RESPONSE_TO_APLIDIN_UP,c2.CGP_ chemical and genetic perturbations
5572,MORI_MATURE_B_LYMPHOCYTE_DN,c2.CGP_ chemical and genetic perturbations
5573,GSE28237_EARLY_VS_LATE_GC_BCELL_UP,C7_ immunologic signatures
5574,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,C7_ immunologic signatures
5575,GGCAGCT_MIR22,c3.MIR_ microRNA targets
5576,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP,C7_ immunologic signatures
5577,KEGG_MISMATCH_REPAIR,c2.CP_BIOCARTA_ BioCarta gene sets
5578,RYTGCNWTGGNR_UNKNOWN,c3.TFT_ transcription factor targets
5579,GO_POSITIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,c5.BP_ GO biological process
5580,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP,C7_ immunologic signatures
5581,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,c2.CGP_ chemical and genetic perturbations
5582,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_DN,C7_ immunologic signatures
5583,GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,c5.BP_ GO biological process
5584,GO_AMINOGLYCAN_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
5585,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
5586,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_UP,C7_ immunologic signatures
5587,GO_RECEPTOR_MEDIATED_ENDOCYTOSIS,c5.BP_ GO biological process
5588,GO_AMMONIUM_TRANSPORT,c5.BP_ GO biological process
5589,GO_GLANDULAR_EPITHELIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
5590,IK2_01,c3.TFT_ transcription factor targets
5591,MODULE_13,c4.CM_ cancer modules
5592,GO_FILOPODIUM,c5.CC_ GO cellular component
5593,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,c2.CGP_ chemical and genetic perturbations
5594,GO_RESPONSE_TO_EXTRACELLULAR_STIMULUS,c5.BP_ GO biological process
5595,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP,C7_ immunologic signatures
5596,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,C7_ immunologic signatures
5597,GO_POSITIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,c5.BP_ GO biological process
5598,GSE14308_TH2_VS_INDUCED_TREG_UP,C7_ immunologic signatures
5599,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,C7_ immunologic signatures
5600,REACTOME_MYOGENESIS,c2.CP_REACTOME_ Reactome gene sets
5601,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_DN,C7_ immunologic signatures
5602,GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN,C7_ immunologic signatures
5603,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP,C7_ immunologic signatures
5604,GO_POSITIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,c5.BP_ GO biological process
5605,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,c2.CGP_ chemical and genetic perturbations
5606,GO_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,c5.GO molecular function
5607,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP,C7_ immunologic signatures
5608,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,C7_ immunologic signatures
5609,MYB_Q5_01,c3.TFT_ transcription factor targets
5610,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_UP,C7_ immunologic signatures
5611,GO_PROTEIN_DEGLYCOSYLATION,c5.BP_ GO biological process
5612,GNF2_ZAP70,c4.CGN_ cancer gene neighborhoods
5613,GSE17721_LPS_VS_CPG_16H_BMDC_UP,C7_ immunologic signatures
5614,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP,C7_ immunologic signatures
5615,GO_DENDRITE,c5.CC_ GO cellular component
5616,GSE360_CTRL_VS_L_MAJOR_DC_UP,C7_ immunologic signatures
5617,FORTSCHEGGER_PHF8_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5618,GO_DORSAL_VENTRAL_AXIS_SPECIFICATION,c5.BP_ GO biological process
5619,GO_DORSAL_VENTRAL_PATTERN_FORMATION,c5.BP_ GO biological process
5620,KEGG_SPHINGOLIPID_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
5621,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP,C7_ immunologic signatures
5622,GO_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS,c5.BP_ GO biological process
5623,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,c2.CGP_ chemical and genetic perturbations
5624,MODULE_289,c4.CM_ cancer modules
5625,LEONARD_HYPOXIA,c2.CGP_ chemical and genetic perturbations
5626,SMAD4_Q6,c3.TFT_ transcription factor targets
5627,GO_REGULATION_OF_ATPASE_ACTIVITY,c5.BP_ GO biological process
5628,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP,C7_ immunologic signatures
5629,GO_LAMININ_BINDING,c5.GO molecular function
5630,GO_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION,c5.BP_ GO biological process
5631,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP,C7_ immunologic signatures
5632,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN,C7_ immunologic signatures
5633,MODULE_105,c4.CM_ cancer modules
5634,MODULE_576,c4.CM_ cancer modules
5635,GO_RESPONSE_TO_STEROL,c5.BP_ GO biological process
5636,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,c2.CGP_ chemical and genetic perturbations
5637,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,C7_ immunologic signatures
5638,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_DN,C7_ immunologic signatures
5639,GSE3982_EOSINOPHIL_VS_BCELL_UP,C7_ immunologic signatures
5640,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_DN,C7_ immunologic signatures
5641,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_UP,C7_ immunologic signatures
5642,GO_RETINA_LAYER_FORMATION,c5.BP_ GO biological process
5643,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
5644,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,C7_ immunologic signatures
5645,GSE15767_MED_VS_SCS_MAC_LN_DN,C7_ immunologic signatures
5646,GO_REGULATION_OF_T_CELL_MIGRATION,c5.BP_ GO biological process
5647,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP,C7_ immunologic signatures
5648,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN,C7_ immunologic signatures
5649,GSE31622_WT_VS_KLF3_KO_BCELL_UP,C7_ immunologic signatures
5650,GTGCAAT_MIR25_MIR32_MIR92_MIR363_MIR367,c3.MIR_ microRNA targets
5651,GO_REGULATION_OF_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,c5.BP_ GO biological process
5652,GO_NEGATIVE_REGULATION_OF_BINDING,c5.BP_ GO biological process
5653,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN,C7_ immunologic signatures
5654,STAEGE_EWING_FAMILY_TUMOR,c2.CGP_ chemical and genetic perturbations
5655,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,C7_ immunologic signatures
5656,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,C7_ immunologic signatures
5657,GO_EMBRYONIC_CRANIAL_SKELETON_MORPHOGENESIS,c5.BP_ GO biological process
5658,MODULE_337,c4.CM_ cancer modules
5659,GO_RESPONSE_TO_AMINO_ACID,c5.BP_ GO biological process
5660,REACTOME_TELOMERE_MAINTENANCE,c2.CP_REACTOME_ Reactome gene sets
5661,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,C7_ immunologic signatures
5662,GO_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
5663,GO_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS,c5.BP_ GO biological process
5664,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN,C7_ immunologic signatures
5665,GO_AXON,c5.CC_ GO cellular component
5666,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN,C7_ immunologic signatures
5667,OLF1_01,c3.TFT_ transcription factor targets
5668,GROSS_ELK3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5669,GO_FUCOSYLATION,c5.BP_ GO biological process
5670,GUO_HEX_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5671,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
5672,PENG_LEUCINE_DEPRIVATION_UP,c2.CGP_ chemical and genetic perturbations
5673,GO_POSITIVE_REGULATION_OF_PROTEIN_IMPORT,c5.BP_ GO biological process
5674,PID_PI3KCI_AKT_PATHWAY,c2.CP_ Canonical pathways
5675,GO_NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION,c5.BP_ GO biological process
5676,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP,C7_ immunologic signatures
5677,FXR_IR1_Q6,c3.TFT_ transcription factor targets
5678,DR4_Q2,c3.TFT_ transcription factor targets
5679,ERB2_UP.V1_UP,C6_ oncogenic signatures
5680,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP,C7_ immunologic signatures
5681,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_DN,C7_ immunologic signatures
5682,NKX25_01,c3.TFT_ transcription factor targets
5683,GO_MEMBRANE_LIPID_METABOLIC_PROCESS,c5.BP_ GO biological process
5684,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,C7_ immunologic signatures
5685,MATZUK_CENTRAL_FOR_FEMALE_FERTILITY,c2.CGP_ chemical and genetic perturbations
5686,GO_COA_HYDROLASE_ACTIVITY,c5.GO molecular function
5687,GO_NEGATIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,c5.BP_ GO biological process
5688,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP,C7_ immunologic signatures
5689,MODULE_372,c4.CM_ cancer modules
5690,AGTTCTC_MIR146A_MIR146B,c3.MIR_ microRNA targets
5691,AAAGGGA_MIR204_MIR211,c3.MIR_ microRNA targets
5692,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,C7_ immunologic signatures
5693,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP,C7_ immunologic signatures
5694,SAFFORD_T_LYMPHOCYTE_ANERGY,c2.CGP_ chemical and genetic perturbations
5695,GSE6875_WT_VS_FOXP3_KO_TREG_DN,C7_ immunologic signatures
5696,GO_DEPHOSPHORYLATION,c5.BP_ GO biological process
5697,OSF2_Q6,c3.TFT_ transcription factor targets
5698,GO_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY,c5.GO molecular function
5699,GO_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,c5.BP_ GO biological process
5700,SENGUPTA_EBNA1_ANTICORRELATED,c2.CGP_ chemical and genetic perturbations
5701,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN,C7_ immunologic signatures
5702,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN,C7_ immunologic signatures
5703,WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,c2.CGP_ chemical and genetic perturbations
5704,TCF4_Q5,c3.TFT_ transcription factor targets
5705,ZID_01,c3.TFT_ transcription factor targets
5706,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN,C7_ immunologic signatures
5707,CAHOY_OLIGODENDROCUTIC,C6_ oncogenic signatures
5708,GO_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
5709,GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING,c5.GO molecular function
5710,GO_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,c5.BP_ GO biological process
5711,GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP,C7_ immunologic signatures
5712,CHR16Q23,26
5713,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN,C7_ immunologic signatures
5714,KEGG_VIRAL_MYOCARDITIS,c2.CP_BIOCARTA_ BioCarta gene sets
5715,WEBER_METHYLATED_HCP_IN_SPERM_DN,c2.CGP_ chemical and genetic perturbations
5716,ZIC3_01,c3.TFT_ transcription factor targets
5717,RELA_DN.V1_UP,C6_ oncogenic signatures
5718,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,C7_ immunologic signatures
5719,ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,c2.CGP_ chemical and genetic perturbations
5720,MATZUK_SPERMATOGONIA,c2.CGP_ chemical and genetic perturbations
5721,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_DN,C7_ immunologic signatures
5722,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,c2.CGP_ chemical and genetic perturbations
5723,GO_PEPTIDYL_TYROSINE_MODIFICATION,c5.BP_ GO biological process
5724,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN,C7_ immunologic signatures
5725,BROWNE_HCMV_INFECTION_2HR_DN,c2.CGP_ chemical and genetic perturbations
5726,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,C7_ immunologic signatures
5727,SESTO_RESPONSE_TO_UV_C3,c2.CGP_ chemical and genetic perturbations
5728,STAT6_01,c3.TFT_ transcription factor targets
5729,CTACCTC_LET7A_LET7B_LET7C_LET7D_LET7E_LET7F_MIR98_LET7G_LET7I,c3.MIR_ microRNA targets
5730,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,C7_ immunologic signatures
5731,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN,C7_ immunologic signatures
5732,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_UP,C7_ immunologic signatures
5733,BASSO_CD40_SIGNALING_UP,c2.CGP_ chemical and genetic perturbations
5734,GSE6259_BCELL_VS_CD4_TCELL_DN,C7_ immunologic signatures
5735,GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP,C7_ immunologic signatures
5736,GO_REGULATION_OF_THYMOCYTE_AGGREGATION,c5.BP_ GO biological process
5737,GO_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS,c5.BP_ GO biological process
5738,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN,C7_ immunologic signatures
5739,GO_SMOOTH_ENDOPLASMIC_RETICULUM,c5.CC_ GO cellular component
5740,KRIEG_HYPOXIA_VIA_KDM3A,c2.CGP_ chemical and genetic perturbations
5741,ATAACCT_MIR154,c3.MIR_ microRNA targets
5742,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP,C7_ immunologic signatures
5743,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN,C7_ immunologic signatures
5744,GO_RESPONSE_TO_OSMOTIC_STRESS,c5.BP_ GO biological process
5745,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_UP,C7_ immunologic signatures
5746,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,C7_ immunologic signatures
5747,ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP,c2.CGP_ chemical and genetic perturbations
5748,GSE27786_LSK_VS_LIN_NEG_CELL_UP,C7_ immunologic signatures
5749,GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP,C7_ immunologic signatures
5750,CHR1P21,26
5751,BIOCARTA_MAL_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
5752,GO_RECEPTOR_INTERNALIZATION,c5.BP_ GO biological process
5753,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
5754,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP,C7_ immunologic signatures
5755,MODULE_3,c4.CM_ cancer modules
5756,GSE9037_WT_VS_IRAK4_KO_BMDM_UP,C7_ immunologic signatures
5757,GO_ATPASE_ACTIVITY_COUPLED,c5.GO molecular function
5758,TERAO_AOX4_TARGETS_SKIN_DN,c2.CGP_ chemical and genetic perturbations
5759,GO_MOLTING_CYCLE,c5.BP_ GO biological process
5760,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_UP,C7_ immunologic signatures
5761,GSE11924_TFH_VS_TH17_CD4_TCELL_UP,C7_ immunologic signatures
5762,ACTGTGA_MIR27A_MIR27B,c3.MIR_ microRNA targets
5763,RUTELLA_RESPONSE_TO_HGF_DN,c2.CGP_ chemical and genetic perturbations
5764,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP,C7_ immunologic signatures
5765,YCATTAA_UNKNOWN,c3.TFT_ transcription factor targets
5766,GSE13522_WT_VS_IFNG_KO_SKIN_UP,C7_ immunologic signatures
5767,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_DN,C7_ immunologic signatures
5768,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP,C7_ immunologic signatures
5769,KEGG_CHRONIC_MYELOID_LEUKEMIA,c2.CP_BIOCARTA_ BioCarta gene sets
5770,HEN1_01,c3.TFT_ transcription factor targets
5771,ATF3_Q6,c3.TFT_ transcription factor targets
5772,KRAS.LUNG_UP.V1_UP,C6_ oncogenic signatures
5773,CHR2Q21,38
5774,NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP,c2.CGP_ chemical and genetic perturbations
5775,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_UP,C7_ immunologic signatures
5776,DBP_Q6,c3.TFT_ transcription factor targets
5777,KOHOUTEK_CCNT2_TARGETS,c2.CGP_ chemical and genetic perturbations
5778,REACTOME_STEROID_HORMONES,c2.CP_REACTOME_ Reactome gene sets
5779,MODULE_525,c4.CM_ cancer modules
5780,MATZUK_SPERMATOZOA,c2.CGP_ chemical and genetic perturbations
5781,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN,C7_ immunologic signatures
5782,GO_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
5783,CHR1P33,29
5784,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP,C7_ immunologic signatures
5785,BIOCARTA_NGF_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
5786,FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,c2.CGP_ chemical and genetic perturbations
5787,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,C7_ immunologic signatures
5788,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,c2.CGP_ chemical and genetic perturbations
5789,GO_ORGAN_REGENERATION,c5.BP_ GO biological process
5790,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,C7_ immunologic signatures
5791,CCCNNNNNNAAGWT_UNKNOWN,c3.TFT_ transcription factor targets
5792,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_UP,C7_ immunologic signatures
5793,GO_AMIDE_BINDING,c5.GO molecular function
5794,ONO_AML1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
5795,GO_ANAPHASE_PROMOTING_COMPLEX,c5.CC_ GO cellular component
5796,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP,C7_ immunologic signatures
5797,GO_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,c5.BP_ GO biological process
5798,GO_POSITIVE_REGULATION_OF_CELL_GROWTH,c5.BP_ GO biological process
5799,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
5800,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP,C7_ immunologic signatures
5801,GSE22886_TH1_VS_TH2_12H_ACT_DN,C7_ immunologic signatures
5802,GNF2_MSH2,c4.CGN_ cancer gene neighborhoods
5803,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_DN,C7_ immunologic signatures
5804,PID_SYNDECAN_2_PATHWAY,c2.CP_ Canonical pathways
5805,DELYS_THYROID_CANCER_UP,c2.CGP_ chemical and genetic perturbations
5806,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP,C7_ immunologic signatures
5807,GO_DENDRITIC_SPINE_DEVELOPMENT,c5.BP_ GO biological process
5808,OCT1_01,c3.TFT_ transcription factor targets
5809,GO_POSITIVE_REGULATION_OF_CELL_ACTIVATION,c5.BP_ GO biological process
5810,MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3,c2.CGP_ chemical and genetic perturbations
5811,GO_TRANSFORMING_GROWTH_FACTOR_BETA_BINDING,c5.GO molecular function
5812,GO_POSITIVE_REGULATION_OF_CHEMOTAXIS,c5.BP_ GO biological process
5813,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,C7_ immunologic signatures
5814,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,C7_ immunologic signatures
5815,TTTNNANAGCYR_UNKNOWN,c3.TFT_ transcription factor targets
5816,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,c2.CGP_ chemical and genetic perturbations
5817,PTEN_DN.V2_DN,C6_ oncogenic signatures
5818,GSE3039_NKT_CELL_VS_B2_BCELL_UP,C7_ immunologic signatures
5819,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_DN,C7_ immunologic signatures
5820,HALLMARK_APICAL_SURFACE,H_ hallmark gene sets
5821,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,C7_ immunologic signatures
5822,GO_MUSCLE_CELL_CELLULAR_HOMEOSTASIS,c5.BP_ GO biological process
5823,GSE23568_ID3_KO_VS_WT_CD8_TCELL_DN,C7_ immunologic signatures
5824,MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED,c2.CGP_ chemical and genetic perturbations
5825,HALLMARK_APICAL_JUNCTION,H_ hallmark gene sets
5826,GO_AUTOPHAGOSOME,c5.CC_ GO cellular component
5827,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
5828,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP,C7_ immunologic signatures
5829,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,C7_ immunologic signatures
5830,CREBP1_Q2,c3.TFT_ transcription factor targets
5831,GO_ORGANELLE_MEMBRANE_FUSION,c5.BP_ GO biological process
5832,GO_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS,c5.BP_ GO biological process
5833,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN,C7_ immunologic signatures
5834,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,c2.CGP_ chemical and genetic perturbations
5835,GSE23695_CD57_POS_VS_NEG_NK_CELL_DN,C7_ immunologic signatures
5836,GO_VENTRICULAR_SEPTUM_DEVELOPMENT,c5.BP_ GO biological process
5837,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_DN,C7_ immunologic signatures
5838,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,c2.CGP_ chemical and genetic perturbations
5839,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
5840,GSE6875_TCONV_VS_FOXP3_KO_TREG_DN,C7_ immunologic signatures
5841,GO_CARBOXYPEPTIDASE_ACTIVITY,c5.GO molecular function
5842,MODULE_503,c4.CM_ cancer modules
5843,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_UP,C7_ immunologic signatures
5844,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,C7_ immunologic signatures
5845,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,c2.CGP_ chemical and genetic perturbations
5846,RICKMAN_HEAD_AND_NECK_CANCER_E,c2.CGP_ chemical and genetic perturbations
5847,YTAAYNGCT_UNKNOWN,c3.TFT_ transcription factor targets
5848,GO_ATP_HYDROLYSIS_COUPLED_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
5849,WEIGEL_OXIDATIVE_STRESS_RESPONSE,c2.CGP_ chemical and genetic perturbations
5850,GO_RESPONSE_TO_OXIDATIVE_STRESS,c5.BP_ GO biological process
5851,GSE6875_TCONV_VS_TREG_UP,C7_ immunologic signatures
5852,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP,C7_ immunologic signatures
5853,GSE39864_WT_VS_GATA3_KO_TREG_UP,C7_ immunologic signatures
5854,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,C7_ immunologic signatures
5855,GSE22886_TCELL_VS_BCELL_NAIVE_DN,C7_ immunologic signatures
5856,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_DN,C7_ immunologic signatures
5857,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP,C7_ immunologic signatures
5858,GO_FEMALE_SEX_DIFFERENTIATION,c5.BP_ GO biological process
5859,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP,C7_ immunologic signatures
5860,GO_RESPONSE_TO_PAIN,c5.BP_ GO biological process
5861,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN,C7_ immunologic signatures
5862,GO_NEURON_SPINE,c5.CC_ GO cellular component
5863,CHR2P21,31
5864,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
5865,GO_POSITIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,c5.BP_ GO biological process
5866,MODULE_491,c4.CM_ cancer modules
5867,JACKSON_DNMT1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5868,FOXO1_02,c3.TFT_ transcription factor targets
5869,YAMASHITA_LIVER_CANCER_STEM_CELL_UP,c2.CGP_ chemical and genetic perturbations
5870,GO_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY,c5.BP_ GO biological process
5871,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,c2.CGP_ chemical and genetic perturbations
5872,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,C7_ immunologic signatures
5873,REACTOME_GABA_B_RECEPTOR_ACTIVATION,c2.CP_REACTOME_ Reactome gene sets
5874,LIU_SOX4_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
5875,KIM_WT1_TARGETS_12HR_UP,c2.CGP_ chemical and genetic perturbations
5876,NAGASHIMA_NRG1_SIGNALING_DN,c2.CGP_ chemical and genetic perturbations
5877,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN,C7_ immunologic signatures
5878,REACTOME_AMYLOIDS,c2.CP_REACTOME_ Reactome gene sets
5879,GO_DENDRITE_DEVELOPMENT,c5.BP_ GO biological process
5880,REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS,c2.CP_REACTOME_ Reactome gene sets
5881,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
5882,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP,c2.CGP_ chemical and genetic perturbations
5883,GO_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,c5.BP_ GO biological process
5884,CAIRO_LIVER_DEVELOPMENT_UP,c2.CGP_ chemical and genetic perturbations
5885,GO_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_CELL_FATE_COMMITMENT,c5.BP_ GO biological process
5886,GO_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
5887,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_UP,C7_ immunologic signatures
5888,GCCNNNWTAAR_UNKNOWN,c3.TFT_ transcription factor targets
5889,MORF_ARL3,c4.CGN_ cancer gene neighborhoods
5890,GO_INSULIN_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
5891,GO_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
5892,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_DN,C7_ immunologic signatures
5893,GO_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,c5.BP_ GO biological process
5894,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP,C7_ immunologic signatures
5895,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP,C7_ immunologic signatures
5896,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,c2.CGP_ chemical and genetic perturbations
5897,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,C7_ immunologic signatures
5898,SNF5_DN.V1_DN,C6_ oncogenic signatures
5899,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_UP,C7_ immunologic signatures
5900,MA_PITUITARY_FETAL_VS_ADULT_DN,c2.CGP_ chemical and genetic perturbations
5901,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN,C7_ immunologic signatures
5902,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,c2.CGP_ chemical and genetic perturbations
5903,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,C7_ immunologic signatures
5904,GO_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,c5.BP_ GO biological process
5905,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN,C7_ immunologic signatures
5906,GO_CLATHRIN_BINDING,c5.GO molecular function
5907,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN,C7_ immunologic signatures
5908,GSE10325_MYELOID_VS_LUPUS_MYELOID_UP,C7_ immunologic signatures
5909,CHR16Q22,119
5910,GO_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,c5.BP_ GO biological process
5911,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN,C7_ immunologic signatures
5912,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,C7_ immunologic signatures
5913,GTTRYCATRR_UNKNOWN,c3.TFT_ transcription factor targets
5914,GO_RESPONSE_TO_COLD,c5.BP_ GO biological process
5915,MORF_RAD51L3,c4.CGN_ cancer gene neighborhoods
5916,GO_NEURON_PROJECTION_TERMINUS,c5.CC_ GO cellular component
5917,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_UP,C7_ immunologic signatures
5918,GO_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS,c5.BP_ GO biological process
5919,GO_SPERM_MOTILITY,c5.BP_ GO biological process
5920,GO_POLYOL_TRANSPORT,c5.BP_ GO biological process
5921,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN,C7_ immunologic signatures
5922,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,C7_ immunologic signatures
5923,MODULE_20,c4.CM_ cancer modules
5924,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN,C7_ immunologic signatures
5925,MODULE_45,c4.CM_ cancer modules
5926,CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY,c2.CGP_ chemical and genetic perturbations
5927,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,c2.CGP_ chemical and genetic perturbations
5928,GO_POSITIVE_REGULATION_OF_DNA_REPLICATION,c5.BP_ GO biological process
5929,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,C7_ immunologic signatures
5930,RICKMAN_HEAD_AND_NECK_CANCER_D,c2.CGP_ chemical and genetic perturbations
5931,CROMER_TUMORIGENESIS_DN,c2.CGP_ chemical and genetic perturbations
5932,REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS,c2.CP_REACTOME_ Reactome gene sets
5933,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,C7_ immunologic signatures
5934,SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,c2.CP_ Canonical pathways
5935,GSE29618_BCELL_VS_PDC_UP,C7_ immunologic signatures
5936,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN,C7_ immunologic signatures
5937,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN,C7_ immunologic signatures
5938,CHR3Q29,33
5939,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN,C7_ immunologic signatures
5940,GO_MULTIVESICULAR_BODY_ORGANIZATION,c5.BP_ GO biological process
5941,AR_Q2,c3.TFT_ transcription factor targets
5942,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN,C7_ immunologic signatures
5943,GO_REGULATION_OF_FAT_CELL_DIFFERENTIATION,c5.BP_ GO biological process
5944,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
5945,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,C7_ immunologic signatures
5946,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN,C7_ immunologic signatures
5947,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP,C7_ immunologic signatures
5948,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
5949,GO_BRANCHING_MORPHOGENESIS_OF_AN_EPITHELIAL_TUBE,c5.BP_ GO biological process
5950,GO_ANATOMICAL_STRUCTURE_MATURATION,c5.BP_ GO biological process
5951,BURTON_ADIPOGENESIS_12,c2.CGP_ chemical and genetic perturbations
5952,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,C7_ immunologic signatures
5953,GO_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,c5.BP_ GO biological process
5954,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN,C7_ immunologic signatures
5955,TATCTGG_MIR488,c3.MIR_ microRNA targets
5956,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_UP,C7_ immunologic signatures
5957,GO_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,c5.BP_ GO biological process
5958,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,c2.CGP_ chemical and genetic perturbations
5959,GSE11924_TH1_VS_TH17_CD4_TCELL_UP,C7_ immunologic signatures
5960,MIKKELSEN_NPC_LCP_WITH_H3K4ME3,c2.CGP_ chemical and genetic perturbations
5961,BIOCARTA_MCALPAIN_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
5962,GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,c5.BP_ GO biological process
5963,MODULE_284,c4.CM_ cancer modules
5964,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN,C7_ immunologic signatures
5965,MODULE_208,c4.CM_ cancer modules
5966,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN,C7_ immunologic signatures
5967,GO_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
5968,CHEN_PDGF_TARGETS,c2.CGP_ chemical and genetic perturbations
5969,GO_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
5970,GSE17721_0.5H_VS_8H_LPS_BMDC_DN,C7_ immunologic signatures
5971,BIOCARTA_CTCF_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
5972,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,C7_ immunologic signatures
5973,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP,C7_ immunologic signatures
5974,GO_EMBRYONIC_DIGIT_MORPHOGENESIS,c5.BP_ GO biological process
5975,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,C7_ immunologic signatures
5976,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_DN,C7_ immunologic signatures
5977,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN,C7_ immunologic signatures
5978,GO_REGULATION_OF_WNT_SIGNALING_PATHWAY,c5.BP_ GO biological process
5979,GSE17721_POLYIC_VS_CPG_6H_BMDC_UP,C7_ immunologic signatures
5980,CREB_Q4,c3.TFT_ transcription factor targets
5981,REACTOME_LIPOPROTEIN_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
5982,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP,C7_ immunologic signatures
5983,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,c2.CGP_ chemical and genetic perturbations
5984,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,c2.CP_REACTOME_ Reactome gene sets
5985,GO_LYMPHOCYTE_ACTIVATION,c5.BP_ GO biological process
5986,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP,C7_ immunologic signatures
5987,GO_REGULATION_OF_EXOSOMAL_SECRETION,c5.BP_ GO biological process
5988,GO_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS,c5.BP_ GO biological process
5989,GSE25087_FETAL_VS_ADULT_TREG_DN,C7_ immunologic signatures
5990,GO_POSITIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION,c5.BP_ GO biological process
5991,GO_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS,c5.BP_ GO biological process
5992,GO_THYMUS_DEVELOPMENT,c5.BP_ GO biological process
5993,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP,C7_ immunologic signatures
5994,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN,C7_ immunologic signatures
5995,BIOCARTA_IGF1_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
5996,GO_LYTIC_VACUOLE_ORGANIZATION,c5.BP_ GO biological process
5997,GO_REGULATION_OF_RECEPTOR_BINDING,c5.BP_ GO biological process
5998,GSE17580_TREG_VS_TEFF_UP,C7_ immunologic signatures
5999,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN,C7_ immunologic signatures
6000,KYNG_DNA_DAMAGE_DN,c2.CGP_ chemical and genetic perturbations
6001,ACAWYAAAG_UNKNOWN,c3.TFT_ transcription factor targets
6002,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_UP,C7_ immunologic signatures
6003,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_UP,C7_ immunologic signatures
6004,GO_ISOPRENOID_METABOLIC_PROCESS,c5.BP_ GO biological process
6005,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
6006,MODULE_408,c4.CM_ cancer modules
6007,GNF2_PTPRC,c4.CGN_ cancer gene neighborhoods
6008,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_UP,C7_ immunologic signatures
6009,GO_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION,c5.BP_ GO biological process
6010,GREENBAUM_E2A_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
6011,GO_PURINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,c5.BP_ GO biological process
6012,MODULE_46,c4.CM_ cancer modules
6013,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN,C7_ immunologic signatures
6014,PID_INSULIN_PATHWAY,c2.CP_ Canonical pathways
6015,GSE3982_NKCELL_VS_TH1_DN,C7_ immunologic signatures
6016,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_DN,C7_ immunologic signatures
6017,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,C7_ immunologic signatures
6018,MODULE_367,c4.CM_ cancer modules
6019,GSE30083_SP3_VS_SP4_THYMOCYTE_DN,C7_ immunologic signatures
6020,KEGG_ADHERENS_JUNCTION,c2.CP_BIOCARTA_ BioCarta gene sets
6021,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP,C7_ immunologic signatures
6022,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
6023,GO_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
6024,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,c2.CGP_ chemical and genetic perturbations
6025,GO_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,c5.BP_ GO biological process
6026,CHR11P15,209
6027,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,c2.CGP_ chemical and genetic perturbations
6028,GO_REGULATION_OF_EXCRETION,c5.BP_ GO biological process
6029,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP,C7_ immunologic signatures
6030,MORF_BCL2L11,c4.CGN_ cancer gene neighborhoods
6031,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
6032,GROSS_HYPOXIA_VIA_ELK3_DN,c2.CGP_ chemical and genetic perturbations
6033,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,c2.CGP_ chemical and genetic perturbations
6034,CCANNAGRKGGC_UNKNOWN,c3.TFT_ transcription factor targets
6035,GO_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
6036,MODULE_480,c4.CM_ cancer modules
6037,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,c2.CGP_ chemical and genetic perturbations
6038,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP,C7_ immunologic signatures
6039,KESHELAVA_MULTIPLE_DRUG_RESISTANCE,c2.CGP_ chemical and genetic perturbations
6040,GO_EXOCYST,c5.CC_ GO cellular component
6041,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN,C7_ immunologic signatures
6042,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_DN,C7_ immunologic signatures
6043,GO_MITOCHONDRIAL_GENOME_MAINTENANCE,c5.BP_ GO biological process
6044,GO_IONOTROPIC_GLUTAMATE_RECEPTOR_BINDING,c5.GO molecular function
6045,AAGGGAT_MIR188,c3.MIR_ microRNA targets
6046,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP,C7_ immunologic signatures
6047,GENTILE_UV_HIGH_DOSE_DN,c2.CGP_ chemical and genetic perturbations
6048,ROZANOV_MMP14_TARGETS_SUBSET,c2.CGP_ chemical and genetic perturbations
6049,GO_PSEUDOPODIUM,c5.CC_ GO cellular component
6050,PAX4_03,c3.TFT_ transcription factor targets
6051,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN,C7_ immunologic signatures
6052,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP,C7_ immunologic signatures
6053,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP,C7_ immunologic signatures
6054,MODULE_492,c4.CM_ cancer modules
6055,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP,C7_ immunologic signatures
6056,GO_CIRCADIAN_RHYTHM,c5.BP_ GO biological process
6057,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN,C7_ immunologic signatures
6058,CHR14Q12,18
6059,GTCTTCC_MIR7,c3.MIR_ microRNA targets
6060,ACACTGG_MIR199A_MIR199B,c3.MIR_ microRNA targets
6061,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN,C7_ immunologic signatures
6062,AAGCAAT_MIR137,c3.MIR_ microRNA targets
6063,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP,C7_ immunologic signatures
6064,PID_MYC_REPRESS_PATHWAY,c2.CP_ Canonical pathways
6065,LIM_MAMMARY_LUMINAL_MATURE_UP,c2.CGP_ chemical and genetic perturbations
6066,GO_POSITIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,c5.BP_ GO biological process
6067,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,c2.CGP_ chemical and genetic perturbations
6068,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
6069,CCTNTMAGA_UNKNOWN,c3.TFT_ transcription factor targets
6070,GO_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.BP_ GO biological process
6071,GO_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,c5.BP_ GO biological process
6072,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_UP,C7_ immunologic signatures
6073,MODULE_179,c4.CM_ cancer modules
6074,MODULE_427,c4.CM_ cancer modules
6075,GO_SARCOPLASM,c5.CC_ GO cellular component
6076,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP,C7_ immunologic signatures
6077,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,C7_ immunologic signatures
6078,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_UP,C7_ immunologic signatures
6079,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
6080,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP,C7_ immunologic signatures
6081,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP,C7_ immunologic signatures
6082,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,c2.CP_BIOCARTA_ BioCarta gene sets
6083,GO_AMINO_ACID_TRANSPORT,c5.BP_ GO biological process
6084,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
6085,GO_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,c5.BP_ GO biological process
6086,GO_STRIATED_MUSCLE_CONTRACTION,c5.BP_ GO biological process
6087,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_UP,C7_ immunologic signatures
6088,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP,C7_ immunologic signatures
6089,SENESE_HDAC1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6090,GSE3982_MAST_CELL_VS_MAC_DN,C7_ immunologic signatures
6091,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN,C7_ immunologic signatures
6092,GO_RESPONSE_TO_LEAD_ION,c5.BP_ GO biological process
6093,GO_ORGANELLE_DISASSEMBLY,c5.BP_ GO biological process
6094,GO_CORE_PROMOTER_PROXIMAL_REGION_DNA_BINDING,c5.GO molecular function
6095,GSE17721_LPS_VS_CPG_1H_BMDC_DN,C7_ immunologic signatures
6096,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP,C7_ immunologic signatures
6097,LABBE_TGFB1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
6098,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN,C7_ immunologic signatures
6099,GO_LIPID_TRANSPORTER_ACTIVITY,c5.GO molecular function
6100,MORF_SUPT3H,c4.CGN_ cancer gene neighborhoods
6101,GSE30083_SP2_VS_SP3_THYMOCYTE_DN,C7_ immunologic signatures
6102,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,C7_ immunologic signatures
6103,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,c2.CGP_ chemical and genetic perturbations
6104,GSE17721_CTRL_VS_POLYIC_2H_BMDC_DN,C7_ immunologic signatures
6105,GO_MONOOXYGENASE_ACTIVITY,c5.GO molecular function
6106,GYORFFY_DOXORUBICIN_RESISTANCE,c2.CGP_ chemical and genetic perturbations
6107,GO_PTERIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
6108,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,c2.CGP_ chemical and genetic perturbations
6109,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,c2.CP_REACTOME_ Reactome gene sets
6110,GO_POSITIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,c5.BP_ GO biological process
6111,KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
6112,MODULE_287,c4.CM_ cancer modules
6113,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP,C7_ immunologic signatures
6114,GCNP_SHH_UP_EARLY.V1_DN,C6_ oncogenic signatures
6115,CHEBOTAEV_GR_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6116,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_DN,C7_ immunologic signatures
6117,FREAC3_01,c3.TFT_ transcription factor targets
6118,GSE17721_0.5H_VS_4H_LPS_BMDC_DN,C7_ immunologic signatures
6119,HALLMARK_NOTCH_SIGNALING,H_ hallmark gene sets
6120,GSE22033_WT_VS_PPARG_KO_MEF_UP,C7_ immunologic signatures
6121,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN,C7_ immunologic signatures
6122,DOANE_BREAST_CANCER_ESR1_UP,c2.CGP_ chemical and genetic perturbations
6123,GO_LEUKOCYTE_ACTIVATION,c5.BP_ GO biological process
6124,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,C7_ immunologic signatures
6125,GO_AROMATIC_AMINO_ACID_FAMILY_CATABOLIC_PROCESS,c5.BP_ GO biological process
6126,GU_PDEF_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
6127,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN,C7_ immunologic signatures
6128,REACTOME_DEVELOPMENTAL_BIOLOGY,c2.CP_REACTOME_ Reactome gene sets
6129,MODULE_301,c4.CM_ cancer modules
6130,ROME_INSULIN_TARGETS_IN_MUSCLE_DN,c2.CGP_ chemical and genetic perturbations
6131,CHR7Q34,33
6132,GSE2706_R848_VS_LPS_8H_STIM_DC_UP,C7_ immunologic signatures
6133,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,c2.CP_REACTOME_ Reactome gene sets
6134,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_UP,C7_ immunologic signatures
6135,GO_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSPORT,c5.BP_ GO biological process
6136,GSE4142_GC_BCELL_VS_MEMORY_BCELL_DN,C7_ immunologic signatures
6137,GRYDER_PAX3FOXO1_TOP_ENHANCERS,c2.CGP_ chemical and genetic perturbations
6138,LEE_DOUBLE_POLAR_THYMOCYTE,c2.CGP_ chemical and genetic perturbations
6139,GO_PHOSPHOLIPASE_ACTIVITY,c5.GO molecular function
6140,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,C7_ immunologic signatures
6141,ACTGTAG_MIR139,c3.MIR_ microRNA targets
6142,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP,C7_ immunologic signatures
6143,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP,C7_ immunologic signatures
6144,AP4_01,c3.TFT_ transcription factor targets
6145,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,C7_ immunologic signatures
6146,GO_GLOMERULUS_DEVELOPMENT,c5.BP_ GO biological process
6147,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP,C7_ immunologic signatures
6148,GO_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION,c5.BP_ GO biological process
6149,GO_GAMMA_TUBULIN_BINDING,c5.GO molecular function
6150,DE_YY1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
6151,GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_CELLULAR_RESPONSE_TO_CHEMICAL_STIMULUS,c5.BP_ GO biological process
6152,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP,C7_ immunologic signatures
6153,CTGTTAC_MIR194,c3.MIR_ microRNA targets
6154,GSE3982_BCELL_VS_BASOPHIL_DN,C7_ immunologic signatures
6155,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN,C7_ immunologic signatures
6156,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP,C7_ immunologic signatures
6157,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_UP,C7_ immunologic signatures
6158,CTCTGGA_MIR520A_MIR525,c3.MIR_ microRNA targets
6159,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN,C7_ immunologic signatures
6160,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,C7_ immunologic signatures
6161,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_DN,C7_ immunologic signatures
6162,GO_NEUROPEPTIDE_RECEPTOR_BINDING,c5.GO molecular function
6163,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP,C7_ immunologic signatures
6164,GO_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS,c5.BP_ GO biological process
6165,MODULE_41,c4.CM_ cancer modules
6166,GATA6_01,c3.TFT_ transcription factor targets
6167,GO_LIMBIC_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
6168,CTGYNNCTYTAA_UNKNOWN,c3.TFT_ transcription factor targets
6169,LEE_NEURAL_CREST_STEM_CELL_UP,c2.CGP_ chemical and genetic perturbations
6170,GCTNWTTGK_UNKNOWN,c3.TFT_ transcription factor targets
6171,CHR18Q21,61
6172,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,c2.CGP_ chemical and genetic perturbations
6173,GSE360_CTRL_VS_L_MAJOR_DC_DN,C7_ immunologic signatures
6174,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
6175,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_UP,C7_ immunologic signatures
6176,GO_REGULATION_OF_FIBROBLAST_MIGRATION,c5.BP_ GO biological process
6177,GO_POSITIVE_REGULATION_OF_LYASE_ACTIVITY,c5.BP_ GO biological process
6178,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
6179,BIOCARTA_P38MAPK_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
6180,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_DN,C7_ immunologic signatures
6181,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_DN,C7_ immunologic signatures
6182,MODULE_113,c4.CM_ cancer modules
6183,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_DN,C7_ immunologic signatures
6184,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,C7_ immunologic signatures
6185,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,c2.CGP_ chemical and genetic perturbations
6186,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP,C7_ immunologic signatures
6187,GO_GLUCURONOSYLTRANSFERASE_ACTIVITY,c5.GO molecular function
6188,GO_DIVALENT_INORGANIC_CATION_HOMEOSTASIS,c5.BP_ GO biological process
6189,PRC1_BMI_UP.V1_DN,C6_ oncogenic signatures
6190,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_UP,C7_ immunologic signatures
6191,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,C7_ immunologic signatures
6192,BIOCARTA_NTHI_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
6193,DEMAGALHAES_AGING_UP,c2.CGP_ chemical and genetic perturbations
6194,GO_PHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS,c5.BP_ GO biological process
6195,AR_02,c3.TFT_ transcription factor targets
6196,PAX4_02,c3.TFT_ transcription factor targets
6197,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
6198,GO_POSITIVE_REGULATION_OF_BEHAVIOR,c5.BP_ GO biological process
6199,GO_LIPASE_ACTIVITY,c5.GO molecular function
6200,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_DN,C7_ immunologic signatures
6201,MODULE_147,c4.CM_ cancer modules
6202,MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,c2.CGP_ chemical and genetic perturbations
6203,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,C7_ immunologic signatures
6204,SHI_SPARC_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6205,GSE39556_CD8A_DC_VS_NK_CELL_DN,C7_ immunologic signatures
6206,GO_POSITIVE_REGULATION_OF_NEURON_DEATH,c5.BP_ GO biological process
6207,MODULE_195,c4.CM_ cancer modules
6208,KRAS.600.LUNG.BREAST_UP.V1_UP,C6_ oncogenic signatures
6209,GSE45365_CD8A_DC_VS_CD11B_DC_UP,C7_ immunologic signatures
6210,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_DN,C7_ immunologic signatures
6211,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP,C7_ immunologic signatures
6212,GO_REGULATION_OF_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
6213,BIOCARTA_ARF_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
6214,RAMALHO_STEMNESS_DN,c2.CGP_ chemical and genetic perturbations
6215,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP,C7_ immunologic signatures
6216,DASU_IL6_SIGNALING_SCAR_DN,c2.CGP_ chemical and genetic perturbations
6217,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN,C7_ immunologic signatures
6218,FOSTER_KDM1A_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
6219,GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_UP,C7_ immunologic signatures
6220,GO_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
6221,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP,C7_ immunologic signatures
6222,SMITH_TERT_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
6223,GSE27786_CD4_TCELL_VS_NKTCELL_UP,C7_ immunologic signatures
6224,GO_REGULATION_OF_HORMONE_LEVELS,c5.BP_ GO biological process
6225,GO_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
6226,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,C7_ immunologic signatures
6227,TTCYNRGAA_STAT5B_01,c3.TFT_ transcription factor targets
6228,GNF2_AF1Q,c4.CGN_ cancer gene neighborhoods
6229,GO_NEGATIVE_REGULATION_OF_TRANSPORT,c5.BP_ GO biological process
6230,GO_ERROR_PRONE_TRANSLESION_SYNTHESIS,c5.BP_ GO biological process
6231,GO_POSITIVE_REGULATION_OF_VASODILATION,c5.BP_ GO biological process
6232,GSE17721_CTRL_VS_LPS_8H_BMDC_DN,C7_ immunologic signatures
6233,GRATIAS_RETINOBLASTOMA_16Q24,c2.CGP_ chemical and genetic perturbations
6234,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN,C7_ immunologic signatures
6235,JI_RESPONSE_TO_FSH_UP,c2.CGP_ chemical and genetic perturbations
6236,GSE16266_CTRL_VS_LPS_STIM_MEF_UP,C7_ immunologic signatures
6237,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN,C7_ immunologic signatures
6238,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,C7_ immunologic signatures
6239,LI_LUNG_CANCER,c2.CGP_ chemical and genetic perturbations
6240,RUAN_RESPONSE_TO_TNF_DN,c2.CGP_ chemical and genetic perturbations
6241,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,c2.CGP_ chemical and genetic perturbations
6242,BIOCARTA_P53HYPOXIA_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
6243,TSENG_ADIPOGENIC_POTENTIAL_UP,c2.CGP_ chemical and genetic perturbations
6244,GO_RECEPTOR_COMPLEX,c5.CC_ GO cellular component
6245,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_UP,C7_ immunologic signatures
6246,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,C7_ immunologic signatures
6247,GO_MULTICELLULAR_ORGANISMAL_MOVEMENT,c5.BP_ GO biological process
6248,GO_NEGATIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,c5.BP_ GO biological process
6249,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
6250,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,C7_ immunologic signatures
6251,MURATA_VIRULENCE_OF_H_PILORI,c2.CGP_ chemical and genetic perturbations
6252,GSE3982_EOSINOPHIL_VS_DC_UP,C7_ immunologic signatures
6253,GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN,C7_ immunologic signatures
6254,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP,C7_ immunologic signatures
6255,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
6256,GSE45365_NK_CELL_VS_CD8A_DC_DN,C7_ immunologic signatures
6257,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,C7_ immunologic signatures
6258,GSE4142_NAIVE_VS_MEMORY_BCELL_DN,C7_ immunologic signatures
6259,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN,C7_ immunologic signatures
6260,GO_MICROTUBULE_BUNDLE_FORMATION,c5.BP_ GO biological process
6261,ATGCACG_MIR517B,c3.MIR_ microRNA targets
6262,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_UP,C7_ immunologic signatures
6263,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP,C7_ immunologic signatures
6264,GO_NEGATIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
6265,GO_COSTAMERE,c5.CC_ GO cellular component
6266,GO_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX,c5.CC_ GO cellular component
6267,GSE17721_CTRL_VS_LPS_6H_BMDC_DN,C7_ immunologic signatures
6268,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN,C7_ immunologic signatures
6269,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,c2.CGP_ chemical and genetic perturbations
6270,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
6271,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP,C7_ immunologic signatures
6272,REACTOME_CA_DEPENDENT_EVENTS,c2.CP_REACTOME_ Reactome gene sets
6273,GO_CHROMOSOME_TELOMERIC_REGION,c5.CC_ GO cellular component
6274,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN,C7_ immunologic signatures
6275,GO_IMMUNOGLOBULIN_PRODUCTION_INVOLVED_IN_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE,c5.BP_ GO biological process
6276,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN,C7_ immunologic signatures
6277,GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN,C7_ immunologic signatures
6278,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2,c2.CGP_ chemical and genetic perturbations
6279,GO_REGULATION_OF_SMAD_PROTEIN_IMPORT_INTO_NUCLEUS,c5.BP_ GO biological process
6280,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,c2.CGP_ chemical and genetic perturbations
6281,GO_CHONDROITIN_SULFATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
6282,MODULE_533,c4.CM_ cancer modules
6283,GSE3982_EOSINOPHIL_VS_TH1_UP,C7_ immunologic signatures
6284,GGTGAAG_MIR412,c3.MIR_ microRNA targets
6285,GSE42724_MEMORY_VS_B1_BCELL_UP,C7_ immunologic signatures
6286,TGCTTTG_MIR330,c3.MIR_ microRNA targets
6287,GO_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY,c5.GO molecular function
6288,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
6289,GO_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,c5.BP_ GO biological process
6290,GO_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,c5.BP_ GO biological process
6291,GO_REGULATION_OF_BODY_FLUID_LEVELS,c5.BP_ GO biological process
6292,OSMAN_BLADDER_CANCER_UP,c2.CGP_ chemical and genetic perturbations
6293,GO_NEGATIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
6294,GO_NUCLEOTIDE_EXCISION_REPAIR_DNA_GAP_FILLING,c5.BP_ GO biological process
6295,SUNG_METASTASIS_STROMA_UP,c2.CGP_ chemical and genetic perturbations
6296,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_DN,C7_ immunologic signatures
6297,GO_REGULATION_OF_CIRCADIAN_RHYTHM,c5.BP_ GO biological process
6298,GO_CALCIUM_ION_REGULATED_EXOCYTOSIS_OF_NEUROTRANSMITTER,c5.BP_ GO biological process
6299,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,c2.CGP_ chemical and genetic perturbations
6300,GO_PLASMA_MEMBRANE_RAFT,c5.CC_ GO cellular component
6301,MODULE_188,c4.CM_ cancer modules
6302,GO_POSITIVE_REGULATION_OF_CELL_ADHESION,c5.BP_ GO biological process
6303,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN,C7_ immunologic signatures
6304,GSE29618_BCELL_VS_MDC_UP,C7_ immunologic signatures
6305,GO_REGULATION_OF_VASODILATION,c5.BP_ GO biological process
6306,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,c2.CGP_ chemical and genetic perturbations
6307,BIOCARTA_STATHMIN_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
6308,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP,C7_ immunologic signatures
6309,GO_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,c5.BP_ GO biological process
6310,MORF_ESPL1,c4.CGN_ cancer gene neighborhoods
6311,GAGCTGG_MIR337,c3.MIR_ microRNA targets
6312,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,c2.CGP_ chemical and genetic perturbations
6313,GO_POSITIVE_REGULATION_OF_AUTOPHAGY,c5.BP_ GO biological process
6314,GO_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_PROTEASE_ACTIVITY,c5.GO molecular function
6315,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP,C7_ immunologic signatures
6316,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
6317,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP,C7_ immunologic signatures
6318,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,c2.CGP_ chemical and genetic perturbations
6319,GO_B_CELL_ACTIVATION,c5.BP_ GO biological process
6320,GO_NUCLEAR_MATRIX,c5.CC_ GO cellular component
6321,BRCA1_DN.V1_DN,C6_ oncogenic signatures
6322,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,c2.CGP_ chemical and genetic perturbations
6323,GO_HORMONE_METABOLIC_PROCESS,c5.BP_ GO biological process
6324,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,C7_ immunologic signatures
6325,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,C7_ immunologic signatures
6326,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_UP,C7_ immunologic signatures
6327,GO_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,c5.GO molecular function
6328,GO_INTRACELLULAR_CALCIUM_ACTIVATED_CHLORIDE_CHANNEL_ACTIVITY,c5.GO molecular function
6329,CEBP_Q2_01,c3.TFT_ transcription factor targets
6330,GO_MOTOR_NEURON_AXON_GUIDANCE,c5.BP_ GO biological process
6331,BURTON_ADIPOGENESIS_1,c2.CGP_ chemical and genetic perturbations
6332,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,C7_ immunologic signatures
6333,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP,C7_ immunologic signatures
6334,GSE6259_33D1_POS_DC_VS_CD8_TCELL_DN,C7_ immunologic signatures
6335,GO_INNERVATION,c5.BP_ GO biological process
6336,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_DN,C7_ immunologic signatures
6337,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,c2.CGP_ chemical and genetic perturbations
6338,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_UP,C7_ immunologic signatures
6339,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_UP,C7_ immunologic signatures
6340,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,C7_ immunologic signatures
6341,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_DN,C7_ immunologic signatures
6342,GO_EMBRYO_IMPLANTATION,c5.BP_ GO biological process
6343,GO_REGULATION_OF_ORGANIC_ACID_TRANSPORT,c5.BP_ GO biological process
6344,REACTOME_AXON_GUIDANCE,c2.CP_REACTOME_ Reactome gene sets
6345,GGAMTNNNNNTCCY_UNKNOWN,c3.TFT_ transcription factor targets
6346,GSE19512_NAUTRAL_VS_INDUCED_TREG_UP,C7_ immunologic signatures
6347,GO_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE,c5.BP_ GO biological process
6348,MANTOVANI_VIRAL_GPCR_SIGNALING_UP,c2.CGP_ chemical and genetic perturbations
6349,GO_PROTEASE_BINDING,c5.GO molecular function
6350,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
6351,MODULE_255,c4.CM_ cancer modules
6352,GNF2_CD53,c4.CGN_ cancer gene neighborhoods
6353,GO_PEPTIDASE_ACTIVITY,c5.GO molecular function
6354,CTTTGTA_MIR524,c3.MIR_ microRNA targets
6355,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_DN,C7_ immunologic signatures
6356,KIM_ALL_DISORDERS_CALB1_CORR_DN,c2.CGP_ chemical and genetic perturbations
6357,GO_NEGATIVE_REGULATION_OF_HORMONE_SECRETION,c5.BP_ GO biological process
6358,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,C7_ immunologic signatures
6359,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_DN,C7_ immunologic signatures
6360,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP,C7_ immunologic signatures
6361,GO_REGULATION_OF_NUCLEOSIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
6362,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,C7_ immunologic signatures
6363,MORF_PTPRB,c4.CGN_ cancer gene neighborhoods
6364,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,C7_ immunologic signatures
6365,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,C7_ immunologic signatures
6366,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN,C7_ immunologic signatures
6367,GO_INTERCELLULAR_BRIDGE,c5.CC_ GO cellular component
6368,HAHTOLA_SEZARY_SYNDROM_UP,c2.CGP_ chemical and genetic perturbations
6369,GSE27859_MACROPHAGE_VS_DC_UP,C7_ immunologic signatures
6370,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,c2.CGP_ chemical and genetic perturbations
6371,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP,C7_ immunologic signatures
6372,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
6373,GSE14350_IL2RB_KO_VS_WT_TREG_UP,C7_ immunologic signatures
6374,AMUNDSON_GENOTOXIC_SIGNATURE,c2.CGP_ chemical and genetic perturbations
6375,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP,C7_ immunologic signatures
6376,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP,C7_ immunologic signatures
6377,GO_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
6378,GO_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
6379,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_DN,C7_ immunologic signatures
6380,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN,c2.CGP_ chemical and genetic perturbations
6381,PAX_Q6,c3.TFT_ transcription factor targets
6382,HIF1_Q3,c3.TFT_ transcription factor targets
6383,LIM_MAMMARY_LUMINAL_PROGENITOR_UP,c2.CGP_ chemical and genetic perturbations
6384,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN,C7_ immunologic signatures
6385,GRESHOCK_CANCER_COPY_NUMBER_UP,c2.CGP_ chemical and genetic perturbations
6386,CACTGTG_MIR128A_MIR128B,c3.MIR_ microRNA targets
6387,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN,C7_ immunologic signatures
6388,YIH_RESPONSE_TO_ARSENITE_C1,c2.CGP_ chemical and genetic perturbations
6389,GO_REGULATION_OF_CELL_PROJECTION_ASSEMBLY,c5.BP_ GO biological process
6390,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,C7_ immunologic signatures
6391,GO_CELL_VOLUME_HOMEOSTASIS,c5.BP_ GO biological process
6392,GO_CHOLESTEROL_EFFLUX,c5.BP_ GO biological process
6393,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,C7_ immunologic signatures
6394,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,c2.CGP_ chemical and genetic perturbations
6395,GO_CELLULAR_RESPONSE_TO_PEPTIDE,c5.BP_ GO biological process
6396,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
6397,GO_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,c5.BP_ GO biological process
6398,GTTAAAG_MIR302B,c3.MIR_ microRNA targets
6399,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP,C7_ immunologic signatures
6400,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN,C7_ immunologic signatures
6401,GO_B_CELL_DIFFERENTIATION,c5.BP_ GO biological process
6402,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN,C7_ immunologic signatures
6403,GSE3565_DUSP1_VS_WT_SPLENOCYTES_UP,C7_ immunologic signatures
6404,MODULE_69,c4.CM_ cancer modules
6405,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_DN,C7_ immunologic signatures
6406,GSE9037_WT_VS_IRAK4_KO_BMDM_DN,C7_ immunologic signatures
6407,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,C7_ immunologic signatures
6408,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,c2.CGP_ chemical and genetic perturbations
6409,CRX_DN.V1_UP,C6_ oncogenic signatures
6410,OSADA_ASCL1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
6411,GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP,C7_ immunologic signatures
6412,VDR_Q6,c3.TFT_ transcription factor targets
6413,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP,c2.CGP_ chemical and genetic perturbations
6414,GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
6415,GO_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY,c5.BP_ GO biological process
6416,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP,C7_ immunologic signatures
6417,GO_REPLISOME,c5.CC_ GO cellular component
6418,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
6419,PETROVA_PROX1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
6420,GO_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
6421,SMTTTTGT_UNKNOWN,c3.TFT_ transcription factor targets
6422,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_UP,C7_ immunologic signatures
6423,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN,C7_ immunologic signatures
6424,GSE4142_NAIVE_VS_GC_BCELL_UP,C7_ immunologic signatures
6425,LU_AGING_BRAIN_DN,c2.CGP_ chemical and genetic perturbations
6426,GSE3982_BASOPHIL_VS_NKCELL_UP,C7_ immunologic signatures
6427,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_UP,C7_ immunologic signatures
6428,GO_REPRODUCTIVE_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
6429,GSE17721_CTRL_VS_CPG_24H_BMDC_DN,C7_ immunologic signatures
6430,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_UP,C7_ immunologic signatures
6431,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,C7_ immunologic signatures
6432,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN,C7_ immunologic signatures
6433,GO_GLIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
6434,RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,c2.CGP_ chemical and genetic perturbations
6435,BIOCARTA_CREB_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
6436,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP,C7_ immunologic signatures
6437,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,C7_ immunologic signatures
6438,REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,c2.CP_REACTOME_ Reactome gene sets
6439,TGAYRTCA_ATF3_Q6,c3.TFT_ transcription factor targets
6440,ROPERO_HDAC2_TARGETS,c2.CGP_ chemical and genetic perturbations
6441,GSE17721_LPS_VS_CPG_6H_BMDC_UP,C7_ immunologic signatures
6442,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,C7_ immunologic signatures
6443,PID_FCER1_PATHWAY,c2.CP_ Canonical pathways
6444,GO_TRANSCRIPTIONALLY_ACTIVE_CHROMATIN,c5.CC_ GO cellular component
6445,GO_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
6446,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
6447,GO_PERIPHERAL_NERVOUS_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
6448,CREB_Q2,c3.TFT_ transcription factor targets
6449,GO_OLIGOSACCHARIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
6450,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN,c2.CGP_ chemical and genetic perturbations
6451,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,C7_ immunologic signatures
6452,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,C7_ immunologic signatures
6453,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
6454,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP,C7_ immunologic signatures
6455,GO_STEROID_HORMONE_RECEPTOR_ACTIVITY,c5.GO molecular function
6456,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,c2.CGP_ chemical and genetic perturbations
6457,BIOCARTA_RACCYCD_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
6458,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,c2.CGP_ chemical and genetic perturbations
6459,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP,C7_ immunologic signatures
6460,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,c2.CGP_ chemical and genetic perturbations
6461,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,C7_ immunologic signatures
6462,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,c2.CGP_ chemical and genetic perturbations
6463,ATF_B,c3.TFT_ transcription factor targets
6464,GO_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING,c5.BP_ GO biological process
6465,GNF2_MYL3,c4.CGN_ cancer gene neighborhoods
6466,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_DN,C7_ immunologic signatures
6467,GO_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,c5.BP_ GO biological process
6468,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,C7_ immunologic signatures
6469,GO_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,c5.BP_ GO biological process
6470,GO_LONG_TERM_SYNAPTIC_POTENTIATION,c5.BP_ GO biological process
6471,CHIBA_RESPONSE_TO_TSA_DN,c2.CGP_ chemical and genetic perturbations
6472,GO_AMINO_SUGAR_METABOLIC_PROCESS,c5.BP_ GO biological process
6473,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN,C7_ immunologic signatures
6474,REACTOME_CELL_CELL_COMMUNICATION,c2.CP_REACTOME_ Reactome gene sets
6475,BROWNE_HCMV_INFECTION_20HR_UP,c2.CGP_ chemical and genetic perturbations
6476,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN,C7_ immunologic signatures
6477,GO_ALPHA_TUBULIN_BINDING,c5.GO molecular function
6478,GRUETZMANN_PANCREATIC_CANCER_DN,c2.CGP_ chemical and genetic perturbations
6479,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,c2.CGP_ chemical and genetic perturbations
6480,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_UP,C7_ immunologic signatures
6481,KHETCHOUMIAN_TRIM24_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6482,CAGCCTC_MIR4855P,c3.MIR_ microRNA targets
6483,GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,c2.CGP_ chemical and genetic perturbations
6484,GO_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS,c5.BP_ GO biological process
6485,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN,C7_ immunologic signatures
6486,ZWANG_EGF_INTERVAL_DN,c2.CGP_ chemical and genetic perturbations
6487,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,c2.CGP_ chemical and genetic perturbations
6488,CDP_01,c3.TFT_ transcription factor targets
6489,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP,C7_ immunologic signatures
6490,GO_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ER,c5.BP_ GO biological process
6491,GO_EXPLORATION_BEHAVIOR,c5.BP_ GO biological process
6492,GO_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
6493,GO_POSITIVE_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION,c5.BP_ GO biological process
6494,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN,C7_ immunologic signatures
6495,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
6496,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN,C7_ immunologic signatures
6497,MODULE_121,c4.CM_ cancer modules
6498,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN,C7_ immunologic signatures
6499,REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D,c2.CP_REACTOME_ Reactome gene sets
6500,PID_EPHRINB_REV_PATHWAY,c2.CP_ Canonical pathways
6501,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_UP,C7_ immunologic signatures
6502,LU_TUMOR_ANGIOGENESIS_UP,c2.CGP_ chemical and genetic perturbations
6503,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,C7_ immunologic signatures
6504,GO_NEGATIVE_REGULATION_OF_NEURON_DEATH,c5.BP_ GO biological process
6505,HALLMARK_KRAS_SIGNALING_UP,H_ hallmark gene sets
6506,GO_ERYTHROCYTE_HOMEOSTASIS,c5.BP_ GO biological process
6507,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN,C7_ immunologic signatures
6508,GO_PEPTIDYL_LYSINE_METHYLATION,c5.BP_ GO biological process
6509,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_UP,C7_ immunologic signatures
6510,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,C7_ immunologic signatures
6511,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP,C7_ immunologic signatures
6512,GO_MORPHOGENESIS_OF_AN_EPITHELIAL_SHEET,c5.BP_ GO biological process
6513,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN,C7_ immunologic signatures
6514,GO_HEMOSTASIS,c5.BP_ GO biological process
6515,KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,c2.CP_BIOCARTA_ BioCarta gene sets
6516,GO_RECEPTOR_ACTIVATOR_ACTIVITY,c5.GO molecular function
6517,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,C7_ immunologic signatures
6518,MORF_IL9,c4.CGN_ cancer gene neighborhoods
6519,GO_REGULATION_OF_BINDING,c5.BP_ GO biological process
6520,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,C7_ immunologic signatures
6521,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,C7_ immunologic signatures
6522,GSE13229_IMM_VS_INTMATURE_NKCELL_DN,C7_ immunologic signatures
6523,GO_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,c5.BP_ GO biological process
6524,GO_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,c5.BP_ GO biological process
6525,GO_SPLEEN_DEVELOPMENT,c5.BP_ GO biological process
6526,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,C7_ immunologic signatures
6527,MODULE_37,c4.CM_ cancer modules
6528,GSE11057_PBMC_VS_MEM_CD4_TCELL_UP,C7_ immunologic signatures
6529,KONDO_PROSTATE_CANCER_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
6530,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,C7_ immunologic signatures
6531,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,C7_ immunologic signatures
6532,MORF_JAK3,c4.CGN_ cancer gene neighborhoods
6533,GO_CELLULAR_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,c5.BP_ GO biological process
6534,GO_REGULATION_OF_PROTEIN_POLYMERIZATION,c5.BP_ GO biological process
6535,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,C7_ immunologic signatures
6536,GO_DICARBOXYLIC_ACID_TRANSPORT,c5.BP_ GO biological process
6537,CUI_GLUCOSE_DEPRIVATION,c2.CGP_ chemical and genetic perturbations
6538,REACTOME_REGULATION_OF_IFNA_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
6539,PID_ER_NONGENOMIC_PATHWAY,c2.CP_ Canonical pathways
6540,GO_REGULATION_OF_ENDOCRINE_PROCESS,c5.BP_ GO biological process
6541,GCM_CALM1,c4.CGN_ cancer gene neighborhoods
6542,GO_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS,c5.BP_ GO biological process
6543,GO_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
6544,EHLERS_ANEUPLOIDY_UP,c2.CGP_ chemical and genetic perturbations
6545,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,C7_ immunologic signatures
6546,MORF_RAP1A,c4.CGN_ cancer gene neighborhoods
6547,GO_EMBRYONIC_AXIS_SPECIFICATION,c5.BP_ GO biological process
6548,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP,C7_ immunologic signatures
6549,GO_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,c5.BP_ GO biological process
6550,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP,C7_ immunologic signatures
6551,MORI_MATURE_B_LYMPHOCYTE_UP,c2.CGP_ chemical and genetic perturbations
6552,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,c2.CGP_ chemical and genetic perturbations
6553,STREICHER_LSM1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6554,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,C7_ immunologic signatures
6555,WIERENGA_STAT5A_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6556,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN,C7_ immunologic signatures
6557,IPF1_Q4,c3.TFT_ transcription factor targets
6558,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_UP,C7_ immunologic signatures
6559,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP,C7_ immunologic signatures
6560,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN,C7_ immunologic signatures
6561,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
6562,REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
6563,REACTOME_PI3K_AKT_ACTIVATION,c2.CP_REACTOME_ Reactome gene sets
6564,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN,C7_ immunologic signatures
6565,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,C7_ immunologic signatures
6566,REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE,c2.CP_REACTOME_ Reactome gene sets
6567,CAGNWMCNNNGAC_UNKNOWN,c3.TFT_ transcription factor targets
6568,AACTGGA_MIR145,c3.MIR_ microRNA targets
6569,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_UP,C7_ immunologic signatures
6570,GO_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,c5.BP_ GO biological process
6571,BROWNE_HCMV_INFECTION_1HR_DN,c2.CGP_ chemical and genetic perturbations
6572,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
6573,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN,C7_ immunologic signatures
6574,PID_DNA_PK_PATHWAY,c2.CP_ Canonical pathways
6575,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,c2.CGP_ chemical and genetic perturbations
6576,GO_RESPONSE_TO_GAMMA_RADIATION,c5.BP_ GO biological process
6577,GO_REGULATION_OF_LYASE_ACTIVITY,c5.BP_ GO biological process
6578,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP,C7_ immunologic signatures
6579,GO_HYALURONIC_ACID_BINDING,c5.GO molecular function
6580,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP,C7_ immunologic signatures
6581,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_UP,C7_ immunologic signatures
6582,MODULE_453,c4.CM_ cancer modules
6583,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_UP,C7_ immunologic signatures
6584,CTCAGGG_MIR125B_MIR125A,c3.MIR_ microRNA targets
6585,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP,C7_ immunologic signatures
6586,GO_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL,c5.BP_ GO biological process
6587,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,C7_ immunologic signatures
6588,GO_CELL_LEADING_EDGE,c5.CC_ GO cellular component
6589,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP,C7_ immunologic signatures
6590,ATCATGA_MIR433,c3.MIR_ microRNA targets
6591,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN,c2.CGP_ chemical and genetic perturbations
6592,GSE17721_CTRL_VS_CPG_24H_BMDC_UP,C7_ immunologic signatures
6593,PID_HEDGEHOG_2PATHWAY,c2.CP_ Canonical pathways
6594,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_UP,C7_ immunologic signatures
6595,TBP_01,c3.TFT_ transcription factor targets
6596,GSE3982_EOSINOPHIL_VS_NKCELL_UP,C7_ immunologic signatures
6597,GO_ACTIVATION_OF_MAPK_ACTIVITY,c5.BP_ GO biological process
6598,ACTGCAG_MIR173P,c3.MIR_ microRNA targets
6599,MORF_PTPRR,c4.CGN_ cancer gene neighborhoods
6600,PID_BETA_CATENIN_NUC_PATHWAY,c2.CP_ Canonical pathways
6601,GSE24210_IL35_TREATED_VS_RESTING_TREG_UP,C7_ immunologic signatures
6602,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,C7_ immunologic signatures
6603,GO_RESPONSE_TO_XENOBIOTIC_STIMULUS,c5.BP_ GO biological process
6604,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_UP,C7_ immunologic signatures
6605,GSE557_WT_VS_CIITA_KO_DC_DN,C7_ immunologic signatures
6606,REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,c2.CP_REACTOME_ Reactome gene sets
6607,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN,C7_ immunologic signatures
6608,GO_NEURON_MIGRATION,c5.BP_ GO biological process
6609,REACTOME_SIGNALING_BY_EGFR_IN_CANCER,c2.CP_REACTOME_ Reactome gene sets
6610,GNF2_FOS,c4.CGN_ cancer gene neighborhoods
6611,GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP,C7_ immunologic signatures
6612,GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN,C7_ immunologic signatures
6613,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP,C7_ immunologic signatures
6614,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,C7_ immunologic signatures
6615,RIZKI_TUMOR_INVASIVENESS_3D_DN,c2.CGP_ chemical and genetic perturbations
6616,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_DN,C7_ immunologic signatures
6617,GO_NEURON_APOPTOTIC_PROCESS,c5.BP_ GO biological process
6618,GO_CEREBELLAR_CORTEX_FORMATION,c5.BP_ GO biological process
6619,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,C7_ immunologic signatures
6620,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_DN,C7_ immunologic signatures
6621,GO_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,c5.BP_ GO biological process
6622,GO_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,c5.BP_ GO biological process
6623,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN,C7_ immunologic signatures
6624,RORA1_01,c3.TFT_ transcription factor targets
6625,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN,C7_ immunologic signatures
6626,GO_CARGO_RECEPTOR_ACTIVITY,c5.GO molecular function
6627,GO_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY,c5.BP_ GO biological process
6628,GRABARCZYK_BCL11B_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
6629,YAGI_AML_FAB_MARKERS,c2.CGP_ chemical and genetic perturbations
6630,GO_REGULATION_OF_MEMBRANE_DEPOLARIZATION,c5.BP_ GO biological process
6631,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_UP,C7_ immunologic signatures
6632,LU_TUMOR_VASCULATURE_UP,c2.CGP_ chemical and genetic perturbations
6633,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
6634,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4,c2.CGP_ chemical and genetic perturbations
6635,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN,C7_ immunologic signatures
6636,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN,C7_ immunologic signatures
6637,CRX_Q4,c3.TFT_ transcription factor targets
6638,GO_POSITIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,c5.BP_ GO biological process
6639,GCM_RAP2A,c4.CGN_ cancer gene neighborhoods
6640,CHR4Q21,65
6641,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_UP,C7_ immunologic signatures
6642,GO_CELL_RECOGNITION,c5.BP_ GO biological process
6643,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN,C7_ immunologic signatures
6644,VERHAAK_GLIOBLASTOMA_CLASSICAL,c2.CGP_ chemical and genetic perturbations
6645,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP,C7_ immunologic signatures
6646,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP,C7_ immunologic signatures
6647,AMIT_EGF_RESPONSE_480_HELA,c2.CGP_ chemical and genetic perturbations
6648,GSE42021_TREG_VS_TCONV_PLN_DN,C7_ immunologic signatures
6649,GO_PLATELET_DENSE_GRANULE,c5.CC_ GO cellular component
6650,GO_REACTIVE_NITROGEN_SPECIES_METABOLIC_PROCESS,c5.BP_ GO biological process
6651,GO_PREASSEMBLY_OF_GPI_ANCHOR_IN_ER_MEMBRANE,c5.BP_ GO biological process
6652,ONO_AML1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6653,GO_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
6654,GO_NODE_OF_RANVIER,c5.CC_ GO cellular component
6655,GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN,C7_ immunologic signatures
6656,GO_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY,c5.BP_ GO biological process
6657,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
6658,GCAAGGA_MIR502,c3.MIR_ microRNA targets
6659,GO_CIRCADIAN_REGULATION_OF_GENE_EXPRESSION,c5.BP_ GO biological process
6660,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP,C7_ immunologic signatures
6661,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN,C7_ immunologic signatures
6662,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_UP,C7_ immunologic signatures
6663,GO_NEGATIVE_REGULATION_OF_CYTOPLASMIC_TRANSPORT,c5.BP_ GO biological process
6664,GO_REGULATION_OF_PROTEIN_BINDING,c5.BP_ GO biological process
6665,GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN,C7_ immunologic signatures
6666,GO_CELLULAR_COMPONENT_MAINTENANCE,c5.BP_ GO biological process
6667,NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON,c2.CGP_ chemical and genetic perturbations
6668,GSE12366_NAIVE_VS_MEMORY_BCELL_UP,C7_ immunologic signatures
6669,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN,C7_ immunologic signatures
6670,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_UP,C7_ immunologic signatures
6671,PR_01,c3.TFT_ transcription factor targets
6672,GO_SECRETORY_GRANULE_MEMBRANE,c5.CC_ GO cellular component
6673,BROWNE_HCMV_INFECTION_18HR_DN,c2.CGP_ chemical and genetic perturbations
6674,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP,C7_ immunologic signatures
6675,MORF_JAG1,c4.CGN_ cancer gene neighborhoods
6676,REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT,c2.CP_REACTOME_ Reactome gene sets
6677,HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2,c2.CGP_ chemical and genetic perturbations
6678,AR_03,c3.TFT_ transcription factor targets
6679,GO_MICROVILLUS_ORGANIZATION,c5.BP_ GO biological process
6680,CAGCAGG_MIR370,c3.MIR_ microRNA targets
6681,GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP,C7_ immunologic signatures
6682,YTTCCNNNGGAMR_UNKNOWN,c3.TFT_ transcription factor targets
6683,GO_NEUROBLAST_PROLIFERATION,c5.BP_ GO biological process
6684,GO_NEURON_PROJECTION_MEMBRANE,c5.CC_ GO cellular component
6685,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,c2.CGP_ chemical and genetic perturbations
6686,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
6687,GSE14308_TH2_VS_TH1_DN,C7_ immunologic signatures
6688,TERAMOTO_OPN_TARGETS_CLUSTER_6,c2.CGP_ chemical and genetic perturbations
6689,GSE29618_MONOCYTE_VS_PDC_UP,C7_ immunologic signatures
6690,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN,c2.CGP_ chemical and genetic perturbations
6691,KTGGYRSGAA_UNKNOWN,c3.TFT_ transcription factor targets
6692,GO_ERROR_FREE_TRANSLESION_SYNTHESIS,c5.BP_ GO biological process
6693,PID_SYNDECAN_4_PATHWAY,c2.CP_ Canonical pathways
6694,PRAMOONJAGO_SOX4_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6695,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN,C7_ immunologic signatures
6696,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN,C7_ immunologic signatures
6697,GO_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,c5.BP_ GO biological process
6698,SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP,c2.CGP_ chemical and genetic perturbations
6699,CHR7Q21,64
6700,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN,C7_ immunologic signatures
6701,HAN_JNK_SINGALING_DN,c2.CGP_ chemical and genetic perturbations
6702,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,C7_ immunologic signatures
6703,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
6704,MORF_ESR1,c4.CGN_ cancer gene neighborhoods
6705,SRC_UP.V1_DN,C6_ oncogenic signatures
6706,MODULE_378,c4.CM_ cancer modules
6707,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP,C7_ immunologic signatures
6708,EGR2_01,c3.TFT_ transcription factor targets
6709,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP,C7_ immunologic signatures
6710,GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN,C7_ immunologic signatures
6711,GALE_APL_WITH_FLT3_MUTATED_UP,c2.CGP_ chemical and genetic perturbations
6712,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_UP,C7_ immunologic signatures
6713,GYORFFY_MITOXANTRONE_RESISTANCE,c2.CGP_ chemical and genetic perturbations
6714,GO_ENDOSOME_TO_LYSOSOME_TRANSPORT,c5.BP_ GO biological process
6715,SANSOM_APC_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6716,GO_PEPTIDYL_LYSINE_MODIFICATION,c5.BP_ GO biological process
6717,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
6718,GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN,C7_ immunologic signatures
6719,GGGGCCC_MIR296,c3.MIR_ microRNA targets
6720,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,c2.CGP_ chemical and genetic perturbations
6721,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP,C7_ immunologic signatures
6722,MODULE_7,c4.CM_ cancer modules
6723,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,C7_ immunologic signatures
6724,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP,C7_ immunologic signatures
6725,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN,C7_ immunologic signatures
6726,BASAKI_YBX1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
6727,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN,C7_ immunologic signatures
6728,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN,C7_ immunologic signatures
6729,AATGTGA_MIR23A_MIR23B,c3.MIR_ microRNA targets
6730,GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN,C7_ immunologic signatures
6731,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,C7_ immunologic signatures
6732,PID_GMCSF_PATHWAY,c2.CP_ Canonical pathways
6733,AP2_Q6_01,c3.TFT_ transcription factor targets
6734,GO_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST,c5.BP_ GO biological process
6735,CHR19P13,401
6736,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,C7_ immunologic signatures
6737,GO_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DEVELOPMENT,c5.BP_ GO biological process
6738,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP,C7_ immunologic signatures
6739,GO_N_ACYLTRANSFERASE_ACTIVITY,c5.GO molecular function
6740,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS,c2.CGP_ chemical and genetic perturbations
6741,GSE7460_TREG_VS_TCONV_ACT_DN,C7_ immunologic signatures
6742,GO_REGULATION_OF_CHOLESTEROL_EFFLUX,c5.BP_ GO biological process
6743,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP,C7_ immunologic signatures
6744,PID_FAS_PATHWAY,c2.CP_ Canonical pathways
6745,GSE27786_LIN_NEG_VS_NKCELL_DN,C7_ immunologic signatures
6746,TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,c2.CGP_ chemical and genetic perturbations
6747,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_UP,C7_ immunologic signatures
6748,WEI_MIR34A_TARGETS,c2.CGP_ chemical and genetic perturbations
6749,GO_MHC_PROTEIN_BINDING,c5.GO molecular function
6750,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP,C7_ immunologic signatures
6751,CEBPDELTA_Q6,c3.TFT_ transcription factor targets
6752,GSE14308_TH2_VS_TH1_UP,C7_ immunologic signatures
6753,CHR6Q16,20
6754,GO_KINESIN_BINDING,c5.GO molecular function
6755,GO_PROTEIN_DNA_COMPLEX_SUBUNIT_ORGANIZATION,c5.BP_ GO biological process
6756,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN,C7_ immunologic signatures
6757,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,C7_ immunologic signatures
6758,GO_TRANSPORTER_COMPLEX,c5.CC_ GO cellular component
6759,MURAKAMI_UV_RESPONSE_6HR_UP,c2.CGP_ chemical and genetic perturbations
6760,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN,C7_ immunologic signatures
6761,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP,C7_ immunologic signatures
6762,GSE14350_IL2RB_KO_VS_WT_TEFF_DN,C7_ immunologic signatures
6763,GSE20715_0H_VS_48H_OZONE_LUNG_UP,C7_ immunologic signatures
6764,GO_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,c5.BP_ GO biological process
6765,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN,C7_ immunologic signatures
6766,HNF4_Q6,c3.TFT_ transcription factor targets
6767,GO_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
6768,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN,C7_ immunologic signatures
6769,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN,C7_ immunologic signatures
6770,HALLMARK_UV_RESPONSE_UP,H_ hallmark gene sets
6771,GO_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
6772,LAIHO_COLORECTAL_CANCER_SERRATED_UP,c2.CGP_ chemical and genetic perturbations
6773,GO_REGULATION_OF_MICROTUBULE_POLYMERIZATION,c5.BP_ GO biological process
6774,GO_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,c5.BP_ GO biological process
6775,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
6776,MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED,c2.CGP_ chemical and genetic perturbations
6777,GO_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,c5.BP_ GO biological process
6778,GO_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,c5.BP_ GO biological process
6779,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN,C7_ immunologic signatures
6780,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_DN,C7_ immunologic signatures
6781,CATRRAGC_UNKNOWN,c3.TFT_ transcription factor targets
6782,GO_POSITIVE_REGULATION_OF_TELOMERE_CAPPING,c5.BP_ GO biological process
6783,CCAWNWWNNNGGC_UNKNOWN,c3.TFT_ transcription factor targets
6784,GO_DEVELOPMENTAL_PROGRAMMED_CELL_DEATH,c5.BP_ GO biological process
6785,GO_NEUROMUSCULAR_SYNAPTIC_TRANSMISSION,c5.BP_ GO biological process
6786,GO_REGULATION_OF_HOMEOSTATIC_PROCESS,c5.BP_ GO biological process
6787,GCM_PRKCG,c4.CGN_ cancer gene neighborhoods
6788,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP,C7_ immunologic signatures
6789,MODULE_317,c4.CM_ cancer modules
6790,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN,C7_ immunologic signatures
6791,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,C7_ immunologic signatures
6792,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,C7_ immunologic signatures
6793,TENEDINI_MEGAKARYOCYTE_MARKERS,c2.CGP_ chemical and genetic perturbations
6794,ZHAN_MULTIPLE_MYELOMA_UP,c2.CGP_ chemical and genetic perturbations
6795,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
6796,GO_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,c5.BP_ GO biological process
6797,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
6798,XU_GH1_EXOGENOUS_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6799,GSE42724_NAIVE_VS_B1_BCELL_UP,C7_ immunologic signatures
6800,SCHEIDEREIT_IKK_INTERACTING_PROTEINS,c2.CGP_ chemical and genetic perturbations
6801,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
6802,GNF2_HLA_C,c4.CGN_ cancer gene neighborhoods
6803,KIM_WT1_TARGETS_8HR_DN,c2.CGP_ chemical and genetic perturbations
6804,GO_NUCLEOPHAGY,c5.BP_ GO biological process
6805,PAL_PRMT5_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6806,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_DN,C7_ immunologic signatures
6807,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,C7_ immunologic signatures
6808,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN,C7_ immunologic signatures
6809,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP,C7_ immunologic signatures
6810,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,C7_ immunologic signatures
6811,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN,C7_ immunologic signatures
6812,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP,C7_ immunologic signatures
6813,GO_PHOSPHOPROTEIN_BINDING,c5.GO molecular function
6814,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
6815,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,C7_ immunologic signatures
6816,REACTOME_SIGNALING_BY_ERBB2,c2.CP_REACTOME_ Reactome gene sets
6817,CAHOY_ASTROCYTIC,C6_ oncogenic signatures
6818,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_DN,C7_ immunologic signatures
6819,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP,C7_ immunologic signatures
6820,GO_CYTOPLASMIC_MICROTUBULE_ORGANIZATION,c5.BP_ GO biological process
6821,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP,C7_ immunologic signatures
6822,CDC5_01,c3.TFT_ transcription factor targets
6823,PID_IFNG_PATHWAY,c2.CP_ Canonical pathways
6824,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
6825,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_DN,C7_ immunologic signatures
6826,CREBP1CJUN_01,c3.TFT_ transcription factor targets
6827,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN,C7_ immunologic signatures
6828,GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING,c5.GO molecular function
6829,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,C7_ immunologic signatures
6830,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP,C7_ immunologic signatures
6831,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
6832,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP,C7_ immunologic signatures
6833,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN,C7_ immunologic signatures
6834,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP,C7_ immunologic signatures
6835,GRADE_COLON_CANCER_DN,c2.CGP_ chemical and genetic perturbations
6836,GO_TRANSCRIPTION_FACTOR_ACTIVITY_DIRECT_LIGAND_REGULATED_SEQUENCE_SPECIFIC_DNA_BINDING,c5.GO molecular function
6837,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_UP,C7_ immunologic signatures
6838,GSE11057_CD4_CENT_MEM_VS_PBMC_DN,C7_ immunologic signatures
6839,OXFORD_RALA_OR_RALB_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
6840,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,C7_ immunologic signatures
6841,GSE27786_NKCELL_VS_NKTCELL_UP,C7_ immunologic signatures
6842,GO_METALLOCARBOXYPEPTIDASE_ACTIVITY,c5.GO molecular function
6843,REACTOME_G_PROTEIN_ACTIVATION,c2.CP_REACTOME_ Reactome gene sets
6844,GO_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,c5.BP_ GO biological process
6845,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN,C7_ immunologic signatures
6846,GSE30083_SP2_VS_SP4_THYMOCYTE_DN,C7_ immunologic signatures
6847,GO_PROTEIN_LIPID_COMPLEX_BINDING,c5.GO molecular function
6848,GO_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,c5.BP_ GO biological process
6849,GO_LIGAND_GATED_CHANNEL_ACTIVITY,c5.GO molecular function
6850,GO_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,c5.BP_ GO biological process
6851,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
6852,LIU_PROSTATE_CANCER_UP,c2.CGP_ chemical and genetic perturbations
6853,AAGCACT_MIR520F,c3.MIR_ microRNA targets
6854,CACTGCC_MIR34A_MIR34C_MIR449,c3.MIR_ microRNA targets
6855,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP,C7_ immunologic signatures
6856,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_DN,C7_ immunologic signatures
6857,GO_MACROPHAGE_ACTIVATION,c5.BP_ GO biological process
6858,GO_PROTEIN_DESTABILIZATION,c5.BP_ GO biological process
6859,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_UP,C7_ immunologic signatures
6860,DELPUECH_FOXO3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6861,GO_INDOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
6862,GO_POSITIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,c5.BP_ GO biological process
6863,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_UP,C7_ immunologic signatures
6864,LIN_NPAS4_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6865,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,C7_ immunologic signatures
6866,OCT1_Q6,c3.TFT_ transcription factor targets
6867,GO_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,c5.BP_ GO biological process
6868,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN,C7_ immunologic signatures
6869,SU_PANCREAS,c2.CGP_ chemical and genetic perturbations
6870,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_DN,C7_ immunologic signatures
6871,CSR_LATE_UP.V1_DN,C6_ oncogenic signatures
6872,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_DN,C7_ immunologic signatures
6873,GO_CHROMATIN_MODIFICATION,c5.BP_ GO biological process
6874,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,c2.CGP_ chemical and genetic perturbations
6875,GO_REGULATION_OF_HORMONE_SECRETION,c5.BP_ GO biological process
6876,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP,C7_ immunologic signatures
6877,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_UP,C7_ immunologic signatures
6878,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,C7_ immunologic signatures
6879,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
6880,GO_BASAL_PART_OF_CELL,c5.CC_ GO cellular component
6881,GO_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,c5.BP_ GO biological process
6882,GO_RESPONSE_TO_EXOGENOUS_DSRNA,c5.BP_ GO biological process
6883,GO_PROTEIN_HOMOTRIMERIZATION,c5.BP_ GO biological process
6884,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_DN,C7_ immunologic signatures
6885,MORF_ARAF1,c4.CGN_ cancer gene neighborhoods
6886,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,C7_ immunologic signatures
6887,GO_RESPONSE_TO_AMPHETAMINE,c5.BP_ GO biological process
6888,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP,c2.CGP_ chemical and genetic perturbations
6889,GO_THYMIC_T_CELL_SELECTION,c5.BP_ GO biological process
6890,GO_NEGATIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
6891,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP,C7_ immunologic signatures
6892,GO_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,c5.BP_ GO biological process
6893,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP,C7_ immunologic signatures
6894,GO_INNER_EAR_RECEPTOR_CELL_DEVELOPMENT,c5.BP_ GO biological process
6895,CEBPB_01,c3.TFT_ transcription factor targets
6896,AMIT_EGF_RESPONSE_40_MCF10A,c2.CGP_ chemical and genetic perturbations
6897,MYOD_Q6,c3.TFT_ transcription factor targets
6898,MODULE_497,c4.CM_ cancer modules
6899,FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,c2.CGP_ chemical and genetic perturbations
6900,TAGGTCA_MIR192_MIR215,c3.MIR_ microRNA targets
6901,GO_RESPONSE_TO_AUDITORY_STIMULUS,c5.BP_ GO biological process
6902,GO_BONE_CELL_DEVELOPMENT,c5.BP_ GO biological process
6903,SHEN_SMARCA2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
6904,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP,C7_ immunologic signatures
6905,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP,C7_ immunologic signatures
6906,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
6907,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP,C7_ immunologic signatures
6908,GSE22886_DC_VS_MONOCYTE_UP,C7_ immunologic signatures
6909,SA_TRKA_RECEPTOR,c2.CP_ Canonical pathways
6910,GO_POSITIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY,c5.BP_ GO biological process
6911,HSIAO_LIVER_SPECIFIC_GENES,c2.CGP_ chemical and genetic perturbations
6912,MODULE_134,c4.CM_ cancer modules
6913,GO_ESTABLISHMENT_OR_MAINTENANCE_OF_BIPOLAR_CELL_POLARITY,c5.BP_ GO biological process
6914,WENG_POR_DOSAGE,c2.CGP_ chemical and genetic perturbations
6915,CCTGAGT_MIR510,c3.MIR_ microRNA targets
6916,ZHAN_MULTIPLE_MYELOMA_HP_DN,c2.CGP_ chemical and genetic perturbations
6917,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,C7_ immunologic signatures
6918,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,C7_ immunologic signatures
6919,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP,C7_ immunologic signatures
6920,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP,C7_ immunologic signatures
6921,GENTILE_UV_RESPONSE_CLUSTER_D1,c2.CGP_ chemical and genetic perturbations
6922,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP,C7_ immunologic signatures
6923,GO_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
6924,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN,C7_ immunologic signatures
6925,GO_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
6926,REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
6927,GSE7509_DC_VS_MONOCYTE_DN,C7_ immunologic signatures
6928,GSE11057_CD4_EFF_MEM_VS_PBMC_UP,C7_ immunologic signatures
6929,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP,C7_ immunologic signatures
6930,GO_POLYOL_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
6931,GO_HORMONE_TRANSPORT,c5.BP_ GO biological process
6932,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP,C7_ immunologic signatures
6933,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,C7_ immunologic signatures
6934,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_UP,C7_ immunologic signatures
6935,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,C7_ immunologic signatures
6936,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
6937,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,C7_ immunologic signatures
6938,GO_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION,c5.BP_ GO biological process
6939,GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS,c5.BP_ GO biological process
6940,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
6941,GO_ORGANELLE_FUSION,c5.BP_ GO biological process
6942,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP,C7_ immunologic signatures
6943,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
6944,GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN,C7_ immunologic signatures
6945,CHR6P24,20
6946,GO_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II,c5.BP_ GO biological process
6947,MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,c2.CGP_ chemical and genetic perturbations
6948,GGCACAT_MIR455,c3.MIR_ microRNA targets
6949,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN,C7_ immunologic signatures
6950,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
6951,MYOGNF1_01,c3.TFT_ transcription factor targets
6952,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_UP,C7_ immunologic signatures
6953,REACTOME_NEURONAL_SYSTEM,c2.CP_REACTOME_ Reactome gene sets
6954,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN,C7_ immunologic signatures
6955,GO_CHANNEL_INHIBITOR_ACTIVITY,c5.GO molecular function
6956,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP,C7_ immunologic signatures
6957,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN,C7_ immunologic signatures
6958,GO_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING,c5.GO molecular function
6959,GO_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,c5.BP_ GO biological process
6960,GGGATGC_MIR3245P,c3.MIR_ microRNA targets
6961,GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN,C7_ immunologic signatures
6962,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_UP,C7_ immunologic signatures
6963,GSE3982_MAC_VS_BASOPHIL_DN,C7_ immunologic signatures
6964,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN,C7_ immunologic signatures
6965,ST_INTEGRIN_SIGNALING_PATHWAY,c2.CP_ Canonical pathways
6966,REACTOME_SIGNALING_BY_FGFR1_MUTANTS,c2.CP_REACTOME_ Reactome gene sets
6967,GSE20727_CTRL_VS_H2O2_TREATED_DC_UP,C7_ immunologic signatures
6968,ENK_UV_RESPONSE_EPIDERMIS_DN,c2.CGP_ chemical and genetic perturbations
6969,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP,C7_ immunologic signatures
6970,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
6971,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN,C7_ immunologic signatures
6972,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,C7_ immunologic signatures
6973,GO_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
6974,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,c2.CGP_ chemical and genetic perturbations
6975,GNF2_DDX5,c4.CGN_ cancer gene neighborhoods
6976,GO_REGULATION_OF_CILIUM_ASSEMBLY,c5.BP_ GO biological process
6977,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_UP,C7_ immunologic signatures
6978,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN,C7_ immunologic signatures
6979,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,c2.CGP_ chemical and genetic perturbations
6980,NIELSEN_GIST,c2.CGP_ chemical and genetic perturbations
6981,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN,C7_ immunologic signatures
6982,MORF_PML,c4.CGN_ cancer gene neighborhoods
6983,GCM_MAP1B,c4.CGN_ cancer gene neighborhoods
6984,GO_LYTIC_VACUOLE,c5.CC_ GO cellular component
6985,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN,C7_ immunologic signatures
6986,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
6987,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN,C7_ immunologic signatures
6988,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_UP,C7_ immunologic signatures
6989,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
6990,GSE22886_NAIVE_VS_MEMORY_TCELL_DN,C7_ immunologic signatures
6991,GO_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,c5.BP_ GO biological process
6992,ONDER_CDH1_TARGETS_3_DN,c2.CGP_ chemical and genetic perturbations
6993,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN,C7_ immunologic signatures
6994,GO_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY,c5.GO molecular function
6995,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP,C7_ immunologic signatures
6996,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
6997,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP,C7_ immunologic signatures
6998,REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,c2.CP_REACTOME_ Reactome gene sets
6999,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_DN,C7_ immunologic signatures
7000,GO_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
7001,E2F_Q2,c3.TFT_ transcription factor targets
7002,GSE14350_TREG_VS_TEFF_DN,C7_ immunologic signatures
7003,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_UP,C7_ immunologic signatures
7004,VERHAAK_AML_WITH_NPM1_MUTATED_UP,c2.CGP_ chemical and genetic perturbations
7005,GSE27786_BCELL_VS_NEUTROPHIL_DN,C7_ immunologic signatures
7006,GO_INSULIN_RECEPTOR_BINDING,c5.GO molecular function
7007,CHR1P34,133
7008,GO_BLASTOCYST_DEVELOPMENT,c5.BP_ GO biological process
7009,GCM_ZNF198,c4.CGN_ cancer gene neighborhoods
7010,WYAAANNRNNNGCG_UNKNOWN,c3.TFT_ transcription factor targets
7011,GO_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,c5.BP_ GO biological process
7012,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN,C7_ immunologic signatures
7013,ACATATC_MIR190,c3.MIR_ microRNA targets
7014,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,c2.CGP_ chemical and genetic perturbations
7015,CHICAS_RB1_TARGETS_LOW_SERUM,c2.CGP_ chemical and genetic perturbations
7016,BENPORATH_ES_2,c2.CGP_ chemical and genetic perturbations
7017,GSE27859_MACROPHAGE_VS_DC_DN,C7_ immunologic signatures
7018,GO_ANTIGEN_BINDING,c5.GO molecular function
7019,JIANG_HYPOXIA_CANCER,c2.CGP_ chemical and genetic perturbations
7020,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP,C7_ immunologic signatures
7021,MORF_CD8A,c4.CGN_ cancer gene neighborhoods
7022,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,C7_ immunologic signatures
7023,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN,C7_ immunologic signatures
7024,GSE40273_GATA1_KO_VS_WT_TREG_DN,C7_ immunologic signatures
7025,GCM_TINF2,c4.CGN_ cancer gene neighborhoods
7026,GSE14308_TH17_VS_NATURAL_TREG_DN,C7_ immunologic signatures
7027,GSE17721_LPS_VS_POLYIC_2H_BMDC_UP,C7_ immunologic signatures
7028,GO_METANEPHROS_MORPHOGENESIS,c5.BP_ GO biological process
7029,GSE557_WT_VS_CIITA_KO_DC_UP,C7_ immunologic signatures
7030,GO_MORPHOGENESIS_OF_A_POLARIZED_EPITHELIUM,c5.BP_ GO biological process
7031,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN,C7_ immunologic signatures
7032,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_UP,C7_ immunologic signatures
7033,GO_NUCLEAR_PERIPHERY,c5.CC_ GO cellular component
7034,GSE14308_INDUCED_VS_NATURAL_TREG_DN,C7_ immunologic signatures
7035,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN,C7_ immunologic signatures
7036,GO_ANION_CATION_SYMPORTER_ACTIVITY,c5.GO molecular function
7037,IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR,c2.CGP_ chemical and genetic perturbations
7038,GO_S_ACYLTRANSFERASE_ACTIVITY,c5.GO molecular function
7039,AAGTCCA_MIR422B_MIR422A,c3.MIR_ microRNA targets
7040,REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
7041,GO_EMBRYONIC_HEART_TUBE_DEVELOPMENT,c5.BP_ GO biological process
7042,GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP,C7_ immunologic signatures
7043,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_DN,C7_ immunologic signatures
7044,GSE3982_EOSINOPHIL_VS_BASOPHIL_UP,C7_ immunologic signatures
7045,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN,C7_ immunologic signatures
7046,NADLER_OBESITY_UP,c2.CGP_ chemical and genetic perturbations
7047,MODULE_332,c4.CM_ cancer modules
7048,PID_ALK1_PATHWAY,c2.CP_ Canonical pathways
7049,REACTOME_CELL_CYCLE_CHECKPOINTS,c2.CP_REACTOME_ Reactome gene sets
7050,HOEBEKE_LYMPHOID_STEM_CELL_UP,c2.CGP_ chemical and genetic perturbations
7051,GO_LAMELLIPODIUM,c5.CC_ GO cellular component
7052,GO_TRANSMISSION_OF_NERVE_IMPULSE,c5.BP_ GO biological process
7053,GO_CELLULAR_PIGMENTATION,c5.BP_ GO biological process
7054,GO_POSITIVE_REGULATION_OF_VASOCONSTRICTION,c5.BP_ GO biological process
7055,GO_POSITIVE_REGULATION_OF_CHEMOKINE_PRODUCTION,c5.BP_ GO biological process
7056,GO_BLOOD_COAGULATION_FIBRIN_CLOT_FORMATION,c5.BP_ GO biological process
7057,GSE17580_TREG_VS_TEFF_DN,C7_ immunologic signatures
7058,GSE3982_BCELL_VS_TH1_UP,C7_ immunologic signatures
7059,GO_GTPASE_BINDING,c5.GO molecular function
7060,GO_POLYOL_METABOLIC_PROCESS,c5.BP_ GO biological process
7061,BENPORATH_ES_1,c2.CGP_ chemical and genetic perturbations
7062,GO_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,c5.BP_ GO biological process
7063,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP,c2.CGP_ chemical and genetic perturbations
7064,GO_REGULATION_OF_LEUKOCYTE_MIGRATION,c5.BP_ GO biological process
7065,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP,C7_ immunologic signatures
7066,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN,C7_ immunologic signatures
7067,REACTOME_ARMS_MEDIATED_ACTIVATION,c2.CP_REACTOME_ Reactome gene sets
7068,BARRIER_COLON_CANCER_RECURRENCE_DN,c2.CGP_ chemical and genetic perturbations
7069,GSE11924_TH1_VS_TH17_CD4_TCELL_DN,C7_ immunologic signatures
7070,RFX1_02,c3.TFT_ transcription factor targets
7071,GO_PROTEIN_C_TERMINUS_BINDING,c5.GO molecular function
7072,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP,C7_ immunologic signatures
7073,BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN,c2.CGP_ chemical and genetic perturbations
7074,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN,C7_ immunologic signatures
7075,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN,C7_ immunologic signatures
7076,GO_STEREOCILIUM_BUNDLE,c5.CC_ GO cellular component
7077,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_UP,C7_ immunologic signatures
7078,GO_INCLUSION_BODY,c5.CC_ GO cellular component
7079,REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS,c2.CP_REACTOME_ Reactome gene sets
7080,GNF2_HAT1,c4.CGN_ cancer gene neighborhoods
7081,GO_MEMORY,c5.BP_ GO biological process
7082,CATGTAA_MIR496,c3.MIR_ microRNA targets
7083,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP,C7_ immunologic signatures
7084,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,C7_ immunologic signatures
7085,GO_CALCIUM_MEDIATED_SIGNALING,c5.BP_ GO biological process
7086,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,C7_ immunologic signatures
7087,MALONEY_RESPONSE_TO_17AAG_UP,c2.CGP_ chemical and genetic perturbations
7088,GO_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,c5.BP_ GO biological process
7089,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN,C7_ immunologic signatures
7090,YIH_RESPONSE_TO_ARSENITE_C4,c2.CGP_ chemical and genetic perturbations
7091,KENNY_CTNNB1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
7092,AMIT_DELAYED_EARLY_GENES,c2.CGP_ chemical and genetic perturbations
7093,GO_B_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,c5.BP_ GO biological process
7094,REACTOME_ADP_SIGNALLING_THROUGH_P2RY12,c2.CP_REACTOME_ Reactome gene sets
7095,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,c2.CGP_ chemical and genetic perturbations
7096,GO_RESPONSE_TO_PROGESTERONE,c5.BP_ GO biological process
7097,LEF1_Q6,c3.TFT_ transcription factor targets
7098,GO_NEGATIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,c5.BP_ GO biological process
7099,SA_B_CELL_RECEPTOR_COMPLEXES,c2.CP_ Canonical pathways
7100,SMAD_Q6,c3.TFT_ transcription factor targets
7101,GO_RESPONSE_TO_ANTIBIOTIC,c5.BP_ GO biological process
7102,GO_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,c5.BP_ GO biological process
7103,GO_NEGATIVE_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL,c5.BP_ GO biological process
7104,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN,C7_ immunologic signatures
7105,GO_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,c5.BP_ GO biological process
7106,GO_NEGATIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,c5.BP_ GO biological process
7107,CHYLA_CBFA2T3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
7108,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
7109,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP,C7_ immunologic signatures
7110,PARK_HSC_MARKERS,c2.CGP_ chemical and genetic perturbations
7111,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,C7_ immunologic signatures
7112,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_DN,C7_ immunologic signatures
7113,KEGG_LINOLEIC_ACID_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
7114,TSENG_IRS1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
7115,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN,C7_ immunologic signatures
7116,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
7117,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_UP,C7_ immunologic signatures
7118,GO_ATPASE_COMPLEX,c5.CC_ GO cellular component
7119,MEK_UP.V1_DN,C6_ oncogenic signatures
7120,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP,C7_ immunologic signatures
7121,OCT1_B,c3.TFT_ transcription factor targets
7122,MODULE_361,c4.CM_ cancer modules
7123,REACTOME_SIGNALING_BY_NODAL,c2.CP_REACTOME_ Reactome gene sets
7124,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,C7_ immunologic signatures
7125,MODULE_192,c4.CM_ cancer modules
7126,GO_EPHRIN_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
7127,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP,c2.CGP_ chemical and genetic perturbations
7128,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN,C7_ immunologic signatures
7129,CHR2Q24,37
7130,GO_PHOSPHATASE_COMPLEX,c5.CC_ GO cellular component
7131,MODULE_568,c4.CM_ cancer modules
7132,CAMPS_COLON_CANCER_COPY_NUMBER_UP,c2.CGP_ chemical and genetic perturbations
7133,GO_ADENYLYLTRANSFERASE_ACTIVITY,c5.GO molecular function
7134,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_DN,C7_ immunologic signatures
7135,CHR12Q23,53
7136,GAVIN_FOXP3_TARGETS_CLUSTER_P3,c2.CGP_ chemical and genetic perturbations
7137,GO_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,c5.BP_ GO biological process
7138,MORF_BNIP1,c4.CGN_ cancer gene neighborhoods
7139,RAO_BOUND_BY_SALL4,c2.CGP_ chemical and genetic perturbations
7140,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,c2.CGP_ chemical and genetic perturbations
7141,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP,C7_ immunologic signatures
7142,BIOCARTA_TEL_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
7143,GO_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
7144,GO_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,c5.BP_ GO biological process
7145,AMUNDSON_RESPONSE_TO_ARSENITE,c2.CGP_ chemical and genetic perturbations
7146,MODULE_327,c4.CM_ cancer modules
7147,TGCTGAY_UNKNOWN,c3.TFT_ transcription factor targets
7148,CEBPA_01,c3.TFT_ transcription factor targets
7149,BROWNE_HCMV_INFECTION_48HR_DN,c2.CGP_ chemical and genetic perturbations
7150,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_UP,C7_ immunologic signatures
7151,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN,C7_ immunologic signatures
7152,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP,C7_ immunologic signatures
7153,GO_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY,c5.GO molecular function
7154,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,C7_ immunologic signatures
7155,CHR20Q12,31
7156,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,C7_ immunologic signatures
7157,GO_LYMPHOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
7158,NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON,c2.CGP_ chemical and genetic perturbations
7159,MODULE_418,c4.CM_ cancer modules
7160,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,c2.CGP_ chemical and genetic perturbations
7161,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP,C7_ immunologic signatures
7162,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_DN,C7_ immunologic signatures
7163,GO_MALE_GENITALIA_DEVELOPMENT,c5.BP_ GO biological process
7164,CHR2P12,18
7165,GSE11057_PBMC_VS_MEM_CD4_TCELL_DN,C7_ immunologic signatures
7166,VERNOCHET_ADIPOGENESIS,c2.CGP_ chemical and genetic perturbations
7167,STK33_DN,C6_ oncogenic signatures
7168,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN,C7_ immunologic signatures
7169,GO_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT,c5.BP_ GO biological process
7170,GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS,c5.BP_ GO biological process
7171,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP,C7_ immunologic signatures
7172,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
7173,KAYO_AGING_MUSCLE_UP,c2.CGP_ chemical and genetic perturbations
7174,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN,C7_ immunologic signatures
7175,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_DN,C7_ immunologic signatures
7176,MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,c2.CGP_ chemical and genetic perturbations
7177,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP,C7_ immunologic signatures
7178,MODULE_16,c4.CM_ cancer modules
7179,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,C7_ immunologic signatures
7180,GO_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,c5.BP_ GO biological process
7181,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP,C7_ immunologic signatures
7182,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,C7_ immunologic signatures
7183,GO_GLIAL_CELL_DEVELOPMENT,c5.BP_ GO biological process
7184,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,c2.CGP_ chemical and genetic perturbations
7185,GTGTGAG_MIR342,c3.MIR_ microRNA targets
7186,GRADE_COLON_AND_RECTAL_CANCER_DN,c2.CGP_ chemical and genetic perturbations
7187,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,C7_ immunologic signatures
7188,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,C7_ immunologic signatures
7189,HALLMARK_HYPOXIA,H_ hallmark gene sets
7190,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN,C7_ immunologic signatures
7191,GSE17721_CTRL_VS_POLYIC_12H_BMDC_DN,C7_ immunologic signatures
7192,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,c2.CGP_ chemical and genetic perturbations
7193,GO_PEPTIDYL_THREONINE_MODIFICATION,c5.BP_ GO biological process
7194,MODULE_238,c4.CM_ cancer modules
7195,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP,C7_ immunologic signatures
7196,GSE27786_LIN_NEG_VS_BCELL_UP,C7_ immunologic signatures
7197,ELLWOOD_MYC_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
7198,GO_ADAPTIVE_IMMUNE_RESPONSE,c5.BP_ GO biological process
7199,HSF_Q6,c3.TFT_ transcription factor targets
7200,MORF_MAGEA8,c4.CGN_ cancer gene neighborhoods
7201,GSE13522_WT_VS_IFNAR_KO_SKIN_DN,C7_ immunologic signatures
7202,PLASARI_NFIC_TARGETS_BASAL_DN,c2.CGP_ chemical and genetic perturbations
7203,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP,C7_ immunologic signatures
7204,CAAGGAT_MIR362,c3.MIR_ microRNA targets
7205,GO_CORECEPTOR_ACTIVITY,c5.GO molecular function
7206,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_DN,C7_ immunologic signatures
7207,CHR15Q15,58
7208,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,C7_ immunologic signatures
7209,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_DN,C7_ immunologic signatures
7210,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,C7_ immunologic signatures
7211,GO_PROTEIN_MONOUBIQUITINATION,c5.BP_ GO biological process
7212,GO_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,c5.BP_ GO biological process
7213,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
7214,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN,C7_ immunologic signatures
7215,HNF4_01,c3.TFT_ transcription factor targets
7216,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,c2.CGP_ chemical and genetic perturbations
7217,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN,C7_ immunologic signatures
7218,KEGG_STEROID_HORMONE_BIOSYNTHESIS,c2.CP_BIOCARTA_ BioCarta gene sets
7219,GO_RAB_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,c5.GO molecular function
7220,GO_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION,c5.BP_ GO biological process
7221,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,C7_ immunologic signatures
7222,GO_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,c5.BP_ GO biological process
7223,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,C7_ immunologic signatures
7224,GO_NUCLEOTIDE_TRANSPORT,c5.BP_ GO biological process
7225,GO_ESCRT_COMPLEX,c5.CC_ GO cellular component
7226,STAT5A_04,c3.TFT_ transcription factor targets
7227,GO_RESPONSE_TO_STARVATION,c5.BP_ GO biological process
7228,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN,C7_ immunologic signatures
7229,GO_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY,c5.GO molecular function
7230,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN,C7_ immunologic signatures
7231,LBP1_Q6,c3.TFT_ transcription factor targets
7232,GSE10325_MYELOID_VS_LUPUS_MYELOID_DN,C7_ immunologic signatures
7233,PXR_Q2,c3.TFT_ transcription factor targets
7234,LIAN_LIPA_TARGETS_6M,c2.CGP_ chemical and genetic perturbations
7235,GO_REPRESSING_TRANSCRIPTION_FACTOR_BINDING,c5.GO molecular function
7236,GO_NEGATIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,c5.BP_ GO biological process
7237,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP,C7_ immunologic signatures
7238,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_UP,C7_ immunologic signatures
7239,GO_REGULATION_OF_NEURON_DEATH,c5.BP_ GO biological process
7240,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,C7_ immunologic signatures
7241,GSE1460_DP_VS_CD4_THYMOCYTE_DN,C7_ immunologic signatures
7242,GSE7852_TREG_VS_TCONV_DN,C7_ immunologic signatures
7243,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,C7_ immunologic signatures
7244,GO_MYELOID_LEUKOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
7245,GCM_LTK,c4.CGN_ cancer gene neighborhoods
7246,GSE17721_POLYIC_VS_CPG_2H_BMDC_UP,C7_ immunologic signatures
7247,GO_RESPONSE_TO_TOXIC_SUBSTANCE,c5.BP_ GO biological process
7248,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
7249,AMIT_SERUM_RESPONSE_240_MCF10A,c2.CGP_ chemical and genetic perturbations
7250,MULLIGHAN_NPM1_SIGNATURE_3_DN,c2.CGP_ chemical and genetic perturbations
7251,MORF_PDCD1,c4.CGN_ cancer gene neighborhoods
7252,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_DN,C7_ immunologic signatures
7253,GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN,C7_ immunologic signatures
7254,KEGG_RETINOL_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
7255,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,C7_ immunologic signatures
7256,BRCA1_DN.V1_UP,C6_ oncogenic signatures
7257,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN,C7_ immunologic signatures
7258,TAGAACC_MIR182,c3.MIR_ microRNA targets
7259,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,C7_ immunologic signatures
7260,NADLER_HYPERGLYCEMIA_AT_OBESITY,c2.CGP_ chemical and genetic perturbations
7261,GO_NUCLEUS_LOCALIZATION,c5.BP_ GO biological process
7262,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP,C7_ immunologic signatures
7263,GSE28130_ACTIVATED_VS_INDUCEED_TREG_DN,C7_ immunologic signatures
7264,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
7265,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_DN,C7_ immunologic signatures
7266,GO_GLYCEROLIPID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
7267,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,C7_ immunologic signatures
7268,MORF_HEAB,c4.CGN_ cancer gene neighborhoods
7269,GO_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
7270,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,C7_ immunologic signatures
7271,GLI1_UP.V1_UP,C6_ oncogenic signatures
7272,GSE27786_LIN_NEG_VS_NKTCELL_UP,C7_ immunologic signatures
7273,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_UP,C7_ immunologic signatures
7274,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN,C7_ immunologic signatures
7275,BROWNE_HCMV_INFECTION_16HR_UP,c2.CGP_ chemical and genetic perturbations
7276,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
7277,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_DN,C7_ immunologic signatures
7278,PR_02,c3.TFT_ transcription factor targets
7279,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN,C7_ immunologic signatures
7280,BIOCARTA_CARDIACEGF_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
7281,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,C7_ immunologic signatures
7282,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,C7_ immunologic signatures
7283,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN,C7_ immunologic signatures
7284,BIDUS_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
7285,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_UP,C7_ immunologic signatures
7286,MODULE_9,c4.CM_ cancer modules
7287,GO_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION,c5.BP_ GO biological process
7288,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP,C7_ immunologic signatures
7289,BIOCARTA_EGF_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
7290,GO_SOMATIC_CELL_DNA_RECOMBINATION,c5.BP_ GO biological process
7291,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,C7_ immunologic signatures
7292,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,C7_ immunologic signatures
7293,KEGG_TIGHT_JUNCTION,c2.CP_BIOCARTA_ BioCarta gene sets
7294,GO_ENDOSOMAL_PART,c5.CC_ GO cellular component
7295,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,c2.CGP_ chemical and genetic perturbations
7296,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,c2.CGP_ chemical and genetic perturbations
7297,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,C7_ immunologic signatures
7298,GSE22033_WT_VS_PPARG_KO_MEF_DN,C7_ immunologic signatures
7299,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_UP,C7_ immunologic signatures
7300,GO_PROTEIN_SELF_ASSOCIATION,c5.GO molecular function
7301,GO_4_IRON_4_SULFUR_CLUSTER_BINDING,c5.GO molecular function
7302,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,C7_ immunologic signatures
7303,LEE_LIVER_CANCER_CIPROFIBRATE_DN,c2.CGP_ chemical and genetic perturbations
7304,GO_DEFENSE_RESPONSE_TO_FUNGUS,c5.BP_ GO biological process
7305,DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,c2.CGP_ chemical and genetic perturbations
7306,GO_PALMITOYLTRANSFERASE_ACTIVITY,c5.GO molecular function
7307,GO_G_PROTEIN_COUPLED_RECEPTOR_BINDING,c5.GO molecular function
7308,GO_CYTOKINE_PRODUCTION,c5.BP_ GO biological process
7309,GO_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION,c5.BP_ GO biological process
7310,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP,C7_ immunologic signatures
7311,GO_LEARNING,c5.BP_ GO biological process
7312,GSE17721_CTRL_VS_CPG_0.5H_BMDC_DN,C7_ immunologic signatures
7313,MORF_PDPK1,c4.CGN_ cancer gene neighborhoods
7314,VEGF_A_UP.V1_DN,C6_ oncogenic signatures
7315,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_DN,C7_ immunologic signatures
7316,IK3_01,c3.TFT_ transcription factor targets
7317,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,C7_ immunologic signatures
7318,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,C7_ immunologic signatures
7319,MCDOWELL_ACUTE_LUNG_INJURY_DN,c2.CGP_ chemical and genetic perturbations
7320,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,C7_ immunologic signatures
7321,GO_HISTONE_LYSINE_N_METHYLTRANSFERASE_ACTIVITY,c5.GO molecular function
7322,ONKEN_UVEAL_MELANOMA_DN,c2.CGP_ chemical and genetic perturbations
7323,GO_MYELOID_CELL_HOMEOSTASIS,c5.BP_ GO biological process
7324,MODULE_145,c4.CM_ cancer modules
7325,GO_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_IONS_PHOSPHORYLATIVE_MECHANISM,c5.GO molecular function
7326,AKL_HTLV1_INFECTION_DN,c2.CGP_ chemical and genetic perturbations
7327,GSE4590_SMALL_VS_LARGE_PRE_BCELL_DN,C7_ immunologic signatures
7328,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,c2.CGP_ chemical and genetic perturbations
7329,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,C7_ immunologic signatures
7330,GO_INTERACTION_WITH_HOST,c5.BP_ GO biological process
7331,GSE3982_BASOPHIL_VS_NKCELL_DN,C7_ immunologic signatures
7332,RIZKI_TUMOR_INVASIVENESS_3D_UP,c2.CGP_ chemical and genetic perturbations
7333,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,c2.CGP_ chemical and genetic perturbations
7334,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_UP,C7_ immunologic signatures
7335,GO_RESPONSE_TO_AMINE,c5.BP_ GO biological process
7336,GO_HEART_TRABECULA_MORPHOGENESIS,c5.BP_ GO biological process
7337,PENG_GLUCOSE_DEPRIVATION_DN,c2.CGP_ chemical and genetic perturbations
7338,ST_WNT_CA2_CYCLIC_GMP_PATHWAY,c2.CP_ Canonical pathways
7339,DAZARD_UV_RESPONSE_CLUSTER_G24,c2.CGP_ chemical and genetic perturbations
7340,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,c2.CGP_ chemical and genetic perturbations
7341,ER_Q6_01,c3.TFT_ transcription factor targets
7342,BROWNE_HCMV_INFECTION_24HR_UP,c2.CGP_ chemical and genetic perturbations
7343,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN,C7_ immunologic signatures
7344,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
7345,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,C7_ immunologic signatures
7346,MAHAJAN_RESPONSE_TO_IL1A_DN,c2.CGP_ chemical and genetic perturbations
7347,GO_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,c5.BP_ GO biological process
7348,AP1FJ_Q2,c3.TFT_ transcription factor targets
7349,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN,C7_ immunologic signatures
7350,GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
7351,STK33_NOMO_DN,C6_ oncogenic signatures
7352,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_DN,C7_ immunologic signatures
7353,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
7354,PID_ARF6_PATHWAY,c2.CP_ Canonical pathways
7355,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP,C7_ immunologic signatures
7356,MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED,c2.CGP_ chemical and genetic perturbations
7357,GSE27786_LIN_NEG_VS_MONO_MAC_DN,C7_ immunologic signatures
7358,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_DN,C7_ immunologic signatures
7359,GCM_USP6,c4.CGN_ cancer gene neighborhoods
7360,GO_ANION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
7361,COATES_MACROPHAGE_M1_VS_M2_UP,c2.CGP_ chemical and genetic perturbations
7362,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN,C7_ immunologic signatures
7363,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN,C7_ immunologic signatures
7364,GO_NEURON_FATE_SPECIFICATION,c5.BP_ GO biological process
7365,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN,C7_ immunologic signatures
7366,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN,C7_ immunologic signatures
7367,GO_NEGATIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,c5.BP_ GO biological process
7368,GO_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION,c5.BP_ GO biological process
7369,GSE3982_NEUTROPHIL_VS_TH1_UP,C7_ immunologic signatures
7370,LEI_MYB_TARGETS,c2.CGP_ chemical and genetic perturbations
7371,GSE17721_LPS_VS_CPG_24H_BMDC_UP,C7_ immunologic signatures
7372,GO_PROTEIN_PHOSPHATASE_TYPE_2A_COMPLEX,c5.CC_ GO cellular component
7373,GO_CELLULAR_RESPONSE_TO_CYTOKINE_STIMULUS,c5.BP_ GO biological process
7374,GSE15330_WT_VS_IKAROS_KO_HSC_DN,C7_ immunologic signatures
7375,GO_NEGATIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY,c5.BP_ GO biological process
7376,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN,C7_ immunologic signatures
7377,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP,C7_ immunologic signatures
7378,PID_ILK_PATHWAY,c2.CP_ Canonical pathways
7379,GO_CELLULAR_RESPONSE_TO_AMINO_ACID_STIMULUS,c5.BP_ GO biological process
7380,REACTOME_GAB1_SIGNALOSOME,c2.CP_REACTOME_ Reactome gene sets
7381,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,C7_ immunologic signatures
7382,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,C7_ immunologic signatures
7383,TGCACTG_MIR148A_MIR152_MIR148B,c3.MIR_ microRNA targets
7384,DOANE_RESPONSE_TO_ANDROGEN_UP,c2.CGP_ chemical and genetic perturbations
7385,GSE42724_NAIVE_VS_MEMORY_BCELL_DN,C7_ immunologic signatures
7386,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP,C7_ immunologic signatures
7387,GO_REGULATION_OF_SYNAPSE_ORGANIZATION,c5.BP_ GO biological process
7388,GO_POSITIVE_REGULATION_OF_PROTEIN_BINDING,c5.BP_ GO biological process
7389,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP,C7_ immunologic signatures
7390,GO_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN,c5.BP_ GO biological process
7391,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN,C7_ immunologic signatures
7392,GO_EARLY_ENDOSOME,c5.CC_ GO cellular component
7393,GSE22886_NEUTROPHIL_VS_DC_UP,C7_ immunologic signatures
7394,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP,C7_ immunologic signatures
7395,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
7396,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,c2.CGP_ chemical and genetic perturbations
7397,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP,C7_ immunologic signatures
7398,PROVENZANI_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
7399,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN,C7_ immunologic signatures
7400,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,C7_ immunologic signatures
7401,MORF_CDH4,c4.CGN_ cancer gene neighborhoods
7402,GO_MUCOPOLYSACCHARIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
7403,HALLMARK_IL2_STAT5_SIGNALING,H_ hallmark gene sets
7404,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP,C7_ immunologic signatures
7405,TCCAGAG_MIR518C,c3.MIR_ microRNA targets
7406,GO_TRANSCRIPTION_COREPRESSOR_ACTIVITY,c5.GO molecular function
7407,STANELLE_E2F1_TARGETS,c2.CGP_ chemical and genetic perturbations
7408,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,C7_ immunologic signatures
7409,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,C7_ immunologic signatures
7410,MA_PITUITARY_FETAL_VS_ADULT_UP,c2.CGP_ chemical and genetic perturbations
7411,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,c2.CGP_ chemical and genetic perturbations
7412,GO_BODY_FLUID_SECRETION,c5.BP_ GO biological process
7413,DELACROIX_RAR_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
7414,GO_REGULATION_OF_B_CELL_ACTIVATION,c5.BP_ GO biological process
7415,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,C7_ immunologic signatures
7416,LY_AGING_PREMATURE_DN,c2.CGP_ chemical and genetic perturbations
7417,GO_RESPONSE_TO_GLUCAGON,c5.BP_ GO biological process
7418,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
7419,GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP,C7_ immunologic signatures
7420,GO_NUCLEOSIDE_PHOSPHATE_CATABOLIC_PROCESS,c5.BP_ GO biological process
7421,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,C7_ immunologic signatures
7422,LEE_DIFFERENTIATING_T_LYMPHOCYTE,c2.CGP_ chemical and genetic perturbations
7423,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_UP,C7_ immunologic signatures
7424,GGTGTGT_MIR329,c3.MIR_ microRNA targets
7425,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
7426,REACTOME_NETRIN1_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
7427,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,C7_ immunologic signatures
7428,MORF_CASP10,c4.CGN_ cancer gene neighborhoods
7429,MODULE_439,c4.CM_ cancer modules
7430,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP,C7_ immunologic signatures
7431,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,C7_ immunologic signatures
7432,LINDVALL_IMMORTALIZED_BY_TERT_UP,c2.CGP_ chemical and genetic perturbations
7433,ROSS_AML_OF_FAB_M7_TYPE,c2.CGP_ chemical and genetic perturbations
7434,GO_LEADING_EDGE_MEMBRANE,c5.CC_ GO cellular component
7435,GSE14769_20MIN_VS_360MIN_LPS_BMDM_UP,C7_ immunologic signatures
7436,GO_MICROVILLUS,c5.CC_ GO cellular component
7437,QI_PLASMACYTOMA_UP,c2.CGP_ chemical and genetic perturbations
7438,GO_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,c5.BP_ GO biological process
7439,GO_NEGATIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,c5.BP_ GO biological process
7440,GO_REGULATION_OF_CYTOKINE_SECRETION,c5.BP_ GO biological process
7441,GSE3982_NEUTROPHIL_VS_BASOPHIL_UP,C7_ immunologic signatures
7442,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,C7_ immunologic signatures
7443,GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN,C7_ immunologic signatures
7444,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP,C7_ immunologic signatures
7445,GSE17721_LPS_VS_POLYIC_1H_BMDC_DN,C7_ immunologic signatures
7446,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN,C7_ immunologic signatures
7447,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,c2.CGP_ chemical and genetic perturbations
7448,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP,C7_ immunologic signatures
7449,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_DN,C7_ immunologic signatures
7450,BROWNE_HCMV_INFECTION_10HR_UP,c2.CGP_ chemical and genetic perturbations
7451,HALLMARK_ESTROGEN_RESPONSE_EARLY,H_ hallmark gene sets
7452,GTGCCAT_MIR183,c3.MIR_ microRNA targets
7453,GO_SODIUM_CHANNEL_ACTIVITY,c5.GO molecular function
7454,FAELT_B_CLL_WITH_VH3_21_DN,c2.CGP_ chemical and genetic perturbations
7455,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,C7_ immunologic signatures
7456,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP,C7_ immunologic signatures
7457,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,C7_ immunologic signatures
7458,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
7459,GSE11386_NAIVE_VS_MEMORY_BCELL_DN,C7_ immunologic signatures
7460,KEGG_ABC_TRANSPORTERS,c2.CP_BIOCARTA_ BioCarta gene sets
7461,HEN1_02,c3.TFT_ transcription factor targets
7462,USF_02,c3.TFT_ transcription factor targets
7463,WWTAAGGC_UNKNOWN,c3.TFT_ transcription factor targets
7464,MARTINEZ_RESPONSE_TO_TRABECTEDIN,c2.CGP_ chemical and genetic perturbations
7465,GO_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,c5.BP_ GO biological process
7466,GSE13229_IMM_VS_MATURE_NKCELL_UP,C7_ immunologic signatures
7467,GO_GABA_RECEPTOR_BINDING,c5.GO molecular function
7468,GO_FEAR_RESPONSE,c5.BP_ GO biological process
7469,GO_GLYCEROLIPID_METABOLIC_PROCESS,c5.BP_ GO biological process
7470,WINNEPENNINCKX_MELANOMA_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
7471,MORF_FDXR,c4.CGN_ cancer gene neighborhoods
7472,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_DN,C7_ immunologic signatures
7473,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_UP,C7_ immunologic signatures
7474,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP,C7_ immunologic signatures
7475,GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
7476,GO_REGULATION_OF_LEUKOCYTE_DEGRANULATION,c5.BP_ GO biological process
7477,GO_REGULATION_OF_POLYSACCHARIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
7478,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_DN,C7_ immunologic signatures
7479,GO_TETRAHYDROFOLATE_METABOLIC_PROCESS,c5.BP_ GO biological process
7480,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,c2.CGP_ chemical and genetic perturbations
7481,GO_RIBONUCLEASE_ACTIVITY,c5.GO molecular function
7482,GO_REGULATION_OF_PROTEIN_DEACETYLATION,c5.BP_ GO biological process
7483,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
7484,CHR12Q21,38
7485,GO_LIPID_MODIFICATION,c5.BP_ GO biological process
7486,GO_REGULATION_OF_FATTY_ACID_TRANSPORT,c5.BP_ GO biological process
7487,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,C7_ immunologic signatures
7488,HNF6_Q6,c3.TFT_ transcription factor targets
7489,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,c2.CGP_ chemical and genetic perturbations
7490,KANG_AR_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
7491,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_DN,C7_ immunologic signatures
7492,LU_IL4_SIGNALING,c2.CGP_ chemical and genetic perturbations
7493,GO_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT,c5.BP_ GO biological process
7494,GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP,C7_ immunologic signatures
7495,CHR1P35,82
7496,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN,C7_ immunologic signatures
7497,GO_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS,c5.BP_ GO biological process
7498,ZWANG_EGF_PERSISTENTLY_DN,c2.CGP_ chemical and genetic perturbations
7499,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,C7_ immunologic signatures
7500,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN,C7_ immunologic signatures
7501,HALLMARK_ANGIOGENESIS,H_ hallmark gene sets
7502,REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,c2.CP_REACTOME_ Reactome gene sets
7503,BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,c2.CGP_ chemical and genetic perturbations
7504,PEART_HDAC_PROLIFERATION_CLUSTER_DN,c2.CGP_ chemical and genetic perturbations
7505,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP,C7_ immunologic signatures
7506,MODULE_119,c4.CM_ cancer modules
7507,GNF2_ATM,c4.CGN_ cancer gene neighborhoods
7508,GO_SPHINGOLIPID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
7509,GO_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,c5.BP_ GO biological process
7510,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,C7_ immunologic signatures
7511,GO_POSITIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,c5.BP_ GO biological process
7512,GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,c5.BP_ GO biological process
7513,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,C7_ immunologic signatures
7514,PID_TGFBR_PATHWAY,c2.CP_ Canonical pathways
7515,MODULE_455,c4.CM_ cancer modules
7516,SMITH_TERT_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
7517,GO_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,c5.GO molecular function
7518,GO_LYMPHOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,c5.BP_ GO biological process
7519,MORF_FRK,c4.CGN_ cancer gene neighborhoods
7520,GGGACCA_MIR133A_MIR133B,c3.MIR_ microRNA targets
7521,GTGTTGA_MIR505,c3.MIR_ microRNA targets
7522,GO_PROTEIN_KINASE_A_CATALYTIC_SUBUNIT_BINDING,c5.GO molecular function
7523,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP,C7_ immunologic signatures
7524,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_DN,C7_ immunologic signatures
7525,WESTON_VEGFA_TARGETS_3HR,c2.CGP_ chemical and genetic perturbations
7526,COLLIS_PRKDC_REGULATORS,c2.CGP_ chemical and genetic perturbations
7527,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,C7_ immunologic signatures
7528,JIANG_AGING_CEREBRAL_CORTEX_UP,c2.CGP_ chemical and genetic perturbations
7529,ALONSO_METASTASIS_EMT_UP,c2.CGP_ chemical and genetic perturbations
7530,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP,C7_ immunologic signatures
7531,VANTVEER_BREAST_CANCER_ESR1_DN,c2.CGP_ chemical and genetic perturbations
7532,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_UP,C7_ immunologic signatures
7533,GO_REGULATION_OF_FEEDING_BEHAVIOR,c5.BP_ GO biological process
7534,GSE8835_CD4_VS_CD8_TCELL_UP,C7_ immunologic signatures
7535,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN,C7_ immunologic signatures
7536,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP,C7_ immunologic signatures
7537,GNF2_CEBPA,c4.CGN_ cancer gene neighborhoods
7538,CHR17Q21,217
7539,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN,C7_ immunologic signatures
7540,GO_NEGATIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,c5.BP_ GO biological process
7541,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP,C7_ immunologic signatures
7542,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
7543,GO_POSITIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION,c5.BP_ GO biological process
7544,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP,C7_ immunologic signatures
7545,GO_GPI_ANCHOR_METABOLIC_PROCESS,c5.BP_ GO biological process
7546,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,c2.CGP_ chemical and genetic perturbations
7547,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,C7_ immunologic signatures
7548,GO_REGULATION_OF_PROTEIN_TARGETING,c5.BP_ GO biological process
7549,BIOCARTA_FAS_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
7550,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_DN,C7_ immunologic signatures
7551,GSE3982_EOSINOPHIL_VS_TH2_DN,C7_ immunologic signatures
7552,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP,C7_ immunologic signatures
7553,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP,C7_ immunologic signatures
7554,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
7555,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_UP,C7_ immunologic signatures
7556,TING_SILENCED_BY_DICER,c2.CGP_ chemical and genetic perturbations
7557,GO_1_PHOSPHATIDYLINOSITOL_BINDING,c5.GO molecular function
7558,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN,C7_ immunologic signatures
7559,GENTILE_UV_HIGH_DOSE_UP,c2.CGP_ chemical and genetic perturbations
7560,GO_SENSORY_PERCEPTION_OF_TASTE,c5.BP_ GO biological process
7561,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN,C7_ immunologic signatures
7562,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_DN,C7_ immunologic signatures
7563,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,c2.CGP_ chemical and genetic perturbations
7564,LEE_LIVER_CANCER_SURVIVAL_DN,c2.CGP_ chemical and genetic perturbations
7565,BROWNE_HCMV_INFECTION_14HR_UP,c2.CGP_ chemical and genetic perturbations
7566,GO_MAIN_AXON,c5.CC_ GO cellular component
7567,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,C7_ immunologic signatures
7568,ZEMBUTSU_SENSITIVITY_TO_CISPLATIN,c2.CGP_ chemical and genetic perturbations
7569,MODULE_136,c4.CM_ cancer modules
7570,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP,C7_ immunologic signatures
7571,REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS,c2.CP_REACTOME_ Reactome gene sets
7572,GO_CERAMIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
7573,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN,C7_ immunologic signatures
7574,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN,C7_ immunologic signatures
7575,REACTOME_GABA_RECEPTOR_ACTIVATION,c2.CP_REACTOME_ Reactome gene sets
7576,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,C7_ immunologic signatures
7577,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,c2.CGP_ chemical and genetic perturbations
7578,GO_GLIAL_CELL_MIGRATION,c5.BP_ GO biological process
7579,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN,C7_ immunologic signatures
7580,GO_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT,c5.BP_ GO biological process
7581,GO_NEGATIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY,c5.BP_ GO biological process
7582,PID_HES_HEY_PATHWAY,c2.CP_ Canonical pathways
7583,NIKOLSKY_BREAST_CANCER_7P22_AMPLICON,c2.CGP_ chemical and genetic perturbations
7584,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,c2.CGP_ chemical and genetic perturbations
7585,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP,C7_ immunologic signatures
7586,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN,C7_ immunologic signatures
7587,GSE20366_TREG_VS_TCONV_UP,C7_ immunologic signatures
7588,REACTOME_SEMAPHORIN_INTERACTIONS,c2.CP_REACTOME_ Reactome gene sets
7589,GO_ENDOCRINE_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
7590,GO_POSITIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION,c5.BP_ GO biological process
7591,GO_CERAMIDE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
7592,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,c2.CGP_ chemical and genetic perturbations
7593,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_UP,C7_ immunologic signatures
7594,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
7595,TBK1.DN.48HRS_DN,C6_ oncogenic signatures
7596,FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN,c2.CGP_ chemical and genetic perturbations
7597,GO_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,c5.BP_ GO biological process
7598,GO_CATION_CHANNEL_COMPLEX,c5.CC_ GO cellular component
7599,REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,c2.CP_REACTOME_ Reactome gene sets
7600,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,C7_ immunologic signatures
7601,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP,C7_ immunologic signatures
7602,TBK1.DF_UP,C6_ oncogenic signatures
7603,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN,C7_ immunologic signatures
7604,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_DN,C7_ immunologic signatures
7605,CGCTGCT_MIR503,c3.MIR_ microRNA targets
7606,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_UP,C7_ immunologic signatures
7607,ATCTTGC_MIR31,c3.MIR_ microRNA targets
7608,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_UP,C7_ immunologic signatures
7609,APRELIKOVA_BRCA1_TARGETS,c2.CGP_ chemical and genetic perturbations
7610,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
7611,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_UP,C7_ immunologic signatures
7612,GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN,C7_ immunologic signatures
7613,GATA1_03,c3.TFT_ transcription factor targets
7614,WATANABE_COLON_CANCER_MSI_VS_MSS_UP,c2.CGP_ chemical and genetic perturbations
7615,RIGGINS_TAMOXIFEN_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
7616,REACTOME_IL_2_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
7617,GSE17721_0.5H_VS_24H_LPS_BMDC_UP,C7_ immunologic signatures
7618,GO_REGULATION_OF_ANION_TRANSPORT,c5.BP_ GO biological process
7619,GO_HISTONE_DEACETYLASE_BINDING,c5.GO molecular function
7620,MARTINEZ_RB1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
7621,GO_POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING,c5.BP_ GO biological process
7622,GO_ENDOCRINE_PANCREAS_DEVELOPMENT,c5.BP_ GO biological process
7623,SERVITJA_LIVER_HNF1A_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
7624,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_DN,C7_ immunologic signatures
7625,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
7626,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP,C7_ immunologic signatures
7627,GO_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,c5.BP_ GO biological process
7628,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP,C7_ immunologic signatures
7629,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN,C7_ immunologic signatures
7630,TGACGTCA_ATF3_Q6,c3.TFT_ transcription factor targets
7631,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN,C7_ immunologic signatures
7632,GO_HYDROGEN_EXPORTING_ATPASE_ACTIVITY,c5.GO molecular function
7633,GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_BINDING,c5.GO molecular function
7634,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP,C7_ immunologic signatures
7635,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,C7_ immunologic signatures
7636,GO_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,c5.BP_ GO biological process
7637,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6,c2.CGP_ chemical and genetic perturbations
7638,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP,C7_ immunologic signatures
7639,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,C7_ immunologic signatures
7640,ACCAATC_MIR509,c3.MIR_ microRNA targets
7641,GO_EMBRYONIC_CAMERA_TYPE_EYE_MORPHOGENESIS,c5.BP_ GO biological process
7642,GO_AMMONIUM_ION_METABOLIC_PROCESS,c5.BP_ GO biological process
7643,GO_MALE_GAMETE_GENERATION,c5.BP_ GO biological process
7644,REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS,c2.CP_REACTOME_ Reactome gene sets
7645,CHR10P15,30
7646,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN,C7_ immunologic signatures
7647,GSE3039_NKT_CELL_VS_B1_BCELL_UP,C7_ immunologic signatures
7648,HUTTMANN_B_CLL_POOR_SURVIVAL_DN,c2.CGP_ chemical and genetic perturbations
7649,GO_REGULATION_OF_MYOTUBE_DIFFERENTIATION,c5.BP_ GO biological process
7650,GO_NEGATIVE_REGULATION_OF_PROTEIN_ACETYLATION,c5.BP_ GO biological process
7651,PID_RHOA_REG_PATHWAY,c2.CP_ Canonical pathways
7652,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
7653,GSE21379_WT_VS_SAP_KO_CD4_TCELL_UP,C7_ immunologic signatures
7654,GO_RIBONUCLEOSIDE_CATABOLIC_PROCESS,c5.BP_ GO biological process
7655,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,C7_ immunologic signatures
7656,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN,c2.CGP_ chemical and genetic perturbations
7657,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_UP,C7_ immunologic signatures
7658,GO_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION,c5.BP_ GO biological process
7659,LYF1_01,c3.TFT_ transcription factor targets
7660,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP,C7_ immunologic signatures
7661,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_DN,C7_ immunologic signatures
7662,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,c2.CGP_ chemical and genetic perturbations
7663,GO_SOMATIC_STEM_CELL_DIVISION,c5.BP_ GO biological process
7664,MEIS1_01,c3.TFT_ transcription factor targets
7665,GO_IN_UTERO_EMBRYONIC_DEVELOPMENT,c5.BP_ GO biological process
7666,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,C7_ immunologic signatures
7667,LEE_TARGETS_OF_PTCH1_AND_SUFU_DN,c2.CGP_ chemical and genetic perturbations
7668,MADAN_DPPA4_TARGETS,c2.CGP_ chemical and genetic perturbations
7669,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,C7_ immunologic signatures
7670,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
7671,GO_ION_CHANNEL_BINDING,c5.GO molecular function
7672,GO_TELOMERE_CAPPING,c5.BP_ GO biological process
7673,NOTCH_DN.V1_DN,C6_ oncogenic signatures
7674,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_UP,C7_ immunologic signatures
7675,GO_SULFOTRANSFERASE_ACTIVITY,c5.GO molecular function
7676,MORF_PRKACA,c4.CGN_ cancer gene neighborhoods
7677,KIM_WT1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
7678,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,c2.CGP_ chemical and genetic perturbations
7679,GO_DRUG_BINDING,c5.GO molecular function
7680,GSE27786_BCELL_VS_NKCELL_DN,C7_ immunologic signatures
7681,GO_VASCULOGENESIS,c5.BP_ GO biological process
7682,GO_MOVEMENT_IN_ENVIRONMENT_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION,c5.BP_ GO biological process
7683,GERHOLD_ADIPOGENESIS_DN,c2.CGP_ chemical and genetic perturbations
7684,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP,C7_ immunologic signatures
7685,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_UP,C7_ immunologic signatures
7686,MODULE_459,c4.CM_ cancer modules
7687,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP,C7_ immunologic signatures
7688,GO_STEROL_TRANSPORT,c5.BP_ GO biological process
7689,REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS,c2.CP_REACTOME_ Reactome gene sets
7690,GO_HOMEOSTASIS_OF_NUMBER_OF_CELLS,c5.BP_ GO biological process
7691,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP,c2.CGP_ chemical and genetic perturbations
7692,DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN,c2.CGP_ chemical and genetic perturbations
7693,GO_MAGNESIUM_ION_BINDING,c5.GO molecular function
7694,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN,C7_ immunologic signatures
7695,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,c2.CGP_ chemical and genetic perturbations
7696,GO_IMMUNOGLOBULIN_BINDING,c5.GO molecular function
7697,CHR6Q24,33
7698,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,C7_ immunologic signatures
7699,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,C7_ immunologic signatures
7700,MODULE_340,c4.CM_ cancer modules
7701,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN,C7_ immunologic signatures
7702,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,C7_ immunologic signatures
7703,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,C7_ immunologic signatures
7704,GO_DNA_GEOMETRIC_CHANGE,c5.BP_ GO biological process
7705,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,C7_ immunologic signatures
7706,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_UP,C7_ immunologic signatures
7707,TTGGGAG_MIR150,c3.MIR_ microRNA targets
7708,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_UP,C7_ immunologic signatures
7709,GSE17721_LPS_VS_POLYIC_12H_BMDC_DN,C7_ immunologic signatures
7710,GO_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
7711,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN,C7_ immunologic signatures
7712,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP,C7_ immunologic signatures
7713,SYATTGTG_UNKNOWN,c3.TFT_ transcription factor targets
7714,GO_PROTEIN_KINASE_A_BINDING,c5.GO molecular function
7715,GO_CELLULAR_RESPONSE_TO_INTERLEUKIN_1,c5.BP_ GO biological process
7716,REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1,c2.CP_REACTOME_ Reactome gene sets
7717,ETF_Q6,c3.TFT_ transcription factor targets
7718,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_DN,C7_ immunologic signatures
7719,PID_VEGFR1_PATHWAY,c2.CP_ Canonical pathways
7720,MODULE_356,c4.CM_ cancer modules
7721,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,C7_ immunologic signatures
7722,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
7723,GO_PCG_PROTEIN_COMPLEX,c5.CC_ GO cellular component
7724,TCTGATA_MIR361,c3.MIR_ microRNA targets
7725,GSE13229_MATURE_VS_INTMATURE_NKCELL_DN,C7_ immunologic signatures
7726,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,C7_ immunologic signatures
7727,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN,C7_ immunologic signatures
7728,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN,C7_ immunologic signatures
7729,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,C7_ immunologic signatures
7730,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP,C7_ immunologic signatures
7731,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP,C7_ immunologic signatures
7732,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP,C7_ immunologic signatures
7733,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,C7_ immunologic signatures
7734,GO_FRIZZLED_BINDING,c5.GO molecular function
7735,OHGUCHI_LIVER_HNF4A_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
7736,GSE17721_LPS_VS_CPG_24H_BMDC_DN,C7_ immunologic signatures
7737,GSE29618_MONOCYTE_VS_MDC_UP,C7_ immunologic signatures
7738,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_UP,C7_ immunologic signatures
7739,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP,C7_ immunologic signatures
7740,KIM_WT1_TARGETS_12HR_DN,c2.CGP_ chemical and genetic perturbations
7741,GO_MAGNESIUM_ION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
7742,TTTGTAG_MIR520D,c3.MIR_ microRNA targets
7743,GR_01,c3.TFT_ transcription factor targets
7744,ZUCCHI_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
7745,BIOCARTA_41BB_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
7746,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
7747,IRF1_Q6,c3.TFT_ transcription factor targets
7748,GO_SNARE_COMPLEX,c5.CC_ GO cellular component
7749,PID_P38_MK2_PATHWAY,c2.CP_ Canonical pathways
7750,GO_REGULATION_OF_SYNAPSE_ASSEMBLY,c5.BP_ GO biological process
7751,GSE10325_CD4_TCELL_VS_MYELOID_UP,C7_ immunologic signatures
7752,GSE17721_LPS_VS_CPG_8H_BMDC_UP,C7_ immunologic signatures
7753,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,C7_ immunologic signatures
7754,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN,C7_ immunologic signatures
7755,GO_POSITIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT,c5.BP_ GO biological process
7756,MODULE_488,c4.CM_ cancer modules
7757,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,C7_ immunologic signatures
7758,GO_PROTEIN_TYROSINE_KINASE_BINDING,c5.GO molecular function
7759,MAZ_Q6,c3.TFT_ transcription factor targets
7760,GO_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,c5.BP_ GO biological process
7761,YIH_RESPONSE_TO_ARSENITE_C3,c2.CGP_ chemical and genetic perturbations
7762,CAGCACT_MIR5123P,c3.MIR_ microRNA targets
7763,GO_PEPTIDE_SECRETION,c5.BP_ GO biological process
7764,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP,C7_ immunologic signatures
7765,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
7766,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,C7_ immunologic signatures
7767,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_DN,C7_ immunologic signatures
7768,GSE2585_CTEC_VS_MTEC_THYMUS_UP,C7_ immunologic signatures
7769,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_DN,C7_ immunologic signatures
7770,WNT_UP.V1_DN,C6_ oncogenic signatures
7771,PDGF_UP.V1_DN,C6_ oncogenic signatures
7772,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN,C7_ immunologic signatures
7773,GO_REGULATION_OF_RENAL_SODIUM_EXCRETION,c5.BP_ GO biological process
7774,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN,C7_ immunologic signatures
7775,GO_COGNITION,c5.BP_ GO biological process
7776,SERVITJA_ISLET_HNF1A_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
7777,GO_NUCLEIC_ACID_PHOSPHODIESTER_BOND_HYDROLYSIS,c5.BP_ GO biological process
7778,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,C7_ immunologic signatures
7779,GO_RUFFLE_ORGANIZATION,c5.BP_ GO biological process
7780,GO_AMIDE_TRANSPORT,c5.BP_ GO biological process
7781,PID_AP1_PATHWAY,c2.CP_ Canonical pathways
7782,GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN,C7_ immunologic signatures
7783,REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,c2.CP_REACTOME_ Reactome gene sets
7784,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN,C7_ immunologic signatures
7785,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_DN,C7_ immunologic signatures
7786,GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN,C7_ immunologic signatures
7787,TAXCREB_01,c3.TFT_ transcription factor targets
7788,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,C7_ immunologic signatures
7789,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_UP,C7_ immunologic signatures
7790,GSE27786_NKCELL_VS_NEUTROPHIL_DN,C7_ immunologic signatures
7791,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,C7_ immunologic signatures
7792,CMYB_01,c3.TFT_ transcription factor targets
7793,MORF_IFNA1,c4.CGN_ cancer gene neighborhoods
7794,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP,C7_ immunologic signatures
7795,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN,C7_ immunologic signatures
7796,BIOCARTA_MET_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
7797,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_UP,C7_ immunologic signatures
7798,GO_WNT_SIGNALING_PATHWAY,c5.BP_ GO biological process
7799,GSE17721_LPS_VS_CPG_0.5H_BMDC_UP,C7_ immunologic signatures
7800,GSE45365_NK_CELL_VS_CD8A_DC_UP,C7_ immunologic signatures
7801,YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN,c2.CGP_ chemical and genetic perturbations
7802,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
7803,MORF_THPO,c4.CGN_ cancer gene neighborhoods
7804,DELACROIX_RAR_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
7805,REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE,c2.CP_REACTOME_ Reactome gene sets
7806,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,c2.CGP_ chemical and genetic perturbations
7807,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP,C7_ immunologic signatures
7808,GO_NEGATIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,c5.BP_ GO biological process
7809,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,C7_ immunologic signatures
7810,GO_RESPONSE_TO_TRANSITION_METAL_NANOPARTICLE,c5.BP_ GO biological process
7811,TITF1_Q3,c3.TFT_ transcription factor targets
7812,MODULE_177,c4.CM_ cancer modules
7813,GCM_PTPRD,c4.CGN_ cancer gene neighborhoods
7814,GO_POSITIVE_T_CELL_SELECTION,c5.BP_ GO biological process
7815,GO_TONGUE_DEVELOPMENT,c5.BP_ GO biological process
7816,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,C7_ immunologic signatures
7817,STEGER_ADIPOGENESIS_UP,c2.CGP_ chemical and genetic perturbations
7818,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP,C7_ immunologic signatures
7819,E47_01,c3.TFT_ transcription factor targets
7820,GSE22886_TH1_VS_TH2_12H_ACT_UP,C7_ immunologic signatures
7821,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,C7_ immunologic signatures
7822,MAYBURD_RESPONSE_TO_L663536_DN,c2.CGP_ chemical and genetic perturbations
7823,GO_VESICLE_ORGANIZATION,c5.BP_ GO biological process
7824,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP,C7_ immunologic signatures
7825,GO_POSITIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING,c5.BP_ GO biological process
7826,GSE27786_CD4_TCELL_VS_NKCELL_UP,C7_ immunologic signatures
7827,NOUZOVA_METHYLATED_IN_APL,c2.CGP_ chemical and genetic perturbations
7828,GO_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,c5.BP_ GO biological process
7829,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_UP,C7_ immunologic signatures
7830,GO_MEGAKARYOCYTE_DEVELOPMENT,c5.BP_ GO biological process
7831,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_UP,C7_ immunologic signatures
7832,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,C7_ immunologic signatures
7833,REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS,c2.CP_REACTOME_ Reactome gene sets
7834,CADWELL_ATG16L1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
7835,GO_AGGRESOME,c5.CC_ GO cellular component
7836,GO_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,c5.BP_ GO biological process
7837,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_DN,C7_ immunologic signatures
7838,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN,C7_ immunologic signatures
7839,GO_POSITIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,c5.BP_ GO biological process
7840,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP,C7_ immunologic signatures
7841,CCAATNNSNNNGCG_UNKNOWN,c3.TFT_ transcription factor targets
7842,GO_COBALAMIN_METABOLIC_PROCESS,c5.BP_ GO biological process
7843,LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP,c2.CGP_ chemical and genetic perturbations
7844,GSE3982_MAC_VS_NEUTROPHIL_UP,C7_ immunologic signatures
7845,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,c2.CGP_ chemical and genetic perturbations
7846,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP,C7_ immunologic signatures
7847,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP,C7_ immunologic signatures
7848,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,C7_ immunologic signatures
7849,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP,C7_ immunologic signatures
7850,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,c2.CGP_ chemical and genetic perturbations
7851,GSE17721_LPS_VS_POLYIC_4H_BMDC_UP,C7_ immunologic signatures
7852,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,C7_ immunologic signatures
7853,GO_KERATIN_FILAMENT,c5.CC_ GO cellular component
7854,GO_LYMPHOCYTE_HOMEOSTASIS,c5.BP_ GO biological process
7855,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,c2.CGP_ chemical and genetic perturbations
7856,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN,C7_ immunologic signatures
7857,GO_BICARBONATE_TRANSPORT,c5.BP_ GO biological process
7858,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_UP,C7_ immunologic signatures
7859,GO_MONOSACCHARIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
7860,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP,C7_ immunologic signatures
7861,GNF2_CD14,c4.CGN_ cancer gene neighborhoods
7862,REACTOME_SIGNALING_BY_HIPPO,c2.CP_REACTOME_ Reactome gene sets
7863,GO_DNA_POLYMERASE_ACTIVITY,c5.GO molecular function
7864,GSE24142_DN2_VS_DN3_THYMOCYTE_DN,C7_ immunologic signatures
7865,WORSCHECH_TUMOR_REJECTION_UP,c2.CGP_ chemical and genetic perturbations
7866,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP,C7_ immunologic signatures
7867,REACTOME_PIP3_ACTIVATES_AKT_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
7868,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_DN,C7_ immunologic signatures
7869,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP,C7_ immunologic signatures
7870,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP,C7_ immunologic signatures
7871,GO_VENTRICULAR_SEPTUM_MORPHOGENESIS,c5.BP_ GO biological process
7872,GO_PANCREAS_DEVELOPMENT,c5.BP_ GO biological process
7873,GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN,C7_ immunologic signatures
7874,GO_POSITIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
7875,IGARASHI_ATF4_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
7876,REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES,c2.CP_REACTOME_ Reactome gene sets
7877,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_DN,C7_ immunologic signatures
7878,MODULE_94,c4.CM_ cancer modules
7879,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN,C7_ immunologic signatures
7880,GSE27786_LSK_VS_BCELL_UP,C7_ immunologic signatures
7881,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP,C7_ immunologic signatures
7882,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP,c2.CGP_ chemical and genetic perturbations
7883,WANG_HCP_PROSTATE_CANCER,c2.CGP_ chemical and genetic perturbations
7884,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN,C7_ immunologic signatures
7885,GO_ATPASE_COUPLED_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
7886,GO_REGULATION_OF_EPIDERMIS_DEVELOPMENT,c5.BP_ GO biological process
7887,GO_CRANIAL_NERVE_MORPHOGENESIS,c5.BP_ GO biological process
7888,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_UP,C7_ immunologic signatures
7889,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_DN,C7_ immunologic signatures
7890,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP,C7_ immunologic signatures
7891,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP,C7_ immunologic signatures
7892,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_DN,C7_ immunologic signatures
7893,GO_N_ACETYLTRANSFERASE_ACTIVITY,c5.GO molecular function
7894,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,C7_ immunologic signatures
7895,GATA_Q6,c3.TFT_ transcription factor targets
7896,GO_JNK_CASCADE,c5.BP_ GO biological process
7897,REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
7898,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
7899,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_UP,C7_ immunologic signatures
7900,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP,C7_ immunologic signatures
7901,ATGTCAC_MIR489,c3.MIR_ microRNA targets
7902,GO_NUCLEAR_MEMBRANE,c5.CC_ GO cellular component
7903,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP,C7_ immunologic signatures
7904,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_DN,C7_ immunologic signatures
7905,GO_KERATAN_SULFATE_METABOLIC_PROCESS,c5.BP_ GO biological process
7906,GO_ANCHORED_COMPONENT_OF_PLASMA_MEMBRANE,c5.CC_ GO cellular component
7907,GO_ANDROGEN_METABOLIC_PROCESS,c5.BP_ GO biological process
7908,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,c2.CGP_ chemical and genetic perturbations
7909,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,c2.CGP_ chemical and genetic perturbations
7910,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN,C7_ immunologic signatures
7911,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
7912,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN,C7_ immunologic signatures
7913,JOHNSTONE_PARVB_TARGETS_3_UP,c2.CGP_ chemical and genetic perturbations
7914,YAGI_AML_WITH_INV_16_TRANSLOCATION,c2.CGP_ chemical and genetic perturbations
7915,GO_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION,c5.BP_ GO biological process
7916,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
7917,GO_NEUROPEPTIDE_SIGNALING_PATHWAY,c5.BP_ GO biological process
7918,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,C7_ immunologic signatures
7919,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP,C7_ immunologic signatures
7920,GO_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
7921,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
7922,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_DN,C7_ immunologic signatures
7923,JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP,c2.CGP_ chemical and genetic perturbations
7924,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN,C7_ immunologic signatures
7925,CREB_01,c3.TFT_ transcription factor targets
7926,ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY,c2.CP_ Canonical pathways
7927,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP,C7_ immunologic signatures
7928,GO_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,c5.GO molecular function
7929,MODULE_261,c4.CM_ cancer modules
7930,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
7931,KRAS.AMP.LUNG_UP.V1_UP,C6_ oncogenic signatures
7932,GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN,C7_ immunologic signatures
7933,GO_MAMMARY_GLAND_EPITHELIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
7934,PPAR_DR1_Q2,c3.TFT_ transcription factor targets
7935,DAIRKEE_CANCER_PRONE_RESPONSE_BPA,c2.CGP_ chemical and genetic perturbations
7936,LEE_EARLY_T_LYMPHOCYTE_DN,c2.CGP_ chemical and genetic perturbations
7937,GO_ERYTHROCYTE_DEVELOPMENT,c5.BP_ GO biological process
7938,ROSS_AML_WITH_CBFB_MYH11_FUSION,c2.CGP_ chemical and genetic perturbations
7939,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,C7_ immunologic signatures
7940,SANSOM_APC_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
7941,NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN,c2.CGP_ chemical and genetic perturbations
7942,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
7943,MANTOVANI_NFKB_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
7944,GCM_ATM,c4.CGN_ cancer gene neighborhoods
7945,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_UP,C7_ immunologic signatures
7946,GO_GLUCOSAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
7947,IK1_01,c3.TFT_ transcription factor targets
7948,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,C7_ immunologic signatures
7949,GO_NERVE_DEVELOPMENT,c5.BP_ GO biological process
7950,ATTACAT_MIR3803P,c3.MIR_ microRNA targets
7951,WIERENGA_STAT5A_TARGETS_GROUP1,c2.CGP_ chemical and genetic perturbations
7952,WINTER_HYPOXIA_METAGENE,c2.CGP_ chemical and genetic perturbations
7953,GSE3982_MAST_CELL_VS_DC_UP,C7_ immunologic signatures
7954,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN,C7_ immunologic signatures
7955,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
7956,ZF5_01,c3.TFT_ transcription factor targets
7957,GO_LIPOSACCHARIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
7958,GO_CYTOKINE_RECEPTOR_BINDING,c5.GO molecular function
7959,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,C7_ immunologic signatures
7960,JIANG_AGING_HYPOTHALAMUS_DN,c2.CGP_ chemical and genetic perturbations
7961,REACTOME_ADP_SIGNALLING_THROUGH_P2RY1,c2.CP_REACTOME_ Reactome gene sets
7962,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_UP,C7_ immunologic signatures
7963,GO_PROTEIN_PHOSPHATASE_BINDING,c5.GO molecular function
7964,GNF2_PAK2,c4.CGN_ cancer gene neighborhoods
7965,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP,C7_ immunologic signatures
7966,MORF_DDX11,c4.CGN_ cancer gene neighborhoods
7967,GO_SIGNALING_ADAPTOR_ACTIVITY,c5.GO molecular function
7968,GO_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
7969,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP,C7_ immunologic signatures
7970,SP3_Q3,c3.TFT_ transcription factor targets
7971,GO_POLYUBIQUITIN_BINDING,c5.GO molecular function
7972,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN,C7_ immunologic signatures
7973,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_DN,C7_ immunologic signatures
7974,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_UP,C7_ immunologic signatures
7975,CHR3Q26,45
7976,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,C7_ immunologic signatures
7977,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,C7_ immunologic signatures
7978,CHIN_BREAST_CANCER_COPY_NUMBER_UP,c2.CGP_ chemical and genetic perturbations
7979,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,C7_ immunologic signatures
7980,LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,c2.CGP_ chemical and genetic perturbations
7981,GO_RESPIRATORY_GASEOUS_EXCHANGE,c5.BP_ GO biological process
7982,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,C7_ immunologic signatures
7983,GO_NEGATIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING,c5.BP_ GO biological process
7984,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP,C7_ immunologic signatures
7985,BILD_HRAS_ONCOGENIC_SIGNATURE,c2.CGP_ chemical and genetic perturbations
7986,GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP,C7_ immunologic signatures
7987,PID_DELTA_NP63_PATHWAY,c2.CP_ Canonical pathways
7988,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,C7_ immunologic signatures
7989,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN,C7_ immunologic signatures
7990,GSE2706_R848_VS_LPS_2H_STIM_DC_UP,C7_ immunologic signatures
7991,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_UP,C7_ immunologic signatures
7992,ST_MYOCYTE_AD_PATHWAY,c2.CP_ Canonical pathways
7993,LAIHO_COLORECTAL_CANCER_SERRATED_DN,c2.CGP_ chemical and genetic perturbations
7994,GO_REGULATION_OF_PLASMA_MEMBRANE_ORGANIZATION,c5.BP_ GO biological process
7995,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP,c2.CGP_ chemical and genetic perturbations
7996,EPPERT_LSC_R,c2.CGP_ chemical and genetic perturbations
7997,GO_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
7998,GSE7852_THYMUS_VS_FAT_TREG_UP,C7_ immunologic signatures
7999,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP,C7_ immunologic signatures
8000,GO_INORGANIC_ION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
8001,BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,c2.CGP_ chemical and genetic perturbations
8002,MIKKELSEN_MCV6_ICP_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
8003,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,C7_ immunologic signatures
8004,CHR7Q11,68
8005,GO_EXOCYTIC_VESICLE,c5.CC_ GO cellular component
8006,DARWICHE_PAPILLOMA_RISK_LOW_DN,c2.CGP_ chemical and genetic perturbations
8007,HAMAI_APOPTOSIS_VIA_TRAIL_DN,c2.CGP_ chemical and genetic perturbations
8008,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP,C7_ immunologic signatures
8009,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_UP,C7_ immunologic signatures
8010,GO_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
8011,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN,C7_ immunologic signatures
8012,GO_ENDORIBONUCLEASE_ACTIVITY,c5.GO molecular function
8013,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP,C7_ immunologic signatures
8014,GSE6259_33D1_POS_DC_VS_BCELL_UP,C7_ immunologic signatures
8015,GO_RETINA_VASCULATURE_DEVELOPMENT_IN_CAMERA_TYPE_EYE,c5.BP_ GO biological process
8016,GO_CLUSTER_OF_ACTIN_BASED_CELL_PROJECTIONS,c5.CC_ GO cellular component
8017,GSE27786_LSK_VS_NKCELL_UP,C7_ immunologic signatures
8018,REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR,c2.CP_REACTOME_ Reactome gene sets
8019,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_UP,C7_ immunologic signatures
8020,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,C7_ immunologic signatures
8021,GO_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,c5.BP_ GO biological process
8022,HOX13_01,c3.TFT_ transcription factor targets
8023,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_UP,C7_ immunologic signatures
8024,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,C7_ immunologic signatures
8025,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN,C7_ immunologic signatures
8026,CHR6Q21,47
8027,GO_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,c5.BP_ GO biological process
8028,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_UP,C7_ immunologic signatures
8029,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN,C7_ immunologic signatures
8030,REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR,c2.CP_REACTOME_ Reactome gene sets
8031,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN,c2.CGP_ chemical and genetic perturbations
8032,GO_POSITIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,c5.BP_ GO biological process
8033,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN,C7_ immunologic signatures
8034,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,c2.CGP_ chemical and genetic perturbations
8035,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_UP,C7_ immunologic signatures
8036,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN,C7_ immunologic signatures
8037,CHR3P26,18
8038,MEL18_DN.V1_UP,C6_ oncogenic signatures
8039,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN,C7_ immunologic signatures
8040,YANG_BREAST_CANCER_ESR1_UP,c2.CGP_ chemical and genetic perturbations
8041,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_DN,C7_ immunologic signatures
8042,TTF1_Q6,c3.TFT_ transcription factor targets
8043,GSE20715_0H_VS_24H_OZONE_LUNG_UP,C7_ immunologic signatures
8044,GR_Q6_01,c3.TFT_ transcription factor targets
8045,GNF2_TM4SF2,c4.CGN_ cancer gene neighborhoods
8046,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
8047,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_DN,C7_ immunologic signatures
8048,GO_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,c5.BP_ GO biological process
8049,GO_ENSHEATHMENT_OF_NEURONS,c5.BP_ GO biological process
8050,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_UP,C7_ immunologic signatures
8051,PID_CONE_PATHWAY,c2.CP_ Canonical pathways
8052,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_UP,C7_ immunologic signatures
8053,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,C7_ immunologic signatures
8054,GO_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
8055,MORF_CDC2L5,c4.CGN_ cancer gene neighborhoods
8056,GO_DETECTION_OF_STIMULUS,c5.BP_ GO biological process
8057,GO_REGULATION_OF_PROTEIN_STABILITY,c5.BP_ GO biological process
8058,GSE339_CD4POS_VS_CD4CD8DN_DC_DN,C7_ immunologic signatures
8059,POS_HISTAMINE_RESPONSE_NETWORK,c2.CGP_ chemical and genetic perturbations
8060,WIKMAN_ASBESTOS_LUNG_CANCER_DN,c2.CGP_ chemical and genetic perturbations
8061,GSE13493_DP_VS_CD8POS_THYMOCYTE_UP,C7_ immunologic signatures
8062,GO_AMELOGENESIS,c5.BP_ GO biological process
8063,GO_NEGATIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,c5.BP_ GO biological process
8064,GNF2_PTX3,c4.CGN_ cancer gene neighborhoods
8065,GO_THIOL_DEPENDENT_UBIQUITIN_SPECIFIC_PROTEASE_ACTIVITY,c5.GO molecular function
8066,GO_ACTIN_FILAMENT_BUNDLE_ORGANIZATION,c5.BP_ GO biological process
8067,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN,C7_ immunologic signatures
8068,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
8069,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_UP,C7_ immunologic signatures
8070,CHR7P13,30
8071,CHR2Q11,46
8072,GO_NEGATIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
8073,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,C7_ immunologic signatures
8074,GO_GLYCOSYL_COMPOUND_CATABOLIC_PROCESS,c5.BP_ GO biological process
8075,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,c2.CGP_ chemical and genetic perturbations
8076,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_UP,C7_ immunologic signatures
8077,GO_RESPONSE_TO_FUNGUS,c5.BP_ GO biological process
8078,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_UP,C7_ immunologic signatures
8079,YAGI_AML_WITH_11Q23_REARRANGED,c2.CGP_ chemical and genetic perturbations
8080,BROWNE_HCMV_INFECTION_14HR_DN,c2.CGP_ chemical and genetic perturbations
8081,KEGG_CARDIAC_MUSCLE_CONTRACTION,c2.CP_BIOCARTA_ BioCarta gene sets
8082,GO_POSITIVE_REGULATION_OF_PROTEIN_SECRETION,c5.BP_ GO biological process
8083,MODULE_532,c4.CM_ cancer modules
8084,GCM_PTK2,c4.CGN_ cancer gene neighborhoods
8085,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP,C7_ immunologic signatures
8086,OZEN_MIR125B1_TARGETS,c2.CGP_ chemical and genetic perturbations
8087,GO_MELANOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
8088,GO_RECEPTOR_METABOLIC_PROCESS,c5.BP_ GO biological process
8089,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN,C7_ immunologic signatures
8090,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN,C7_ immunologic signatures
8091,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,C7_ immunologic signatures
8092,GSE6681_DELETED_FOXP3_VS_WT_TREG_DN,C7_ immunologic signatures
8093,GO_GUANYL_NUCLEOTIDE_BINDING,c5.GO molecular function
8094,GSE360_L_MAJOR_VS_T_GONDII_MAC_UP,C7_ immunologic signatures
8095,GO_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING,c5.GO molecular function
8096,GO_REGULATION_OF_SYNAPTIC_VESICLE_TRANSPORT,c5.BP_ GO biological process
8097,GSE360_L_DONOVANI_VS_T_GONDII_DC_UP,C7_ immunologic signatures
8098,MCCLUNG_CREB1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
8099,GO_MAP_KINASE_KINASE_KINASE_ACTIVITY,c5.GO molecular function
8100,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
8101,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP,C7_ immunologic signatures
8102,GNF2_CYP2B6,c4.CGN_ cancer gene neighborhoods
8103,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN,C7_ immunologic signatures
8104,CHR3P22,51
8105,GO_DICARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
8106,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN,C7_ immunologic signatures
8107,REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE,c2.CP_REACTOME_ Reactome gene sets
8108,CREL_01,c3.TFT_ transcription factor targets
8109,ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS,c2.CP_ Canonical pathways
8110,ALFANO_MYC_TARGETS,c2.CGP_ chemical and genetic perturbations
8111,GO_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
8112,GO_POSITIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
8113,NAGASHIMA_EGF_SIGNALING_UP,c2.CGP_ chemical and genetic perturbations
8114,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_DN,C7_ immunologic signatures
8115,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,C7_ immunologic signatures
8116,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
8117,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP,C7_ immunologic signatures
8118,STAT_01,c3.TFT_ transcription factor targets
8119,GO_CAMP_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
8120,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,c2.CGP_ chemical and genetic perturbations
8121,GO_LYSINE_N_METHYLTRANSFERASE_ACTIVITY,c5.GO molecular function
8122,STAT_Q6,c3.TFT_ transcription factor targets
8123,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP,C7_ immunologic signatures
8124,GSE38304_MYC_NEG_VS_POS_GC_BCELL_DN,C7_ immunologic signatures
8125,GO_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING,c5.GO molecular function
8126,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,C7_ immunologic signatures
8127,GO_SYNCYTIUM_FORMATION,c5.BP_ GO biological process
8128,GO_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,c5.BP_ GO biological process
8129,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP,C7_ immunologic signatures
8130,GO_STAT_CASCADE,c5.BP_ GO biological process
8131,GO_REGULATION_OF_CELLULAR_EXTRAVASATION,c5.BP_ GO biological process
8132,GO_RESPONSE_TO_NITRIC_OXIDE,c5.BP_ GO biological process
8133,WANG_TUMOR_INVASIVENESS_DN,c2.CGP_ chemical and genetic perturbations
8134,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
8135,GCM_RBM8A,c4.CGN_ cancer gene neighborhoods
8136,CHANDRAN_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
8137,YAMASHITA_METHYLATED_IN_PROSTATE_CANCER,c2.CGP_ chemical and genetic perturbations
8138,ESC_J1_UP_LATE.V1_DN,C6_ oncogenic signatures
8139,GO_CELLULAR_CHEMICAL_HOMEOSTASIS,c5.BP_ GO biological process
8140,GSE3982_EOSINOPHIL_VS_MAC_UP,C7_ immunologic signatures
8141,GO_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY,c5.GO molecular function
8142,NFKAPPAB_01,c3.TFT_ transcription factor targets
8143,GO_SOLUTE_CATION_ANTIPORTER_ACTIVITY,c5.GO molecular function
8144,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP,C7_ immunologic signatures
8145,GSE11057_CD4_EFF_MEM_VS_PBMC_DN,C7_ immunologic signatures
8146,GO_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,c5.BP_ GO biological process
8147,WHN_B,c3.TFT_ transcription factor targets
8148,GO_POSITIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,c5.BP_ GO biological process
8149,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP,C7_ immunologic signatures
8150,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN,C7_ immunologic signatures
8151,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN,C7_ immunologic signatures
8152,GO_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
8153,GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN,C7_ immunologic signatures
8154,GO_GOLGI_CISTERNA_MEMBRANE,c5.CC_ GO cellular component
8155,GO_LATE_ENDOSOME,c5.CC_ GO cellular component
8156,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN,C7_ immunologic signatures
8157,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP,c2.CGP_ chemical and genetic perturbations
8158,HUPER_BREAST_BASAL_VS_LUMINAL_DN,c2.CGP_ chemical and genetic perturbations
8159,LINSLEY_MIR16_TARGETS,c2.CGP_ chemical and genetic perturbations
8160,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_UP,C7_ immunologic signatures
8161,BAE_BRCA1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
8162,GO_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
8163,GO_NEGATIVE_REGULATION_OF_HEART_CONTRACTION,c5.BP_ GO biological process
8164,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_UP,C7_ immunologic signatures
8165,BIOCARTA_HIVNEF_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
8166,TIEN_INTESTINE_PROBIOTICS_2HR_DN,c2.CGP_ chemical and genetic perturbations
8167,ZUCCHI_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
8168,LEE_LIVER_CANCER,c2.CGP_ chemical and genetic perturbations
8169,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,c2.CGP_ chemical and genetic perturbations
8170,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_DN,C7_ immunologic signatures
8171,GO_BONE_GROWTH,c5.BP_ GO biological process
8172,GTTATAT_MIR410,c3.MIR_ microRNA targets
8173,GENTILE_UV_RESPONSE_CLUSTER_D9,c2.CGP_ chemical and genetic perturbations
8174,JACKSON_DNMT1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
8175,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,C7_ immunologic signatures
8176,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,c2.CGP_ chemical and genetic perturbations
8177,GO_RESPONSE_TO_ISCHEMIA,c5.BP_ GO biological process
8178,MODULE_334,c4.CM_ cancer modules
8179,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP,C7_ immunologic signatures
8180,MODULE_294,c4.CM_ cancer modules
8181,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,C7_ immunologic signatures
8182,HOXA9_DN.V1_DN,C6_ oncogenic signatures
8183,MULLIGHAN_MLL_SIGNATURE_1_UP,c2.CGP_ chemical and genetic perturbations
8184,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
8185,GO_REGULATION_OF_CELL_FATE_COMMITMENT,c5.BP_ GO biological process
8186,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,c2.CGP_ chemical and genetic perturbations
8187,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,C7_ immunologic signatures
8188,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,C7_ immunologic signatures
8189,CHR5Q14,32
8190,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,c2.CGP_ chemical and genetic perturbations
8191,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,C7_ immunologic signatures
8192,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN,C7_ immunologic signatures
8193,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,C7_ immunologic signatures
8194,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_DN,C7_ immunologic signatures
8195,RUTELLA_RESPONSE_TO_HGF_UP,c2.CGP_ chemical and genetic perturbations
8196,GO_PRESYNAPSE,c5.CC_ GO cellular component
8197,LU_TUMOR_ENDOTHELIAL_MARKERS_UP,c2.CGP_ chemical and genetic perturbations
8198,GO_METAL_ION_TRANSPORT,c5.BP_ GO biological process
8199,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,C7_ immunologic signatures
8200,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN,C7_ immunologic signatures
8201,GO_LEUKOCYTE_HOMEOSTASIS,c5.BP_ GO biological process
8202,AUNG_GASTRIC_CANCER,c2.CGP_ chemical and genetic perturbations
8203,GO_PARTURITION,c5.BP_ GO biological process
8204,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_UP,C7_ immunologic signatures
8205,GO_SERINE_HYDROLASE_ACTIVITY,c5.GO molecular function
8206,GO_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
8207,GO_POSITIVE_REGULATION_OF_PROTEOLYSIS,c5.BP_ GO biological process
8208,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_DN,C7_ immunologic signatures
8209,SCHRAMM_INHBA_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
8210,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN,C7_ immunologic signatures
8211,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP,C7_ immunologic signatures
8212,GSE14699_NAIVE_VS_ACT_CD8_TCELL_UP,C7_ immunologic signatures
8213,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN,C7_ immunologic signatures
8214,GO_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,c5.BP_ GO biological process
8215,GO_THYMOCYTE_AGGREGATION,c5.BP_ GO biological process
8216,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP,C7_ immunologic signatures
8217,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
8218,GO_INDOLALKYLAMINE_METABOLIC_PROCESS,c5.BP_ GO biological process
8219,GO_VESICLE_MEDIATED_TRANSPORT_BETWEEN_ENDOSOMAL_COMPARTMENTS,c5.BP_ GO biological process
8220,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP,c2.CGP_ chemical and genetic perturbations
8221,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN,C7_ immunologic signatures
8222,EVI1_03,c3.TFT_ transcription factor targets
8223,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,c2.CGP_ chemical and genetic perturbations
8224,ZHAN_MULTIPLE_MYELOMA_CD2_UP,c2.CGP_ chemical and genetic perturbations
8225,GO_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING,c5.BP_ GO biological process
8226,MTOR_UP.V1_UP,C6_ oncogenic signatures
8227,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN,C7_ immunologic signatures
8228,GO_CATION_CHANNEL_ACTIVITY,c5.GO molecular function
8229,GO_REGULATION_OF_PROTEIN_SECRETION,c5.BP_ GO biological process
8230,GO_DNA_METHYLATION_INVOLVED_IN_GAMETE_GENERATION,c5.BP_ GO biological process
8231,GO_HUMORAL_IMMUNE_RESPONSE,c5.BP_ GO biological process
8232,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_DN,C7_ immunologic signatures
8233,GO_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
8234,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_DN,C7_ immunologic signatures
8235,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN,C7_ immunologic signatures
8236,GGGNRMNNYCAT_UNKNOWN,c3.TFT_ transcription factor targets
8237,GNF2_MCM5,c4.CGN_ cancer gene neighborhoods
8238,MORF_FANCG,c4.CGN_ cancer gene neighborhoods
8239,GO_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY,c5.GO molecular function
8240,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,C7_ immunologic signatures
8241,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_DN,C7_ immunologic signatures
8242,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,C7_ immunologic signatures
8243,GO_CANONICAL_WNT_SIGNALING_PATHWAY,c5.BP_ GO biological process
8244,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP,C7_ immunologic signatures
8245,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
8246,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
8247,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_DN,C7_ immunologic signatures
8248,GO_NEGATIVE_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
8249,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN,C7_ immunologic signatures
8250,GSE28408_LY6G_POS_VS_NEG_DC_UP,C7_ immunologic signatures
8251,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP,C7_ immunologic signatures
8252,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP,C7_ immunologic signatures
8253,GO_PROTEIN_K48_LINKED_UBIQUITINATION,c5.BP_ GO biological process
8254,SP1_Q6,c3.TFT_ transcription factor targets
8255,PTEN_DN.V2_UP,C6_ oncogenic signatures
8256,GSE3039_CD4_TCELL_VS_B1_BCELL_UP,C7_ immunologic signatures
8257,PID_AR_NONGENOMIC_PATHWAY,c2.CP_ Canonical pathways
8258,GO_AU_RICH_ELEMENT_BINDING,c5.GO molecular function
8259,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP,C7_ immunologic signatures
8260,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,C7_ immunologic signatures
8261,MORF_PSMF1,c4.CGN_ cancer gene neighborhoods
8262,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN,C7_ immunologic signatures
8263,GSE11057_CD4_CENT_MEM_VS_PBMC_UP,C7_ immunologic signatures
8264,GSE3982_NEUTROPHIL_VS_TH2_UP,C7_ immunologic signatures
8265,GO_BINDING_BRIDGING,c5.GO molecular function
8266,MA_MYELOID_DIFFERENTIATION_UP,c2.CGP_ chemical and genetic perturbations
8267,GSE25087_TREG_VS_TCONV_FETUS_DN,C7_ immunologic signatures
8268,VALK_AML_CLUSTER_7,c2.CGP_ chemical and genetic perturbations
8269,LEE_AGING_CEREBELLUM_UP,c2.CGP_ chemical and genetic perturbations
8270,GO_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,c5.BP_ GO biological process
8271,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_UP,C7_ immunologic signatures
8272,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_UP,C7_ immunologic signatures
8273,GO_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,c5.BP_ GO biological process
8274,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP,C7_ immunologic signatures
8275,GO_RETINAL_GANGLION_CELL_AXON_GUIDANCE,c5.BP_ GO biological process
8276,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,C7_ immunologic signatures
8277,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_DN,C7_ immunologic signatures
8278,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,C7_ immunologic signatures
8279,GO_RESPONSE_TO_COPPER_ION,c5.BP_ GO biological process
8280,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP,C7_ immunologic signatures
8281,GO_RESPONSE_TO_CARBOHYDRATE,c5.BP_ GO biological process
8282,REACTOME_CIRCADIAN_CLOCK,c2.CP_REACTOME_ Reactome gene sets
8283,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP,c2.CGP_ chemical and genetic perturbations
8284,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
8285,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP,C7_ immunologic signatures
8286,GO_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS,c5.BP_ GO biological process
8287,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,C7_ immunologic signatures
8288,GO_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION,c5.BP_ GO biological process
8289,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,c2.CGP_ chemical and genetic perturbations
8290,GO_EPITHELIAL_CELL_MORPHOGENESIS,c5.BP_ GO biological process
8291,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,C7_ immunologic signatures
8292,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,c2.CGP_ chemical and genetic perturbations
8293,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP,C7_ immunologic signatures
8294,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,c2.CP_REACTOME_ Reactome gene sets
8295,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN,C7_ immunologic signatures
8296,REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS,c2.CP_REACTOME_ Reactome gene sets
8297,COREBINDINGFACTOR_Q6,c3.TFT_ transcription factor targets
8298,CHR1Q24,33
8299,GSE3982_BCELL_VS_TH2_UP,C7_ immunologic signatures
8300,GO_ENDOTHELIUM_DEVELOPMENT,c5.BP_ GO biological process
8301,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,c2.CGP_ chemical and genetic perturbations
8302,ATGCTGC_MIR103_MIR107,c3.MIR_ microRNA targets
8303,GSE3039_NKT_CELL_VS_B1_BCELL_DN,C7_ immunologic signatures
8304,REACTOME_SIGNALING_BY_SCF_KIT,c2.CP_REACTOME_ Reactome gene sets
8305,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN,C7_ immunologic signatures
8306,GO_ENDOCYTOSIS,c5.BP_ GO biological process
8307,GO_3_5_EXONUCLEASE_ACTIVITY,c5.GO molecular function
8308,GO_LIPID_LOCALIZATION,c5.BP_ GO biological process
8309,YGCGYRCGC_UNKNOWN,c3.TFT_ transcription factor targets
8310,GO_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS,c5.BP_ GO biological process
8311,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_DN,C7_ immunologic signatures
8312,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN,C7_ immunologic signatures
8313,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,C7_ immunologic signatures
8314,LEE_AGING_MUSCLE_DN,c2.CGP_ chemical and genetic perturbations
8315,PID_PS1_PATHWAY,c2.CP_ Canonical pathways
8316,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,C7_ immunologic signatures
8317,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN,C7_ immunologic signatures
8318,SYED_ESTRADIOL_RESPONSE,c2.CGP_ chemical and genetic perturbations
8319,GO_NEGATIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT,c5.BP_ GO biological process
8320,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP,c2.CGP_ chemical and genetic perturbations
8321,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN,C7_ immunologic signatures
8322,GO_BLOOD_MICROPARTICLE,c5.CC_ GO cellular component
8323,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,C7_ immunologic signatures
8324,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,C7_ immunologic signatures
8325,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_UP,C7_ immunologic signatures
8326,GO_PROTEIN_LIPID_COMPLEX_SUBUNIT_ORGANIZATION,c5.BP_ GO biological process
8327,GO_MIDDLE_EAR_MORPHOGENESIS,c5.BP_ GO biological process
8328,GO_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,c5.BP_ GO biological process
8329,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP,C7_ immunologic signatures
8330,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP,C7_ immunologic signatures
8331,ROVERSI_GLIOMA_COPY_NUMBER_DN,c2.CGP_ chemical and genetic perturbations
8332,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_UP,C7_ immunologic signatures
8333,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN,C7_ immunologic signatures
8334,GO_CELL_PROJECTION_ASSEMBLY,c5.BP_ GO biological process
8335,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
8336,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_UP,C7_ immunologic signatures
8337,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_UP,C7_ immunologic signatures
8338,GO_EXOPEPTIDASE_ACTIVITY,c5.GO molecular function
8339,CUI_TCF21_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
8340,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_DN,C7_ immunologic signatures
8341,OCT1_Q5_01,c3.TFT_ transcription factor targets
8342,PENG_RAPAMYCIN_RESPONSE_UP,c2.CGP_ chemical and genetic perturbations
8343,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,C7_ immunologic signatures
8344,GO_RHO_PROTEIN_SIGNAL_TRANSDUCTION,c5.BP_ GO biological process
8345,GO_EMBRYONIC_PLACENTA_DEVELOPMENT,c5.BP_ GO biological process
8346,GO_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
8347,GSE360_CTRL_VS_T_GONDII_DC_UP,C7_ immunologic signatures
8348,GO_REGULATION_OF_LYMPHOCYTE_MIGRATION,c5.BP_ GO biological process
8349,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,C7_ immunologic signatures
8350,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_UP,C7_ immunologic signatures
8351,OCT_Q6,c3.TFT_ transcription factor targets
8352,GO_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT,c5.BP_ GO biological process
8353,BIOCARTA_DEATH_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
8354,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_DN,C7_ immunologic signatures
8355,GSE27786_BCELL_VS_NKTCELL_DN,C7_ immunologic signatures
8356,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP,C7_ immunologic signatures
8357,ACTACCT_MIR196A_MIR196B,c3.MIR_ microRNA targets
8358,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_UP,C7_ immunologic signatures
8359,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,C7_ immunologic signatures
8360,GO_INTRASPECIES_INTERACTION_BETWEEN_ORGANISMS,c5.BP_ GO biological process
8361,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN,C7_ immunologic signatures
8362,GO_CHROMATIN_REMODELING,c5.BP_ GO biological process
8363,REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS,c2.CP_REACTOME_ Reactome gene sets
8364,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
8365,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_DN,C7_ immunologic signatures
8366,GO_REGULATION_OF_GLUCONEOGENESIS,c5.BP_ GO biological process
8367,WU_ALZHEIMER_DISEASE_DN,c2.CGP_ chemical and genetic perturbations
8368,GNF2_MYL2,c4.CGN_ cancer gene neighborhoods
8369,GO_RENAL_SYSTEM_VASCULATURE_DEVELOPMENT,c5.BP_ GO biological process
8370,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
8371,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN,C7_ immunologic signatures
8372,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP,C7_ immunologic signatures
8373,SHEN_SMARCA2_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
8374,PU1_Q6,c3.TFT_ transcription factor targets
8375,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_UP,C7_ immunologic signatures
8376,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP,C7_ immunologic signatures
8377,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN,C7_ immunologic signatures
8378,TRACEY_RESISTANCE_TO_IFNA2_DN,c2.CGP_ chemical and genetic perturbations
8379,GO_REGULATION_OF_COFACTOR_METABOLIC_PROCESS,c5.BP_ GO biological process
8380,GO_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY,c5.BP_ GO biological process
8381,GO_HISTONE_H3_K4_METHYLATION,c5.BP_ GO biological process
8382,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,c2.CGP_ chemical and genetic perturbations
8383,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,C7_ immunologic signatures
8384,GSE17721_CTRL_VS_POLYIC_4H_BMDC_UP,C7_ immunologic signatures
8385,MORF_CASP2,c4.CGN_ cancer gene neighborhoods
8386,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_UP,C7_ immunologic signatures
8387,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_UP,C7_ immunologic signatures
8388,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,c2.CGP_ chemical and genetic perturbations
8389,LEE_LIVER_CANCER_SURVIVAL_UP,c2.CGP_ chemical and genetic perturbations
8390,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN,C7_ immunologic signatures
8391,RODRIGUES_NTN1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
8392,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,c2.CGP_ chemical and genetic perturbations
8393,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
8394,EIF4E_DN,C6_ oncogenic signatures
8395,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP,C7_ immunologic signatures
8396,GO_REGULATION_OF_ARF_PROTEIN_SIGNAL_TRANSDUCTION,c5.BP_ GO biological process
8397,BRUINS_UVC_RESPONSE_MIDDLE,c2.CGP_ chemical and genetic perturbations
8398,NAKAMURA_CANCER_MICROENVIRONMENT_UP,c2.CGP_ chemical and genetic perturbations
8399,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN,C7_ immunologic signatures
8400,MORF_RBM8A,c4.CGN_ cancer gene neighborhoods
8401,GSE3039_NKT_CELL_VS_B2_BCELL_DN,C7_ immunologic signatures
8402,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN,C7_ immunologic signatures
8403,GO_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS,c5.BP_ GO biological process
8404,MARSON_FOXP3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
8405,GO_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,c5.BP_ GO biological process
8406,LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,c2.CGP_ chemical and genetic perturbations
8407,STEARMAN_TUMOR_FIELD_EFFECT_UP,c2.CGP_ chemical and genetic perturbations
8408,GO_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,c5.BP_ GO biological process
8409,KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,c2.CP_BIOCARTA_ BioCarta gene sets
8410,PID_TRAIL_PATHWAY,c2.CP_ Canonical pathways
8411,GO_CYTOKINE_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
8412,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,C7_ immunologic signatures
8413,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,C7_ immunologic signatures
8414,GO_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING,c5.BP_ GO biological process
8415,GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN,C7_ immunologic signatures
8416,LE_EGR2_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
8417,GO_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,c5.BP_ GO biological process
8418,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_DN,C7_ immunologic signatures
8419,CAGCTTT_MIR320,c3.MIR_ microRNA targets
8420,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
8421,GSE14415_ACT_VS_CTRL_NATURAL_TREG_UP,C7_ immunologic signatures
8422,MANN_RESPONSE_TO_AMIFOSTINE_UP,c2.CGP_ chemical and genetic perturbations
8423,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,C7_ immunologic signatures
8424,GO_PHOSPHOLIPID_DEPHOSPHORYLATION,c5.BP_ GO biological process
8425,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,c2.CGP_ chemical and genetic perturbations
8426,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_DN,C7_ immunologic signatures
8427,GO_MITOCHONDRION_LOCALIZATION,c5.BP_ GO biological process
8428,GO_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,c5.BP_ GO biological process
8429,MODULE_511,c4.CM_ cancer modules
8430,GO_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
8431,GO_ACROSOMAL_VESICLE,c5.CC_ GO cellular component
8432,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN,C7_ immunologic signatures
8433,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,C7_ immunologic signatures
8434,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,c2.CGP_ chemical and genetic perturbations
8435,LEI_HOXC8_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
8436,GO_REGULATION_OF_PEPTIDE_SECRETION,c5.BP_ GO biological process
8437,GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP,C7_ immunologic signatures
8438,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP,C7_ immunologic signatures
8439,WONG_IFNA2_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
8440,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,c2.CGP_ chemical and genetic perturbations
8441,GSE27896_HDAC6_KO_VS_WT_TREG_UP,C7_ immunologic signatures
8442,GO_CELL_PROJECTION_MEMBRANE,c5.CC_ GO cellular component
8443,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,C7_ immunologic signatures
8444,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,c2.CGP_ chemical and genetic perturbations
8445,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,C7_ immunologic signatures
8446,GNF2_TST,c4.CGN_ cancer gene neighborhoods
8447,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,C7_ immunologic signatures
8448,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,C7_ immunologic signatures
8449,GO_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
8450,REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI,c2.CP_REACTOME_ Reactome gene sets
8451,GO_RESPONSE_TO_ANGIOTENSIN,c5.BP_ GO biological process
8452,GO_PEPTIDYL_LYSINE_TRIMETHYLATION,c5.BP_ GO biological process
8453,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,C7_ immunologic signatures
8454,PID_WNT_CANONICAL_PATHWAY,c2.CP_ Canonical pathways
8455,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN,C7_ immunologic signatures
8456,GO_ESTABLISHMENT_OR_MAINTENANCE_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY,c5.BP_ GO biological process
8457,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,C7_ immunologic signatures
8458,GO_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,c5.BP_ GO biological process
8459,LABBE_TGFB1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
8460,HEB_Q6,c3.TFT_ transcription factor targets
8461,GO_NUCLEAR_CHROMOSOME_TELOMERIC_REGION,c5.CC_ GO cellular component
8462,GO_GTPASE_ACTIVITY,c5.GO molecular function
8463,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,C7_ immunologic signatures
8464,LUI_THYROID_CANCER_CLUSTER_2,c2.CGP_ chemical and genetic perturbations
8465,KEGG_INSULIN_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
8466,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN,C7_ immunologic signatures
8467,GO_METALLOEXOPEPTIDASE_ACTIVITY,c5.GO molecular function
8468,GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN,C7_ immunologic signatures
8469,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_UP,C7_ immunologic signatures
8470,YUAN_ZNF143_PARTNERS,c2.CGP_ chemical and genetic perturbations
8471,GO_TRANS_GOLGI_NETWORK,c5.CC_ GO cellular component
8472,GSE6259_DEC205_POS_DC_VS_BCELL_DN,C7_ immunologic signatures
8473,GO_PROTEIN_LIPID_COMPLEX,c5.CC_ GO cellular component
8474,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_DN,C7_ immunologic signatures
8475,GO_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS,c5.BP_ GO biological process
8476,CREB_Q3,c3.TFT_ transcription factor targets
8477,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,C7_ immunologic signatures
8478,GO_REGULATION_OF_HISTONE_DEACETYLATION,c5.BP_ GO biological process
8479,GO_FLUID_TRANSPORT,c5.BP_ GO biological process
8480,GO_BRUSH_BORDER,c5.CC_ GO cellular component
8481,GSE557_WT_VS_I_AB_KO_DC_DN,C7_ immunologic signatures
8482,GO_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_KINASE_BINDING,c5.GO molecular function
8483,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,C7_ immunologic signatures
8484,REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION,c2.CP_REACTOME_ Reactome gene sets
8485,WAGNER_APO2_SENSITIVITY,c2.CGP_ chemical and genetic perturbations
8486,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_DN,C7_ immunologic signatures
8487,GO_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION,c5.BP_ GO biological process
8488,GO_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,c5.BP_ GO biological process
8489,GO_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
8490,GO_RHYTHMIC_BEHAVIOR,c5.BP_ GO biological process
8491,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
8492,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN,C7_ immunologic signatures
8493,MORF_TFDP2,c4.CGN_ cancer gene neighborhoods
8494,DAZARD_RESPONSE_TO_UV_SCC_DN,c2.CGP_ chemical and genetic perturbations
8495,SA_CASPASE_CASCADE,c2.CP_ Canonical pathways
8496,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,c2.CGP_ chemical and genetic perturbations
8497,DOANE_BREAST_CANCER_CLASSES_DN,c2.CGP_ chemical and genetic perturbations
8498,GNF2_DNM1,c4.CGN_ cancer gene neighborhoods
8499,GO_STEROL_BINDING,c5.GO molecular function
8500,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN,C7_ immunologic signatures
8501,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN,C7_ immunologic signatures
8502,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,C7_ immunologic signatures
8503,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
8504,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP,C7_ immunologic signatures
8505,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,c2.CGP_ chemical and genetic perturbations
8506,GO_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,c5.BP_ GO biological process
8507,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP,C7_ immunologic signatures
8508,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN,C7_ immunologic signatures
8509,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
8510,BIOCARTA_MCM_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
8511,GO_SINGLE_ORGANISM_MEMBRANE_FUSION,c5.BP_ GO biological process
8512,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_UP,C7_ immunologic signatures
8513,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_UP,C7_ immunologic signatures
8514,BIOCARTA_FCER1_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
8515,GSE15215_CD2_POS_VS_NEG_PDC_UP,C7_ immunologic signatures
8516,GO_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,c5.BP_ GO biological process
8517,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,C7_ immunologic signatures
8518,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
8519,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_UP,C7_ immunologic signatures
8520,GO_MULTI_ORGANISM_MEMBRANE_ORGANIZATION,c5.BP_ GO biological process
8521,AP1_Q2_01,c3.TFT_ transcription factor targets
8522,MORF_MYST2,c4.CGN_ cancer gene neighborhoods
8523,MODULE_248,c4.CM_ cancer modules
8524,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,C7_ immunologic signatures
8525,AREB6_01,c3.TFT_ transcription factor targets
8526,CAR_WBSCR22,c4.CGN_ cancer gene neighborhoods
8527,GO_LAMIN_BINDING,c5.GO molecular function
8528,GO_MANGANESE_ION_BINDING,c5.GO molecular function
8529,GO_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION,c5.BP_ GO biological process
8530,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,C7_ immunologic signatures
8531,PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,c2.CGP_ chemical and genetic perturbations
8532,GSE22886_NAIVE_CD4_TCELL_VS_DC_UP,C7_ immunologic signatures
8533,GO_PHOTOPERIODISM,c5.BP_ GO biological process
8534,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP,C7_ immunologic signatures
8535,MODULE_485,c4.CM_ cancer modules
8536,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,c2.CGP_ chemical and genetic perturbations
8537,WENG_POR_TARGETS_LIVER_DN,c2.CGP_ chemical and genetic perturbations
8538,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,c2.CGP_ chemical and genetic perturbations
8539,GO_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS,c5.BP_ GO biological process
8540,CHR2Q23,21
8541,MYOD_Q6_01,c3.TFT_ transcription factor targets
8542,MODULE_206,c4.CM_ cancer modules
8543,GSE27786_LSK_VS_NEUTROPHIL_UP,C7_ immunologic signatures
8544,MORI_PRE_BI_LYMPHOCYTE_DN,c2.CGP_ chemical and genetic perturbations
8545,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP,C7_ immunologic signatures
8546,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
8547,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_DN,C7_ immunologic signatures
8548,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_DN,C7_ immunologic signatures
8549,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_UP,C7_ immunologic signatures
8550,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN,C7_ immunologic signatures
8551,BYSTROEM_CORRELATED_WITH_IL5_DN,c2.CGP_ chemical and genetic perturbations
8552,GSE7764_NKCELL_VS_SPLENOCYTE_DN,C7_ immunologic signatures
8553,RICKMAN_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
8554,GO_MYELOID_LEUKOCYTE_ACTIVATION,c5.BP_ GO biological process
8555,HUMMEL_BURKITTS_LYMPHOMA_UP,c2.CGP_ chemical and genetic perturbations
8556,GSE18893_TCONV_VS_TREG_2H_CULTURE_UP,C7_ immunologic signatures
8557,GO_POSITIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS,c5.BP_ GO biological process
8558,CYCLIN_D1_UP.V1_UP,C6_ oncogenic signatures
8559,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN,C7_ immunologic signatures
8560,GO_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,c5.BP_ GO biological process
8561,STAT1_01,c3.TFT_ transcription factor targets
8562,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP,C7_ immunologic signatures
8563,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_UP,C7_ immunologic signatures
8564,GO_PROTEIN_COMPLEX_INVOLVED_IN_CELL_ADHESION,c5.CC_ GO cellular component
8565,GSE6875_TCONV_VS_TREG_DN,C7_ immunologic signatures
8566,GSE45365_NK_CELL_VS_BCELL_DN,C7_ immunologic signatures
8567,ZAMORA_NOS2_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
8568,GO_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION,c5.BP_ GO biological process
8569,GO_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,c5.BP_ GO biological process
8570,GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP,C7_ immunologic signatures
8571,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,C7_ immunologic signatures
8572,GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN,C7_ immunologic signatures
8573,LI_ADIPOGENESIS_BY_ACTIVATED_PPARG,c2.CGP_ chemical and genetic perturbations
8574,GCM_CRKL,c4.CGN_ cancer gene neighborhoods
8575,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,C7_ immunologic signatures
8576,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN,C7_ immunologic signatures
8577,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,c2.CGP_ chemical and genetic perturbations
8578,WANG_LMO4_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
8579,GO_CYTOKINE_METABOLIC_PROCESS,c5.BP_ GO biological process
8580,GO_NUCLEAR_INNER_MEMBRANE,c5.CC_ GO cellular component
8581,GO_INTRINSIC_COMPONENT_OF_GOLGI_MEMBRANE,c5.CC_ GO cellular component
8582,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_DN,C7_ immunologic signatures
8583,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP,C7_ immunologic signatures
8584,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
8585,AHR_01,c3.TFT_ transcription factor targets
8586,MORF_PPP2R5B,c4.CGN_ cancer gene neighborhoods
8587,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN,c2.CGP_ chemical and genetic perturbations
8588,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN,C7_ immunologic signatures
8589,MORF_ATF2,c4.CGN_ cancer gene neighborhoods
8590,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_DN,C7_ immunologic signatures
8591,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN,C7_ immunologic signatures
8592,GO_SCAFFOLD_PROTEIN_BINDING,c5.GO molecular function
8593,GSE31082_DN_VS_DP_THYMOCYTE_DN,C7_ immunologic signatures
8594,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
8595,BROWNE_HCMV_INFECTION_30MIN_DN,c2.CGP_ chemical and genetic perturbations
8596,GO_EPITHELIAL_CELL_DEVELOPMENT,c5.BP_ GO biological process
8597,RASHI_RESPONSE_TO_IONIZING_RADIATION_6,c2.CGP_ chemical and genetic perturbations
8598,GO_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL,c5.BP_ GO biological process
8599,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP,C7_ immunologic signatures
8600,GO_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,c5.BP_ GO biological process
8601,GO_PROTEIN_DEALKYLATION,c5.BP_ GO biological process
8602,GSE11924_TFH_VS_TH2_CD4_TCELL_UP,C7_ immunologic signatures
8603,GSE3982_CTRL_VS_LPS_4H_MAC_UP,C7_ immunologic signatures
8604,VERHAAK_GLIOBLASTOMA_NEURAL,c2.CGP_ chemical and genetic perturbations
8605,GSE18281_CORTEX_VS_MEDULLA_THYMUS_UP,C7_ immunologic signatures
8606,MORF_EPHA7,c4.CGN_ cancer gene neighborhoods
8607,NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP,c2.CGP_ chemical and genetic perturbations
8608,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP,c2.CGP_ chemical and genetic perturbations
8609,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
8610,GENTILE_RESPONSE_CLUSTER_D3,c2.CGP_ chemical and genetic perturbations
8611,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN,C7_ immunologic signatures
8612,MORF_DMPK,c4.CGN_ cancer gene neighborhoods
8613,GO_RESPONSE_TO_FLUID_SHEAR_STRESS,c5.BP_ GO biological process
8614,GO_ANTIMICROBIAL_HUMORAL_RESPONSE,c5.BP_ GO biological process
8615,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP,C7_ immunologic signatures
8616,GO_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
8617,GO_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,c5.BP_ GO biological process
8618,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,C7_ immunologic signatures
8619,GO_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_BINDING,c5.GO molecular function
8620,GO_REGULATION_OF_MRNA_3_END_PROCESSING,c5.BP_ GO biological process
8621,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN,C7_ immunologic signatures
8622,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_DN,C7_ immunologic signatures
8623,GO_ENDOPLASMIC_RETICULUM_CALCIUM_ION_HOMEOSTASIS,c5.BP_ GO biological process
8624,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP,C7_ immunologic signatures
8625,OXFORD_RALA_OR_RALB_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
8626,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN,C7_ immunologic signatures
8627,PID_S1P_META_PATHWAY,c2.CP_ Canonical pathways
8628,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,c2.CGP_ chemical and genetic perturbations
8629,MODULE_279,c4.CM_ cancer modules
8630,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_DN,C7_ immunologic signatures
8631,BIOCARTA_ETS_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
8632,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,C7_ immunologic signatures
8633,ZWANG_EGF_INTERVAL_UP,c2.CGP_ chemical and genetic perturbations
8634,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_UP,C7_ immunologic signatures
8635,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
8636,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,C7_ immunologic signatures
8637,CAMP_UP.V1_DN,C6_ oncogenic signatures
8638,MODULE_350,c4.CM_ cancer modules
8639,DARWICHE_PAPILLOMA_RISK_HIGH_DN,c2.CGP_ chemical and genetic perturbations
8640,GSE17721_POLYIC_VS_CPG_12H_BMDC_UP,C7_ immunologic signatures
8641,VALK_AML_CLUSTER_8,c2.CGP_ chemical and genetic perturbations
8642,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,C7_ immunologic signatures
8643,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN,C7_ immunologic signatures
8644,GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP,C7_ immunologic signatures
8645,GO_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,c5.BP_ GO biological process
8646,GSE27786_LIN_NEG_VS_CD8_TCELL_UP,C7_ immunologic signatures
8647,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,C7_ immunologic signatures
8648,GSE2706_2H_VS_8H_LPS_STIM_DC_UP,C7_ immunologic signatures
8649,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,C7_ immunologic signatures
8650,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,C7_ immunologic signatures
8651,GO_PROTEIN_INSERTION_INTO_MEMBRANE,c5.BP_ GO biological process
8652,SPZ1_01,c3.TFT_ transcription factor targets
8653,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_UP,C7_ immunologic signatures
8654,GO_REGULATION_OF_AUTOPHAGY,c5.BP_ GO biological process
8655,GO_PROTEIN_K63_LINKED_DEUBIQUITINATION,c5.BP_ GO biological process
8656,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
8657,GO_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
8658,GO_NEGATIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,c5.BP_ GO biological process
8659,CRX_NRL_DN.V1_DN,C6_ oncogenic signatures
8660,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
8661,ROSS_AML_WITH_PML_RARA_FUSION,c2.CGP_ chemical and genetic perturbations
8662,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN,C7_ immunologic signatures
8663,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,C7_ immunologic signatures
8664,GO_SPHINGOLIPID_METABOLIC_PROCESS,c5.BP_ GO biological process
8665,GO_EXTRINSIC_COMPONENT_OF_MEMBRANE,c5.CC_ GO cellular component
8666,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN,C7_ immunologic signatures
8667,GO_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,c5.BP_ GO biological process
8668,GO_CRANIAL_SKELETAL_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
8669,LEE_AGING_CEREBELLUM_DN,c2.CGP_ chemical and genetic perturbations
8670,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP,c2.CGP_ chemical and genetic perturbations
8671,MMS_MOUSE_LYMPH_HIGH_4HRS_UP,c2.CGP_ chemical and genetic perturbations
8672,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP,C7_ immunologic signatures
8673,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_DN,C7_ immunologic signatures
8674,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_UP,C7_ immunologic signatures
8675,GO_CELLULAR_RESPONSE_TO_AMINO_ACID_STARVATION,c5.BP_ GO biological process
8676,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN,C7_ immunologic signatures
8677,SCHRAETS_MLL_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
8678,GO_SULFUR_COMPOUND_TRANSPORT,c5.BP_ GO biological process
8679,WANG_BARRETTS_ESOPHAGUS_UP,c2.CGP_ chemical and genetic perturbations
8680,GO_NEUROTRANSMITTER_BINDING,c5.GO molecular function
8681,CCAGGGG_MIR331,c3.MIR_ microRNA targets
8682,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN,C7_ immunologic signatures
8683,GO_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_KINASE_ACTIVITY,c5.GO molecular function
8684,VALK_AML_CLUSTER_15,c2.CGP_ chemical and genetic perturbations
8685,GSE43955_1H_VS_10H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
8686,GO_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL,c5.BP_ GO biological process
8687,BIOCARTA_MTA3_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
8688,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN,C7_ immunologic signatures
8689,CAR_TNFRSF25,c4.CGN_ cancer gene neighborhoods
8690,REACTOME_COMPLEMENT_CASCADE,c2.CP_REACTOME_ Reactome gene sets
8691,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,C7_ immunologic signatures
8692,GO_COENZYME_A_METABOLIC_PROCESS,c5.BP_ GO biological process
8693,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP,C7_ immunologic signatures
8694,GO_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,c5.BP_ GO biological process
8695,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,c2.CGP_ chemical and genetic perturbations
8696,KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
8697,GO_CHROMATIN,c5.CC_ GO cellular component
8698,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,c2.CP_BIOCARTA_ BioCarta gene sets
8699,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
8700,GO_ASTROCYTE_DIFFERENTIATION,c5.BP_ GO biological process
8701,BASSO_CD40_SIGNALING_DN,c2.CGP_ chemical and genetic perturbations
8702,BARIS_THYROID_CANCER_DN,c2.CGP_ chemical and genetic perturbations
8703,GO_CARBOHYDRATE_BINDING,c5.GO molecular function
8704,NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN,c2.CGP_ chemical and genetic perturbations
8705,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,c2.CGP_ chemical and genetic perturbations
8706,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN,C7_ immunologic signatures
8707,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,C7_ immunologic signatures
8708,ALONSO_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
8709,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP,C7_ immunologic signatures
8710,GO_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,c5.BP_ GO biological process
8711,GSE27786_LSK_VS_MONO_MAC_DN,C7_ immunologic signatures
8712,GO_TELOMERIC_DNA_BINDING,c5.GO molecular function
8713,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP,C7_ immunologic signatures
8714,GO_PROXIMAL_DISTAL_PATTERN_FORMATION,c5.BP_ GO biological process
8715,GO_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
8716,CHR18Q11,27
8717,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP,C7_ immunologic signatures
8718,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP,c2.CGP_ chemical and genetic perturbations
8719,GO_MEMBRANE_FUSION,c5.BP_ GO biological process
8720,GO_PROTEIN_K63_LINKED_UBIQUITINATION,c5.BP_ GO biological process
8721,CHANG_IMMORTALIZED_BY_HPV31_DN,c2.CGP_ chemical and genetic perturbations
8722,GSE17721_LPS_VS_POLYIC_6H_BMDC_DN,C7_ immunologic signatures
8723,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,c2.CGP_ chemical and genetic perturbations
8724,KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,c2.CGP_ chemical and genetic perturbations
8725,CHR2P13,64
8726,GO_RESPONSE_TO_INTERFERON_BETA,c5.BP_ GO biological process
8727,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN,C7_ immunologic signatures
8728,REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING,c2.CP_REACTOME_ Reactome gene sets
8729,RB_DN.V1_DN,C6_ oncogenic signatures
8730,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP,C7_ immunologic signatures
8731,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP,C7_ immunologic signatures
8732,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP,C7_ immunologic signatures
8733,GSE17721_CTRL_VS_LPS_24H_BMDC_UP,C7_ immunologic signatures
8734,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
8735,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN,C7_ immunologic signatures
8736,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN,C7_ immunologic signatures
8737,GSE3982_BCELL_VS_BASOPHIL_UP,C7_ immunologic signatures
8738,GSE37532_WT_VS_PPARG_KO_LN_TREG_UP,C7_ immunologic signatures
8739,KYNG_DNA_DAMAGE_BY_UV,c2.CGP_ chemical and genetic perturbations
8740,GSE9650_NAIVE_VS_EFF_CD8_TCELL_DN,C7_ immunologic signatures
8741,PARK_APL_PATHOGENESIS_DN,c2.CGP_ chemical and genetic perturbations
8742,PID_CD8_TCR_DOWNSTREAM_PATHWAY,c2.CP_ Canonical pathways
8743,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
8744,REACTOME_RNA_POL_I_PROMOTER_OPENING,c2.CP_REACTOME_ Reactome gene sets
8745,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN,c2.CGP_ chemical and genetic perturbations
8746,KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,c2.CGP_ chemical and genetic perturbations
8747,ONDER_CDH1_TARGETS_3_UP,c2.CGP_ chemical and genetic perturbations
8748,MORF_PRKCA,c4.CGN_ cancer gene neighborhoods
8749,GSE27786_NKCELL_VS_MONO_MAC_DN,C7_ immunologic signatures
8750,KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,c2.CP_BIOCARTA_ BioCarta gene sets
8751,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN,C7_ immunologic signatures
8752,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,C7_ immunologic signatures
8753,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN,C7_ immunologic signatures
8754,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
8755,GO_RESPONSE_TO_INTERLEUKIN_1,c5.BP_ GO biological process
8756,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN,C7_ immunologic signatures
8757,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,C7_ immunologic signatures
8758,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,C7_ immunologic signatures
8759,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_UP,C7_ immunologic signatures
8760,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_UP,C7_ immunologic signatures
8761,GO_CELL_DIFFERENTIATION_IN_SPINAL_CORD,c5.BP_ GO biological process
8762,GO_NUCLEOCYTOPLASMIC_TRANSPORTER_ACTIVITY,c5.GO molecular function
8763,BIOCARTA_PDGF_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
8764,PID_IL12_STAT4_PATHWAY,c2.CP_ Canonical pathways
8765,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_UP,C7_ immunologic signatures
8766,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,C7_ immunologic signatures
8767,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_UP,C7_ immunologic signatures
8768,MORF_IL16,c4.CGN_ cancer gene neighborhoods
8769,GCM_NCAM1,c4.CGN_ cancer gene neighborhoods
8770,GSE14308_TH17_VS_NATURAL_TREG_UP,C7_ immunologic signatures
8771,GSE17721_LPS_VS_CPG_12H_BMDC_DN,C7_ immunologic signatures
8772,GO_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
8773,YU_MYC_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
8774,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN,C7_ immunologic signatures
8775,VALK_AML_CLUSTER_16,c2.CGP_ chemical and genetic perturbations
8776,GSE7852_LN_VS_FAT_TCONV_UP,C7_ immunologic signatures
8777,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP,C7_ immunologic signatures
8778,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_UP,C7_ immunologic signatures
8779,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP,C7_ immunologic signatures
8780,MYOD_01,c3.TFT_ transcription factor targets
8781,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,C7_ immunologic signatures
8782,GO_RECYCLING_ENDOSOME_MEMBRANE,c5.CC_ GO cellular component
8783,GO_METANEPHRIC_NEPHRON_MORPHOGENESIS,c5.BP_ GO biological process
8784,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,C7_ immunologic signatures
8785,GO_REGULATION_OF_SYNAPTIC_PLASTICITY,c5.BP_ GO biological process
8786,GSE7831_1H_VS_4H_CPG_STIM_PDC_UP,C7_ immunologic signatures
8787,REACTOME_S_PHASE,c2.CP_REACTOME_ Reactome gene sets
8788,HIF1_Q5,c3.TFT_ transcription factor targets
8789,CCTGCTG_MIR214,c3.MIR_ microRNA targets
8790,GO_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDES,c5.GO molecular function
8791,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,C7_ immunologic signatures
8792,GSE2706_2H_VS_8H_R848_STIM_DC_UP,C7_ immunologic signatures
8793,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_UP,C7_ immunologic signatures
8794,GO_BROWN_FAT_CELL_DIFFERENTIATION,c5.BP_ GO biological process
8795,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,C7_ immunologic signatures
8796,BIOCARTA_CALCINEURIN_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
8797,GO_DNA_ALKYLATION,c5.BP_ GO biological process
8798,LEE_LIVER_CANCER_MYC_DN,c2.CGP_ chemical and genetic perturbations
8799,COLLIS_PRKDC_SUBSTRATES,c2.CGP_ chemical and genetic perturbations
8800,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,c2.CGP_ chemical and genetic perturbations
8801,MORF_ERCC2,c4.CGN_ cancer gene neighborhoods
8802,GSE10325_CD4_TCELL_VS_MYELOID_DN,C7_ immunologic signatures
8803,GSE3982_MAST_CELL_VS_DC_DN,C7_ immunologic signatures
8804,HANSON_HRAS_SIGNALING_VIA_NFKB,c2.CGP_ chemical and genetic perturbations
8805,GSE27786_LSK_VS_NEUTROPHIL_DN,C7_ immunologic signatures
8806,MORF_DCC,c4.CGN_ cancer gene neighborhoods
8807,GSE14308_TH1_VS_INDUCED_TREG_DN,C7_ immunologic signatures
8808,CHR2P23,60
8809,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP,C7_ immunologic signatures
8810,GO_PHAGOSOME_MATURATION,c5.BP_ GO biological process
8811,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_UP,C7_ immunologic signatures
8812,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,C7_ immunologic signatures
8813,CYCLIN_D1_KE_.V1_DN,C6_ oncogenic signatures
8814,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
8815,GO_RECEPTOR_REGULATOR_ACTIVITY,c5.GO molecular function
8816,GSE27786_CD4_TCELL_VS_NKTCELL_DN,C7_ immunologic signatures
8817,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN,C7_ immunologic signatures
8818,GO_CHLORIDE_CHANNEL_COMPLEX,c5.CC_ GO cellular component
8819,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN,C7_ immunologic signatures
8820,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN,C7_ immunologic signatures
8821,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP,C7_ immunologic signatures
8822,GO_ROUGH_ENDOPLASMIC_RETICULUM,c5.CC_ GO cellular component
8823,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,C7_ immunologic signatures
8824,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP,C7_ immunologic signatures
8825,GSE29618_BCELL_VS_PDC_DN,C7_ immunologic signatures
8826,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN,C7_ immunologic signatures
8827,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN,c2.CGP_ chemical and genetic perturbations
8828,GO_GATED_CHANNEL_ACTIVITY,c5.GO molecular function
8829,ST_GA13_PATHWAY,c2.CP_ Canonical pathways
8830,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,C7_ immunologic signatures
8831,GSE27786_BCELL_VS_NKCELL_UP,C7_ immunologic signatures
8832,MZF1_02,c3.TFT_ transcription factor targets
8833,NFKB_Q6_01,c3.TFT_ transcription factor targets
8834,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP,C7_ immunologic signatures
8835,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
8836,ACTWSNACTNY_UNKNOWN,c3.TFT_ transcription factor targets
8837,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
8838,GO_NUCLEAR_ENVELOPE,c5.CC_ GO cellular component
8839,GO_CATION_CATION_ANTIPORTER_ACTIVITY,c5.GO molecular function
8840,KEGG_JAK_STAT_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
8841,GSE360_L_DONOVANI_VS_T_GONDII_DC_DN,C7_ immunologic signatures
8842,GO_REGULATION_OF_CELL_MATURATION,c5.BP_ GO biological process
8843,GCM_AQP4,c4.CGN_ cancer gene neighborhoods
8844,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN,C7_ immunologic signatures
8845,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP,C7_ immunologic signatures
8846,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,C7_ immunologic signatures
8847,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_UP,C7_ immunologic signatures
8848,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,C7_ immunologic signatures
8849,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
8850,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,C7_ immunologic signatures
8851,MODULE_131,c4.CM_ cancer modules
8852,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP,C7_ immunologic signatures
8853,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN,C7_ immunologic signatures
8854,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN,C7_ immunologic signatures
8855,NRL_DN.V1_DN,C6_ oncogenic signatures
8856,TCCCCAC_MIR491,c3.MIR_ microRNA targets
8857,GO_REGULATION_OF_CELL_KILLING,c5.BP_ GO biological process
8858,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,C7_ immunologic signatures
8859,LAMB_CCND1_TARGETS,c2.CGP_ chemical and genetic perturbations
8860,GO_POSITIVE_REGULATION_OF_PROTEIN_DEACETYLATION,c5.BP_ GO biological process
8861,YY1_01,c3.TFT_ transcription factor targets
8862,GO_RESPONSE_TO_HEAT,c5.BP_ GO biological process
8863,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,c2.CP_REACTOME_ Reactome gene sets
8864,GSE3982_CTRL_VS_LPS_48H_DC_UP,C7_ immunologic signatures
8865,GO_EUCHROMATIN,c5.CC_ GO cellular component
8866,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP,c2.CGP_ chemical and genetic perturbations
8867,MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
8868,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,c2.CGP_ chemical and genetic perturbations
8869,BROCKE_APOPTOSIS_REVERSED_BY_IL6,c2.CGP_ chemical and genetic perturbations
8870,GO_FERROUS_IRON_BINDING,c5.GO molecular function
8871,PID_S1P_S1P2_PATHWAY,c2.CP_ Canonical pathways
8872,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,c2.CGP_ chemical and genetic perturbations
8873,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN,C7_ immunologic signatures
8874,JOHNSTONE_PARVB_TARGETS_1_DN,c2.CGP_ chemical and genetic perturbations
8875,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN,C7_ immunologic signatures
8876,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN,C7_ immunologic signatures
8877,GO_NEGATIVE_REGULATION_OF_SECRETION,c5.BP_ GO biological process
8878,REACTOME_INNATE_IMMUNE_SYSTEM,c2.CP_REACTOME_ Reactome gene sets
8879,GO_NEGATIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,c5.BP_ GO biological process
8880,CHR5Q31,166
8881,GSE24142_DN2_VS_DN3_THYMOCYTE_UP,C7_ immunologic signatures
8882,OUYANG_PROSTATE_CANCER_PROGRESSION_DN,c2.CGP_ chemical and genetic perturbations
8883,GSE17721_CTRL_VS_LPS_12H_BMDC_UP,C7_ immunologic signatures
8884,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,C7_ immunologic signatures
8885,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,C7_ immunologic signatures
8886,HU_GENOTOXIC_DAMAGE_24HR,c2.CGP_ chemical and genetic perturbations
8887,GO_VESICLE_LOCALIZATION,c5.BP_ GO biological process
8888,AGGTGCA_MIR500,c3.MIR_ microRNA targets
8889,GO_BRAIN_MORPHOGENESIS,c5.BP_ GO biological process
8890,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,c2.CP_BIOCARTA_ BioCarta gene sets
8891,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN,C7_ immunologic signatures
8892,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP,C7_ immunologic signatures
8893,GO_ENDOTHELIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
8894,HOFMANN_CELL_LYMPHOMA_UP,c2.CGP_ chemical and genetic perturbations
8895,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP,C7_ immunologic signatures
8896,GO_PHOSPHOLIPID_METABOLIC_PROCESS,c5.BP_ GO biological process
8897,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP,C7_ immunologic signatures
8898,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,C7_ immunologic signatures
8899,GO_CELLULAR_RESPONSE_TO_HEAT,c5.BP_ GO biological process
8900,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP,C7_ immunologic signatures
8901,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,c2.CGP_ chemical and genetic perturbations
8902,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_UP,C7_ immunologic signatures
8903,PID_IGF1_PATHWAY,c2.CP_ Canonical pathways
8904,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,C7_ immunologic signatures
8905,GO_CHROMATIN_DNA_BINDING,c5.GO molecular function
8906,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,C7_ immunologic signatures
8907,CHR3Q23,18
8908,KYNG_NORMAL_AGING_DN,c2.CGP_ chemical and genetic perturbations
8909,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
8910,GO_NEGATIVE_REGULATION_OF_ANOIKIS,c5.BP_ GO biological process
8911,XBP1_01,c3.TFT_ transcription factor targets
8912,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP,C7_ immunologic signatures
8913,CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,c2.CGP_ chemical and genetic perturbations
8914,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,c2.CGP_ chemical and genetic perturbations
8915,GSE2706_UNSTIM_VS_8H_LPS_DC_UP,C7_ immunologic signatures
8916,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN,C7_ immunologic signatures
8917,GO_CELLULAR_RESPONSE_TO_ESTRADIOL_STIMULUS,c5.BP_ GO biological process
8918,GO_CELLULAR_COMPONENT_DISASSEMBLY,c5.BP_ GO biological process
8919,GO_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS,c5.BP_ GO biological process
8920,WONG_ENDMETRIUM_CANCER_UP,c2.CGP_ chemical and genetic perturbations
8921,GO_PROTEIN_SERINE_THREONINE_TYROSINE_KINASE_ACTIVITY,c5.GO molecular function
8922,DR1_Q3,c3.TFT_ transcription factor targets
8923,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP,C7_ immunologic signatures
8924,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
8925,ACAGGGT_MIR10A_MIR10B,c3.MIR_ microRNA targets
8926,TCCATTKW_UNKNOWN,c3.TFT_ transcription factor targets
8927,GSE14308_TH2_VS_NATURAL_TREG_UP,C7_ immunologic signatures
8928,CHOW_RASSF1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
8929,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_UP,C7_ immunologic signatures
8930,GO_SIGNAL_TRANSDUCTION_BY_PROTEIN_PHOSPHORYLATION,c5.BP_ GO biological process
8931,ATGTAGC_MIR221_MIR222,c3.MIR_ microRNA targets
8932,GO_TRANSPORT_VESICLE,c5.CC_ GO cellular component
8933,GO_POSITIVE_REGULATION_OF_BINDING,c5.BP_ GO biological process
8934,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN,C7_ immunologic signatures
8935,GO_HEART_VALVE_DEVELOPMENT,c5.BP_ GO biological process
8936,POU3F2_01,c3.TFT_ transcription factor targets
8937,LI_CYTIDINE_ANALOG_PATHWAY,c2.CGP_ chemical and genetic perturbations
8938,GO_POSITIVE_REGULATION_OF_HOMEOSTATIC_PROCESS,c5.BP_ GO biological process
8939,MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,c2.CGP_ chemical and genetic perturbations
8940,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_DN,C7_ immunologic signatures
8941,SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,c2.CGP_ chemical and genetic perturbations
8942,MODULE_318,c4.CM_ cancer modules
8943,GO_RESPONSE_TO_CORTICOSTERONE,c5.BP_ GO biological process
8944,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
8945,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,C7_ immunologic signatures
8946,GO_HIPPO_SIGNALING,c5.BP_ GO biological process
8947,CHR2P16,28
8948,BIOCARTA_IL7_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
8949,PID_IL3_PATHWAY,c2.CP_ Canonical pathways
8950,PID_RAC1_REG_PATHWAY,c2.CP_ Canonical pathways
8951,GSE17721_12H_VS_24H_POLYIC_BMDC_DN,C7_ immunologic signatures
8952,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,C7_ immunologic signatures
8953,MCCABE_HOXC6_TARGETS_CANCER_DN,c2.CGP_ chemical and genetic perturbations
8954,GO_RNA_POLYMERASE_II_REPRESSING_TRANSCRIPTION_FACTOR_BINDING,c5.GO molecular function
8955,GO_ENTRAINMENT_OF_CIRCADIAN_CLOCK,c5.BP_ GO biological process
8956,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,c2.CGP_ chemical and genetic perturbations
8957,REACTOME_SIGNAL_AMPLIFICATION,c2.CP_REACTOME_ Reactome gene sets
8958,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_UP,C7_ immunologic signatures
8959,GO_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,c5.BP_ GO biological process
8960,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN,C7_ immunologic signatures
8961,GENTILE_UV_RESPONSE_CLUSTER_D5,c2.CGP_ chemical and genetic perturbations
8962,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
8963,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN,C7_ immunologic signatures
8964,MORF_MAP3K14,c4.CGN_ cancer gene neighborhoods
8965,GO_ORGANOPHOSPHATE_CATABOLIC_PROCESS,c5.BP_ GO biological process
8966,GALLUZZI_PERMEABILIZE_MITOCHONDRIA,c2.CGP_ chemical and genetic perturbations
8967,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN,c2.CGP_ chemical and genetic perturbations
8968,TTGCWCAAY_CEBPB_02,c3.TFT_ transcription factor targets
8969,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,c2.CGP_ chemical and genetic perturbations
8970,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,C7_ immunologic signatures
8971,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,C7_ immunologic signatures
8972,GSE29618_MONOCYTE_VS_PDC_DN,C7_ immunologic signatures
8973,REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS,c2.CP_REACTOME_ Reactome gene sets
8974,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,C7_ immunologic signatures
8975,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN,C7_ immunologic signatures
8976,GO_NONMOTILE_PRIMARY_CILIUM_ASSEMBLY,c5.BP_ GO biological process
8977,MODULE_157,c4.CM_ cancer modules
8978,GO_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING,c5.BP_ GO biological process
8979,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN,C7_ immunologic signatures
8980,URS_ADIPOCYTE_DIFFERENTIATION_DN,c2.CGP_ chemical and genetic perturbations
8981,MAZR_01,c3.TFT_ transcription factor targets
8982,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,C7_ immunologic signatures
8983,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,c2.CGP_ chemical and genetic perturbations
8984,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
8985,GSE43955_1H_VS_60H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
8986,GO_RNA_POLYMERASE_II_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING,c5.GO molecular function
8987,KRAS.BREAST_UP.V1_UP,C6_ oncogenic signatures
8988,CREB_Q4_01,c3.TFT_ transcription factor targets
8989,GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP,C7_ immunologic signatures
8990,GGCAGAC_MIR346,c3.MIR_ microRNA targets
8991,GO_PROTEIN_LIPID_COMPLEX_ASSEMBLY,c5.BP_ GO biological process
8992,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_UP,C7_ immunologic signatures
8993,GSE20727_CTRL_VS_H2O2_TREATED_DC_DN,C7_ immunologic signatures
8994,GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN,C7_ immunologic signatures
8995,MORF_RBBP8,c4.CGN_ cancer gene neighborhoods
8996,VILIMAS_NOTCH1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
8997,KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
8998,GO_TRNA_SPECIFIC_RIBONUCLEASE_ACTIVITY,c5.GO molecular function
8999,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP,C7_ immunologic signatures
9000,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,C7_ immunologic signatures
9001,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,C7_ immunologic signatures
9002,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP,C7_ immunologic signatures
9003,MORF_MAP2K7,c4.CGN_ cancer gene neighborhoods
9004,GSE27786_LIN_NEG_VS_CD4_TCELL_DN,C7_ immunologic signatures
9005,LIAN_LIPA_TARGETS_3M,c2.CGP_ chemical and genetic perturbations
9006,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,C7_ immunologic signatures
9007,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,c2.CGP_ chemical and genetic perturbations
9008,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
9009,GAVIN_FOXP3_TARGETS_CLUSTER_T4,c2.CGP_ chemical and genetic perturbations
9010,GO_ANTIGEN_PROCESSING_AND_PRESENTATION,c5.BP_ GO biological process
9011,GO_ACTIN_CYTOSKELETON_REORGANIZATION,c5.BP_ GO biological process
9012,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,C7_ immunologic signatures
9013,BROWNE_HCMV_INFECTION_10HR_DN,c2.CGP_ chemical and genetic perturbations
9014,GO_HEPATICOBILIARY_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
9015,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP,C7_ immunologic signatures
9016,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
9017,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,C7_ immunologic signatures
9018,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN,C7_ immunologic signatures
9019,GO_CHROMATIN_BINDING,c5.GO molecular function
9020,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_UP,C7_ immunologic signatures
9021,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
9022,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_DN,C7_ immunologic signatures
9023,GO_MONOAMINE_TRANSPORT,c5.BP_ GO biological process
9024,YGCANTGCR_UNKNOWN,c3.TFT_ transcription factor targets
9025,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_DN,C7_ immunologic signatures
9026,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN,C7_ immunologic signatures
9027,GO_ALCOHOL_BINDING,c5.GO molecular function
9028,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
9029,STARK_HYPPOCAMPUS_22Q11_DELETION_UP,c2.CGP_ chemical and genetic perturbations
9030,NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,c2.CGP_ chemical and genetic perturbations
9031,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
9032,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP,C7_ immunologic signatures
9033,GO_REGULATION_OF_WATER_LOSS_VIA_SKIN,c5.BP_ GO biological process
9034,GO_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE,c5.BP_ GO biological process
9035,GO_PROTEIN_HETEROOLIGOMERIZATION,c5.BP_ GO biological process
9036,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_DN,C7_ immunologic signatures
9037,MODULE_49,c4.CM_ cancer modules
9038,GO_MULTIVESICULAR_BODY,c5.CC_ GO cellular component
9039,RB_P130_DN.V1_DN,C6_ oncogenic signatures
9040,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,c2.CGP_ chemical and genetic perturbations
9041,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN,C7_ immunologic signatures
9042,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP,C7_ immunologic signatures
9043,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP,C7_ immunologic signatures
9044,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_UP,C7_ immunologic signatures
9045,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,C7_ immunologic signatures
9046,CAR_MYST2,c4.CGN_ cancer gene neighborhoods
9047,GO_M_BAND,c5.CC_ GO cellular component
9048,GSE15330_HSC_VS_PRO_BCELL_UP,C7_ immunologic signatures
9049,GO_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_EXONUCLEOLYTIC,c5.BP_ GO biological process
9050,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_UP,C7_ immunologic signatures
9051,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN,C7_ immunologic signatures
9052,RELA_DN.V1_DN,C6_ oncogenic signatures
9053,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN,C7_ immunologic signatures
9054,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
9055,GO_HOMEOSTASIS_OF_NUMBER_OF_CELLS_WITHIN_A_TISSUE,c5.BP_ GO biological process
9056,GO_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,c5.BP_ GO biological process
9057,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN,C7_ immunologic signatures
9058,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_UP,C7_ immunologic signatures
9059,MORF_ZNF10,c4.CGN_ cancer gene neighborhoods
9060,GSE22886_NAIVE_BCELL_VS_DC_DN,C7_ immunologic signatures
9061,CREB_Q2_01,c3.TFT_ transcription factor targets
9062,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,c2.CGP_ chemical and genetic perturbations
9063,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP,C7_ immunologic signatures
9064,CHR5Q22,18
9065,BOYLAN_MULTIPLE_MYELOMA_D_UP,c2.CGP_ chemical and genetic perturbations
9066,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN,C7_ immunologic signatures
9067,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP,C7_ immunologic signatures
9068,GO_ORGANELLE_SUBCOMPARTMENT,c5.CC_ GO cellular component
9069,GO_ANION_TRANSPORT,c5.BP_ GO biological process
9070,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,c2.CGP_ chemical and genetic perturbations
9071,GO_POSITIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
9072,ATCMNTCCGY_UNKNOWN,c3.TFT_ transcription factor targets
9073,GO_CYTOLYSIS,c5.BP_ GO biological process
9074,CRX_NRL_DN.V1_UP,C6_ oncogenic signatures
9075,GO_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_RENIN_ANGIOTENSIN,c5.BP_ GO biological process
9076,GO_APOPTOTIC_NUCLEAR_CHANGES,c5.BP_ GO biological process
9077,GTATGAT_MIR154_MIR487,c3.MIR_ microRNA targets
9078,SP1_Q2_01,c3.TFT_ transcription factor targets
9079,CHR6Q23,36
9080,AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G,c2.CGP_ chemical and genetic perturbations
9081,GO_SIGNAL_PEPTIDE_PROCESSING,c5.BP_ GO biological process
9082,REACTOME_BOTULINUM_NEUROTOXICITY,c2.CP_REACTOME_ Reactome gene sets
9083,GENTILE_UV_RESPONSE_CLUSTER_D8,c2.CGP_ chemical and genetic perturbations
9084,GO_REGULATION_OF_CHROMATIN_ORGANIZATION,c5.BP_ GO biological process
9085,GO_ORGANIC_ANION_TRANSPORT,c5.BP_ GO biological process
9086,GO_VENTRAL_SPINAL_CORD_DEVELOPMENT,c5.BP_ GO biological process
9087,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN,C7_ immunologic signatures
9088,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_DN,C7_ immunologic signatures
9089,GSE16385_MONOCYTE_VS_MACROPHAGE_UP,C7_ immunologic signatures
9090,GO_REGULATION_OF_SYMBIOSIS_ENCOMPASSING_MUTUALISM_THROUGH_PARASITISM,c5.BP_ GO biological process
9091,GO_CELLULAR_RESPONSE_TO_DSRNA,c5.BP_ GO biological process
9092,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP,C7_ immunologic signatures
9093,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN,C7_ immunologic signatures
9094,GO_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL,c5.BP_ GO biological process
9095,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,c2.CGP_ chemical and genetic perturbations
9096,TCATCTC_MIR143,c3.MIR_ microRNA targets
9097,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN,C7_ immunologic signatures
9098,KIM_GERMINAL_CENTER_T_HELPER_UP,c2.CGP_ chemical and genetic perturbations
9099,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN,C7_ immunologic signatures
9100,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP,C7_ immunologic signatures
9101,GO_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
9102,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN,C7_ immunologic signatures
9103,TTCYRGAA_UNKNOWN,c3.TFT_ transcription factor targets
9104,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN,C7_ immunologic signatures
9105,GO_FIBRINOLYSIS,c5.BP_ GO biological process
9106,GO_AROMATIC_AMINO_ACID_FAMILY_METABOLIC_PROCESS,c5.BP_ GO biological process
9107,GCTGAGT_MIR5125P,c3.MIR_ microRNA targets
9108,PAX4_01,c3.TFT_ transcription factor targets
9109,CTACTAG_MIR325,c3.MIR_ microRNA targets
9110,XU_CREBBP_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
9111,GO_NUCLEAR_CHROMATIN,c5.CC_ GO cellular component
9112,GSE6875_WT_VS_FOXP3_KO_TREG_UP,C7_ immunologic signatures
9113,BIOCARTA_BAD_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9114,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN,C7_ immunologic signatures
9115,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN,C7_ immunologic signatures
9116,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,C7_ immunologic signatures
9117,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN,C7_ immunologic signatures
9118,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_UP,C7_ immunologic signatures
9119,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,C7_ immunologic signatures
9120,GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS,c5.BP_ GO biological process
9121,CHR4Q31,52
9122,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN,C7_ immunologic signatures
9123,GO_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY,c5.BP_ GO biological process
9124,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN,C7_ immunologic signatures
9125,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN,C7_ immunologic signatures
9126,GO_ACETYLCHOLINE_RECEPTOR_ACTIVITY,c5.GO molecular function
9127,GO_ION_HOMEOSTASIS,c5.BP_ GO biological process
9128,GO_COPPER_ION_BINDING,c5.GO molecular function
9129,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS,c2.CGP_ chemical and genetic perturbations
9130,MCCLUNG_CREB1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
9131,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN,C7_ immunologic signatures
9132,REACTOME_EXTENSION_OF_TELOMERES,c2.CP_REACTOME_ Reactome gene sets
9133,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_DN,C7_ immunologic signatures
9134,TTCNRGNNNNTTC_HSF_Q6,c3.TFT_ transcription factor targets
9135,GSE45365_NK_CELL_VS_CD8_TCELL_DN,C7_ immunologic signatures
9136,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,c2.CGP_ chemical and genetic perturbations
9137,GO_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
9138,GO_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
9139,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,C7_ immunologic signatures
9140,BCAT_GDS748_UP,C6_ oncogenic signatures
9141,GO_ENTEROENDOCRINE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
9142,KEGG_GLYCEROLIPID_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
9143,GO_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING,c5.GO molecular function
9144,GNF2_CD33,c4.CGN_ cancer gene neighborhoods
9145,GO_EXONUCLEASE_ACTIVITY,c5.GO molecular function
9146,GO_STEROID_HORMONE_RECEPTOR_BINDING,c5.GO molecular function
9147,PID_P38_ALPHA_BETA_PATHWAY,c2.CP_ Canonical pathways
9148,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_DN,C7_ immunologic signatures
9149,MODULE_333,c4.CM_ cancer modules
9150,GENTILE_UV_RESPONSE_CLUSTER_D7,c2.CGP_ chemical and genetic perturbations
9151,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_DN,C7_ immunologic signatures
9152,PIGF_UP.V1_UP,C6_ oncogenic signatures
9153,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
9154,GSE7852_LN_VS_FAT_TREG_UP,C7_ immunologic signatures
9155,GO_SH3_SH2_ADAPTOR_ACTIVITY,c5.GO molecular function
9156,GO_GOLGI_ORGANIZATION,c5.BP_ GO biological process
9157,CHR20Q13,131
9158,GO_POSITIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY,c5.BP_ GO biological process
9159,GSE15215_CD2_POS_VS_NEG_PDC_DN,C7_ immunologic signatures
9160,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_DN,C7_ immunologic signatures
9161,PID_EPHA_FWDPATHWAY,c2.CP_ Canonical pathways
9162,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP,C7_ immunologic signatures
9163,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN,C7_ immunologic signatures
9164,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN,C7_ immunologic signatures
9165,GO_OMEGA_PEPTIDASE_ACTIVITY,c5.GO molecular function
9166,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_UP,C7_ immunologic signatures
9167,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP,C7_ immunologic signatures
9168,ATF4_Q2,c3.TFT_ transcription factor targets
9169,GO_AMINE_CATABOLIC_PROCESS,c5.BP_ GO biological process
9170,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_DN,C7_ immunologic signatures
9171,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_UP,C7_ immunologic signatures
9172,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN,C7_ immunologic signatures
9173,GO_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,c5.BP_ GO biological process
9174,REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,c2.CP_REACTOME_ Reactome gene sets
9175,GO_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
9176,MODULE_375,c4.CM_ cancer modules
9177,MARSHALL_VIRAL_INFECTION_RESPONSE_DN,c2.CGP_ chemical and genetic perturbations
9178,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP,C7_ immunologic signatures
9179,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN,c2.CGP_ chemical and genetic perturbations
9180,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
9181,CHANDRAN_METASTASIS_TOP50_DN,c2.CGP_ chemical and genetic perturbations
9182,LASTOWSKA_COAMPLIFIED_WITH_MYCN,c2.CGP_ chemical and genetic perturbations
9183,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_DN,C7_ immunologic signatures
9184,KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM,c2.CP_BIOCARTA_ BioCarta gene sets
9185,GSE13887_RESTING_VS_ACT_CD4_TCELL_DN,C7_ immunologic signatures
9186,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_UP,C7_ immunologic signatures
9187,GO_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,c5.BP_ GO biological process
9188,GRABARCZYK_BCL11B_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
9189,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_UP,C7_ immunologic signatures
9190,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_UP,C7_ immunologic signatures
9191,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP,C7_ immunologic signatures
9192,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN,C7_ immunologic signatures
9193,GO_NEUROPEPTIDE_HORMONE_ACTIVITY,c5.GO molecular function
9194,KEGG_ENDOCYTOSIS,c2.CP_BIOCARTA_ BioCarta gene sets
9195,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_DN,C7_ immunologic signatures
9196,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP,C7_ immunologic signatures
9197,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,C7_ immunologic signatures
9198,YOKOE_CANCER_TESTIS_ANTIGENS,c2.CGP_ chemical and genetic perturbations
9199,GO_STEM_CELL_DIVISION,c5.BP_ GO biological process
9200,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,C7_ immunologic signatures
9201,REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS,c2.CP_REACTOME_ Reactome gene sets
9202,GSE360_DC_VS_MAC_L_MAJOR_DN,C7_ immunologic signatures
9203,KIM_GASTRIC_CANCER_CHEMOSENSITIVITY,c2.CGP_ chemical and genetic perturbations
9204,GO_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,c5.BP_ GO biological process
9205,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
9206,MARTENS_BOUND_BY_PML_RARA_FUSION,c2.CGP_ chemical and genetic perturbations
9207,GO_MEMBRANE_BIOGENESIS,c5.BP_ GO biological process
9208,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP,C7_ immunologic signatures
9209,GO_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,c5.GO molecular function
9210,GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN,C7_ immunologic signatures
9211,GO_CYTOSOLIC_TRANSPORT,c5.BP_ GO biological process
9212,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,C7_ immunologic signatures
9213,ATGGYGGA_UNKNOWN,c3.TFT_ transcription factor targets
9214,PID_TNF_PATHWAY,c2.CP_ Canonical pathways
9215,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
9216,PDGF_ERK_DN.V1_UP,C6_ oncogenic signatures
9217,REACTOME_ENOS_ACTIVATION_AND_REGULATION,c2.CP_REACTOME_ Reactome gene sets
9218,KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
9219,BCAT_GDS748_DN,C6_ oncogenic signatures
9220,GO_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,c5.BP_ GO biological process
9221,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
9222,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_DN,C7_ immunologic signatures
9223,NOJIMA_SFRP2_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
9224,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN,C7_ immunologic signatures
9225,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP,C7_ immunologic signatures
9226,GO_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY,c5.GO molecular function
9227,GO_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
9228,GO_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM,c5.BP_ GO biological process
9229,ACTAYRNNNCCCR_UNKNOWN,c3.TFT_ transcription factor targets
9230,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN,C7_ immunologic signatures
9231,GO_RESPONSE_TO_ACTIVITY,c5.BP_ GO biological process
9232,GSE36095_WT_VS_HDAC9_KO_TREG_DN,C7_ immunologic signatures
9233,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,C7_ immunologic signatures
9234,MIKKELSEN_MEF_HCP_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
9235,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,c2.CP_BIOCARTA_ BioCarta gene sets
9236,GSE17721_CTRL_VS_CPG_2H_BMDC_UP,C7_ immunologic signatures
9237,GO_NEGATIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,c5.BP_ GO biological process
9238,PID_THROMBIN_PAR1_PATHWAY,c2.CP_ Canonical pathways
9239,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_DN,C7_ immunologic signatures
9240,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN,C7_ immunologic signatures
9241,GO_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,c5.BP_ GO biological process
9242,GO_REGULATION_OF_DOPAMINE_SECRETION,c5.BP_ GO biological process
9243,GO_GLYCOPROTEIN_METABOLIC_PROCESS,c5.BP_ GO biological process
9244,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
9245,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP,C7_ immunologic signatures
9246,GTCAGGA_MIR378,c3.MIR_ microRNA targets
9247,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,c2.CGP_ chemical and genetic perturbations
9248,GO_PEPTIDE_RECEPTOR_ACTIVITY,c5.GO molecular function
9249,GSE22886_NAIVE_VS_MEMORY_TCELL_UP,C7_ immunologic signatures
9250,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP,C7_ immunologic signatures
9251,GSE3982_NEUTROPHIL_VS_BCELL_UP,C7_ immunologic signatures
9252,CGTSACG_PAX3_B,c3.TFT_ transcription factor targets
9253,MORF_PTPN9,c4.CGN_ cancer gene neighborhoods
9254,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN,C7_ immunologic signatures
9255,CHR2P25,39
9256,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,C7_ immunologic signatures
9257,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP,C7_ immunologic signatures
9258,HEIDENBLAD_AMPLICON_8Q24_UP,c2.CGP_ chemical and genetic perturbations
9259,GCM_VAV1,c4.CGN_ cancer gene neighborhoods
9260,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_UP,C7_ immunologic signatures
9261,REACTOME_GLYCOSPHINGOLIPID_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
9262,GO_DNA_CATABOLIC_PROCESS_ENDONUCLEOLYTIC,c5.BP_ GO biological process
9263,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,C7_ immunologic signatures
9264,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN,C7_ immunologic signatures
9265,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP,C7_ immunologic signatures
9266,BAKKER_FOXO3_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
9267,GO_PROTEIN_POLYUBIQUITINATION,c5.BP_ GO biological process
9268,GTAAGAT_MIR200A,c3.MIR_ microRNA targets
9269,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,C7_ immunologic signatures
9270,GSE27786_LIN_NEG_VS_NKTCELL_DN,C7_ immunologic signatures
9271,CHR16P11,78
9272,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
9273,GNF2_GSTM1,c4.CGN_ cancer gene neighborhoods
9274,GSE27786_BCELL_VS_CD8_TCELL_DN,C7_ immunologic signatures
9275,GO_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,c5.BP_ GO biological process
9276,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN,C7_ immunologic signatures
9277,MODULE_323,c4.CM_ cancer modules
9278,MORF_CNTN1,c4.CGN_ cancer gene neighborhoods
9279,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
9280,GO_RESPONSE_TO_DEXAMETHASONE,c5.BP_ GO biological process
9281,GO_GROWTH_FACTOR_RECEPTOR_BINDING,c5.GO molecular function
9282,GO_ACYLGLYCEROL_HOMEOSTASIS,c5.BP_ GO biological process
9283,GO_RESPONSE_TO_THYROID_HORMONE,c5.BP_ GO biological process
9284,GSE10325_BCELL_VS_MYELOID_DN,C7_ immunologic signatures
9285,BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,c2.CGP_ chemical and genetic perturbations
9286,MORF_PPP5C,c4.CGN_ cancer gene neighborhoods
9287,CHR12P11,28
9288,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN,C7_ immunologic signatures
9289,GO_COVALENT_CHROMATIN_MODIFICATION,c5.BP_ GO biological process
9290,VALK_AML_CLUSTER_11,c2.CGP_ chemical and genetic perturbations
9291,MORF_MLLT10,c4.CGN_ cancer gene neighborhoods
9292,NFKB_Q6,c3.TFT_ transcription factor targets
9293,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_DN,C7_ immunologic signatures
9294,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,C7_ immunologic signatures
9295,AACYNNNNTTCCS_UNKNOWN,c3.TFT_ transcription factor targets
9296,LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES,c2.CGP_ chemical and genetic perturbations
9297,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN,C7_ immunologic signatures
9298,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP,C7_ immunologic signatures
9299,GO_HETEROTYPIC_CELL_CELL_ADHESION,c5.BP_ GO biological process
9300,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP,C7_ immunologic signatures
9301,GO_CYTOPLASMIC_SIDE_OF_MEMBRANE,c5.CC_ GO cellular component
9302,HOLLMANN_APOPTOSIS_VIA_CD40_UP,c2.CGP_ chemical and genetic perturbations
9303,GSE27786_LSK_VS_NKTCELL_DN,C7_ immunologic signatures
9304,GO_PROTEIN_OLIGOMERIZATION,c5.BP_ GO biological process
9305,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,c2.CGP_ chemical and genetic perturbations
9306,GO_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
9307,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN,C7_ immunologic signatures
9308,AP2GAMMA_01,c3.TFT_ transcription factor targets
9309,HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY,c2.CGP_ chemical and genetic perturbations
9310,BIOCARTA_TNFR1_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9311,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_DN,C7_ immunologic signatures
9312,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP,C7_ immunologic signatures
9313,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,C7_ immunologic signatures
9314,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN,C7_ immunologic signatures
9315,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN,c2.CGP_ chemical and genetic perturbations
9316,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_UP,C7_ immunologic signatures
9317,RODWELL_AGING_KIDNEY_NO_BLOOD_DN,c2.CGP_ chemical and genetic perturbations
9318,AMIT_EGF_RESPONSE_120_HELA,c2.CGP_ chemical and genetic perturbations
9319,CHR20P11,36
9320,GO_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY,c5.GO molecular function
9321,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,C7_ immunologic signatures
9322,GO_HIPPOCAMPUS_DEVELOPMENT,c5.BP_ GO biological process
9323,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_UP,C7_ immunologic signatures
9324,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_UP,C7_ immunologic signatures
9325,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,c2.CGP_ chemical and genetic perturbations
9326,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP,C7_ immunologic signatures
9327,GO_PROTEIN_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,c5.GO molecular function
9328,REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE,c2.CP_REACTOME_ Reactome gene sets
9329,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP,C7_ immunologic signatures
9330,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP,C7_ immunologic signatures
9331,GO_CILIUM,c5.CC_ GO cellular component
9332,WOTTON_RUNX_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
9333,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN,C7_ immunologic signatures
9334,SPIRA_SMOKERS_LUNG_CANCER_UP,c2.CGP_ chemical and genetic perturbations
9335,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,c2.CGP_ chemical and genetic perturbations
9336,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP,C7_ immunologic signatures
9337,GSE27434_WT_VS_DNMT1_KO_TREG_DN,C7_ immunologic signatures
9338,GO_ESTROGEN_METABOLIC_PROCESS,c5.BP_ GO biological process
9339,GO_REGULATION_OF_LIGASE_ACTIVITY,c5.BP_ GO biological process
9340,GO_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE,c5.BP_ GO biological process
9341,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
9342,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
9343,REACTOME_SYNTHESIS_OF_DNA,c2.CP_REACTOME_ Reactome gene sets
9344,T3R_Q6,c3.TFT_ transcription factor targets
9345,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
9346,GSE27786_NEUTROPHIL_VS_MONO_MAC_UP,C7_ immunologic signatures
9347,DE_YY1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
9348,GSE22045_TREG_VS_TCONV_DN,C7_ immunologic signatures
9349,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_UP,C7_ immunologic signatures
9350,BIOCARTA_HCMV_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9351,BIOCARTA_TPO_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9352,REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE,c2.CP_REACTOME_ Reactome gene sets
9353,GO_ESTABLISHMENT_OF_LOCALIZATION_BY_MOVEMENT_ALONG_MICROTUBULE,c5.BP_ GO biological process
9354,GO_PHAGOCYTIC_VESICLE_MEMBRANE,c5.CC_ GO cellular component
9355,GSE17721_LPS_VS_POLYIC_2H_BMDC_DN,C7_ immunologic signatures
9356,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_DN,C7_ immunologic signatures
9357,TACTTGA_MIR26A_MIR26B,c3.MIR_ microRNA targets
9358,LU_EZH2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
9359,NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,c2.CGP_ chemical and genetic perturbations
9360,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP,C7_ immunologic signatures
9361,GO_MEMBRANE_ASSEMBLY,c5.BP_ GO biological process
9362,GO_DETECTION_OF_LIGHT_STIMULUS,c5.BP_ GO biological process
9363,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP,C7_ immunologic signatures
9364,GO_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,c5.BP_ GO biological process
9365,GO_MUSCLE_CELL_PROLIFERATION,c5.BP_ GO biological process
9366,WALLACE_JAK2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
9367,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN,C7_ immunologic signatures
9368,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,C7_ immunologic signatures
9369,GO_RESPONSE_TO_GROWTH_HORMONE,c5.BP_ GO biological process
9370,BIOCARTA_NOS1_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9371,TGCGCANK_UNKNOWN,c3.TFT_ transcription factor targets
9372,GO_EMBRYONIC_HINDLIMB_MORPHOGENESIS,c5.BP_ GO biological process
9373,MODULE_17,c4.CM_ cancer modules
9374,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP,C7_ immunologic signatures
9375,ST_GRANULE_CELL_SURVIVAL_PATHWAY,c2.CP_ Canonical pathways
9376,GO_CELL_PROJECTION_CYTOPLASM,c5.CC_ GO cellular component
9377,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_DN,C7_ immunologic signatures
9378,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,C7_ immunologic signatures
9379,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,C7_ immunologic signatures
9380,BIOCARTA_PTDINS_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9381,GO_HISTONE_DEMETHYLASE_ACTIVITY,c5.GO molecular function
9382,REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS,c2.CP_REACTOME_ Reactome gene sets
9383,MODULE_204,c4.CM_ cancer modules
9384,HELLER_SILENCED_BY_METHYLATION_DN,c2.CGP_ chemical and genetic perturbations
9385,GO_OLIGODENDROCYTE_DIFFERENTIATION,c5.BP_ GO biological process
9386,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7,c2.CGP_ chemical and genetic perturbations
9387,PID_ERBB1_INTERNALIZATION_PATHWAY,c2.CP_ Canonical pathways
9388,GO_CELLULAR_RESPONSE_TO_MECHANICAL_STIMULUS,c5.BP_ GO biological process
9389,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_UP,C7_ immunologic signatures
9390,GCM_BMPR2,c4.CGN_ cancer gene neighborhoods
9391,GO_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY,c5.BP_ GO biological process
9392,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP,C7_ immunologic signatures
9393,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,C7_ immunologic signatures
9394,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP,C7_ immunologic signatures
9395,AHR_Q5,c3.TFT_ transcription factor targets
9396,BIOCARTA_ERK_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9397,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,C7_ immunologic signatures
9398,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN,C7_ immunologic signatures
9399,GO_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
9400,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_DN,C7_ immunologic signatures
9401,GO_CELLULAR_PROTEIN_COMPLEX_LOCALIZATION,c5.BP_ GO biological process
9402,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
9403,GO_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY,c5.BP_ GO biological process
9404,GTTTGTT_MIR495,c3.MIR_ microRNA targets
9405,RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2,c2.CGP_ chemical and genetic perturbations
9406,GSE22886_NAIVE_BCELL_VS_DC_UP,C7_ immunologic signatures
9407,GO_CELLULAR_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS,c5.BP_ GO biological process
9408,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN,C7_ immunologic signatures
9409,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN,c2.CGP_ chemical and genetic perturbations
9410,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_UP,C7_ immunologic signatures
9411,P300_01,c3.TFT_ transcription factor targets
9412,YYCATTCAWW_UNKNOWN,c3.TFT_ transcription factor targets
9413,GO_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING,c5.BP_ GO biological process
9414,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN,C7_ immunologic signatures
9415,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_UP,C7_ immunologic signatures
9416,GO_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
9417,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_DN,C7_ immunologic signatures
9418,GO_STEROID_DEHYDROGENASE_ACTIVITY,c5.GO molecular function
9419,GO_PROTEIN_KINASE_A_REGULATORY_SUBUNIT_BINDING,c5.GO molecular function
9420,MODULE_257,c4.CM_ cancer modules
9421,GO_DNA_METHYLATION_OR_DEMETHYLATION,c5.BP_ GO biological process
9422,GO_NITROGEN_COMPOUND_TRANSPORT,c5.BP_ GO biological process
9423,GGGNNTTTCC_NFKB_Q6_01,c3.TFT_ transcription factor targets
9424,GSE17721_LPS_VS_POLYIC_24H_BMDC_DN,C7_ immunologic signatures
9425,GSE27786_LSK_VS_NKCELL_DN,C7_ immunologic signatures
9426,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,C7_ immunologic signatures
9427,KEGG_DRUG_METABOLISM_OTHER_ENZYMES,c2.CP_BIOCARTA_ BioCarta gene sets
9428,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,c2.CGP_ chemical and genetic perturbations
9429,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,C7_ immunologic signatures
9430,GO_PIGMENT_GRANULE_ORGANIZATION,c5.BP_ GO biological process
9431,AMIT_EGF_RESPONSE_240_HELA,c2.CGP_ chemical and genetic perturbations
9432,GO_NEGATIVE_REGULATION_OF_JNK_CASCADE,c5.BP_ GO biological process
9433,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN,c2.CGP_ chemical and genetic perturbations
9434,GSE17721_CTRL_VS_CPG_2H_BMDC_DN,C7_ immunologic signatures
9435,SUNG_METASTASIS_STROMA_DN,c2.CGP_ chemical and genetic perturbations
9436,NRF1_Q6,c3.TFT_ transcription factor targets
9437,GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP,C7_ immunologic signatures
9438,RODRIGUES_NTN1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
9439,GO_NEGATIVE_REGULATION_OF_AUTOPHAGY,c5.BP_ GO biological process
9440,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP,C7_ immunologic signatures
9441,GO_ATPASE_ACTIVATOR_ACTIVITY,c5.GO molecular function
9442,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,c2.CGP_ chemical and genetic perturbations
9443,REACTOME_ACTIVATED_TLR4_SIGNALLING,c2.CP_REACTOME_ Reactome gene sets
9444,GSE17186_MEMORY_VS_NAIVE_BCELL_UP,C7_ immunologic signatures
9445,GO_PEPTIDYL_TYROSINE_AUTOPHOSPHORYLATION,c5.BP_ GO biological process
9446,GO_REGULATION_OF_MESONEPHROS_DEVELOPMENT,c5.BP_ GO biological process
9447,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN,C7_ immunologic signatures
9448,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_DN,C7_ immunologic signatures
9449,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_UP,C7_ immunologic signatures
9450,GO_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
9451,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP,C7_ immunologic signatures
9452,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_UP,C7_ immunologic signatures
9453,GO_NUCLEAR_BODY,c5.CC_ GO cellular component
9454,GO_THIOLESTER_HYDROLASE_ACTIVITY,c5.GO molecular function
9455,GO_REGULATION_OF_HAIR_CYCLE,c5.BP_ GO biological process
9456,GO_MACROMOLECULAR_COMPLEX_REMODELING,c5.BP_ GO biological process
9457,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,C7_ immunologic signatures
9458,KASLER_HDAC7_TARGETS_1_UP,c2.CGP_ chemical and genetic perturbations
9459,HALLMARK_HEME_METABOLISM,H_ hallmark gene sets
9460,VALK_AML_CLUSTER_1,c2.CGP_ chemical and genetic perturbations
9461,GO_PROTEIN_LOCALIZATION_TO_NUCLEUS,c5.BP_ GO biological process
9462,KEGG_BASE_EXCISION_REPAIR,c2.CP_BIOCARTA_ BioCarta gene sets
9463,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_DN,C7_ immunologic signatures
9464,TTTGCAG_MIR518A2,c3.MIR_ microRNA targets
9465,GO_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
9466,GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP,C7_ immunologic signatures
9467,REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
9468,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,C7_ immunologic signatures
9469,LIM_MAMMARY_STEM_CELL_DN,c2.CGP_ chemical and genetic perturbations
9470,GO_NEGATIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
9471,GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN,C7_ immunologic signatures
9472,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP,C7_ immunologic signatures
9473,GO_NEGATIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,c5.BP_ GO biological process
9474,GO_NEURAL_RETINA_DEVELOPMENT,c5.BP_ GO biological process
9475,PID_TOLL_ENDOGENOUS_PATHWAY,c2.CP_ Canonical pathways
9476,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_UP,C7_ immunologic signatures
9477,TCTATGA_MIR376A_MIR376B,c3.MIR_ microRNA targets
9478,GO_VESICLE_CYTOSKELETAL_TRAFFICKING,c5.BP_ GO biological process
9479,GO_RAB_GTPASE_BINDING,c5.GO molecular function
9480,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_UP,C7_ immunologic signatures
9481,GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP,C7_ immunologic signatures
9482,GO_DEATH_RECEPTOR_ACTIVITY,c5.GO molecular function
9483,GO_ONE_CARBON_METABOLIC_PROCESS,c5.BP_ GO biological process
9484,VERRECCHIA_RESPONSE_TO_TGFB1_C2,c2.CGP_ chemical and genetic perturbations
9485,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
9486,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR,c2.CGP_ chemical and genetic perturbations
9487,GO_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY,c5.GO molecular function
9488,NFKAPPAB65_01,c3.TFT_ transcription factor targets
9489,GO_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
9490,CHR3Q12,25
9491,GO_ETHANOLAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
9492,KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9493,GSE14308_TH2_VS_INDUCED_TREG_DN,C7_ immunologic signatures
9494,GO_REGULATION_OF_STEROID_HORMONE_SECRETION,c5.BP_ GO biological process
9495,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP,C7_ immunologic signatures
9496,GO_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,c5.BP_ GO biological process
9497,AP2_Q3,c3.TFT_ transcription factor targets
9498,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,C7_ immunologic signatures
9499,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
9500,PID_IL1_PATHWAY,c2.CP_ Canonical pathways
9501,REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,c2.CP_REACTOME_ Reactome gene sets
9502,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN,C7_ immunologic signatures
9503,GO_REGULATION_OF_HISTONE_METHYLATION,c5.BP_ GO biological process
9504,TFIII_Q6,c3.TFT_ transcription factor targets
9505,GO_NEURAL_TUBE_PATTERNING,c5.BP_ GO biological process
9506,GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS,c5.BP_ GO biological process
9507,SILIGAN_BOUND_BY_EWS_FLT1_FUSION,c2.CGP_ chemical and genetic perturbations
9508,KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,c2.CP_BIOCARTA_ BioCarta gene sets
9509,VALK_AML_CLUSTER_2,c2.CGP_ chemical and genetic perturbations
9510,GO_NEUROTRANSMITTER_TRANSPORT,c5.BP_ GO biological process
9511,GO_WATER_HOMEOSTASIS,c5.BP_ GO biological process
9512,SP1_Q4_01,c3.TFT_ transcription factor targets
9513,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
9514,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,C7_ immunologic signatures
9515,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP,C7_ immunologic signatures
9516,GO_PHOSPHATIDYLINOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,c5.GO molecular function
9517,COUP_DR1_Q6,c3.TFT_ transcription factor targets
9518,PEA3_Q6,c3.TFT_ transcription factor targets
9519,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN,C7_ immunologic signatures
9520,GO_CILIARY_PLASM,c5.CC_ GO cellular component
9521,WENDT_COHESIN_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
9522,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,c2.CGP_ chemical and genetic perturbations
9523,GO_TRANSLATION_REPRESSOR_ACTIVITY,c5.GO molecular function
9524,GSE14308_INDUCED_VS_NATURAL_TREG_UP,C7_ immunologic signatures
9525,KIM_LRRC3B_TARGETS,c2.CGP_ chemical and genetic perturbations
9526,GO_MULTICELLULAR_ORGANISMAL_WATER_HOMEOSTASIS,c5.BP_ GO biological process
9527,GO_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,c5.BP_ GO biological process
9528,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,c2.CGP_ chemical and genetic perturbations
9529,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
9530,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_DN,C7_ immunologic signatures
9531,GO_KERATAN_SULFATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
9532,BIOCARTA_AT1R_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9533,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP,C7_ immunologic signatures
9534,ELF1_Q6,c3.TFT_ transcription factor targets
9535,GO_POSITIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,c5.BP_ GO biological process
9536,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_UP,C7_ immunologic signatures
9537,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP,C7_ immunologic signatures
9538,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP,C7_ immunologic signatures
9539,CAFFAREL_RESPONSE_TO_THC_UP,c2.CGP_ chemical and genetic perturbations
9540,GNF2_CD48,c4.CGN_ cancer gene neighborhoods
9541,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP,C7_ immunologic signatures
9542,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,C7_ immunologic signatures
9543,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP,C7_ immunologic signatures
9544,GO_ENTRAINMENT_OF_CIRCADIAN_CLOCK_BY_PHOTOPERIOD,c5.BP_ GO biological process
9545,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,c2.CGP_ chemical and genetic perturbations
9546,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,C7_ immunologic signatures
9547,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,c2.CGP_ chemical and genetic perturbations
9548,AGGAGTG_MIR483,c3.MIR_ microRNA targets
9549,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN,c2.CGP_ chemical and genetic perturbations
9550,GSE18148_CBFB_KO_VS_WT_TREG_UP,C7_ immunologic signatures
9551,GSE34515_CD16_POS_MONOCYTE_VS_DC_UP,C7_ immunologic signatures
9552,PAX5_01,c3.TFT_ transcription factor targets
9553,CHR1Q44,35
9554,AGTCTAG_MIR151,c3.MIR_ microRNA targets
9555,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,c2.CGP_ chemical and genetic perturbations
9556,GO_V_D_J_RECOMBINATION,c5.BP_ GO biological process
9557,GO_NUCLEAR_EUCHROMATIN,c5.CC_ GO cellular component
9558,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN,C7_ immunologic signatures
9559,GO_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS,c5.BP_ GO biological process
9560,GSE27786_LSK_VS_CD4_TCELL_UP,C7_ immunologic signatures
9561,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
9562,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,c2.CGP_ chemical and genetic perturbations
9563,GSE2585_THYMIC_DC_VS_MTEC_UP,C7_ immunologic signatures
9564,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,C7_ immunologic signatures
9565,GSE14308_TH2_VS_TH17_DN,C7_ immunologic signatures
9566,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP,C7_ immunologic signatures
9567,GO_PROTEIN_TARGETING_TO_PLASMA_MEMBRANE,c5.BP_ GO biological process
9568,MAINA_VHL_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
9569,GO_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL,c5.BP_ GO biological process
9570,BIOCARTA_BARRESTIN_SRC_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9571,GO_RETINA_HOMEOSTASIS,c5.BP_ GO biological process
9572,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
9573,GOLUB_ALL_VS_AML_UP,c2.CGP_ chemical and genetic perturbations
9574,GSE7460_CD8_TCELL_VS_TREG_ACT_UP,C7_ immunologic signatures
9575,GO_REGULATION_OF_DENDRITE_DEVELOPMENT,c5.BP_ GO biological process
9576,GO_RUFFLE,c5.CC_ GO cellular component
9577,GCM_DDX11,c4.CGN_ cancer gene neighborhoods
9578,PDGF_UP.V1_UP,C6_ oncogenic signatures
9579,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,C7_ immunologic signatures
9580,GO_PTERIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
9581,GO_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,c5.BP_ GO biological process
9582,GO_MULTI_ORGANISM_ORGANELLE_ORGANIZATION,c5.BP_ GO biological process
9583,GO_WW_DOMAIN_BINDING,c5.GO molecular function
9584,PID_CDC42_PATHWAY,c2.CP_ Canonical pathways
9585,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,c2.CGP_ chemical and genetic perturbations
9586,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,C7_ immunologic signatures
9587,GO_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,c5.BP_ GO biological process
9588,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,C7_ immunologic signatures
9589,GO_LEUKOCYTE_CELL_CELL_ADHESION,c5.BP_ GO biological process
9590,CCACACA_MIR147,c3.MIR_ microRNA targets
9591,CREB_02,c3.TFT_ transcription factor targets
9592,GO_NEGATIVE_REGULATION_OF_HOMEOSTATIC_PROCESS,c5.BP_ GO biological process
9593,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,c2.CGP_ chemical and genetic perturbations
9594,GO_REGULATION_OF_CAMP_MEDIATED_SIGNALING,c5.BP_ GO biological process
9595,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN,C7_ immunologic signatures
9596,GO_ARF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,c5.GO molecular function
9597,GO_PROTEIN_COMPLEX_SCAFFOLD,c5.GO molecular function
9598,GSE21033_3H_VS_24H_POLYIC_STIM_DC_DN,C7_ immunologic signatures
9599,GO_RNA_STABILIZATION,c5.BP_ GO biological process
9600,GSE27786_BCELL_VS_CD4_TCELL_DN,C7_ immunologic signatures
9601,REACTOME_SIGNALLING_BY_NGF,c2.CP_REACTOME_ Reactome gene sets
9602,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,c2.CGP_ chemical and genetic perturbations
9603,GO_VITAMIN_D_RECEPTOR_BINDING,c5.GO molecular function
9604,GO_SEX_DETERMINATION,c5.BP_ GO biological process
9605,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,C7_ immunologic signatures
9606,BIOCARTA_IL1R_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9607,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,C7_ immunologic signatures
9608,GSE3039_CD4_TCELL_VS_B1_BCELL_DN,C7_ immunologic signatures
9609,HASLINGER_B_CLL_WITH_11Q23_DELETION,c2.CGP_ chemical and genetic perturbations
9610,GO_CYSTEINE_TYPE_ENDOPEPTIDASE_REGULATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,c5.GO molecular function
9611,BRIDEAU_IMPRINTED_GENES,c2.CGP_ chemical and genetic perturbations
9612,GO_T_CELL_HOMEOSTASIS,c5.BP_ GO biological process
9613,GO_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
9614,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,c2.CGP_ chemical and genetic perturbations
9615,SREBP1_02,c3.TFT_ transcription factor targets
9616,GO_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,c5.BP_ GO biological process
9617,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_UP,C7_ immunologic signatures
9618,GO_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
9619,TCTGATC_MIR383,c3.MIR_ microRNA targets
9620,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_DN,C7_ immunologic signatures
9621,GO_HELICASE_ACTIVITY,c5.GO molecular function
9622,CHR7P21,28
9623,GO_LIPID_CATABOLIC_PROCESS,c5.BP_ GO biological process
9624,GO_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,c5.BP_ GO biological process
9625,STAMBOLSKY_BOUND_BY_MUTATED_TP53,c2.CGP_ chemical and genetic perturbations
9626,GO_MAINTENANCE_OF_LOCATION,c5.BP_ GO biological process
9627,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,C7_ immunologic signatures
9628,GO_R_SMAD_BINDING,c5.GO molecular function
9629,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,C7_ immunologic signatures
9630,MELLMAN_TUT1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
9631,ST_P38_MAPK_PATHWAY,c2.CP_ Canonical pathways
9632,DARWICHE_PAPILLOMA_PROGRESSION_RISK,c2.CGP_ chemical and genetic perturbations
9633,CYCLIN_D1_UP.V1_DN,C6_ oncogenic signatures
9634,GO_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND,c5.BP_ GO biological process
9635,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN,C7_ immunologic signatures
9636,LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,c2.CGP_ chemical and genetic perturbations
9637,GO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
9638,WANG_BARRETTS_ESOPHAGUS_DN,c2.CGP_ chemical and genetic perturbations
9639,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN,C7_ immunologic signatures
9640,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN,C7_ immunologic signatures
9641,VANASSE_BCL2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
9642,TBK1.DN.48HRS_UP,C6_ oncogenic signatures
9643,GO_LATE_ENDOSOME_MEMBRANE,c5.CC_ GO cellular component
9644,REACTOME_BIOLOGICAL_OXIDATIONS,c2.CP_REACTOME_ Reactome gene sets
9645,LIU_COMMON_CANCER_GENES,c2.CGP_ chemical and genetic perturbations
9646,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
9647,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_DN,C7_ immunologic signatures
9648,MORF_ORC1L,c4.CGN_ cancer gene neighborhoods
9649,ROSS_LEUKEMIA_WITH_MLL_FUSIONS,c2.CGP_ chemical and genetic perturbations
9650,STEIN_ESR1_TARGETS,c2.CGP_ chemical and genetic perturbations
9651,HINATA_NFKB_TARGETS_KERATINOCYTE_DN,c2.CGP_ chemical and genetic perturbations
9652,GO_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
9653,KEGG_MTOR_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9654,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN,C7_ immunologic signatures
9655,GO_ACROSOMAL_MEMBRANE,c5.CC_ GO cellular component
9656,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN,C7_ immunologic signatures
9657,GO_ENDOCARDIAL_CUSHION_MORPHOGENESIS,c5.BP_ GO biological process
9658,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,C7_ immunologic signatures
9659,GO_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS,c5.BP_ GO biological process
9660,GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
9661,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP,C7_ immunologic signatures
9662,GO_POSITIVE_REGULATION_OF_HORMONE_SECRETION,c5.BP_ GO biological process
9663,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_DN,C7_ immunologic signatures
9664,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,c2.CGP_ chemical and genetic perturbations
9665,GO_CLATHRIN_COATED_VESICLE,c5.CC_ GO cellular component
9666,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,c5.GO molecular function
9667,GO_RAC_GTPASE_BINDING,c5.GO molecular function
9668,RACCACAR_AML_Q6,c3.TFT_ transcription factor targets
9669,GO_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,c5.GO molecular function
9670,GO_METANEPHRIC_EPITHELIUM_DEVELOPMENT,c5.BP_ GO biological process
9671,CCTGTGA_MIR513,c3.MIR_ microRNA targets
9672,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,c2.CGP_ chemical and genetic perturbations
9673,MORF_CTSB,c4.CGN_ cancer gene neighborhoods
9674,GO_ANION_CHANNEL_ACTIVITY,c5.GO molecular function
9675,CHR16Q13,27
9676,KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,c2.CP_BIOCARTA_ BioCarta gene sets
9677,CHR10P13,24
9678,BAKER_HEMATOPOIESIS_STAT3_TARGETS,c2.CGP_ chemical and genetic perturbations
9679,TCANNTGAY_SREBP1_01,c3.TFT_ transcription factor targets
9680,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP,C7_ immunologic signatures
9681,VERNELL_RETINOBLASTOMA_PATHWAY_DN,c2.CGP_ chemical and genetic perturbations
9682,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN,C7_ immunologic signatures
9683,CTACTGT_MIR199A,c3.MIR_ microRNA targets
9684,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN,C7_ immunologic signatures
9685,GO_TERMINAL_BOUTON,c5.CC_ GO cellular component
9686,DALESSIO_TSA_RESPONSE,c2.CGP_ chemical and genetic perturbations
9687,GSE27786_LSK_VS_CD4_TCELL_DN,C7_ immunologic signatures
9688,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN,C7_ immunologic signatures
9689,GO_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,c5.BP_ GO biological process
9690,MCCLUNG_DELTA_FOSB_TARGETS_8WK,c2.CGP_ chemical and genetic perturbations
9691,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN,C7_ immunologic signatures
9692,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP,C7_ immunologic signatures
9693,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,C7_ immunologic signatures
9694,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_UP,C7_ immunologic signatures
9695,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,C7_ immunologic signatures
9696,GATA1_01,c3.TFT_ transcription factor targets
9697,IKEDA_MIR30_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
9698,GO_VIRUS_RECEPTOR_ACTIVITY,c5.GO molecular function
9699,GO_TETRAPYRROLE_BINDING,c5.GO molecular function
9700,GO_REGULATION_OF_B_CELL_PROLIFERATION,c5.BP_ GO biological process
9701,GO_ADRENAL_GLAND_DEVELOPMENT,c5.BP_ GO biological process
9702,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP,C7_ immunologic signatures
9703,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP,C7_ immunologic signatures
9704,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP,C7_ immunologic signatures
9705,GSE27786_NKCELL_VS_NKTCELL_DN,C7_ immunologic signatures
9706,GSE14000_UNSTIM_VS_4H_LPS_DC_UP,C7_ immunologic signatures
9707,WALLACE_PROSTATE_CANCER_RACE_DN,c2.CGP_ chemical and genetic perturbations
9708,GSE3982_DC_VS_TH1_UP,C7_ immunologic signatures
9709,WATANABE_COLON_CANCER_MSI_VS_MSS_DN,c2.CGP_ chemical and genetic perturbations
9710,BIOCARTA_AKT_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9711,CHR3Q25,41
9712,GENTILE_UV_RESPONSE_CLUSTER_D2,c2.CGP_ chemical and genetic perturbations
9713,GO_REGULATION_OF_VASCULAR_PERMEABILITY,c5.BP_ GO biological process
9714,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,C7_ immunologic signatures
9715,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,C7_ immunologic signatures
9716,GO_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
9717,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN,C7_ immunologic signatures
9718,MODULE_331,c4.CM_ cancer modules
9719,GO_REGULATION_OF_MITOCHONDRIAL_FISSION,c5.BP_ GO biological process
9720,BROWN_MYELOID_CELL_DEVELOPMENT_UP,c2.CGP_ chemical and genetic perturbations
9721,REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
9722,GSE557_WT_VS_I_AB_KO_DC_UP,C7_ immunologic signatures
9723,GSE17721_LPS_VS_POLYIC_8H_BMDC_DN,C7_ immunologic signatures
9724,GO_ION_GATED_CHANNEL_ACTIVITY,c5.GO molecular function
9725,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP,c2.CGP_ chemical and genetic perturbations
9726,GO_TRANSFERASE_ACTIVITY_TRANSFERRING_PENTOSYL_GROUPS,c5.GO molecular function
9727,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP,C7_ immunologic signatures
9728,TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN,c2.CGP_ chemical and genetic perturbations
9729,AIYAR_COBRA1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
9730,BILANGES_SERUM_SENSITIVE_VIA_TSC1,c2.CGP_ chemical and genetic perturbations
9731,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,c2.CGP_ chemical and genetic perturbations
9732,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
9733,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP,C7_ immunologic signatures
9734,GO_TRANS_GOLGI_NETWORK_MEMBRANE,c5.CC_ GO cellular component
9735,GO_RUFFLE_MEMBRANE,c5.CC_ GO cellular component
9736,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,c2.CGP_ chemical and genetic perturbations
9737,GO_NEGATIVE_REGULATION_OF_LYASE_ACTIVITY,c5.BP_ GO biological process
9738,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP,C7_ immunologic signatures
9739,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP,C7_ immunologic signatures
9740,GO_MODULATION_BY_HOST_OF_VIRAL_PROCESS,c5.BP_ GO biological process
9741,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,C7_ immunologic signatures
9742,GO_PARASYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
9743,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
9744,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
9745,WONG_PROTEASOME_GENE_MODULE,c2.CGP_ chemical and genetic perturbations
9746,WHITFIELD_CELL_CYCLE_M_G1,c2.CGP_ chemical and genetic perturbations
9747,PAX3_01,c3.TFT_ transcription factor targets
9748,GO_PATTERNING_OF_BLOOD_VESSELS,c5.BP_ GO biological process
9749,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP,C7_ immunologic signatures
9750,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,c2.CGP_ chemical and genetic perturbations
9751,KEGG_GLYCEROPHOSPHOLIPID_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
9752,GO_POSITIVE_REGULATION_OF_PROTEIN_ACETYLATION,c5.BP_ GO biological process
9753,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP,C7_ immunologic signatures
9754,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,C7_ immunologic signatures
9755,GO_TRANSCRIPTIONAL_REPRESSOR_COMPLEX,c5.CC_ GO cellular component
9756,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,C7_ immunologic signatures
9757,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP,C7_ immunologic signatures
9758,GSE3982_DC_VS_BASOPHIL_DN,C7_ immunologic signatures
9759,GO_VIRAL_GENOME_REPLICATION,c5.BP_ GO biological process
9760,GNF2_ITGB2,c4.CGN_ cancer gene neighborhoods
9761,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP,C7_ immunologic signatures
9762,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,C7_ immunologic signatures
9763,BEIER_GLIOMA_STEM_CELL_DN,c2.CGP_ chemical and genetic perturbations
9764,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,C7_ immunologic signatures
9765,ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,c2.CGP_ chemical and genetic perturbations
9766,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_DN,C7_ immunologic signatures
9767,GO_GOLGI_CISTERNA,c5.CC_ GO cellular component
9768,ROESSLER_LIVER_CANCER_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
9769,DARWICHE_SKIN_TUMOR_PROMOTER_DN,c2.CGP_ chemical and genetic perturbations
9770,BROWNE_HCMV_INFECTION_4HR_DN,c2.CGP_ chemical and genetic perturbations
9771,GO_CELLULAR_GLUCOSE_HOMEOSTASIS,c5.BP_ GO biological process
9772,GO_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
9773,WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1,c2.CGP_ chemical and genetic perturbations
9774,NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON,c2.CGP_ chemical and genetic perturbations
9775,CROMER_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
9776,GO_T_CELL_DIFFERENTIATION,c5.BP_ GO biological process
9777,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,C7_ immunologic signatures
9778,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_UP,C7_ immunologic signatures
9779,WOO_LIVER_CANCER_RECURRENCE_DN,c2.CGP_ chemical and genetic perturbations
9780,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,C7_ immunologic signatures
9781,GO_DOPAMINE_RECEPTOR_BINDING,c5.GO molecular function
9782,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_UP,C7_ immunologic signatures
9783,GO_PROTEIN_STABILIZATION,c5.BP_ GO biological process
9784,GO_BASE_EXCISION_REPAIR,c5.BP_ GO biological process
9785,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
9786,GO_SH3_DOMAIN_BINDING,c5.GO molecular function
9787,GO_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
9788,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN,C7_ immunologic signatures
9789,GO_POLYOL_CATABOLIC_PROCESS,c5.BP_ GO biological process
9790,GTCAACC_MIR3805P,c3.MIR_ microRNA targets
9791,MODULE_325,c4.CM_ cancer modules
9792,GO_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,c5.BP_ GO biological process
9793,GO_DNA_N_GLYCOSYLASE_ACTIVITY,c5.GO molecular function
9794,REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,c2.CP_REACTOME_ Reactome gene sets
9795,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
9796,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP,c2.CGP_ chemical and genetic perturbations
9797,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN,C7_ immunologic signatures
9798,MORF_IKBKG,c4.CGN_ cancer gene neighborhoods
9799,KEGG_CHEMOKINE_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9800,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
9801,GO_ORGANIC_HYDROXY_COMPOUND_TRANSPORT,c5.BP_ GO biological process
9802,BIOCARTA_IL2_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9803,PID_CDC42_REG_PATHWAY,c2.CP_ Canonical pathways
9804,GO_PROTEIN_KINASE_COMPLEX,c5.CC_ GO cellular component
9805,KEGG_GLIOMA,c2.CP_BIOCARTA_ BioCarta gene sets
9806,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,c2.CGP_ chemical and genetic perturbations
9807,GO_REGULATION_OF_RESPONSE_TO_INTERFERON_GAMMA,c5.BP_ GO biological process
9808,REACTOME_IL_RECEPTOR_SHC_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
9809,GO_ECTODERM_DEVELOPMENT,c5.BP_ GO biological process
9810,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
9811,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN,C7_ immunologic signatures
9812,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN,C7_ immunologic signatures
9813,GO_CHLORIDE_TRANSPORT,c5.BP_ GO biological process
9814,BIOCARTA_TCR_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9815,SUMI_HNF4A_TARGETS,c2.CGP_ chemical and genetic perturbations
9816,GSE17721_4_VS_24H_CPG_BMDC_DN,C7_ immunologic signatures
9817,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP,C7_ immunologic signatures
9818,GO_HETEROCHROMATIN,c5.CC_ GO cellular component
9819,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,C7_ immunologic signatures
9820,GO_SNAP_RECEPTOR_ACTIVITY,c5.GO molecular function
9821,GO_TRANSCRIPTION_FACTOR_COMPLEX,c5.CC_ GO cellular component
9822,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_UP,C7_ immunologic signatures
9823,MODULE_366,c4.CM_ cancer modules
9824,MAF_Q6,c3.TFT_ transcription factor targets
9825,CTAGGAA_MIR384,c3.MIR_ microRNA targets
9826,CACGTTT_MIR302A,c3.MIR_ microRNA targets
9827,GO_NEGATIVE_REGULATION_OF_MACROAUTOPHAGY,c5.BP_ GO biological process
9828,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_UP,C7_ immunologic signatures
9829,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,C7_ immunologic signatures
9830,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,C7_ immunologic signatures
9831,GO_POSITIVE_REGULATION_OF_GLIOGENESIS,c5.BP_ GO biological process
9832,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_UP,C7_ immunologic signatures
9833,GO_ENDOTHELIAL_CELL_DEVELOPMENT,c5.BP_ GO biological process
9834,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN,C7_ immunologic signatures
9835,GO_DEVELOPMENTAL_PIGMENTATION,c5.BP_ GO biological process
9836,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN,C7_ immunologic signatures
9837,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_DN,C7_ immunologic signatures
9838,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN,C7_ immunologic signatures
9839,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,c2.CGP_ chemical and genetic perturbations
9840,AGGCACT_MIR5153P,c3.MIR_ microRNA targets
9841,GO_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
9842,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN,c2.CGP_ chemical and genetic perturbations
9843,GO_LIGASE_ACTIVITY,c5.GO molecular function
9844,MODULE_567,c4.CM_ cancer modules
9845,CHR2Q37,84
9846,YGTCCTTGR_UNKNOWN,c3.TFT_ transcription factor targets
9847,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
9848,HTF_01,c3.TFT_ transcription factor targets
9849,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
9850,GO_POSITIVE_REGULATION_OF_MRNA_3_END_PROCESSING,c5.BP_ GO biological process
9851,GO_ANATOMICAL_STRUCTURE_ARRANGEMENT,c5.BP_ GO biological process
9852,ENK_UV_RESPONSE_KERATINOCYTE_DN,c2.CGP_ chemical and genetic perturbations
9853,GO_DNA_DEALKYLATION,c5.BP_ GO biological process
9854,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,C7_ immunologic signatures
9855,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
9856,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,C7_ immunologic signatures
9857,GSE2826_XID_VS_BTK_KO_BCELL_UP,C7_ immunologic signatures
9858,GO_PHOSPHOLIPASE_BINDING,c5.GO molecular function
9859,LEE_AGING_NEOCORTEX_UP,c2.CGP_ chemical and genetic perturbations
9860,TAXCREB_02,c3.TFT_ transcription factor targets
9861,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,C7_ immunologic signatures
9862,GO_CARBOHYDRATE_TRANSPORTER_ACTIVITY,c5.GO molecular function
9863,GO_SIN3_TYPE_COMPLEX,c5.CC_ GO cellular component
9864,GO_CELLULAR_LIPID_CATABOLIC_PROCESS,c5.BP_ GO biological process
9865,MODULE_78,c4.CM_ cancer modules
9866,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_DN,C7_ immunologic signatures
9867,EFC_Q6,c3.TFT_ transcription factor targets
9868,SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,c2.CGP_ chemical and genetic perturbations
9869,YY1_02,c3.TFT_ transcription factor targets
9870,KUMAR_AUTOPHAGY_NETWORK,c2.CGP_ chemical and genetic perturbations
9871,ACACTCC_MIR122A,c3.MIR_ microRNA targets
9872,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP,C7_ immunologic signatures
9873,GO_REGULATION_OF_PLASMA_LIPOPROTEIN_PARTICLE_LEVELS,c5.BP_ GO biological process
9874,GCM_HMGA2,c4.CGN_ cancer gene neighborhoods
9875,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_UP,C7_ immunologic signatures
9876,YAN_ESCAPE_FROM_ANOIKIS,c2.CGP_ chemical and genetic perturbations
9877,GO_SERTOLI_CELL_DIFFERENTIATION,c5.BP_ GO biological process
9878,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP,C7_ immunologic signatures
9879,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN,C7_ immunologic signatures
9880,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,c2.CGP_ chemical and genetic perturbations
9881,REACTOME_ADAPTIVE_IMMUNE_SYSTEM,c2.CP_REACTOME_ Reactome gene sets
9882,REACTOME_SIGNALING_BY_ILS,c2.CP_REACTOME_ Reactome gene sets
9883,GO_NEGATIVE_REGULATION_OF_HISTONE_METHYLATION,c5.BP_ GO biological process
9884,GRADE_COLON_VS_RECTAL_CANCER_DN,c2.CGP_ chemical and genetic perturbations
9885,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN,C7_ immunologic signatures
9886,GSE42724_NAIVE_VS_MEMORY_BCELL_UP,C7_ immunologic signatures
9887,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_UP,C7_ immunologic signatures
9888,GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN,C7_ immunologic signatures
9889,GO_PHOSPHOLIPID_CATABOLIC_PROCESS,c5.BP_ GO biological process
9890,TCCCRNNRTGC_UNKNOWN,c3.TFT_ transcription factor targets
9891,REACTOME_REGULATION_OF_SIGNALING_BY_CBL,c2.CP_REACTOME_ Reactome gene sets
9892,MCCABE_HOXC6_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
9893,GO_PROTEIN_HOMOOLIGOMERIZATION,c5.BP_ GO biological process
9894,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_UP,C7_ immunologic signatures
9895,PID_ERBB2_ERBB3_PATHWAY,c2.CP_ Canonical pathways
9896,KMCATNNWGGA_UNKNOWN,c3.TFT_ transcription factor targets
9897,USF_Q6,c3.TFT_ transcription factor targets
9898,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN,C7_ immunologic signatures
9899,GO_NEURAL_NUCLEUS_DEVELOPMENT,c5.BP_ GO biological process
9900,BIOCARTA_EDG1_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9901,GO_CORNIFIED_ENVELOPE,c5.CC_ GO cellular component
9902,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,C7_ immunologic signatures
9903,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
9904,GO_BRUSH_BORDER_MEMBRANE,c5.CC_ GO cellular component
9905,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP,C7_ immunologic signatures
9906,CHR7P22,58
9907,GO_RESPONSE_TO_CAFFEINE,c5.BP_ GO biological process
9908,GO_PROTEIN_SECRETION,c5.BP_ GO biological process
9909,PID_IL6_7_PATHWAY,c2.CP_ Canonical pathways
9910,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN,C7_ immunologic signatures
9911,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
9912,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_DN,C7_ immunologic signatures
9913,GO_ENERGY_RESERVE_METABOLIC_PROCESS,c5.BP_ GO biological process
9914,GCM_RING1,c4.CGN_ cancer gene neighborhoods
9915,GSE11924_TFH_VS_TH1_CD4_TCELL_DN,C7_ immunologic signatures
9916,GNF2_PECAM1,c4.CGN_ cancer gene neighborhoods
9917,MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP,c2.CGP_ chemical and genetic perturbations
9918,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
9919,MODULE_120,c4.CM_ cancer modules
9920,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN,C7_ immunologic signatures
9921,MORF_RRM1,c4.CGN_ cancer gene neighborhoods
9922,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN,C7_ immunologic signatures
9923,GO_CATION_SUGAR_SYMPORTER_ACTIVITY,c5.GO molecular function
9924,GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,c5.BP_ GO biological process
9925,CHR4P14,19
9926,CP2_01,c3.TFT_ transcription factor targets
9927,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_UP,C7_ immunologic signatures
9928,GSE27786_LSK_VS_BCELL_DN,C7_ immunologic signatures
9929,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP,C7_ immunologic signatures
9930,GO_REGULATION_OF_CELL_SHAPE,c5.BP_ GO biological process
9931,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,c2.CGP_ chemical and genetic perturbations
9932,MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,c2.CGP_ chemical and genetic perturbations
9933,GO_PROTEIN_N_TERMINUS_BINDING,c5.GO molecular function
9934,PID_VEGFR1_2_PATHWAY,c2.CP_ Canonical pathways
9935,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
9936,PID_IL2_STAT5_PATHWAY,c2.CP_ Canonical pathways
9937,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,C7_ immunologic signatures
9938,GO_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,c5.GO molecular function
9939,GO_POSITIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,c5.BP_ GO biological process
9940,GGTAACC_MIR4095P,c3.MIR_ microRNA targets
9941,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP,C7_ immunologic signatures
9942,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,C7_ immunologic signatures
9943,GO_CHROMATIN_SILENCING,c5.BP_ GO biological process
9944,REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
9945,GO_NEGATIVE_REGULATION_OF_BLOOD_CIRCULATION,c5.BP_ GO biological process
9946,GO_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS_OTHER_THAN_AMINO_ACYL_GROUPS,c5.GO molecular function
9947,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,C7_ immunologic signatures
9948,PPARA_01,c3.TFT_ transcription factor targets
9949,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN,C7_ immunologic signatures
9950,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP,C7_ immunologic signatures
9951,YWATTWNNRGCT_UNKNOWN,c3.TFT_ transcription factor targets
9952,MODULE_416,c4.CM_ cancer modules
9953,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,c2.CGP_ chemical and genetic perturbations
9954,GCM_RAN,c4.CGN_ cancer gene neighborhoods
9955,MOOTHA_GLYCOGEN_METABOLISM,c2.CGP_ chemical and genetic perturbations
9956,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN,C7_ immunologic signatures
9957,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP,C7_ immunologic signatures
9958,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,C7_ immunologic signatures
9959,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_DN,C7_ immunologic signatures
9960,GO_DEMETHYLATION,c5.BP_ GO biological process
9961,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_UP,C7_ immunologic signatures
9962,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP,C7_ immunologic signatures
9963,ROVERSI_GLIOMA_COPY_NUMBER_UP,c2.CGP_ chemical and genetic perturbations
9964,PETRETTO_HEART_MASS_QTL_CIS_UP,c2.CGP_ chemical and genetic perturbations
9965,GO_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS,c5.BP_ GO biological process
9966,GO_ENDOCYTIC_VESICLE_MEMBRANE,c5.CC_ GO cellular component
9967,GSE17721_CTRL_VS_LPS_6H_BMDC_UP,C7_ immunologic signatures
9968,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP,C7_ immunologic signatures
9969,GSE3982_DC_VS_MAC_LPS_STIM_UP,C7_ immunologic signatures
9970,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN,C7_ immunologic signatures
9971,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
9972,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP,C7_ immunologic signatures
9973,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN,C7_ immunologic signatures
9974,GO_RAC_PROTEIN_SIGNAL_TRANSDUCTION,c5.BP_ GO biological process
9975,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN,C7_ immunologic signatures
9976,KEGG_TASTE_TRANSDUCTION,c2.CP_BIOCARTA_ BioCarta gene sets
9977,GSE11924_TH1_VS_TH2_CD4_TCELL_UP,C7_ immunologic signatures
9978,GNF2_PCAF,c4.CGN_ cancer gene neighborhoods
9979,GAJATE_RESPONSE_TO_TRABECTEDIN_DN,c2.CGP_ chemical and genetic perturbations
9980,RFX1_01,c3.TFT_ transcription factor targets
9981,GCM_PRKAG1,c4.CGN_ cancer gene neighborhoods
9982,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN,C7_ immunologic signatures
9983,BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP,c2.CGP_ chemical and genetic perturbations
9984,GO_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS,c5.GO molecular function
9985,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
9986,STEIN_ESRRA_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
9987,GSE27786_NEUTROPHIL_VS_MONO_MAC_DN,C7_ immunologic signatures
9988,GCM_ERCC4,c4.CGN_ cancer gene neighborhoods
9989,GO_REGULATION_OF_MEMBRANE_PERMEABILITY,c5.BP_ GO biological process
9990,CCGNMNNTNACG_UNKNOWN,c3.TFT_ transcription factor targets
9991,GO_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
9992,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,C7_ immunologic signatures
9993,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN,C7_ immunologic signatures
9994,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_UP,C7_ immunologic signatures
9995,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP,C7_ immunologic signatures
9996,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_UP,C7_ immunologic signatures
9997,CHR16Q12,33
9998,REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI,c2.CP_REACTOME_ Reactome gene sets
9999,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,c2.CP_ Canonical pathways
10000,GO_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION,c5.BP_ GO biological process
10001,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,C7_ immunologic signatures
10002,GO_POSITIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,c5.BP_ GO biological process
10003,MODULE_243,c4.CM_ cancer modules
10004,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP,C7_ immunologic signatures
10005,AMUNDSON_GAMMA_RADIATION_RESISTANCE,c2.CGP_ chemical and genetic perturbations
10006,LXR_Q3,c3.TFT_ transcription factor targets
10007,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,c2.CGP_ chemical and genetic perturbations
10008,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_UP,C7_ immunologic signatures
10009,ONDER_CDH1_TARGETS_1_DN,c2.CGP_ chemical and genetic perturbations
10010,GO_POSITIVE_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING,c5.BP_ GO biological process
10011,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,C7_ immunologic signatures
10012,GO_HORMONE_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
10013,PID_ERBB1_DOWNSTREAM_PATHWAY,c2.CP_ Canonical pathways
10014,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP,C7_ immunologic signatures
10015,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN,C7_ immunologic signatures
10016,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,C7_ immunologic signatures
10017,GO_ADP_BINDING,c5.GO molecular function
10018,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,C7_ immunologic signatures
10019,GTCNYYATGR_UNKNOWN,c3.TFT_ transcription factor targets
10020,GO_LOCALIZATION_WITHIN_MEMBRANE,c5.BP_ GO biological process
10021,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,C7_ immunologic signatures
10022,GO_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,c5.BP_ GO biological process
10023,GO_RESPONSE_TO_INSULIN,c5.BP_ GO biological process
10024,DAZARD_RESPONSE_TO_UV_SCC_UP,c2.CGP_ chemical and genetic perturbations
10025,TOMIDA_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
10026,KYNG_NORMAL_AGING_UP,c2.CGP_ chemical and genetic perturbations
10027,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_DN,C7_ immunologic signatures
10028,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
10029,REACTOME_PHOSPHOLIPID_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
10030,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,c2.CGP_ chemical and genetic perturbations
10031,GO_EYE_PHOTORECEPTOR_CELL_DEVELOPMENT,c5.BP_ GO biological process
10032,LIU_BREAST_CANCER,c2.CGP_ chemical and genetic perturbations
10033,ACTGCCT_MIR34B,c3.MIR_ microRNA targets
10034,GCGSCMNTTT_UNKNOWN,c3.TFT_ transcription factor targets
10035,GO_EXTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE,c5.CC_ GO cellular component
10036,BIOCARTA_PTEN_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10037,CHR17P13,176
10038,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
10039,GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP,C7_ immunologic signatures
10040,GO_NEPHRON_TUBULE_FORMATION,c5.BP_ GO biological process
10041,SIG_BCR_SIGNALING_PATHWAY,c2.CP_ Canonical pathways
10042,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
10043,DANG_MYC_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
10044,GO_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
10045,GO_RNA_POLYMERASE_II_TRANSCRIPTION_COACTIVATOR_ACTIVITY,c5.GO molecular function
10046,GO_TUMOR_NECROSIS_FACTOR_RECEPTOR_BINDING,c5.GO molecular function
10047,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,C7_ immunologic signatures
10048,BIOCARTA_GCR_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10049,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP,C7_ immunologic signatures
10050,GCM_FCGR2B,c4.CGN_ cancer gene neighborhoods
10051,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_UP,C7_ immunologic signatures
10052,GO_NEGATIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION,c5.BP_ GO biological process
10053,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,C7_ immunologic signatures
10054,GUILLAUMOND_KLF10_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
10055,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,c2.CGP_ chemical and genetic perturbations
10056,PID_CERAMIDE_PATHWAY,c2.CP_ Canonical pathways
10057,GNF2_TYK2,c4.CGN_ cancer gene neighborhoods
10058,GO_GOLGI_VESICLE_TRANSPORT,c5.BP_ GO biological process
10059,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN,C7_ immunologic signatures
10060,GO_REGULATION_OF_PH,c5.BP_ GO biological process
10061,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP,C7_ immunologic signatures
10062,PID_EPO_PATHWAY,c2.CP_ Canonical pathways
10063,GO_SKELETAL_MUSCLE_CONTRACTION,c5.BP_ GO biological process
10064,PID_TRKR_PATHWAY,c2.CP_ Canonical pathways
10065,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN,C7_ immunologic signatures
10066,PID_CASPASE_PATHWAY,c2.CP_ Canonical pathways
10067,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,C7_ immunologic signatures
10068,BIOCARTA_TID_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10069,ERR1_Q2,c3.TFT_ transcription factor targets
10070,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP,C7_ immunologic signatures
10071,GO_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
10072,GNF2_CD1D,c4.CGN_ cancer gene neighborhoods
10073,REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,c2.CP_REACTOME_ Reactome gene sets
10074,GO_NEGATIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,c5.BP_ GO biological process
10075,GO_NUCLEAR_ENVELOPE_ORGANIZATION,c5.BP_ GO biological process
10076,GO_PYRIMIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
10077,BIOCARTA_GPCR_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10078,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,C7_ immunologic signatures
10079,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,c2.CGP_ chemical and genetic perturbations
10080,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,C7_ immunologic signatures
10081,GO_VESICLE_MEMBRANE,c5.CC_ GO cellular component
10082,GO_TRANSFERASE_ACTIVITY_TRANSFERRING_AMINO_ACYL_GROUPS,c5.GO molecular function
10083,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_DN,C7_ immunologic signatures
10084,GO_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING,c5.GO molecular function
10085,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,C7_ immunologic signatures
10086,GO_PHOTORECEPTOR_CELL_DEVELOPMENT,c5.BP_ GO biological process
10087,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,c2.CGP_ chemical and genetic perturbations
10088,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_UP,C7_ immunologic signatures
10089,GO_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,c5.GO molecular function
10090,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,C7_ immunologic signatures
10091,GO_QUATERNARY_AMMONIUM_GROUP_TRANSPORT,c5.BP_ GO biological process
10092,AMIT_SERUM_RESPONSE_480_MCF10A,c2.CGP_ chemical and genetic perturbations
10093,GO_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
10094,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_DN,C7_ immunologic signatures
10095,GO_INNER_EAR_RECEPTOR_STEREOCILIUM_ORGANIZATION,c5.BP_ GO biological process
10096,WANG_CLIM2_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
10097,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP,c2.CGP_ chemical and genetic perturbations
10098,REACTOME_ERK_MAPK_TARGETS,c2.CP_REACTOME_ Reactome gene sets
10099,GO_KINASE_ACTIVATOR_ACTIVITY,c5.GO molecular function
10100,GO_NECROTIC_CELL_DEATH,c5.BP_ GO biological process
10101,GSE18281_CORTEX_VS_MEDULLA_THYMUS_DN,C7_ immunologic signatures
10102,GO_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
10103,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_UP,C7_ immunologic signatures
10104,GO_LYTIC_VACUOLE_MEMBRANE,c5.CC_ GO cellular component
10105,GO_VACUOLE_FUSION,c5.BP_ GO biological process
10106,TOMLINS_PROSTATE_CANCER_UP,c2.CGP_ chemical and genetic perturbations
10107,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP,C7_ immunologic signatures
10108,GO_DENDRITIC_SPINE_ORGANIZATION,c5.BP_ GO biological process
10109,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
10110,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP,C7_ immunologic signatures
10111,GO_SPINAL_CORD_DEVELOPMENT,c5.BP_ GO biological process
10112,REACTOME_RECYCLING_PATHWAY_OF_L1,c2.CP_REACTOME_ Reactome gene sets
10113,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN,C7_ immunologic signatures
10114,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP,c2.CGP_ chemical and genetic perturbations
10115,AIYAR_COBRA1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
10116,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_UP,C7_ immunologic signatures
10117,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,C7_ immunologic signatures
10118,CHR12P12,38
10119,GO_LONG_TERM_MEMORY,c5.BP_ GO biological process
10120,GO_STEROID_BINDING,c5.GO molecular function
10121,GSE17721_LPS_VS_POLYIC_1H_BMDC_UP,C7_ immunologic signatures
10122,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,C7_ immunologic signatures
10123,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP,C7_ immunologic signatures
10124,GO_HISTONE_H3_ACETYLATION,c5.BP_ GO biological process
10125,GO_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
10126,GSE27786_LSK_VS_CD8_TCELL_DN,C7_ immunologic signatures
10127,GO_EMBRYONIC_PLACENTA_MORPHOGENESIS,c5.BP_ GO biological process
10128,MARCHINI_TRABECTEDIN_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
10129,REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
10130,GSE17721_POLYIC_VS_CPG_1H_BMDC_DN,C7_ immunologic signatures
10131,GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN,C7_ immunologic signatures
10132,GO_OSTEOCLAST_DIFFERENTIATION,c5.BP_ GO biological process
10133,LEE_LIVER_CANCER_MYC_E2F1_DN,c2.CGP_ chemical and genetic perturbations
10134,ACACTAC_MIR1423P,c3.MIR_ microRNA targets
10135,EGR_Q6,c3.TFT_ transcription factor targets
10136,PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,c2.CP_ Canonical pathways
10137,GO_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE,c5.BP_ GO biological process
10138,GO_NECROPTOTIC_PROCESS,c5.BP_ GO biological process
10139,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,C7_ immunologic signatures
10140,GO_CELLULAR_PROTEIN_COMPLEX_ASSEMBLY,c5.BP_ GO biological process
10141,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_UP,C7_ immunologic signatures
10142,CHR8Q11,18
10143,GO_SH2_DOMAIN_BINDING,c5.GO molecular function
10144,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN,C7_ immunologic signatures
10145,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,c2.CGP_ chemical and genetic perturbations
10146,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,c2.CGP_ chemical and genetic perturbations
10147,GO_REGULATION_OF_VACUOLAR_TRANSPORT,c5.BP_ GO biological process
10148,GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS,c5.BP_ GO biological process
10149,GSE3982_MAC_VS_TH2_DN,C7_ immunologic signatures
10150,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_DN,C7_ immunologic signatures
10151,CHR8Q13,28
10152,SCIBETTA_KDM5B_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
10153,GENTILE_UV_RESPONSE_CLUSTER_D6,c2.CGP_ chemical and genetic perturbations
10154,GO_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
10155,GO_INOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,c5.GO molecular function
10156,HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,c2.CGP_ chemical and genetic perturbations
10157,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,C7_ immunologic signatures
10158,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP,C7_ immunologic signatures
10159,CHEOK_RESPONSE_TO_HD_MTX_UP,c2.CGP_ chemical and genetic perturbations
10160,GO_MITOCHONDRION_MORPHOGENESIS,c5.BP_ GO biological process
10161,GO_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS,c5.BP_ GO biological process
10162,CHR11Q14,32
10163,MODULE_239,c4.CM_ cancer modules
10164,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,c2.CGP_ chemical and genetic perturbations
10165,GCM_MYST2,c4.CGN_ cancer gene neighborhoods
10166,GSE27786_NKCELL_VS_MONO_MAC_UP,C7_ immunologic signatures
10167,GCM_DLG1,c4.CGN_ cancer gene neighborhoods
10168,GO_LYSOSOMAL_TRANSPORT,c5.BP_ GO biological process
10169,GO_LABYRINTHINE_LAYER_DEVELOPMENT,c5.BP_ GO biological process
10170,REACTOME_GLOBAL_GENOMIC_NER_GG_NER,c2.CP_REACTOME_ Reactome gene sets
10171,MORI_PLASMA_CELL_DN,c2.CGP_ chemical and genetic perturbations
10172,GO_NEGATIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
10173,GO_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
10174,GO_FEMALE_GENITALIA_DEVELOPMENT,c5.BP_ GO biological process
10175,GO_POSITIVE_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,c5.BP_ GO biological process
10176,GSE27786_LIN_NEG_VS_NEUTROPHIL_DN,C7_ immunologic signatures
10177,CHEN_ETV5_TARGETS_SERTOLI,c2.CGP_ chemical and genetic perturbations
10178,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,C7_ immunologic signatures
10179,GO_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS,c5.GO molecular function
10180,GSE11818_WT_VS_DICER_KO_TREG_DN,C7_ immunologic signatures
10181,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,C7_ immunologic signatures
10182,GSE27786_CD8_TCELL_VS_NKTCELL_DN,C7_ immunologic signatures
10183,RRCCGTTA_UNKNOWN,c3.TFT_ transcription factor targets
10184,GO_MEMBRANE_LIPID_CATABOLIC_PROCESS,c5.BP_ GO biological process
10185,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_DN,C7_ immunologic signatures
10186,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN,C7_ immunologic signatures
10187,BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP,c2.CGP_ chemical and genetic perturbations
10188,ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE,c2.CGP_ chemical and genetic perturbations
10189,GO_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS,c5.BP_ GO biological process
10190,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_UP,C7_ immunologic signatures
10191,HALLMARK_BILE_ACID_METABOLISM,H_ hallmark gene sets
10192,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN,C7_ immunologic signatures
10193,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,C7_ immunologic signatures
10194,GO_NEGATIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
10195,GO_INTERMEDIATE_FILAMENT_CYTOSKELETON,c5.CC_ GO cellular component
10196,GNF2_ANP32B,c4.CGN_ cancer gene neighborhoods
10197,GO_NUCLEUS_ORGANIZATION,c5.BP_ GO biological process
10198,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_DN,C7_ immunologic signatures
10199,GO_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING,c5.BP_ GO biological process
10200,GO_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,c5.BP_ GO biological process
10201,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP,C7_ immunologic signatures
10202,GO_REGULATION_OF_FILOPODIUM_ASSEMBLY,c5.BP_ GO biological process
10203,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN,C7_ immunologic signatures
10204,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP,C7_ immunologic signatures
10205,SASSON_RESPONSE_TO_FORSKOLIN_UP,c2.CGP_ chemical and genetic perturbations
10206,GO_RESPONSE_TO_VITAMIN_A,c5.BP_ GO biological process
10207,GSE19512_NAUTRAL_VS_INDUCED_TREG_DN,C7_ immunologic signatures
10208,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP,C7_ immunologic signatures
10209,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_UP,C7_ immunologic signatures
10210,PID_NFAT_3PATHWAY,c2.CP_ Canonical pathways
10211,REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,c2.CP_REACTOME_ Reactome gene sets
10212,GO_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION,c5.BP_ GO biological process
10213,TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN,c2.CGP_ chemical and genetic perturbations
10214,GO_NEUROTRANSMITTER_METABOLIC_PROCESS,c5.BP_ GO biological process
10215,ST_TUMOR_NECROSIS_FACTOR_PATHWAY,c2.CP_ Canonical pathways
10216,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN,C7_ immunologic signatures
10217,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN,C7_ immunologic signatures
10218,REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,c2.CP_REACTOME_ Reactome gene sets
10219,GSE15659_RESTING_VS_ACTIVATED_TREG_DN,C7_ immunologic signatures
10220,GO_PIGMENT_GRANULE_LOCALIZATION,c5.BP_ GO biological process
10221,GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING,c5.GO molecular function
10222,REACTOME_DOWNSTREAM_TCR_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
10223,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN,C7_ immunologic signatures
10224,GO_REGULATION_OF_NEURONAL_SYNAPTIC_PLASTICITY,c5.BP_ GO biological process
10225,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,C7_ immunologic signatures
10226,LIN_MELANOMA_COPY_NUMBER_DN,c2.CGP_ chemical and genetic perturbations
10227,GO_PHOTOTRANSDUCTION_VISIBLE_LIGHT,c5.BP_ GO biological process
10228,GO_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE,c5.CC_ GO cellular component
10229,TAANNYSGCG_UNKNOWN,c3.TFT_ transcription factor targets
10230,BIOCARTA_VEGF_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10231,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,c2.CP_BIOCARTA_ BioCarta gene sets
10232,GO_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT,c5.CC_ GO cellular component
10233,STAT1_03,c3.TFT_ transcription factor targets
10234,GO_GOLGI_TO_PLASMA_MEMBRANE_TRANSPORT,c5.BP_ GO biological process
10235,GO_INTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE,c5.CC_ GO cellular component
10236,GO_MAINTENANCE_OF_LOCATION_IN_CELL,c5.BP_ GO biological process
10237,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP,C7_ immunologic signatures
10238,GO_PIGMENTATION,c5.BP_ GO biological process
10239,GO_MEMBRANE_DISASSEMBLY,c5.BP_ GO biological process
10240,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_UP,C7_ immunologic signatures
10241,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN,C7_ immunologic signatures
10242,REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION,c2.CP_REACTOME_ Reactome gene sets
10243,GCM_FANCL,c4.CGN_ cancer gene neighborhoods
10244,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP,C7_ immunologic signatures
10245,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN,C7_ immunologic signatures
10246,GO_REGULATION_OF_VESICLE_FUSION,c5.BP_ GO biological process
10247,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,c2.CGP_ chemical and genetic perturbations
10248,PID_TCPTP_PATHWAY,c2.CP_ Canonical pathways
10249,GO_FOLIC_ACID_CONTAINING_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
10250,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,C7_ immunologic signatures
10251,CHANGOLKAR_H2AFY_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
10252,GNF2_TNFRSF1B,c4.CGN_ cancer gene neighborhoods
10253,GSE14308_TH1_VS_TH17_DN,C7_ immunologic signatures
10254,NIELSEN_LEIOMYOSARCOMA_CNN1_DN,c2.CGP_ chemical and genetic perturbations
10255,GO_POSITIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,c5.BP_ GO biological process
10256,GSE17721_CTRL_VS_LPS_2H_BMDC_UP,C7_ immunologic signatures
10257,GO_IRON_ION_BINDING,c5.GO molecular function
10258,GO_PRE_AUTOPHAGOSOMAL_STRUCTURE,c5.CC_ GO cellular component
10259,GO_SECONDARY_METABOLIC_PROCESS,c5.BP_ GO biological process
10260,GO_REGULATION_OF_PROTEIN_ACETYLATION,c5.BP_ GO biological process
10261,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN,C7_ immunologic signatures
10262,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
10263,MODULE_218,c4.CM_ cancer modules
10264,WU_HBX_TARGETS_1_DN,c2.CGP_ chemical and genetic perturbations
10265,GO_LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_BINDING,c5.GO molecular function
10266,GSE360_CTRL_VS_L_MAJOR_MAC_UP,C7_ immunologic signatures
10267,FINETTI_BREAST_CANCER_KINOME_GREEN,c2.CGP_ chemical and genetic perturbations
10268,GO_ORGANIC_ACID_SODIUM_SYMPORTER_ACTIVITY,c5.GO molecular function
10269,CHR11P13,34
10270,BIOCARTA_NFKB_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10271,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN,C7_ immunologic signatures
10272,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
10273,AAGWWRNYGGC_UNKNOWN,c3.TFT_ transcription factor targets
10274,GO_POSITIVE_REGULATION_OF_STEROL_TRANSPORT,c5.BP_ GO biological process
10275,GO_NEGATIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,c5.BP_ GO biological process
10276,CHR17Q24,28
10277,DORMOY_ELAVL1_TARGETS,c2.CGP_ chemical and genetic perturbations
10278,KEGG_PRIMARY_IMMUNODEFICIENCY,c2.CP_BIOCARTA_ BioCarta gene sets
10279,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP,C7_ immunologic signatures
10280,WU_HBX_TARGETS_2_UP,c2.CGP_ chemical and genetic perturbations
10281,GO_UTERUS_DEVELOPMENT,c5.BP_ GO biological process
10282,GO_ATRIOVENTRICULAR_VALVE_MORPHOGENESIS,c5.BP_ GO biological process
10283,GO_REGULATION_OF_NUCLEASE_ACTIVITY,c5.BP_ GO biological process
10284,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,C7_ immunologic signatures
10285,MILI_PSEUDOPODIA_HAPTOTAXIS_UP,c2.CGP_ chemical and genetic perturbations
10286,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP,C7_ immunologic signatures
10287,GO_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,c5.BP_ GO biological process
10288,GO_RESPONSE_TO_SALT_STRESS,c5.BP_ GO biological process
10289,GSE7852_TREG_VS_TCONV_THYMUS_DN,C7_ immunologic signatures
10290,GO_PHOSPHATIDYLSERINE_METABOLIC_PROCESS,c5.BP_ GO biological process
10291,CAGNYGKNAAA_UNKNOWN,c3.TFT_ transcription factor targets
10292,GO_CLATHRIN_COAT,c5.CC_ GO cellular component
10293,GO_PIGMENT_CELL_DIFFERENTIATION,c5.BP_ GO biological process
10294,SCHLOSSER_SERUM_RESPONSE_UP,c2.CGP_ chemical and genetic perturbations
10295,GO_P53_BINDING,c5.GO molecular function
10296,GO_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE,c5.CC_ GO cellular component
10297,GO_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,c5.BP_ GO biological process
10298,BIOCARTA_MAPK_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10299,GO_B_CELL_HOMEOSTASIS,c5.BP_ GO biological process
10300,BIOCARTA_TOLL_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10301,GO_LAMELLIPODIUM_ASSEMBLY,c5.BP_ GO biological process
10302,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,C7_ immunologic signatures
10303,CHR15Q13,25
10304,GO_PROTEIN_ACYLATION,c5.BP_ GO biological process
10305,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN,C7_ immunologic signatures
10306,GO_COPPER_ION_HOMEOSTASIS,c5.BP_ GO biological process
10307,GO_CARBOHYDRATE_DERIVATIVE_TRANSPORTER_ACTIVITY,c5.GO molecular function
10308,GO_RENAL_WATER_HOMEOSTASIS,c5.BP_ GO biological process
10309,GO_CORTICAL_CYTOSKELETON_ORGANIZATION,c5.BP_ GO biological process
10310,BIOCARTA_CCR3_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10311,GO_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT,c5.BP_ GO biological process
10312,BIOCARTA_PYK2_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10313,GO_POSITIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,c5.BP_ GO biological process
10314,CHEN_LIVER_METABOLISM_QTL_CIS,c2.CGP_ chemical and genetic perturbations
10315,WANG_RECURRENT_LIVER_CANCER_UP,c2.CGP_ chemical and genetic perturbations
10316,GO_LIPID_STORAGE,c5.BP_ GO biological process
10317,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN,C7_ immunologic signatures
10318,MEISSNER_ES_ICP_WITH_H3K4ME3,c2.CGP_ chemical and genetic perturbations
10319,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
10320,LOPES_METHYLATED_IN_COLON_CANCER_DN,c2.CGP_ chemical and genetic perturbations
10321,BLUM_RESPONSE_TO_SALIRASIB_UP,c2.CGP_ chemical and genetic perturbations
10322,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,C7_ immunologic signatures
10323,GSE36009_UNSTIM_VS_LPS_STIM_DC_DN,C7_ immunologic signatures
10324,KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION,c2.CGP_ chemical and genetic perturbations
10325,GO_DYNEIN_COMPLEX,c5.CC_ GO cellular component
10326,GO_REGULATION_OF_RECEPTOR_RECYCLING,c5.BP_ GO biological process
10327,PID_RETINOIC_ACID_PATHWAY,c2.CP_ Canonical pathways
10328,PID_IL2_PI3K_PATHWAY,c2.CP_ Canonical pathways
10329,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,c2.CP_REACTOME_ Reactome gene sets
10330,GO_SOLUTE_CATION_SYMPORTER_ACTIVITY,c5.GO molecular function
10331,GNF2_CBFB,c4.CGN_ cancer gene neighborhoods
10332,REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS,c2.CP_REACTOME_ Reactome gene sets
10333,GO_GLUCAN_METABOLIC_PROCESS,c5.BP_ GO biological process
10334,LEE_AGING_NEOCORTEX_DN,c2.CGP_ chemical and genetic perturbations
10335,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,C7_ immunologic signatures
10336,GO_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
10337,GO_POSITIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,c5.BP_ GO biological process
10338,MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,c2.CGP_ chemical and genetic perturbations
10339,KEGG_APOPTOSIS,c2.CP_BIOCARTA_ BioCarta gene sets
10340,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN,C7_ immunologic signatures
10341,NAKAJIMA_EOSINOPHIL,c2.CGP_ chemical and genetic perturbations
10342,GNF2_MYD88,c4.CGN_ cancer gene neighborhoods
10343,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN,C7_ immunologic signatures
10344,GO_BETA_CATENIN_DESTRUCTION_COMPLEX_DISASSEMBLY,c5.BP_ GO biological process
10345,MODULE_288,c4.CM_ cancer modules
10346,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
10347,MODULE_186,c4.CM_ cancer modules
10348,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_DN,C7_ immunologic signatures
10349,PID_TXA2PATHWAY,c2.CP_ Canonical pathways
10350,AGTCTTA_MIR499,c3.MIR_ microRNA targets
10351,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP,C7_ immunologic signatures
10352,PID_REELIN_PATHWAY,c2.CP_ Canonical pathways
10353,GO_POSITIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION,c5.BP_ GO biological process
10354,BIOCARTA_RELA_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10355,GO_SODIUM_ION_TRANSPORT,c5.BP_ GO biological process
10356,GO_ENDORIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,c5.GO molecular function
10357,GO_RESPONSE_TO_PH,c5.BP_ GO biological process
10358,SA_PTEN_PATHWAY,c2.CP_ Canonical pathways
10359,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,c2.CP_REACTOME_ Reactome gene sets
10360,GO_PROTEIN_O_LINKED_GLYCOSYLATION,c5.BP_ GO biological process
10361,BURTON_ADIPOGENESIS_10,c2.CGP_ chemical and genetic perturbations
10362,PID_NETRIN_PATHWAY,c2.CP_ Canonical pathways
10363,CHR20Q11,83
10364,PID_REG_GR_PATHWAY,c2.CP_ Canonical pathways
10365,GO_OXYGEN_BINDING,c5.GO molecular function
10366,DORSAM_HOXA9_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
10367,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN,C7_ immunologic signatures
10368,GO_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,c5.BP_ GO biological process
10369,GO_CELLULAR_RESPONSE_TO_REACTIVE_NITROGEN_SPECIES,c5.BP_ GO biological process
10370,GO_MODULATION_BY_VIRUS_OF_HOST_MORPHOLOGY_OR_PHYSIOLOGY,c5.BP_ GO biological process
10371,PID_AR_PATHWAY,c2.CP_ Canonical pathways
10372,GO_REGULATION_OF_CHROMATIN_SILENCING,c5.BP_ GO biological process
10373,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,C7_ immunologic signatures
10374,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_DN,C7_ immunologic signatures
10375,REACTOME_IL1_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
10376,PID_BCR_5PATHWAY,c2.CP_ Canonical pathways
10377,BIOCARTA_CASPASE_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10378,GCM_RAB10,c4.CGN_ cancer gene neighborhoods
10379,GO_DNA_MODIFICATION,c5.BP_ GO biological process
10380,REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,c2.CP_REACTOME_ Reactome gene sets
10381,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,C7_ immunologic signatures
10382,GO_ENDOSOME_LUMEN,c5.CC_ GO cellular component
10383,SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP,c2.CGP_ chemical and genetic perturbations
10384,REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,c2.CP_REACTOME_ Reactome gene sets
10385,REACTOME_IL_3_5_AND_GM_CSF_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
10386,MODULE_448,c4.CM_ cancer modules
10387,GO_NEGATIVE_REGULATION_OF_HISTONE_ACETYLATION,c5.BP_ GO biological process
10388,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,c2.CGP_ chemical and genetic perturbations
10389,GO_DRUG_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
10390,KEGG_NON_SMALL_CELL_LUNG_CANCER,c2.CP_BIOCARTA_ BioCarta gene sets
10391,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN,C7_ immunologic signatures
10392,GNF2_ITGAL,c4.CGN_ cancer gene neighborhoods
10393,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN,C7_ immunologic signatures
10394,GO_LAMELLIPODIUM_ORGANIZATION,c5.BP_ GO biological process
10395,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_DN,C7_ immunologic signatures
10396,MODULE_153,c4.CM_ cancer modules
10397,MODULE_162,c4.CM_ cancer modules
10398,BIOCARTA_GLEEVEC_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10399,REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,c2.CP_REACTOME_ Reactome gene sets
10400,GO_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
10401,ONO_FOXP3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
10402,GO_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
10403,GO_VACUOLAR_TRANSPORT,c5.BP_ GO biological process
10404,PID_NFKAPPAB_CANONICAL_PATHWAY,c2.CP_ Canonical pathways
10405,SUZUKI_RESPONSE_TO_TSA,c2.CGP_ chemical and genetic perturbations
10406,GO_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT,c5.BP_ GO biological process
10407,GO_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
10408,GO_MICROBODY_LUMEN,c5.CC_ GO cellular component
10409,GO_NEGATIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
10410,GO_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_BINDING,c5.GO molecular function
10411,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN,C7_ immunologic signatures
10412,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN,c2.CGP_ chemical and genetic perturbations
10413,PID_PI3K_PLC_TRK_PATHWAY,c2.CP_ Canonical pathways
10414,BIOCARTA_PPARA_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10415,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
10416,GO_CYTOKINE_SECRETION,c5.BP_ GO biological process
10417,HASLINGER_B_CLL_WITH_17P13_DELETION,c2.CGP_ chemical and genetic perturbations
10418,GO_DEMETHYLASE_ACTIVITY,c5.GO molecular function
10419,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_UP,C7_ immunologic signatures
10420,GO_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,c5.BP_ GO biological process
10421,GO_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,c5.BP_ GO biological process
10422,GO_APOPTOTIC_MITOCHONDRIAL_CHANGES,c5.BP_ GO biological process
10423,MIKKELSEN_MEF_ICP_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
10424,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP,C7_ immunologic signatures
10425,GO_PROTEIN_LOCALIZATION_TO_VACUOLE,c5.BP_ GO biological process
10426,MODULE_400,c4.CM_ cancer modules
10427,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN,C7_ immunologic signatures
10428,GSE17721_CTRL_VS_LPS_24H_BMDC_DN,C7_ immunologic signatures
10429,GNF2_VAV1,c4.CGN_ cancer gene neighborhoods
10430,REACTOME_SIGNALING_BY_ERBB4,c2.CP_REACTOME_ Reactome gene sets
10431,REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR,c2.CP_REACTOME_ Reactome gene sets
10432,TERAMOTO_OPN_TARGETS_CLUSTER_7,c2.CGP_ chemical and genetic perturbations
10433,REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,c2.CP_REACTOME_ Reactome gene sets
10434,GNF2_STAT6,c4.CGN_ cancer gene neighborhoods
10435,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP,C7_ immunologic signatures
10436,GO_NEGATIVE_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS,c5.BP_ GO biological process
10437,REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS,c2.CP_REACTOME_ Reactome gene sets
10438,GO_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,c5.GO molecular function
10439,GO_REGULATION_OF_HORMONE_METABOLIC_PROCESS,c5.BP_ GO biological process
10440,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,c2.CGP_ chemical and genetic perturbations
10441,GO_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER,c5.BP_ GO biological process
10442,CHR6Q27,22
10443,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,C7_ immunologic signatures
10444,GO_MANNOSYLATION,c5.BP_ GO biological process
10445,MAYBURD_RESPONSE_TO_L663536_UP,c2.CGP_ chemical and genetic perturbations
10446,SEIDEN_ONCOGENESIS_BY_MET,c2.CGP_ chemical and genetic perturbations
10447,GO_DNA_DAMAGE_RESPONSE_DETECTION_OF_DNA_DAMAGE,c5.BP_ GO biological process
10448,GO_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,c5.BP_ GO biological process
10449,GO_DSRNA_FRAGMENTATION,c5.BP_ GO biological process
10450,WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN,c2.CGP_ chemical and genetic perturbations
10451,ST_ERK1_ERK2_MAPK_PATHWAY,c2.CP_ Canonical pathways
10452,CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,c2.CGP_ chemical and genetic perturbations
10453,GO_PROTEIN_PHOSPHATASE_1_BINDING,c5.GO molecular function
10454,GO_LYSINE_ACETYLATED_HISTONE_BINDING,c5.GO molecular function
10455,REACTOME_TCR_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
10456,GCM_DFFA,c4.CGN_ cancer gene neighborhoods
10457,GO_DEOXYRIBOSE_PHOSPHATE_CATABOLIC_PROCESS,c5.BP_ GO biological process
10458,GO_VACUOLAR_ACIDIFICATION,c5.BP_ GO biological process
10459,REACTOME_SHC_RELATED_EVENTS,c2.CP_REACTOME_ Reactome gene sets
10460,CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY,c2.CGP_ chemical and genetic perturbations
10461,BIOCARTA_HER2_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10462,KEGG_RENAL_CELL_CARCINOMA,c2.CP_BIOCARTA_ BioCarta gene sets
10463,CTCAAGA_MIR526B,c3.MIR_ microRNA targets
10464,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,C7_ immunologic signatures
10465,HALLMARK_PI3K_AKT_MTOR_SIGNALING,H_ hallmark gene sets
10466,GO_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,c5.BP_ GO biological process
10467,BIOCARTA_IL10_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10468,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,C7_ immunologic signatures
10469,CHR5Q33,41
10470,GO_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY,c5.BP_ GO biological process
10471,BIOCARTA_CERAMIDE_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10472,REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE,c2.CP_REACTOME_ Reactome gene sets
10473,GO_SOLUTE_PROTON_SYMPORTER_ACTIVITY,c5.GO molecular function
10474,GO_FATTY_ACYL_COA_BINDING,c5.GO molecular function
10475,GO_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
10476,REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,c2.CP_REACTOME_ Reactome gene sets
10477,REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,c2.CP_REACTOME_ Reactome gene sets
10478,PECE_MAMMARY_STEM_CELL_DN,c2.CGP_ chemical and genetic perturbations
10479,GO_AXONEME_ASSEMBLY,c5.BP_ GO biological process
10480,GTAAACC_MIR2995P,c3.MIR_ microRNA targets
10481,PID_NEPHRIN_NEPH1_PATHWAY,c2.CP_ Canonical pathways
10482,GO_MULTI_ORGANISM_LOCALIZATION,c5.BP_ GO biological process
10483,PID_WNT_NONCANONICAL_PATHWAY,c2.CP_ Canonical pathways
10484,GO_NATURAL_KILLER_CELL_ACTIVATION,c5.BP_ GO biological process
10485,GCM_GSPT1,c4.CGN_ cancer gene neighborhoods
10486,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP,c2.CGP_ chemical and genetic perturbations
10487,GO_HISTONE_METHYLTRANSFERASE_COMPLEX,c5.CC_ GO cellular component
10488,GO_DNA_CATABOLIC_PROCESS,c5.BP_ GO biological process
10489,GO_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
10490,GO_BAF_TYPE_COMPLEX,c5.CC_ GO cellular component
10491,GO_DEACETYLASE_ACTIVITY,c5.GO molecular function
10492,MORF_REV3L,c4.CGN_ cancer gene neighborhoods
10493,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_DN,C7_ immunologic signatures
10494,GO_THYROID_HORMONE_RECEPTOR_BINDING,c5.GO molecular function
10495,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN,c2.CGP_ chemical and genetic perturbations
10496,GO_REGULATION_OF_GENE_SILENCING,c5.BP_ GO biological process
10497,GO_C21_STEROID_HORMONE_METABOLIC_PROCESS,c5.BP_ GO biological process
10498,BIOCARTA_RARRXR_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10499,REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN,c2.CP_REACTOME_ Reactome gene sets
10500,GO_EXECUTION_PHASE_OF_APOPTOSIS,c5.BP_ GO biological process
10501,BIOCARTA_ERK5_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10502,GO_PROTEIN_ALKYLATION,c5.BP_ GO biological process
10503,GO_MODULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,c5.BP_ GO biological process
10504,GO_CLATHRIN_COATED_ENDOCYTIC_VESICLE,c5.CC_ GO cellular component
10505,BIOCARTA_IL2RB_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10506,GO_REGULATION_OF_SULFUR_METABOLIC_PROCESS,c5.BP_ GO biological process
10507,GO_COMPLEMENT_BINDING,c5.GO molecular function
10508,NIELSEN_SYNOVIAL_SARCOMA_DN,c2.CGP_ chemical and genetic perturbations
10509,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA,c5.BP_ GO biological process
10510,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,c2.CGP_ chemical and genetic perturbations
10511,GO_MANNOSYLTRANSFERASE_ACTIVITY,c5.GO molecular function
10512,PID_MAPK_TRK_PATHWAY,c2.CP_ Canonical pathways
10513,GCTTGAA_MIR498,c3.MIR_ microRNA targets
10514,PID_P75_NTR_PATHWAY,c2.CP_ Canonical pathways
10515,REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK,c2.CP_REACTOME_ Reactome gene sets
10516,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN,C7_ immunologic signatures
10517,GO_PHOSPHATASE_REGULATOR_ACTIVITY,c5.GO molecular function
10518,GO_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,c5.BP_ GO biological process
10519,PID_HIV_NEF_PATHWAY,c2.CP_ Canonical pathways
10520,YANG_MUC2_TARGETS_DUODENUM_3MO_DN,c2.CGP_ chemical and genetic perturbations
10521,GO_GASTRULATION_WITH_MOUTH_FORMING_SECOND,c5.BP_ GO biological process
10522,GO_AMMONIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
10523,GO_NUCLEAR_LOCALIZATION_SEQUENCE_BINDING,c5.GO molecular function
10524,PID_ERBB4_PATHWAY,c2.CP_ Canonical pathways
10525,PID_INSULIN_GLUCOSE_PATHWAY,c2.CP_ Canonical pathways
10526,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS,c2.CGP_ chemical and genetic perturbations
10527,GO_EXONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,c5.GO molecular function
10528,GO_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
10529,MORF_CSNK1D,c4.CGN_ cancer gene neighborhoods
10530,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,c2.CGP_ chemical and genetic perturbations
10531,BIOCARTA_MITOCHONDRIA_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10532,BIOCARTA_PML_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10533,GO_HISTONE_METHYLATION,c5.BP_ GO biological process
10534,REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT,c2.CP_REACTOME_ Reactome gene sets
10535,SU_THYMUS,c2.CGP_ chemical and genetic perturbations
10536,GNF2_CD97,c4.CGN_ cancer gene neighborhoods
10537,GO_NEGATIVE_REGULATION_OF_HISTONE_MODIFICATION,c5.BP_ GO biological process
10538,GO_ERBB2_SIGNALING_PATHWAY,c5.BP_ GO biological process
10539,BIOCARTA_RAS_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10540,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER,c5.BP_ GO biological process
10541,GO_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,c5.BP_ GO biological process
10542,HOWLIN_CITED1_TARGETS_2_DN,c2.CGP_ chemical and genetic perturbations
10543,BIOCARTA_EPO_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10544,GO_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX,c5.CC_ GO cellular component
10545,GO_DORSAL_SPINAL_CORD_DEVELOPMENT,c5.BP_ GO biological process
10546,GO_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_BINDING,c5.GO molecular function
10547,GO_PROTEIN_PHOSPHORYLATED_AMINO_ACID_BINDING,c5.GO molecular function
10548,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,c2.CGP_ chemical and genetic perturbations
10549,GCM_ING1,c4.CGN_ cancer gene neighborhoods
10550,GO_CLATHRIN_COATED_VESICLE_MEMBRANE,c5.CC_ GO cellular component
10551,GO_NEGATIVE_REGULATION_OF_CHROMATIN_MODIFICATION,c5.BP_ GO biological process
10552,SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,c2.CP_ Canonical pathways
10553,PID_MET_PATHWAY,c2.CP_ Canonical pathways
10554,GO_LONG_CHAIN_FATTY_ACID_TRANSPORT,c5.BP_ GO biological process
10555,KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT,c2.CP_BIOCARTA_ BioCarta gene sets
10556,GO_CLATHRIN_VESICLE_COAT,c5.CC_ GO cellular component
10557,BIOCARTA_CHEMICAL_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10558,MORF_RFC1,c4.CGN_ cancer gene neighborhoods
10559,VISALA_AGING_LYMPHOCYTE_DN,c2.CGP_ chemical and genetic perturbations
10560,GO_PODOSOME,c5.CC_ GO cellular component
10561,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,c2.CGP_ chemical and genetic perturbations
10562,GLI1_UP.V1_DN,C6_ oncogenic signatures
10563,GO_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
10564,GGCNNMSMYNTTG_UNKNOWN,c3.TFT_ transcription factor targets
10565,KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS,c2.CP_BIOCARTA_ BioCarta gene sets
10566,PAL_PRMT5_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
10567,LEE_CALORIE_RESTRICTION_MUSCLE_DN,c2.CGP_ chemical and genetic perturbations
10568,GCM_GSTA4,c4.CGN_ cancer gene neighborhoods
10569,GO_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,c5.BP_ GO biological process
10570,GCM_MLL,c4.CGN_ cancer gene neighborhoods
10571,GO_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER,c5.BP_ GO biological process
10572,GCM_CSNK1A1,c4.CGN_ cancer gene neighborhoods
10573,GO_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,c5.BP_ GO biological process
10574,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,C7_ immunologic signatures
10575,GO_PYRIMIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,c5.BP_ GO biological process
10576,GO_PLATELET_MORPHOGENESIS,c5.BP_ GO biological process
10577,GO_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,c5.BP_ GO biological process
10578,HATADA_METHYLATED_IN_LUNG_CANCER_DN,c2.CGP_ chemical and genetic perturbations
10579,MARSON_FOXP3_CORE_DIRECT_TARGETS,c2.CGP_ chemical and genetic perturbations
10580,GO_PROTEIN_K48_LINKED_DEUBIQUITINATION,c5.BP_ GO biological process
10581,GO_PROTEIN_LOCALIZATION_TO_CILIUM,c5.BP_ GO biological process
10582,GCM_NF2,c4.CGN_ cancer gene neighborhoods
10583,GO_VIRION_ASSEMBLY,c5.BP_ GO biological process
10584,GO_PLASMA_MEMBRANE_FUSION,c5.BP_ GO biological process
10585,GO_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_BINDING,c5.GO molecular function
10586,REACTOME_DARPP_32_EVENTS,c2.CP_REACTOME_ Reactome gene sets
10587,GO_PEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,c5.GO molecular function
10588,GCM_CASP2,c4.CGN_ cancer gene neighborhoods
10589,GO_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
10590,REACTOME_APOPTOTIC_EXECUTION_PHASE,c2.CP_REACTOME_ Reactome gene sets
10591,GO_HISTONE_MONOUBIQUITINATION,c5.BP_ GO biological process
10592,GO_BILE_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
10593,GO_PROTEIN_DEACETYLASE_ACTIVITY,c5.GO molecular function
10594,REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX,c2.CP_REACTOME_ Reactome gene sets
10595,GO_DETECTION_OF_BIOTIC_STIMULUS,c5.BP_ GO biological process
10596,GO_BENZENE_CONTAINING_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
10597,GO_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
10598,REACTOME_GLUCOSE_TRANSPORT,c2.CP_REACTOME_ Reactome gene sets
10599,REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN,c2.CP_REACTOME_ Reactome gene sets
10600,MARSON_FOXP3_TARGETS_STIMULATED_UP,c2.CGP_ chemical and genetic perturbations
10601,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP,c2.CGP_ chemical and genetic perturbations
10602,GO_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,c5.BP_ GO biological process
10603,GO_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
10604,REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS,c2.CP_REACTOME_ Reactome gene sets
10605,GCM_SUFU,c4.CGN_ cancer gene neighborhoods
10606,BCAT_BILD_ET_AL_DN,C6_ oncogenic signatures
10607,GO_PEROXISOMAL_TRANSPORT,c5.BP_ GO biological process
10608,GCM_DEAF1,c4.CGN_ cancer gene neighborhoods
10609,GCM_UBE2N,c4.CGN_ cancer gene neighborhoods
10610,REACTOME_PEROXISOMAL_LIPID_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
10611,CHEOK_RESPONSE_TO_HD_MTX_DN,c2.CGP_ chemical and genetic perturbations
10612,GO_ENDOCYTIC_RECYCLING,c5.BP_ GO biological process
10613,GO_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS,c5.BP_ GO biological process
10614,GO_GOLGI_TO_VACUOLE_TRANSPORT,c5.BP_ GO biological process
10615,REACTOME_INSULIN_RECEPTOR_RECYCLING,c2.CP_REACTOME_ Reactome gene sets
10616,GO_NAD_DEPENDENT_PROTEIN_DEACETYLASE_ACTIVITY,c5.GO molecular function
10617,GO_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX,c5.CC_ GO cellular component
10618,REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION,c2.CP_REACTOME_ Reactome gene sets
10619,GO_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
10620,SANDERSON_PPARA_TARGETS,c2.CGP_ chemical and genetic perturbations
10621,GO_ENDOPLASMIC_RETICULUM_ORGANIZATION,c5.BP_ GO biological process
10622,GO_OLFACTORY_RECEPTOR_ACTIVITY,c5.GO molecular function
10623,REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY,c2.CP_REACTOME_ Reactome gene sets
10624,GO_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,c5.BP_ GO biological process
10625,GO_RNA_POLYMERASE_II_CARBOXY_TERMINAL_DOMAIN_KINASE_ACTIVITY,c5.GO molecular function
10626,GO_HSP90_PROTEIN_BINDING,c5.GO molecular function
10627,REACTOME_OLFACTORY_SIGNALING_PATHWAY,c2.CP_REACTOME_ Reactome gene sets
10628,MODULE_352,c4.CM_ cancer modules
10629,GO_GOLGI_TO_ENDOSOME_TRANSPORT,c5.BP_ GO biological process
10630,KEGG_OLFACTORY_TRANSDUCTION,c2.CP_BIOCARTA_ BioCarta gene sets
10631,GO_PHOSPHOTRANSFERASE_ACTIVITY_FOR_OTHER_SUBSTITUTED_PHOSPHATE_GROUPS,c5.GO molecular function
10632,GO_NUCLEAR_NUCLEOSOME,c5.CC_ GO cellular component
10633,GNF2_EIF3S6,c4.CGN_ cancer gene neighborhoods
10634,REACTOME_TRANSLATION,c2.CP_REACTOME_ Reactome gene sets
10635,REACTOME_PEPTIDE_CHAIN_ELONGATION,c2.CP_REACTOME_ Reactome gene sets
10636,REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,c2.CP_REACTOME_ Reactome gene sets
10637,REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX,c2.CP_REACTOME_ Reactome gene sets
10638,REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION,c2.CP_REACTOME_ Reactome gene sets
10639,REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION,c2.CP_REACTOME_ Reactome gene sets
10640,KEGG_RIBOSOME,c2.CP_BIOCARTA_ BioCarta gene sets
10641,MORF_NPM1,c4.CGN_ cancer gene neighborhoods
10642,GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,c5.BP_ GO biological process
10643,GCM_TPT1,c4.CGN_ cancer gene neighborhoods
10644,GO_TRANSLATIONAL_INITIATION,c5.BP_ GO biological process
10645,GO_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,c5.BP_ GO biological process
10646,GCM_NPM1,c4.CGN_ cancer gene neighborhoods
10647,GNF2_ST13,c4.CGN_ cancer gene neighborhoods
10648,GO_RRNA_METABOLIC_PROCESS,c5.BP_ GO biological process
10649,GO_CYTOSOLIC_RIBOSOME,c5.CC_ GO cellular component
10650,GO_RIBOSOMAL_SUBUNIT,c5.CC_ GO cellular component
10651,GO_RIBOSOME_BIOGENESIS,c5.BP_ GO biological process
10652,MORF_TPT1,c4.CGN_ cancer gene neighborhoods
10653,MORF_ACTG1,c4.CGN_ cancer gene neighborhoods
10654,GO_CYTOSOLIC_LARGE_RIBOSOMAL_SUBUNIT,c5.CC_ GO cellular component
10655,GO_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,c5.BP_ GO biological process
10656,GNF2_FBL,c4.CGN_ cancer gene neighborhoods
10657,REACTOME_INFLUENZA_LIFE_CYCLE,c2.CP_REACTOME_ Reactome gene sets
10658,MORF_NME2,c4.CGN_ cancer gene neighborhoods
10659,GO_RIBOSOME,c5.CC_ GO cellular component
10660,GO_MULTI_ORGANISM_METABOLIC_PROCESS,c5.BP_ GO biological process
10661,GO_LARGE_RIBOSOMAL_SUBUNIT,c5.CC_ GO cellular component
10662,GO_PRERIBOSOME,c5.CC_ GO cellular component
10663,GO_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS,c5.BP_ GO biological process
10664,REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX,c2.CP_REACTOME_ Reactome gene sets
10665,GO_STRUCTURAL_CONSTITUENT_OF_RIBOSOME,c5.GO molecular function
10666,MORF_RAN,c4.CGN_ cancer gene neighborhoods
10667,GO_NCRNA_PROCESSING,c5.BP_ GO biological process
10668,BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,c2.CGP_ chemical and genetic perturbations
10669,GNF2_NPM1,c4.CGN_ cancer gene neighborhoods
10670,GNF2_GLTSCR2,c4.CGN_ cancer gene neighborhoods
10671,REACTOME_METABOLISM_OF_MRNA,c2.CP_REACTOME_ Reactome gene sets
10672,REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,c2.CP_REACTOME_ Reactome gene sets
10673,MODULE_83,c4.CM_ cancer modules
10674,GO_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS,c5.BP_ GO biological process
10675,MORF_EIF3S6,c4.CGN_ cancer gene neighborhoods
10676,GNF2_TPT1,c4.CGN_ cancer gene neighborhoods
10677,GCM_ACTG1,c4.CGN_ cancer gene neighborhoods
10678,GO_CYTOSOLIC_PART,c5.CC_ GO cellular component
10679,MORF_UBE2I,c4.CGN_ cancer gene neighborhoods
10680,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_UP,C7_ immunologic signatures
10681,REACTOME_METABOLISM_OF_RNA,c2.CP_REACTOME_ Reactome gene sets
10682,GO_OXIDATIVE_PHOSPHORYLATION,c5.BP_ GO biological process
10683,REACTOME_METABOLISM_OF_PROTEINS,c2.CP_REACTOME_ Reactome gene sets
10684,GO_NUCLEOLAR_PART,c5.CC_ GO cellular component
10685,GNF2_DAP3,c4.CGN_ cancer gene neighborhoods
10686,MORF_JUND,c4.CGN_ cancer gene neighborhoods
10687,GO_NCRNA_METABOLIC_PROCESS,c5.BP_ GO biological process
10688,MORF_G22P1,c4.CGN_ cancer gene neighborhoods
10689,PENG_RAPAMYCIN_RESPONSE_DN,c2.CGP_ chemical and genetic perturbations
10690,GO_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS,c5.BP_ GO biological process
10691,MORF_ANP32B,c4.CGN_ cancer gene neighborhoods
10692,GNF2_UBE2I,c4.CGN_ cancer gene neighborhoods
10693,MODULE_151,c4.CM_ cancer modules
10694,GCM_CSNK2B,c4.CGN_ cancer gene neighborhoods
10695,GO_MITOCHONDRIAL_TRANSLATION,c5.BP_ GO biological process
10696,MORF_DAP3,c4.CGN_ cancer gene neighborhoods
10697,GO_ELECTRON_TRANSPORT_CHAIN,c5.BP_ GO biological process
10698,GCM_APEX1,c4.CGN_ cancer gene neighborhoods
10699,MODULE_114,c4.CM_ cancer modules
10700,GO_PROTEIN_TARGETING_TO_MEMBRANE,c5.BP_ GO biological process
10701,GO_RIBOSOME_ASSEMBLY,c5.BP_ GO biological process
10702,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,C7_ immunologic signatures
10703,GO_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT,c5.CC_ GO cellular component
10704,GO_RIBONUCLEOPROTEIN_COMPLEX_SUBUNIT_ORGANIZATION,c5.BP_ GO biological process
10705,COLLER_MYC_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
10706,GO_SMALL_RIBOSOMAL_SUBUNIT,c5.CC_ GO cellular component
10707,GO_TRANSLATIONAL_ELONGATION,c5.BP_ GO biological process
10708,HALLMARK_MYC_TARGETS_V2,H_ hallmark gene sets
10709,BURTON_ADIPOGENESIS_5,c2.CGP_ chemical and genetic perturbations
10710,GO_RNA_CATABOLIC_PROCESS,c5.BP_ GO biological process
10711,REACTOME_RESPIRATORY_ELECTRON_TRANSPORT,c2.CP_REACTOME_ Reactome gene sets
10712,REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_,c2.CP_REACTOME_ Reactome gene sets
10713,CHR22Q13,140
10714,MORF_SART1,c4.CGN_ cancer gene neighborhoods
10715,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,c2.CGP_ chemical and genetic perturbations
10716,GO_INNER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX,c5.CC_ GO cellular component
10717,GCM_PSME1,c4.CGN_ cancer gene neighborhoods
10718,GO_MATURATION_OF_SSU_RRNA,c5.BP_ GO biological process
10719,REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT,c2.CP_REACTOME_ Reactome gene sets
10720,MODULE_29,c4.CM_ cancer modules
10721,GO_TRANSLATIONAL_TERMINATION,c5.BP_ GO biological process
10722,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,C7_ immunologic signatures
10723,HALLMARK_MYC_TARGETS_V1,H_ hallmark gene sets
10724,GO_AMIDE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
10725,MODULE_32,c4.CM_ cancer modules
10726,MORF_PPP1CA,c4.CGN_ cancer gene neighborhoods
10727,MORF_CSNK2B,c4.CGN_ cancer gene neighborhoods
10728,BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,c2.CGP_ chemical and genetic perturbations
10729,GSE24210_RESTING_TREG_VS_TCONV_DN,C7_ immunologic signatures
10730,MORF_FBL,c4.CGN_ cancer gene neighborhoods
10731,REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT,c2.CP_REACTOME_ Reactome gene sets
10732,GO_SMALL_SUBUNIT_PROCESSOME,c5.CC_ GO cellular component
10733,MORF_AP2M1,c4.CGN_ cancer gene neighborhoods
10734,MORF_CCNI,c4.CGN_ cancer gene neighborhoods
10735,GCM_PFN1,c4.CGN_ cancer gene neighborhoods
10736,GO_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR,c5.CC_ GO cellular component
10737,TIEN_INTESTINE_PROBIOTICS_6HR_UP,c2.CGP_ chemical and genetic perturbations
10738,WONG_MITOCHONDRIA_GENE_MODULE,c2.CGP_ chemical and genetic perturbations
10739,LUI_THYROID_CANCER_CLUSTER_3,c2.CGP_ chemical and genetic perturbations
10740,MORF_SOD1,c4.CGN_ cancer gene neighborhoods
10741,GO_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_,c5.BP_ GO biological process
10742,MODULE_91,c4.CM_ cancer modules
10743,GO_MITOCHONDRIAL_PROTEIN_COMPLEX,c5.CC_ GO cellular component
10744,GO_CYTOPLASMIC_TRANSLATION,c5.BP_ GO biological process
10745,GCM_ANP32B,c4.CGN_ cancer gene neighborhoods
10746,GO_MITOCHONDRIAL_MEMBRANE_PART,c5.CC_ GO cellular component
10747,MORF_EIF4A2,c4.CGN_ cancer gene neighborhoods
10748,LUI_TARGETS_OF_PAX8_PPARG_FUSION,c2.CGP_ chemical and genetic perturbations
10749,MODULE_28,c4.CM_ cancer modules
10750,MORF_ERH,c4.CGN_ cancer gene neighborhoods
10751,MODULE_149,c4.CM_ cancer modules
10752,MORF_EIF3S2,c4.CGN_ cancer gene neighborhoods
10753,MYC_UP.V1_UP,C6_ oncogenic signatures
10754,GNF2_G22P1,c4.CGN_ cancer gene neighborhoods
10755,REACTOME_MRNA_SPLICING_MINOR_PATHWAY,c2.CP_REACTOME_ Reactome gene sets
10756,HORTON_SREBF_TARGETS,c2.CGP_ chemical and genetic perturbations
10757,MORF_ACP1,c4.CGN_ cancer gene neighborhoods
10758,CHR11Q13,219
10759,GO_RRNA_BINDING,c5.GO molecular function
10760,GO_MONOCYTE_CHEMOTAXIS,c5.BP_ GO biological process
10761,REACTOME_MRNA_SPLICING,c2.CP_REACTOME_ Reactome gene sets
10762,PENG_GLUTAMINE_DEPRIVATION_DN,c2.CGP_ chemical and genetic perturbations
10763,MORF_HDAC1,c4.CGN_ cancer gene neighborhoods
10764,MOOTHA_HUMAN_MITODB_6_2002,c2.CGP_ chemical and genetic perturbations
10765,MENSSEN_MYC_TARGETS,c2.CGP_ chemical and genetic perturbations
10766,IRITANI_MAD1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
10767,HSIAO_HOUSEKEEPING_GENES,c2.CGP_ chemical and genetic perturbations
10768,GO_90S_PRERIBOSOME,c5.CC_ GO cellular component
10769,GO_PROTEIN_TARGETING_TO_MITOCHONDRION,c5.BP_ GO biological process
10770,GO_ORGANELLAR_RIBOSOME,c5.CC_ GO cellular component
10771,GO_PEPTIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
10772,GO_RESPIRATORY_CHAIN,c5.CC_ GO cellular component
10773,MORF_SKP1A,c4.CGN_ cancer gene neighborhoods
10774,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR,c5.GO molecular function
10775,SCHUHMACHER_MYC_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
10776,GO_RIBOSOMAL_LARGE_SUBUNIT_ASSEMBLY,c5.BP_ GO biological process
10777,GO_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,c5.BP_ GO biological process
10778,BILANGES_SERUM_RESPONSE_TRANSLATION,c2.CGP_ chemical and genetic perturbations
10779,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,c2.CGP_ chemical and genetic perturbations
10780,HALLMARK_OXIDATIVE_PHOSPHORYLATION,H_ hallmark gene sets
10781,REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC,c2.CP_REACTOME_ Reactome gene sets
10782,GAURNIER_PSMD4_TARGETS,c2.CGP_ chemical and genetic perturbations
10783,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_DN,C7_ immunologic signatures
10784,GNF2_APEX1,c4.CGN_ cancer gene neighborhoods
10785,MOOTHA_VOXPHOS,c2.CGP_ chemical and genetic perturbations
10786,GO_DNA_DIRECTED_RNA_POLYMERASE_III_COMPLEX,c5.CC_ GO cellular component
10787,GO_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY,c5.BP_ GO biological process
10788,GO_CELLULAR_RESPIRATION,c5.BP_ GO biological process
10789,GO_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,c5.BP_ GO biological process
10790,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP,c2.CGP_ chemical and genetic perturbations
10791,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP,c2.CGP_ chemical and genetic perturbations
10792,MODULE_432,c4.CM_ cancer modules
10793,GO_PURINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
10794,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,C7_ immunologic signatures
10795,PENG_LEUCINE_DEPRIVATION_DN,c2.CGP_ chemical and genetic perturbations
10796,MORF_MTA1,c4.CGN_ cancer gene neighborhoods
10797,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_UP,C7_ immunologic signatures
10798,KEGG_OXIDATIVE_PHOSPHORYLATION,c2.CP_BIOCARTA_ BioCarta gene sets
10799,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_DN,C7_ immunologic signatures
10800,GO_NADH_DEHYDROGENASE_COMPLEX,c5.CC_ GO cellular component
10801,MORF_RAD21,c4.CGN_ cancer gene neighborhoods
10802,MODULE_263,c4.CM_ cancer modules
10803,GO_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,c5.GO molecular function
10804,GO_FORMATION_OF_TRANSLATION_PREINITIATION_COMPLEX,c5.BP_ GO biological process
10805,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
10806,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,C7_ immunologic signatures
10807,GO_MITOCHONDRIAL_RNA_METABOLIC_PROCESS,c5.BP_ GO biological process
10808,MOOTHA_MITOCHONDRIA,c2.CGP_ chemical and genetic perturbations
10809,REACTOME_TRIGLYCERIDE_BIOSYNTHESIS,c2.CP_REACTOME_ Reactome gene sets
10810,DANG_MYC_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
10811,MODULE_115,c4.CM_ cancer modules
10812,GO_NADH_METABOLIC_PROCESS,c5.BP_ GO biological process
10813,PECE_MAMMARY_STEM_CELL_UP,c2.CGP_ chemical and genetic perturbations
10814,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP,C7_ immunologic signatures
10815,MORF_RAD23B,c4.CGN_ cancer gene neighborhoods
10816,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP,C7_ immunologic signatures
10817,GCM_PPP1CC,c4.CGN_ cancer gene neighborhoods
10818,GNF2_DENR,c4.CGN_ cancer gene neighborhoods
10819,GO_SMALL_NUCLEOLAR_RIBONUCLEOPROTEIN_COMPLEX,c5.CC_ GO cellular component
10820,LI_DCP2_BOUND_MRNA,c2.CGP_ chemical and genetic perturbations
10821,GO_ORGANELLAR_LARGE_RIBOSOMAL_SUBUNIT,c5.CC_ GO cellular component
10822,KEGG_SPLICEOSOME,c2.CP_BIOCARTA_ BioCarta gene sets
10823,REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,c2.CP_REACTOME_ Reactome gene sets
10824,KEGG_RNA_POLYMERASE,c2.CP_BIOCARTA_ BioCarta gene sets
10825,GNF2_XRCC5,c4.CGN_ cancer gene neighborhoods
10826,KEGG_PENTOSE_PHOSPHATE_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10827,GO_LYMPHOCYTE_MIGRATION,c5.BP_ GO biological process
10828,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H,c5.GO molecular function
10829,MORF_PRKAR1A,c4.CGN_ cancer gene neighborhoods
10830,MODULE_108,c4.CM_ cancer modules
10831,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_DN,C7_ immunologic signatures
10832,MORF_PSMC1,c4.CGN_ cancer gene neighborhoods
10833,BIOCARTA_PROTEASOME_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
10834,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,c2.CGP_ chemical and genetic perturbations
10835,GO_TRANSLATION_PREINITIATION_COMPLEX,c5.CC_ GO cellular component
10836,GO_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
10837,GO_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I_BIOGENESIS,c5.BP_ GO biological process
10838,GO_PROTEASOME_ACCESSORY_COMPLEX,c5.CC_ GO cellular component
10839,MORF_AATF,c4.CGN_ cancer gene neighborhoods
10840,GO_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX,c5.CC_ GO cellular component
10841,MODULE_43,c4.CM_ cancer modules
10842,WENG_POR_TARGETS_GLOBAL_UP,c2.CGP_ chemical and genetic perturbations
10843,GO_SPLICEOSOMAL_SNRNP_ASSEMBLY,c5.BP_ GO biological process
10844,REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES,c2.CP_REACTOME_ Reactome gene sets
10845,REACTOME_REGULATION_OF_APOPTOSIS,c2.CP_REACTOME_ Reactome gene sets
10846,MORF_RAD23A,c4.CGN_ cancer gene neighborhoods
10847,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_UP,C7_ immunologic signatures
10848,REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS,c2.CP_REACTOME_ Reactome gene sets
10849,KEGG_PROTEASOME,c2.CP_BIOCARTA_ BioCarta gene sets
10850,GNF2_ELAC2,c4.CGN_ cancer gene neighborhoods
10851,MORF_PSMC2,c4.CGN_ cancer gene neighborhoods
10852,REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0,c2.CP_REACTOME_ Reactome gene sets
10853,GSE369_IFNG_KO_VS_WT_LIVER_DN,C7_ immunologic signatures
10854,REACTOME_CHOLESTEROL_BIOSYNTHESIS,c2.CP_REACTOME_ Reactome gene sets
10855,GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE,c5.BP_ GO biological process
10856,SWEET_KRAS_ONCOGENIC_SIGNATURE,c2.CGP_ chemical and genetic perturbations
10857,GO_MONOSACCHARIDE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
10858,MORF_DEK,c4.CGN_ cancer gene neighborhoods
10859,YAGI_AML_RELAPSE_PROGNOSIS,c2.CGP_ chemical and genetic perturbations
10860,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
10861,MORF_PPP2CA,c4.CGN_ cancer gene neighborhoods
10862,MORF_UNG,c4.CGN_ cancer gene neighborhoods
10863,REACTOME_SIGNALING_BY_WNT,c2.CP_REACTOME_ Reactome gene sets
10864,REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS,c2.CP_REACTOME_ Reactome gene sets
10865,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_DN,C7_ immunologic signatures
10866,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_UP,C7_ immunologic signatures
10867,GO_MITOCHONDRIAL_MATRIX,c5.CC_ GO cellular component
10868,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP,C7_ immunologic signatures
10869,XU_CREBBP_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
10870,MORF_ATOX1,c4.CGN_ cancer gene neighborhoods
10871,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,c2.CGP_ chemical and genetic perturbations
10872,MORF_MAP2K2,c4.CGN_ cancer gene neighborhoods
10873,KEGG_GLYCOLYSIS_GLUCONEOGENESIS,c2.CP_BIOCARTA_ BioCarta gene sets
10874,GO_TRANSLATION_INITIATION_FACTOR_ACTIVITY,c5.GO molecular function
10875,GCM_HDAC1,c4.CGN_ cancer gene neighborhoods
10876,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,c2.CP_BIOCARTA_ BioCarta gene sets
10877,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
10878,MORF_DAP,c4.CGN_ cancer gene neighborhoods
10879,GSE22886_NEUTROPHIL_VS_MONOCYTE_DN,C7_ immunologic signatures
10880,GO_HEXOSE_CATABOLIC_PROCESS,c5.BP_ GO biological process
10881,GO_GLUCOSE_CATABOLIC_PROCESS,c5.BP_ GO biological process
10882,GO_U12_TYPE_SPLICEOSOMAL_COMPLEX,c5.CC_ GO cellular component
10883,KEGG_PROTEIN_EXPORT,c2.CP_BIOCARTA_ BioCarta gene sets
10884,MORF_CTBP1,c4.CGN_ cancer gene neighborhoods
10885,GO_NUCLEOTIDE_PHOSPHORYLATION,c5.BP_ GO biological process
10886,CHR10Q24,83
10887,REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,c2.CP_REACTOME_ Reactome gene sets
10888,CHRXP11,113
10889,REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT,c2.CP_REACTOME_ Reactome gene sets
10890,MODULE_42,c4.CM_ cancer modules
10891,REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1,c2.CP_REACTOME_ Reactome gene sets
10892,GNF2_RBBP6,c4.CGN_ cancer gene neighborhoods
10893,REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,c2.CP_REACTOME_ Reactome gene sets
10894,SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY,c2.CGP_ chemical and genetic perturbations
10895,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN,c2.CGP_ chemical and genetic perturbations
10896,GAVIN_FOXP3_TARGETS_CLUSTER_T7,c2.CGP_ chemical and genetic perturbations
10897,GSE31082_DN_VS_DP_THYMOCYTE_UP,C7_ immunologic signatures
10898,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_DN,C7_ immunologic signatures
10899,GO_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,c5.BP_ GO biological process
10900,GO_ORGANELLE_INNER_MEMBRANE,c5.CC_ GO cellular component
10901,REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,c2.CP_REACTOME_ Reactome gene sets
10902,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,c2.CGP_ chemical and genetic perturbations
10903,CHR8Q24,111
10904,GNF2_RAN,c4.CGN_ cancer gene neighborhoods
10905,REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,c2.CP_REACTOME_ Reactome gene sets
10906,BARIS_THYROID_CANCER_UP,c2.CGP_ chemical and genetic perturbations
10907,CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN,c2.CGP_ chemical and genetic perturbations
10908,MORF_RAC1,c4.CGN_ cancer gene neighborhoods
10909,GO_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING,c5.GO molecular function
10910,GO_SPERM_EGG_RECOGNITION,c5.BP_ GO biological process
10911,GO_CATALYTIC_STEP_2_SPLICEOSOME,c5.CC_ GO cellular component
10912,MORF_AP3D1,c4.CGN_ cancer gene neighborhoods
10913,RAHMAN_TP53_TARGETS_PHOSPHORYLATED,c2.CGP_ chemical and genetic perturbations
10914,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN,C7_ immunologic signatures
10915,LUI_THYROID_CANCER_PAX8_PPARG_DN,c2.CGP_ chemical and genetic perturbations
10916,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,C7_ immunologic signatures
10917,YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,c2.CGP_ chemical and genetic perturbations
10918,MORF_USP5,c4.CGN_ cancer gene neighborhoods
10919,MORF_CUL1,c4.CGN_ cancer gene neighborhoods
10920,GO_CELL_CELL_RECOGNITION,c5.BP_ GO biological process
10921,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
10922,GNF2_NS,c4.CGN_ cancer gene neighborhoods
10923,GO_ADP_METABOLIC_PROCESS,c5.BP_ GO biological process
10924,GSE45837_WT_VS_GFI1_KO_PDC_DN,C7_ immunologic signatures
10925,MODULE_152,c4.CM_ cancer modules
10926,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,c2.CGP_ chemical and genetic perturbations
10927,REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_,c2.CP_REACTOME_ Reactome gene sets
10928,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,c2.CGP_ chemical and genetic perturbations
10929,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_DN,C7_ immunologic signatures
10930,GO_RNA_CAPPING,c5.BP_ GO biological process
10931,GO_VIRAL_LIFE_CYCLE,c5.BP_ GO biological process
10932,REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX,c2.CP_REACTOME_ Reactome gene sets
10933,WANG_TUMOR_INVASIVENESS_UP,c2.CGP_ chemical and genetic perturbations
10934,TAKAO_RESPONSE_TO_UVB_RADIATION_UP,c2.CGP_ chemical and genetic perturbations
10935,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,c2.CGP_ chemical and genetic perturbations
10936,GO_TRNA_METHYLATION,c5.BP_ GO biological process
10937,GO_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA,c5.BP_ GO biological process
10938,GO_CCR_CHEMOKINE_RECEPTOR_BINDING,c5.GO molecular function
10939,GO_ORGANELLAR_SMALL_RIBOSOMAL_SUBUNIT,c5.CC_ GO cellular component
10940,GO_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS,c5.BP_ GO biological process
10941,GO_OXIDOREDUCTASE_COMPLEX,c5.CC_ GO cellular component
10942,GO_GLYCOSYL_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
10943,GCM_CBFB,c4.CGN_ cancer gene neighborhoods
10944,GO_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX,c5.CC_ GO cellular component
10945,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,c2.CP_REACTOME_ Reactome gene sets
10946,ANDERSEN_LIVER_CANCER_KRT19_UP,c2.CGP_ chemical and genetic perturbations
10947,GO_REGULATION_OF_TRANSLATIONAL_INITIATION,c5.BP_ GO biological process
10948,GO_GUANOSINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
10949,BURTON_ADIPOGENESIS_2,c2.CGP_ chemical and genetic perturbations
10950,GO_POSITIVE_REGULATION_OF_TISSUE_REMODELING,c5.BP_ GO biological process
10951,GO_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER,c5.BP_ GO biological process
10952,GO_PEPTIDYL_ARGININE_MODIFICATION,c5.BP_ GO biological process
10953,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,C7_ immunologic signatures
10954,PID_MYC_ACTIV_PATHWAY,c2.CP_ Canonical pathways
10955,CHR10Q25,37
10956,GO_STEROL_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
10957,REACTOME_ER_PHAGOSOME_PATHWAY,c2.CP_REACTOME_ Reactome gene sets
10958,NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,c2.CGP_ chemical and genetic perturbations
10959,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP,C7_ immunologic signatures
10960,GO_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,c5.BP_ GO biological process
10961,MORF_UBE2N,c4.CGN_ cancer gene neighborhoods
10962,GO_CHEMOKINE_ACTIVITY,c5.GO molecular function
10963,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN,C7_ immunologic signatures
10964,MODULE_77,c4.CM_ cancer modules
10965,GO_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER,c5.BP_ GO biological process
10966,REACTOME_ELONGATION_ARREST_AND_RECOVERY,c2.CP_REACTOME_ Reactome gene sets
10967,GO_RNA_POLYMERASE_ACTIVITY,c5.GO molecular function
10968,GO_PROTEIN_TRANSPORT_ALONG_MICROTUBULE,c5.BP_ GO biological process
10969,MOOTHA_GLUCONEOGENESIS,c2.CGP_ chemical and genetic perturbations
10970,GROSS_HIF1A_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
10971,GO_NIK_NF_KAPPAB_SIGNALING,c5.BP_ GO biological process
10972,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_UP,C7_ immunologic signatures
10973,MODULE_306,c4.CM_ cancer modules
10974,MORF_RAB1A,c4.CGN_ cancer gene neighborhoods
10975,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN,C7_ immunologic signatures
10976,GO_POLYSOME,c5.CC_ GO cellular component
10977,MODULE_388,c4.CM_ cancer modules
10978,MODULE_62,c4.CM_ cancer modules
10979,GO_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,c5.BP_ GO biological process
10980,REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT,c2.CP_REACTOME_ Reactome gene sets
10981,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_DN,C7_ immunologic signatures
10982,SANA_RESPONSE_TO_IFNG_DN,c2.CGP_ chemical and genetic perturbations
10983,GO_GTP_METABOLIC_PROCESS,c5.BP_ GO biological process
10984,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP,C7_ immunologic signatures
10985,REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,c2.CP_REACTOME_ Reactome gene sets
10986,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_UP,C7_ immunologic signatures
10987,MORF_BUB3,c4.CGN_ cancer gene neighborhoods
10988,GO_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
10989,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,C7_ immunologic signatures
10990,MORF_PCNA,c4.CGN_ cancer gene neighborhoods
10991,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
10992,REACTOME_HIV_INFECTION,c2.CP_REACTOME_ Reactome gene sets
10993,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,c2.CGP_ chemical and genetic perturbations
10994,CHR12Q12,48
10995,GO_MONOSACCHARIDE_CATABOLIC_PROCESS,c5.BP_ GO biological process
10996,PID_NFAT_TFPATHWAY,c2.CP_ Canonical pathways
10997,MORF_GPX4,c4.CGN_ cancer gene neighborhoods
10998,MORF_XPC,c4.CGN_ cancer gene neighborhoods
10999,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP,C7_ immunologic signatures
11000,GO_CELLULAR_ALDEHYDE_METABOLIC_PROCESS,c5.BP_ GO biological process
11001,GO_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION,c5.BP_ GO biological process
11002,MORF_RAB6A,c4.CGN_ cancer gene neighborhoods
11003,GO_ORGANIC_CYCLIC_COMPOUND_CATABOLIC_PROCESS,c5.BP_ GO biological process
11004,GO_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,c5.BP_ GO biological process
11005,MORF_BAG5,c4.CGN_ cancer gene neighborhoods
11006,GSE3039_CD4_TCELL_VS_B2_BCELL_DN,C7_ immunologic signatures
11007,GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,c5.BP_ GO biological process
11008,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,C7_ immunologic signatures
11009,REACTOME_PURINE_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
11010,GO_ATP_GENERATION_FROM_ADP,c5.BP_ GO biological process
11011,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN,C7_ immunologic signatures
11012,REACTOME_MRNA_CAPPING,c2.CP_REACTOME_ Reactome gene sets
11013,GO_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,c5.BP_ GO biological process
11014,GO_U2_SNRNP,c5.CC_ GO cellular component
11015,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_UP,C7_ immunologic signatures
11016,GO_PURINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11017,GO_TRANSLATION_ELONGATION_FACTOR_ACTIVITY,c5.GO molecular function
11018,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN,C7_ immunologic signatures
11019,MORF_PRKAG1,c4.CGN_ cancer gene neighborhoods
11020,HONMA_DOCETAXEL_RESISTANCE,c2.CGP_ chemical and genetic perturbations
11021,GO_MACROMOLECULE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
11022,GO_NAD_BINDING,c5.GO molecular function
11023,GO_PROTEASOME_COMPLEX,c5.CC_ GO cellular component
11024,GO_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,c5.BP_ GO biological process
11025,BURTON_ADIPOGENESIS_4,c2.CGP_ chemical and genetic perturbations
11026,MUNSHI_MULTIPLE_MYELOMA_UP,c2.CGP_ chemical and genetic perturbations
11027,GROSS_HYPOXIA_VIA_HIF1A_UP,c2.CGP_ chemical and genetic perturbations
11028,REACTOME_GLUCONEOGENESIS,c2.CP_REACTOME_ Reactome gene sets
11029,REACTOME_GLYCOLYSIS,c2.CP_REACTOME_ Reactome gene sets
11030,GO_TRNA_METABOLIC_PROCESS,c5.BP_ GO biological process
11031,GO_TELOMERASE_HOLOENZYME_COMPLEX,c5.CC_ GO cellular component
11032,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_UP,C7_ immunologic signatures
11033,WELCSH_BRCA1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
11034,GCM_RAD21,c4.CGN_ cancer gene neighborhoods
11035,MOOTHA_FFA_OXYDATION,c2.CGP_ chemical and genetic perturbations
11036,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_DN,C7_ immunologic signatures
11037,GSE22886_NAIVE_TCELL_VS_DC_UP,C7_ immunologic signatures
11038,MODULE_102,c4.CM_ cancer modules
11039,GO_SPLICEOSOMAL_COMPLEX,c5.CC_ GO cellular component
11040,GO_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS,c5.BP_ GO biological process
11041,GO_AEROBIC_RESPIRATION,c5.BP_ GO biological process
11042,GO_INTRAMOLECULAR_TRANSFERASE_ACTIVITY,c5.GO molecular function
11043,GSE22886_CTRL_VS_LPS_24H_DC_UP,C7_ immunologic signatures
11044,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_DN,C7_ immunologic signatures
11045,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
11046,GO_POLY_PYRIMIDINE_TRACT_BINDING,c5.GO molecular function
11047,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,C7_ immunologic signatures
11048,GO_PROTEIN_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
11049,ENK_UV_RESPONSE_KERATINOCYTE_UP,c2.CGP_ chemical and genetic perturbations
11050,AMIT_SERUM_RESPONSE_20_MCF10A,c2.CGP_ chemical and genetic perturbations
11051,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP,C7_ immunologic signatures
11052,LI_AMPLIFIED_IN_LUNG_CANCER,c2.CGP_ chemical and genetic perturbations
11053,KRAS.300_UP.V1_UP,C6_ oncogenic signatures
11054,GSE369_SOCS3_KO_VS_WT_LIVER_UP,C7_ immunologic signatures
11055,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_UP,C7_ immunologic signatures
11056,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,c2.CGP_ chemical and genetic perturbations
11057,GO_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS,c5.BP_ GO biological process
11058,GO_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS,c5.BP_ GO biological process
11059,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,C7_ immunologic signatures
11060,GO_MATURATION_OF_5_8S_RRNA,c5.BP_ GO biological process
11061,REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION,c2.CP_REACTOME_ Reactome gene sets
11062,KARLSSON_TGFB1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
11063,GO_GLUTATHIONE_DERIVATIVE_METABOLIC_PROCESS,c5.BP_ GO biological process
11064,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,c2.CGP_ chemical and genetic perturbations
11065,GO_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,c5.BP_ GO biological process
11066,REACTOME_MRNA_PROCESSING,c2.CP_REACTOME_ Reactome gene sets
11067,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
11068,REACTOME_MICRORNA_MIRNA_BIOGENESIS,c2.CP_REACTOME_ Reactome gene sets
11069,GO_RNA_SPLICING,c5.BP_ GO biological process
11070,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
11071,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,C7_ immunologic signatures
11072,MODULE_81,c4.CM_ cancer modules
11073,GO_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11074,GO_LIPID_DIGESTION,c5.BP_ GO biological process
11075,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_UP,C7_ immunologic signatures
11076,GO_COPPER_ION_TRANSPORT,c5.BP_ GO biological process
11077,IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,c2.CGP_ chemical and genetic perturbations
11078,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,c2.CGP_ chemical and genetic perturbations
11079,MODULE_183,c4.CM_ cancer modules
11080,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,c2.CGP_ chemical and genetic perturbations
11081,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_DN,C7_ immunologic signatures
11082,GO_OXIDOREDUCTION_COENZYME_METABOLIC_PROCESS,c5.BP_ GO biological process
11083,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_UP,C7_ immunologic signatures
11084,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,c2.CGP_ chemical and genetic perturbations
11085,GGAANCGGAANY_UNKNOWN,c3.TFT_ transcription factor targets
11086,GO_TRICARBOXYLIC_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
11087,VIETOR_IFRD1_TARGETS,c2.CGP_ chemical and genetic perturbations
11088,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_DN,C7_ immunologic signatures
11089,GRADE_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
11090,GO_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
11091,RODRIGUES_NTN1_AND_DCC_TARGETS,c2.CGP_ chemical and genetic perturbations
11092,MORF_GMPS,c4.CGN_ cancer gene neighborhoods
11093,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN,C7_ immunologic signatures
11094,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
11095,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP,C7_ immunologic signatures
11096,MODULE_310,c4.CM_ cancer modules
11097,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,c2.CGP_ chemical and genetic perturbations
11098,REACTOME_REGULATORY_RNA_PATHWAYS,c2.CP_REACTOME_ Reactome gene sets
11099,GO_PROTEIN_TARGETING,c5.BP_ GO biological process
11100,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,c2.CGP_ chemical and genetic perturbations
11101,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,C7_ immunologic signatures
11102,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN,C7_ immunologic signatures
11103,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_DN,C7_ immunologic signatures
11104,GO_COFACTOR_METABOLIC_PROCESS,c5.BP_ GO biological process
11105,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP,C7_ immunologic signatures
11106,KEGG_PYRUVATE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
11107,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN,c2.CGP_ chemical and genetic perturbations
11108,GO_BRANCHED_CHAIN_AMINO_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
11109,GO_MICROVILLUS_MEMBRANE,c5.CC_ GO cellular component
11110,GO_2_OXOGLUTARATE_METABOLIC_PROCESS,c5.BP_ GO biological process
11111,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_UP,C7_ immunologic signatures
11112,GO_CONNEXON_COMPLEX,c5.CC_ GO cellular component
11113,KEGG_PARKINSONS_DISEASE,c2.CP_BIOCARTA_ BioCarta gene sets
11114,REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C,c2.CP_REACTOME_ Reactome gene sets
11115,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_DN,C7_ immunologic signatures
11116,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,C7_ immunologic signatures
11117,GO_NAD_METABOLIC_PROCESS,c5.BP_ GO biological process
11118,REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS,c2.CP_REACTOME_ Reactome gene sets
11119,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP,C7_ immunologic signatures
11120,MORF_PPP2R4,c4.CGN_ cancer gene neighborhoods
11121,GO_COENZYME_METABOLIC_PROCESS,c5.BP_ GO biological process
11122,GSE42724_NAIVE_VS_B1_BCELL_DN,C7_ immunologic signatures
11123,LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN,c2.CGP_ chemical and genetic perturbations
11124,REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX,c2.CP_REACTOME_ Reactome gene sets
11125,GO_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11126,GO_RRNA_MODIFICATION,c5.BP_ GO biological process
11127,GO_DNA_DIRECTED_RNA_POLYMERASE_II_CORE_COMPLEX,c5.CC_ GO cellular component
11128,MORF_EI24,c4.CGN_ cancer gene neighborhoods
11129,GO_PURINE_NUCLEOBASE_METABOLIC_PROCESS,c5.BP_ GO biological process
11130,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
11131,KEGG_ARGININE_AND_PROLINE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
11132,KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS,c2.CP_BIOCARTA_ BioCarta gene sets
11133,GO_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,c5.BP_ GO biological process
11134,GO_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN,c5.BP_ GO biological process
11135,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
11136,KIM_MYC_AMPLIFICATION_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
11137,MODULE_184,c4.CM_ cancer modules
11138,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,c2.CGP_ chemical and genetic perturbations
11139,GO_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,c5.BP_ GO biological process
11140,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP,C7_ immunologic signatures
11141,REACTOME_GLUCOSE_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
11142,MORF_HAT1,c4.CGN_ cancer gene neighborhoods
11143,GO_SMN_SM_PROTEIN_COMPLEX,c5.CC_ GO cellular component
11144,GO_RESPONSE_TO_WATER,c5.BP_ GO biological process
11145,MORF_HDAC2,c4.CGN_ cancer gene neighborhoods
11146,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,c2.CP_REACTOME_ Reactome gene sets
11147,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,C7_ immunologic signatures
11148,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP,C7_ immunologic signatures
11149,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_DN,C7_ immunologic signatures
11150,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
11151,REACTOME_RNA_POL_III_CHAIN_ELONGATION,c2.CP_REACTOME_ Reactome gene sets
11152,GO_REGULATION_OF_INTERLEUKIN_5_PRODUCTION,c5.BP_ GO biological process
11153,REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX,c2.CP_REACTOME_ Reactome gene sets
11154,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,c2.CGP_ chemical and genetic perturbations
11155,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,C7_ immunologic signatures
11156,GO_INNATE_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
11157,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_UP,C7_ immunologic signatures
11158,GO_DIGESTION,c5.BP_ GO biological process
11159,MORF_DDB1,c4.CGN_ cancer gene neighborhoods
11160,REACTOME_METABOLISM_OF_NUCLEOTIDES,c2.CP_REACTOME_ Reactome gene sets
11161,GO_SNRNA_PROCESSING,c5.BP_ GO biological process
11162,GO_GLYCOSPHINGOLIPID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11163,ZHANG_RESPONSE_TO_CANTHARIDIN_DN,c2.CGP_ chemical and genetic perturbations
11164,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,C7_ immunologic signatures
11165,GO_LIPID_PARTICLE,c5.CC_ GO cellular component
11166,GO_OXIDOREDUCTASE_ACTIVITY_OXIDIZING_METAL_IONS,c5.GO molecular function
11167,GO_TRNA_BINDING,c5.GO molecular function
11168,GSE40443_INDUCED_VS_TOTAL_TREG_UP,C7_ immunologic signatures
11169,GO_POSITIVE_REGULATION_OF_VIRAL_TRANSCRIPTION,c5.BP_ GO biological process
11170,GO_NEURONAL_CELL_BODY_MEMBRANE,c5.CC_ GO cellular component
11171,MODULE_440,c4.CM_ cancer modules
11172,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
11173,GO_PSEUDOURIDINE_SYNTHESIS,c5.BP_ GO biological process
11174,GCM_RAF1,c4.CGN_ cancer gene neighborhoods
11175,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS,c5.GO molecular function
11176,GO_RETINOIC_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
11177,CHR22Q12,82
11178,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN,C7_ immunologic signatures
11179,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP,C7_ immunologic signatures
11180,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_DN,C7_ immunologic signatures
11181,HILLION_HMGA1B_TARGETS,c2.CGP_ chemical and genetic perturbations
11182,JISON_SICKLE_CELL_DISEASE_DN,c2.CGP_ chemical and genetic perturbations
11183,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,C7_ immunologic signatures
11184,GO_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,c5.BP_ GO biological process
11185,REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM,c2.CP_REACTOME_ Reactome gene sets
11186,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN,C7_ immunologic signatures
11187,MORF_PRDX3,c4.CGN_ cancer gene neighborhoods
11188,MOOTHA_TCA,c2.CGP_ chemical and genetic perturbations
11189,GO_CYTOCHROME_COMPLEX,c5.CC_ GO cellular component
11190,MATZUK_IMPLANTATION_AND_UTERINE,c2.CGP_ chemical and genetic perturbations
11191,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,c2.CGP_ chemical and genetic perturbations
11192,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_DN,C7_ immunologic signatures
11193,HALLMARK_ADIPOGENESIS,H_ hallmark gene sets
11194,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_DN,C7_ immunologic signatures
11195,GO_GABA_RECEPTOR_ACTIVITY,c5.GO molecular function
11196,GO_RNA_MODIFICATION,c5.BP_ GO biological process
11197,GO_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,c5.BP_ GO biological process
11198,GO_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE,c5.BP_ GO biological process
11199,BURTON_ADIPOGENESIS_PEAK_AT_8HR,c2.CGP_ chemical and genetic perturbations
11200,GO_MRNA_PROCESSING,c5.BP_ GO biological process
11201,GO_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,c5.GO molecular function
11202,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_DN,C7_ immunologic signatures
11203,GO_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,c5.BP_ GO biological process
11204,MOOTHA_GLYCOLYSIS,c2.CGP_ chemical and genetic perturbations
11205,WILENSKY_RESPONSE_TO_DARAPLADIB,c2.CGP_ chemical and genetic perturbations
11206,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP,C7_ immunologic signatures
11207,GO_TRNA_MODIFICATION,c5.BP_ GO biological process
11208,GO_TRNA_PROCESSING,c5.BP_ GO biological process
11209,GO_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,c5.BP_ GO biological process
11210,PID_IL23_PATHWAY,c2.CP_ Canonical pathways
11211,REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,c2.CP_REACTOME_ Reactome gene sets
11212,GO_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,c5.GO molecular function
11213,GNF2_HDAC1,c4.CGN_ cancer gene neighborhoods
11214,GO_ISOPRENOID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11215,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,c2.CGP_ chemical and genetic perturbations
11216,MORF_MBD4,c4.CGN_ cancer gene neighborhoods
11217,MORF_RPA1,c4.CGN_ cancer gene neighborhoods
11218,VANDESLUIS_NORMAL_EMBRYOS_DN,c2.CGP_ chemical and genetic perturbations
11219,GO_QUINONE_METABOLIC_PROCESS,c5.BP_ GO biological process
11220,MODULE_159,c4.CM_ cancer modules
11221,GO_ISOMERASE_ACTIVITY,c5.GO molecular function
11222,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
11223,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP,C7_ immunologic signatures
11224,GO_THREONINE_TYPE_PEPTIDASE_ACTIVITY,c5.GO molecular function
11225,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN,C7_ immunologic signatures
11226,REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE,c2.CP_REACTOME_ Reactome gene sets
11227,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_UP,C7_ immunologic signatures
11228,GO_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_MEMBRANE,c5.CC_ GO cellular component
11229,MOREIRA_RESPONSE_TO_TSA_UP,c2.CGP_ chemical and genetic perturbations
11230,GO_U2_TYPE_SPLICEOSOMAL_COMPLEX,c5.CC_ GO cellular component
11231,GO_CHEMOKINE_RECEPTOR_BINDING,c5.GO molecular function
11232,GRADE_COLON_AND_RECTAL_CANCER_UP,c2.CGP_ chemical and genetic perturbations
11233,GNF2_TDG,c4.CGN_ cancer gene neighborhoods
11234,GSE17721_0.5H_VS_8H_CPG_BMDC_UP,C7_ immunologic signatures
11235,ZHAN_MULTIPLE_MYELOMA_DN,c2.CGP_ chemical and genetic perturbations
11236,HUNSBERGER_EXERCISE_REGULATED_GENES,c2.CGP_ chemical and genetic perturbations
11237,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP,C7_ immunologic signatures
11238,PID_AJDISS_2PATHWAY,c2.CP_ Canonical pathways
11239,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,C7_ immunologic signatures
11240,KEGG_STEROID_BIOSYNTHESIS,c2.CP_BIOCARTA_ BioCarta gene sets
11241,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP,C7_ immunologic signatures
11242,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_DN,C7_ immunologic signatures
11243,KEGG_CITRATE_CYCLE_TCA_CYCLE,c2.CP_BIOCARTA_ BioCarta gene sets
11244,GO_ELECTRON_CARRIER_ACTIVITY,c5.GO molecular function
11245,MODULE_305,c4.CM_ cancer modules
11246,GCM_DDX5,c4.CGN_ cancer gene neighborhoods
11247,GO_INO80_TYPE_COMPLEX,c5.CC_ GO cellular component
11248,MODULE_221,c4.CM_ cancer modules
11249,MORF_GSPT1,c4.CGN_ cancer gene neighborhoods
11250,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,c2.CP_REACTOME_ Reactome gene sets
11251,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_UP,C7_ immunologic signatures
11252,GO_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
11253,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,c2.CGP_ chemical and genetic perturbations
11254,GO_RNA_POLYMERASE_COMPLEX,c5.CC_ GO cellular component
11255,GO_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
11256,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_UP,C7_ immunologic signatures
11257,REACTOME_GAP_JUNCTION_TRAFFICKING,c2.CP_REACTOME_ Reactome gene sets
11258,MODULE_61,c4.CM_ cancer modules
11259,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP,C7_ immunologic signatures
11260,GO_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,c5.BP_ GO biological process
11261,REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER,c2.CP_REACTOME_ Reactome gene sets
11262,GNF2_KPNB1,c4.CGN_ cancer gene neighborhoods
11263,MORF_XRCC5,c4.CGN_ cancer gene neighborhoods
11264,MOOTHA_PGC,c2.CGP_ chemical and genetic perturbations
11265,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
11266,RB_P107_DN.V1_DN,C6_ oncogenic signatures
11267,GO_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,c5.GO molecular function
11268,GO_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11269,KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
11270,CHRXQ21,29
11271,REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE,c2.CP_REACTOME_ Reactome gene sets
11272,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,C7_ immunologic signatures
11273,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,c2.CGP_ chemical and genetic perturbations
11274,BILD_MYC_ONCOGENIC_SIGNATURE,c2.CGP_ chemical and genetic perturbations
11275,GO_STEROID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11276,REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,c2.CP_REACTOME_ Reactome gene sets
11277,KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
11278,GNF2_BUB3,c4.CGN_ cancer gene neighborhoods
11279,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN,C7_ immunologic signatures
11280,GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN,C7_ immunologic signatures
11281,CHR1Q21,175
11282,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_DN,C7_ immunologic signatures
11283,MCLACHLAN_DENTAL_CARIES_UP,c2.CGP_ chemical and genetic perturbations
11284,GO_RESPONSE_TO_MANGANESE_ION,c5.BP_ GO biological process
11285,TIEN_INTESTINE_PROBIOTICS_2HR_UP,c2.CGP_ chemical and genetic perturbations
11286,GO_AMINE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11287,GO_SPLICEOSOMAL_COMPLEX_ASSEMBLY,c5.BP_ GO biological process
11288,KEGG_FATTY_ACID_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
11289,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
11290,VANLOO_SP3_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
11291,GO_RIBOSOME_BINDING,c5.GO molecular function
11292,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,c5.GO molecular function
11293,MAEKAWA_ATF2_TARGETS,c2.CGP_ chemical and genetic perturbations
11294,GO_CHROMATIN_DISASSEMBLY,c5.BP_ GO biological process
11295,GSE17721_LPS_VS_POLYIC_8H_BMDC_UP,C7_ immunologic signatures
11296,GO_SNRNA_BINDING,c5.GO molecular function
11297,GO_NEGATIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,c5.BP_ GO biological process
11298,MODULE_404,c4.CM_ cancer modules
11299,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP,C7_ immunologic signatures
11300,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN,C7_ immunologic signatures
11301,REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER,c2.CP_REACTOME_ Reactome gene sets
11302,GO_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC,c5.BP_ GO biological process
11303,GCM_DPF2,c4.CGN_ cancer gene neighborhoods
11304,GO_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS,c5.BP_ GO biological process
11305,GO_LYMPHOCYTE_CHEMOTAXIS,c5.BP_ GO biological process
11306,GO_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11307,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
11308,GO_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11309,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_DN,C7_ immunologic signatures
11310,GO_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,c5.BP_ GO biological process
11311,JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN,c2.CGP_ chemical and genetic perturbations
11312,GO_PYRUVATE_METABOLIC_PROCESS,c5.BP_ GO biological process
11313,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS,c5.GO molecular function
11314,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_UP,C7_ immunologic signatures
11315,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP,C7_ immunologic signatures
11316,REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS,c2.CP_REACTOME_ Reactome gene sets
11317,BYSTROEM_CORRELATED_WITH_IL5_UP,c2.CGP_ chemical and genetic perturbations
11318,USF_C,c3.TFT_ transcription factor targets
11319,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
11320,GO_REGULATION_OF_NEUTROPHIL_MIGRATION,c5.BP_ GO biological process
11321,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
11322,REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES,c2.CP_REACTOME_ Reactome gene sets
11323,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN,C7_ immunologic signatures
11324,GO_SNORNA_BINDING,c5.GO molecular function
11325,REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,c2.CP_REACTOME_ Reactome gene sets
11326,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_UP,C7_ immunologic signatures
11327,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP,C7_ immunologic signatures
11328,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_DN,C7_ immunologic signatures
11329,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,C7_ immunologic signatures
11330,GO_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,c5.BP_ GO biological process
11331,GO_U5_SNRNP,c5.CC_ GO cellular component
11332,MORF_DEAF1,c4.CGN_ cancer gene neighborhoods
11333,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN,C7_ immunologic signatures
11334,GO_CILIARY_TIP,c5.CC_ GO cellular component
11335,GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER,c5.BP_ GO biological process
11336,CHRXQ28,69
11337,WINTER_HYPOXIA_UP,c2.CGP_ chemical and genetic perturbations
11338,GO_MRNA_CLEAVAGE_FACTOR_COMPLEX,c5.CC_ GO cellular component
11339,GO_U1_SNRNP,c5.CC_ GO cellular component
11340,KEGG_GLUTATHIONE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
11341,GO_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,c5.BP_ GO biological process
11342,KEGG_PROPANOATE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
11343,GO_RIBONUCLEOPROTEIN_COMPLEX_BINDING,c5.GO molecular function
11344,LEE_METASTASIS_AND_RNA_PROCESSING_UP,c2.CGP_ chemical and genetic perturbations
11345,REACTOME_TRNA_AMINOACYLATION,c2.CP_REACTOME_ Reactome gene sets
11346,GO_VITAMIN_TRANSPORTER_ACTIVITY,c5.GO molecular function
11347,GSE27786_CD4_VS_CD8_TCELL_DN,C7_ immunologic signatures
11348,REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION,c2.CP_REACTOME_ Reactome gene sets
11349,GO_SINGLE_STRANDED_RNA_BINDING,c5.GO molecular function
11350,GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP,C7_ immunologic signatures
11351,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,c2.CGP_ chemical and genetic perturbations
11352,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_DN,C7_ immunologic signatures
11353,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP,c2.CGP_ chemical and genetic perturbations
11354,CHR10Q21,39
11355,KEGG_HUNTINGTONS_DISEASE,c2.CP_BIOCARTA_ BioCarta gene sets
11356,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN,C7_ immunologic signatures
11357,KEGG_PYRIMIDINE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
11358,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,c2.CGP_ chemical and genetic perturbations
11359,GO_SPLICEOSOMAL_TRI_SNRNP_COMPLEX,c5.CC_ GO cellular component
11360,GO_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_,c5.BP_ GO biological process
11361,GSE29618_MONOCYTE_VS_MDC_DN,C7_ immunologic signatures
11362,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_DN,C7_ immunologic signatures
11363,MORF_PHB,c4.CGN_ cancer gene neighborhoods
11364,LEE_CALORIE_RESTRICTION_MUSCLE_UP,c2.CGP_ chemical and genetic perturbations
11365,GO_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,c5.GO molecular function
11366,SMID_BREAST_CANCER_ERBB2_UP,c2.CGP_ chemical and genetic perturbations
11367,GO_ACUTE_PHASE_RESPONSE,c5.BP_ GO biological process
11368,REACTOME_REGULATION_OF_KIT_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
11369,GSE27786_LSK_VS_MONO_MAC_UP,C7_ immunologic signatures
11370,MORF_RAF1,c4.CGN_ cancer gene neighborhoods
11371,GNF2_LYN,c4.CGN_ cancer gene neighborhoods
11372,NRF2_01,c3.TFT_ transcription factor targets
11373,MORF_SP3,c4.CGN_ cancer gene neighborhoods
11374,HILLION_HMGA1_TARGETS,c2.CGP_ chemical and genetic perturbations
11375,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
11376,GO_NEGATIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,c5.BP_ GO biological process
11377,GSE29618_BCELL_VS_MDC_DN,C7_ immunologic signatures
11378,KOBAYASHI_EGFR_SIGNALING_6HR_DN,c2.CGP_ chemical and genetic perturbations
11379,GO_LIGASE_ACTIVITY_FORMING_CARBON_SULFUR_BONDS,c5.GO molecular function
11380,GO_LEUKOTRIENE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11381,GNF2_MSH6,c4.CGN_ cancer gene neighborhoods
11382,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_DN,C7_ immunologic signatures
11383,INGRAM_SHH_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
11384,FARMER_BREAST_CANCER_CLUSTER_3,c2.CGP_ chemical and genetic perturbations
11385,CHR1P13,77
11386,GO_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,c5.BP_ GO biological process
11387,GO_PROTEIN_TRANSPORTER_ACTIVITY,c5.GO molecular function
11388,GO_VENTRICULAR_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
11389,GO_ORGANELLE_ENVELOPE_LUMEN,c5.CC_ GO cellular component
11390,NUTT_GBM_VS_AO_GLIOMA_DN,c2.CGP_ chemical and genetic perturbations
11391,ELVIDGE_HYPOXIA_DN,c2.CGP_ chemical and genetic perturbations
11392,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,C7_ immunologic signatures
11393,GSE22886_NEUTROPHIL_VS_DC_DN,C7_ immunologic signatures
11394,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN,C7_ immunologic signatures
11395,BHATTACHARYA_EMBRYONIC_STEM_CELL,c2.CGP_ chemical and genetic perturbations
11396,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_DN,C7_ immunologic signatures
11397,GSE25087_FETAL_VS_ADULT_TREG_UP,C7_ immunologic signatures
11398,GO_NEGATIVE_REGULATION_OF_RNA_SPLICING,c5.BP_ GO biological process
11399,GO_TRNA_METHYLTRANSFERASE_ACTIVITY,c5.GO molecular function
11400,GNF2_PA2G4,c4.CGN_ cancer gene neighborhoods
11401,GO_MYELOID_LEUKOCYTE_MIGRATION,c5.BP_ GO biological process
11402,KEGG_BUTANOATE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
11403,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN,C7_ immunologic signatures
11404,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,C7_ immunologic signatures
11405,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP,C7_ immunologic signatures
11406,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,C7_ immunologic signatures
11407,GO_RNA_METHYLATION,c5.BP_ GO biological process
11408,GO_GMP_METABOLIC_PROCESS,c5.BP_ GO biological process
11409,GO_NUCLEOSIDE_DIPHOSPHATE_KINASE_ACTIVITY,c5.GO molecular function
11410,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP,C7_ immunologic signatures
11411,GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP,C7_ immunologic signatures
11412,GSE13493_DP_VS_CD8POS_THYMOCYTE_DN,C7_ immunologic signatures
11413,DOANE_BREAST_CANCER_ESR1_DN,c2.CGP_ chemical and genetic perturbations
11414,GO_ENDORIBONUCLEASE_COMPLEX,c5.CC_ GO cellular component
11415,GO_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11416,KRAS.50_UP.V1_UP,C6_ oncogenic signatures
11417,GSE17721_0.5H_VS_24H_CPG_BMDC_UP,C7_ immunologic signatures
11418,NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,c2.CGP_ chemical and genetic perturbations
11419,GO_ORGANIC_HYDROXY_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
11420,CHR11Q12,109
11421,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,c2.CGP_ chemical and genetic perturbations
11422,GNF2_SERPINI2,c4.CGN_ cancer gene neighborhoods
11423,REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,c2.CP_REACTOME_ Reactome gene sets
11424,HOLLERN_PAPILLARY_BREAST_TUMOR,c2.CGP_ chemical and genetic perturbations
11425,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,C7_ immunologic signatures
11426,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_UP,C7_ immunologic signatures
11427,TIAN_TNF_SIGNALING_VIA_NFKB,c2.CGP_ chemical and genetic perturbations
11428,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN,C7_ immunologic signatures
11429,FARMER_BREAST_CANCER_CLUSTER_7,c2.CGP_ chemical and genetic perturbations
11430,REACTOME_POTASSIUM_CHANNELS,c2.CP_REACTOME_ Reactome gene sets
11431,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN,c2.CGP_ chemical and genetic perturbations
11432,RYCACNNRNNRNCAG_UNKNOWN,c3.TFT_ transcription factor targets
11433,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,c2.CGP_ chemical and genetic perturbations
11434,GSE3982_NEUTROPHIL_VS_BCELL_DN,C7_ immunologic signatures
11435,TERAO_AOX4_TARGETS_SKIN_UP,c2.CGP_ chemical and genetic perturbations
11436,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,C7_ immunologic signatures
11437,GO_CLEAVAGE_INVOLVED_IN_RRNA_PROCESSING,c5.BP_ GO biological process
11438,GO_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR,c5.GO molecular function
11439,GSE34515_CD16_NEG_VS_POS_MONOCYTE_DN,C7_ immunologic signatures
11440,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
11441,GO_TRIGLYCERIDE_LIPASE_ACTIVITY,c5.GO molecular function
11442,GO_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH,c5.BP_ GO biological process
11443,MODULE_40,c4.CM_ cancer modules
11444,GO_NUCLEOTIDE_EXCISION_REPAIR_DNA_DUPLEX_UNWINDING,c5.BP_ GO biological process
11445,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN,C7_ immunologic signatures
11446,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,C7_ immunologic signatures
11447,LIN_APC_TARGETS,c2.CGP_ chemical and genetic perturbations
11448,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_UP,C7_ immunologic signatures
11449,NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN,c2.CGP_ chemical and genetic perturbations
11450,REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION,c2.CP_REACTOME_ Reactome gene sets
11451,OSMAN_BLADDER_CANCER_DN,c2.CGP_ chemical and genetic perturbations
11452,GO_CELLULAR_PROTEIN_COMPLEX_DISASSEMBLY,c5.BP_ GO biological process
11453,GO_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS,c5.BP_ GO biological process
11454,GO_REGULATION_OF_RNA_STABILITY,c5.BP_ GO biological process
11455,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP,C7_ immunologic signatures
11456,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_UP,C7_ immunologic signatures
11457,PID_UPA_UPAR_PATHWAY,c2.CP_ Canonical pathways
11458,LIU_NASOPHARYNGEAL_CARCINOMA,c2.CGP_ chemical and genetic perturbations
11459,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_DN,C7_ immunologic signatures
11460,REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S,c2.CP_REACTOME_ Reactome gene sets
11461,GO_POSITIVE_REGULATION_OF_PHAGOCYTOSIS,c5.BP_ GO biological process
11462,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,c2.CGP_ chemical and genetic perturbations
11463,GSE24726_WT_VS_E2_22_KO_PDC_DAY4_POST_DELETION_DN,C7_ immunologic signatures
11464,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_UP,C7_ immunologic signatures
11465,MODULE_154,c4.CM_ cancer modules
11466,GO_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE,c5.CC_ GO cellular component
11467,GO_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
11468,GO_B_CELL_PROLIFERATION,c5.BP_ GO biological process
11469,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_DN,C7_ immunologic signatures
11470,GO_HSP70_PROTEIN_BINDING,c5.GO molecular function
11471,GO_CHAPERONE_MEDIATED_PROTEIN_FOLDING,c5.BP_ GO biological process
11472,MODULE_297,c4.CM_ cancer modules
11473,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_UP,C7_ immunologic signatures
11474,GO_NUCLEOTIDE_EXCISION_REPAIR_DNA_DAMAGE_RECOGNITION,c5.BP_ GO biological process
11475,GO_SNRNA_METABOLIC_PROCESS,c5.BP_ GO biological process
11476,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,C7_ immunologic signatures
11477,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN,C7_ immunologic signatures
11478,GO_AMINO_ACID_ACTIVATION,c5.BP_ GO biological process
11479,MODULE_76,c4.CM_ cancer modules
11480,GO_REGULATION_OF_INTERLEUKIN_17_PRODUCTION,c5.BP_ GO biological process
11481,GO_GLUCOSE_6_PHOSPHATE_METABOLIC_PROCESS,c5.BP_ GO biological process
11482,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,c2.CGP_ chemical and genetic perturbations
11483,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP,C7_ immunologic signatures
11484,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,C7_ immunologic signatures
11485,MODY_HIPPOCAMPUS_POSTNATAL,c2.CGP_ chemical and genetic perturbations
11486,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,C7_ immunologic signatures
11487,GO__DE_NOVO_PROTEIN_FOLDING,c5.BP_ GO biological process
11488,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_DN,C7_ immunologic signatures
11489,REACTOME_RNA_POL_III_TRANSCRIPTION,c2.CP_REACTOME_ Reactome gene sets
11490,MODULE_22,c4.CM_ cancer modules
11491,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN,C7_ immunologic signatures
11492,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP,C7_ immunologic signatures
11493,GO_CELLULAR_IRON_ION_HOMEOSTASIS,c5.BP_ GO biological process
11494,GO_PHOTORECEPTOR_CONNECTING_CILIUM,c5.CC_ GO cellular component
11495,GO_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR,c5.BP_ GO biological process
11496,LINDSTEDT_DENDRITIC_CELL_MATURATION_D,c2.CGP_ chemical and genetic perturbations
11497,REACTOME_ACYL_CHAIN_REMODELLING_OF_PC,c2.CP_REACTOME_ Reactome gene sets
11498,GO_INTRACILIARY_TRANSPORT_PARTICLE,c5.CC_ GO cellular component
11499,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,c2.CGP_ chemical and genetic perturbations
11500,GO_GLYCERALDEHYDE_3_PHOSPHATE_METABOLIC_PROCESS,c5.BP_ GO biological process
11501,SHIN_B_CELL_LYMPHOMA_CLUSTER_9,c2.CGP_ chemical and genetic perturbations
11502,GSE21033_1H_VS_24H_POLYIC_STIM_DC_DN,C7_ immunologic signatures
11503,BROWN_MYELOID_CELL_DEVELOPMENT_DN,c2.CGP_ chemical and genetic perturbations
11504,REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,c2.CP_REACTOME_ Reactome gene sets
11505,HALLMARK_ANDROGEN_RESPONSE,H_ hallmark gene sets
11506,REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,c2.CP_REACTOME_ Reactome gene sets
11507,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
11508,WONG_EMBRYONIC_STEM_CELL_CORE,c2.CGP_ chemical and genetic perturbations
11509,GO_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
11510,REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX,c2.CP_REACTOME_ Reactome gene sets
11511,GSE3982_EOSINOPHIL_VS_MAST_CELL_DN,C7_ immunologic signatures
11512,GO_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11513,GO_ENDOCARDIAL_CUSHION_FORMATION,c5.BP_ GO biological process
11514,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
11515,GO_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR,c5.BP_ GO biological process
11516,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,C7_ immunologic signatures
11517,TOMLINS_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
11518,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,c2.CGP_ chemical and genetic perturbations
11519,GO_PRECATALYTIC_SPLICEOSOME,c5.CC_ GO cellular component
11520,GO_THIOESTER_METABOLIC_PROCESS,c5.BP_ GO biological process
11521,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
11522,GSE22886_IL2_VS_IL15_STIM_NKCELL_DN,C7_ immunologic signatures
11523,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,C7_ immunologic signatures
11524,MODULE_357,c4.CM_ cancer modules
11525,GO_BASAL_TRANSCRIPTION_MACHINERY_BINDING,c5.GO molecular function
11526,GO_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
11527,GO_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY,c5.GO molecular function
11528,WU_CELL_MIGRATION,c2.CGP_ chemical and genetic perturbations
11529,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN,C7_ immunologic signatures
11530,GO_PROTEIN_LOCALIZATION_TO_MEMBRANE,c5.BP_ GO biological process
11531,GO_PROSTANOID_METABOLIC_PROCESS,c5.BP_ GO biological process
11532,GO_RNA_SECONDARY_STRUCTURE_UNWINDING,c5.BP_ GO biological process
11533,GO_MITOCHONDRIAL_TRANSPORT,c5.BP_ GO biological process
11534,CHR10Q23,63
11535,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN,c2.CGP_ chemical and genetic perturbations
11536,GSE6269_FLU_VS_E_COLI_INF_PBMC_DN,C7_ immunologic signatures
11537,GO_IRON_ION_HOMEOSTASIS,c5.BP_ GO biological process
11538,GO_RECEPTOR_CATABOLIC_PROCESS,c5.BP_ GO biological process
11539,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_UP,C7_ immunologic signatures
11540,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_DN,C7_ immunologic signatures
11541,GO_REGULATION_OF_RNA_SPLICING,c5.BP_ GO biological process
11542,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
11543,HALLMARK_FATTY_ACID_METABOLISM,H_ hallmark gene sets
11544,TOMIDA_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
11545,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_UP,C7_ immunologic signatures
11546,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP,C7_ immunologic signatures
11547,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN,C7_ immunologic signatures
11548,MODULE_275,c4.CM_ cancer modules
11549,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,c2.CGP_ chemical and genetic perturbations
11550,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_UP,C7_ immunologic signatures
11551,MODULE_223,c4.CM_ cancer modules
11552,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP,C7_ immunologic signatures
11553,CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,c2.CGP_ chemical and genetic perturbations
11554,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_UP,C7_ immunologic signatures
11555,GO_RNA_3_END_PROCESSING,c5.BP_ GO biological process
11556,GO_WIDE_PORE_CHANNEL_ACTIVITY,c5.GO molecular function
11557,REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING,c2.CP_REACTOME_ Reactome gene sets
11558,BENPORATH_MYC_TARGETS_WITH_EBOX,c2.CGP_ chemical and genetic perturbations
11559,LEE_INTRATHYMIC_T_PROGENITOR,c2.CGP_ chemical and genetic perturbations
11560,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,c2.CGP_ chemical and genetic perturbations
11561,REACTOME_RNA_POL_II_TRANSCRIPTION,c2.CP_REACTOME_ Reactome gene sets
11562,GO_POTASSIUM_CHANNEL_ACTIVITY,c5.GO molecular function
11563,TONG_INTERACT_WITH_PTTG1,c2.CGP_ chemical and genetic perturbations
11564,GO_SMALL_MOLECULE_CATABOLIC_PROCESS,c5.BP_ GO biological process
11565,GO_NEGATIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,c5.BP_ GO biological process
11566,GO_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,c5.BP_ GO biological process
11567,GO_PROTEIN_LOCALIZATION_TO_ORGANELLE,c5.BP_ GO biological process
11568,GO_CELLULAR_KETONE_METABOLIC_PROCESS,c5.BP_ GO biological process
11569,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,c2.CGP_ chemical and genetic perturbations
11570,GO_POLY_PURINE_TRACT_BINDING,c5.GO molecular function
11571,GO_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,c5.BP_ GO biological process
11572,KIM_HYPOXIA,c2.CGP_ chemical and genetic perturbations
11573,KEGG_PURINE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
11574,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_DN,C7_ immunologic signatures
11575,GO_ISOPRENOID_BINDING,c5.GO molecular function
11576,GO_TRANSLATION_INITIATION_FACTOR_BINDING,c5.GO molecular function
11577,GO_MUSCLE_CELL_MIGRATION,c5.BP_ GO biological process
11578,SHIPP_DLBCL_CURED_VS_FATAL_DN,c2.CGP_ chemical and genetic perturbations
11579,LI_WILMS_TUMOR,c2.CGP_ chemical and genetic perturbations
11580,GO_PROTEIN_COMPLEX_LOCALIZATION,c5.BP_ GO biological process
11581,MYC_Q2,c3.TFT_ transcription factor targets
11582,GO_CELL_REDOX_HOMEOSTASIS,c5.BP_ GO biological process
11583,YE_METASTATIC_LIVER_CANCER,c2.CGP_ chemical and genetic perturbations
11584,GO_LEUKOCYTE_MIGRATION,c5.BP_ GO biological process
11585,REACTOME_MEMBRANE_TRAFFICKING,c2.CP_REACTOME_ Reactome gene sets
11586,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN,C7_ immunologic signatures
11587,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN,C7_ immunologic signatures
11588,CHR2P22,34
11589,MODULE_93,c4.CM_ cancer modules
11590,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,H_ hallmark gene sets
11591,GO_LEUKOCYTE_CHEMOTAXIS,c5.BP_ GO biological process
11592,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP,C7_ immunologic signatures
11593,GO_FC_EPSILON_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
11594,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,c2.CGP_ chemical and genetic perturbations
11595,REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE,c2.CP_REACTOME_ Reactome gene sets
11596,GO_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS,c5.BP_ GO biological process
11597,BURTON_ADIPOGENESIS_6,c2.CGP_ chemical and genetic perturbations
11598,FARDIN_HYPOXIA_11,c2.CGP_ chemical and genetic perturbations
11599,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_UP,C7_ immunologic signatures
11600,GO_REGULATION_OF_CLATHRIN_MEDIATED_ENDOCYTOSIS,c5.BP_ GO biological process
11601,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,C7_ immunologic signatures
11602,GO_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
11603,GO_RNA_HELICASE_ACTIVITY,c5.GO molecular function
11604,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN,C7_ immunologic signatures
11605,EIF4E_UP,C6_ oncogenic signatures
11606,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,C7_ immunologic signatures
11607,HOUSTIS_ROS,c2.CGP_ chemical and genetic perturbations
11608,REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21,c2.CP_REACTOME_ Reactome gene sets
11609,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,C7_ immunologic signatures
11610,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_UP,C7_ immunologic signatures
11611,GO_DIGESTIVE_SYSTEM_PROCESS,c5.BP_ GO biological process
11612,GO_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11613,GO_POSITIVE_REGULATION_OF_NEUTROPHIL_MIGRATION,c5.BP_ GO biological process
11614,GO_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
11615,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN,c2.CGP_ chemical and genetic perturbations
11616,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,C7_ immunologic signatures
11617,MORF_PRKDC,c4.CGN_ cancer gene neighborhoods
11618,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,c2.CGP_ chemical and genetic perturbations
11619,GO_POSITIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,c5.BP_ GO biological process
11620,GSE22886_NAIVE_TCELL_VS_NKCELL_UP,C7_ immunologic signatures
11621,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,C7_ immunologic signatures
11622,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN,C7_ immunologic signatures
11623,KIM_ALL_DISORDERS_DURATION_CORR_DN,c2.CGP_ chemical and genetic perturbations
11624,GO_COFACTOR_TRANSPORTER_ACTIVITY,c5.GO molecular function
11625,PRAMOONJAGO_SOX4_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
11626,GO_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,c5.BP_ GO biological process
11627,SWEET_LUNG_CANCER_KRAS_UP,c2.CGP_ chemical and genetic perturbations
11628,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,c2.CGP_ chemical and genetic perturbations
11629,MORF_RAB5A,c4.CGN_ cancer gene neighborhoods
11630,GO_OUTER_MEMBRANE,c5.CC_ GO cellular component
11631,LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS,c2.CGP_ chemical and genetic perturbations
11632,BIOCARTA_EIF_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
11633,GO_RESPONSE_TO_MAGNESIUM_ION,c5.BP_ GO biological process
11634,GSE7852_LN_VS_THYMUS_TCONV_UP,C7_ immunologic signatures
11635,ABRAMSON_INTERACT_WITH_AIRE,c2.CGP_ chemical and genetic perturbations
11636,CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,c2.CGP_ chemical and genetic perturbations
11637,GO_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
11638,REACTOME_UNFOLDED_PROTEIN_RESPONSE,c2.CP_REACTOME_ Reactome gene sets
11639,GSE13411_NAIVE_VS_MEMORY_BCELL_DN,C7_ immunologic signatures
11640,GNF2_HCK,c4.CGN_ cancer gene neighborhoods
11641,MORF_UBE2A,c4.CGN_ cancer gene neighborhoods
11642,GO_UNFOLDED_PROTEIN_BINDING,c5.GO molecular function
11643,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_UP,C7_ immunologic signatures
11644,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,c2.CP_REACTOME_ Reactome gene sets
11645,HALLMARK_CHOLESTEROL_HOMEOSTASIS,H_ hallmark gene sets
11646,DAZARD_UV_RESPONSE_CLUSTER_G1,c2.CGP_ chemical and genetic perturbations
11647,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
11648,NGO_MALIGNANT_GLIOMA_1P_LOH,c2.CGP_ chemical and genetic perturbations
11649,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR,c5.GO molecular function
11650,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
11651,GCM_SMARCC1,c4.CGN_ cancer gene neighborhoods
11652,ELVIDGE_HIF1A_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
11653,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_UP,C7_ immunologic signatures
11654,GSE17721_0.5H_VS_12H_LPS_BMDC_UP,C7_ immunologic signatures
11655,GO_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,c5.BP_ GO biological process
11656,GO_SWI_SNF_SUPERFAMILY_TYPE_COMPLEX,c5.CC_ GO cellular component
11657,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
11658,GO_RNA_METHYLTRANSFERASE_ACTIVITY,c5.GO molecular function
11659,MODULE_299,c4.CM_ cancer modules
11660,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP,C7_ immunologic signatures
11661,GO_GRANULOCYTE_MIGRATION,c5.BP_ GO biological process
11662,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP,C7_ immunologic signatures
11663,GO_TRANSITION_METAL_ION_HOMEOSTASIS,c5.BP_ GO biological process
11664,ABE_VEGFA_TARGETS_30MIN,c2.CGP_ chemical and genetic perturbations
11665,REACTOME_DEADENYLATION_OF_MRNA,c2.CP_REACTOME_ Reactome gene sets
11666,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN,C7_ immunologic signatures
11667,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP,C7_ immunologic signatures
11668,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,C7_ immunologic signatures
11669,DAIRKEE_TERT_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
11670,GO_ALDITOL_METABOLIC_PROCESS,c5.BP_ GO biological process
11671,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,c2.CGP_ chemical and genetic perturbations
11672,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_UP,C7_ immunologic signatures
11673,PID_S1P_S1P1_PATHWAY,c2.CP_ Canonical pathways
11674,SIRNA_EIF4GI_UP,C6_ oncogenic signatures
11675,MODULE_155,c4.CM_ cancer modules
11676,MODULE_307,c4.CM_ cancer modules
11677,KOINUMA_COLON_CANCER_MSI_UP,c2.CGP_ chemical and genetic perturbations
11678,GO_CELLULAR_METABOLIC_COMPOUND_SALVAGE,c5.BP_ GO biological process
11679,GO_T_CELL_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
11680,GO_PHARYNGEAL_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
11681,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN,C7_ immunologic signatures
11682,REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
11683,GO_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE,c5.BP_ GO biological process
11684,CHRXP22,76
11685,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,c2.CGP_ chemical and genetic perturbations
11686,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP,c2.CGP_ chemical and genetic perturbations
11687,GO_GAP_JUNCTION,c5.CC_ GO cellular component
11688,GO_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11689,GO_DNA_DIRECTED_RNA_POLYMERASE_II_HOLOENZYME,c5.CC_ GO cellular component
11690,GO_COFACTOR_BINDING,c5.GO molecular function
11691,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP,C7_ immunologic signatures
11692,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN,C7_ immunologic signatures
11693,NAKAMURA_METASTASIS,c2.CGP_ chemical and genetic perturbations
11694,GO_ALPHA_AMINO_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
11695,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_UP,C7_ immunologic signatures
11696,GO_MACROMOLECULAR_COMPLEX_DISASSEMBLY,c5.BP_ GO biological process
11697,GO_COENZYME_BINDING,c5.GO molecular function
11698,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,C7_ immunologic signatures
11699,PID_TCR_CALCIUM_PATHWAY,c2.CP_ Canonical pathways
11700,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
11701,GO_CELLULAR_RESPONSE_TO_DEXAMETHASONE_STIMULUS,c5.BP_ GO biological process
11702,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_UP,C7_ immunologic signatures
11703,NADLER_OBESITY_DN,c2.CGP_ chemical and genetic perturbations
11704,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,C7_ immunologic signatures
11705,GSE5960_TH1_VS_ANERGIC_TH1_DN,C7_ immunologic signatures
11706,GO_DISRUPTION_OF_CELLS_OF_OTHER_ORGANISM,c5.BP_ GO biological process
11707,OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP,c2.CGP_ chemical and genetic perturbations
11708,GO_ALDEHYDE_DEHYDROGENASE_NAD_ACTIVITY,c5.GO molecular function
11709,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,c2.CGP_ chemical and genetic perturbations
11710,GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP,C7_ immunologic signatures
11711,GO_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS,c5.BP_ GO biological process
11712,MODULE_286,c4.CM_ cancer modules
11713,REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC,c2.CP_REACTOME_ Reactome gene sets
11714,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP,C7_ immunologic signatures
11715,GSE17721_0.5H_VS_12H_CPG_BMDC_UP,C7_ immunologic signatures
11716,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_UP,C7_ immunologic signatures
11717,KAPOSI_LIVER_CANCER_MET_UP,c2.CGP_ chemical and genetic perturbations
11718,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN,C7_ immunologic signatures
11719,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_UP,C7_ immunologic signatures
11720,CHR17Q11,84
11721,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
11722,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,c2.CGP_ chemical and genetic perturbations
11723,GSE4142_NAIVE_VS_GC_BCELL_DN,C7_ immunologic signatures
11724,LEIN_MIDBRAIN_MARKERS,c2.CGP_ chemical and genetic perturbations
11725,GO_REGULATION_OF_PHAGOCYTOSIS,c5.BP_ GO biological process
11726,KIM_WT1_TARGETS_8HR_UP,c2.CGP_ chemical and genetic perturbations
11727,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP,C7_ immunologic signatures
11728,GSE30083_SP1_VS_SP3_THYMOCYTE_UP,C7_ immunologic signatures
11729,KEGG_TYPE_I_DIABETES_MELLITUS,c2.CP_BIOCARTA_ BioCarta gene sets
11730,CHR3Q28,16
11731,GO_LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_TRANSCRIPTION_COACTIVATOR_ACTIVITY,c5.GO molecular function
11732,LANDIS_ERBB2_BREAST_TUMORS_65_UP,c2.CGP_ chemical and genetic perturbations
11733,GERHOLD_ADIPOGENESIS_UP,c2.CGP_ chemical and genetic perturbations
11734,LIN_MELANOMA_COPY_NUMBER_UP,c2.CGP_ chemical and genetic perturbations
11735,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
11736,GO_POSITIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,c5.BP_ GO biological process
11737,GO_STEROL_METABOLIC_PROCESS,c5.BP_ GO biological process
11738,LIU_IL13_MEMORY_MODEL_UP,c2.CGP_ chemical and genetic perturbations
11739,GO_RESPONSE_TO_FOOD,c5.BP_ GO biological process
11740,GO_RETINOIC_ACID_BINDING,c5.GO molecular function
11741,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN,C7_ immunologic signatures
11742,GO_COPI_COATED_VESICLE,c5.CC_ GO cellular component
11743,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN,C7_ immunologic signatures
11744,GSE17721_4H_VS_24H_POLYIC_BMDC_UP,C7_ immunologic signatures
11745,SESTO_RESPONSE_TO_UV_C7,c2.CGP_ chemical and genetic perturbations
11746,AKL_HTLV1_INFECTION_UP,c2.CGP_ chemical and genetic perturbations
11747,GO_ASPARTATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
11748,MIKKELSEN_IPS_ICP_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
11749,GO_RETINOID_X_RECEPTOR_BINDING,c5.GO molecular function
11750,DIRMEIER_LMP1_RESPONSE_EARLY,c2.CGP_ chemical and genetic perturbations
11751,BRACHAT_RESPONSE_TO_METHOTREXATE_DN,c2.CGP_ chemical and genetic perturbations
11752,GNF2_MMP1,c4.CGN_ cancer gene neighborhoods
11753,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP,C7_ immunologic signatures
11754,GO_WATER_SOLUBLE_VITAMIN_METABOLIC_PROCESS,c5.BP_ GO biological process
11755,CRGAARNNNNCGA_UNKNOWN,c3.TFT_ transcription factor targets
11756,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,c2.CGP_ chemical and genetic perturbations
11757,GO_T_HELPER_1_TYPE_IMMUNE_RESPONSE,c5.BP_ GO biological process
11758,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,C7_ immunologic signatures
11759,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_DN,C7_ immunologic signatures
11760,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_DN,C7_ immunologic signatures
11761,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_DN,C7_ immunologic signatures
11762,GO_RESPONSE_TO_INTERLEUKIN_4,c5.BP_ GO biological process
11763,WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,c2.CGP_ chemical and genetic perturbations
11764,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,C7_ immunologic signatures
11765,CHR17Q12,57
11766,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN,C7_ immunologic signatures
11767,GO_DENDRITIC_CELL_MIGRATION,c5.BP_ GO biological process
11768,KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN,c2.CGP_ chemical and genetic perturbations
11769,VALK_AML_CLUSTER_12,c2.CGP_ chemical and genetic perturbations
11770,GO_PURINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11771,YAGI_AML_SURVIVAL,c2.CGP_ chemical and genetic perturbations
11772,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP,C7_ immunologic signatures
11773,MODULE_175,c4.CM_ cancer modules
11774,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP,C7_ immunologic signatures
11775,CAMP_UP.V1_UP,C6_ oncogenic signatures
11776,GO_MLL1_2_COMPLEX,c5.CC_ GO cellular component
11777,WOTTON_RUNX_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
11778,CHOI_ATL_STAGE_PREDICTOR,c2.CGP_ chemical and genetic perturbations
11779,REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,c2.CP_REACTOME_ Reactome gene sets
11780,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS,c5.GO molecular function
11781,GSE17721_12H_VS_24H_LPS_BMDC_DN,C7_ immunologic signatures
11782,GO_POSTTRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION,c5.BP_ GO biological process
11783,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP,C7_ immunologic signatures
11784,GO_CHD_TYPE_COMPLEX,c5.CC_ GO cellular component
11785,FINETTI_BREAST_CANCERS_KINOME_BLUE,c2.CGP_ chemical and genetic perturbations
11786,REACTOME_PI_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
11787,MORF_PTPN11,c4.CGN_ cancer gene neighborhoods
11788,GNF2_PPP6C,c4.CGN_ cancer gene neighborhoods
11789,GO_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,c5.BP_ GO biological process
11790,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
11791,GSE3982_EOSINOPHIL_VS_DC_DN,C7_ immunologic signatures
11792,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_UP,C7_ immunologic signatures
11793,GO_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE,c5.BP_ GO biological process
11794,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_UP,C7_ immunologic signatures
11795,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_DN,C7_ immunologic signatures
11796,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP,C7_ immunologic signatures
11797,REACTOME_SYNTHESIS_OF_PA,c2.CP_REACTOME_ Reactome gene sets
11798,GO_DENDRITE_CYTOPLASM,c5.CC_ GO cellular component
11799,LEF1_Q2,c3.TFT_ transcription factor targets
11800,GO_GAP_JUNCTION_CHANNEL_ACTIVITY,c5.GO molecular function
11801,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_DN,C7_ immunologic signatures
11802,REACTOME_APOPTOSIS,c2.CP_REACTOME_ Reactome gene sets
11803,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,c2.CGP_ chemical and genetic perturbations
11804,HALLMARK_MTORC1_SIGNALING,H_ hallmark gene sets
11805,GO_MYELIN_SHEATH,c5.CC_ GO cellular component
11806,MODULE_245,c4.CM_ cancer modules
11807,MORF_GNB1,c4.CGN_ cancer gene neighborhoods
11808,GO_RESPONSE_TO_TUMOR_NECROSIS_FACTOR,c5.BP_ GO biological process
11809,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,c2.CGP_ chemical and genetic perturbations
11810,TEL2_Q6,c3.TFT_ transcription factor targets
11811,GO_VITAMIN_METABOLIC_PROCESS,c5.BP_ GO biological process
11812,MYCMAX_B,c3.TFT_ transcription factor targets
11813,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_UP,C7_ immunologic signatures
11814,KLEIN_TARGETS_OF_BCR_ABL1_FUSION,c2.CGP_ chemical and genetic perturbations
11815,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_DN,C7_ immunologic signatures
11816,MODULE_522,c4.CM_ cancer modules
11817,GO_PRESPLICEOSOME,c5.CC_ GO cellular component
11818,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN,C7_ immunologic signatures
11819,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_UP,C7_ immunologic signatures
11820,JEPSEN_SMRT_TARGETS,c2.CGP_ chemical and genetic perturbations
11821,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
11822,GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN,C7_ immunologic signatures
11823,GSE3982_EOSINOPHIL_VS_TH1_DN,C7_ immunologic signatures
11824,MORF_RPA2,c4.CGN_ cancer gene neighborhoods
11825,TGASTMAGC_NFE2_01,c3.TFT_ transcription factor targets
11826,LENAOUR_DENDRITIC_CELL_MATURATION_DN,c2.CGP_ chemical and genetic perturbations
11827,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,C7_ immunologic signatures
11828,DANG_REGULATED_BY_MYC_UP,c2.CGP_ chemical and genetic perturbations
11829,GO_OVULATION,c5.BP_ GO biological process
11830,RICKMAN_HEAD_AND_NECK_CANCER_C,c2.CGP_ chemical and genetic perturbations
11831,GSE3982_BCELL_VS_NKCELL_UP,C7_ immunologic signatures
11832,MODULE_484,c4.CM_ cancer modules
11833,GATGKMRGCG_UNKNOWN,c3.TFT_ transcription factor targets
11834,GO_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS,c5.GO molecular function
11835,E2F1_UP.V1_DN,C6_ oncogenic signatures
11836,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
11837,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN,c2.CGP_ chemical and genetic perturbations
11838,GSE339_CD8POS_VS_CD4CD8DN_DC_UP,C7_ immunologic signatures
11839,GSE17721_LPS_VS_POLYIC_24H_BMDC_UP,C7_ immunologic signatures
11840,MODULE_237,c4.CM_ cancer modules
11841,RYTGCNNRGNAAC_MIF1_01,c3.TFT_ transcription factor targets
11842,NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,c2.CGP_ chemical and genetic perturbations
11843,GO_COP9_SIGNALOSOME,c5.CC_ GO cellular component
11844,CHEN_HOXA5_TARGETS_9HR_DN,c2.CGP_ chemical and genetic perturbations
11845,HALLMARK_HEDGEHOG_SIGNALING,H_ hallmark gene sets
11846,MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,c2.CGP_ chemical and genetic perturbations
11847,GO_POSITIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,c5.BP_ GO biological process
11848,GO_MICROBODY_MEMBRANE,c5.CC_ GO cellular component
11849,TIEN_INTESTINE_PROBIOTICS_24HR_DN,c2.CGP_ chemical and genetic perturbations
11850,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,c2.CGP_ chemical and genetic perturbations
11851,GO_MONOCARBOXYLIC_ACID_BINDING,c5.GO molecular function
11852,PID_ECADHERIN_NASCENT_AJ_PATHWAY,c2.CP_ Canonical pathways
11853,WENG_POR_TARGETS_LIVER_UP,c2.CGP_ chemical and genetic perturbations
11854,GO_NEGATIVE_REGULATION_OF_CYTOKINE_SECRETION,c5.BP_ GO biological process
11855,GO_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
11856,GO_REGULATION_OF_ACTIN_NUCLEATION,c5.BP_ GO biological process
11857,GSE3982_DC_VS_NEUTROPHIL_UP,C7_ immunologic signatures
11858,GO_NUCLEOBASE_CONTAINING_COMPOUND_KINASE_ACTIVITY,c5.GO molecular function
11859,REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,c2.CP_REACTOME_ Reactome gene sets
11860,GO_FC_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
11861,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP,C7_ immunologic signatures
11862,GO_DETOXIFICATION,c5.BP_ GO biological process
11863,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,c2.CGP_ chemical and genetic perturbations
11864,GO_CELLULAR_RESPONSE_TO_INTERLEUKIN_4,c5.BP_ GO biological process
11865,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_DN,C7_ immunologic signatures
11866,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,c2.CGP_ chemical and genetic perturbations
11867,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_UP,C7_ immunologic signatures
11868,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,C7_ immunologic signatures
11869,KEGG_ALZHEIMERS_DISEASE,c2.CP_BIOCARTA_ BioCarta gene sets
11870,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN,C7_ immunologic signatures
11871,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN,C7_ immunologic signatures
11872,GO_WATER_TRANSPORT,c5.BP_ GO biological process
11873,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,c2.CGP_ chemical and genetic perturbations
11874,GO_PROTEIN_FOLDING,c5.BP_ GO biological process
11875,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN,C7_ immunologic signatures
11876,BIOCARTA_IL12_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
11877,LEIN_PONS_MARKERS,c2.CGP_ chemical and genetic perturbations
11878,GO_REGULATION_OF_HYDROGEN_PEROXIDE_INDUCED_CELL_DEATH,c5.BP_ GO biological process
11879,NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP,c2.CGP_ chemical and genetic perturbations
11880,GO_SINGLE_ORGANISM_MEMBRANE_BUDDING,c5.BP_ GO biological process
11881,CERVERA_SDHB_TARGETS_1_DN,c2.CGP_ chemical and genetic perturbations
11882,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_DN,C7_ immunologic signatures
11883,LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,c2.CGP_ chemical and genetic perturbations
11884,GNF2_SPINK1,c4.CGN_ cancer gene neighborhoods
11885,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_UP,C7_ immunologic signatures
11886,GO_NCRNA_TRANSCRIPTION,c5.BP_ GO biological process
11887,KEGG_CYSTEINE_AND_METHIONINE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
11888,PID_PTP1B_PATHWAY,c2.CP_ Canonical pathways
11889,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_DN,C7_ immunologic signatures
11890,GO_CELLULAR_AMINO_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
11891,GO_DICARBOXYLIC_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
11892,GSE14308_TH17_VS_INDUCED_TREG_DN,C7_ immunologic signatures
11893,GO_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
11894,MORF_PPP6C,c4.CGN_ cancer gene neighborhoods
11895,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,c2.CGP_ chemical and genetic perturbations
11896,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN,C7_ immunologic signatures
11897,GO_CARBON_CARBON_LYASE_ACTIVITY,c5.GO molecular function
11898,GO_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,c5.BP_ GO biological process
11899,MORF_RAD54L,c4.CGN_ cancer gene neighborhoods
11900,CHRXQ24,24
11901,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
11902,GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,c5.BP_ GO biological process
11903,GO_HYDRO_LYASE_ACTIVITY,c5.GO molecular function
11904,GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN,C7_ immunologic signatures
11905,GO_ACUTE_INFLAMMATORY_RESPONSE,c5.BP_ GO biological process
11906,GNF2_MAPT,c4.CGN_ cancer gene neighborhoods
11907,GO_REGULATION_OF_TISSUE_REMODELING,c5.BP_ GO biological process
11908,GO_PROTEIN_TETRAMERIZATION,c5.BP_ GO biological process
11909,GO_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,c5.BP_ GO biological process
11910,GO_METHIONINE_METABOLIC_PROCESS,c5.BP_ GO biological process
11911,GO_REGULATION_OF_VIRAL_TRANSCRIPTION,c5.BP_ GO biological process
11912,KEGG_LEISHMANIA_INFECTION,c2.CP_BIOCARTA_ BioCarta gene sets
11913,CHR18Q12,31
11914,TSENG_ADIPOGENIC_POTENTIAL_DN,c2.CGP_ chemical and genetic perturbations
11915,GO_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
11916,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN,C7_ immunologic signatures
11917,GO_REGULATION_OF_CELL_AGING,c5.BP_ GO biological process
11918,GARY_CD5_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
11919,GSE3982_DC_VS_NKCELL_UP,C7_ immunologic signatures
11920,GO_NUCLEOBASE_METABOLIC_PROCESS,c5.BP_ GO biological process
11921,GCM_TPR,c4.CGN_ cancer gene neighborhoods
11922,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,c2.CGP_ chemical and genetic perturbations
11923,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_UP,C7_ immunologic signatures
11924,GSE17721_LPS_VS_CPG_1H_BMDC_UP,C7_ immunologic signatures
11925,GO_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,c5.GO molecular function
11926,MELLMAN_TUT1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
11927,GO_INFLAMMATORY_RESPONSE,c5.BP_ GO biological process
11928,GO_ANCHORED_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE,c5.CC_ GO cellular component
11929,GO_ESTROGEN_RECEPTOR_BINDING,c5.GO molecular function
11930,BIOCARTA_WNT_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
11931,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN,C7_ immunologic signatures
11932,MODULE_165,c4.CM_ cancer modules
11933,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
11934,GCM_MSN,c4.CGN_ cancer gene neighborhoods
11935,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN,C7_ immunologic signatures
11936,KRAS.600_UP.V1_UP,C6_ oncogenic signatures
11937,GO_NEUROPEPTIDE_RECEPTOR_ACTIVITY,c5.GO molecular function
11938,GO_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER,c5.BP_ GO biological process
11939,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
11940,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_UP,C7_ immunologic signatures
11941,GO_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION,c5.BP_ GO biological process
11942,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_UP,C7_ immunologic signatures
11943,MORF_SMC1L1,c4.CGN_ cancer gene neighborhoods
11944,GO_LEUKOTRIENE_METABOLIC_PROCESS,c5.BP_ GO biological process
11945,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_DN,C7_ immunologic signatures
11946,GSE17721_0.5H_VS_12H_POLYIC_BMDC_UP,C7_ immunologic signatures
11947,GO_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
11948,GO_CARBOHYDRATE_CATABOLIC_PROCESS,c5.BP_ GO biological process
11949,GO_POSITIVE_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
11950,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN,c2.CGP_ chemical and genetic perturbations
11951,USF2_Q6,c3.TFT_ transcription factor targets
11952,BACH2_01,c3.TFT_ transcription factor targets
11953,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_DN,C7_ immunologic signatures
11954,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,c2.CGP_ chemical and genetic perturbations
11955,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
11956,GSE17721_0.5H_VS_4H_CPG_BMDC_UP,C7_ immunologic signatures
11957,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP,C7_ immunologic signatures
11958,GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_BINDING,c5.GO molecular function
11959,GUO_TARGETS_OF_IRS1_AND_IRS2,c2.CGP_ chemical and genetic perturbations
11960,GO_NADP_BINDING,c5.GO molecular function
11961,GO_NUCLEOID,c5.CC_ GO cellular component
11962,GSE40493_BCL6_KO_VS_WT_TREG_DN,C7_ immunologic signatures
11963,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_DN,C7_ immunologic signatures
11964,KEGG_THYROID_CANCER,c2.CP_BIOCARTA_ BioCarta gene sets
11965,HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP,c2.CGP_ chemical and genetic perturbations
11966,GO_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,c5.BP_ GO biological process
11967,GO_IRON_ION_TRANSPORT,c5.BP_ GO biological process
11968,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_UP,C7_ immunologic signatures
11969,GSE17721_0.5H_VS_8H_POLYIC_BMDC_UP,C7_ immunologic signatures
11970,MORF_PPP2R5E,c4.CGN_ cancer gene neighborhoods
11971,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN,C7_ immunologic signatures
11972,GCM_MYCL1,c4.CGN_ cancer gene neighborhoods
11973,REACTOME_METABOLISM_OF_NON_CODING_RNA,c2.CP_REACTOME_ Reactome gene sets
11974,REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION,c2.CP_REACTOME_ Reactome gene sets
11975,GO_CELLULAR_TRANSITION_METAL_ION_HOMEOSTASIS,c5.BP_ GO biological process
11976,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,c2.CGP_ chemical and genetic perturbations
11977,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP,C7_ immunologic signatures
11978,GO_POSITIVE_REGULATION_OF_INSULIN_SECRETION,c5.BP_ GO biological process
11979,DORN_ADENOVIRUS_INFECTION_12HR_DN,c2.CGP_ chemical and genetic perturbations
11980,GO_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,c5.BP_ GO biological process
11981,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,C7_ immunologic signatures
11982,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,c5.GO molecular function
11983,MODULE_219,c4.CM_ cancer modules
11984,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP,C7_ immunologic signatures
11985,GO_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,c5.GO molecular function
11986,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_DN,C7_ immunologic signatures
11987,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN,C7_ immunologic signatures
11988,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,c2.CGP_ chemical and genetic perturbations
11989,GO_NEGATIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,c5.BP_ GO biological process
11990,GO_FATTY_ACID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
11991,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP,C7_ immunologic signatures
11992,GO_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE,c5.BP_ GO biological process
11993,KEGG_STARCH_AND_SUCROSE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
11994,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,c2.CP_REACTOME_ Reactome gene sets
11995,HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,c2.CGP_ chemical and genetic perturbations
11996,GNF2_CARD15,c4.CGN_ cancer gene neighborhoods
11997,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
11998,MODULE_280,c4.CM_ cancer modules
11999,RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,c2.CGP_ chemical and genetic perturbations
12000,GO_REGULATION_OF_TRANSLATIONAL_ELONGATION,c5.BP_ GO biological process
12001,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_UP,C7_ immunologic signatures
12002,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_DN,C7_ immunologic signatures
12003,KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,c2.CP_BIOCARTA_ BioCarta gene sets
12004,BARRIER_COLON_CANCER_RECURRENCE_UP,c2.CGP_ chemical and genetic perturbations
12005,GSE17721_LPS_VS_POLYIC_6H_BMDC_UP,C7_ immunologic signatures
12006,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_UP,C7_ immunologic signatures
12007,GO_MACROLIDE_BINDING,c5.GO molecular function
12008,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN,C7_ immunologic signatures
12009,GO_TOXIN_TRANSPORT,c5.BP_ GO biological process
12010,REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,c2.CP_REACTOME_ Reactome gene sets
12011,GO_PRIMARY_ALCOHOL_METABOLIC_PROCESS,c5.BP_ GO biological process
12012,MODULE_265,c4.CM_ cancer modules
12013,GSE27434_WT_VS_DNMT1_KO_TREG_UP,C7_ immunologic signatures
12014,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP,C7_ immunologic signatures
12015,KEGG_ALLOGRAFT_REJECTION,c2.CP_BIOCARTA_ BioCarta gene sets
12016,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_DN,C7_ immunologic signatures
12017,GO_CYTOPLASMIC_STRESS_GRANULE,c5.CC_ GO cellular component
12018,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,C7_ immunologic signatures
12019,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,c2.CGP_ chemical and genetic perturbations
12020,GO_COPI_COATED_VESICLE_MEMBRANE,c5.CC_ GO cellular component
12021,GSE25087_TREG_VS_TCONV_ADULT_DN,C7_ immunologic signatures
12022,MORF_MSH2,c4.CGN_ cancer gene neighborhoods
12023,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
12024,GSE3982_MAST_CELL_VS_NEUTROPHIL_UP,C7_ immunologic signatures
12025,GO_PEPTIDE_CATABOLIC_PROCESS,c5.BP_ GO biological process
12026,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_DN,C7_ immunologic signatures
12027,GO_RESPONSE_TO_ZINC_ION,c5.BP_ GO biological process
12028,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,C7_ immunologic signatures
12029,GSE17721_POLYIC_VS_CPG_16H_BMDC_DN,C7_ immunologic signatures
12030,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_UP,C7_ immunologic signatures
12031,NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,c2.CGP_ chemical and genetic perturbations
12032,GSE3982_MAC_VS_BCELL_DN,C7_ immunologic signatures
12033,ZHAN_MULTIPLE_MYELOMA_CD2_DN,c2.CGP_ chemical and genetic perturbations
12034,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_UP,C7_ immunologic signatures
12035,GO_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,c5.BP_ GO biological process
12036,GSE17721_12H_VS_24H_CPG_BMDC_DN,C7_ immunologic signatures
12037,ENK_UV_RESPONSE_EPIDERMIS_UP,c2.CGP_ chemical and genetic perturbations
12038,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,C7_ immunologic signatures
12039,GO_DYNEIN_BINDING,c5.GO molecular function
12040,MODULE_447,c4.CM_ cancer modules
12041,GO_CARBOHYDRATE_PHOSPHORYLATION,c5.BP_ GO biological process
12042,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP,C7_ immunologic signatures
12043,KEGG_HISTIDINE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
12044,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN,C7_ immunologic signatures
12045,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
12046,GO_CARBOHYDRATE_KINASE_ACTIVITY,c5.GO molecular function
12047,GSE17721_CTRL_VS_POLYIC_24H_BMDC_UP,C7_ immunologic signatures
12048,SANSOM_APC_TARGETS_REQUIRE_MYC,c2.CGP_ chemical and genetic perturbations
12049,ZHANG_GATA6_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
12050,MODULE_355,c4.CM_ cancer modules
12051,GO_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
12052,GSE27896_HDAC6_KO_VS_WT_TREG_DN,C7_ immunologic signatures
12053,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS,c2.CGP_ chemical and genetic perturbations
12054,GNF2_RAB3A,c4.CGN_ cancer gene neighborhoods
12055,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
12056,IL15_UP.V1_UP,C6_ oncogenic signatures
12057,REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE,c2.CP_REACTOME_ Reactome gene sets
12058,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,c2.CGP_ chemical and genetic perturbations
12059,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,c2.CGP_ chemical and genetic perturbations
12060,PID_RAC1_PATHWAY,c2.CP_ Canonical pathways
12061,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN,C7_ immunologic signatures
12062,JIANG_HYPOXIA_VIA_VHL,c2.CGP_ chemical and genetic perturbations
12063,GO_UDP_GALACTOSYLTRANSFERASE_ACTIVITY,c5.GO molecular function
12064,REACTOME_PROTEIN_FOLDING,c2.CP_REACTOME_ Reactome gene sets
12065,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_DN,C7_ immunologic signatures
12066,GO_BETA_CATENIN_TCF_COMPLEX_ASSEMBLY,c5.BP_ GO biological process
12067,KAAB_FAILED_HEART_VENTRICLE_DN,c2.CGP_ chemical and genetic perturbations
12068,GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_BINDING,c5.GO molecular function
12069,GSE14415_ACT_VS_CTRL_NATURAL_TREG_DN,C7_ immunologic signatures
12070,GO_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,c5.BP_ GO biological process
12071,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
12072,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_DN,C7_ immunologic signatures
12073,BOUDOUKHA_BOUND_BY_IGF2BP2,c2.CGP_ chemical and genetic perturbations
12074,DEN_INTERACT_WITH_LCA5,c2.CGP_ chemical and genetic perturbations
12075,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN,c2.CGP_ chemical and genetic perturbations
12076,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,c2.CGP_ chemical and genetic perturbations
12077,KIM_TIAL1_TARGETS,c2.CGP_ chemical and genetic perturbations
12078,GO_CYTOPLASMIC_SEQUESTERING_OF_PROTEIN,c5.BP_ GO biological process
12079,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,c2.CGP_ chemical and genetic perturbations
12080,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_DN,C7_ immunologic signatures
12081,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS,c5.GO molecular function
12082,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN,C7_ immunologic signatures
12083,GO_ALPHA_AMINO_ACID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12084,GO_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,c5.BP_ GO biological process
12085,GO_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_OUTER_MEMBRANE,c5.CC_ GO cellular component
12086,GSE40273_EOS_KO_VS_WT_TREG_UP,C7_ immunologic signatures
12087,BIOCARTA_TH1TH2_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
12088,MODULE_87,c4.CM_ cancer modules
12089,GO_RNA_POLYMERASE_II_TRANSCRIPTION_COFACTOR_ACTIVITY,c5.GO molecular function
12090,GO_DECIDUALIZATION,c5.BP_ GO biological process
12091,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_DN,C7_ immunologic signatures
12092,BECKER_TAMOXIFEN_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
12093,GCM_CDH5,c4.CGN_ cancer gene neighborhoods
12094,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN,C7_ immunologic signatures
12095,GSE17721_LPS_VS_POLYIC_12H_BMDC_UP,C7_ immunologic signatures
12096,GO_MONOSACCHARIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
12097,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
12098,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,C7_ immunologic signatures
12099,GSE43955_1H_VS_42H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
12100,MA_MYELOID_DIFFERENTIATION_DN,c2.CGP_ chemical and genetic perturbations
12101,GO_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
12102,DORN_ADENOVIRUS_INFECTION_32HR_DN,c2.CGP_ chemical and genetic perturbations
12103,GO_NEGATIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS,c5.BP_ GO biological process
12104,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN,C7_ immunologic signatures
12105,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,c2.CGP_ chemical and genetic perturbations
12106,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_UP,C7_ immunologic signatures
12107,GO_LAMELLIPODIUM_MEMBRANE,c5.CC_ GO cellular component
12108,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
12109,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_UP,C7_ immunologic signatures
12110,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_UP,C7_ immunologic signatures
12111,GO_CALCIUM_DEPENDENT_PROTEIN_BINDING,c5.GO molecular function
12112,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,C7_ immunologic signatures
12113,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_DN,C7_ immunologic signatures
12114,GSE22886_NAIVE_CD8_TCELL_VS_DC_DN,C7_ immunologic signatures
12115,ZHENG_RESPONSE_TO_ARSENITE_DN,c2.CGP_ chemical and genetic perturbations
12116,AP1_01,c3.TFT_ transcription factor targets
12117,DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS,c2.CGP_ chemical and genetic perturbations
12118,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,c2.CGP_ chemical and genetic perturbations
12119,GSE27786_CD8_TCELL_VS_NKCELL_UP,C7_ immunologic signatures
12120,SINGH_KRAS_DEPENDENCY_SIGNATURE_,C6_ oncogenic signatures
12121,GO_COFACTOR_TRANSPORT,c5.BP_ GO biological process
12122,GNF2_ICAM3,c4.CGN_ cancer gene neighborhoods
12123,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP,C7_ immunologic signatures
12124,REACTOME_SIGNAL_TRANSDUCTION_BY_L1,c2.CP_REACTOME_ Reactome gene sets
12125,MODULE_363,c4.CM_ cancer modules
12126,KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,c2.CP_BIOCARTA_ BioCarta gene sets
12127,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_DN,C7_ immunologic signatures
12128,SIG_CHEMOTAXIS,c2.CP_ Canonical pathways
12129,GO_FATTY_ACID_TRANSPORT,c5.BP_ GO biological process
12130,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,c2.CGP_ chemical and genetic perturbations
12131,GO_OLIGOSACCHARIDE_LIPID_INTERMEDIATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12132,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_UP,C7_ immunologic signatures
12133,GO_SPINAL_CORD_PATTERNING,c5.BP_ GO biological process
12134,GO_RESPONSE_TO_ATP,c5.BP_ GO biological process
12135,REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,c2.CP_REACTOME_ Reactome gene sets
12136,CHEN_LUNG_CANCER_SURVIVAL,c2.CGP_ chemical and genetic perturbations
12137,MATTIOLI_MGUS_VS_PCL,c2.CGP_ chemical and genetic perturbations
12138,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_DN,C7_ immunologic signatures
12139,GO_ALCOHOL_CATABOLIC_PROCESS,c5.BP_ GO biological process
12140,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_DN,C7_ immunologic signatures
12141,GSE360_DC_VS_MAC_L_DONOVANI_DN,C7_ immunologic signatures
12142,GO_B_CELL_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
12143,PID_MYC_PATHWAY,c2.CP_ Canonical pathways
12144,GO_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,c5.BP_ GO biological process
12145,GO_SIALYLATION,c5.BP_ GO biological process
12146,GNF2_TAL1,c4.CGN_ cancer gene neighborhoods
12147,GO_MRNA_CIS_SPLICING_VIA_SPLICEOSOME,c5.BP_ GO biological process
12148,LEF1_UP.V1_UP,C6_ oncogenic signatures
12149,GO_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS,c5.GO molecular function
12150,GO_ORGANIC_ACID_BINDING,c5.GO molecular function
12151,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN,C7_ immunologic signatures
12152,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_DN,C7_ immunologic signatures
12153,GSE360_L_MAJOR_VS_T_GONDII_MAC_DN,C7_ immunologic signatures
12154,GO_FATTY_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
12155,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,c2.CGP_ chemical and genetic perturbations
12156,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,c2.CGP_ chemical and genetic perturbations
12157,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,c2.CGP_ chemical and genetic perturbations
12158,CHR8Q12,25
12159,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,c2.CGP_ chemical and genetic perturbations
12160,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN,C7_ immunologic signatures
12161,GO_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,c5.BP_ GO biological process
12162,GO_U2_TYPE_PRESPLICEOSOME,c5.CC_ GO cellular component
12163,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP,C7_ immunologic signatures
12164,GO_CELLULAR_EXTRAVASATION,c5.BP_ GO biological process
12165,REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
12166,GNF2_CDC27,c4.CGN_ cancer gene neighborhoods
12167,GO_GLYOXYLATE_METABOLIC_PROCESS,c5.BP_ GO biological process
12168,ESC_V6.5_UP_LATE.V1_DN,C6_ oncogenic signatures
12169,GO_PYRIMIDINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12170,REACTOME_TRANSCRIPTION,c2.CP_REACTOME_ Reactome gene sets
12171,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP,C7_ immunologic signatures
12172,GO_REGULATION_OF_CGMP_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12173,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,c2.CGP_ chemical and genetic perturbations
12174,CSR_EARLY_UP.V1_UP,C6_ oncogenic signatures
12175,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP,C7_ immunologic signatures
12176,GO_POSITIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,c5.BP_ GO biological process
12177,GO_GANGLIOSIDE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12178,GO_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
12179,LIU_SOX4_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
12180,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP,C7_ immunologic signatures
12181,MUELLER_METHYLATED_IN_GLIOBLASTOMA,c2.CGP_ chemical and genetic perturbations
12182,GSE39864_WT_VS_GATA3_KO_TREG_DN,C7_ immunologic signatures
12183,GO_REGULATION_OF_LIPID_TRANSPORT,c5.BP_ GO biological process
12184,GSE27786_CD8_TCELL_VS_MONO_MAC_UP,C7_ immunologic signatures
12185,CHR19Q13,499
12186,GSE3982_NEUTROPHIL_VS_TH1_DN,C7_ immunologic signatures
12187,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP,C7_ immunologic signatures
12188,REACTOME_GLUTATHIONE_CONJUGATION,c2.CP_REACTOME_ Reactome gene sets
12189,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
12190,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_DN,C7_ immunologic signatures
12191,GO_MEDIATOR_COMPLEX,c5.CC_ GO cellular component
12192,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
12193,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN,C7_ immunologic signatures
12194,BIOCARTA_DC_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
12195,ETS_Q4,c3.TFT_ transcription factor targets
12196,ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN,c2.CGP_ chemical and genetic perturbations
12197,LMO2COM_01,c3.TFT_ transcription factor targets
12198,GAVIN_PDE3B_TARGETS,c2.CGP_ chemical and genetic perturbations
12199,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN,C7_ immunologic signatures
12200,GSE360_DC_VS_MAC_L_DONOVANI_UP,C7_ immunologic signatures
12201,REACTOME_HIV_LIFE_CYCLE,c2.CP_REACTOME_ Reactome gene sets
12202,GO_VOLTAGE_GATED_ION_CHANNEL_ACTIVITY,c5.GO molecular function
12203,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN,C7_ immunologic signatures
12204,GO_CELLULAR_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS,c5.BP_ GO biological process
12205,PID_INTEGRIN5_PATHWAY,c2.CP_ Canonical pathways
12206,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP,C7_ immunologic signatures
12207,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP,C7_ immunologic signatures
12208,ATF6_01,c3.TFT_ transcription factor targets
12209,PIONTEK_PKD1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
12210,WALLACE_PROSTATE_CANCER_UP,c2.CGP_ chemical and genetic perturbations
12211,KEGG_ARACHIDONIC_ACID_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
12212,KYNG_DNA_DAMAGE_UP,c2.CGP_ chemical and genetic perturbations
12213,GO_VESICLE_COATING,c5.BP_ GO biological process
12214,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
12215,ATF1_Q6,c3.TFT_ transcription factor targets
12216,GO_PHOTOTRANSDUCTION,c5.BP_ GO biological process
12217,GO_VITAMIN_BINDING,c5.GO molecular function
12218,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,C7_ immunologic signatures
12219,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP,C7_ immunologic signatures
12220,GO_NEGATIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION,c5.BP_ GO biological process
12221,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN,C7_ immunologic signatures
12222,GO_PRESYNAPTIC_ACTIVE_ZONE,c5.CC_ GO cellular component
12223,CHR21Q22,99
12224,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_UP,C7_ immunologic signatures
12225,GO_PROTEIN_N_LINKED_GLYCOSYLATION,c5.BP_ GO biological process
12226,PID_ARF_3PATHWAY,c2.CP_ Canonical pathways
12227,KEGG_AUTOIMMUNE_THYROID_DISEASE,c2.CP_BIOCARTA_ BioCarta gene sets
12228,GO_OLIGODENDROCYTE_DEVELOPMENT,c5.BP_ GO biological process
12229,GO_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,c5.BP_ GO biological process
12230,GO_PEPTIDYL_ASPARAGINE_MODIFICATION,c5.BP_ GO biological process
12231,UEDA_CENTRAL_CLOCK,c2.CGP_ chemical and genetic perturbations
12232,MORF_TTN,c4.CGN_ cancer gene neighborhoods
12233,GO_GLUTAMINE_METABOLIC_PROCESS,c5.BP_ GO biological process
12234,GO_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,c5.BP_ GO biological process
12235,ABBUD_LIF_SIGNALING_1_UP,c2.CGP_ chemical and genetic perturbations
12236,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,C7_ immunologic signatures
12237,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,C7_ immunologic signatures
12238,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
12239,GO_T_CELL_RECEPTOR_COMPLEX,c5.CC_ GO cellular component
12240,KEGG_DRUG_METABOLISM_CYTOCHROME_P450,c2.CP_BIOCARTA_ BioCarta gene sets
12241,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_DN,C7_ immunologic signatures
12242,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN,C7_ immunologic signatures
12243,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
12244,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,C7_ immunologic signatures
12245,GO_MRNA_3_END_PROCESSING,c5.BP_ GO biological process
12246,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_DN,C7_ immunologic signatures
12247,GO_POSITIVE_REGULATION_OF_HEMOPOIESIS,c5.BP_ GO biological process
12248,ELVIDGE_HYPOXIA_BY_DMOG_DN,c2.CGP_ chemical and genetic perturbations
12249,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
12250,GO_LUMENAL_SIDE_OF_MEMBRANE,c5.CC_ GO cellular component
12251,GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN,C7_ immunologic signatures
12252,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_UP,C7_ immunologic signatures
12253,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
12254,CROMER_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
12255,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_UP,C7_ immunologic signatures
12256,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,C7_ immunologic signatures
12257,KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450,c2.CP_BIOCARTA_ BioCarta gene sets
12258,FERRANDO_TAL1_NEIGHBORS,c2.CGP_ chemical and genetic perturbations
12259,GO_PRIMARY_CILIUM,c5.CC_ GO cellular component
12260,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,c2.CGP_ chemical and genetic perturbations
12261,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP,C7_ immunologic signatures
12262,GO_HETEROPHILIC_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,c5.BP_ GO biological process
12263,GO_MRNA_BINDING,c5.GO molecular function
12264,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,c2.CGP_ chemical and genetic perturbations
12265,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_DN,C7_ immunologic signatures
12266,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN,C7_ immunologic signatures
12267,GSE339_CD4POS_VS_CD8POS_DC_DN,C7_ immunologic signatures
12268,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN,C7_ immunologic signatures
12269,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN,C7_ immunologic signatures
12270,GO_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS,c5.GO molecular function
12271,GO_CARBOXY_LYASE_ACTIVITY,c5.GO molecular function
12272,CHR2Q32,38
12273,KASLER_HDAC7_TARGETS_1_DN,c2.CGP_ chemical and genetic perturbations
12274,GSE17721_12H_VS_24H_POLYIC_BMDC_UP,C7_ immunologic signatures
12275,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP,C7_ immunologic signatures
12276,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP,C7_ immunologic signatures
12277,GSE13306_TREG_VS_TCONV_DN,C7_ immunologic signatures
12278,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN,C7_ immunologic signatures
12279,MANALO_HYPOXIA_DN,c2.CGP_ chemical and genetic perturbations
12280,GO_POSITIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION,c5.BP_ GO biological process
12281,MORI_IMMATURE_B_LYMPHOCYTE_UP,c2.CGP_ chemical and genetic perturbations
12282,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
12283,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,C7_ immunologic signatures
12284,IL2_UP.V1_UP,C6_ oncogenic signatures
12285,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_DN,C7_ immunologic signatures
12286,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN,C7_ immunologic signatures
12287,GCM_BECN1,c4.CGN_ cancer gene neighborhoods
12288,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,C7_ immunologic signatures
12289,BIOCARTA_MEF2D_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
12290,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP,C7_ immunologic signatures
12291,GO_GLYCOSPHINGOLIPID_METABOLIC_PROCESS,c5.BP_ GO biological process
12292,GSE3982_BASOPHIL_VS_TH1_DN,C7_ immunologic signatures
12293,MODY_HIPPOCAMPUS_PRENATAL,c2.CGP_ chemical and genetic perturbations
12294,GO_REGULATION_OF_GLIAL_CELL_PROLIFERATION,c5.BP_ GO biological process
12295,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,C7_ immunologic signatures
12296,GSE45365_NK_CELL_VS_BCELL_UP,C7_ immunologic signatures
12297,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,c2.CGP_ chemical and genetic perturbations
12298,GSE27786_LIN_NEG_VS_MONO_MAC_UP,C7_ immunologic signatures
12299,CHR12Q13,188
12300,PENG_GLUCOSE_DEPRIVATION_UP,c2.CGP_ chemical and genetic perturbations
12301,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,c5.GO molecular function
12302,GO_LYMPHOCYTE_APOPTOTIC_PROCESS,c5.BP_ GO biological process
12303,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
12304,MATTHEWS_AP1_TARGETS,c2.CGP_ chemical and genetic perturbations
12305,GSE3982_NEUTROPHIL_VS_BASOPHIL_DN,C7_ immunologic signatures
12306,DIRMEIER_LMP1_RESPONSE_LATE_DN,c2.CGP_ chemical and genetic perturbations
12307,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN,C7_ immunologic signatures
12308,GENTLES_LEUKEMIC_STEM_CELL_UP,c2.CGP_ chemical and genetic perturbations
12309,LIU_CMYB_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
12310,GO_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,c5.BP_ GO biological process
12311,GO_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,c5.BP_ GO biological process
12312,GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP,C7_ immunologic signatures
12313,GO_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,c5.BP_ GO biological process
12314,ROSS_AML_WITH_MLL_FUSIONS,c2.CGP_ chemical and genetic perturbations
12315,GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN,C7_ immunologic signatures
12316,GO_NONMOTILE_PRIMARY_CILIUM,c5.CC_ GO cellular component
12317,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
12318,LI_INDUCED_T_TO_NATURAL_KILLER_UP,c2.CGP_ chemical and genetic perturbations
12319,GO_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE,c5.BP_ GO biological process
12320,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP,C7_ immunologic signatures
12321,GARY_CD5_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
12322,YAMASHITA_LIVER_CANCER_STEM_CELL_DN,c2.CGP_ chemical and genetic perturbations
12323,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN,C7_ immunologic signatures
12324,GO_SULFUR_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
12325,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN,C7_ immunologic signatures
12326,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_DN,C7_ immunologic signatures
12327,GSE3039_B2_VS_B1_BCELL_DN,C7_ immunologic signatures
12328,ZHAN_MULTIPLE_MYELOMA_MF_UP,c2.CGP_ chemical and genetic perturbations
12329,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN,C7_ immunologic signatures
12330,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,C7_ immunologic signatures
12331,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN,C7_ immunologic signatures
12332,MYCMAX_02,c3.TFT_ transcription factor targets
12333,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
12334,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN,C7_ immunologic signatures
12335,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,c2.CGP_ chemical and genetic perturbations
12336,WOOD_EBV_EBNA1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
12337,GSE27786_BCELL_VS_NEUTROPHIL_UP,C7_ immunologic signatures
12338,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_UP,C7_ immunologic signatures
12339,GO_NUCLEOTIDE_EXCISION_REPAIR_PREINCISION_COMPLEX_ASSEMBLY,c5.BP_ GO biological process
12340,GO_NEGATIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,c5.BP_ GO biological process
12341,GO_LEUKOCYTE_PROLIFERATION,c5.BP_ GO biological process
12342,GO_PYRIMIDINE_RIBONUCLEOTIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
12343,KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,c2.CP_BIOCARTA_ BioCarta gene sets
12344,REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS,c2.CP_REACTOME_ Reactome gene sets
12345,GO_RRNA_TRANSCRIPTION,c5.BP_ GO biological process
12346,GO_REGULATION_OF_ALPHA_AMINO_3_HYDROXY_5_METHYL_4_ISOXAZOLE_PROPIONATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY,c5.BP_ GO biological process
12347,GSE29618_PDC_VS_MDC_DN,C7_ immunologic signatures
12348,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN,C7_ immunologic signatures
12349,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN,C7_ immunologic signatures
12350,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_UP,C7_ immunologic signatures
12351,GSE17721_0.5H_VS_8H_LPS_BMDC_UP,C7_ immunologic signatures
12352,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP,C7_ immunologic signatures
12353,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_DN,C7_ immunologic signatures
12354,GO_HMG_BOX_DOMAIN_BINDING,c5.GO molecular function
12355,ALCALA_APOPTOSIS,c2.CGP_ chemical and genetic perturbations
12356,GO_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12357,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_DN,C7_ immunologic signatures
12358,GO_PYRIMIDINE_RIBONUCLEOSIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
12359,GSE39022_LN_VS_SPLEEN_DC_DN,C7_ immunologic signatures
12360,MORF_PAPSS1,c4.CGN_ cancer gene neighborhoods
12361,REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC,c2.CP_REACTOME_ Reactome gene sets
12362,GO_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,c5.BP_ GO biological process
12363,WOOD_EBV_EBNA1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
12364,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
12365,ZHAN_MULTIPLE_MYELOMA_SUBGROUPS,c2.CGP_ chemical and genetic perturbations
12366,DARWICHE_PAPILLOMA_RISK_LOW_UP,c2.CGP_ chemical and genetic perturbations
12367,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,C7_ immunologic signatures
12368,GSE3982_MAST_CELL_VS_BASOPHIL_UP,C7_ immunologic signatures
12369,GO_REGULATION_OF_BONE_RESORPTION,c5.BP_ GO biological process
12370,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
12371,GO_INTRACILIARY_TRANSPORT_PARTICLE_B,c5.CC_ GO cellular component
12372,GO_REGULATION_OF_INFLAMMATORY_RESPONSE,c5.BP_ GO biological process
12373,MORF_FEN1,c4.CGN_ cancer gene neighborhoods
12374,GO_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
12375,MARZEC_IL2_SIGNALING_UP,c2.CGP_ chemical and genetic perturbations
12376,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
12377,GO_NEUTROPHIL_MEDIATED_IMMUNITY,c5.BP_ GO biological process
12378,NAM_FXYD5_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
12379,SHEPARD_CRUSH_AND_BURN_MUTANT_UP,c2.CGP_ chemical and genetic perturbations
12380,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN,C7_ immunologic signatures
12381,GSE30083_SP1_VS_SP4_THYMOCYTE_UP,C7_ immunologic signatures
12382,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,c2.CGP_ chemical and genetic perturbations
12383,GO_U4_U6_X_U5_TRI_SNRNP_COMPLEX,c5.CC_ GO cellular component
12384,MUELLER_PLURINET,c2.CGP_ chemical and genetic perturbations
12385,GO_NCRNA_3_END_PROCESSING,c5.BP_ GO biological process
12386,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP,C7_ immunologic signatures
12387,GO_O_ACYLTRANSFERASE_ACTIVITY,c5.GO molecular function
12388,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP,C7_ immunologic signatures
12389,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN,C7_ immunologic signatures
12390,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,C7_ immunologic signatures
12391,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,C7_ immunologic signatures
12392,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN,C7_ immunologic signatures
12393,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
12394,NMYC_01,c3.TFT_ transcription factor targets
12395,GO_TRANSFERASE_ACTIVITY_TRANSFERRING_ALKYL_OR_ARYL_OTHER_THAN_METHYL_GROUPS,c5.GO molecular function
12396,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,C7_ immunologic signatures
12397,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,c2.CGP_ chemical and genetic perturbations
12398,GO_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,c5.BP_ GO biological process
12399,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP,C7_ immunologic signatures
12400,PID_IL27_PATHWAY,c2.CP_ Canonical pathways
12401,GO_ORGANIC_ACID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12402,VILIMAS_NOTCH1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
12403,AKT_UP_MTOR_DN.V1_DN,C6_ oncogenic signatures
12404,BILANGES_SERUM_SENSITIVE_GENES,c2.CGP_ chemical and genetic perturbations
12405,CHR22Q11,94
12406,SESTO_RESPONSE_TO_UV_C6,c2.CGP_ chemical and genetic perturbations
12407,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_DN,C7_ immunologic signatures
12408,AP1_C,c3.TFT_ transcription factor targets
12409,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
12410,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,c2.CGP_ chemical and genetic perturbations
12411,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,C7_ immunologic signatures
12412,HALLMARK_IL6_JAK_STAT3_SIGNALING,H_ hallmark gene sets
12413,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,c2.CGP_ chemical and genetic perturbations
12414,KAMIKUBO_MYELOID_CEBPA_NETWORK,c2.CGP_ chemical and genetic perturbations
12415,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_DN,C7_ immunologic signatures
12416,GO_PORE_COMPLEX,c5.CC_ GO cellular component
12417,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN,C7_ immunologic signatures
12418,GSE14000_UNSTIM_VS_16H_LPS_DC_UP,C7_ immunologic signatures
12419,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_DN,C7_ immunologic signatures
12420,HALLMARK_DNA_REPAIR,H_ hallmark gene sets
12421,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
12422,GSE17721_POLYIC_VS_CPG_12H_BMDC_DN,C7_ immunologic signatures
12423,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN,C7_ immunologic signatures
12424,GO_HEAT_SHOCK_PROTEIN_BINDING,c5.GO molecular function
12425,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,C7_ immunologic signatures
12426,WANG_TARGETS_OF_MLL_CBP_FUSION_DN,c2.CGP_ chemical and genetic perturbations
12427,GO_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS,c5.BP_ GO biological process
12428,REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,c2.CP_REACTOME_ Reactome gene sets
12429,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,C7_ immunologic signatures
12430,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP,C7_ immunologic signatures
12431,GO_NEUTRAL_LIPID_METABOLIC_PROCESS,c5.BP_ GO biological process
12432,GO_NUCLEAR_TRANSCRIPTION_FACTOR_COMPLEX,c5.CC_ GO cellular component
12433,GO_NEGATIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,c5.BP_ GO biological process
12434,GSE25087_FETAL_VS_ADULT_TCONV_UP,C7_ immunologic signatures
12435,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,C7_ immunologic signatures
12436,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP,C7_ immunologic signatures
12437,DAZARD_RESPONSE_TO_UV_NHEK_UP,c2.CGP_ chemical and genetic perturbations
12438,LIN_NPAS4_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
12439,GO_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT,c5.BP_ GO biological process
12440,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN,C7_ immunologic signatures
12441,GO_LACTATION,c5.BP_ GO biological process
12442,GO_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
12443,GO_NF_KAPPAB_BINDING,c5.GO molecular function
12444,WILLERT_WNT_SIGNALING,c2.CGP_ chemical and genetic perturbations
12445,PID_FRA_PATHWAY,c2.CP_ Canonical pathways
12446,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,C7_ immunologic signatures
12447,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP,C7_ immunologic signatures
12448,GO_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,c5.BP_ GO biological process
12449,GO_GALACTOSYLTRANSFERASE_ACTIVITY,c5.GO molecular function
12450,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_DN,C7_ immunologic signatures
12451,GO_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,c5.BP_ GO biological process
12452,REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,c2.CP_REACTOME_ Reactome gene sets
12453,GSE12505_WT_VS_E2_2_HET_PDC_DN,C7_ immunologic signatures
12454,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,C7_ immunologic signatures
12455,REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION,c2.CP_REACTOME_ Reactome gene sets
12456,GO_MATERNAL_PLACENTA_DEVELOPMENT,c5.BP_ GO biological process
12457,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP,C7_ immunologic signatures
12458,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
12459,REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_,c2.CP_REACTOME_ Reactome gene sets
12460,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN,C7_ immunologic signatures
12461,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP,C7_ immunologic signatures
12462,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP,C7_ immunologic signatures
12463,ABE_INNER_EAR,c2.CGP_ chemical and genetic perturbations
12464,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN,C7_ immunologic signatures
12465,GSE3982_NEUTROPHIL_VS_TH2_DN,C7_ immunologic signatures
12466,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN,C7_ immunologic signatures
12467,GO_RESPONSE_TO_OXYGEN_RADICAL,c5.BP_ GO biological process
12468,GO_THIOESTER_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12469,GO_RNA_LOCALIZATION,c5.BP_ GO biological process
12470,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,C7_ immunologic signatures
12471,BIOCARTA_ARAP_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
12472,GSE43955_10H_VS_60H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
12473,CAIRO_HEPATOBLASTOMA_UP,c2.CGP_ chemical and genetic perturbations
12474,GO_ORGANIC_HYDROXY_COMPOUND_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12475,GSE27786_CD4_TCELL_VS_MONO_MAC_UP,C7_ immunologic signatures
12476,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_DN,C7_ immunologic signatures
12477,MODULE_417,c4.CM_ cancer modules
12478,NAKAMURA_METASTASIS_MODEL_UP,c2.CGP_ chemical and genetic perturbations
12479,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP,C7_ immunologic signatures
12480,P53_DN.V2_UP,C6_ oncogenic signatures
12481,GSE23695_CD57_POS_VS_NEG_NK_CELL_UP,C7_ immunologic signatures
12482,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN,C7_ immunologic signatures
12483,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,C7_ immunologic signatures
12484,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_DN,C7_ immunologic signatures
12485,GO_SKELETAL_MUSCLE_TISSUE_REGENERATION,c5.BP_ GO biological process
12486,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,C7_ immunologic signatures
12487,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,c2.CGP_ chemical and genetic perturbations
12488,BIOCARTA_SHH_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
12489,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
12490,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,c2.CGP_ chemical and genetic perturbations
12491,MODULE_379,c4.CM_ cancer modules
12492,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_UP,C7_ immunologic signatures
12493,NRF2_Q4,c3.TFT_ transcription factor targets
12494,NIKOLSKY_BREAST_CANCER_16P13_AMPLICON,c2.CGP_ chemical and genetic perturbations
12495,GO_NUCLEOTIDYLTRANSFERASE_ACTIVITY,c5.GO molecular function
12496,LEIN_NEURON_MARKERS,c2.CGP_ chemical and genetic perturbations
12497,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN,C7_ immunologic signatures
12498,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,C7_ immunologic signatures
12499,ZHOU_TNF_SIGNALING_30MIN,c2.CGP_ chemical and genetic perturbations
12500,GSE3982_EOSINOPHIL_VS_NKCELL_DN,C7_ immunologic signatures
12501,GO_MAST_CELL_GRANULE,c5.CC_ GO cellular component
12502,STEIN_ESRRA_TARGETS,c2.CGP_ chemical and genetic perturbations
12503,BIOCARTA_GSK3_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
12504,SINGH_NFE2L2_TARGETS,c2.CGP_ chemical and genetic perturbations
12505,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN,C7_ immunologic signatures
12506,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,c2.CGP_ chemical and genetic perturbations
12507,GO_HYDROGEN_PEROXIDE_CATABOLIC_PROCESS,c5.BP_ GO biological process
12508,MODULE_247,c4.CM_ cancer modules
12509,GNF2_MLH1,c4.CGN_ cancer gene neighborhoods
12510,VANTVEER_BREAST_CANCER_BRCA1_UP,c2.CGP_ chemical and genetic perturbations
12511,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP,C7_ immunologic signatures
12512,GO_REGULATION_OF_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
12513,GSE24726_WT_VS_E2_2_KO_PDC_DAY4_POST_DELETION_UP,C7_ immunologic signatures
12514,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP,C7_ immunologic signatures
12515,BURTON_ADIPOGENESIS_PEAK_AT_16HR,c2.CGP_ chemical and genetic perturbations
12516,AP2ALPHA_01,c3.TFT_ transcription factor targets
12517,GSE3982_MAST_CELL_VS_NKCELL_UP,C7_ immunologic signatures
12518,HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY,H_ hallmark gene sets
12519,SF1_Q6,c3.TFT_ transcription factor targets
12520,GO_MODIFIED_AMINO_ACID_TRANSPORT,c5.BP_ GO biological process
12521,GO_POSITIVE_REGULATION_OF_ACTIN_NUCLEATION,c5.BP_ GO biological process
12522,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,C7_ immunologic signatures
12523,GO_AP_TYPE_MEMBRANE_COAT_ADAPTOR_COMPLEX,c5.CC_ GO cellular component
12524,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_UP,C7_ immunologic signatures
12525,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,c2.CGP_ chemical and genetic perturbations
12526,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,c2.CP_BIOCARTA_ BioCarta gene sets
12527,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP,c2.CGP_ chemical and genetic perturbations
12528,GO_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX,c5.CC_ GO cellular component
12529,HALLMARK_GLYCOLYSIS,H_ hallmark gene sets
12530,GO_ZINC_ION_HOMEOSTASIS,c5.BP_ GO biological process
12531,CHR2Q14,27
12532,GO_SINGLE_FERTILIZATION,c5.BP_ GO biological process
12533,MYCMAX_01,c3.TFT_ transcription factor targets
12534,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,c2.CGP_ chemical and genetic perturbations
12535,ST_FAS_SIGNALING_PATHWAY,c2.CP_ Canonical pathways
12536,GO_LYASE_ACTIVITY,c5.GO molecular function
12537,GO_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS,c5.BP_ GO biological process
12538,GCGCTTT_MIR518B_MIR518C_MIR518D,c3.MIR_ microRNA targets
12539,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN,C7_ immunologic signatures
12540,GO_BASAL_PLASMA_MEMBRANE,c5.CC_ GO cellular component
12541,GO_EPITHELIAL_STRUCTURE_MAINTENANCE,c5.BP_ GO biological process
12542,HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC,c2.CGP_ chemical and genetic perturbations
12543,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
12544,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
12545,GSE20715_0H_VS_6H_OZONE_LUNG_UP,C7_ immunologic signatures
12546,ENGELMANN_CANCER_PROGENITORS_UP,c2.CGP_ chemical and genetic perturbations
12547,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,C7_ immunologic signatures
12548,GO_GANGLIOSIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
12549,TCF11MAFG_01,c3.TFT_ transcription factor targets
12550,CHESLER_BRAIN_QTL_CIS,c2.CGP_ chemical and genetic perturbations
12551,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_DN,C7_ immunologic signatures
12552,GO_RESPONSE_TO_NERVE_GROWTH_FACTOR,c5.BP_ GO biological process
12553,SEIDEN_MET_SIGNALING,c2.CGP_ chemical and genetic perturbations
12554,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,c2.CGP_ chemical and genetic perturbations
12555,GO_REGULATION_OF_CELLULAR_SENESCENCE,c5.BP_ GO biological process
12556,GO_RETINOIC_ACID_RECEPTOR_BINDING,c5.GO molecular function
12557,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_DN,C7_ immunologic signatures
12558,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,c2.CGP_ chemical and genetic perturbations
12559,GO_POTASSIUM_ION_TRANSPORT,c5.BP_ GO biological process
12560,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,C7_ immunologic signatures
12561,GO_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,c5.BP_ GO biological process
12562,E2F3_UP.V1_DN,C6_ oncogenic signatures
12563,GO_FLAVIN_ADENINE_DINUCLEOTIDE_BINDING,c5.GO molecular function
12564,CHR9P24,30
12565,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,c2.CGP_ chemical and genetic perturbations
12566,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_DN,C7_ immunologic signatures
12567,CHRXQ25,17
12568,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,C7_ immunologic signatures
12569,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,c2.CGP_ chemical and genetic perturbations
12570,MODULE_229,c4.CM_ cancer modules
12571,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN,C7_ immunologic signatures
12572,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
12573,GO_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,c5.BP_ GO biological process
12574,GO_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,c5.BP_ GO biological process
12575,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,C7_ immunologic signatures
12576,USF_Q6_01,c3.TFT_ transcription factor targets
12577,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN,C7_ immunologic signatures
12578,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,C7_ immunologic signatures
12579,GO_TRIVALENT_INORGANIC_CATION_TRANSPORT,c5.BP_ GO biological process
12580,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,C7_ immunologic signatures
12581,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,c2.CGP_ chemical and genetic perturbations
12582,GO_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,c5.BP_ GO biological process
12583,GO_ALCOHOL_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12584,GO_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12585,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN,C7_ immunologic signatures
12586,TIAN_TNF_SIGNALING_NOT_VIA_NFKB,c2.CGP_ chemical and genetic perturbations
12587,NERF_Q2,c3.TFT_ transcription factor targets
12588,GSE17721_0.5H_VS_4H_LPS_BMDC_UP,C7_ immunologic signatures
12589,GO_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
12590,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP,C7_ immunologic signatures
12591,RAMALHO_STEMNESS_UP,c2.CGP_ chemical and genetic perturbations
12592,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
12593,GNF2_SMC1L1,c4.CGN_ cancer gene neighborhoods
12594,GSE3982_EOSINOPHIL_VS_BCELL_DN,C7_ immunologic signatures
12595,LANG_MYB_FAMILY_TARGETS,c2.CGP_ chemical and genetic perturbations
12596,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN,C7_ immunologic signatures
12597,REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION,c2.CP_REACTOME_ Reactome gene sets
12598,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_DN,C7_ immunologic signatures
12599,CAIRO_LIVER_DEVELOPMENT_DN,c2.CGP_ chemical and genetic perturbations
12600,GO_INTESTINAL_ABSORPTION,c5.BP_ GO biological process
12601,REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY,c2.CP_REACTOME_ Reactome gene sets
12602,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
12603,GSE20715_WT_VS_TLR4_KO_LUNG_DN,C7_ immunologic signatures
12604,GO_PIGMENT_METABOLIC_PROCESS,c5.BP_ GO biological process
12605,PODAR_RESPONSE_TO_ADAPHOSTIN_DN,c2.CGP_ chemical and genetic perturbations
12606,GCM_AIP,c4.CGN_ cancer gene neighborhoods
12607,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
12608,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN,C7_ immunologic signatures
12609,REACTOME_ACYL_CHAIN_REMODELLING_OF_PE,c2.CP_REACTOME_ Reactome gene sets
12610,GO_2_IRON_2_SULFUR_CLUSTER_BINDING,c5.GO molecular function
12611,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
12612,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_UP,C7_ immunologic signatures
12613,GOLDRATH_HOMEOSTATIC_PROLIFERATION,c2.CGP_ chemical and genetic perturbations
12614,GO_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER,c5.BP_ GO biological process
12615,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,C7_ immunologic signatures
12616,GSE3982_MAST_CELL_VS_BCELL_DN,C7_ immunologic signatures
12617,GO_CELLULAR_MODIFIED_AMINO_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
12618,MODULE_133,c4.CM_ cancer modules
12619,GO_POSITIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,c5.BP_ GO biological process
12620,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,C7_ immunologic signatures
12621,GO_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,c5.BP_ GO biological process
12622,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_DN,C7_ immunologic signatures
12623,CHR18Q22,16
12624,GO_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12625,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,c2.CGP_ chemical and genetic perturbations
12626,GSE3982_MAST_CELL_VS_MAC_UP,C7_ immunologic signatures
12627,GO_NUCLEAR_OUTER_MEMBRANE,c5.CC_ GO cellular component
12628,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN,C7_ immunologic signatures
12629,CHRXQ13,48
12630,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN,C7_ immunologic signatures
12631,STEIN_ESRRA_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
12632,GO_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12633,KIM_ALL_DISORDERS_CALB1_CORR_UP,c2.CGP_ chemical and genetic perturbations
12634,NFE2_01,c3.TFT_ transcription factor targets
12635,GO_PRE_MRNA_BINDING,c5.GO molecular function
12636,MODULE_139,c4.CM_ cancer modules
12637,GSE3982_MAST_CELL_VS_TH1_UP,C7_ immunologic signatures
12638,GO_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME,c5.BP_ GO biological process
12639,GSE17721_CTRL_VS_CPG_8H_BMDC_UP,C7_ immunologic signatures
12640,MODULE_300,c4.CM_ cancer modules
12641,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS,c5.GO molecular function
12642,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,C7_ immunologic signatures
12643,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_DN,C7_ immunologic signatures
12644,KAAB_FAILED_HEART_ATRIUM_DN,c2.CGP_ chemical and genetic perturbations
12645,ALONSO_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
12646,ETS1_B,c3.TFT_ transcription factor targets
12647,GO_POSITIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
12648,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,c2.CP_REACTOME_ Reactome gene sets
12649,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_DN,C7_ immunologic signatures
12650,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
12651,GO_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,c5.BP_ GO biological process
12652,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,C7_ immunologic signatures
12653,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,c2.CGP_ chemical and genetic perturbations
12654,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,c2.CGP_ chemical and genetic perturbations
12655,KIM_LIVER_CANCER_POOR_SURVIVAL_UP,c2.CGP_ chemical and genetic perturbations
12656,GO_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,c5.BP_ GO biological process
12657,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
12658,GO_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION,c5.BP_ GO biological process
12659,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,C7_ immunologic signatures
12660,GO_AMINOPEPTIDASE_ACTIVITY,c5.GO molecular function
12661,ST_ADRENERGIC,c2.CP_ Canonical pathways
12662,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP,C7_ immunologic signatures
12663,KEEN_RESPONSE_TO_ROSIGLITAZONE_UP,c2.CGP_ chemical and genetic perturbations
12664,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
12665,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_UP,C7_ immunologic signatures
12666,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_UP,C7_ immunologic signatures
12667,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
12668,GO_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS,c5.BP_ GO biological process
12669,GO_REGULATION_OF_DNA_BINDING,c5.BP_ GO biological process
12670,GO_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR,c5.BP_ GO biological process
12671,BILANGES_RAPAMYCIN_SENSITIVE_GENES,c2.CGP_ chemical and genetic perturbations
12672,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,c2.CGP_ chemical and genetic perturbations
12673,AML_Q6,c3.TFT_ transcription factor targets
12674,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP,C7_ immunologic signatures
12675,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,c2.CGP_ chemical and genetic perturbations
12676,GSE27786_BCELL_VS_ERYTHROBLAST_UP,C7_ immunologic signatures
12677,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
12678,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP,C7_ immunologic signatures
12679,WANG_TNF_TARGETS,c2.CGP_ chemical and genetic perturbations
12680,GO_RNA_POLYADENYLATION,c5.BP_ GO biological process
12681,GO_INTRINSIC_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE,c5.CC_ GO cellular component
12682,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,c2.CGP_ chemical and genetic perturbations
12683,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,C7_ immunologic signatures
12684,ZIC1_01,c3.TFT_ transcription factor targets
12685,GO_REGULATION_OF_RECEPTOR_INTERNALIZATION,c5.BP_ GO biological process
12686,GO_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,c5.BP_ GO biological process
12687,GO_MATERNAL_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY,c5.BP_ GO biological process
12688,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_UP,C7_ immunologic signatures
12689,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,C7_ immunologic signatures
12690,GO_PROSTANOID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12691,GO_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,c5.BP_ GO biological process
12692,GO_REGULATION_OF_BONE_REMODELING,c5.BP_ GO biological process
12693,GNF2_MBD4,c4.CGN_ cancer gene neighborhoods
12694,HALLMARK_ALLOGRAFT_REJECTION,H_ hallmark gene sets
12695,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17,c2.CGP_ chemical and genetic perturbations
12696,GO_RIBONUCLEOPROTEIN_GRANULE,c5.CC_ GO cellular component
12697,GO_POSITIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS,c5.BP_ GO biological process
12698,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN,C7_ immunologic signatures
12699,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP,C7_ immunologic signatures
12700,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_DN,C7_ immunologic signatures
12701,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN,C7_ immunologic signatures
12702,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP,C7_ immunologic signatures
12703,GNF2_BNIP3L,c4.CGN_ cancer gene neighborhoods
12704,REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
12705,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,C7_ immunologic signatures
12706,PID_RET_PATHWAY,c2.CP_ Canonical pathways
12707,GO_TRANSFERASE_COMPLEX_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS,c5.CC_ GO cellular component
12708,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,c2.CGP_ chemical and genetic perturbations
12709,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,C7_ immunologic signatures
12710,GNATENKO_PLATELET_SIGNATURE,c2.CGP_ chemical and genetic perturbations
12711,YANG_BREAST_CANCER_ESR1_LASER_UP,c2.CGP_ chemical and genetic perturbations
12712,GO_POSITIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,c5.BP_ GO biological process
12713,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,C7_ immunologic signatures
12714,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,C7_ immunologic signatures
12715,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP,c2.CGP_ chemical and genetic perturbations
12716,GO_NUCLEAR_ENVELOPE_REASSEMBLY,c5.BP_ GO biological process
12717,DELACROIX_RARG_BOUND_MEF,c2.CGP_ chemical and genetic perturbations
12718,GO_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,c5.BP_ GO biological process
12719,GO_POSITIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,c5.BP_ GO biological process
12720,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,c2.CGP_ chemical and genetic perturbations
12721,VERRECCHIA_RESPONSE_TO_TGFB1_C5,c2.CGP_ chemical and genetic perturbations
12722,GO_ALKALI_METAL_ION_BINDING,c5.GO molecular function
12723,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,c2.CGP_ chemical and genetic perturbations
12724,GO_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12725,GSE42724_B1_BCELL_VS_PLASMABLAST_UP,C7_ immunologic signatures
12726,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,c2.CGP_ chemical and genetic perturbations
12727,CHRXQ22,61
12728,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,C7_ immunologic signatures
12729,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP,C7_ immunologic signatures
12730,GO_REGULATION_OF_STEROID_METABOLIC_PROCESS,c5.BP_ GO biological process
12731,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,c2.CGP_ chemical and genetic perturbations
12732,GO_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,c5.BP_ GO biological process
12733,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,c2.CGP_ chemical and genetic perturbations
12734,GO_LEUKOCYTE_APOPTOTIC_PROCESS,c5.BP_ GO biological process
12735,AP1_Q6,c3.TFT_ transcription factor targets
12736,GO_POSITIVE_REGULATION_OF_PEPTIDE_SECRETION,c5.BP_ GO biological process
12737,GO_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,c5.BP_ GO biological process
12738,GSE22886_NAIVE_CD8_TCELL_VS_DC_UP,C7_ immunologic signatures
12739,GO_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING,c5.BP_ GO biological process
12740,GO_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12741,MODULE_322,c4.CM_ cancer modules
12742,GO_DEAMINASE_ACTIVITY,c5.GO molecular function
12743,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP,C7_ immunologic signatures
12744,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_UP,C7_ immunologic signatures
12745,MODULE_209,c4.CM_ cancer modules
12746,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN,C7_ immunologic signatures
12747,BHAT_ESR1_TARGETS_VIA_AKT1_UP,c2.CGP_ chemical and genetic perturbations
12748,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP,C7_ immunologic signatures
12749,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
12750,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN,C7_ immunologic signatures
12751,GO_NUCLEOTIDE_KINASE_ACTIVITY,c5.GO molecular function
12752,GSE29618_BCELL_VS_MONOCYTE_DN,C7_ immunologic signatures
12753,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,C7_ immunologic signatures
12754,GO_FATTY_ACYL_COA_METABOLIC_PROCESS,c5.BP_ GO biological process
12755,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_DN,C7_ immunologic signatures
12756,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN,C7_ immunologic signatures
12757,GO_RIBONUCLEOPROTEIN_COMPLEX_LOCALIZATION,c5.BP_ GO biological process
12758,KEGG_SELENOAMINO_ACID_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
12759,GO_NUCLEAR_EXPORT,c5.BP_ GO biological process
12760,MORF_RAB11A,c4.CGN_ cancer gene neighborhoods
12761,GSE30083_SP1_VS_SP2_THYMOCYTE_UP,C7_ immunologic signatures
12762,JAZAG_TGFB1_SIGNALING_UP,c2.CGP_ chemical and genetic perturbations
12763,MODULE_180,c4.CM_ cancer modules
12764,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_DN,C7_ immunologic signatures
12765,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP,C7_ immunologic signatures
12766,SP1_01,c3.TFT_ transcription factor targets
12767,GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP,C7_ immunologic signatures
12768,GSE2826_WT_VS_XID_BCELL_DN,C7_ immunologic signatures
12769,QI_HYPOXIA,c2.CGP_ chemical and genetic perturbations
12770,AP1_Q2,c3.TFT_ transcription factor targets
12771,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5,c2.CGP_ chemical and genetic perturbations
12772,MODULE_104,c4.CM_ cancer modules
12773,GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP,C7_ immunologic signatures
12774,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN,C7_ immunologic signatures
12775,GO_NUCLEAR_TRANSPORT,c5.BP_ GO biological process
12776,GSE18893_TCONV_VS_TREG_24H_CULTURE_UP,C7_ immunologic signatures
12777,ANDERSEN_LIVER_CANCER_KRT19_DN,c2.CGP_ chemical and genetic perturbations
12778,GO_N_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION,c5.BP_ GO biological process
12779,GSE17721_POLYIC_VS_CPG_4H_BMDC_DN,C7_ immunologic signatures
12780,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,c2.CGP_ chemical and genetic perturbations
12781,MODULE_181,c4.CM_ cancer modules
12782,GO_POTASSIUM_CHANNEL_COMPLEX,c5.CC_ GO cellular component
12783,GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,c5.BP_ GO biological process
12784,GO_PHOTORECEPTOR_OUTER_SEGMENT_MEMBRANE,c5.CC_ GO cellular component
12785,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP,C7_ immunologic signatures
12786,JIANG_AGING_HYPOTHALAMUS_UP,c2.CGP_ chemical and genetic perturbations
12787,HU_ANGIOGENESIS_DN,c2.CGP_ chemical and genetic perturbations
12788,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
12789,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP,C7_ immunologic signatures
12790,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN,C7_ immunologic signatures
12791,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,C7_ immunologic signatures
12792,HOLLERN_EMT_BREAST_TUMOR_UP,c2.CGP_ chemical and genetic perturbations
12793,CHOW_RASSF1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
12794,GO_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN,c5.BP_ GO biological process
12795,GSE4142_PLASMA_CELL_VS_GC_BCELL_DN,C7_ immunologic signatures
12796,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,C7_ immunologic signatures
12797,GO_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12798,RIZKI_TUMOR_INVASIVENESS_2D_UP,c2.CGP_ chemical and genetic perturbations
12799,GO_NUCLEOSOMAL_DNA_BINDING,c5.GO molecular function
12800,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_DN,C7_ immunologic signatures
12801,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
12802,MORF_PPP1CC,c4.CGN_ cancer gene neighborhoods
12803,GO_METHYLTRANSFERASE_COMPLEX,c5.CC_ GO cellular component
12804,CHR6P21,243
12805,GO_TETRAPYRROLE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12806,WANG_RESPONSE_TO_BEXAROTENE_UP,c2.CGP_ chemical and genetic perturbations
12807,JIANG_TIP30_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
12808,BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE,c2.CGP_ chemical and genetic perturbations
12809,MODULE_210,c4.CM_ cancer modules
12810,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_UP,C7_ immunologic signatures
12811,GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,c2.CGP_ chemical and genetic perturbations
12812,GO_NEURONAL_ACTION_POTENTIAL,c5.BP_ GO biological process
12813,MTOR_UP.N4.V1_UP,C6_ oncogenic signatures
12814,NELSON_RESPONSE_TO_ANDROGEN_UP,c2.CGP_ chemical and genetic perturbations
12815,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP,C7_ immunologic signatures
12816,GO_ACETYL_COA_METABOLIC_PROCESS,c5.BP_ GO biological process
12817,GO_HEXOSE_METABOLIC_PROCESS,c5.BP_ GO biological process
12818,GO_HISTONE_DEUBIQUITINATION,c5.BP_ GO biological process
12819,NGUYEN_NOTCH1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
12820,GO_ER_ASSOCIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
12821,CROONQUIST_NRAS_SIGNALING_UP,c2.CGP_ chemical and genetic perturbations
12822,LEIN_ASTROCYTE_MARKERS,c2.CGP_ chemical and genetic perturbations
12823,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_UP,C7_ immunologic signatures
12824,GO_CILIUM_MOVEMENT,c5.BP_ GO biological process
12825,GO_NEGATIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12826,PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,c2.CGP_ chemical and genetic perturbations
12827,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP,C7_ immunologic signatures
12828,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,C7_ immunologic signatures
12829,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
12830,MODULE_242,c4.CM_ cancer modules
12831,GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP,C7_ immunologic signatures
12832,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP,C7_ immunologic signatures
12833,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP,C7_ immunologic signatures
12834,GO_STEROID_METABOLIC_PROCESS,c5.BP_ GO biological process
12835,GO_COFACTOR_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12836,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP,C7_ immunologic signatures
12837,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
12838,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,C7_ immunologic signatures
12839,GO_GOLGI_ASSOCIATED_VESICLE_MEMBRANE,c5.CC_ GO cellular component
12840,GSE28237_EARLY_VS_LATE_GC_BCELL_DN,C7_ immunologic signatures
12841,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN,C7_ immunologic signatures
12842,GO_CARBON_OXYGEN_LYASE_ACTIVITY,c5.GO molecular function
12843,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP,C7_ immunologic signatures
12844,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,c2.CP_REACTOME_ Reactome gene sets
12845,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN,c2.CGP_ chemical and genetic perturbations
12846,MODULE_562,c4.CM_ cancer modules
12847,AP1_Q6_01,c3.TFT_ transcription factor targets
12848,GO_TRANSFERASE_ACTIVITY_TRANSFERRING_SULFUR_CONTAINING_GROUPS,c5.GO molecular function
12849,GO_MYOTUBE_DIFFERENTIATION,c5.BP_ GO biological process
12850,GO_ADIPOSE_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
12851,LEIN_MEDULLA_MARKERS,c2.CGP_ chemical and genetic perturbations
12852,GSE27786_LSK_VS_NKTCELL_UP,C7_ immunologic signatures
12853,GO_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,c5.BP_ GO biological process
12854,GO_NEGATIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
12855,GO_VESICLE_TARGETING,c5.BP_ GO biological process
12856,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP,C7_ immunologic signatures
12857,MALONEY_RESPONSE_TO_17AAG_DN,c2.CGP_ chemical and genetic perturbations
12858,REACTOME_PLATELET_SENSITIZATION_BY_LDL,c2.CP_REACTOME_ Reactome gene sets
12859,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_UP,C7_ immunologic signatures
12860,GO_RNA_POLYMERASE_BINDING,c5.GO molecular function
12861,HOWLIN_PUBERTAL_MAMMARY_GLAND,c2.CGP_ chemical and genetic perturbations
12862,GSE360_CTRL_VS_T_GONDII_MAC_UP,C7_ immunologic signatures
12863,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,c2.CGP_ chemical and genetic perturbations
12864,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_DN,C7_ immunologic signatures
12865,GO_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION,c5.BP_ GO biological process
12866,GO_CEREBRAL_CORTEX_CELL_MIGRATION,c5.BP_ GO biological process
12867,KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
12868,PID_ERA_GENOMIC_PATHWAY,c2.CP_ Canonical pathways
12869,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,C7_ immunologic signatures
12870,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,c2.CGP_ chemical and genetic perturbations
12871,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_UP,C7_ immunologic signatures
12872,GO_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,c5.BP_ GO biological process
12873,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP,C7_ immunologic signatures
12874,GO_N_GLYCAN_PROCESSING,c5.BP_ GO biological process
12875,GCM_BNIP1,c4.CGN_ cancer gene neighborhoods
12876,GSE40685_NAIVE_CD4_TCELL_VS_TREG_UP,C7_ immunologic signatures
12877,CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN,c2.CGP_ chemical and genetic perturbations
12878,GSE20715_0H_VS_24H_OZONE_LUNG_DN,C7_ immunologic signatures
12879,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_UP,C7_ immunologic signatures
12880,GO_PIGMENT_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12881,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN,C7_ immunologic signatures
12882,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,C7_ immunologic signatures
12883,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN,C7_ immunologic signatures
12884,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN,C7_ immunologic signatures
12885,YANG_BREAST_CANCER_ESR1_DN,c2.CGP_ chemical and genetic perturbations
12886,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,C7_ immunologic signatures
12887,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP,C7_ immunologic signatures
12888,GO_POSITIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE,c5.BP_ GO biological process
12889,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,c2.CGP_ chemical and genetic perturbations
12890,PID_LIS1_PATHWAY,c2.CP_ Canonical pathways
12891,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP,c2.CGP_ chemical and genetic perturbations
12892,YY1_Q6,c3.TFT_ transcription factor targets
12893,SHIN_B_CELL_LYMPHOMA_CLUSTER_2,c2.CGP_ chemical and genetic perturbations
12894,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_DN,C7_ immunologic signatures
12895,GO_CELL_CHEMOTAXIS,c5.BP_ GO biological process
12896,GO_POSITIVE_REGULATION_OF_VIRAL_PROCESS,c5.BP_ GO biological process
12897,GO_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,c5.BP_ GO biological process
12898,REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,c2.CP_REACTOME_ Reactome gene sets
12899,GO_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS,c5.BP_ GO biological process
12900,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP,C7_ immunologic signatures
12901,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_UP,C7_ immunologic signatures
12902,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP,C7_ immunologic signatures
12903,STAT1_02,c3.TFT_ transcription factor targets
12904,CHANDRAN_METASTASIS_TOP50_UP,c2.CGP_ chemical and genetic perturbations
12905,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_DN,C7_ immunologic signatures
12906,GO_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,c5.BP_ GO biological process
12907,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP,C7_ immunologic signatures
12908,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,C7_ immunologic signatures
12909,KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS,c2.CP_BIOCARTA_ BioCarta gene sets
12910,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN,c5.GO molecular function
12911,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN,C7_ immunologic signatures
12912,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,C7_ immunologic signatures
12913,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP,C7_ immunologic signatures
12914,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,c2.CGP_ chemical and genetic perturbations
12915,GSE3982_BASOPHIL_VS_TH2_DN,C7_ immunologic signatures
12916,MODULE_156,c4.CM_ cancer modules
12917,CHR15Q25,33
12918,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN,C7_ immunologic signatures
12919,GO_ALCOHOL_METABOLIC_PROCESS,c5.BP_ GO biological process
12920,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,c2.CGP_ chemical and genetic perturbations
12921,DARWICHE_PAPILLOMA_RISK_HIGH_UP,c2.CGP_ chemical and genetic perturbations
12922,GO_EPITHELIAL_CILIUM_MOVEMENT,c5.BP_ GO biological process
12923,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN,C7_ immunologic signatures
12924,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
12925,GO_S_ADENOSYLMETHIONINE_METABOLIC_PROCESS,c5.BP_ GO biological process
12926,GO_POSITIVE_REGULATION_OF_RNA_SPLICING,c5.BP_ GO biological process
12927,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,c2.CGP_ chemical and genetic perturbations
12928,GSE40655_FOXO1_KO_VS_WT_NTREG_UP,C7_ immunologic signatures
12929,CHRXP21,15
12930,GSE17721_CTRL_VS_POLYIC_2H_BMDC_UP,C7_ immunologic signatures
12931,GSE3982_DC_VS_BASOPHIL_UP,C7_ immunologic signatures
12932,KEGG_BETA_ALANINE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
12933,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,C7_ immunologic signatures
12934,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP,C7_ immunologic signatures
12935,UEDA_PERIFERAL_CLOCK,c2.CGP_ chemical and genetic perturbations
12936,GO_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,c5.GO molecular function
12937,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,C7_ immunologic signatures
12938,GERY_CEBP_TARGETS,c2.CGP_ chemical and genetic perturbations
12939,AP1_Q4_01,c3.TFT_ transcription factor targets
12940,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN,C7_ immunologic signatures
12941,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
12942,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN,C7_ immunologic signatures
12943,GO_REGULATION_OF_LIPID_STORAGE,c5.BP_ GO biological process
12944,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,C7_ immunologic signatures
12945,GSE37301_PRO_BCELL_VS_CD4_TCELL_UP,C7_ immunologic signatures
12946,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN,C7_ immunologic signatures
12947,HNF4_DR1_Q3,c3.TFT_ transcription factor targets
12948,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
12949,KEGG_PEROXISOME,c2.CP_BIOCARTA_ BioCarta gene sets
12950,GO_POSITIVE_REGULATION_OF_ENDOCYTOSIS,c5.BP_ GO biological process
12951,GO_DRUG_TRANSPORTER_ACTIVITY,c5.GO molecular function
12952,PROVENZANI_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
12953,EGR1_01,c3.TFT_ transcription factor targets
12954,LEE_LIVER_CANCER_E2F1_DN,c2.CGP_ chemical and genetic perturbations
12955,ER_Q6_02,c3.TFT_ transcription factor targets
12956,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_DN,C7_ immunologic signatures
12957,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,c2.CGP_ chemical and genetic perturbations
12958,GO_PRENYLTRANSFERASE_ACTIVITY,c5.GO molecular function
12959,GSE27786_NKCELL_VS_ERYTHROBLAST_UP,C7_ immunologic signatures
12960,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,c2.CGP_ chemical and genetic perturbations
12961,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN,C7_ immunologic signatures
12962,GSE17721_LPS_VS_POLYIC_16H_BMDC_UP,C7_ immunologic signatures
12963,GO_CELLULAR_HORMONE_METABOLIC_PROCESS,c5.BP_ GO biological process
12964,GO_S_ADENOSYLMETHIONINE_DEPENDENT_METHYLTRANSFERASE_ACTIVITY,c5.GO molecular function
12965,MEF2_04,c3.TFT_ transcription factor targets
12966,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,c2.CGP_ chemical and genetic perturbations
12967,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN,C7_ immunologic signatures
12968,GO_PYRIMIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12969,TERAO_AOX4_TARGETS_HG_UP,c2.CGP_ chemical and genetic perturbations
12970,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_UP,C7_ immunologic signatures
12971,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_UP,C7_ immunologic signatures
12972,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_DN,C7_ immunologic signatures
12973,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,C7_ immunologic signatures
12974,ACEVEDO_LIVER_CANCER_DN,c2.CGP_ chemical and genetic perturbations
12975,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,c2.CP_REACTOME_ Reactome gene sets
12976,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP,c2.CGP_ chemical and genetic perturbations
12977,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,C7_ immunologic signatures
12978,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_UP,C7_ immunologic signatures
12979,GO_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY,c5.BP_ GO biological process
12980,GO_EMBRYONIC_FORELIMB_MORPHOGENESIS,c5.BP_ GO biological process
12981,GO_VOLTAGE_GATED_CATION_CHANNEL_ACTIVITY,c5.GO molecular function
12982,AP1_Q4,c3.TFT_ transcription factor targets
12983,HMX1_01,c3.TFT_ transcription factor targets
12984,GO_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
12985,GCM_PTPRU,c4.CGN_ cancer gene neighborhoods
12986,GNF2_SPTA1,c4.CGN_ cancer gene neighborhoods
12987,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_DN,C7_ immunologic signatures
12988,AMIT_EGF_RESPONSE_120_MCF10A,c2.CGP_ chemical and genetic perturbations
12989,APPIERTO_RESPONSE_TO_FENRETINIDE_DN,c2.CGP_ chemical and genetic perturbations
12990,GO_REGULATION_OF_CELLULAR_RESPIRATION,c5.BP_ GO biological process
12991,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
12992,GSE45365_NK_CELL_VS_CD11B_DC_DN,C7_ immunologic signatures
12993,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN,C7_ immunologic signatures
12994,GSE27786_LSK_VS_LIN_NEG_CELL_DN,C7_ immunologic signatures
12995,GSE24726_WT_VS_E2_2_KO_PDC_DN,C7_ immunologic signatures
12996,GO_MEMBRANE_BUDDING,c5.BP_ GO biological process
12997,GO_NEUTRAL_LIPID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
12998,MODULE_107,c4.CM_ cancer modules
12999,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,c2.CP_REACTOME_ Reactome gene sets
13000,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,c2.CGP_ chemical and genetic perturbations
13001,GO_ACETYLTRANSFERASE_COMPLEX,c5.CC_ GO cellular component
13002,GROSS_ELK3_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
13003,GO_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI,c5.BP_ GO biological process
13004,BASSO_B_LYMPHOCYTE_NETWORK,c2.CGP_ chemical and genetic perturbations
13005,NAKAJIMA_MAST_CELL,c2.CGP_ chemical and genetic perturbations
13006,GO_SYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,c5.BP_ GO biological process
13007,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,c2.CGP_ chemical and genetic perturbations
13008,GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_ARREST,c5.BP_ GO biological process
13009,DORN_ADENOVIRUS_INFECTION_48HR_DN,c2.CGP_ chemical and genetic perturbations
13010,GSE360_DC_VS_MAC_DN,C7_ immunologic signatures
13011,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_UP,C7_ immunologic signatures
13012,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,C7_ immunologic signatures
13013,NFMUE1_Q6,c3.TFT_ transcription factor targets
13014,GO_CELLULAR_AMINO_ACID_CATABOLIC_PROCESS,c5.BP_ GO biological process
13015,GO_MONOSACCHARIDE_BINDING,c5.GO molecular function
13016,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN,C7_ immunologic signatures
13017,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,c2.CGP_ chemical and genetic perturbations
13018,DAUER_STAT3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
13019,GSE17721_LPS_VS_CPG_4H_BMDC_DN,C7_ immunologic signatures
13020,GO_LIPID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
13021,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP,C7_ immunologic signatures
13022,GO_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,c5.BP_ GO biological process
13023,GO_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
13024,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_DN,C7_ immunologic signatures
13025,GO_FORELIMB_MORPHOGENESIS,c5.BP_ GO biological process
13026,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP,C7_ immunologic signatures
13027,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP,C7_ immunologic signatures
13028,GO_GENE_SILENCING_BY_RNA,c5.BP_ GO biological process
13029,GO_NEGATIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,c5.BP_ GO biological process
13030,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN,C7_ immunologic signatures
13031,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN,C7_ immunologic signatures
13032,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP,C7_ immunologic signatures
13033,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,C7_ immunologic signatures
13034,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_DN,C7_ immunologic signatures
13035,GO_REGULATION_OF_VACUOLE_ORGANIZATION,c5.BP_ GO biological process
13036,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,c2.CGP_ chemical and genetic perturbations
13037,GO_PHOSPHATIDYLCHOLINE_ACYL_CHAIN_REMODELING,c5.BP_ GO biological process
13038,GO_TRANSITION_METAL_ION_TRANSPORT,c5.BP_ GO biological process
13039,GNF2_MAP2K3,c4.CGN_ cancer gene neighborhoods
13040,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,c2.CGP_ chemical and genetic perturbations
13041,BRUNO_HEMATOPOIESIS,c2.CGP_ chemical and genetic perturbations
13042,CHR6Q22,49
13043,GO_RNA_POLYMERASE_CORE_ENZYME_BINDING,c5.GO molecular function
13044,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP,C7_ immunologic signatures
13045,SWEET_KRAS_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
13046,REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,c2.CP_REACTOME_ Reactome gene sets
13047,VILLANUEVA_LIVER_CANCER_KRT19_DN,c2.CGP_ chemical and genetic perturbations
13048,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,C7_ immunologic signatures
13049,HAHTOLA_CTCL_CUTANEOUS,c2.CGP_ chemical and genetic perturbations
13050,REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,c2.CP_REACTOME_ Reactome gene sets
13051,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_DN,C7_ immunologic signatures
13052,UDAYAKUMAR_MED1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
13053,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,c2.CGP_ chemical and genetic perturbations
13054,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_UP,C7_ immunologic signatures
13055,MIKKELSEN_ES_ICP_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
13056,MODULE_212,c4.CM_ cancer modules
13057,GO_MAMMARY_GLAND_DUCT_MORPHOGENESIS,c5.BP_ GO biological process
13058,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,C7_ immunologic signatures
13059,GO_MONOVALENT_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
13060,MODULE_371,c4.CM_ cancer modules
13061,BIOCARTA_VIP_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
13062,GO_ANION_HOMEOSTASIS,c5.BP_ GO biological process
13063,GO_NUCLEOTIDE_SUGAR_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
13064,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,C7_ immunologic signatures
13065,GO_LYSOSOME_LOCALIZATION,c5.BP_ GO biological process
13066,GSE2826_WT_VS_BTK_KO_BCELL_DN,C7_ immunologic signatures
13067,GSE360_DC_VS_MAC_T_GONDII_DN,C7_ immunologic signatures
13068,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_DN,C7_ immunologic signatures
13069,RUAN_RESPONSE_TO_TROGLITAZONE_DN,c2.CGP_ chemical and genetic perturbations
13070,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_UP,C7_ immunologic signatures
13071,GSE2585_CD80_HIGH_VS_LOW_MTEC_DN,C7_ immunologic signatures
13072,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP,C7_ immunologic signatures
13073,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,C7_ immunologic signatures
13074,GTAGGCA_MIR189,c3.MIR_ microRNA targets
13075,GO_PLACENTA_DEVELOPMENT,c5.BP_ GO biological process
13076,GO_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_VIRUS,c5.BP_ GO biological process
13077,CAR_MLANA,c4.CGN_ cancer gene neighborhoods
13078,AHRARNT_01,c3.TFT_ transcription factor targets
13079,SHIN_B_CELL_LYMPHOMA_CLUSTER_3,c2.CGP_ chemical and genetic perturbations
13080,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN,c2.CGP_ chemical and genetic perturbations
13081,GO_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
13082,PID_CMYB_PATHWAY,c2.CP_ Canonical pathways
13083,GO_MICROBODY,c5.CC_ GO cellular component
13084,GO_PROTEIN_KINASE_B_SIGNALING,c5.BP_ GO biological process
13085,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP,C7_ immunologic signatures
13086,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,C7_ immunologic signatures
13087,GO_GLUTATHIONE_METABOLIC_PROCESS,c5.BP_ GO biological process
13088,GSE17721_POLYIC_VS_CPG_24H_BMDC_UP,C7_ immunologic signatures
13089,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN,C7_ immunologic signatures
13090,KEGG_GALACTOSE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
13091,PTEN_DN.V1_DN,C6_ oncogenic signatures
13092,SRY_01,c3.TFT_ transcription factor targets
13093,GSE17721_CTRL_VS_CPG_12H_BMDC_UP,C7_ immunologic signatures
13094,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_UP,C7_ immunologic signatures
13095,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP,C7_ immunologic signatures
13096,GO_ACTIVATION_OF_IMMUNE_RESPONSE,c5.BP_ GO biological process
13097,WIERENGA_PML_INTERACTOME,c2.CGP_ chemical and genetic perturbations
13098,ZIRN_TRETINOIN_RESPONSE_WT1_UP,c2.CGP_ chemical and genetic perturbations
13099,GO_CYTOKINE_ACTIVITY,c5.GO molecular function
13100,GO_NADP_METABOLIC_PROCESS,c5.BP_ GO biological process
13101,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP,C7_ immunologic signatures
13102,GO_HYDROGEN_TRANSPORT,c5.BP_ GO biological process
13103,GSE5960_TH1_VS_ANERGIC_TH1_UP,C7_ immunologic signatures
13104,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP,C7_ immunologic signatures
13105,GO_POSITIVE_REGULATION_OF_DNA_BINDING,c5.BP_ GO biological process
13106,KEGG_HEMATOPOIETIC_CELL_LINEAGE,c2.CP_BIOCARTA_ BioCarta gene sets
13107,GSE360_CTRL_VS_L_DONOVANI_DC_UP,C7_ immunologic signatures
13108,ER_Q6,c3.TFT_ transcription factor targets
13109,GNF2_PRDX2,c4.CGN_ cancer gene neighborhoods
13110,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,c2.CGP_ chemical and genetic perturbations
13111,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN,C7_ immunologic signatures
13112,GO_TRANSLATION_REGULATOR_ACTIVITY,c5.GO molecular function
13113,GO_SYMPORTER_ACTIVITY,c5.GO molecular function
13114,CHR6P25,26
13115,MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,c2.CGP_ chemical and genetic perturbations
13116,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_DN,C7_ immunologic signatures
13117,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP,C7_ immunologic signatures
13118,GSE40493_BCL6_KO_VS_WT_TREG_UP,C7_ immunologic signatures
13119,GO_MONOVALENT_INORGANIC_CATION_TRANSPORT,c5.BP_ GO biological process
13120,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
13121,DORN_ADENOVIRUS_INFECTION_24HR_DN,c2.CGP_ chemical and genetic perturbations
13122,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,C7_ immunologic signatures
13123,MODULE_321,c4.CM_ cancer modules
13124,MORF_BMI1,c4.CGN_ cancer gene neighborhoods
13125,CHR15Q14,31
13126,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP,C7_ immunologic signatures
13127,GO_LIPID_OXIDATION,c5.BP_ GO biological process
13128,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_DN,C7_ immunologic signatures
13129,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI,c2.CP_REACTOME_ Reactome gene sets
13130,GO_GLUTATHIONE_TRANSFERASE_ACTIVITY,c5.GO molecular function
13131,YANG_BREAST_CANCER_ESR1_LASER_DN,c2.CGP_ chemical and genetic perturbations
13132,ST_B_CELL_ANTIGEN_RECEPTOR,c2.CP_ Canonical pathways
13133,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,c2.CGP_ chemical and genetic perturbations
13134,JIANG_VHL_TARGETS,c2.CGP_ chemical and genetic perturbations
13135,GO_NUCLEOSIDE_TRANSPORT,c5.BP_ GO biological process
13136,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,c2.CGP_ chemical and genetic perturbations
13137,BACH1_01,c3.TFT_ transcription factor targets
13138,MORF_CDK2,c4.CGN_ cancer gene neighborhoods
13139,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
13140,DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,c2.CGP_ chemical and genetic perturbations
13141,GO_NUCLEOSOME_BINDING,c5.GO molecular function
13142,LEE_LIVER_CANCER_MYC_TGFA_UP,c2.CGP_ chemical and genetic perturbations
13143,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,C7_ immunologic signatures
13144,KRAS.DF.V1_UP,C6_ oncogenic signatures
13145,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN,C7_ immunologic signatures
13146,NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON,c2.CGP_ chemical and genetic perturbations
13147,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP,c2.CGP_ chemical and genetic perturbations
13148,GO_POSITIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
13149,GO_HINDLIMB_MORPHOGENESIS,c5.BP_ GO biological process
13150,GO_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,c5.BP_ GO biological process
13151,KANG_CISPLATIN_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
13152,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,C7_ immunologic signatures
13153,HUANG_GATA2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
13154,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,c2.CGP_ chemical and genetic perturbations
13155,GAGCCAG_MIR149,c3.MIR_ microRNA targets
13156,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
13157,HEIDENBLAD_AMPLICON_12P11_12_UP,c2.CGP_ chemical and genetic perturbations
13158,GCGNNANTTCC_UNKNOWN,c3.TFT_ transcription factor targets
13159,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP,C7_ immunologic signatures
13160,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,c2.CGP_ chemical and genetic perturbations
13161,GSE3982_NEUTROPHIL_VS_NKCELL_UP,C7_ immunologic signatures
13162,GO_MRNA_3_UTR_BINDING,c5.GO molecular function
13163,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,c2.CGP_ chemical and genetic perturbations
13164,MODULE_444,c4.CM_ cancer modules
13165,GO_CELLULAR_RESPONSE_TO_GLUCAGON_STIMULUS,c5.BP_ GO biological process
13166,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_UP,C7_ immunologic signatures
13167,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
13168,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,c2.CGP_ chemical and genetic perturbations
13169,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN,C7_ immunologic signatures
13170,GO_MONOCARBOXYLIC_ACID_TRANSPORT,c5.BP_ GO biological process
13171,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,C7_ immunologic signatures
13172,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_UP,C7_ immunologic signatures
13173,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_UP,C7_ immunologic signatures
13174,REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,c2.CP_REACTOME_ Reactome gene sets
13175,DARWICHE_SKIN_TUMOR_PROMOTER_UP,c2.CGP_ chemical and genetic perturbations
13176,GO_REGULATION_OF_ENDOCYTOSIS,c5.BP_ GO biological process
13177,GO_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_COMPLEX,c5.CC_ GO cellular component
13178,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN,C7_ immunologic signatures
13179,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,C7_ immunologic signatures
13180,REACTOME_MRNA_3_END_PROCESSING,c2.CP_REACTOME_ Reactome gene sets
13181,GSE360_CTRL_VS_T_GONDII_MAC_DN,C7_ immunologic signatures
13182,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_UP,C7_ immunologic signatures
13183,GO_CRANIAL_NERVE_DEVELOPMENT,c5.BP_ GO biological process
13184,GO_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
13185,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,c2.CGP_ chemical and genetic perturbations
13186,HELLER_HDAC_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
13187,KEGG_VEGF_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
13188,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP,C7_ immunologic signatures
13189,GO_POSITIVE_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS,c5.BP_ GO biological process
13190,MODULE_172,c4.CM_ cancer modules
13191,GO_APOPTOTIC_CELL_CLEARANCE,c5.BP_ GO biological process
13192,GO_PYRIMIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
13193,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP,C7_ immunologic signatures
13194,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP,C7_ immunologic signatures
13195,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,C7_ immunologic signatures
13196,LEE_LIVER_CANCER_HEPATOBLAST,c2.CGP_ chemical and genetic perturbations
13197,GO_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,c5.BP_ GO biological process
13198,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN,C7_ immunologic signatures
13199,GSE17721_0.5H_VS_24H_POLYIC_BMDC_UP,C7_ immunologic signatures
13200,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN,C7_ immunologic signatures
13201,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_DN,C7_ immunologic signatures
13202,GSE27786_NKTCELL_VS_ERYTHROBLAST_UP,C7_ immunologic signatures
13203,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_UP,C7_ immunologic signatures
13204,GO_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE,c5.BP_ GO biological process
13205,GSE11924_TFH_VS_TH2_CD4_TCELL_DN,C7_ immunologic signatures
13206,TOOKER_GEMCITABINE_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
13207,GSE15330_HSC_VS_PRO_BCELL_DN,C7_ immunologic signatures
13208,GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP,C7_ immunologic signatures
13209,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN,C7_ immunologic signatures
13210,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_DN,C7_ immunologic signatures
13211,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN,C7_ immunologic signatures
13212,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,C7_ immunologic signatures
13213,GO_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
13214,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN,C7_ immunologic signatures
13215,GO_LIPOPOLYSACCHARIDE_BINDING,c5.GO molecular function
13216,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN,C7_ immunologic signatures
13217,GSE27786_NKTCELL_VS_NEUTROPHIL_UP,C7_ immunologic signatures
13218,GO_CELLULAR_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
13219,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP,C7_ immunologic signatures
13220,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
13221,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,C7_ immunologic signatures
13222,REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS,c2.CP_REACTOME_ Reactome gene sets
13223,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP,C7_ immunologic signatures
13224,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,C7_ immunologic signatures
13225,CHR10Q11,44
13226,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_UP,C7_ immunologic signatures
13227,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
13228,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN,C7_ immunologic signatures
13229,ROESSLER_LIVER_CANCER_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
13230,VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,c2.CGP_ chemical and genetic perturbations
13231,GO_METHYLATION,c5.BP_ GO biological process
13232,GO_SPECTRIN_BINDING,c5.GO molecular function
13233,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_DN,C7_ immunologic signatures
13234,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_DN,C7_ immunologic signatures
13235,GSE31622_WT_VS_KLF3_KO_BCELL_DN,C7_ immunologic signatures
13236,GO_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,c5.BP_ GO biological process
13237,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,c2.CGP_ chemical and genetic perturbations
13238,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP,C7_ immunologic signatures
13239,GO_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
13240,E47_02,c3.TFT_ transcription factor targets
13241,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN,c2.CGP_ chemical and genetic perturbations
13242,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
13243,LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,c2.CGP_ chemical and genetic perturbations
13244,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,C7_ immunologic signatures
13245,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,c2.CGP_ chemical and genetic perturbations
13246,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN,C7_ immunologic signatures
13247,GO_LEFT_RIGHT_PATTERN_FORMATION,c5.BP_ GO biological process
13248,WNT_SIGNALING,c2.CP_ Canonical pathways
13249,GSE7509_DC_VS_MONOCYTE_UP,C7_ immunologic signatures
13250,GNF2_ANK1,c4.CGN_ cancer gene neighborhoods
13251,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,C7_ immunologic signatures
13252,PID_ANTHRAX_PATHWAY,c2.CP_ Canonical pathways
13253,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_UP,C7_ immunologic signatures
13254,BIOCARTA_INFLAM_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
13255,GSE27786_LSK_VS_ERYTHROBLAST_UP,C7_ immunologic signatures
13256,GO_GENITALIA_DEVELOPMENT,c5.BP_ GO biological process
13257,GO_PHOTORECEPTOR_OUTER_SEGMENT,c5.CC_ GO cellular component
13258,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,c2.CP_BIOCARTA_ BioCarta gene sets
13259,BOYLAN_MULTIPLE_MYELOMA_D_DN,c2.CGP_ chemical and genetic perturbations
13260,GO_NEGATIVE_REGULATION_OF_LIPID_TRANSPORT,c5.BP_ GO biological process
13261,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,C7_ immunologic signatures
13262,GO_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,c5.BP_ GO biological process
13263,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_UP,C7_ immunologic signatures
13264,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,C7_ immunologic signatures
13265,GO_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,c5.BP_ GO biological process
13266,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,C7_ immunologic signatures
13267,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP,C7_ immunologic signatures
13268,ZWANG_EGF_PERSISTENTLY_UP,c2.CGP_ chemical and genetic perturbations
13269,GO_SMOOTHENED_SIGNALING_PATHWAY,c5.BP_ GO biological process
13270,GATA2_01,c3.TFT_ transcription factor targets
13271,KEGG_O_GLYCAN_BIOSYNTHESIS,c2.CP_BIOCARTA_ BioCarta gene sets
13272,GO_LYSOPHOSPHOLIPID_ACYLTRANSFERASE_ACTIVITY,c5.GO molecular function
13273,LANDIS_ERBB2_BREAST_TUMORS_324_UP,c2.CGP_ chemical and genetic perturbations
13274,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN,C7_ immunologic signatures
13275,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,C7_ immunologic signatures
13276,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
13277,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP,C7_ immunologic signatures
13278,GSE17721_CTRL_VS_POLYIC_6H_BMDC_UP,C7_ immunologic signatures
13279,GO_NUCLEOBASE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
13280,GO_ORGANIC_HYDROXY_COMPOUND_METABOLIC_PROCESS,c5.BP_ GO biological process
13281,DASU_IL6_SIGNALING_UP,c2.CGP_ chemical and genetic perturbations
13282,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_UP,C7_ immunologic signatures
13283,GO_BLASTOCYST_FORMATION,c5.BP_ GO biological process
13284,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_UP,C7_ immunologic signatures
13285,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,C7_ immunologic signatures
13286,HNF4_01_B,c3.TFT_ transcription factor targets
13287,GNF2_SPTB,c4.CGN_ cancer gene neighborhoods
13288,CHANG_CORE_SERUM_RESPONSE_UP,c2.CGP_ chemical and genetic perturbations
13289,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN,C7_ immunologic signatures
13290,KCCGNSWTTT_UNKNOWN,c3.TFT_ transcription factor targets
13291,KYNG_DNA_DAMAGE_BY_4NQO,c2.CGP_ chemical and genetic perturbations
13292,GO_VITAMIN_TRANSPORT,c5.BP_ GO biological process
13293,PPARG_01,c3.TFT_ transcription factor targets
13294,EPPERT_HSC_R,c2.CGP_ chemical and genetic perturbations
13295,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
13296,ZAMORA_NOS2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
13297,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP,C7_ immunologic signatures
13298,SANSOM_APC_MYC_TARGETS,c2.CGP_ chemical and genetic perturbations
13299,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,C7_ immunologic signatures
13300,GO_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,c5.BP_ GO biological process
13301,HOELZEL_NF1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
13302,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_DN,C7_ immunologic signatures
13303,BILD_SRC_ONCOGENIC_SIGNATURE,c2.CGP_ chemical and genetic perturbations
13304,GSE36826_WT_VS_IL1R_KO_SKIN_DN,C7_ immunologic signatures
13305,GSE3982_NEUTROPHIL_VS_NKCELL_DN,C7_ immunologic signatures
13306,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_UP,C7_ immunologic signatures
13307,GO_RETROMER_COMPLEX,c5.CC_ GO cellular component
13308,GO_CHAPERONE_BINDING,c5.GO molecular function
13309,MODULE_399,c4.CM_ cancer modules
13310,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,c2.CGP_ chemical and genetic perturbations
13311,GNF2_HPN,c4.CGN_ cancer gene neighborhoods
13312,TGANNYRGCA_TCF11MAFG_01,c3.TFT_ transcription factor targets
13313,HALLMARK_COMPLEMENT,H_ hallmark gene sets
13314,GSE11924_TH2_VS_TH17_CD4_TCELL_DN,C7_ immunologic signatures
13315,GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP,C7_ immunologic signatures
13316,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,C7_ immunologic signatures
13317,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP,C7_ immunologic signatures
13318,GGCNRNWCTTYS_UNKNOWN,c3.TFT_ transcription factor targets
13319,GO_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,c5.BP_ GO biological process
13320,JIANG_HYPOXIA_NORMAL,c2.CGP_ chemical and genetic perturbations
13321,SENESE_HDAC2_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
13322,KEGG_VIBRIO_CHOLERAE_INFECTION,c2.CP_BIOCARTA_ BioCarta gene sets
13323,REACTOME_L1CAM_INTERACTIONS,c2.CP_REACTOME_ Reactome gene sets
13324,GO_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE,c5.BP_ GO biological process
13325,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN,C7_ immunologic signatures
13326,TAVOR_CEBPA_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
13327,HWANG_PROSTATE_CANCER_MARKERS,c2.CGP_ chemical and genetic perturbations
13328,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN,C7_ immunologic signatures
13329,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_UP,C7_ immunologic signatures
13330,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP,C7_ immunologic signatures
13331,STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA,c2.CGP_ chemical and genetic perturbations
13332,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP,C7_ immunologic signatures
13333,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN,C7_ immunologic signatures
13334,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,C7_ immunologic signatures
13335,REACTOME_LYSOSOME_VESICLE_BIOGENESIS,c2.CP_REACTOME_ Reactome gene sets
13336,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,c2.CGP_ chemical and genetic perturbations
13337,GO_LEUKOCYTE_DEGRANULATION,c5.BP_ GO biological process
13338,GO_CILIARY_TRANSITION_ZONE,c5.CC_ GO cellular component
13339,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP,C7_ immunologic signatures
13340,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN,C7_ immunologic signatures
13341,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
13342,GO_PROTEIN_HOMOTETRAMERIZATION,c5.BP_ GO biological process
13343,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,C7_ immunologic signatures
13344,GO_MEMBRANE_PROTEIN_PROTEOLYSIS,c5.BP_ GO biological process
13345,GNF2_IL2RB,c4.CGN_ cancer gene neighborhoods
13346,GSE29618_BCELL_VS_MONOCYTE_UP,C7_ immunologic signatures
13347,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP,C7_ immunologic signatures
13348,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN,C7_ immunologic signatures
13349,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
13350,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_DN,C7_ immunologic signatures
13351,GSE43955_1H_VS_20H_ACT_CD4_TCELL_UP,C7_ immunologic signatures
13352,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,C7_ immunologic signatures
13353,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN,C7_ immunologic signatures
13354,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
13355,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_DN,C7_ immunologic signatures
13356,ETS2_B,c3.TFT_ transcription factor targets
13357,GSE34006_WT_VS_A2AR_KO_TREG_UP,C7_ immunologic signatures
13358,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_UP,C7_ immunologic signatures
13359,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN,C7_ immunologic signatures
13360,GO_PHOTORECEPTOR_DISC_MEMBRANE,c5.CC_ GO cellular component
13361,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_UP,C7_ immunologic signatures
13362,REACTOME_IRON_UPTAKE_AND_TRANSPORT,c2.CP_REACTOME_ Reactome gene sets
13363,CHR5Q32,24
13364,PID_RHODOPSIN_PATHWAY,c2.CP_ Canonical pathways
13365,GO_PROTEASOME_BINDING,c5.GO molecular function
13366,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
13367,GO_REGULATION_OF_NECROTIC_CELL_DEATH,c5.BP_ GO biological process
13368,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN,C7_ immunologic signatures
13369,MODULE_349,c4.CM_ cancer modules
13370,HALLMARK_ESTROGEN_RESPONSE_LATE,H_ hallmark gene sets
13371,GO_ZINC_II_ION_TRANSPORT,c5.BP_ GO biological process
13372,GO_CELLULAR_AMINO_ACID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
13373,GO_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
13374,GO_HEME_METABOLIC_PROCESS,c5.BP_ GO biological process
13375,GO_POSITIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,c5.BP_ GO biological process
13376,GSE360_CTRL_VS_L_DONOVANI_DC_DN,C7_ immunologic signatures
13377,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,C7_ immunologic signatures
13378,GO_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,c5.BP_ GO biological process
13379,KEGG_INOSITOL_PHOSPHATE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
13380,MORF_MYL3,c4.CGN_ cancer gene neighborhoods
13381,CHANGOLKAR_H2AFY_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
13382,GSE17721_POLYIC_VS_CPG_1H_BMDC_UP,C7_ immunologic signatures
13383,GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,c5.BP_ GO biological process
13384,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
13385,GO_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES,c5.GO molecular function
13386,REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS,c2.CP_REACTOME_ Reactome gene sets
13387,ZHAN_V2_LATE_DIFFERENTIATION_GENES,c2.CGP_ chemical and genetic perturbations
13388,REACTOME_METABOLISM_OF_CARBOHYDRATES,c2.CP_REACTOME_ Reactome gene sets
13389,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN,C7_ immunologic signatures
13390,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN,C7_ immunologic signatures
13391,FERNANDEZ_BOUND_BY_MYC,c2.CGP_ chemical and genetic perturbations
13392,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP,C7_ immunologic signatures
13393,GO_PYRIMIDINE_NUCLEOSIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
13394,MARSON_FOXP3_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
13395,GO_REGULATION_OF_KIDNEY_DEVELOPMENT,c5.BP_ GO biological process
13396,GO_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION,c5.BP_ GO biological process
13397,TGACCTTG_SF1_Q6,c3.TFT_ transcription factor targets
13398,KEGG_TRYPTOPHAN_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
13399,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN,C7_ immunologic signatures
13400,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,C7_ immunologic signatures
13401,GO_UDP_GLYCOSYLTRANSFERASE_ACTIVITY,c5.GO molecular function
13402,GO_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,c5.BP_ GO biological process
13403,GO_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT,c5.BP_ GO biological process
13404,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_UP,C7_ immunologic signatures
13405,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN,C7_ immunologic signatures
13406,REACTOME_PYRUVATE_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
13407,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP,C7_ immunologic signatures
13408,OKUMURA_INFLAMMATORY_RESPONSE_LPS,c2.CGP_ chemical and genetic perturbations
13409,REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES,c2.CP_REACTOME_ Reactome gene sets
13410,GO_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION,c5.BP_ GO biological process
13411,GSE27786_CD8_TCELL_VS_NKTCELL_UP,C7_ immunologic signatures
13412,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
13413,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,C7_ immunologic signatures
13414,GO_SPERM_FLAGELLUM,c5.CC_ GO cellular component
13415,SHEPARD_BMYB_MORPHOLINO_UP,c2.CGP_ chemical and genetic perturbations
13416,GSE14308_TH1_VS_NATURAL_TREG_UP,C7_ immunologic signatures
13417,GCM_MAX,c4.CGN_ cancer gene neighborhoods
13418,GO_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,c5.BP_ GO biological process
13419,GSE27786_LIN_NEG_VS_CD4_TCELL_UP,C7_ immunologic signatures
13420,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_UP,C7_ immunologic signatures
13421,KEGG_PPAR_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
13422,GO_LYMPH_NODE_DEVELOPMENT,c5.BP_ GO biological process
13423,MAHADEVAN_IMATINIB_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
13424,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN,C7_ immunologic signatures
13425,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN,C7_ immunologic signatures
13426,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_DN,C7_ immunologic signatures
13427,REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_,c2.CP_REACTOME_ Reactome gene sets
13428,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN,C7_ immunologic signatures
13429,REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION,c2.CP_REACTOME_ Reactome gene sets
13430,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,C7_ immunologic signatures
13431,GO_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,c5.BP_ GO biological process
13432,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
13433,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_UP,C7_ immunologic signatures
13434,GO_RETINOL_METABOLIC_PROCESS,c5.BP_ GO biological process
13435,GO_FATTY_ACID_BETA_OXIDATION,c5.BP_ GO biological process
13436,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP,C7_ immunologic signatures
13437,ASTIER_INTEGRIN_SIGNALING,c2.CGP_ chemical and genetic perturbations
13438,GSE29618_PDC_VS_MDC_UP,C7_ immunologic signatures
13439,ZHENG_IL22_SIGNALING_UP,c2.CGP_ chemical and genetic perturbations
13440,GO_O_GLYCAN_PROCESSING,c5.BP_ GO biological process
13441,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,C7_ immunologic signatures
13442,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_DN,C7_ immunologic signatures
13443,GGCKCATGS_UNKNOWN,c3.TFT_ transcription factor targets
13444,GNF2_RAD23A,c4.CGN_ cancer gene neighborhoods
13445,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,c2.CGP_ chemical and genetic perturbations
13446,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,C7_ immunologic signatures
13447,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_DN,C7_ immunologic signatures
13448,GO_COATED_PIT,c5.CC_ GO cellular component
13449,ZHAN_LATE_DIFFERENTIATION_GENES_UP,c2.CGP_ chemical and genetic perturbations
13450,GO_POSITIVE_REGULATION_OF_MESONEPHROS_DEVELOPMENT,c5.BP_ GO biological process
13451,GO_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,c5.BP_ GO biological process
13452,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP,C7_ immunologic signatures
13453,GSE27786_BCELL_VS_MONO_MAC_UP,C7_ immunologic signatures
13454,GO_NEUROTRANSMITTER_TRANSPORTER_ACTIVITY,c5.GO molecular function
13455,RICKMAN_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
13456,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN,C7_ immunologic signatures
13457,GNF2_DEK,c4.CGN_ cancer gene neighborhoods
13458,GO_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS,c5.BP_ GO biological process
13459,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,C7_ immunologic signatures
13460,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_UP,C7_ immunologic signatures
13461,CHR12Q22,21
13462,GSE13306_TREG_RA_VS_TCONV_RA_DN,C7_ immunologic signatures
13463,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN,C7_ immunologic signatures
13464,MODULE_313,c4.CM_ cancer modules
13465,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,C7_ immunologic signatures
13466,GO_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,c5.BP_ GO biological process
13467,GO_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS,c5.GO molecular function
13468,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,C7_ immunologic signatures
13469,GO_REGULATION_OF_HEMOPOIESIS,c5.BP_ GO biological process
13470,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_DN,C7_ immunologic signatures
13471,GO_MODULATION_OF_TRANSCRIPTION_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION,c5.BP_ GO biological process
13472,DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN,c2.CGP_ chemical and genetic perturbations
13473,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_DN,C7_ immunologic signatures
13474,GO_ERAD_PATHWAY,c5.BP_ GO biological process
13475,NGFIC_01,c3.TFT_ transcription factor targets
13476,CHR3Q27,45
13477,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,C7_ immunologic signatures
13478,BIOCARTA_MTOR_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
13479,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,C7_ immunologic signatures
13480,GSE360_CTRL_VS_L_DONOVANI_MAC_UP,C7_ immunologic signatures
13481,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,C7_ immunologic signatures
13482,VERRECCHIA_RESPONSE_TO_TGFB1_C1,c2.CGP_ chemical and genetic perturbations
13483,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_UP,C7_ immunologic signatures
13484,GO_ALPHA_BETA_T_CELL_DIFFERENTIATION,c5.BP_ GO biological process
13485,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP,C7_ immunologic signatures
13486,GO_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,c5.BP_ GO biological process
13487,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
13488,GO_E_BOX_BINDING,c5.GO molecular function
13489,GO_NUCLEOTIDE_EXCISION_REPAIR_PREINCISION_COMPLEX_STABILIZATION,c5.BP_ GO biological process
13490,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_UP,C7_ immunologic signatures
13491,PID_CXCR4_PATHWAY,c2.CP_ Canonical pathways
13492,MAX_01,c3.TFT_ transcription factor targets
13493,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP,C7_ immunologic signatures
13494,GO_HYDROGEN_ION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
13495,GO_SULFUR_AMINO_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
13496,KRAS.50_UP.V1_DN,C6_ oncogenic signatures
13497,GO_PHOTORECEPTOR_CELL_DIFFERENTIATION,c5.BP_ GO biological process
13498,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,C7_ immunologic signatures
13499,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_UP,C7_ immunologic signatures
13500,GO_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS,c5.BP_ GO biological process
13501,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,C7_ immunologic signatures
13502,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP,c2.CGP_ chemical and genetic perturbations
13503,QI_PLASMACYTOMA_DN,c2.CGP_ chemical and genetic perturbations
13504,GO_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,c5.BP_ GO biological process
13505,KORKOLA_EMBRYONAL_CARCINOMA_UP,c2.CGP_ chemical and genetic perturbations
13506,GSE10325_CD4_TCELL_VS_BCELL_DN,C7_ immunologic signatures
13507,GSE27786_LIN_NEG_VS_NEUTROPHIL_UP,C7_ immunologic signatures
13508,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,C7_ immunologic signatures
13509,APPIERTO_RESPONSE_TO_FENRETINIDE_UP,c2.CGP_ chemical and genetic perturbations
13510,GO_REGULATION_OF_TELOMERE_MAINTENANCE,c5.BP_ GO biological process
13511,PID_FAK_PATHWAY,c2.CP_ Canonical pathways
13512,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP,c2.CGP_ chemical and genetic perturbations
13513,GSE13306_RA_VS_UNTREATED_TCONV_UP,C7_ immunologic signatures
13514,CHR16P12,54
13515,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,c2.CGP_ chemical and genetic perturbations
13516,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_DN,C7_ immunologic signatures
13517,GO_ALPHA_AMINO_ACID_CATABOLIC_PROCESS,c5.BP_ GO biological process
13518,JAZAG_TGFB1_SIGNALING_DN,c2.CGP_ chemical and genetic perturbations
13519,YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP,c2.CGP_ chemical and genetic perturbations
13520,GO_REGULATION_OF_MITOPHAGY,c5.BP_ GO biological process
13521,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,C7_ immunologic signatures
13522,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP,C7_ immunologic signatures
13523,GO_ENHANCER_BINDING,c5.GO molecular function
13524,GSE10325_BCELL_VS_MYELOID_UP,C7_ immunologic signatures
13525,REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER,c2.CP_REACTOME_ Reactome gene sets
13526,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,C7_ immunologic signatures
13527,GO_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,c5.BP_ GO biological process
13528,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN,C7_ immunologic signatures
13529,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN,C7_ immunologic signatures
13530,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
13531,GO_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
13532,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN,C7_ immunologic signatures
13533,GTTGNYNNRGNAAC_UNKNOWN,c3.TFT_ transcription factor targets
13534,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,C7_ immunologic signatures
13535,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_UP,C7_ immunologic signatures
13536,REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,c2.CP_REACTOME_ Reactome gene sets
13537,GSE22886_TCELL_VS_BCELL_NAIVE_UP,C7_ immunologic signatures
13538,GO_RESPONSE_TO_PROTOZOAN,c5.BP_ GO biological process
13539,GO_MAST_CELL_ACTIVATION,c5.BP_ GO biological process
13540,GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP,C7_ immunologic signatures
13541,MOHANKUMAR_HOXA1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
13542,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP,C7_ immunologic signatures
13543,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP,C7_ immunologic signatures
13544,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_DN,C7_ immunologic signatures
13545,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP,C7_ immunologic signatures
13546,GSE40273_GATA1_KO_VS_WT_TREG_UP,C7_ immunologic signatures
13547,GNF2_MSN,c4.CGN_ cancer gene neighborhoods
13548,MODULE_240,c4.CM_ cancer modules
13549,CHENG_RESPONSE_TO_NICKEL_ACETATE,c2.CGP_ chemical and genetic perturbations
13550,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP,C7_ immunologic signatures
13551,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,C7_ immunologic signatures
13552,GSE17721_POLYIC_VS_CPG_8H_BMDC_DN,C7_ immunologic signatures
13553,MORF_DNMT1,c4.CGN_ cancer gene neighborhoods
13554,GO_MYOTUBE_CELL_DEVELOPMENT,c5.BP_ GO biological process
13555,IVANOVA_HEMATOPOIESIS_STEM_CELL,c2.CGP_ chemical and genetic perturbations
13556,GSE360_DC_VS_MAC_UP,C7_ immunologic signatures
13557,GO_NON_CANONICAL_WNT_SIGNALING_PATHWAY,c5.BP_ GO biological process
13558,HALLMARK_PEROXISOME,H_ hallmark gene sets
13559,GO_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE,c5.BP_ GO biological process
13560,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_DN,C7_ immunologic signatures
13561,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,C7_ immunologic signatures
13562,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN,C7_ immunologic signatures
13563,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP,C7_ immunologic signatures
13564,VALK_AML_WITH_11Q23_REARRANGED,c2.CGP_ chemical and genetic perturbations
13565,GO_TRANSFERASE_ACTIVITY_TRANSFERRING_HEXOSYL_GROUPS,c5.GO molecular function
13566,GO_REGULATION_OF_ERAD_PATHWAY,c5.BP_ GO biological process
13567,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP,C7_ immunologic signatures
13568,JIANG_AGING_CEREBRAL_CORTEX_DN,c2.CGP_ chemical and genetic perturbations
13569,RHODES_CANCER_META_SIGNATURE,c2.CGP_ chemical and genetic perturbations
13570,GO_TOR_SIGNALING,c5.BP_ GO biological process
13571,NAKAMURA_METASTASIS_MODEL_DN,c2.CGP_ chemical and genetic perturbations
13572,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN,C7_ immunologic signatures
13573,BOYLAN_MULTIPLE_MYELOMA_C_DN,c2.CGP_ chemical and genetic perturbations
13574,GO_CADHERIN_BINDING,c5.GO molecular function
13575,MCCLUNG_DELTA_FOSB_TARGETS_2WK,c2.CGP_ chemical and genetic perturbations
13576,GO_NEGATIVE_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME,c5.BP_ GO biological process
13577,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_UP,C7_ immunologic signatures
13578,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,C7_ immunologic signatures
13579,CHR8Q22,53
13580,GSE14000_4H_VS_16H_LPS_DC_UP,C7_ immunologic signatures
13581,EGR3_01,c3.TFT_ transcription factor targets
13582,CHR9Q34,168
13583,GO_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
13584,GO_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS,c5.BP_ GO biological process
13585,GO_POSITIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,c5.BP_ GO biological process
13586,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,c2.CGP_ chemical and genetic perturbations
13587,GCM_SMO,c4.CGN_ cancer gene neighborhoods
13588,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_UP,C7_ immunologic signatures
13589,CHR5P13,42
13590,TOOKER_GEMCITABINE_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
13591,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,C7_ immunologic signatures
13592,MORF_CDC10,c4.CGN_ cancer gene neighborhoods
13593,GSE24210_TCONV_VS_TREG_UP,C7_ immunologic signatures
13594,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,C7_ immunologic signatures
13595,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN,C7_ immunologic signatures
13596,MODULE_235,c4.CM_ cancer modules
13597,GO_MAST_CELL_MEDIATED_IMMUNITY,c5.BP_ GO biological process
13598,GSE11924_TFH_VS_TH17_CD4_TCELL_DN,C7_ immunologic signatures
13599,GSE17721_CTRL_VS_LPS_4H_BMDC_UP,C7_ immunologic signatures
13600,GCM_HBP1,c4.CGN_ cancer gene neighborhoods
13601,GSE6681_DELETED_FOXP3_VS_WT_TREG_UP,C7_ immunologic signatures
13602,GO_SULFUR_AMINO_ACID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
13603,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_DN,C7_ immunologic signatures
13604,GO_CELL_DIFFERENTIATION_IN_HINDBRAIN,c5.BP_ GO biological process
13605,GO_MRNA_SPLICE_SITE_SELECTION,c5.BP_ GO biological process
13606,JAIN_NFKB_SIGNALING,c2.CGP_ chemical and genetic perturbations
13607,GO_REGULATION_OF_STEROL_TRANSPORT,c5.BP_ GO biological process
13608,GO_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT,c5.BP_ GO biological process
13609,JOHNSTONE_PARVB_TARGETS_2_UP,c2.CGP_ chemical and genetic perturbations
13610,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_UP,C7_ immunologic signatures
13611,GO_POSITIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,c5.BP_ GO biological process
13612,BIOCARTA_FMLP_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
13613,GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN,C7_ immunologic signatures
13614,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
13615,HEDENFALK_BREAST_CANCER_BRACX_UP,c2.CGP_ chemical and genetic perturbations
13616,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,c2.CGP_ chemical and genetic perturbations
13617,GO_POSITIVE_REGULATION_OF_LIGASE_ACTIVITY,c5.BP_ GO biological process
13618,GSE17721_LPS_VS_CPG_6H_BMDC_DN,C7_ immunologic signatures
13619,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,c2.CGP_ chemical and genetic perturbations
13620,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_UP,C7_ immunologic signatures
13621,ATF_01,c3.TFT_ transcription factor targets
13622,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,c2.CGP_ chemical and genetic perturbations
13623,GSE6674_CPG_VS_PL2_3_STIM_BCELL_UP,C7_ immunologic signatures
13624,GO_VESICLE_COAT,c5.CC_ GO cellular component
13625,GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,c5.BP_ GO biological process
13626,GO_CLATHRIN_ADAPTOR_COMPLEX,c5.CC_ GO cellular component
13627,ARNT_02,c3.TFT_ transcription factor targets
13628,GSE13306_TREG_VS_TCONV_SPLEEN_DN,C7_ immunologic signatures
13629,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,C7_ immunologic signatures
13630,GO_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL,c5.BP_ GO biological process
13631,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_UP,C7_ immunologic signatures
13632,MODULE_343,c4.CM_ cancer modules
13633,GNF2_SPI1,c4.CGN_ cancer gene neighborhoods
13634,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP,C7_ immunologic signatures
13635,ZHAN_MULTIPLE_MYELOMA_HP_UP,c2.CGP_ chemical and genetic perturbations
13636,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,C7_ immunologic signatures
13637,PID_INTEGRIN2_PATHWAY,c2.CP_ Canonical pathways
13638,GO_TRANSCRIPTION_FACTOR_BINDING,c5.GO molecular function
13639,GO_PYRIMIDINE_NUCLEOTIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
13640,GROSS_HYPOXIA_VIA_HIF1A_DN,c2.CGP_ chemical and genetic perturbations
13641,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,C7_ immunologic signatures
13642,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP,C7_ immunologic signatures
13643,CHR2Q35,42
13644,PID_IL12_2PATHWAY,c2.CP_ Canonical pathways
13645,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_UP,C7_ immunologic signatures
13646,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN,C7_ immunologic signatures
13647,MODULE_249,c4.CM_ cancer modules
13648,VALK_AML_WITH_CEBPA,c2.CGP_ chemical and genetic perturbations
13649,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,C7_ immunologic signatures
13650,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_UP,C7_ immunologic signatures
13651,MODULE_160,c4.CM_ cancer modules
13652,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,C7_ immunologic signatures
13653,GO_ORGANIC_HYDROXY_COMPOUND_CATABOLIC_PROCESS,c5.BP_ GO biological process
13654,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,C7_ immunologic signatures
13655,GO_AMINE_METABOLIC_PROCESS,c5.BP_ GO biological process
13656,REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE,c2.CP_REACTOME_ Reactome gene sets
13657,WCTCNATGGY_UNKNOWN,c3.TFT_ transcription factor targets
13658,GO_FERTILIZATION,c5.BP_ GO biological process
13659,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP,C7_ immunologic signatures
13660,MULLIGHAN_MLL_SIGNATURE_2_UP,c2.CGP_ chemical and genetic perturbations
13661,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN,C7_ immunologic signatures
13662,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
13663,PID_HIF1_TFPATHWAY,c2.CP_ Canonical pathways
13664,MODULE_373,c4.CM_ cancer modules
13665,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN,C7_ immunologic signatures
13666,GO_ESTROUS_CYCLE,c5.BP_ GO biological process
13667,GO_ORGAN_MATURATION,c5.BP_ GO biological process
13668,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP,C7_ immunologic signatures
13669,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN,C7_ immunologic signatures
13670,REACTOME_NUCLEOTIDE_EXCISION_REPAIR,c2.CP_REACTOME_ Reactome gene sets
13671,GSE17721_POLYIC_VS_CPG_4H_BMDC_UP,C7_ immunologic signatures
13672,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP,C7_ immunologic signatures
13673,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
13674,GNF2_S100A4,c4.CGN_ cancer gene neighborhoods
13675,KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
13676,GABP_B,c3.TFT_ transcription factor targets
13677,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP,C7_ immunologic signatures
13678,KEGG_TYROSINE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
13679,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
13680,BIOCARTA_NDKDYNAMIN_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
13681,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,c2.CGP_ chemical and genetic perturbations
13682,CHR7Q22,87
13683,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_UP,C7_ immunologic signatures
13684,FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,c2.CGP_ chemical and genetic perturbations
13685,GO_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
13686,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_UP,C7_ immunologic signatures
13687,PID_INTEGRIN_CS_PATHWAY,c2.CP_ Canonical pathways
13688,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,C7_ immunologic signatures
13689,LANDEMAINE_LUNG_METASTASIS,c2.CGP_ chemical and genetic perturbations
13690,MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED,c2.CGP_ chemical and genetic perturbations
13691,GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,c2.CGP_ chemical and genetic perturbations
13692,MODULE_489,c4.CM_ cancer modules
13693,HALLMARK_XENOBIOTIC_METABOLISM,H_ hallmark gene sets
13694,GO_ER_TO_GOLGI_TRANSPORT_VESICLE_MEMBRANE,c5.CC_ GO cellular component
13695,GO_GLYCOSYLATION,c5.BP_ GO biological process
13696,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN,C7_ immunologic signatures
13697,GO_ALPHA_BETA_T_CELL_ACTIVATION,c5.BP_ GO biological process
13698,AR_01,c3.TFT_ transcription factor targets
13699,HUANG_GATA2_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
13700,CHR4Q22,23
13701,GO_PHOSPHOLIPASE_A2_ACTIVITY,c5.GO molecular function
13702,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,c2.CGP_ chemical and genetic perturbations
13703,GSE17721_POLYIC_VS_CPG_24H_BMDC_DN,C7_ immunologic signatures
13704,GO_PIGMENT_GRANULE,c5.CC_ GO cellular component
13705,GO_NEGATIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,c5.BP_ GO biological process
13706,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN,C7_ immunologic signatures
13707,KAYO_CALORIE_RESTRICTION_MUSCLE_DN,c2.CGP_ chemical and genetic perturbations
13708,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,C7_ immunologic signatures
13709,SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,c2.CGP_ chemical and genetic perturbations
13710,GSE20715_0H_VS_6H_OZONE_LUNG_DN,C7_ immunologic signatures
13711,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_DN,C7_ immunologic signatures
13712,GO_INORGANIC_ANION_TRANSPORT,c5.BP_ GO biological process
13713,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP,C7_ immunologic signatures
13714,GO_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
13715,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,C7_ immunologic signatures
13716,CYTAGCAAY_UNKNOWN,c3.TFT_ transcription factor targets
13717,MODULE_273,c4.CM_ cancer modules
13718,ARNT_01,c3.TFT_ transcription factor targets
13719,GSE17721_CTRL_VS_CPG_6H_BMDC_UP,C7_ immunologic signatures
13720,ELK1_02,c3.TFT_ transcription factor targets
13721,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,C7_ immunologic signatures
13722,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_DN,C7_ immunologic signatures
13723,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN,C7_ immunologic signatures
13724,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,c2.CGP_ chemical and genetic perturbations
13725,GO_T_CELL_PROLIFERATION,c5.BP_ GO biological process
13726,MODULE_285,c4.CM_ cancer modules
13727,GO_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,c5.BP_ GO biological process
13728,ROME_INSULIN_TARGETS_IN_MUSCLE_UP,c2.CGP_ chemical and genetic perturbations
13729,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,c2.CGP_ chemical and genetic perturbations
13730,LI_PROSTATE_CANCER_EPIGENETIC,c2.CGP_ chemical and genetic perturbations
13731,GO_SAGA_TYPE_COMPLEX,c5.CC_ GO cellular component
13732,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,C7_ immunologic signatures
13733,SU_PLACENTA,c2.CGP_ chemical and genetic perturbations
13734,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,C7_ immunologic signatures
13735,GO_PHOSPHATIDYLETHANOLAMINE_ACYL_CHAIN_REMODELING,c5.BP_ GO biological process
13736,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
13737,HALLMARK_PANCREAS_BETA_CELLS,H_ hallmark gene sets
13738,GO_PHAGOCYTIC_VESICLE,c5.CC_ GO cellular component
13739,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_UP,C7_ immunologic signatures
13740,GO_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION,c5.BP_ GO biological process
13741,BIOCARTA_HDAC_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
13742,GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN,C7_ immunologic signatures
13743,LUCAS_HNF4A_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
13744,GO_POSITIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT,c5.BP_ GO biological process
13745,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,C7_ immunologic signatures
13746,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP,C7_ immunologic signatures
13747,PID_S1P_S1P3_PATHWAY,c2.CP_ Canonical pathways
13748,COATES_MACROPHAGE_M1_VS_M2_DN,c2.CGP_ chemical and genetic perturbations
13749,CYCLIN_D1_KE_.V1_UP,C6_ oncogenic signatures
13750,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,c2.CGP_ chemical and genetic perturbations
13751,REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA,c2.CP_REACTOME_ Reactome gene sets
13752,GO_BASOLATERAL_PLASMA_MEMBRANE,c5.CC_ GO cellular component
13753,HOLLMANN_APOPTOSIS_VIA_CD40_DN,c2.CGP_ chemical and genetic perturbations
13754,ZHANG_BREAST_CANCER_PROGENITORS_DN,c2.CGP_ chemical and genetic perturbations
13755,GO_TRANSFERASE_ACTIVITY_TRANSFERRING_GLYCOSYL_GROUPS,c5.GO molecular function
13756,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_DN,C7_ immunologic signatures
13757,WELCH_GATA1_TARGETS,c2.CGP_ chemical and genetic perturbations
13758,HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,c2.CGP_ chemical and genetic perturbations
13759,GO_CILIARY_BASE,c5.CC_ GO cellular component
13760,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP,C7_ immunologic signatures
13761,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,c2.CGP_ chemical and genetic perturbations
13762,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,C7_ immunologic signatures
13763,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
13764,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_UP,C7_ immunologic signatures
13765,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_DN,C7_ immunologic signatures
13766,GO_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION,c5.BP_ GO biological process
13767,GO_PROTEIN_HETEROTETRAMERIZATION,c5.BP_ GO biological process
13768,GO_MODIFIED_AMINO_ACID_BINDING,c5.GO molecular function
13769,XU_GH1_AUTOCRINE_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
13770,KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
13771,ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE,c2.CGP_ chemical and genetic perturbations
13772,GO_NEGATIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,c5.BP_ GO biological process
13773,REACTOME_M_G1_TRANSITION,c2.CP_REACTOME_ Reactome gene sets
13774,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN,c2.CGP_ chemical and genetic perturbations
13775,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,C7_ immunologic signatures
13776,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
13777,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN,C7_ immunologic signatures
13778,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
13779,MYCMAX_03,c3.TFT_ transcription factor targets
13780,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,C7_ immunologic signatures
13781,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP,C7_ immunologic signatures
13782,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP,C7_ immunologic signatures
13783,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
13784,GNF2_TNFSF10,c4.CGN_ cancer gene neighborhoods
13785,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_UP,C7_ immunologic signatures
13786,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP,C7_ immunologic signatures
13787,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,C7_ immunologic signatures
13788,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP,C7_ immunologic signatures
13789,GO_MRNA_CLEAVAGE,c5.BP_ GO biological process
13790,GSE3982_MAST_CELL_VS_BCELL_UP,C7_ immunologic signatures
13791,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,c2.CGP_ chemical and genetic perturbations
13792,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,C7_ immunologic signatures
13793,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,c2.CGP_ chemical and genetic perturbations
13794,ST_T_CELL_SIGNAL_TRANSDUCTION,c2.CP_ Canonical pathways
13795,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_UP,C7_ immunologic signatures
13796,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP,C7_ immunologic signatures
13797,ODONNELL_METASTASIS_DN,c2.CGP_ chemical and genetic perturbations
13798,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_UP,C7_ immunologic signatures
13799,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,C7_ immunologic signatures
13800,GSE14026_TH1_VS_TH17_UP,C7_ immunologic signatures
13801,GO_GLUCOSE_METABOLIC_PROCESS,c5.BP_ GO biological process
13802,MODULE_8,c4.CM_ cancer modules
13803,FARMER_BREAST_CANCER_CLUSTER_6,c2.CGP_ chemical and genetic perturbations
13804,GO_COENZYME_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
13805,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,C7_ immunologic signatures
13806,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,C7_ immunologic signatures
13807,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_DN,C7_ immunologic signatures
13808,GO_PLACENTA_BLOOD_VESSEL_DEVELOPMENT,c5.BP_ GO biological process
13809,MIKKELSEN_MEF_LCP_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
13810,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,c2.CGP_ chemical and genetic perturbations
13811,GO_TETRAPYRROLE_METABOLIC_PROCESS,c5.BP_ GO biological process
13812,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
13813,GO_FILOPODIUM_MEMBRANE,c5.CC_ GO cellular component
13814,BOYAULT_LIVER_CANCER_SUBCLASS_G2,c2.CGP_ chemical and genetic perturbations
13815,PID_PDGFRB_PATHWAY,c2.CP_ Canonical pathways
13816,GO_METALLO_SULFUR_CLUSTER_ASSEMBLY,c5.BP_ GO biological process
13817,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,c2.CP_REACTOME_ Reactome gene sets
13818,ZHENG_IL22_SIGNALING_DN,c2.CGP_ chemical and genetic perturbations
13819,ELK1_01,c3.TFT_ transcription factor targets
13820,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP,C7_ immunologic signatures
13821,GO_CYTOSKELETAL_ADAPTOR_ACTIVITY,c5.GO molecular function
13822,GO_RNA_DEPENDENT_DNA_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
13823,GO_REGULATION_OF_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
13824,SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,c2.CP_ Canonical pathways
13825,GSE17721_CTRL_VS_POLYIC_8H_BMDC_UP,C7_ immunologic signatures
13826,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP,C7_ immunologic signatures
13827,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,C7_ immunologic signatures
13828,GO_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
13829,GO_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
13830,GSE6259_33D1_POS_DC_VS_CD8_TCELL_UP,C7_ immunologic signatures
13831,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN,C7_ immunologic signatures
13832,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP,c2.CGP_ chemical and genetic perturbations
13833,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS,c5.GO molecular function
13834,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,C7_ immunologic signatures
13835,MORF_TERF2IP,c4.CGN_ cancer gene neighborhoods
13836,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN,C7_ immunologic signatures
13837,GSE27786_NKTCELL_VS_MONO_MAC_UP,C7_ immunologic signatures
13838,GTTNYYNNGGTNA_UNKNOWN,c3.TFT_ transcription factor targets
13839,ACAWNRNSRCGG_UNKNOWN,c3.TFT_ transcription factor targets
13840,WU_HBX_TARGETS_3_UP,c2.CGP_ chemical and genetic perturbations
13841,GSE17721_CTRL_VS_LPS_8H_BMDC_UP,C7_ immunologic signatures
13842,GO_MICROBODY_PART,c5.CC_ GO cellular component
13843,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,C7_ immunologic signatures
13844,GO_AMINO_ACID_BINDING,c5.GO molecular function
13845,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN,C7_ immunologic signatures
13846,GO_LENS_FIBER_CELL_DIFFERENTIATION,c5.BP_ GO biological process
13847,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,c2.CGP_ chemical and genetic perturbations
13848,GO_POSITIVE_REGULATION_OF_LIPID_TRANSPORT,c5.BP_ GO biological process
13849,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,c2.CGP_ chemical and genetic perturbations
13850,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
13851,AGGGCCA_MIR328,c3.MIR_ microRNA targets
13852,GO_POLYSACCHARIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
13853,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
13854,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,C7_ immunologic signatures
13855,GO_PEPTIDYL_CYSTEINE_MODIFICATION,c5.BP_ GO biological process
13856,E4F1_Q6,c3.TFT_ transcription factor targets
13857,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP,C7_ immunologic signatures
13858,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,C7_ immunologic signatures
13859,MODULE_430,c4.CM_ cancer modules
13860,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP,C7_ immunologic signatures
13861,XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,c2.CGP_ chemical and genetic perturbations
13862,GTGTCAA_MIR514,c3.MIR_ microRNA targets
13863,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,C7_ immunologic signatures
13864,HINATA_NFKB_TARGETS_FIBROBLAST_UP,c2.CGP_ chemical and genetic perturbations
13865,ZHOU_TNF_SIGNALING_4HR,c2.CGP_ chemical and genetic perturbations
13866,GSE13306_RA_VS_UNTREATED_TREG_UP,C7_ immunologic signatures
13867,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_DN,C7_ immunologic signatures
13868,GO_REGULATION_OF_CELLULAR_PH,c5.BP_ GO biological process
13869,ESC_V6.5_UP_EARLY.V1_UP,C6_ oncogenic signatures
13870,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP,C7_ immunologic signatures
13871,GO_INSULIN_SECRETION,c5.BP_ GO biological process
13872,GO_REGULATION_OF_INNATE_IMMUNE_RESPONSE,c5.BP_ GO biological process
13873,GSE27786_LIN_NEG_VS_NKCELL_UP,C7_ immunologic signatures
13874,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,c2.CGP_ chemical and genetic perturbations
13875,GO_PROTEIN_MATURATION,c5.BP_ GO biological process
13876,GO_RNA_POLYMERASE_II_TRANSCRIPTION_COREPRESSOR_ACTIVITY,c5.GO molecular function
13877,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,C7_ immunologic signatures
13878,BOCHKIS_FOXA2_TARGETS,c2.CGP_ chemical and genetic perturbations
13879,KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
13880,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,C7_ immunologic signatures
13881,GCM_MAPK10,c4.CGN_ cancer gene neighborhoods
13882,GO_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL,c5.BP_ GO biological process
13883,EPPERT_CE_HSC_LSC,c2.CGP_ chemical and genetic perturbations
13884,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
13885,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_UP,C7_ immunologic signatures
13886,GO_REGULATION_OF_DENDRITE_MORPHOGENESIS,c5.BP_ GO biological process
13887,REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1,c2.CP_REACTOME_ Reactome gene sets
13888,GO_FOLIC_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
13889,GO_SARCOMERE_ORGANIZATION,c5.BP_ GO biological process
13890,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,c2.CGP_ chemical and genetic perturbations
13891,GO_FATTY_ACID_BINDING,c5.GO molecular function
13892,GO_ORGANIC_ACID_TRANSPORT,c5.BP_ GO biological process
13893,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_DN,C7_ immunologic signatures
13894,RIZKI_TUMOR_INVASIVENESS_2D_DN,c2.CGP_ chemical and genetic perturbations
13895,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP,c2.CGP_ chemical and genetic perturbations
13896,GO_GOLGI_ASSOCIATED_VESICLE,c5.CC_ GO cellular component
13897,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN,C7_ immunologic signatures
13898,MODULE_15,c4.CM_ cancer modules
13899,GSE3982_EOSINOPHIL_VS_MAC_DN,C7_ immunologic signatures
13900,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN,C7_ immunologic signatures
13901,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,c2.CGP_ chemical and genetic perturbations
13902,GCM_FANCC,c4.CGN_ cancer gene neighborhoods
13903,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN,C7_ immunologic signatures
13904,GO_GLUCAN_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
13905,PID_NECTIN_PATHWAY,c2.CP_ Canonical pathways
13906,GO_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_ENDONUCLEOLYTIC,c5.BP_ GO biological process
13907,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,c2.CGP_ chemical and genetic perturbations
13908,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,c2.CGP_ chemical and genetic perturbations
13909,GO_HISTONE_H4_ACETYLATION,c5.BP_ GO biological process
13910,DAIRKEE_CANCER_PRONE_RESPONSE_E2,c2.CGP_ chemical and genetic perturbations
13911,KEGG_RNA_DEGRADATION,c2.CP_BIOCARTA_ BioCarta gene sets
13912,MORF_RFC4,c4.CGN_ cancer gene neighborhoods
13913,PARK_HSC_AND_MULTIPOTENT_PROGENITORS,c2.CGP_ chemical and genetic perturbations
13914,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,C7_ immunologic signatures
13915,GO_GDP_BINDING,c5.GO molecular function
13916,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_UP,C7_ immunologic signatures
13917,GSE360_CTRL_VS_L_DONOVANI_MAC_DN,C7_ immunologic signatures
13918,GO_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
13919,GO_EXOCYTIC_VESICLE_MEMBRANE,c5.CC_ GO cellular component
13920,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_UP,C7_ immunologic signatures
13921,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_UP,C7_ immunologic signatures
13922,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,C7_ immunologic signatures
13923,GSE14308_TH2_VS_NATURAL_TREG_DN,C7_ immunologic signatures
13924,GO_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
13925,GO_INTERMEDIATE_FILAMENT_ORGANIZATION,c5.BP_ GO biological process
13926,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
13927,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,C7_ immunologic signatures
13928,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,C7_ immunologic signatures
13929,GO_INORGANIC_ANION_EXCHANGER_ACTIVITY,c5.GO molecular function
13930,LIU_LIVER_CANCER,c2.CGP_ chemical and genetic perturbations
13931,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,C7_ immunologic signatures
13932,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN,C7_ immunologic signatures
13933,GO_INACTIVATION_OF_MAPK_ACTIVITY,c5.BP_ GO biological process
13934,SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,c2.CGP_ chemical and genetic perturbations
13935,GO_ENDOCYTIC_VESICLE,c5.CC_ GO cellular component
13936,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,c2.CGP_ chemical and genetic perturbations
13937,EPPERT_PROGENITOR,c2.CGP_ chemical and genetic perturbations
13938,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN,C7_ immunologic signatures
13939,AMIT_EGF_RESPONSE_40_HELA,c2.CGP_ chemical and genetic perturbations
13940,LEE_LIVER_CANCER_MYC_TGFA_DN,c2.CGP_ chemical and genetic perturbations
13941,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP,C7_ immunologic signatures
13942,GO_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,c5.BP_ GO biological process
13943,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN,C7_ immunologic signatures
13944,GO_RESPONSE_TO_ELECTRICAL_STIMULUS,c5.BP_ GO biological process
13945,CHR12Q14,32
13946,GO_NEGATIVE_REGULATION_OF_HEMOPOIESIS,c5.BP_ GO biological process
13947,GUTIERREZ_MULTIPLE_MYELOMA_UP,c2.CGP_ chemical and genetic perturbations
13948,GSE17721_LPS_VS_CPG_8H_BMDC_DN,C7_ immunologic signatures
13949,MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3,c2.CGP_ chemical and genetic perturbations
13950,YTCCCRNNAGGY_UNKNOWN,c3.TFT_ transcription factor targets
13951,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP,C7_ immunologic signatures
13952,REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS,c2.CP_REACTOME_ Reactome gene sets
13953,GSE36078_WT_VS_IL1R_KO_LUNG_DC_DN,C7_ immunologic signatures
13954,CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,c2.CGP_ chemical and genetic perturbations
13955,GO_NEGATIVE_REGULATION_OF_LIPID_STORAGE,c5.BP_ GO biological process
13956,GO_REGULATION_OF_T_CELL_DIFFERENTIATION,c5.BP_ GO biological process
13957,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_DN,C7_ immunologic signatures
13958,GNF2_LCAT,c4.CGN_ cancer gene neighborhoods
13959,GO_INTERMEDIATE_FILAMENT_BASED_PROCESS,c5.BP_ GO biological process
13960,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_DN,C7_ immunologic signatures
13961,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP,C7_ immunologic signatures
13962,GO_SPERM_PART,c5.CC_ GO cellular component
13963,GO_COATED_VESICLE_MEMBRANE,c5.CC_ GO cellular component
13964,GO_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME,c5.BP_ GO biological process
13965,GO_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
13966,REACTOME_SULFUR_AMINO_ACID_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
13967,GO_POSITIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,c5.BP_ GO biological process
13968,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,C7_ immunologic signatures
13969,GO_ZYMOGEN_ACTIVATION,c5.BP_ GO biological process
13970,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_DN,C7_ immunologic signatures
13971,GO_NEUTRAL_AMINO_ACID_TRANSPORT,c5.BP_ GO biological process
13972,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP,C7_ immunologic signatures
13973,SAGIV_CD24_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
13974,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
13975,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_DN,C7_ immunologic signatures
13976,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,C7_ immunologic signatures
13977,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,C7_ immunologic signatures
13978,GO_REGULATION_OF_ICOSANOID_SECRETION,c5.BP_ GO biological process
13979,GO_NUCLEOSIDE_SALVAGE,c5.BP_ GO biological process
13980,GO_TRANSITION_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
13981,GO_CILIARY_PART,c5.CC_ GO cellular component
13982,CETS1P54_01,c3.TFT_ transcription factor targets
13983,GO_CAJAL_BODY,c5.CC_ GO cellular component
13984,GSE11924_TH1_VS_TH2_CD4_TCELL_DN,C7_ immunologic signatures
13985,GO_REGULATION_OF_ANOIKIS,c5.BP_ GO biological process
13986,LANDIS_BREAST_CANCER_PROGRESSION_UP,c2.CGP_ chemical and genetic perturbations
13987,GO_HETEROTRIMERIC_G_PROTEIN_COMPLEX,c5.CC_ GO cellular component
13988,NRL_DN.V1_UP,C6_ oncogenic signatures
13989,MIF1_01,c3.TFT_ transcription factor targets
13990,CHR2Q31,61
13991,CHR1Q41,27
13992,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP,C7_ immunologic signatures
13993,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS,c5.GO molecular function
13994,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,c2.CGP_ chemical and genetic perturbations
13995,BIOCARTA_LAIR_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
13996,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,C7_ immunologic signatures
13997,ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE,c2.CGP_ chemical and genetic perturbations
13998,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,c2.CGP_ chemical and genetic perturbations
13999,RASHI_NFKB1_TARGETS,c2.CGP_ chemical and genetic perturbations
14000,GO_EMBRYONIC_HEMOPOIESIS,c5.BP_ GO biological process
14001,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,C7_ immunologic signatures
14002,GO_PYRIDOXAL_PHOSPHATE_BINDING,c5.GO molecular function
14003,GO_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,c5.BP_ GO biological process
14004,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,c2.CGP_ chemical and genetic perturbations
14005,GO_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,c5.BP_ GO biological process
14006,GO_ACETYLTRANSFERASE_ACTIVITY,c5.GO molecular function
14007,CHR20P13,51
14008,LEE_LIVER_CANCER_ACOX1_DN,c2.CGP_ chemical and genetic perturbations
14009,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN,C7_ immunologic signatures
14010,RODWELL_AGING_KIDNEY_DN,c2.CGP_ chemical and genetic perturbations
14011,GSE17721_CTRL_VS_CPG_4H_BMDC_UP,C7_ immunologic signatures
14012,MODULE_110,c4.CM_ cancer modules
14013,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,c2.CGP_ chemical and genetic perturbations
14014,GO_EXOSOME_RNASE_COMPLEX_,c5.CC_ GO cellular component
14015,SIG_CD40PATHWAYMAP,c2.CP_ Canonical pathways
14016,BROWNE_HCMV_INFECTION_1HR_UP,c2.CGP_ chemical and genetic perturbations
14017,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,C7_ immunologic signatures
14018,GO_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,c5.BP_ GO biological process
14019,PID_ECADHERIN_KERATINOCYTE_PATHWAY,c2.CP_ Canonical pathways
14020,HEIDENBLAD_AMPLICON_12P11_12_DN,c2.CGP_ chemical and genetic perturbations
14021,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP,C7_ immunologic signatures
14022,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP,C7_ immunologic signatures
14023,KIM_MYCL1_AMPLIFICATION_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
14024,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,C7_ immunologic signatures
14025,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,C7_ immunologic signatures
14026,GO_GLYCOLIPID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
14027,GO_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,c5.CC_ GO cellular component
14028,PID_SYNDECAN_3_PATHWAY,c2.CP_ Canonical pathways
14029,GO_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,c5.BP_ GO biological process
14030,PID_HEDGEHOG_GLI_PATHWAY,c2.CP_ Canonical pathways
14031,PID_IL8_CXCR2_PATHWAY,c2.CP_ Canonical pathways
14032,ST_GAQ_PATHWAY,c2.CP_ Canonical pathways
14033,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,C7_ immunologic signatures
14034,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
14035,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN,C7_ immunologic signatures
14036,MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED,c2.CGP_ chemical and genetic perturbations
14037,GO_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,c5.BP_ GO biological process
14038,GO_REGULATION_OF_PEPTIDE_TRANSPORT,c5.BP_ GO biological process
14039,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,C7_ immunologic signatures
14040,PID_HIF2PATHWAY,c2.CP_ Canonical pathways
14041,GNF2_HPX,c4.CGN_ cancer gene neighborhoods
14042,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_DN,C7_ immunologic signatures
14043,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,C7_ immunologic signatures
14044,GSE22886_NAIVE_TCELL_VS_DC_DN,C7_ immunologic signatures
14045,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN,C7_ immunologic signatures
14046,MEISSNER_BRAIN_ICP_WITH_H3K4ME3,c2.CGP_ chemical and genetic perturbations
14047,CAFFAREL_RESPONSE_TO_THC_DN,c2.CGP_ chemical and genetic perturbations
14048,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN,C7_ immunologic signatures
14049,GO_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,c5.GO molecular function
14050,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,c2.CGP_ chemical and genetic perturbations
14051,GO_CILIUM_ORGANIZATION,c5.BP_ GO biological process
14052,GSE13887_RESTING_VS_ACT_CD4_TCELL_UP,C7_ immunologic signatures
14053,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,c2.CGP_ chemical and genetic perturbations
14054,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN,C7_ immunologic signatures
14055,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN,C7_ immunologic signatures
14056,MORF_BMPR2,c4.CGN_ cancer gene neighborhoods
14057,MODULE_295,c4.CM_ cancer modules
14058,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN,C7_ immunologic signatures
14059,GO_NUCLEOTIDE_EXCISION_REPAIR,c5.BP_ GO biological process
14060,GO_MODULATION_BY_SYMBIONT_OF_HOST_CELLULAR_PROCESS,c5.BP_ GO biological process
14061,CCAGGTT_MIR490,c3.MIR_ microRNA targets
14062,LFA1_Q6,c3.TFT_ transcription factor targets
14063,GO_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
14064,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_UP,C7_ immunologic signatures
14065,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP,C7_ immunologic signatures
14066,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,C7_ immunologic signatures
14067,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,C7_ immunologic signatures
14068,MODULE_71,c4.CM_ cancer modules
14069,MANTOVANI_VIRAL_GPCR_SIGNALING_DN,c2.CGP_ chemical and genetic perturbations
14070,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,C7_ immunologic signatures
14071,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,c2.CGP_ chemical and genetic perturbations
14072,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_UP,C7_ immunologic signatures
14073,CHR12Q24,180
14074,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_DN,C7_ immunologic signatures
14075,GNF2_SERPINB5,c4.CGN_ cancer gene neighborhoods
14076,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP,C7_ immunologic signatures
14077,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP,C7_ immunologic signatures
14078,GO_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_CELL_CELL_SIGNALING,c5.BP_ GO biological process
14079,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP,C7_ immunologic signatures
14080,GO_HEME_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
14081,GO_DOUBLE_STRANDED_RNA_BINDING,c5.GO molecular function
14082,GO_STEROL_HOMEOSTASIS,c5.BP_ GO biological process
14083,GSE43955_10H_VS_30H_ACT_CD4_TCELL_DN,C7_ immunologic signatures
14084,GO_DRUG_TRANSPORT,c5.BP_ GO biological process
14085,KEGG_LYSINE_DEGRADATION,c2.CP_BIOCARTA_ BioCarta gene sets
14086,KEGG_HEDGEHOG_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14087,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,C7_ immunologic signatures
14088,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN,C7_ immunologic signatures
14089,GO_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY,c5.GO molecular function
14090,GO_DICARBOXYLIC_ACID_CATABOLIC_PROCESS,c5.BP_ GO biological process
14091,GO_CIS_GOLGI_NETWORK,c5.CC_ GO cellular component
14092,TGTYNNNNNRGCARM_UNKNOWN,c3.TFT_ transcription factor targets
14093,KEGG_N_GLYCAN_BIOSYNTHESIS,c2.CP_BIOCARTA_ BioCarta gene sets
14094,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,c2.CGP_ chemical and genetic perturbations
14095,GO_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,c5.BP_ GO biological process
14096,GO_POSTTRANSCRIPTIONAL_GENE_SILENCING,c5.BP_ GO biological process
14097,MORF_EIF4E,c4.CGN_ cancer gene neighborhoods
14098,GO_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR,c5.BP_ GO biological process
14099,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,C7_ immunologic signatures
14100,GSE22886_NAIVE_CD4_TCELL_VS_DC_DN,C7_ immunologic signatures
14101,GO_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
14102,GO_NEGATIVE_REGULATION_OF_ENDOCYTOSIS,c5.BP_ GO biological process
14103,GO_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,c5.BP_ GO biological process
14104,GO_MATURE_B_CELL_DIFFERENTIATION,c5.BP_ GO biological process
14105,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,c2.CGP_ chemical and genetic perturbations
14106,GO_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS,c5.GO molecular function
14107,MEISSNER_BRAIN_HCP_WITH_H3K4ME2,c2.CGP_ chemical and genetic perturbations
14108,REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,c2.CP_REACTOME_ Reactome gene sets
14109,GO_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,c5.CC_ GO cellular component
14110,MORF_TPR,c4.CGN_ cancer gene neighborhoods
14111,GNF2_RAB7L1,c4.CGN_ cancer gene neighborhoods
14112,GO_BICARBONATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
14113,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP,C7_ immunologic signatures
14114,GO_RECEPTOR_SIGNALING_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,c5.GO molecular function
14115,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN,C7_ immunologic signatures
14116,REACTOME_PHASE_II_CONJUGATION,c2.CP_REACTOME_ Reactome gene sets
14117,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,C7_ immunologic signatures
14118,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP,C7_ immunologic signatures
14119,GO_CYTOKINE_RECEPTOR_ACTIVITY,c5.GO molecular function
14120,QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,c2.CGP_ chemical and genetic perturbations
14121,PID_IL8_CXCR1_PATHWAY,c2.CP_ Canonical pathways
14122,GO_TELOMERE_MAINTENANCE_VIA_TELOMERASE,c5.BP_ GO biological process
14123,GO_COATED_MEMBRANE,c5.CC_ GO cellular component
14124,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_UP,C7_ immunologic signatures
14125,GO_NEGATIVE_REGULATION_OF_DNA_BINDING,c5.BP_ GO biological process
14126,GO_ER_TO_GOLGI_TRANSPORT_VESICLE,c5.CC_ GO cellular component
14127,CGGAARNGGCNG_UNKNOWN,c3.TFT_ transcription factor targets
14128,GO_POSITIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION,c5.BP_ GO biological process
14129,GO_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,c5.BP_ GO biological process
14130,GO_MYOSIN_V_BINDING,c5.GO molecular function
14131,GO_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,c5.BP_ GO biological process
14132,GO_NUCLEAR_TRANSCRIPTIONAL_REPRESSOR_COMPLEX,c5.CC_ GO cellular component
14133,GO_MYELOID_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,c5.BP_ GO biological process
14134,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,C7_ immunologic signatures
14135,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_UP,C7_ immunologic signatures
14136,PETRETTO_HEART_MASS_QTL_CIS_DN,c2.CGP_ chemical and genetic perturbations
14137,REACTOME_SIGNALING_BY_NOTCH,c2.CP_REACTOME_ Reactome gene sets
14138,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN,C7_ immunologic signatures
14139,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,C7_ immunologic signatures
14140,GO_LIVER_REGENERATION,c5.BP_ GO biological process
14141,KAYO_AGING_MUSCLE_DN,c2.CGP_ chemical and genetic perturbations
14142,GO_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_DEHYDROGENASE,c5.BP_ GO biological process
14143,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER,c5.BP_ GO biological process
14144,GO_POSITIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,c5.BP_ GO biological process
14145,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN,C7_ immunologic signatures
14146,GO_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT,c5.BP_ GO biological process
14147,GO_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT,c5.BP_ GO biological process
14148,GO_REGULATION_OF_PROTEIN_OLIGOMERIZATION,c5.BP_ GO biological process
14149,GO_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,c5.BP_ GO biological process
14150,WEBER_METHYLATED_HCP_IN_SPERM_UP,c2.CGP_ chemical and genetic perturbations
14151,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_UP,C7_ immunologic signatures
14152,REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE,c2.CP_REACTOME_ Reactome gene sets
14153,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_UP,C7_ immunologic signatures
14154,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_UP,C7_ immunologic signatures
14155,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP,C7_ immunologic signatures
14156,GO_NEGATIVE_REGULATION_OF_CELL_AGING,c5.BP_ GO biological process
14157,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,C7_ immunologic signatures
14158,GO_TRANSCRIPTION_COACTIVATOR_ACTIVITY,c5.GO molecular function
14159,GO_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,c5.BP_ GO biological process
14160,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,C7_ immunologic signatures
14161,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN,C7_ immunologic signatures
14162,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,C7_ immunologic signatures
14163,REACTOME_TOLL_RECEPTOR_CASCADES,c2.CP_REACTOME_ Reactome gene sets
14164,GCM_SMARCD1,c4.CGN_ cancer gene neighborhoods
14165,CONRAD_STEM_CELL,c2.CGP_ chemical and genetic perturbations
14166,GO_DIOXYGENASE_ACTIVITY,c5.GO molecular function
14167,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_UP,C7_ immunologic signatures
14168,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP,C7_ immunologic signatures
14169,MODULE_411,c4.CM_ cancer modules
14170,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN,C7_ immunologic signatures
14171,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_DN,C7_ immunologic signatures
14172,GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP,C7_ immunologic signatures
14173,PPARA_02,c3.TFT_ transcription factor targets
14174,SP1_Q6_01,c3.TFT_ transcription factor targets
14175,RASHI_RESPONSE_TO_IONIZING_RADIATION_3,c2.CGP_ chemical and genetic perturbations
14176,VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN,c2.CGP_ chemical and genetic perturbations
14177,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,C7_ immunologic signatures
14178,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,C7_ immunologic signatures
14179,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_DN,C7_ immunologic signatures
14180,REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,c2.CP_REACTOME_ Reactome gene sets
14181,GO_REGULATION_OF_MITOCHONDRION_ORGANIZATION,c5.BP_ GO biological process
14182,GO_MEMBRANE_PROTEIN_INTRACELLULAR_DOMAIN_PROTEOLYSIS,c5.BP_ GO biological process
14183,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA,c2.CP_REACTOME_ Reactome gene sets
14184,GSE17721_CTRL_VS_POLYIC_1H_BMDC_UP,C7_ immunologic signatures
14185,GSE14308_TH1_VS_NATURAL_TREG_DN,C7_ immunologic signatures
14186,KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
14187,GSE7460_TCONV_VS_TREG_THYMUS_UP,C7_ immunologic signatures
14188,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,c2.CGP_ chemical and genetic perturbations
14189,GO_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_S_S_BONDS,c5.GO molecular function
14190,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,C7_ immunologic signatures
14191,GO_ER_NUCLEUS_SIGNALING_PATHWAY,c5.BP_ GO biological process
14192,CTCNANGTGNY_UNKNOWN,c3.TFT_ transcription factor targets
14193,GO_PHOTORECEPTOR_INNER_SEGMENT,c5.CC_ GO cellular component
14194,MORI_PLASMA_CELL_UP,c2.CGP_ chemical and genetic perturbations
14195,BIOCARTA_CARM_ER_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14196,PID_AVB3_OPN_PATHWAY,c2.CP_ Canonical pathways
14197,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP,C7_ immunologic signatures
14198,SESTO_RESPONSE_TO_UV_C1,c2.CGP_ chemical and genetic perturbations
14199,GO_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,c5.BP_ GO biological process
14200,GO_ACYL_COA_DEHYDROGENASE_ACTIVITY,c5.GO molecular function
14201,FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,c2.CGP_ chemical and genetic perturbations
14202,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP,C7_ immunologic signatures
14203,GSE17721_CTRL_VS_LPS_12H_BMDC_DN,C7_ immunologic signatures
14204,REACTOME_SIGNALLING_TO_RAS,c2.CP_REACTOME_ Reactome gene sets
14205,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,C7_ immunologic signatures
14206,GO_POSITIVE_REGULATION_OF_TOR_SIGNALING,c5.BP_ GO biological process
14207,GO_LIPID_HOMEOSTASIS,c5.BP_ GO biological process
14208,GSE3982_MAC_VS_BASOPHIL_UP,C7_ immunologic signatures
14209,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_NAD_P_H_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,c5.GO molecular function
14210,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,c2.CP_BIOCARTA_ BioCarta gene sets
14211,GO_ATRIOVENTRICULAR_VALVE_DEVELOPMENT,c5.BP_ GO biological process
14212,GNF2_MATK,c4.CGN_ cancer gene neighborhoods
14213,FAELT_B_CLL_WITH_VH3_21_UP,c2.CGP_ chemical and genetic perturbations
14214,GO_PURINE_NTP_DEPENDENT_HELICASE_ACTIVITY,c5.GO molecular function
14215,MORF_TERF1,c4.CGN_ cancer gene neighborhoods
14216,WANG_TARGETS_OF_MLL_CBP_FUSION_UP,c2.CGP_ chemical and genetic perturbations
14217,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,C7_ immunologic signatures
14218,CCCACAT_MIR2993P,c3.MIR_ microRNA targets
14219,GSE6259_BCELL_VS_CD4_TCELL_UP,C7_ immunologic signatures
14220,AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G,c2.CGP_ chemical and genetic perturbations
14221,GO_BILE_ACID_AND_BILE_SALT_TRANSPORT,c5.BP_ GO biological process
14222,REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS,c2.CP_REACTOME_ Reactome gene sets
14223,PID_ECADHERIN_STABILIZATION_PATHWAY,c2.CP_ Canonical pathways
14224,GO_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,c5.BP_ GO biological process
14225,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_DN,C7_ immunologic signatures
14226,CHR1Q22,56
14227,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,C7_ immunologic signatures
14228,MODULE_341,c4.CM_ cancer modules
14229,GO_GLUTAMINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,c5.BP_ GO biological process
14230,PID_AR_TF_PATHWAY,c2.CP_ Canonical pathways
14231,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_UP,C7_ immunologic signatures
14232,GSE45365_CD8A_DC_VS_CD11B_DC_DN,C7_ immunologic signatures
14233,GO_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING,c5.BP_ GO biological process
14234,GO_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
14235,GO_CELL_DEATH_IN_RESPONSE_TO_OXIDATIVE_STRESS,c5.BP_ GO biological process
14236,COUP_01,c3.TFT_ transcription factor targets
14237,GO_MAMMARY_GLAND_LOBULE_DEVELOPMENT,c5.BP_ GO biological process
14238,LEE_LIVER_CANCER_DENA_DN,c2.CGP_ chemical and genetic perturbations
14239,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_UP,C7_ immunologic signatures
14240,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN,c2.CGP_ chemical and genetic perturbations
14241,GO_KETONE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
14242,PID_HNF3B_PATHWAY,c2.CP_ Canonical pathways
14243,PID_EPHA2_FWD_PATHWAY,c2.CP_ Canonical pathways
14244,GO_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
14245,GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN,C7_ immunologic signatures
14246,STOSSI_RESPONSE_TO_ESTRADIOL,c2.CGP_ chemical and genetic perturbations
14247,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN,C7_ immunologic signatures
14248,REACTOME_NOD1_2_SIGNALING_PATHWAY,c2.CP_REACTOME_ Reactome gene sets
14249,ABE_VEGFA_TARGETS_2HR,c2.CGP_ chemical and genetic perturbations
14250,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,C7_ immunologic signatures
14251,GO_CILIUM_MORPHOGENESIS,c5.BP_ GO biological process
14252,GHANDHI_DIRECT_IRRADIATION_DN,c2.CGP_ chemical and genetic perturbations
14253,GO_INTERACTION_WITH_SYMBIONT,c5.BP_ GO biological process
14254,GO_IMMUNOLOGICAL_SYNAPSE,c5.CC_ GO cellular component
14255,USF_01,c3.TFT_ transcription factor targets
14256,GO_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING,c5.GO molecular function
14257,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP,C7_ immunologic signatures
14258,GO_PHAGOCYTOSIS,c5.BP_ GO biological process
14259,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_UP,C7_ immunologic signatures
14260,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN,C7_ immunologic signatures
14261,SESTO_RESPONSE_TO_UV_C4,c2.CGP_ chemical and genetic perturbations
14262,GO_CARBOHYDRATE_DERIVATIVE_TRANSPORT,c5.BP_ GO biological process
14263,GSE17721_4H_VS_24H_POLYIC_BMDC_DN,C7_ immunologic signatures
14264,GO_PROTEIN_ACETYLATION,c5.BP_ GO biological process
14265,GO_ASPARTATE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
14266,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,C7_ immunologic signatures
14267,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN,C7_ immunologic signatures
14268,COLDREN_GEFITINIB_RESISTANCE_UP,c2.CGP_ chemical and genetic perturbations
14269,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,C7_ immunologic signatures
14270,GO_GLANDULAR_EPITHELIAL_CELL_DEVELOPMENT,c5.BP_ GO biological process
14271,LUND_SILENCED_BY_METHYLATION,c2.CGP_ chemical and genetic perturbations
14272,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN,C7_ immunologic signatures
14273,GSE28130_ACTIVATED_VS_INDUCEED_TREG_UP,C7_ immunologic signatures
14274,GO_IMPORT_INTO_CELL,c5.BP_ GO biological process
14275,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,c2.CGP_ chemical and genetic perturbations
14276,GO_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
14277,GO_CYTOPLASMIC_MRNA_PROCESSING_BODY,c5.CC_ GO cellular component
14278,PID_CXCR3_PATHWAY,c2.CP_ Canonical pathways
14279,REACTOME_SIGNALING_BY_NOTCH1,c2.CP_REACTOME_ Reactome gene sets
14280,GO_POSITIVE_REGULATION_OF_ANION_TRANSPORT,c5.BP_ GO biological process
14281,GO_REGULATION_OF_DENDRITE_EXTENSION,c5.BP_ GO biological process
14282,PID_HDAC_CLASSII_PATHWAY,c2.CP_ Canonical pathways
14283,GO_ORGANIC_ACID_CATABOLIC_PROCESS,c5.BP_ GO biological process
14284,GSE17721_LPS_VS_POLYIC_4H_BMDC_DN,C7_ immunologic signatures
14285,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN,C7_ immunologic signatures
14286,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_DN,C7_ immunologic signatures
14287,GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_DN,C7_ immunologic signatures
14288,GO_TRANSPORT_VESICLE_MEMBRANE,c5.CC_ GO cellular component
14289,KEGG_ETHER_LIPID_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
14290,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN,C7_ immunologic signatures
14291,GCM_PPM1D,c4.CGN_ cancer gene neighborhoods
14292,GO_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE,c5.BP_ GO biological process
14293,GO_MODIFICATION_OF_MORPHOLOGY_OR_PHYSIOLOGY_OF_OTHER_ORGANISM,c5.BP_ GO biological process
14294,GSE17721_POLYIC_VS_CPG_6H_BMDC_DN,C7_ immunologic signatures
14295,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP,C7_ immunologic signatures
14296,GO_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,c5.BP_ GO biological process
14297,BIOCARTA_BCR_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14298,GSE557_CIITA_KO_VS_I_AB_KO_DC_DN,C7_ immunologic signatures
14299,CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,c2.CGP_ chemical and genetic perturbations
14300,GO_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
14301,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
14302,GO_GOLGI_STACK,c5.CC_ GO cellular component
14303,GO_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX_BINDING,c5.GO molecular function
14304,GO_ASTROCYTE_DEVELOPMENT,c5.BP_ GO biological process
14305,GO_PROTEIN_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,c5.GO molecular function
14306,GO_POSITIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,c5.BP_ GO biological process
14307,GSE17721_CTRL_VS_CPG_1H_BMDC_UP,C7_ immunologic signatures
14308,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_UP,C7_ immunologic signatures
14309,AGGGCAG_MIR18A,c3.MIR_ microRNA targets
14310,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN,C7_ immunologic signatures
14311,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,C7_ immunologic signatures
14312,GO_NEGATIVE_REGULATION_OF_NUCLEOSIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
14313,TMTCGCGANR_UNKNOWN,c3.TFT_ transcription factor targets
14314,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,c2.CGP_ chemical and genetic perturbations
14315,GO_POSITIVE_REGULATION_OF_B_CELL_PROLIFERATION,c5.BP_ GO biological process
14316,GSE36009_WT_VS_NLRP10_KO_DC_DN,C7_ immunologic signatures
14317,GNF2_CDH3,c4.CGN_ cancer gene neighborhoods
14318,GSE17721_POLYIC_VS_CPG_8H_BMDC_UP,C7_ immunologic signatures
14319,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP,C7_ immunologic signatures
14320,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
14321,NAGY_TFTC_COMPONENTS_HUMAN,c2.CGP_ chemical and genetic perturbations
14322,GO_PHOTORECEPTOR_CELL_MAINTENANCE,c5.BP_ GO biological process
14323,GO_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION,c5.BP_ GO biological process
14324,GSE3982_EOSINOPHIL_VS_BASOPHIL_DN,C7_ immunologic signatures
14325,GO_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,c5.BP_ GO biological process
14326,PARENT_MTOR_SIGNALING_DN,c2.CGP_ chemical and genetic perturbations
14327,GO_HISTONE_H2A_UBIQUITINATION,c5.BP_ GO biological process
14328,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP,C7_ immunologic signatures
14329,GO_PEPTIDYL_PROLINE_MODIFICATION,c5.BP_ GO biological process
14330,MODULE_236,c4.CM_ cancer modules
14331,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,c2.CGP_ chemical and genetic perturbations
14332,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP,C7_ immunologic signatures
14333,CHR10Q22,68
14334,HEIDENBLAD_AMPLICON_8Q24_DN,c2.CGP_ chemical and genetic perturbations
14335,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN,c2.CGP_ chemical and genetic perturbations
14336,GO_FATTY_ACID_CATABOLIC_PROCESS,c5.BP_ GO biological process
14337,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP,C7_ immunologic signatures
14338,CHR10Q26,71
14339,SREBP1_01,c3.TFT_ transcription factor targets
14340,GSE34515_CD16_NEG_MONOCYTE_VS_DC_DN,C7_ immunologic signatures
14341,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,c2.CGP_ chemical and genetic perturbations
14342,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP,C7_ immunologic signatures
14343,GO_RNA_DESTABILIZATION,c5.BP_ GO biological process
14344,MODULE_410,c4.CM_ cancer modules
14345,GO_RESPONSE_TO_CADMIUM_ION,c5.BP_ GO biological process
14346,GO_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_INTERCONVERSION,c5.BP_ GO biological process
14347,GCM_SUPT4H1,c4.CGN_ cancer gene neighborhoods
14348,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP,C7_ immunologic signatures
14349,PID_KIT_PATHWAY,c2.CP_ Canonical pathways
14350,GO_ACID_AMINO_ACID_LIGASE_ACTIVITY,c5.GO molecular function
14351,GO_TBP_CLASS_PROTEIN_BINDING,c5.GO molecular function
14352,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN,C7_ immunologic signatures
14353,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN,C7_ immunologic signatures
14354,GO_POSITIVE_REGULATION_OF_CELL_KILLING,c5.BP_ GO biological process
14355,MODULE_96,c4.CM_ cancer modules
14356,GO_POSITIVE_REGULATION_OF_PROTEIN_OLIGOMERIZATION,c5.BP_ GO biological process
14357,GO_ALDO_KETO_REDUCTASE_NADP_ACTIVITY,c5.GO molecular function
14358,MODULE_233,c4.CM_ cancer modules
14359,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP,C7_ immunologic signatures
14360,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP,C7_ immunologic signatures
14361,MORF_PTEN,c4.CGN_ cancer gene neighborhoods
14362,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_DN,C7_ immunologic signatures
14363,ALONSO_METASTASIS_NEURAL_UP,c2.CGP_ chemical and genetic perturbations
14364,GO_PROTEIN_REFOLDING,c5.BP_ GO biological process
14365,SU_LIVER,c2.CGP_ chemical and genetic perturbations
14366,GO_SOLUTE_SODIUM_SYMPORTER_ACTIVITY,c5.GO molecular function
14367,STONER_ESOPHAGEAL_CARCINOGENESIS_UP,c2.CGP_ chemical and genetic perturbations
14368,GO_PRESYNAPTIC_MEMBRANE,c5.CC_ GO cellular component
14369,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN,C7_ immunologic signatures
14370,KEGG_ALPHA_LINOLENIC_ACID_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
14371,SHIN_B_CELL_LYMPHOMA_CLUSTER_5,c2.CGP_ chemical and genetic perturbations
14372,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_DN,C7_ immunologic signatures
14373,GO_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,c5.BP_ GO biological process
14374,GO_PRE_AUTOPHAGOSOMAL_STRUCTURE_MEMBRANE,c5.CC_ GO cellular component
14375,GSE18148_CBFB_KO_VS_WT_TREG_DN,C7_ immunologic signatures
14376,JIANG_TIP30_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
14377,MARTIN_INTERACT_WITH_HDAC,c2.CGP_ chemical and genetic perturbations
14378,PID_RXR_VDR_PATHWAY,c2.CP_ Canonical pathways
14379,FARMER_BREAST_CANCER_CLUSTER_5,c2.CGP_ chemical and genetic perturbations
14380,VARELA_ZMPSTE24_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
14381,REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE,c2.CP_REACTOME_ Reactome gene sets
14382,PID_NFKAPPAB_ATYPICAL_PATHWAY,c2.CP_ Canonical pathways
14383,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN,c2.CGP_ chemical and genetic perturbations
14384,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_DN,C7_ immunologic signatures
14385,GCM_BCL2L1,c4.CGN_ cancer gene neighborhoods
14386,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP,C7_ immunologic signatures
14387,GO_CELLULAR_RESPONSE_TO_INTERLEUKIN_6,c5.BP_ GO biological process
14388,GO_WNT_SIGNALING_PATHWAY_CALCIUM_MODULATING_PATHWAY,c5.BP_ GO biological process
14389,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,C7_ immunologic signatures
14390,GO_CIS_TRANS_ISOMERASE_ACTIVITY,c5.GO molecular function
14391,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,C7_ immunologic signatures
14392,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN,C7_ immunologic signatures
14393,TNCATNTCCYR_UNKNOWN,c3.TFT_ transcription factor targets
14394,GO_REGULATION_OF_RECEPTOR_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
14395,KANNAN_TP53_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
14396,GO_RECEPTOR_SIGNALING_PROTEIN_ACTIVITY,c5.GO molecular function
14397,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN,C7_ immunologic signatures
14398,PID_IL4_2PATHWAY,c2.CP_ Canonical pathways
14399,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP,C7_ immunologic signatures
14400,ZHAN_MULTIPLE_MYELOMA_MF_DN,c2.CGP_ chemical and genetic perturbations
14401,DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,c2.CGP_ chemical and genetic perturbations
14402,GSE27786_NKCELL_VS_NEUTROPHIL_UP,C7_ immunologic signatures
14403,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_DN,C7_ immunologic signatures
14404,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP,C7_ immunologic signatures
14405,GO_GTP_RHO_BINDING,c5.GO molecular function
14406,KEGG_ACUTE_MYELOID_LEUKEMIA,c2.CP_BIOCARTA_ BioCarta gene sets
14407,REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION,c2.CP_REACTOME_ Reactome gene sets
14408,SESTO_RESPONSE_TO_UV_C0,c2.CGP_ chemical and genetic perturbations
14409,PID_HNF3A_PATHWAY,c2.CP_ Canonical pathways
14410,GO_NEGATIVE_REGULATION_OF_RECEPTOR_ACTIVITY,c5.BP_ GO biological process
14411,DOANE_BREAST_CANCER_CLASSES_UP,c2.CGP_ chemical and genetic perturbations
14412,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,C7_ immunologic signatures
14413,MODULE_545,c4.CM_ cancer modules
14414,GO_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,c5.BP_ GO biological process
14415,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,C7_ immunologic signatures
14416,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,C7_ immunologic signatures
14417,REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION,c2.CP_REACTOME_ Reactome gene sets
14418,YANG_BREAST_CANCER_ESR1_BULK_UP,c2.CGP_ chemical and genetic perturbations
14419,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_UP,C7_ immunologic signatures
14420,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B,c2.CGP_ chemical and genetic perturbations
14421,GO_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION,c5.BP_ GO biological process
14422,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,c2.CP_REACTOME_ Reactome gene sets
14423,WANG_RESPONSE_TO_FORSKOLIN_UP,c2.CGP_ chemical and genetic perturbations
14424,GO_CELLULAR_RESPONSE_TO_PH,c5.BP_ GO biological process
14425,GO_SUBSTANTIA_NIGRA_DEVELOPMENT,c5.BP_ GO biological process
14426,GO_MACROMOLECULE_DEACYLATION,c5.BP_ GO biological process
14427,GO_CILIARY_BASAL_BODY,c5.CC_ GO cellular component
14428,CHR13Q12,57
14429,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,C7_ immunologic signatures
14430,GO_REGULATION_OF_METANEPHROS_DEVELOPMENT,c5.BP_ GO biological process
14431,GO_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
14432,GO_NUCLEAR_IMPORT,c5.BP_ GO biological process
14433,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_DN,C7_ immunologic signatures
14434,GO_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_EXONUCLEOLYTIC,c5.BP_ GO biological process
14435,GO_CILIARY_MEMBRANE,c5.CC_ GO cellular component
14436,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN,C7_ immunologic signatures
14437,BIOCARTA_GH_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14438,GO_CELLULAR_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR_STIMULUS,c5.BP_ GO biological process
14439,GSE42724_B1_BCELL_VS_PLASMABLAST_DN,C7_ immunologic signatures
14440,GO_POSITIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,c5.BP_ GO biological process
14441,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN,C7_ immunologic signatures
14442,CAFFAREL_RESPONSE_TO_THC_24HR_5_UP,c2.CGP_ chemical and genetic perturbations
14443,GSE2826_WT_VS_BTK_KO_BCELL_UP,C7_ immunologic signatures
14444,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,c2.CGP_ chemical and genetic perturbations
14445,GO_COATED_VESICLE,c5.CC_ GO cellular component
14446,GO_EXCRETION,c5.BP_ GO biological process
14447,DITTMER_PTHLH_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
14448,REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS,c2.CP_REACTOME_ Reactome gene sets
14449,GO_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,c5.BP_ GO biological process
14450,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP,C7_ immunologic signatures
14451,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,c2.CGP_ chemical and genetic perturbations
14452,DUTTA_APOPTOSIS_VIA_NFKB,c2.CGP_ chemical and genetic perturbations
14453,GO_CELLULAR_MODIFIED_AMINO_ACID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
14454,GO_L_ASCORBIC_ACID_BINDING,c5.GO molecular function
14455,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP,C7_ immunologic signatures
14456,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN,C7_ immunologic signatures
14457,GO_RRNA_CATABOLIC_PROCESS,c5.BP_ GO biological process
14458,GO_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS,c5.BP_ GO biological process
14459,GO_FOREBRAIN_CELL_MIGRATION,c5.BP_ GO biological process
14460,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,c2.CGP_ chemical and genetic perturbations
14461,GO_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS,c5.BP_ GO biological process
14462,GO_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING,c5.GO molecular function
14463,REACTOME_PKB_MEDIATED_EVENTS,c2.CP_REACTOME_ Reactome gene sets
14464,GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP,C7_ immunologic signatures
14465,GO_POSITIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,c5.BP_ GO biological process
14466,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN,C7_ immunologic signatures
14467,GNF2_CASP1,c4.CGN_ cancer gene neighborhoods
14468,GO_REGULATION_OF_MRNA_METABOLIC_PROCESS,c5.BP_ GO biological process
14469,MATZUK_MALE_REPRODUCTION_SERTOLI,c2.CGP_ chemical and genetic perturbations
14470,REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,c2.CP_REACTOME_ Reactome gene sets
14471,GO_PROTEIN_IMPORT,c5.BP_ GO biological process
14472,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP,C7_ immunologic signatures
14473,REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP,c2.CP_REACTOME_ Reactome gene sets
14474,VALK_AML_CLUSTER_5,c2.CGP_ chemical and genetic perturbations
14475,GO_POSITIVE_REGULATION_OF_MRNA_PROCESSING,c5.BP_ GO biological process
14476,KYNG_WERNER_SYNDROM_DN,c2.CGP_ chemical and genetic perturbations
14477,GO_SUPEROXIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
14478,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_UP,C7_ immunologic signatures
14479,GUO_HEX_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
14480,GO_GLUTAMATE_METABOLIC_PROCESS,c5.BP_ GO biological process
14481,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP,c2.CGP_ chemical and genetic perturbations
14482,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,c2.CGP_ chemical and genetic perturbations
14483,TCTGGAC_MIR198,c3.MIR_ microRNA targets
14484,GO_ASPARTATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,c5.BP_ GO biological process
14485,GO_COFACTOR_CATABOLIC_PROCESS,c5.BP_ GO biological process
14486,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_DN,C7_ immunologic signatures
14487,MORF_SNRP70,c4.CGN_ cancer gene neighborhoods
14488,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_2_OXOGLUTARATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_EACH_OF_OXYGEN_INTO_BOTH_DONORS,c5.GO molecular function
14489,BIOCARTA_NKT_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14490,GO_N_METHYLTRANSFERASE_ACTIVITY,c5.GO molecular function
14491,GO_METHYL_CPG_BINDING,c5.GO molecular function
14492,WHITEHURST_PACLITAXEL_SENSITIVITY,c2.CGP_ chemical and genetic perturbations
14493,GO_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
14494,GO_FILOPODIUM_ASSEMBLY,c5.BP_ GO biological process
14495,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE,c2.CP_REACTOME_ Reactome gene sets
14496,PID_HDAC_CLASSI_PATHWAY,c2.CP_ Canonical pathways
14497,GNF2_TTN,c4.CGN_ cancer gene neighborhoods
14498,GO_GENE_SILENCING,c5.BP_ GO biological process
14499,KEGG_ENDOMETRIAL_CANCER,c2.CP_BIOCARTA_ BioCarta gene sets
14500,GO_HORMONE_RECEPTOR_BINDING,c5.GO molecular function
14501,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN,C7_ immunologic signatures
14502,GO_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT,c5.BP_ GO biological process
14503,GO_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX,c5.CC_ GO cellular component
14504,GO_MOTILE_CILIUM,c5.CC_ GO cellular component
14505,GKCGCNNNNNNNTGAYG_UNKNOWN,c3.TFT_ transcription factor targets
14506,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP,C7_ immunologic signatures
14507,MODULE_36,c4.CM_ cancer modules
14508,GO_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,c5.BP_ GO biological process
14509,GO_REGULATION_OF_PRI_MIRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER,c5.BP_ GO biological process
14510,GO_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,c5.BP_ GO biological process
14511,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP,C7_ immunologic signatures
14512,RACTNNRTTTNC_UNKNOWN,c3.TFT_ transcription factor targets
14513,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,c2.CP_BIOCARTA_ BioCarta gene sets
14514,GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS,c5.BP_ GO biological process
14515,CHR8Q21,44
14516,BOYLAN_MULTIPLE_MYELOMA_C_UP,c2.CGP_ chemical and genetic perturbations
14517,GO_PHOSPHATIDIC_ACID_METABOLIC_PROCESS,c5.BP_ GO biological process
14518,GO_CELLULAR_CARBOHYDRATE_CATABOLIC_PROCESS,c5.BP_ GO biological process
14519,REACTOME_TRIF_MEDIATED_TLR3_SIGNALING,c2.CP_REACTOME_ Reactome gene sets
14520,KEGG_ERBB_SIGNALING_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14521,KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,c2.CP_BIOCARTA_ BioCarta gene sets
14522,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,C7_ immunologic signatures
14523,GO_RESPONSE_TO_INTERLEUKIN_6,c5.BP_ GO biological process
14524,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN,C7_ immunologic signatures
14525,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP,c2.CGP_ chemical and genetic perturbations
14526,GO_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY,c5.GO molecular function
14527,GO_RECEPTOR_SIGNALING_COMPLEX_SCAFFOLD_ACTIVITY,c5.GO molecular function
14528,GO_MONOCARBOXYLIC_ACID_CATABOLIC_PROCESS,c5.BP_ GO biological process
14529,GO_ATPASE_BINDING,c5.GO molecular function
14530,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,c2.CGP_ chemical and genetic perturbations
14531,SCHEIDEREIT_IKK_TARGETS,c2.CGP_ chemical and genetic perturbations
14532,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_DN,C7_ immunologic signatures
14533,KANG_GLIS3_TARGETS,c2.CGP_ chemical and genetic perturbations
14534,GNF2_MCL1,c4.CGN_ cancer gene neighborhoods
14535,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,c2.CGP_ chemical and genetic perturbations
14536,GO_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
14537,KAAB_FAILED_HEART_ATRIUM_UP,c2.CGP_ chemical and genetic perturbations
14538,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_UP,C7_ immunologic signatures
14539,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,c2.CGP_ chemical and genetic perturbations
14540,GO_NEGATIVE_REGULATION_OF_GENE_SILENCING,c5.BP_ GO biological process
14541,GO_POSITIVE_REGULATION_OF_B_CELL_ACTIVATION,c5.BP_ GO biological process
14542,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_UP,C7_ immunologic signatures
14543,MODULE_59,c4.CM_ cancer modules
14544,GO_MACROMOLECULE_METHYLATION,c5.BP_ GO biological process
14545,BIOCARTA_CHREBP2_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14546,DORN_ADENOVIRUS_INFECTION_12HR_UP,c2.CGP_ chemical and genetic perturbations
14547,REACTOME_METAL_ION_SLC_TRANSPORTERS,c2.CP_REACTOME_ Reactome gene sets
14548,GO_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
14549,VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,c2.CGP_ chemical and genetic perturbations
14550,GO_METAL_CLUSTER_BINDING,c5.GO molecular function
14551,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN,C7_ immunologic signatures
14552,REACTOME_PYRIMIDINE_METABOLISM,c2.CP_REACTOME_ Reactome gene sets
14553,GO_REGULATION_OF_MYOBLAST_FUSION,c5.BP_ GO biological process
14554,GO_REGULATION_OF_PROTEIN_ACTIVATION_CASCADE,c5.BP_ GO biological process
14555,CHR11Q11,40
14556,GO_NUCLEOTIDE_SUGAR_METABOLIC_PROCESS,c5.BP_ GO biological process
14557,GO_NUCLEAR_SPECK,c5.CC_ GO cellular component
14558,GO_POSITIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,c5.BP_ GO biological process
14559,RAMASWAMY_METASTASIS_UP,c2.CGP_ chemical and genetic perturbations
14560,KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,c2.CP_BIOCARTA_ BioCarta gene sets
14561,BIOCARTA_RAC1_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14562,GO_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX,c5.CC_ GO cellular component
14563,REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP,c2.CP_REACTOME_ Reactome gene sets
14564,GO_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS,c5.BP_ GO biological process
14565,KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,c2.CP_BIOCARTA_ BioCarta gene sets
14566,MORF_BECN1,c4.CGN_ cancer gene neighborhoods
14567,MODULE_226,c4.CM_ cancer modules
14568,GO_NCRNA_CATABOLIC_PROCESS,c5.BP_ GO biological process
14569,GO_POLYSACCHARIDE_CATABOLIC_PROCESS,c5.BP_ GO biological process
14570,GO_PEPTIDE_N_ACETYLTRANSFERASE_ACTIVITY,c5.GO molecular function
14571,NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON,c2.CGP_ chemical and genetic perturbations
14572,GO_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS,c5.BP_ GO biological process
14573,REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,c2.CP_REACTOME_ Reactome gene sets
14574,GO_CALCIUM_ACTIVATED_CATION_CHANNEL_ACTIVITY,c5.GO molecular function
14575,GO_SPERMATID_DIFFERENTIATION,c5.BP_ GO biological process
14576,PID_NCADHERIN_PATHWAY,c2.CP_ Canonical pathways
14577,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN,C7_ immunologic signatures
14578,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,C7_ immunologic signatures
14579,GO_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
14580,MODULE_73,c4.CM_ cancer modules
14581,GO_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,c5.BP_ GO biological process
14582,GO_TRANSCRIPTION_FACTOR_TFIID_COMPLEX,c5.CC_ GO cellular component
14583,GO_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
14584,REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS,c2.CP_REACTOME_ Reactome gene sets
14585,GO_CLATHRIN_COATED_ENDOCYTIC_VESICLE_MEMBRANE,c5.CC_ GO cellular component
14586,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,C7_ immunologic signatures
14587,JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER,c2.CGP_ chemical and genetic perturbations
14588,KORKOLA_SEMINOMA_UP,c2.CGP_ chemical and genetic perturbations
14589,GO_ODORANT_BINDING,c5.GO molecular function
14590,CHR16P13,198
14591,LUI_THYROID_CANCER_PAX8_PPARG_UP,c2.CGP_ chemical and genetic perturbations
14592,STARK_HYPPOCAMPUS_22Q11_DELETION_DN,c2.CGP_ chemical and genetic perturbations
14593,GNF2_FGR,c4.CGN_ cancer gene neighborhoods
14594,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN,C7_ immunologic signatures
14595,GO_CHROMATIN_SILENCING_AT_RDNA,c5.BP_ GO biological process
14596,FRASOR_TAMOXIFEN_RESPONSE_UP,c2.CGP_ chemical and genetic perturbations
14597,GO_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,c5.BP_ GO biological process
14598,GCCATNTTG_YY1_Q6,c3.TFT_ transcription factor targets
14599,GO_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,c5.BP_ GO biological process
14600,GO_AMINO_ACID_BETAINE_METABOLIC_PROCESS,c5.BP_ GO biological process
14601,BIOCARTA_EIF4_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14602,REACTOME_SIGNALLING_TO_ERKS,c2.CP_REACTOME_ Reactome gene sets
14603,GO_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,c5.BP_ GO biological process
14604,GNF2_JAK1,c4.CGN_ cancer gene neighborhoods
14605,GO_INTRINSIC_COMPONENT_OF_ENDOPLASMIC_RETICULUM_MEMBRANE,c5.CC_ GO cellular component
14606,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN,c2.CGP_ chemical and genetic perturbations
14607,GO_PH_REDUCTION,c5.BP_ GO biological process
14608,CHOI_ATL_CHRONIC_VS_ACUTE_DN,c2.CGP_ chemical and genetic perturbations
14609,GO_PROTEIN_EXPORT_FROM_NUCLEUS,c5.BP_ GO biological process
14610,MODULE_4,c4.CM_ cancer modules
14611,GO_CELLULAR_DEFENSE_RESPONSE,c5.BP_ GO biological process
14612,GO_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS,c5.BP_ GO biological process
14613,PID_PDGFRA_PATHWAY,c2.CP_ Canonical pathways
14614,PID_MTOR_4PATHWAY,c2.CP_ Canonical pathways
14615,CHR9Q21,36
14616,GO_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
14617,REACTOME_RNA_POL_I_TRANSCRIPTION,c2.CP_REACTOME_ Reactome gene sets
14618,GO_POSITIVE_REGULATION_OF_NUCLEASE_ACTIVITY,c5.BP_ GO biological process
14619,GO_PHOSPHATASE_INHIBITOR_ACTIVITY,c5.GO molecular function
14620,GO_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS,c5.BP_ GO biological process
14621,PID_PI3KCI_PATHWAY,c2.CP_ Canonical pathways
14622,GO_ATPASE_REGULATOR_ACTIVITY,c5.GO molecular function
14623,GO_CELLULAR_RESPONSE_TO_GROWTH_HORMONE_STIMULUS,c5.BP_ GO biological process
14624,MARKS_HDAC_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
14625,GGCNKCCATNK_UNKNOWN,c3.TFT_ transcription factor targets
14626,GO_REGULATION_OF_MONOCYTE_CHEMOTAXIS,c5.BP_ GO biological process
14627,GO_NEURONAL_POSTSYNAPTIC_DENSITY,c5.CC_ GO cellular component
14628,BIOCARTA_KERATINOCYTE_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14629,PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,c2.CGP_ chemical and genetic perturbations
14630,GO_SIGNAL_SEQUENCE_BINDING,c5.GO molecular function
14631,GO_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
14632,MORF_RAB3A,c4.CGN_ cancer gene neighborhoods
14633,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES,c2.CP_BIOCARTA_ BioCarta gene sets
14634,GO_HISTONE_MRNA_METABOLIC_PROCESS,c5.BP_ GO biological process
14635,AGCGCTT_MIR518F_MIR518E_MIR518A,c3.MIR_ microRNA targets
14636,REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,c2.CP_REACTOME_ Reactome gene sets
14637,GO_CEREBRAL_CORTEX_RADIALLY_ORIENTED_CELL_MIGRATION,c5.BP_ GO biological process
14638,GNF2_BNIP2,c4.CGN_ cancer gene neighborhoods
14639,GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN,c5.GO molecular function
14640,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_UP,C7_ immunologic signatures
14641,GNF2_CASP4,c4.CGN_ cancer gene neighborhoods
14642,GO_NUCLEOTIDE_EXCISION_REPAIR_DNA_INCISION,c5.BP_ GO biological process
14643,MODULE_278,c4.CM_ cancer modules
14644,REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,c2.CP_REACTOME_ Reactome gene sets
14645,GO_PROLINE_RICH_REGION_BINDING,c5.GO molecular function
14646,REACTOME_SIGNALING_BY_ROBO_RECEPTOR,c2.CP_REACTOME_ Reactome gene sets
14647,GO_INTERMEDIATE_FILAMENT,c5.CC_ GO cellular component
14648,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,c2.CGP_ chemical and genetic perturbations
14649,GO_RETROGRADE_TRANSPORT_VESICLE_RECYCLING_WITHIN_GOLGI,c5.BP_ GO biological process
14650,GO_POST_GOLGI_VESICLE_MEDIATED_TRANSPORT,c5.BP_ GO biological process
14651,HEDENFALK_BREAST_CANCER_BRACX_DN,c2.CGP_ chemical and genetic perturbations
14652,CHESLER_BRAIN_HIGHEST_EXPRESSION,c2.CGP_ chemical and genetic perturbations
14653,ABBUD_LIF_SIGNALING_1_DN,c2.CGP_ chemical and genetic perturbations
14654,GO_MODIFICATION_BY_SYMBIONT_OF_HOST_MORPHOLOGY_OR_PHYSIOLOGY,c5.BP_ GO biological process
14655,GO_EPIBOLY,c5.BP_ GO biological process
14656,GO_CLATHRIN_COAT_OF_COATED_PIT,c5.CC_ GO cellular component
14657,GO_ACTIVATION_OF_NF_KAPPAB_INDUCING_KINASE_ACTIVITY,c5.BP_ GO biological process
14658,GO_HISTONE_METHYLTRANSFERASE_ACTIVITY,c5.GO molecular function
14659,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN,c2.CGP_ chemical and genetic perturbations
14660,MORF_CDC16,c4.CGN_ cancer gene neighborhoods
14661,GTGGTGA_MIR197,c3.MIR_ microRNA targets
14662,GO_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,c5.BP_ GO biological process
14663,GO_PROTEIN_MANNOSYLATION,c5.BP_ GO biological process
14664,BIOCARTA_TFF_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14665,REACTOME_BASE_EXCISION_REPAIR,c2.CP_REACTOME_ Reactome gene sets
14666,GO_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE,c5.CC_ GO cellular component
14667,GO_PEROXISOME_ORGANIZATION,c5.BP_ GO biological process
14668,MODULE_35,c4.CM_ cancer modules
14669,REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT,c2.CP_REACTOME_ Reactome gene sets
14670,BIOCARTA_CK1_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14671,BIOCARTA_RHO_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14672,GNF2_PTPN4,c4.CGN_ cancer gene neighborhoods
14673,MODULE_281,c4.CM_ cancer modules
14674,GO_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,c5.BP_ GO biological process
14675,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
14676,GO_PHAGOCYTIC_CUP,c5.CC_ GO cellular component
14677,GO_MYELIN_ASSEMBLY,c5.BP_ GO biological process
14678,GO_HISTONE_UBIQUITINATION,c5.BP_ GO biological process
14679,HALLMARK_PROTEIN_SECRETION,H_ hallmark gene sets
14680,GO_REGULATION_OF_PROTEIN_PHOSPHATASE_TYPE_2A_ACTIVITY,c5.BP_ GO biological process
14681,MODULE_82,c4.CM_ cancer modules
14682,REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY,c2.CP_REACTOME_ Reactome gene sets
14683,GO_PROTEIN_METHYLTRANSFERASE_ACTIVITY,c5.GO molecular function
14684,GO_REGULATION_OF_MYELINATION,c5.BP_ GO biological process
14685,WANG_THOC1_TARGETS_DN,c2.CGP_ chemical and genetic perturbations
14686,GO_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,c5.BP_ GO biological process
14687,GO_PROTEIN_LOCALIZATION_TO_LYSOSOME,c5.BP_ GO biological process
14688,GO_PYRIMIDINE_NUCLEOBASE_METABOLIC_PROCESS,c5.BP_ GO biological process
14689,GO_REGULATION_OF_HISTONE_H3_K4_METHYLATION,c5.BP_ GO biological process
14690,GCM_CHUK,c4.CGN_ cancer gene neighborhoods
14691,REACTOME_PERK_REGULATED_GENE_EXPRESSION,c2.CP_REACTOME_ Reactome gene sets
14692,GO_RAN_GTPASE_BINDING,c5.GO molecular function
14693,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,c2.CGP_ chemical and genetic perturbations
14694,GO_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE,c5.CC_ GO cellular component
14695,GO_HISTONE_DEACETYLASE_COMPLEX,c5.CC_ GO cellular component
14696,GNF2_PTPN6,c4.CGN_ cancer gene neighborhoods
14697,GO_PEPTIDASE_ACTIVATOR_ACTIVITY,c5.GO molecular function
14698,GO_NEGATIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,c5.BP_ GO biological process
14699,GO_PLASMA_LIPOPROTEIN_PARTICLE_CLEARANCE,c5.BP_ GO biological process
14700,GO_TELENCEPHALON_GLIAL_CELL_MIGRATION,c5.BP_ GO biological process
14701,GO_ESTABLISHMENT_OF_ENDOTHELIAL_BARRIER,c5.BP_ GO biological process
14702,GO_GRANULOCYTE_ACTIVATION,c5.BP_ GO biological process
14703,CHR15Q11,24
14704,MEISSNER_NPC_ICP_WITH_H3K4ME3,c2.CGP_ chemical and genetic perturbations
14705,GO_POSITIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,c5.BP_ GO biological process
14706,ST_INTERLEUKIN_4_PATHWAY,c2.CP_ Canonical pathways
14707,PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,c2.CP_ Canonical pathways
14708,GNF2_SELL,c4.CGN_ cancer gene neighborhoods
14709,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,c2.CP_REACTOME_ Reactome gene sets
14710,REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER,c2.CP_REACTOME_ Reactome gene sets
14711,GO_ALDITOL_PHOSPHATE_METABOLIC_PROCESS,c5.BP_ GO biological process
14712,GNF2_CD7,c4.CGN_ cancer gene neighborhoods
14713,GCM_TEC,c4.CGN_ cancer gene neighborhoods
14714,GO_PORE_COMPLEX_ASSEMBLY,c5.BP_ GO biological process
14715,NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,c2.CGP_ chemical and genetic perturbations
14716,KEGG_NUCLEOTIDE_EXCISION_REPAIR,c2.CP_BIOCARTA_ BioCarta gene sets
14717,REACTOME_SYNTHESIS_OF_PC,c2.CP_REACTOME_ Reactome gene sets
14718,GO_POSITIVE_REGULATION_OF_LIPID_STORAGE,c5.BP_ GO biological process
14719,GO_CYTOPLASMIC_SEQUESTERING_OF_TRANSCRIPTION_FACTOR,c5.BP_ GO biological process
14720,GNF2_RPA1,c4.CGN_ cancer gene neighborhoods
14721,GO_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_BINDING,c5.GO molecular function
14722,BIOCARTA_IGF1MTOR_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14723,MORF_SS18,c4.CGN_ cancer gene neighborhoods
14724,GO_REGULATION_OF_PROTEIN_HOMODIMERIZATION_ACTIVITY,c5.BP_ GO biological process
14725,GO_ERBB_SIGNALING_PATHWAY,c5.BP_ GO biological process
14726,CTCTAGA_MIR526C_MIR518F_MIR526A,c3.MIR_ microRNA targets
14727,REACTOME_ACTIVATION_OF_GENES_BY_ATF4,c2.CP_REACTOME_ Reactome gene sets
14728,WANG_RESPONSE_TO_ANDROGEN_UP,c2.CGP_ chemical and genetic perturbations
14729,KEGG_PRION_DISEASES,c2.CP_BIOCARTA_ BioCarta gene sets
14730,DORSAM_HOXA9_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
14731,CHR4Q24,17
14732,GO_REGULATION_OF_ISOTYPE_SWITCHING,c5.BP_ GO biological process
14733,GCM_NUMA1,c4.CGN_ cancer gene neighborhoods
14734,GCM_DENR,c4.CGN_ cancer gene neighborhoods
14735,GO_EXCITATORY_POSTSYNAPTIC_POTENTIAL,c5.BP_ GO biological process
14736,GCM_CSNK1D,c4.CGN_ cancer gene neighborhoods
14737,FINETTI_BREAST_CANCERS_KINOME_GRAY,c2.CGP_ chemical and genetic perturbations
14738,PID_LKB1_PATHWAY,c2.CP_ Canonical pathways
14739,REACTOME_EGFR_DOWNREGULATION,c2.CP_REACTOME_ Reactome gene sets
14740,GO_BETA_TUBULIN_BINDING,c5.GO molecular function
14741,CHR7Q35,24
14742,GTCTACC_MIR379,c3.MIR_ microRNA targets
14743,BIOCARTA_ACTINY_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14744,PID_ARF6_DOWNSTREAM_PATHWAY,c2.CP_ Canonical pathways
14745,GO_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT,c5.BP_ GO biological process
14746,REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,c2.CP_REACTOME_ Reactome gene sets
14747,GO_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX,c5.CC_ GO cellular component
14748,GO_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,c5.BP_ GO biological process
14749,GO_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_VACUOLE,c5.BP_ GO biological process
14750,GO_SYNTAXIN_1_BINDING,c5.GO molecular function
14751,GO_REGULATION_OF_ANION_TRANSMEMBRANE_TRANSPORT,c5.BP_ GO biological process
14752,NICK_RESPONSE_TO_PROC_TREATMENT_DN,c2.CGP_ chemical and genetic perturbations
14753,PID_CD40_PATHWAY,c2.CP_ Canonical pathways
14754,GO_STEROID_CATABOLIC_PROCESS,c5.BP_ GO biological process
14755,GO_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,c5.BP_ GO biological process
14756,GO_NUCLEAR_PORE,c5.CC_ GO cellular component
14757,GO_MONOVALENT_INORGANIC_ANION_HOMEOSTASIS,c5.BP_ GO biological process
14758,KONDO_COLON_CANCER_HCP_WITH_H3K27ME1,c2.CGP_ chemical and genetic perturbations
14759,GO_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,c5.BP_ GO biological process
14760,CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE,c2.CGP_ chemical and genetic perturbations
14761,KEGG_BASAL_TRANSCRIPTION_FACTORS,c2.CP_BIOCARTA_ BioCarta gene sets
14762,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN,c2.CGP_ chemical and genetic perturbations
14763,REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING,c2.CP_REACTOME_ Reactome gene sets
14764,KEGG_ASCORBATE_AND_ALDARATE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
14765,GO_AXONEME_PART,c5.CC_ GO cellular component
14766,BIOCARTA_STRESS_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14767,REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES,c2.CP_REACTOME_ Reactome gene sets
14768,GNF2_RAP1B,c4.CGN_ cancer gene neighborhoods
14769,GO_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
14770,GO_REGULATION_OF_PROTEIN_SUMOYLATION,c5.BP_ GO biological process
14771,CHR2Q12,33
14772,GO_MRNA_TRANSCRIPTION,c5.BP_ GO biological process
14773,IKEDA_MIR133_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
14774,CHR2P14,21
14775,REACTOME_DEFENSINS,c2.CP_REACTOME_ Reactome gene sets
14776,GO_HISTONE_H3_DEACETYLATION,c5.BP_ GO biological process
14777,MODULE_86,c4.CM_ cancer modules
14778,GOLUB_ALL_VS_AML_DN,c2.CGP_ chemical and genetic perturbations
14779,GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,c5.BP_ GO biological process
14780,REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT,c2.CP_REACTOME_ Reactome gene sets
14781,GO_REGULATION_OF_POSTTRANSCRIPTIONAL_GENE_SILENCING,c5.BP_ GO biological process
14782,GO_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,c5.BP_ GO biological process
14783,GO_MISFOLDED_OR_INCOMPLETELY_SYNTHESIZED_PROTEIN_CATABOLIC_PROCESS,c5.BP_ GO biological process
14784,GO_BILE_ACID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
14785,GO_PHAGOSOME_ACIDIFICATION,c5.BP_ GO biological process
14786,GO_PROTEIN_ADP_RIBOSYLATION,c5.BP_ GO biological process
14787,CHR13Q32,26
14788,HUMMERICH_MALIGNANT_SKIN_TUMOR_DN,c2.CGP_ chemical and genetic perturbations
14789,GO_TRNA_TRANSPORT,c5.BP_ GO biological process
14790,GCM_BAG5,c4.CGN_ cancer gene neighborhoods
14791,REACTOME_ZINC_TRANSPORTERS,c2.CP_REACTOME_ Reactome gene sets
14792,GO_EXON_EXON_JUNCTION_COMPLEX,c5.CC_ GO cellular component
14793,GO_FLAVONOID_METABOLIC_PROCESS,c5.BP_ GO biological process
14794,GO_PIRNA_METABOLIC_PROCESS,c5.BP_ GO biological process
14795,GO_FATTY_ACID_DERIVATIVE_TRANSPORT,c5.BP_ GO biological process
14796,WEBER_METHYLATED_ICP_IN_FIBROBLAST,c2.CGP_ chemical and genetic perturbations
14797,GO_DETECTION_OF_TEMPERATURE_STIMULUS,c5.BP_ GO biological process
14798,PHESSE_TARGETS_OF_APC_AND_MBD2_UP,c2.CGP_ chemical and genetic perturbations
14799,GO_XY_BODY,c5.CC_ GO cellular component
14800,GO_POSITIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,c5.BP_ GO biological process
14801,MODULE_368,c4.CM_ cancer modules
14802,GO_INOSITOL_PHOSPHATE_MEDIATED_SIGNALING,c5.BP_ GO biological process
14803,REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS,c2.CP_REACTOME_ Reactome gene sets
14804,GO_MEMBRANE_RAFT_ORGANIZATION,c5.BP_ GO biological process
14805,GO_SODIUM_CHANNEL_COMPLEX,c5.CC_ GO cellular component
14806,KEGG_GRAFT_VERSUS_HOST_DISEASE,c2.CP_BIOCARTA_ BioCarta gene sets
14807,GO_OLFACTORY_BULB_INTERNEURON_DIFFERENTIATION,c5.BP_ GO biological process
14808,GO_NARROW_PORE_CHANNEL_ACTIVITY,c5.GO molecular function
14809,REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS,c2.CP_REACTOME_ Reactome gene sets
14810,GO_REGULATION_OF_INTERLEUKIN_8_SECRETION,c5.BP_ GO biological process
14811,GO_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,c5.BP_ GO biological process
14812,GO_MALE_MEIOSIS_I,c5.BP_ GO biological process
14813,GO_ESTABLISHMENT_OF_TISSUE_POLARITY,c5.BP_ GO biological process
14814,CHR7P12,15
14815,GO_RETINOL_DEHYDROGENASE_ACTIVITY,c5.GO molecular function
14816,GO_POSITIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
14817,NIELSEN_LIPOSARCOMA_UP,c2.CGP_ chemical and genetic perturbations
14818,BIOCARTA_COMP_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14819,GO_INORGANIC_ION_IMPORT_INTO_CELL,c5.BP_ GO biological process
14820,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,c2.CGP_ chemical and genetic perturbations
14821,GO_REGULATION_OF_INTERLEUKIN_13_PRODUCTION,c5.BP_ GO biological process
14822,MODULE_431,c4.CM_ cancer modules
14823,GO_NITRIC_OXIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
14824,MODULE_267,c4.CM_ cancer modules
14825,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP,c2.CGP_ chemical and genetic perturbations
14826,GENTLES_LEUKEMIC_STEM_CELL_DN,c2.CGP_ chemical and genetic perturbations
14827,KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION,c2.CGP_ chemical and genetic perturbations
14828,GO_NEGATIVE_REGULATION_OF_TISSUE_REMODELING,c5.BP_ GO biological process
14829,GO_NEGATIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,c5.BP_ GO biological process
14830,GO_PHOSPHATIDYLINOSITOL_ACYL_CHAIN_REMODELING,c5.BP_ GO biological process
14831,REACTOME_INTRINSIC_PATHWAY,c2.CP_REACTOME_ Reactome gene sets
14832,GO_CATION_AMINO_ACID_SYMPORTER_ACTIVITY,c5.GO molecular function
14833,GO_ARGININE_METABOLIC_PROCESS,c5.BP_ GO biological process
14834,GO_MUSCLE_MYOSIN_COMPLEX,c5.CC_ GO cellular component
14835,REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS,c2.CP_REACTOME_ Reactome gene sets
14836,KEGG_ASTHMA,c2.CP_BIOCARTA_ BioCarta gene sets
14837,KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS,c2.CP_BIOCARTA_ BioCarta gene sets
14838,NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON,c2.CGP_ chemical and genetic perturbations
14839,GO_VENTRAL_SPINAL_CORD_INTERNEURON_DIFFERENTIATION,c5.BP_ GO biological process
14840,GO_REGULATION_OF_EXIT_FROM_MITOSIS,c5.BP_ GO biological process
14841,GO_RESPONSE_TO_FOLIC_ACID,c5.BP_ GO biological process
14842,GO_MODIFIED_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
14843,GO_DENTATE_GYRUS_DEVELOPMENT,c5.BP_ GO biological process
14844,REACTOME_ACYL_CHAIN_REMODELLING_OF_PI,c2.CP_REACTOME_ Reactome gene sets
14845,GO_LIPASE_INHIBITOR_ACTIVITY,c5.GO molecular function
14846,GO_PHOSPHATIDYLCHOLINE_BINDING,c5.GO molecular function
14847,GO_FATTY_ACID_LIGASE_ACTIVITY,c5.GO molecular function
14848,GO_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL,c5.BP_ GO biological process
14849,GO_PYRIMIDINE_NUCLEOSIDE_CATABOLIC_PROCESS,c5.BP_ GO biological process
14850,GO_NEGATIVE_REGULATION_OF_GLUCOSE_TRANSPORT,c5.BP_ GO biological process
14851,ABE_VEGFA_TARGETS,c2.CGP_ chemical and genetic perturbations
14852,GO_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.BP_ GO biological process
14853,GO_POSITIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,c5.BP_ GO biological process
14854,GO_PHOSPHATIDYLSERINE_ACYL_CHAIN_REMODELING,c5.BP_ GO biological process
14855,GO_PEPTIDE_ANTIGEN_BINDING,c5.GO molecular function
14856,KANG_FLUOROURACIL_RESISTANCE_DN,c2.CGP_ chemical and genetic perturbations
14857,GO_G_PROTEIN_COUPLED_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
14858,GO_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,c5.BP_ GO biological process
14859,BIOCARTA_GATA3_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14860,MURAKAMI_UV_RESPONSE_6HR_DN,c2.CGP_ chemical and genetic perturbations
14861,OZANNE_AP1_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
14862,GO_ACETYLCHOLINE_BINDING,c5.GO molecular function
14863,LE_SKI_TARGETS_UP,c2.CGP_ chemical and genetic perturbations
14864,MURAKAMI_UV_RESPONSE_1HR_UP,c2.CGP_ chemical and genetic perturbations
14865,GO_MORPHOGENESIS_OF_AN_ENDOTHELIUM,c5.BP_ GO biological process
14866,GO_NOSE_DEVELOPMENT,c5.BP_ GO biological process
14867,GO_POSITIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION,c5.BP_ GO biological process
14868,GO_POSITIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,c5.BP_ GO biological process
14869,GO_NEGATIVE_REGULATION_OF_LIPASE_ACTIVITY,c5.BP_ GO biological process
14870,GO_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_BINDING,c5.GO molecular function
14871,GO_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,c5.BP_ GO biological process
14872,GO_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,c5.BP_ GO biological process
14873,GO_NEUROTRANSMITTER_SODIUM_SYMPORTER_ACTIVITY,c5.GO molecular function
14874,REACTOME_ACYL_CHAIN_REMODELLING_OF_PS,c2.CP_REACTOME_ Reactome gene sets
14875,ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE,c2.CGP_ chemical and genetic perturbations
14876,GO_VOLTAGE_GATED_ANION_CHANNEL_ACTIVITY,c5.GO molecular function
14877,GO_GABAERGIC_NEURON_DIFFERENTIATION,c5.BP_ GO biological process
14878,GO_EPITHELIAL_CELL_FATE_COMMITMENT,c5.BP_ GO biological process
14879,REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN,c2.CP_REACTOME_ Reactome gene sets
14880,GO_REGULATION_OF_COLLATERAL_SPROUTING,c5.BP_ GO biological process
14881,NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON,c2.CGP_ chemical and genetic perturbations
14882,MODULE_215,c4.CM_ cancer modules
14883,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS,c2.CP_REACTOME_ Reactome gene sets
14884,GO_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS,c5.BP_ GO biological process
14885,GO_GLUTATHIONE_PEROXIDASE_ACTIVITY,c5.GO molecular function
14886,GO_PHAGOCYTOSIS_RECOGNITION,c5.BP_ GO biological process
14887,GO_POST_ANAL_TAIL_MORPHOGENESIS,c5.BP_ GO biological process
14888,GO_PHOSPHATIDYLGLYCEROL_ACYL_CHAIN_REMODELING,c5.BP_ GO biological process
14889,GO_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY,c5.GO molecular function
14890,GO_SIGNAL_TRANSDUCTION_INVOLVED_IN_REGULATION_OF_GENE_EXPRESSION,c5.BP_ GO biological process
14891,GO_SERTOLI_CELL_DEVELOPMENT,c5.BP_ GO biological process
14892,CHR5Q15,15
14893,GO_ACTIVATION_OF_PROTEIN_KINASE_A_ACTIVITY,c5.BP_ GO biological process
14894,GO_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,c5.BP_ GO biological process
14895,PID_LPA4_PATHWAY,c2.CP_ Canonical pathways
14896,GO_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,c5.BP_ GO biological process
14897,GO_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY,c5.GO molecular function
14898,GO_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT,c5.BP_ GO biological process
14899,MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH,c2.CGP_ chemical and genetic perturbations
14900,MODULE_116,c4.CM_ cancer modules
14901,REACTOME_ACYL_CHAIN_REMODELLING_OF_PG,c2.CP_REACTOME_ Reactome gene sets
14902,BIOCARTA_TALL1_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14903,BIOCARTA_IL22BP_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14904,KEGG_RENIN_ANGIOTENSIN_SYSTEM,c2.CP_BIOCARTA_ BioCarta gene sets
14905,GO_CATECHOLAMINE_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
14906,GO_RECEPTOR_AGONIST_ACTIVITY,c5.GO molecular function
14907,GO_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,c5.GO molecular function
14908,GO_ACID_THIOL_LIGASE_ACTIVITY,c5.GO molecular function
14909,TGCACGA_MIR517A_MIR517C,c3.MIR_ microRNA targets
14910,GO_INTRINSIC_COMPONENT_OF_THE_CYTOPLASMIC_SIDE_OF_THE_PLASMA_MEMBRANE,c5.CC_ GO cellular component
14911,GO_CELLULAR_RESPONSE_TO_LEPTIN_STIMULUS,c5.BP_ GO biological process
14912,GO_PHOSPHATIDYLINOSITOL_PHOSPHATE_KINASE_ACTIVITY,c5.GO molecular function
14913,GO_CHLORIDE_CHANNEL_REGULATOR_ACTIVITY,c5.GO molecular function
14914,BIOCARTA_LONGEVITY_PATHWAY,c2.CP_BIOCARTA_ BioCarta gene sets
14915,CHR18Q23,15
14916,MURAKAMI_UV_RESPONSE_24HR,c2.CGP_ chemical and genetic perturbations
14917,LOPEZ_EPITHELIOID_MESOTHELIOMA,c2.CGP_ chemical and genetic perturbations
14918,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL,c2.CGP_ chemical and genetic perturbations
14919,GO_SPERM_CAPACITATION,c5.BP_ GO biological process
14920,GO_PROTEIN_LOCALIZATION_TO_SYNAPSE,c5.BP_ GO biological process
14921,GO_GABA_RECEPTOR_COMPLEX,c5.CC_ GO cellular component
14922,GO_AMINO_ACID_IMPORT,c5.BP_ GO biological process
14923,GO_NEGATIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,c5.BP_ GO biological process
14924,ST_G_ALPHA_S_PATHWAY,c2.CP_ Canonical pathways
14925,GO_OTIC_VESICLE_DEVELOPMENT,c5.BP_ GO biological process
14926,GO_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,c5.BP_ GO biological process
14927,GO_RESPONSE_TO_SALT,c5.BP_ GO biological process
14928,GO_SPERMATID_NUCLEUS_DIFFERENTIATION,c5.BP_ GO biological process
14929,GO_CARDIAC_MYOFIBRIL_ASSEMBLY,c5.BP_ GO biological process
14930,WANG_RECURRENT_LIVER_CANCER_DN,c2.CGP_ chemical and genetic perturbations
14931,GO_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS,c5.BP_ GO biological process
14932,GO_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT5_PROTEIN,c5.BP_ GO biological process
14933,GO_GTP_DEPENDENT_PROTEIN_BINDING,c5.GO molecular function
14934,GO_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE,c5.BP_ GO biological process
14935,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,c2.CGP_ chemical and genetic perturbations
14936,GO_NEUROPEPTIDE_BINDING,c5.GO molecular function
14937,GO_NEGATIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,c5.BP_ GO biological process
14938,GO_SOLUTE_PROTON_ANTIPORTER_ACTIVITY,c5.GO molecular function
14939,GO_PARAXIAL_MESODERM_DEVELOPMENT,c5.BP_ GO biological process
14940,KEGG_PHENYLALANINE_METABOLISM,c2.CP_BIOCARTA_ BioCarta gene sets
14941,GO_GRANULOCYTE_DIFFERENTIATION,c5.BP_ GO biological process
14942,HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,c2.CGP_ chemical and genetic perturbations
14943,CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL,c2.CGP_ chemical and genetic perturbations
14944,HUMMERICH_BENIGN_SKIN_TUMOR_DN,c2.CGP_ chemical and genetic perturbations
14945,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD,c2.CGP_ chemical and genetic perturbations
14946,REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT,c2.CP_REACTOME_ Reactome gene sets
14947,GO_CHEMOKINE_BINDING,c5.GO molecular function
14948,GO_T_CELL_LINEAGE_COMMITMENT,c5.BP_ GO biological process
14949,GO_APOPTOTIC_DNA_FRAGMENTATION,c5.BP_ GO biological process
14950,GO_REGULATION_OF_MESODERM_DEVELOPMENT,c5.BP_ GO biological process
14951,GO_MESENCHYMAL_TO_EPITHELIAL_TRANSITION,c5.BP_ GO biological process
14952,GO_POSITIVE_REGULATION_OF_DNA_RECOMBINATION,c5.BP_ GO biological process
14953,GO_HEPARAN_SULFATE_PROTEOGLYCAN_BINDING,c5.GO molecular function
14954,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP,c2.CGP_ chemical and genetic perturbations
14955,GO_MRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER,c5.BP_ GO biological process
14956,GO_REGULATION_OF_TUMOR_NECROSIS_FACTOR_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
14957,GO_RESPONSE_TO_VITAMIN_E,c5.BP_ GO biological process
14958,GO_CARDIAC_RIGHT_VENTRICLE_MORPHOGENESIS,c5.BP_ GO biological process
14959,GO_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING,c5.BP_ GO biological process
14960,MODULE_68,c4.CM_ cancer modules
14961,GO_POSITIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,c5.BP_ GO biological process
14962,GO_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,c5.BP_ GO biological process
14963,REACTOME_GAP_JUNCTION_ASSEMBLY,c2.CP_REACTOME_ Reactome gene sets
14964,MIKKELSEN_MCV6_LCP_WITH_H3K27ME3,c2.CGP_ chemical and genetic perturbations
14965,GO_STRUCTURAL_CONSTITUENT_OF_EYE_LENS,c5.GO molecular function
14966,GO_JAK_STAT_CASCADE_INVOLVED_IN_GROWTH_HORMONE_SIGNALING_PATHWAY,c5.BP_ GO biological process
14967,GO_PROTEIN_HYDROXYLATION,c5.BP_ GO biological process
14968,GO_REGULATION_OF_RESPONSE_TO_FOOD,c5.BP_ GO biological process
14969,REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN,c2.CP_REACTOME_ Reactome gene sets
14970,GO_CELLULAR_SODIUM_ION_HOMEOSTASIS,c5.BP_ GO biological process
14971,GO_REGULATION_OF_ACROSOME_REACTION,c5.BP_ GO biological process
14972,GO_RESPONSE_TO_ACIDIC_PH,c5.BP_ GO biological process
14973,GO_DNA_BINDING_BENDING,c5.GO molecular function
14974,GO_REVERSE_CHOLESTEROL_TRANSPORT,c5.BP_ GO biological process
14975,GO_EXODEOXYRIBONUCLEASE_ACTIVITY,c5.GO molecular function
14976,GO_STEROL_TRANSPORTER_ACTIVITY,c5.GO molecular function
14977,GO_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,c5.BP_ GO biological process
14978,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP,c2.CGP_ chemical and genetic perturbations
14979,GO_NEGATIVE_REGULATION_OF_BEHAVIOR,c5.BP_ GO biological process
14980,MODULE_298,c4.CM_ cancer modules
14981,GO_REGULATION_OF_APPETITE,c5.BP_ GO biological process
14982,GO_REGULATION_OF_INTERLEUKIN_6_BIOSYNTHETIC_PROCESS,c5.BP_ GO biological process
14983,GO_NEGATIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,c5.BP_ GO biological process
14984,GO_PHASIC_SMOOTH_MUSCLE_CONTRACTION,c5.BP_ GO biological process
14985,GO_CYTOPLASMIC_DYNEIN_COMPLEX,c5.CC_ GO cellular component
14986,VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,c2.CGP_ chemical and genetic perturbations
14987,GO_POTASSIUM_ION_HOMEOSTASIS,c5.BP_ GO biological process
14988,GO_MANNOSE_BINDING,c5.GO molecular function
14989,GO_GLUCOSYLTRANSFERASE_ACTIVITY,c5.GO molecular function
14990,MODULE_539,c4.CM_ cancer modules
14991,NIELSEN_LEIOMYOSARCOMA_UP,c2.CGP_ chemical and genetic perturbations
14992,GO_NEPHRIC_DUCT_DEVELOPMENT,c5.BP_ GO biological process
14993,GO_RRNA_METHYLATION,c5.BP_ GO biological process
14994,REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1,c2.CP_REACTOME_ Reactome gene sets
14995,GO_ENDOLYSOSOME,c5.CC_ GO cellular component
